Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ALPI		ENSG00000163295	"Alkaline phosphatase, intestinal"	P09923	2	232456123-232460032	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	406	"intestine: 133.2"	"Cell line enriched"	"Detected in some"	12	"CACO-2: 12.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA038764, HPA038765, HPA051699"	Supported		Approved	"Plasma membrane"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"HPA038764: AB_2676194, HPA038765: AB_2676195, HPA051699: AB_2681577"			"unprognostic (1.01e-1)"	"unprognostic (7.71e-2)"			"unprognostic (4.14e-2)"			"unprognostic (1.47e-1)"	"unprognostic (9.57e-4)"		"unprognostic (8.07e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.99e-2)"			0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	63.0	0.0	0.0	57.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	1.3	0.0	0.1	0.0	0.1	0.1	133.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
C17orf78	FLJ39647	ENSG00000278505	"Chromosome 17 open reading frame 78"	Q8N4C9	17	37375986-37392708	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	401	"intestine: 83.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.5;NB-4: 1.6;RPMI-8226: 1.4"	"Group enriched"	"Detected in some"	8	"colorectal cancer: 0.8;stomach cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.73e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-6)"	"unprognostic (1.94e-2)"	"unprognostic (7.23e-3)"	"unprognostic (4.85e-2)"	"unprognostic (3.19e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	44.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.0	1.6	0.2	0.3	0.2	0.1	1.4	0.1	0.0	0.9	0.7	0.2	0.0	0.2	0.3	0.0	0.3	0.1	0.1	0.8	0.2	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC17		ENSG00000169876	"Mucin 17, cell surface associated"	Q685J3	7	101020072-101058745	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	299	"intestine: 125.2"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.3"	"Group enriched"	"Detected in some"	29	"colorectal cancer: 6.1;pancreatic cancer: 4.9;stomach cancer: 22.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA031634	Enhanced				"Intracellular and membrane"					"HPA031634: AB_10603021"			"unprognostic (2.37e-2)"	"unprognostic (2.41e-1)"		"unprognostic (8.17e-3)"					"unprognostic (5.57e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.79e-8)"	"unprognostic (1.28e-1)"	"unprognostic (2.47e-2)"			0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	64.7	0.0	0.0	15.8	0.0	0.0	0.1	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.5	0.0	0.1	0.0	0.1	0.1	125.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	8	"BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"			Vesicles	Vesicles	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favourable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	1.7	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	198	"intestine: 333.2"	"Cell line enriched"	"Detected in some"	7	"CACO-2: 40.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 8.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 4.6"	"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		96000	96000	"Golgi apparatus"	"Golgi apparatus"	"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.2	130.1	0.0	0.0	221.8	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	1.6	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	333.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	40.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	2.1	5.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
DEFA6	"DEF6, HD-6"	ENSG00000164822	"Defensin alpha 6"	Q01524	8	6924693-6926076	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	189	"intestine: 316.3"	"Group enriched"	"Detected in some"	12	"BEWO: 12.5;NB-4: 13.1;RPMI-8226: 15.4;SH-SY5Y: 10.6;U-2197: 4.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 75.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"									HPA019462	Enhanced				"Secreted to digestive system"					"HPA019462: AB_1847595"			"unprognostic (7.48e-3)"											"unprognostic (1.63e-1)"	"unprognostic (1.34e-1)"			0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	262.3	0.0	0.0	181.7	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	316.3	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.9	10.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804011	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	175	"intestine: 76.0"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.6;BEWO: 1.8;CACO-2: 7.4;RPMI-8226: 1.7;TIME: 3.4"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA069392	Enhanced				"Secreted to blood"					"HPA069392: AB_2686136"					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	58.4	0.0	0.0	76.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	30.6	0.0	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	1.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	167	"intestine: 241.5"	"Cell line enhanced"	"Detected in some"		"SCLC-21H: 10.3"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 3.0;stomach cancer: 0.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029119	Enhanced				"Secreted to digestive system"	120000	120000			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.3	0.1	0.1	78.8	0.0	0.0	54.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	241.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	0.4	0.3	0.3	0.0	1.4	0.5	0.2	0.0	0.0	0.5	0.6	0.0	2.0	1.0	0.3	0.2	0.1	0.5	1.4	1.7	0.5	0.0	0.2	0.0	0.0	0.0	0.7	0.9	1.1	0.7	0.6	0.4	1.3	0.3	0.0	0.7	0.0	0.1	0.4	1.1	0.2	0.0	1.9	1.3	4.0	1.3	0.0	1.8	1.7	2.9	0.0	0.7	10.3	2.3	0.8	0.2	0.3	0.4	3.0	0.9	1.3	0.8	3.4	0.0	0.5	2.2	0.5	2.6	0.0	0.5	0.0	0.3	0.3	1.0	0.1	1.3	1.1	0.7	1.4	0.4	0.1	1.2	0.3	0.2	0.0	0.1	0.2	0.5	0.5	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	0.0
APOB		ENSG00000084674	"Apolipoprotein B"	P04114	2	21001429-21044073	"Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	145	"intestine: 224.8;liver: 442.2"	"Cell line enriched"	"Detected in some"	30	"Hep G2: 151.8"	"Cancer enriched"	"Detected in some"	99	"liver cancer: 295.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016070, HPA049793"	Supported		Supported	Vesicles,Cytosol	"Secreted to blood"	89000000000	89000000000	"Vesicles, Cytosol"	"Vesicles, Cytosol"	"CAB016070: AB_626690, HPA049793: AB_2680885"	"unprognostic (1.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.46e-2)"	"unprognostic (6.53e-3)"	"unprognostic (4.43e-2)"	"unprognostic (8.89e-3)"	"unprognostic (3.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (3.60e-3)"	"unprognostic (2.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.23e-2)"	0.3	0.1	0.1	0.0	0.1	0.0	2.3	0.1	0.1	0.1	68.9	0.0	0.0	24.9	0.1	0.0	0.1	0.1	0.0	1.2	0.1	0.1	0.1	442.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	224.8	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.4	0.3	0.9	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	151.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.4	0.2	0.1	0.9	0.3	0.0	0.3	0.3	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
LCT		ENSG00000115850	Lactase	P09848	2	135787840-135837180	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	133	"intestine: 255.5"	"Group enriched"	"Detected in some"	5	"MOLT-4: 6.8;RPMI-8226: 13.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	19	"dendritic cells: 1.9"	"Region enriched"	"Detected in single"	16	"hippocampal formation: 17.3"																"unprognostic (2.21e-2)"	"unprognostic (1.65e-4)"	"unprognostic (2.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.39e-2)"	"unprognostic (8.03e-4)"	"unprognostic (3.55e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.64e-4)"	"unprognostic (4.90e-2)"	"unprognostic (8.92e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.02e-1)"	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.1	0.1	209.8	0.0	0.0	67.7	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	255.5	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.8	1.1	0.0	0.0	1.6	0.0	13.6	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.1	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.0
SI		ENSG00000090402	Sucrase-isomaltase	P14410	3	164978898-165078495	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	123	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 4.0;HeLa: 3.1;NB-4: 3.3;RPMI-8226: 4.8;SH-SY5Y: 2.9"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011897	Enhanced									"HPA011897: AB_1856840"			"unprognostic (2.71e-2)"								"unprognostic (1.62e-2)"	"unprognostic (2.68e-1)"		"unprognostic (2.05e-1)"	"unprognostic (4.41e-2)"			0.1	0.1	0.1	1.4	0.1	0.0	0.1	0.1	0.1	0.1	93.3	0.0	0.0	94.1	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.4	0.0	0.1	0.0	0.1	0.1	181.4	0.0	0.1	0.1	0.1	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CREB3L3	CREB-H	ENSG00000060566	"CAMP responsive element binding protein 3 like 3"	Q68CJ9	19	4153601-4173054	"Predicted intracellular proteins, Predicted membrane proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	95	"intestine: 117.4;liver: 179.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 30.8;Hep G2: 9.7;HMC-1: 5.6;U-266/70: 6.7"	"Cancer enriched"	"Detected in many"	18	"liver cancer: 91.4"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.0;T-reg: 1.5"	"Group enriched"	"Detected in many"	13	"granulocytes: 1.0;T-cells: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA040671, HPA056228"	Enhanced									"HPA040671: AB_2677072, HPA056228: AB_2683072"	"unprognostic (1.86e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.41e-4)"	"unprognostic (1.79e-4)"	"unprognostic (1.88e-1)"	"unprognostic (5.28e-4)"	"unprognostic (3.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (3.53e-6)"	"unprognostic (3.18e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.35e-2)"	0.1	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	38.6	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.5	179.5	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.4	0.0	0.1	0.1	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	9.7	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	2.5	0.3	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	6.7	2.8	0.0	0.0	2.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362156-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	86	"intestine: 147.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.1;RPMI-8226: 4.4"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	46.5	0.0	0.0	73.5	0.1	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.1	0.1	147.8	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.1	1.2	1.1	0.5	1.7	0.7	0.0	0.1	7.1	0.2	0.1	0.0	0.0	1.3	0.8	0.1	0.0	0.0	1.3	0.5	0.2	0.1	0.4	0.2	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.2	0.0	0.5	0.3	0.0	0.1	0.0	0.0	0.0	0.4	0.8	0.3	0.0	0.1	1.6	0.3	0.1	0.4	0.1	4.4	0.1	0.3	0.6	1.7	1.0	0.1	0.0	0.3	0.1	0.3	0.6	0.3	1.9	0.2	0.5	0.3	0.4	0.2	0.2	0.2	0.8	0.5	0.1	0.7	0.3	0.3	0.7	0.4	0.4	0.0	1.1	0.7	0.5	1.1	1.7	0.1	1.2	0.4	0.0	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	85	"intestine: 54.3;liver: 40.9"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favourable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	19.5	0.0	0.0	27.6	0.1	0.2	0.1	0.1	0.5	0.1	0.1	0.1	0.1	40.9	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	54.3	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
FABP6	"I-15P, I-BABP, I-BALB, I-BAP, ILBP, ILBP3, ILLBP"	ENSG00000170231	"Fatty acid binding protein 6"	P51161	5	160187367-160238735	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	68	"intestine: 299.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.2;EFO-21: 19.4;HDLM-2: 8.5;NB-4: 7.9;RPMI-8226: 9.3;RT4: 8.9;U-2197: 8.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 1.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA012601, CAB024713"	Enhanced				"Intracellular and membrane"	650000	650000			"CAB024713: , HPA012601: AB_1848435"	"unprognostic (3.03e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-3)"	"unprognostic (1.48e-2)"	"unprognostic (3.53e-1)"	"unprognostic (5.35e-7)"	"unprognostic (3.05e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.56e-1)"	"prognostic unfavourable (4.35e-9)"	"unprognostic (2.10e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.85e-3)"	0.1	0.9	0.2	0.1	0.4	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.1	0.2	0.3	0.1	0.1	4.3	0.1	0.1	0.4	0.5	0.1	0.1	1.3	0.1	0.4	0.1	0.5	0.1	0.0	0.2	0.1	1.0	0.1	0.0	0.1	0.4	0.1	0.1	0.0	299.2	0.1	0.2	0.1	0.0	0.1	0.2	1.2	0.1	0.5	0.2	0.2	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	6.3	0.0	0.0	0.0	0.0	3.4	0.6	20.2	19.4	0.0	0.0	0.0	0.0	0.0	8.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.8	0.2	0.0	0.0	0.0	7.9	0.0	1.8	0.0	0.6	9.3	0.0	8.9	1.7	0.4	0.0	5.1	0.1	0.0	0.1	0.0	0.0	0.0	8.4	1.0	1.1	4.4	2.2	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.1	0.4	0.5	0.4	0.1	1.0	0.2
TMPRSS15	"ENTK, MGC133046, PRSS7"	ENSG00000154646	"Transmembrane serine protease 15"	P98073	21	18269116-18485879	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	67	"intestine: 154.6"	"Group enriched"	"Detected in some"	20	"U-138 MG: 19.8;U-87 MG: 55.3"	"Group enriched"	"Detected in some"	12	"liver cancer: 0.7;pancreatic cancer: 1.5;stomach cancer: 1.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"olfactory region: 9.3"	"HPA015611, HPA034857, HPA072934"	Enhanced		Approved	"Nucleoli,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA015611: AB_1855791, HPA034857: , HPA072934: AB_2732214"					"unprognostic (9.26e-2)"	"unprognostic (4.14e-1)"		"unprognostic (3.52e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.70e-2)"		"unprognostic (6.35e-2)"	"unprognostic (5.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	80.5	0.0	0.0	154.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	42.4	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.5	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.8	0.0	0.1	0.0	0.3	0.0	0.0	55.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0
GIP		ENSG00000159224	"Gastric inhibitory polypeptide"	P09681	17	48958554-48968596	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	64	"intestine: 87.5"	"Group enriched"	"Detected in some"	4	"A549: 8.6;BEWO: 7.8;Hep G2: 12.3"	"Cancer enriched"	"Detected in some"	63	"testis cancer: 74.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB016729, HPA021612"	Enhanced				"Secreted to blood"					"CAB016729: , HPA021612: AB_1849506"										"unprognostic (2.95e-1)"	"unprognostic (2.70e-3)"			"unprognostic (4.42e-2)"	"unprognostic (1.82e-1)"			0.2	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	87.5	0.0	0.0	75.4	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	61.7	0.0	0.1	0.1	0.2	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.4	0.7	7.8	0.3	0.0	0.1	0.0	2.2	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.5	12.3	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CEACAM18		ENSG00000213822	"Carcinoembryonic antigen related cell adhesion molecule 18"	A8MTB9	19	51478622-51490952	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	62	"intestine: 31.3"	"Group enriched"	"Detected in some"	13	"CACO-2: 9.4;RT4: 3.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.8;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA059487	Uncertain		Approved	Midbody				Midbody	Midbody	"HPA059487: AB_2684036"			"unprognostic (1.12e-1)"								"unprognostic (1.87e-2)"			"unprognostic (1.00e-1)"				0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	16.6	0.0	0.0	14.6	0.1	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	31.3	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	62	"intestine: 354.2;pancreas: 502.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 12.2;EFO-21: 11.5;HDLM-2: 10.6;NB-4: 11.9;RPMI-8226: 15.3;SH-SY5Y: 10.0;U-2 OS: 19.0;U-266/84: 10.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	22000000	22000000	Cytosol	Cytosol	"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				0.2	0.4	0.2	0.4	0.2	0.0	0.2	0.2	0.2	0.2	73.1	0.2	0.2	276.3	0.2	0.2	0.2	0.0	1.1	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	502.4	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	354.2	0.2	0.2	0.2	6.9	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	0.1	0.0	0.0	0.0	15.3	0.0	0.0	1.2	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	3.7	7.1	0.0	10.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793390-46839782	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	52	"intestine: 243.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 6.9;Hep G2: 1.8;NB-4: 3.0;RPMI-8226: 3.4;SH-SY5Y: 2.1;U-2197: 2.0"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.6"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025163, HPA029416"	Enhanced					990000	990000			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.1	0.1	0.1	4.7	0.1	0.0	0.1	0.1	0.1	0.1	100.5	0.1	0.1	51.7	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.0	0.1	0.1	0.1	0.1	19.8	0.1	0.2	0.1	0.1	0.1	243.0	0.2	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.1
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665903	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	51	"intestine: 56.1"	"Cell line enriched"	"Detected in single"	20	"CAPAN-2: 7.7"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 6.2;pancreatic cancer: 6.1;stomach cancer: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"																"unprognostic (2.35e-1)"					"unprognostic (3.80e-4)"			"unprognostic (7.96e-3)"			"unprognostic (1.79e-1)"	"unprognostic (4.38e-1)"			0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	56.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MTTP	"ABL, MTP"	ENSG00000138823	"Microsomal triglyceride transfer protein"	P55157	4	99563761-99623999	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"intestine: 211.4;liver: 60.8"	"Group enriched"	"Detected in some"	6	"AF22: 12.5;Hep G2: 13.7"	"Cancer enriched"	"Detected in many"	13	"liver cancer: 28.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"B-cells: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA051170, HPA054862"	Uncertain		Approved	Cytosol	"Intracellular and membrane"	450000	450000	Cytosol	Cytosol	"HPA051170: , HPA054862: AB_2682628"	"unprognostic (1.66e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.64e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.49e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.27e-3)"	"unprognostic (2.02e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.31e-1)"	0.1	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.2	0.0	53.2	0.2	0.1	53.4	0.0	0.0	0.2	0.2	0.4	0.4	0.3	0.4	2.7	60.8	0.1	0.0	0.4	0.1	1.1	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	211.4	0.7	0.4	0.1	0.2	1.8	0.2	0.1	0.1	0.1	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	12.5	0.0	0.0	0.1	1.1	0.1	0.0	0.0	0.3	0.5	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.3	0.1	13.7	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.6	0.3	0.3	0.2	1.2	0.0	0.0	0.8	0.9	0.2	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.3	0.4	0.4	0.1	0.3	0.2
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591817	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	48	"intestine: 98.4;salivary gland: 189.6;stomach 1: 54.2;tongue: 122.6"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.7;WM-115: 4.8"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	41000	41000			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.4	0.0	98.4	0.1	0.0	2.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	2.3	0.0	0.1	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	189.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	54.2	0.2	0.0	0.0	0.1	122.6	1.7	0.1	0.1	1.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.3	0.1	0.3	0.3	0.2	0.0	1.0	0.3	0.4	0.5	0.1	0.0	0.0	0.8	0.9	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.1	0.5	0.2	0.4	1.0	0.3	0.2	0.3	0.0	6.7	0.7	0.1	0.2	1.0	0.3	0.0	0.0	0.0	0.1	0.3	1.5	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
FABP2	I-FABP	ENSG00000145384	"Fatty acid binding protein 2"	P12104	4	119317250-119322390	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"intestine: 358.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;Hep G2: 2.4;NB-4: 3.8;RPMI-8226: 3.2;SH-SY5Y: 2.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 3.2;pancreatic cancer: 1.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 2.1;neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 7.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034607, CAB047325, CAB047326"	Enhanced		Approved	"Plasma membrane,Actin filaments,Cytosol"		46000	46000	"Actin filaments, Cytosol"	"Actin filaments, Cytosol"	"CAB047325: , CAB047326: , HPA034607: AB_10601317"		"unprognostic (3.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.05e-1)"				"unprognostic (4.58e-1)"		"unprognostic (1.51e-2)"	"unprognostic (2.61e-2)"		"unprognostic (1.69e-4)"	"unprognostic (1.93e-1)"	"unprognostic (1.02e-1)"			0.1	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	47.0	0.0	0.0	50.0	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	5.9	0.1	0.1	0.0	0.1	0.1	358.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.5	0.5	7.6	0.7	0.9	0.5	0.0	0.2	0.3	0.2	0.4	0.0	0.0	2.8	0.4	0.0	0.0	0.0	0.4	0.3	0.4	0.1	0.0	0.3	0.0	0.2	0.1	0.1	0.3	0.1	0.4	2.4	0.0	0.5	0.4	0.2	0.0	0.2	0.1	0.0	0.2	0.5	0.0	0.1	0.4	3.8	0.2	0.5	0.3	0.2	3.2	0.0	0.5	1.0	2.6	0.1	0.4	0.0	0.3	0.1	0.9	0.4	0.4	1.4	0.1	0.7	0.2	0.6	0.3	0.2	0.1	2.1	0.7	0.7	0.4	0.3	0.4	0.2	0.4	0.3	0.2	0.5	0.5	0.5	7.6	0.9	0.2	0.5	0.5	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
CYP3A4	CYP3A3	ENSG00000160868	"Cytochrome P450 family 3 subfamily A member 4"	P08684	7	99756960-99784265	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	45	"intestine: 145.3;liver: 464.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.1;NB-4: 4.4;RPMI-8226: 6.6;SCLC-21H: 2.5;SH-SY5Y: 4.9"	"Cancer enriched"	"Detected in some"	240	"liver cancer: 351.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB033671, HPA072245"	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"CAB033671: AB_782375, HPA072245: "	"unprognostic (4.55e-2)"	"unprognostic (8.95e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.37e-2)"	"unprognostic (7.07e-3)"	"unprognostic (9.09e-2)"	"unprognostic (8.27e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.78e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.89e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-2)"	"unprognostic (9.79e-2)"	"unprognostic (6.82e-2)"	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	145.3	0.1	0.1	56.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.2	464.6	0.1	0.1	0.1	0.1	0.1	6.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.2	126.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.2	0.6	0.2	0.6	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.2	0.0	1.9	0.4	0.0	1.2	0.0	0.4	0.0	0.5	0.0	0.5	0.0	0.1	4.4	0.3	0.0	0.0	2.1	6.6	0.0	0.4	2.5	4.9	0.4	0.0	0.0	0.1	0.0	0.8	0.0	0.0	1.3	0.0	0.7	0.0	0.7	0.1	0.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.6	0.0	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
S100G	"CABP1, CABP9K, CALB3"	ENSG00000169906	"S100 calcium binding protein G"	P29377	X	16650158-16654670	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	44	"intestine: 74.2"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;PC-3: 2.2;RPMI-8226: 6.8;SH-SY5Y: 1.2"	"Group enriched"	"Detected in some"	5	"breast cancer: 4.7;renal cancer: 0.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.5"	"Region enriched"	"Detected in single"	5	"pons and medulla: 1.2"	"Low region specificity"	"Detected in all"			"CAB017688, HPA055873"	Enhanced									"CAB017688: AB_1119899, HPA055873: AB_2682952"	"unprognostic (2.68e-2)"									"unprognostic (2.78e-1)"				"unprognostic (9.88e-3)"				0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.2	18.0	0.0	0.0	74.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	6.8	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MS4A12	"FLJ20217, Ms4a10"	ENSG00000071203	"Membrane spanning 4-domains A12"	Q9NXJ0	11	60492778-60507430	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	41	"intestine: 64.7;lymphoid tissue: 28.6"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.5;LHCN-M2: 2.1;NTERA-2: 3.0;RH-30: 4.2;U-2 OS: 1.7"	"Cancer enriched"	"Detected in some"	8	"colorectal cancer: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA048616, HPA057657"	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA048616: , HPA057657: AB_2683491"			"unprognostic (2.64e-2)"						"unprognostic (2.33e-1)"			"unprognostic (1.49e-1)"		"unprognostic (3.26e-1)"	"unprognostic (2.83e-1)"	"unprognostic (9.20e-3)"		0.1	0.0	0.1	28.6	0.1	0.0	0.1	0.1	0.1	0.1	57.7	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	64.7	0.1	0.1	0.1	0.1	0.0	0.2	1.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	3.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GUCA2A	"GUCA2, STARA"	ENSG00000197273	"Guanylate cyclase activator 2A"	Q02747	1	42162691-42164718	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"intestine: 265.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.5;CACO-2: 11.3;NB-4: 3.7;U-2197: 3.2"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 31.6;urothelial cancer: 8.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"amygdala: 0.2"	HPA018215	Enhanced				"Secreted to blood"	26000000	26000000			"HPA018215: AB_1850443"			"unprognostic (7.98e-3)"		"unprognostic (1.60e-1)"		"unprognostic (1.16e-1)"	"unprognostic (9.07e-2)"			"unprognostic (1.14e-1)"			"unprognostic (8.06e-2)"	"unprognostic (2.89e-1)"	"unprognostic (3.10e-1)"	"unprognostic (9.15e-2)"	0.2	0.1	0.2	8.0	0.2	0.0	0.2	0.2	0.2	0.2	87.3	0.2	0.2	6.6	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.7	0.0	0.2	3.5	0.2	0.2	91.9	0.2	0.2	0.2	0.2	0.1	265.7	2.1	0.2	0.2	0.1	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	11.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785348-60801305	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	33	"intestine: 115.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.3;NB-4: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			HPA014778	Uncertain									"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	28.3	0.0	0.0	33.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	115.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	3.5	0.5	0.9	0.5	0.1	0.3	0.9	0.4	0.2	0.2	0.0	2.3	0.2	0.1	0.1	0.0	0.8	0.2	0.4	0.3	0.1	0.7	0.2	0.3	0.2	0.0	0.3	2.1	0.7	0.3	0.1	0.5	1.8	0.0	0.0	0.5	0.3	0.0	0.5	1.4	0.7	0.3	0.5	2.4	0.0	0.3	0.2	0.0	1.7	0.1	0.4	1.0	0.9	0.4	0.6	0.0	0.4	0.2	1.4	0.7	0.2	1.4	0.3	0.2	0.2	0.4	0.4	0.7	0.2	3.5	0.4	0.7	0.5	0.3	0.4	0.5	0.3	0.3	0.2	0.8	0.5	0.5	1.4	0.9	0.5	0.7	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMIGD1	"TMIGD, UNQ9372"	ENSG00000182271	"Transmembrane and immunoglobulin domain containing 1"	Q6UXZ0	17	30316333-30334059	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	33	"intestine: 47.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;NB-4: 1.3;U-2197: 1.8;U-698: 1.9"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021946			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA021946: "			"unprognostic (1.28e-1)"										"unprognostic (1.30e-1)"	"unprognostic (1.61e-1)"				0.2	0.0	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2	26.8	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	1.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.9	0.2	0.2	0.2	0.2	0.0	47.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	1.9	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ADGRG7	"FLJ14454, GPR128"	ENSG00000144820	"Adhesion G protein-coupled receptor G7"	Q96K78	3	100609589-100695479	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	31	"intestine: 58.4;liver: 26.9"	"Group enriched"	"Detected in some"	6	"BEWO: 2.8;CACO-2: 4.7"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"															"unprognostic (1.65e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.79e-1)"	"unprognostic (8.46e-3)"	"unprognostic (1.26e-1)"	"unprognostic (6.71e-2)"			"unprognostic (9.37e-3)"		"unprognostic (2.84e-5)"	"unprognostic (1.17e-1)"	"unprognostic (2.16e-1)"		"unprognostic (6.77e-2)"	0.1	0.2	0.1	0.5	0.1	1.2	0.1	0.1	0.1	0.9	17.1	0.1	0.1	25.7	0.3	0.1	0.2	0.9	0.3	0.2	0.1	0.1	0.1	26.9	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.1	0.2	0.4	1.7	0.1	0.1	0.1	0.1	0.2	58.4	0.8	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.1	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
TMEM253	"C14orf176, C14orf95, NCRNA00220"	ENSG00000232070	"Transmembrane protein 253"	P0C7T8	14	21098937-21103724	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	31	"intestine: 110.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	7	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA052329, HPA065092"	Enhanced									"HPA052329: AB_2681791, HPA065092: AB_2685420"	"unprognostic (7.48e-3)"	"unprognostic (1.33e-2)"	"unprognostic (7.19e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.90e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.46e-2)"	"unprognostic (9.93e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.04e-1)"	0.4	1.5	0.4	2.2	0.4	0.0	0.3	0.5	0.5	0.5	32.6	0.4	2.0	41.8	0.4	0.8	0.9	0.2	3.1	0.9	0.3	0.4	0.4	0.5	0.4	0.2	0.5	0.4	0.4	0.7	0.4	0.3	0.5	0.4	0.5	5.7	0.4	2.8	0.7	0.3	0.6	110.5	0.6	0.3	0.4	0.2	0.4	0.2	0.2	3.6	0.8	0.7	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.4	0.9	2.7	2.6	4.0	1.0	4.4	1.0	2.0	0.5	0.9	2.3	2.1	3.2	0.6	0.2	4.2	0.9	5.0	0.6	1.9	0.2	1.6	3.0	2.7	0.6	0.0	0.1	1.9	4.3	2.1	3.4	0.3	1.1	0.2	1.3	0.9	0.1	0.3	3.5	0.1	0.7	1.3	1.8	2.3	2.0	0.7	1.4	1.1	0.8	2.4	0.8	0.0	0.0	0.0	1.5	0.5	0.3	0.8	0.4	0.0	0.2	1.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.2	0.0	0.0	0.4	0.4	0.5	0.5	0.3	0.4	0.5	0.4	0.4	0.2
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882987	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 62.4;liver: 64.4"	"Cell line enriched"	"Detected in single"	47	"Hep G2: 14.4"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019556	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.1	0.4	0.1	21.2	0.0	0.0	24.0	0.1	0.1	0.1	0.1	1.7	0.1	0.2	0.3	0.2	64.4	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	62.4	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.6	2.1	0.3	0.5	0.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.2	14.4	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	2.1	0.3	0.4	0.7	0.3	0.5	0.5	0.6	0.5	0.1	0.7	0.8	0.7	1.7	0.5	0.3	0.6	0.3	0.2	0.2	0.3	0.1	0.4	0.2	0.3	0.2	0.0	0.0	0.0
ALDOB		ENSG00000136872	"Aldolase, fructose-bisphosphate B"	P05062	9	101420578-101435823	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"intestine: 804.1;kidney: 253.1;liver: 598.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 14.1;NB-4: 13.2;RPMI-8226: 15.2;SH-SY5Y: 13.2"	"Cancer enriched"	"Detected in many"	31	"liver cancer: 1414.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA002198, CAB020827"	Enhanced					930000000	930000000			"CAB020827: , HPA002198: AB_1078129"	"unprognostic (6.58e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.03e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.44e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.79e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.96e-2)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.2	0.1	334.5	0.2	0.2	145.9	0.2	0.6	0.1	0.1	5.7	0.1	0.1	0.1	253.1	598.8	0.1	0.1	0.1	0.1	0.1	18.3	0.0	0.4	0.1	0.4	0.1	0.0	0.2	0.2	0.1	0.1	0.1	804.1	0.1	0.1	0.2	1.5	0.3	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.3	0.0	2.9	1.4	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	13.2	0.2	0.0	0.2	3.1	15.2	0.0	0.0	2.5	13.2	1.5	0.0	0.0	0.0	0.1	0.7	0.0	0.7	5.3	0.2	0.4	0.2	1.6	0.0	1.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.4	0.1
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228940	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	29	"intestine: 40.9;pancreas: 163.4"	"Cell line enriched"	"Detected in single"	6	"Hep G2: 4.9"	"Group enriched"	"Detected in some"	42	"colorectal cancer: 6.4;liver cancer: 3.2;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced									"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.2	0.0	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	40.9	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	163.4	0.0	0.2	0.2	0.2	0.2	19.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.0	4.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	0.1	0.1	0.5	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ITLN2	HL-2	ENSG00000158764	"Intelectin 2"	Q8WWU7	1	160945025-160954799	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"intestine: 88.4"	"Cell line enhanced"	"Detected in some"		"HEL: 15.3;HHSteC: 2.6;HMC-1: 4.6;SK-MEL-30: 4.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA006683, HPA067326"	Enhanced				"Secreted to digestive system"					"HPA006683: AB_2129681, HPA067326: AB_2732764"		"unprognostic (1.42e-1)"	"unprognostic (9.62e-3)"	"unprognostic (4.61e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.84e-4)"	"unprognostic (2.47e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.01e-1)"		"unprognostic (1.84e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.91e-2)"	3.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	27.4	0.1	0.1	53.3	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	2.5	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.1	88.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	2.6	0.0	4.6	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC5A4	"DJ90G24.4, SAAT1, SGLT3"	ENSG00000100191	"Solute carrier family 5 member 4"	Q9NY91	22	32218476-32255341	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	29	"intestine: 73.6"	"Cell line enriched"	"Detected in some"	19	"SK-MEL-30: 24.6"	"Cancer enriched"	"Detected in some"	10	"melanoma: 7.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"														"unprognostic (1.93e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.50e-1)"	"unprognostic (1.99e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.69e-1)"	1.2	0.1	0.4	0.4	0.4	0.1	1.6	0.4	0.5	1.2	41.7	0.4	0.4	18.0	1.8	0.4	0.4	1.2	0.6	0.9	0.5	0.6	1.0	0.4	2.5	0.4	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.9	0.1	0.4	0.4	0.4	0.4	0.3	73.6	1.5	0.6	0.6	0.2	0.7	0.4	0.4	2.4	0.4	0.4	0.4	1.3	0.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	24.6	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.5	0.6	0.6	0.4	0.4	0.4
INSL5		ENSG00000172410	"Insulin like 5"	Q9Y5Q6	1	66797741-66801256	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"intestine: 52.9"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;hTCEpi: 1.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 1.2;prostate cancer: 0.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030100, CAB033849"	Enhanced				"Secreted to blood"					"CAB033849: AB_2264904, HPA030100: AB_10601915"	"unprognostic (2.48e-1)"		"unprognostic (4.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.18e-1)"					"unprognostic (2.76e-2)"		"unprognostic (1.30e-1)"	"unprognostic (2.62e-2)"			"unprognostic (7.53e-2)"		0.0	0.0	0.8	0.0	1.3	0.0	0.0	0.1	1.0	0.0	30.8			0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	1.8	0.4	0.0	0.0	0.0	0.5		0.0	0.0	0.0	0.5	0.0		0.2	52.9		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.9			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYO1A	"DFNA48, MYHL"	ENSG00000166866	"Myosin IA"	Q9UBC5	12	57028517-57051198	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	27	"intestine: 148.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;CACO-2: 11.9;Hep G2: 7.9;NB-4: 2.3"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 17.8;pancreatic cancer: 4.8;stomach cancer: 9.8"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.3"	"Group enriched"	"Detected in some"	5	"classical monocyte: 1.2;intermediate monocyte: 1.1;myeloid DC: 2.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;monocytes: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053490	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053490: AB_2682168"	"unprognostic (2.77e-2)"	"unprognostic (2.00e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.31e-2)"	"unprognostic (7.11e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.57e-1)"	"unprognostic (6.04e-2)"	"unprognostic (4.26e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.38e-2)"	"unprognostic (6.89e-2)"	"unprognostic (5.01e-1)"	"unprognostic (5.81e-2)"	"unprognostic (8.72e-2)"	0.1	0.1	0.1	5.2	0.2	0.0	0.1	0.1	0.2	0.1	57.2	0.3	0.1	70.0	0.1	0.1	0.1	0.1	5.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.2	1.3	0.1	14.1	0.1	0.2	0.1	0.1	0.1	148.0	0.4	4.7	0.1	3.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	2.9	0.0	1.2	0.0	0.3	0.1	0.0	0.4	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.0	11.9	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	7.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	2.3	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.7	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	1.1	0.3	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.5	0.1	1.3	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945796	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	25	"intestine: 32.7;kidney: 35.6;liver: 43.8"	"Cell line enhanced"	"Detected in some"		"A-431: 3.4;BEWO: 2.0;Karpas-707: 1.1;RPMI-8226: 1.5;SK-BR-3: 1.8"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019551	Enhanced									"HPA019551: AB_2670187"	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	5.0	0.1	0.1	17.3	0.1	1.5	0.1	0.1	0.1	0.5	0.1	0.1	35.6	43.8	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	32.7	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	3.4	0.3	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.0	0.9	0.1	0.0	0.0	0.5	1.5	0.0	0.0	0.1	0.4	0.1	1.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
SSU72P4		ENSG00000283873	"SSU72 pseudogene 4"		11	4287499-4288083	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in single"	24	"intestine: 2.4"	"Cell line enriched"	"Detected in single"	16	"U-2 OS: 1.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.4		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CCL25	"Ckb15, SCYA25, TECK"	ENSG00000131142	"C-C motif chemokine ligand 25"	O15444	19	8052767-8062650	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	23	"intestine: 136.8;lymphoid tissue: 185.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.8;HEL: 4.9;NB-4: 3.8;REH: 10.1;RPMI-8226: 2.9;SH-SY5Y: 3.3"	"Group enriched"	"Detected in many"	5	"liver cancer: 25.4;stomach cancer: 33.5;testis cancer: 6.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 1.8;NK-cell: 7.0"	"Group enriched"	"Detected in many"	12	"B-cells: 1.8;NK-cells: 7.0"									HPA055883	Approved				"Secreted to blood"					"HPA055883: AB_2682955"	"unprognostic (9.22e-3)"	"unprognostic (3.13e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.30e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.27e-4)"	"unprognostic (6.43e-2)"	"unprognostic (3.86e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.17e-1)"	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.2	0.2	0.1	64.9	0.0	0.0	91.9	0.1	0.0	0.1	0.1	0.0	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	136.8	0.0	0.2	0.4	0.1	0.4	0.0	185.2	0.1	0.0	0.0	0.1	0.1	1.8	0.1	0.0	0.0	7.0	0.3	0.4	0.0	0.0	0.1	0.8	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.4	0.0	3.8	0.2	0.5	10.1	0.0	2.9	0.0	0.0	0.8	3.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.1	0.0	0.3	0.2	0.0	7.0	0.0	0.0	0.0	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.0	0.0	0.0
NAT2	AAC2	ENSG00000156006	"N-acetyltransferase 2"	P11245	8	18391245-18401218	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"intestine: 28.4;liver: 75.5"	"Cell line enhanced"	"Detected in some"		"RPTEC TERT1: 2.8;RT4: 4.1;SCLC-21H: 5.7;SK-BR-3: 3.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.0;liver cancer: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043704	Uncertain									"HPA043704: AB_2678625"	"unprognostic (2.74e-3)"	"unprognostic (4.03e-1)"	"prognostic favourable (4.61e-5)"	"unprognostic (1.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.67e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.64e-1)"	0.2	0.1	0.2	2.3	0.3	0.0	0.3	0.1	0.2	0.3	14.0	0.1	0.1	13.0	0.4	0.4	0.1	0.2	0.3	0.4	0.1	0.1	0.6	75.5	0.2	0.1	0.2	0.2	0.2	0.1	0.0	0.2	0.2	0.3	0.3	5.1	0.1	0.1	0.1	0.1	0.1	28.4	0.4	0.2	0.6	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.3	0.0	1.7	0.0	0.1	0.0	1.4	0.0	0.0	0.2	0.3	0.1	0.5	0.1	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.6	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.1	1.0	0.0	0.0	0.9	0.0	2.8	4.1	5.7	0.1	0.1	3.6	0.0	1.0	0.5	1.5	1.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.2	0.1	0.1	0.2	0.2	0.3	0.1
ADGRG4	"GPR112, PGR17, RP1-299I16"	ENSG00000156920	"Adhesion G protein-coupled receptor G4"	Q8IZF6	X	136300963-136416888	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	21	"intestine: 23.6"	"Cell line enhanced"	"Detected in single"		"TIME: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA035324	Uncertain									"HPA035324: AB_10671512"											"unprognostic (3.40e-3)"		"unprognostic (7.68e-5)"	"unprognostic (7.61e-2)"				0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	12.9	0.0	0.0	7.1	0.7	1.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.1	0.0	23.6	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 33.8;liver: 67.3"	"Cell line enriched"	"Detected in some"	12	"Hep G2: 41.5"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA066060	Uncertain									"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	14.0	0.0	0.0	7.8	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.1	2.3	67.3	0.1	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
MUC13	DRCC1	ENSG00000173702	"Mucin 13, cell surface associated"	Q9H3R2	3	124905442-124953819	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 334.4"	"Cell line enhanced"	"Detected in some"		"A549: 8.0;CACO-2: 6.9;CAPAN-2: 14.9;Karpas-707: 8.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 198.4;stomach cancer: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045163	Enhanced				"Secreted to digestive system"					"HPA045163: AB_10960396"	"unprognostic (8.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.93e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.02e-1)"	"unprognostic (9.64e-2)"	"prognostic unfavourable (9.73e-5)"	"unprognostic (2.05e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.42e-1)"	0.5	0.6	0.5	16.4	0.5	0.0	0.5	0.5	0.5	0.5	83.1	0.0	0.0	79.9	0.5	0.3	0.5	0.5	16.7	0.5	0.5	0.5	3.3	8.7	0.5	0.0	0.5	0.0	0.5	1.8	0.0	0.5	0.1	0.1	0.5	40.6	0.1	0.5	0.0	0.5	0.5	334.4	1.0	0.5	0.5	4.1	0.5	0.0	0.1	0.5	0.0	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	1.2	1.0	0.0	0.0	0.1	6.9	14.9	0.0	0.9	0.2	1.1	0.0	0.0	0.0	0.1	0.2	0.0	1.7	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.1	0.0	0.0	1.1	0.0	1.2	0.1	0.1	2.7	0.0	0.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.4	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.0	0.1	0.0
MUC2		ENSG00000198788	"Mucin 2, oligomeric mucus/gel-forming"		11	1074875-1110511	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enriched"	"Detected in some"	20	"intestine: 28.1"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.0;RPMI-8226: 1.0;RT4: 2.6"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 93.2;pancreatic cancer: 27.7;stomach cancer: 21.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											CAB016275	Enhanced				"Intracellular and membrane"					"CAB016275: AB_627970"	"unprognostic (6.37e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.76e-3)"	"unprognostic (5.09e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.76e-3)"	"unprognostic (7.87e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.37e-3)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.38e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.10e-2)"	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	11.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696585	"Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"intestine: 85.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.7;BEWO: 2.2;CACO-2: 3.1;CAPAN-2: 4.5;SiHa: 4.2"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 4.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavourable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.2	0.1	0.2	3.4	0.2	0.0	0.2	0.2	0.2	0.2	38.8	0.2	0.2	28.0	0.3	0.2	0.4	0.2	0.3	0.4	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.2	17.5	0.2	0.5	0.2	0.2	1.0	85.1	0.3	0.2	0.2	0.5	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	4.3	0.7	2.7	1.7	0.0	0.0	0.6	1.1	0.1	0.0	3.7	0.0	0.0	2.2	0.1	0.0	0.0	0.0	3.1	4.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.4	0.4	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.5	4.2	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.1	1.3	0.8	1.3	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.5	0.0	4.3	0.0	0.0	0.7	2.3	0.0	0.0	2.7	0.0	0.0	0.7	0.0	0.6	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
NXPE4	"C11orf33, FAM55D, FLJ20127"	ENSG00000137634	"Neurexophilin and PC-esterase domain family member 4"	Q6UWF7	11	114570591-114595762	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"intestine: 44.3;lymphoid tissue: 21.7;salivary gland: 71.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042801	Approved				"Secreted to digestive system"					"HPA042801: AB_10793986"	"unprognostic (1.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.27e-1)"		"unprognostic (3.51e-3)"		"unprognostic (1.06e-1)"		"unprognostic (1.32e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-1)"	"unprognostic (7.47e-3)"	"unprognostic (4.36e-2)"		"unprognostic (2.05e-1)"		0.2	0.2	0.2	21.7	0.2	0.0	0.2	0.2	0.2	0.2	41.5	0.1	0.1	0.0	0.2	2.4	0.3	0.3	0.1	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	2.1	44.3	0.1	71.7	0.1	0.2	0.2	0.5	1.9	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.3	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
GUCA2B		ENSG00000044012	"Guanylate cyclase activator 2B"	Q16661	1	42153421-42155824	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"intestine: 92.4"	"Group enriched"	"Detected in some"	6	"A549: 3.3;CACO-2: 8.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	19	"intermediate monocyte: 1.9"	"Lineage enriched"	"Detected in single"	19	"monocytes: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 0.8;hippocampal formation: 0.5"						"Secreted to blood"	740000	740000						"unprognostic (2.59e-2)"				"unprognostic (1.44e-2)"				"unprognostic (1.34e-1)"		"unprognostic (6.22e-2)"	"unprognostic (1.86e-1)"				0.1	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.1	55.2	0.1	0.1	13.5	0.1	0.1	0.1	0.0	0.7	0.1	0.1	0.0	0.1	2.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.1	0.1	0.1	0.1	8.7	0.1	0.1	0.1	0.1	0.0	92.4	0.1	0.1	0.2	5.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.9	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
ADAMDEC1	M12.219	ENSG00000134028	"ADAM like decysin 1"	O15204	8	24384285-24406013	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"intestine: 126.7;lymphoid tissue: 46.3"	"Cell line enriched"	"Detected in some"	4	"U-266/70: 15.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 4.5"	"Group enriched"	"Detected in many"	7	"B-cells: 2.7;granulocytes: 4.5;monocytes: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	22000000	22000000				"unprognostic (1.17e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.15e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.21e-2)"	"unprognostic (3.84e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.99e-3)"	"unprognostic (2.79e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.23e-2)"	0.6	0.6	0.3	46.3	0.3	0.0	0.4	0.3	0.3	0.4	57.4	0.1	0.1	30.4	0.3	0.4	0.6	0.4	0.4	0.4	0.3	0.3	0.5	0.4	1.4	30.0	0.3	0.1	0.4	0.4	0.0	0.4	0.9	0.1	0.4	52.2	0.2	0.8	0.1	0.3	0.5	126.7	1.7	0.4	5.2	0.8	0.4	0.1	1.9	0.5	0.5	5.4	5.0	0.4	2.7	0.4	4.5	2.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	15.2	3.6	0.0	0.0	0.0	0.0	0.0	2.0	4.5	0.0	2.1	0.0	2.7	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	1200000	1200000	"Focal adhesion sites"	"Focal adhesion sites"	"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.5	7.4	0.8	2.5	1.2	2.5	1.5	1.4	0.1	4.8	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	1.5	1.0	2.0	1.9	4.3	4.7	6.0	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1										
CIDEC	"CIDE-3, FLJ20871, Fsp27"	ENSG00000187288	"Cell death inducing DFFA like effector c"	Q96AQ7	3	9866711-9880254	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	16	"adipose tissue: 129.9;breast: 63.7;intestine: 60.5"	"Cell line enriched"	"Detected in some"	4	"ASC diff: 192.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.2;plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA018837, HPA020553"	Approved									"HPA018837: AB_1846767, HPA020553: AB_1846769"	"unprognostic (1.83e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.26e-5)"	"unprognostic (9.03e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.48e-3)"	"unprognostic (8.14e-2)"	"unprognostic (5.37e-5)"	"unprognostic (9.47e-3)"	"unprognostic (2.02e-1)"	"unprognostic (7.46e-3)"	"unprognostic (2.94e-2)"	129.9	1.1	0.1	5.3	0.1	0.0	63.7	0.1	0.1	0.4	44.3	0.1	0.9	13.5	0.5	0.6	0.1	0.2	5.3	2.3	0.1	0.0	0.6	2.6	0.1	2.7	0.1	0.1	0.1	1.4	0.0	0.1	0.1	0.1	0.4	0.8	0.1	2.9	0.8	1.7	2.4	60.5	0.8	0.1	0.1	0.8	0.4	0.1	0.1	0.4	1.9	0.2	2.4	1.1	2.2	1.8	0.1	0.5	0.2	0.2	0.2	0.0	0.0	0.0	0.0	192.5	43.4	0.1	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.3	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.5	0.0	2.2	0.1	0.0	0.5	0.6	0.0	0.2	0.0	0.2	0.4	1.8	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
CYP2C19	"CPCJ, CYP2C, P450IIC19"	ENSG00000165841	"Cytochrome P450 family 2 subfamily C member 19"	P33261	10	94762681-94853205	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 47.7;liver: 76.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;RPMI-8226: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015066	Supported				"Intracellular and membrane"					"HPA015066: AB_1847433"			"unprognostic (3.15e-2)"			"unprognostic (2.13e-1)"	"unprognostic (2.48e-1)"				"unprognostic (1.83e-2)"			"unprognostic (1.53e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	30.0	0.0	0.0	14.7	0.0	0.0	1.0	0.0	3.7	0.0	0.0	0.0	0.0	76.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	47.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0
LYPD8		ENSG00000259823	"LY6/PLAUR domain containing 8"	Q6UX82	1	248718649-248755739	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 60.0;lymphoid tissue: 40.9"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.1;THP-1: 2.5"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 15.2"					"Group enriched"	"Detected in some"	6	"classical monocyte: 1.0;intermediate monocyte: 1.1;MAIT T-cell: 1.7;neutrophil: 2.3;plasmacytoid DC: 3.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in many"								"Secreted to digestive system"						"unprognostic (6.69e-3)"		"unprognostic (3.53e-2)"	"unprognostic (1.08e-5)"	"unprognostic (1.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.16e-4)"	"unprognostic (8.62e-2)"	"unprognostic (7.28e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.57e-1)"	"unprognostic (2.89e-1)"		"unprognostic (1.07e-1)"	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.1	0.0	60.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	36.8	0.0	0.0	0.0	0.0	0.0	8.1	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	3.1	2.3	1.1	0.0	1.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.1	1.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	3.1	0.0	0.2										
UGT1A1	"GNT1, UGT1, UGT1A"	ENSG00000241635	"UDP glucuronosyltransferase family 1 member A1"	P22309	2	233760248-233773299	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 48.6;liver: 120.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 4.2;HaCaT: 11.0;PC-3: 5.0;RT4: 26.1"	"Cancer enriched"	"Detected in some"	19	"liver cancer: 16.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 4.7"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"																				"unprognostic (7.28e-2)"			"unprognostic (2.49e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.69e-2)"			"unprognostic (4.17e-3)"	"unprognostic (6.31e-3)"	"unprognostic (1.94e-5)"	"unprognostic (2.78e-3)"			"unprognostic (2.99e-4)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.2	35.6	0.1	0.1	48.6	0.1	0.1	4.3	0.0	0.3	0.1	0.1	0.0	4.5	120.3	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.4	0.1	0.7	0.1	0.1	0.9	48.2	0.5	0.1	0.1	1.3	0.2	0.1	0.1	0.2	0.1	0.1	5.2	0.8	1.0	0.4	4.7	0.4	1.1	0.5	0.2	0.2	0.8	0.1	0.2	0.1	0.1	0.5	0.0	0.0	0.0	0.0	4.2	0.3	0.1	2.0	0.0	11.0	0.0	0.2	0.0	0.2	0.1	0.1	0.4	1.1	0.0	0.4	0.1	0.2	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.5	0.1	0.2	0.4	5.0	0.1	0.1	0.4	0.0	26.1	0.2	0.3	2.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.6	0.3	0.2	2.1	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.3	0.1	1.0	0.4	0.5	4.7	1.1	0.4	0.4	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
BLK	MGC10442	ENSG00000136573	"BLK proto-oncogene, Src family tyrosine kinase"	P51451	8	11486894-11564604	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"blood: 47.8;intestine: 23.5;lymphoid tissue: 39.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 43.0;REH: 11.6;RPMI-8226: 14.2;U-698: 21.0;U-87 MG: 8.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"memory B-cell: 47.8;naive B-cell: 33.9"	"Lineage enriched"	"Detected in many"	5	"B-cells: 47.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005093, HPA069571"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB005093: AB_2274756, HPA069571: AB_2732137"	"unprognostic (6.50e-5)"	"unprognostic (4.22e-3)"	"unprognostic (5.64e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.45e-1)"	"unprognostic (5.98e-6)"	"unprognostic (1.59e-2)"	"unprognostic (8.94e-4)"	"unprognostic (1.02e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-2)"	"unprognostic (4.66e-2)"	"unprognostic (9.05e-6)"	"unprognostic (5.62e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.16e-1)"	0.5	0.2	0.1	32.3	0.1	1.7	0.2	0.1	0.1	0.1	1.2	0.0	0.0	0.3	0.1	0.0	1.9	0.2	0.4	0.3	0.1	0.1	1.3	0.5	0.6	27.6	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.4	0.4	0.3	2.4	0.0	0.1	0.1	23.5	0.0	0.1	31.9	1.4	0.2	0.0	3.9	0.7	0.4	39.8	2.5	0.4	47.8	4.3	0.1	0.0	0.0	9.8	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.6	0.0	14.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	3.7	21.0	8.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	9.8	47.8	0.3	1.1	0.0	33.9	0.2	0.1	0.1	0.0	0.0	4.3	0.4	1.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0
DHRS11	"MGC4172, SDR24C1"	ENSG00000278535	"Dehydrogenase/reductase 11"	Q6UWP2	17	36591798-36600806	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"intestine: 88.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041226, HPA048236, HPA053623"	Enhanced		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	11000	11000	Cytosol	Cytosol	"HPA041226: AB_2677372, HPA048236: AB_2680322, HPA053623: AB_2682209"	"unprognostic (2.00e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.61e-3)"	"unprognostic (2.03e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.67e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.33e-2)"	"unprognostic (4.11e-2)"	"prognostic favourable (3.24e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.16e-2)"	"unprognostic (9.35e-2)"	1.3	0.6	1.2	4.1	2.4	0.4	0.7	0.5	5.7	0.4	38.7	0.4	0.4	42.7	0.4	0.1	1.2	1.1	1.4	2.0	0.5		2.5	1.7	0.1	0.0	0.0	2.4	0.1	2.8	1.5	0.2	0.0	1.6	0.5	12.4	2.8	2.1	0.8	2.0	0.8	88.0	0.9	0.1	0.0	1.1	2.2	0.3	0.0	1.3	1.3	1.0	0.4	0.0	0.9	0.2	0.9	0.7	0.1	2.7	0.1	6.5	5.9	2.8	7.4	0.6	1.7	5.5	2.0	1.4	6.4	5.8	9.6	5.3	0.7	1.4	2.0	6.9	6.0	4.1	6.5	3.4	11.4	1.7	5.7	18.6	3.1	1.9	0.6	0.9	3.9	4.4	3.3	4.9	15.6	5.8	3.5	5.8	6.4	3.5	2.2	2.3	8.0	7.0	11.0	6.5	5.6	6.0	2.6	7.0	7.3	16.4	10.0	1.8	1.8	0.9	9.1	4.8	5.0	9.5	8.0	2.3	3.3	4.7	2.8	0.4	0.5	0.9	1.0	0.7	0.1	0.4	1.0	0.6	0.1	0.9	1.3	0.9	0.5	0.1	0.1	0.2	2.7	0.1										
HHLA2	"B7-H5, B7H7, B7y"	ENSG00000114455	"HERV-H LTR-associating 2"	Q9UM44	3	108296490-108378285	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 125.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.9;Karpas-707: 5.8"	"Group enriched"	"Detected in many"	12	"colorectal cancer: 9.2;lung cancer: 5.0;pancreatic cancer: 5.1;renal cancer: 16.6;stomach cancer: 6.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 5.1"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA055478	Enhanced									"HPA055478: AB_2682830"	"unprognostic (1.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-2)"	"unprognostic (8.14e-5)"	"unprognostic (1.76e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.08e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.66e-2)"	0.2	0.2	0.3	4.3	0.3	0.0	0.2	0.2	0.3	0.3	39.6	0.2	0.2	25.5	0.2	0.5	0.2	0.9	8.5	0.2	0.3	0.3	7.8	0.4	2.2	0.2	0.3	0.2	0.6	1.2	0.0	0.3	0.2	0.2	0.2	25.2	0.2	0.2	0.2	0.2	0.1	125.2	0.3	0.5	0.3	2.5	1.9	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	5.1	1.2	1.5	0.3	0.5	0.7	0.4	0.6	0.4	0.5	0.0	0.0	1.5	0.0	0.0	0.0	0.5	3.5	0.4	0.3	0.4	0.1	0.4	1.2	0.0	0.0	7.9	0.2	0.2	2.7	0.5	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.1	0.7	5.8	0.0	0.5	0.8	3.0	1.2	0.6	0.7	0.3	1.6	0.1	0.3	1.4	1.4	1.4	0.1	0.3	0.3	0.4	0.3	0.3	1.5	0.5	0.4	3.1	1.4	0.8	0.1	0.9	0.2	1.2	0.3	1.1	0.1	0.4	0.1	0.3	0.2	0.5	5.1	0.3	0.2	0.1	0.5	0.3	1.5	0.1	0.0	0.7	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.2	0.2
MYRFL	"bcm1377, C12orf15, C12orf28, FLJ25056"	ENSG00000166268	"Myelin regulatory factor-like"	Q96LU7	12	69825304-69959097	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	15	"intestine: 56.1"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 6.8;SK-BR-3: 3.4;T-47d: 15.4"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049340	Approved		Approved	Nucleoli	"Intracellular and membrane"			Nucleoli	Nucleoli	"HPA049340: AB_2680719"	"unprognostic (2.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.34e-1)"	"unprognostic (5.45e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.08e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.91e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.96e-2)"	0.3	0.3	0.5	0.0	0.6	0.0	0.5	3.6	0.6	0.1	20.7	0.0	0.4	21.4	0.1	0.9	0.1	0.1	0.7	0.2	0.4	0.2	2.0	0.3	0.2	0.2	0.5	0.2	0.0	0.8	0.0	1.0	0.3	0.7	0.6	0.1	0.3	1.3	0.4	0.0	1.6	56.1	0.1	1.0	0.1	0.1	2.4	0.5	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	6.8	0.0	0.1	0.0	1.1	1.0	0.0	0.3	0.1	0.0	3.4	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.4	0.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	3.6	0.6	0.4	0.2	0.5	0.2	0.7	0.5
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 alpha subunit"	Q86UW1	3	196211487-196243178	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"intestine: 53.9;liver: 59.5"	"Cell line enhanced"	"Detected in many"		"REH: 7.9"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 1.7;neutrophil: 1.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039123	Enhanced									"HPA039123: AB_10672770"	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favourable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	0.5	2.3	0.3	3.8	0.3	2.4	0.4	0.3	0.4	0.5	12.3	0.4	0.7	13.6	0.4	2.8	0.5	0.5	0.5	0.5	0.3	0.1	2.2	59.5	0.8	0.3	0.3	0.3	0.6	0.3	1.4	0.5	0.3	0.3	0.5	0.1	0.3	0.6	0.3	0.5	1.0	53.9	0.3	0.3	0.8	0.2	1.8	0.3	0.6	0.8	0.3	0.5	0.3	0.7	0.2	0.0	1.7	0.6	0.4	0.6	0.1	1.0	1.6	1.4	1.7	0.0	1.0	0.1	0.8	0.0	0.1	0.0	0.7	0.4	0.1	1.9	1.1	0.9	0.2	0.0	0.0	0.7	2.8	1.0	0.8	1.7	0.2	1.4	1.4	0.3	0.0	0.2	1.3	0.2	0.2	3.3	0.0	0.6	0.1	1.2	0.1	2.0	7.9	0.1	0.5	0.0	0.9	0.3	0.5	0.5	3.2	0.3	2.3	0.5	0.5	1.6	0.7	1.3	0.9	3.3	4.0	0.6	1.1	0.6	0.6	0.0	0.2	1.7	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.2	0.1	0.6	1.6	0.4	0.5	0.0	0.1	0.1	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.3	0.3
TMEM236	"bA162I21.2, bA16O1.2, FAM23A, FAM23B"	ENSG00000148483	"Transmembrane protein 236"	Q5W0B7	10	17752252-17800868	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 76.4"	"Cell line enriched"	"Detected in some"	10	"MOLT-4: 14.9"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045096	Enhanced									"HPA045096: AB_2732516"	"unprognostic (4.95e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.88e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.54e-2)"	0.5	0.3	0.3	4.9	0.3	0.0	0.3	0.3	0.3	0.4	32.0	0.1	0.1	13.7	0.5	0.1	0.4	0.2	0.1	0.3	0.3	0.3	0.5	0.4	0.6	0.1	0.3	0.1	0.3	0.7	0.0	0.3	0.6	0.1	0.3	9.1	0.1	0.3	0.1	0.5	0.3	76.4	0.3	0.3	0.3	0.3	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	1.3	0.9	2.6	0.6	1.0	0.6	0.1	0.3	0.2	0.4	0.5	0.1	0.1	0.5	0.3	0.0	0.1	0.3	0.5	0.5	0.2	0.2	0.2	0.3	0.2	0.2	0.8	0.2	0.5	0.6	0.5	0.5	0.1	0.5	1.5	0.2	0.4	0.1	0.2	0.4	0.2	0.4	0.2	0.3	14.9	0.3	0.3	0.1	0.6	0.4	0.3	0.1	0.3	0.3	0.2	0.2	0.1	0.5	0.2	0.0	0.7	0.5	0.6	0.2	0.2	0.3	0.2	0.3	0.2	0.2	0.2	2.6	0.6	0.9	0.6	0.4	0.4	0.7	0.5	0.4	0.4	1.3	0.5	0.6	2.2	1.0	0.4	0.9	0.4	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
C11orf86	FLJ22675	ENSG00000173237	"Chromosome 11 open reading frame 86"	A6NJI1	11	66975277-66977004	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	14	"intestine: 57.7"	"Group enriched"	"Detected in some"	5	"HeLa: 6.7;SiHa: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039348	Uncertain									"HPA039348: AB_10673421"		"unprognostic (1.54e-2)"	"unprognostic (7.67e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.90e-4)"	"prognostic unfavourable (8.97e-4)"		"unprognostic (4.17e-1)"	"prognostic unfavourable (6.97e-5)"		"prognostic unfavourable (1.02e-5)"	"unprognostic (7.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.58e-3)"	0.1	4.0	0.1	1.1	0.1	0.0	0.1	0.1	0.1	0.1	24.4	0.1	0.1	33.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.5	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	2.1	0.1	0.1	3.0	0.1	0.1	0.1	0.1	0.0	57.7	0.2	0.1	0.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	22.8	3.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	14	"brain: 21.0;intestine: 11.1"	"Cell line enriched"	"Detected in single"	33	"AN3-CA: 19.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved									"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.4	0.5	14.5	0.7	13.2	0.7	0.5	21.0	10.8	0.4	4.1	0.1	0.0	0.7	0.5	0.5	0.4	0.8	0.7	0.4	3.6	13.9	0.5	0.5	0.4	0.5	1.6	8.4	0.9	0.5	0.4	0.5	0.8	10.1	0.4	11.1	1.1	0.8	0.5	0.5	0.8	0.9	0.7	6.5	0.5	0.5	0.9	0.8	0.0	0.5	0.0	0.4	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	19.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	13.2	21.0	10.4	3.6	13.9	1.6	8.4	10.1	0.8
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499958-49527047	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 2.0;liver: 5.6"	"Cell line enriched"	"Detected in single"	73	"T-47d: 18.0"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain									"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTC		ENSG00000036473	"Ornithine carbamoyltransferase"	P00480	X	38352545-38421450	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"intestine: 59.1;liver: 90.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 1.8;RPMI-8226: 1.0;SH-SY5Y: 1.1;SiHa: 1.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 59.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA000243, HPA000570"	Enhanced		Supported	Mitochondria		1800000	1800000	Mitochondria	Mitochondria	"HPA000243: AB_1079535, HPA000570: AB_1079534"			"unprognostic (6.93e-2)"		"unprognostic (2.48e-1)"		"unprognostic (1.89e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.19e-2)"			"unprognostic (7.70e-3)"	"unprognostic (5.61e-2)"			0.4	0.1	0.1	0.4	0.2	0.0	0.2	0.1	0.1	0.8	16.5	0.0	0.2	26.9	1.1	0.2	0.2	0.3	5.3	0.2	0.1	0.2	0.1	90.3	0.7	2.3	0.2	0.0	0.2	0.8	0.0	0.1	0.0	0.0	0.4	0.5	0.0	0.1	0.0	0.1	0.1	59.1	0.8	0.3	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.6	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0
PLS1	"I-plastin, Plastin-1"	ENSG00000120756	"Plastin 1"	Q14651	3	142596387-142713664	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"intestine: 193.0"	"Cell line enhanced"	"Detected in many"		"A-431: 27.4;BEWO: 36.0;RPTEC TERT1: 45.9;RT4: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 4.9;NK-cells: 5.9;T-cells: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055744	Enhanced					50000000	50000000			"HPA055744: AB_2682903"	"unprognostic (1.29e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.15e-3)"	"unprognostic (2.22e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavourable (4.84e-4)"	"unprognostic (3.14e-2)"	"prognostic favourable (8.76e-6)"	"unprognostic (1.99e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.22e-2)"	"unprognostic (3.82e-2)"	0.5	2.3	1.0	8.2	1.0	1.0	1.7	1.5	2.0	2.0	42.3	0.6	0.2	40.0	0.5	1.1	5.7	1.3	6.3	0.9	1.2	1.1	12.5	10.6	4.4	0.3	0.9	1.0	0.6	5.0	3.8	13.6	0.8	4.5	1.8	30.0	2.9	5.3	0.9	0.5	1.2	193.0	0.6	1.2	0.5	9.6	2.6	0.5	2.5	3.7	1.3	1.6	5.1	2.3	0.7	0.9	4.9	0.4	5.9	5.0	1.8	27.4	21.6	1.5	3.3	0.2	0.0	36.0	0.5	0.7	3.0	6.5	9.8	21.7	4.7	11.5	0.1	5.9	5.9	9.0	6.4	1.7	8.5	8.3	3.4	3.5	0.2	3.9	0.5	0.1	1.5	5.7	3.7	1.4	3.5	0.5	0.3	6.4	6.4	2.1	6.0	8.2	2.6	6.5	3.8	45.9	25.4	7.7	3.1	3.1	2.2	2.5	17.7	0.7	0.3	0.3	3.7	1.1	6.6	4.1	3.8	5.5	1.0	3.9	1.1	3.4	0.4	4.9	2.9	0.3	3.8	0.7	3.5	3.8	0.7	0.6	4.3	5.0	3.3	5.9	0.4	0.9	2.1	1.8	1.0	1.0	1.5	2.0	1.2	1.1	0.9	1.0	4.5	0.5
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103518-53124538	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"intestine: 60.8"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.6;Hep G2: 20.9;U-266/70: 7.0"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.7;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.7;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.5	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.2	0.9	16.4	0.2	0.2	12.3	0.7	0.3	0.2	0.9	0.4	0.2	0.2	0.0	0.6	4.2	0.2	0.6	0.2	0.2	0.4	0.2	0.0	0.3	0.2	0.2	0.6	0.0	0.2	0.4	0.2	0.2	0.4	60.8	0.2	0.3	2.2	0.3	0.2	0.2	0.2	0.4	0.2	0.3	0.3	1.1	0.0	0.0	0.0	0.3	0.5	3.7	0.2	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.6	0.1	0.0	0.0	0.4	0.7	0.0	0.0	0.6	0.0	0.0	0.9	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.7	0.0	1.5	2.7	0.0	0.0	0.4	1.5	0.0	0.5	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
TBX10	"TBX13, TBX7"	ENSG00000167800	"T-box 10"	O75333	11	67631303-67639560	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in single"	14	"intestine: 12.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.9;NTERA-2: 6.6;RPMI-8226: 4.3;SK-BR-3: 15.5;U-2 OS: 3.3"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.8;colorectal cancer: 2.6;liver cancer: 0.5;prostate cancer: 1.9;stomach cancer: 0.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"pons and medulla: 0.4"	"Low region specificity"	"Detected in many"			HPA047881	Uncertain				"Intracellular and membrane"					"HPA047881: AB_2680199"	"unprognostic (4.66e-2)"	"unprognostic (2.96e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.83e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.29e-2)"		"unprognostic (5.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.90e-1)"	"unprognostic (1.17e-10)"	"unprognostic (6.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.75e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	9.9	0.2	0.2	6.4	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.4	0.2	0.2	0.0	12.1	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.1	0.0	15.5	0.0	0.0	0.1	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866273	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in single"	13	"intestine: 7.3"	"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved									"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.0	0.0	7.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	6.3	0.0	0.2	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 194.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (3.30e-4)"	15.4	0.7	1.0	5.2	1.0	3.9	12.5	1.3	1.1	2.5	172.9	1.1	1.2	76.6	2.4	4.4	1.8	3.2	7.2	2.1	1.7	0.8	3.7	7.0	2.2	2.9	1.7	0.8	4.4	1.3	1.1	1.3	2.0	1.7	2.2	2.4	0.8	1.4	1.2	1.1	2.1	194.8	1.6	2.3	5.7	1.7	2.4	1.4	1.0	1.8	1.3	2.3	2.7	3.0	1.0	1.8	1.7	1.2	0.8	1.9	1.4	2.1	6.7	3.6	5.6	5.7	4.6	2.5	2.1	2.7	2.7	3.9	4.5	2.6	7.3	3.8	1.4	4.1	5.9	1.2	2.7	9.0	12.7	3.3	3.8	5.8	5.0	3.7	7.3	4.4	6.0	3.5	4.6	2.2	15.6	11.8	2.0	7.5	5.9	21.4	2.8	4.7	8.0	3.1	6.0	1.6	2.7	3.5	12.4	1.9	3.7	10.4	3.4	7.5	3.2	8.8	7.7	13.3	2.6	12.5	15.7	7.7	2.5	9.8	5.1	0.2	1.2	0.1	1.9	0.7	0.6	0.4	1.9	0.2	0.8	1.0	1.3	1.4	1.7	0.8	0.9	1.8	0.8	1.4	1.0	1.0	1.3	1.0	1.7	0.8	1.7	0.8	1.7	1.4
MALRD1	"bA265G8.2, C10orf112, Diet1"	ENSG00000204740	"MAM and LDL receptor class A domain containing 1"	Q5VYJ5	10	19048771-19790401	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	13	"intestine: 60.5"	"Cell line enriched"	"Detected in some"	10	"Karpas-707: 31.2"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.6"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035732, HPA038106, HPA046848"	Uncertain		Enhanced	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA035732: AB_2674756, HPA038106: AB_2675836, HPA046848: AB_2679837"	"unprognostic (9.03e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.74e-2)"	"unprognostic (5.57e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.80e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.78e-4)"	0.5	0.8	2.0	0.3	2.0	0.4	0.6	0.3	0.9	0.8	19.4	0.6	0.1	25.2	1.3	2.3	0.3	0.3	0.4	1.3	1.6	0.8	1.3	0.3	0.9	0.2	0.8	0.0	1.1	0.3	0.1	4.7	0.4	0.8	0.9	0.2	1.4	0.5	0.4	0.5	0.4	60.5	1.3	0.7	0.3	0.5	1.7	0.7	2.6	0.6	0.3	0.1	0.5	0.5	0.0	3.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	1.7	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	31.2	0.0	3.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.1	0.0	3.6	0.0	0.0	2.0	2.0	0.3	0.9	1.6	0.8	0.8	0.0	0.8	0.7
MOGAT2	"DGAT2L5, FLJ22644, MGAT2"	ENSG00000166391	"Monoacylglycerol O-acyltransferase 2"	Q3SYC2	11	75717819-75732958	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 90.2;liver: 40.5"	"Group enriched"	"Detected in some"	7	"Hep G2: 8.4;RPMI-8226: 5.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA028834	Uncertain									"HPA028834: AB_10601865"	"unprognostic (5.63e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.15e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.24e-5)"	"unprognostic (2.13e-3)"	"unprognostic (1.84e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-3)"	0.1	0.0	0.1	4.8	0.1	0.0	2.1	0.1	0.1	0.2	34.0	0.1	1.4	22.3	0.1	0.1	0.2	0.0	2.6	0.1	0.1	0.0	0.2	40.5	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	7.0	0.1	0.4	2.2	0.4	0.9	90.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	5.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
PHGR1		ENSG00000233041	"Proline, histidine and glycine rich 1"	C9JFL3	15	40351033-40356434	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"intestine: 308.0;lymphoid tissue: 83.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.3;HaCaT: 10.3;NB-4: 6.1;RPMI-8226: 5.7;SCLC-21H: 35.7"	"Group enriched"	"Detected in many"	16	"colorectal cancer: 248.3;stomach cancer: 94.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA068787	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA068787: AB_2686035"	"prognostic favourable (2.05e-4)"		"unprognostic (1.73e-1)"				"unprognostic (5.18e-2)"				"unprognostic (1.18e-1)"	"unprognostic (2.80e-1)"		"unprognostic (1.20e-1)"			"unprognostic (1.27e-2)"	0.3	0.1	0.3	83.6	0.3	0.0	0.6	0.3	0.3	0.3	245.3	0.3	0.3	77.9	0.3	0.3	0.4	0.5	4.1	0.3	0.3	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.4	32.9	0.3	0.4	0.3	0.3	0.3	308.0	1.3	0.3	0.3	15.1	0.3	0.3	0.3	0.3	0.3	0.3	0.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.1	0.0	0.0	5.7	0.0	0.8	35.7	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.3	0.3
CDX2	CDX3	ENSG00000165556	"Caudal type homeobox 2"	Q99626	13	27962137-27971139	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"intestine: 21.2"	"Group enriched"	"Detected in some"	6	"CACO-2: 14.4;CAPAN-2: 4.8;HEK 293: 8.0"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 63.7"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB002221, HPA045669, HPA049580"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB002221: AB_563649, HPA045669: AB_2679413, HPA049580: "		"unprognostic (1.42e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.92e-1)"		"unprognostic (8.11e-3)"	"unprognostic (4.19e-6)"	"unprognostic (1.73e-4)"		"unprognostic (1.71e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.51e-2)"		"unprognostic (6.07e-3)"	"unprognostic (1.13e-1)"		"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	21.2			13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.1	14.3		0.0	0.0	0.0	0.0	16.3	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.4	4.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	8.0	0.0	0.2	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRTAP13-2	KAP13-2	ENSG00000182816	"Keratin associated protein 13-2"	Q52LG2	21	30371391-30372257	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"intestine: 5.9;skin 1: 14.9;tongue: 19.7"	"Cell line enhanced"	"Detected in single"		"HaCaT: 1.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	1300000	1300000												"unprognostic (2.44e-2)"			"unprognostic (5.68e-2)"						0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.0	14.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NAALADL1		ENSG00000168060	"N-acetylated alpha-linked acidic dipeptidase like 1"	Q9UQQ1	11	65044818-65058549	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"blood: 49.5;intestine: 123.4"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.3;fHDF/TERT166: 6.7;HHSteC: 18.6;HSkMC: 12.2;SCLC-21H: 9.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 49.5"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047123	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"HPA047123: AB_2679942"	"unprognostic (2.98e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.75e-4)"	"unprognostic (2.10e-3)"	"unprognostic (3.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.80e-2)"	4.1	0.9	1.4	3.3	1.6	7.0	4.1	1.9	1.4	6.0	54.3	1.2	2.6	7.8	7.2	1.8	2.7	4.4	3.4	3.5	1.3	0.6	2.3	1.2	3.4	5.2	1.5	1.5	6.2	1.0	0.9	2.0	1.5	1.6	4.6	2.6	3.1	2.3	4.8	2.0	1.6	123.4	4.3	1.4	5.0	2.8	1.8	1.2	1.8	1.8	2.3	2.9	3.1	5.4	8.8	4.9	49.5	6.3	22.2	12.9	7.0	0.0	0.0	0.1	0.2	0.4	5.3	0.9	2.0	0.0	2.5	1.1	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.1	3.0	18.6	0.0	0.0	12.2	0.0	2.4	0.0	3.2	0.0	0.2	0.0	0.2	0.2	0.6	0.0	0.1	0.1	0.0	0.8	0.2	0.0	9.6	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.7	0.0	0.1	0.1	49.5	6.3	10.3	9.5	4.3	4.9	8.0	7.6	4.8	4.9	8.8	8.8	4.9	1.1	22.2	2.5	0.2	12.9	7.0	1.4	1.6	1.9	1.4	1.3	0.6	1.5	1.5	1.6	1.2
CEACAM20	UNQ9366	ENSG00000273777	"Carcinoembryonic antigen related cell adhesion molecule 20"		19	44501677-44529788	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"intestine: 64.6"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 5.5"	"Group enriched"	"Detected in some"	9	"liver cancer: 1.2;prostate cancer: 5.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"														"unprognostic (1.04e-2)"	"unprognostic (5.03e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.92e-1)"			"unprognostic (1.23e-2)"	"unprognostic (3.75e-1)"		"unprognostic (9.89e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.14e-5)"	"unprognostic (7.13e-2)"	"unprognostic (2.51e-2)"		"unprognostic (1.44e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	23.9	0.0	0.0	0.0	0.0	1.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	5.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CHST5	"FLJ22167, I-GLCNAC-6-ST"	ENSG00000135702	"Carbohydrate sulfotransferase 5"	Q9GZS9	16	75528535-75535247	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 32.9"	"Cell line enhanced"	"Detected in many"		"PC-3: 4.6"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 1.4;stomach cancer: 1.5"	"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA043804	Enhanced				"Intracellular and membrane"					"HPA043804: AB_10960563"	"unprognostic (6.82e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.46e-2)"		"unprognostic (6.76e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.09e-2)"	"unprognostic (9.03e-3)"	"unprognostic (4.27e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.42e-2)"	0.4	0.0	0.7	0.4	1.7	0.0	0.4	2.4	1.1	0.4	17.5	0.4	0.4	32.9	0.4	0.4	0.4	1.1	0.4	0.4	0.8	0.8	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.5	0.4	0.4	0.4	21.6	0.4	0.4	0.4	2.1	0.0	28.5	0.4	0.4	0.4	1.7	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	1.3	1.1	3.0	1.3	1.1	1.1	0.4	0.4	1.0	1.4	1.6	0.4	0.9	0.7	0.0	0.3	0.6	0.5	0.6	1.9	1.2	0.6	0.3	1.1	0.1	0.7	0.0	0.4	1.4	0.2	0.5	1.8	0.3	0.7	0.8	1.1	0.1	0.0	0.4	0.2	0.4	1.3	0.0	2.7	0.7	3.7	0.9	4.6	0.5	0.4	2.6	1.6	0.4	2.1	3.6	1.9	1.4	0.2	1.0	0.3	0.3	1.5	1.0	2.6	0.3	0.7	1.8	0.2	1.0	0.3	0.9	3.0	1.0	1.0	0.9	1.0	0.8	1.0	0.8	0.7	0.5	1.3	1.1	1.1	2.6	1.1	1.3	1.1	0.7	0.4	0.7	1.7	2.4	1.1	0.8	0.8	0.4	0.4	0.4	0.4
DPEP1		ENSG00000015413	"Dipeptidase 1"	P16444	16	89613308-89638456	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 161.7;kidney: 52.2;pancreas: 100.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.1;Hep G2: 19.9;HHSteC: 9.0;U-937: 28.3"	"Cancer enriched"	"Detected in many"	8	"colorectal cancer: 107.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA009426, HPA012783"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	270000	270000	"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"HPA009426: AB_1847842, HPA012783: AB_1847843"	"unprognostic (3.31e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.18e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.27e-1)"	"prognostic favourable (6.84e-4)"	"unprognostic (6.12e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.93e-2)"	0.1	0.4	0.1	0.9	0.1	0.0	0.1	0.1	0.1	1.5	53.6	0.1	0.4	16.1	0.2	3.4	0.3	0.1	0.9	0.1	0.1	0.1	52.2	0.1	0.3	0.9	0.1	0.1	0.2	100.5	0.0	0.2	0.1	0.2	0.1	0.0	0.2	0.3	0.4	0.1	0.4	161.7	0.1	0.1	0.9	0.2	9.8	0.1	0.2	0.1	0.1	0.5	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.0	1.1	0.1	2.8	0.0	0.0	0.0	0.0	5.1	0.1	0.0	1.8	0.0	0.0	0.1	0.0	0.0	1.3	0.4	0.0	0.0	19.9	9.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.0	28.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1
DQX1	FLJ23757	ENSG00000144045	"DEAQ-box RNA dependent ATPase 1"	Q8TE96	2	74518131-74526336	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 41.0"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 6.4;Hep G2: 18.0;hTCEpi: 6.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039158	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039158: AB_10960125"	"unprognostic (2.17e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-2)"	"unprognostic (9.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-2)"	"unprognostic (3.93e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.68e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.13e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.16e-3)"	0.1	0.0	0.1	2.1	0.2	0.0	0.1	0.1	0.1	0.8	13.3	0.2	0.1	14.7	0.1	0.1	3.7	0.2	3.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.0	0.1	0.2	5.1	0.1	0.6	0.1	0.1	1.5	41.0	0.3	0.1	0.2	2.9	0.1	0.1	0.2	0.1	0.7	1.5	1.1	1.4	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.5	0.1	0.3	0.0	0.0	0.7	0.1	6.4	0.1	0.0	0.3	0.4	0.1	18.0	0.0	0.2	0.3	0.0	6.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.1	0.1	0.1	0.0	1.2	0.0	0.1	0.0	2.5	0.0	0.6	0.0	0.0	0.8	0.2	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
HNF4G	NR2A2	ENSG00000164749	"Hepatocyte nuclear factor 4 gamma"	Q14541	8	75407914-75566843	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 139.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.6;CAPAN-2: 17.3;Karpas-707: 4.9;PC-3: 5.3;THP-1: 5.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"gdTCR: 1.3"	"Lineage enriched"	"Detected in single"	13	"T-cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA005438, HPA010610"	Enhanced		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA005438: AB_1850822, HPA010610: AB_2668318"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.44e-2)"	"unprognostic (5.60e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.27e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.09e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.83e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-2)"	0.2	0.2	0.5	5.0	0.5	0.0	0.3	0.3	0.3	0.6	56.2	0.1	0.3	35.9	0.4	1.1	0.4	0.3	12.6	0.2	0.3	0.3	6.1	12.1	0.4	0.0	0.4	0.2	0.2	10.9	0.0	0.2	0.0	0.3	0.6	6.9	0.2	0.4	0.6	0.2	0.2	139.6	0.2	0.3	0.2	2.6	0.9	0.1	0.1	0.2	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	1.3	0.0	1.1	4.6	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.3	17.3	0.0	2.5	0.0	0.0	2.2	0.0	0.0	0.0	1.9	0.0	0.0	3.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.0	0.3	0.3	5.3	0.0	0.0	0.3	3.0	0.1	0.3	1.7	0.4	0.1	0.0	0.3	5.8	0.0	0.4	0.2	0.1	0.0	1.2	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	0.3	0.3	0.3	0.4	0.2	0.3	0.1
ISX	RAXLX	ENSG00000175329	"Intestine specific homeobox"	Q2M1V0	22	35066136-35087387	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	11	"intestine: 22.2"	"Group enriched"	"Detected in some"	15	"CACO-2: 3.4;Hep G2: 9.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA060328			Supported	"Nucleoplasm,Nuclear bodies"				Nucleoplasm	Nucleoplasm	"HPA060328: AB_2684254"			"unprognostic (5.02e-2)"				"unprognostic (2.68e-1)"				"unprognostic (2.23e-1)"	"unprognostic (3.33e-1)"		"unprognostic (3.86e-1)"	"unprognostic (2.55e-1)"			0.1	0.0	0.1	2.0	0.1	0.0	0.1	0.1	0.1	0.1	16.3	0.1	0.1	22.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	15.8	0.1	0.1	0.1	0.1	0.0	19.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LINC00483	"C17orf73, FLJ20694"	ENSG00000167117	"Long intergenic non-protein coding RNA 483"		17	50761029-50767557	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	11	"intestine: 73.0"	"Group enriched"	"Detected in some"	5	"CACO-2: 12.6;HDLM-2: 9.4"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 3.3;pancreatic cancer: 0.8;stomach cancer: 2.0"					"Cell type enhanced"	"Detected in some"		"neutrophil: 6.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 0.4"	"Low region specificity"	"Detected in all"														"unprognostic (2.98e-1)"		"unprognostic (1.96e-2)"	"unprognostic (2.02e-3)"			"unprognostic (2.76e-1)"	"unprognostic (4.52e-1)"		"unprognostic (1.95e-1)"	"unprognostic (2.09e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.67e-1)"		"unprognostic (1.05e-3)"	0.1	0.0	0.1	4.6	0.1	0.7	0.1	0.1	0.1	0.1	28.3	0.1	0.1	27.1	0.1	0.1	0.1	0.0	2.2	0.1	0.1		0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	9.7	0.1	0.1	0.1	0.1	0.2	73.0	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.8	6.5	1.5	0.9	0.9	0.4	0.6	1.0	0.6	1.4	0.0	0.6	1.2	0.5	0.0	0.0	0.0	12.6	0.8	0.3	0.3	0.3	0.8	0.0	0.2	0.1	9.4	0.8	0.7	2.1	1.6	0.0	0.7	1.9	0.6	0.1	0.2	0.0	0.0	0.2	0.9	0.0	0.5	0.4	1.3	0.2	0.5	0.9	0.6	0.5	0.1	2.1	0.4	1.0	0.5	1.0	0.1	1.2	0.0	1.0	1.2	0.7	0.8	0.4	0.5	0.4	1.0	0.4	0.4	0.5	4.6	1.5	0.8	0.7	0.8	0.4	0.7	0.7	0.7	0.2	1.1	0.9	0.6	6.5	0.9	0.8	0.8	0.5	0.4										
NXPE1	"FAM55A, MGC34290"	ENSG00000095110	"Neurexophilin and PC-esterase domain family member 1"	Q8N323	11	114521645-114559895	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 44.0;lymphoid tissue: 20.4"	"Cell line enhanced"	"Detected in single"		"U-138 MG: 1.0"	"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 3.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049133	Enhanced				"Intracellular and membrane"					"HPA049133: AB_2680647"	"unprognostic (2.81e-1)"		"unprognostic (2.19e-3)"		"unprognostic (3.40e-3)"			"unprognostic (4.10e-1)"		"unprognostic (1.05e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.76e-1)"				0.1	0.0	0.1	20.4	0.1	0.0	0.1	0.1	0.1	0.1	44.0	0.1	0.1	0.4	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	36.9	0.1	0.3	0.1	0.1	0.0	4.4	1.0	0.1	0.1	0.0	2.8	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
OTOP3		ENSG00000182938	"Otopetrin 3"	Q7RTS5	17	74935719-74949992	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	11	"esophagus: 17.5;intestine: 42.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;HDLM-2: 2.4;RPMI-8226: 2.2;SH-SY5Y: 1.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"															"unprognostic (9.28e-3)"				"prognostic favourable (3.86e-4)"			"unprognostic (2.77e-1)"		"unprognostic (8.60e-2)"	"unprognostic (3.42e-1)"		"unprognostic (1.03e-1)"	"unprognostic (8.36e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	34.1	0.0	0.0	42.9	0.0	0.0	17.5	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	2.5	29.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.7	1.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 181.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 2.0;RPMI-8226: 2.3;SH-SY5Y: 1.2;SK-BR-3: 1.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.8"	HPA014963	Enhanced									"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.1	0.1	0.1	0.0	0.1	0.0	1.4	0.1	0.1	0.1	142.8	0.0	10.7	34.6	0.1	0.5	0.1	0.1	3.4	0.1	0.1	0.1	12.5	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	1.8	0.0	14.9	17.1	0.1	2.1	181.4	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.7	0.1	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	11	"intestine: 36.5;kidney: 32.4"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 8.9;U-266/70: 6.5"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.3"	"Low region specificity"	"Detected in single"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA019059: "	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	0.4	0.0	0.3	2.3	0.3	0.0	0.5	0.3	0.5	0.8	14.9	0.3	0.3	5.3	1.1	0.3	0.9	0.5	0.3	0.3	0.3	0.0	32.4	3.1	0.7	0.3	0.3	0.3	1.0	0.4	0.5	0.3	0.5	0.3	1.4	0.8	0.3	0.4	0.3	0.3	1.1	36.5	0.3	0.3	0.4	0.5	0.3	0.3	0.3	1.3	0.3	0.4	0.6	1.3	0.8	0.0	0.0	0.8	0.0	0.5	0.0	0.9	0.4	0.2	1.1	3.9	2.2	0.8	2.2	0.6	0.4	1.3	2.3	1.6	0.5	0.8	1.5	3.2	0.7	0.3	0.6	1.8	1.8	2.0	1.9	0.1	0.7	0.2	0.9	0.7	8.9	0.9	2.9	1.2	0.3	0.9	0.6	0.3	0.1	1.0	0.0	0.2	0.5	0.5	0.8	3.1	3.7	0.5	1.0	0.2	0.0	2.3	0.9	1.1	2.6	2.1	1.4	2.2	0.7	6.5	0.3	2.9	0.6	0.7	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.8	0.0	0.2	0.0	0.3	0.3	0.3	0.5	0.3	0.0	0.3	0.3	0.3	0.3
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043032-32113029	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"intestine: 274.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.3;NB-4: 2.4;RPMI-8226: 4.8;SCLC-21H: 1.8;SH-SY5Y: 2.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	26	"cerebellum: 8.6"	"Low region specificity"	"Detected in all"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"CAB015467: , HPA051805: AB_2681618, HPA055106: "	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favourable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favourable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.2	0.0	0.2	1.3	0.2	0.0	1.5	0.2	0.2	2.2	181.5	0.2	2.9	95.5	0.3	0.8	1.9	0.0	14.1	24.5	0.2	0.0	1.0	0.9	0.3	0.2	0.2	0.2	0.2	0.4	0.0	1.0	0.2	0.2	0.8	1.6	0.2	5.7	3.5	0.2	4.6	274.9	0.2	0.2	0.7	1.2	0.8	0.2	0.2	0.2	3.5	1.5	0.2	2.0	0.3	0.1	0.6	0.8	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.6	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.0	2.4	0.1	0.0	0.0	0.0	4.8	0.0	0.1	1.8	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.6	0.3	0.8	0.1	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"intestine: 77.3"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 17.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"				"Actin filaments"	"Actin filaments"	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	33.0	0.1	0.8	26.0	0.1	7.2	0.1	0.2	2.2	0.1	0.0	0.0	3.1	4.9	2.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.4	0.0	1.0	77.3	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390152	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"intestine: 27.2;kidney: 53.0"	"Cell line enriched"	"Detected in some"	34	"RPTEC TERT1: 45.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 15.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	26000	26000			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavourable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favourable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.2	0.0	9.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.1	53.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.4	0.0
AC026461.4		ENSG00000275691			16	56676132-56677763	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	10	"blood: 1.1;intestine: 2.7;kidney: 1.0;thyroid gland: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;naive CD4 T-cell: 1.1"	"Low lineage specificity"	"Detected in single"																															"unprognostic (1.03e-1)"					"unprognostic (2.92e-2)"	"unprognostic (2.63e-4)"		0.0	0.0		0.0		0.0	0.0		0.0	0.0	1.8			2.4	0.0	0.0	0.0	0.1	0.0	0.0			1.0	0.1	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.7		0.0	0.0	0.0	0.0	1.4	0.0		0.0	0.1	0.0			2.7		0.1	0.0		0.3	0.0	0.0	0.6	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.5	0.0	0.3	0.2	0.1	0.0	0.1	1.1	0.0	0.0	0.1	0.6	0.0	0.2	0.2										
CDH17	"cadherin, HPT-1"	ENSG00000079112	"Cadherin 17"	Q12864	8	94127171-94217303	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 184.4"	"Group enriched"	"Detected in some"	7	"CACO-2: 33.3;U-266/70: 55.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 156.4;stomach cancer: 54.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 12.1"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 12.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023614, HPA023616, CAB025143, HPA026556"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"		3400000	3400000	"Cell Junctions"	"Cell Junctions"	"CAB025143: , HPA023614: AB_1845896, HPA023616: AB_1845895, HPA026556: AB_1845897"	"unprognostic (2.08e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.60e-2)"	"unprognostic (3.38e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.46e-2)"	0.3	0.2	0.2	17.6	0.3	0.3	0.3	0.2	0.2	0.3	88.9	0.2	0.2	54.5	0.4	0.3	0.4	0.4	7.0	0.6	0.2	0.3	0.3	0.3	0.3	0.5	0.2	0.2	0.3	0.4	0.0	0.3	0.2	0.2	0.4	44.0	0.2	0.3	0.2	0.3	0.2	184.4	1.4	0.2	0.6	0.3	0.3	0.2	0.3	0.2	0.2	0.5	0.4	0.3	1.5	0.8	12.1	1.0	1.4	0.6	0.1	0.1	6.1	0.3	0.4	0.0	0.1	0.5	0.1	0.1	0.0	0.1	33.3	1.5	0.2	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.5	0.1	0.6	0.2	0.1	0.1	1.7	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.4	0.2	0.5	0.2	0.2	0.4	0.1	1.0	0.1	0.1	0.6	0.4	0.2	0.2	0.2	0.3	0.3	0.2	0.3	0.3	0.5	0.2	55.3	0.1	0.1	0.1	0.2	0.3	2.5	1.0	1.2	0.5	0.8	0.3	0.6	0.5	0.4	0.8	1.5	0.5	0.6	12.1	1.4	0.5	0.7	0.5	0.1	0.2	0.3	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2
GNAT3	"GDCA, gustducin"	ENSG00000214415	"G protein subunit alpha transducin 3"	A8MTJ3	7	80458671-80512020	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 14.5"	"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 8.6"	"Group enriched"	"Detected in some"	6	"breast cancer: 0.8;urothelial cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	17	"olfactory region: 1.8"																						"unprognostic (2.01e-1)"							1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	6.8	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.5	0.0	0.0	0.0	0.1	1.1	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0
MYO15B	MYO15BP	ENSG00000266714	"Myosin XVB"		17	75588058-75626501	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in all"	10	"intestine: 155.3"	"Cell line enhanced"	"Detected in many"		"A549: 25.6;HEL: 10.7;HMC-1: 14.7;THP-1: 21.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"							"HPA022857, HPA023105"			Approved	Cytosol				Cytosol	Cytosol	"HPA022857: , HPA023105: "	"prognostic favourable (9.34e-4)"	"unprognostic (7.55e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.59e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.48e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.28e-1)"	"unprognostic (8.54e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.35e-1)"	"prognostic favourable (6.90e-5)"	7.5	2.8	4.2	7.3	5.3	13.8	8.9	1.6	4.3	8.0	58.9	8.1	5.4	48.9	13.6	4.5	2.8	10.8	13.5	5.8	4.5	1.7	13.0	2.0	10.7	5.0	6.5	5.5	14.9	3.6	1.8	3.7	4.0	5.1	7.1	5.9	6.5	5.2	4.5	3.1	3.9	155.3	5.9	4.0	13.2	4.8	3.1	5.9	5.5	14.0	2.3	4.0	4.9	7.2	2.8	2.0	6.2	1.5	1.9	1.4	1.1	0.3	25.6	0.3	0.9	0.2	0.4	0.3	0.1	0.0	0.0	0.0	3.3	7.3	0.3	1.0	0.0	0.4	0.0	0.0	0.0	0.3	1.9	10.7	4.9	6.3	0.7	0.0	14.7	0.7	0.4	0.0	0.0	0.1	0.6	2.8	0.0	3.5	0.2	4.2	0.5	6.4	6.6	0.2	1.1	0.1	0.5	1.0	2.0	0.2	0.4	0.8	2.2	21.1	0.5	0.1	1.1	0.1	0.1	1.4	0.8	0.1	0.6	5.2	0.4	2.4	1.5	1.2	1.4	1.4	0.9	1.5	0.7	0.5	0.8	2.8	0.5	1.0	6.2	1.9	1.5	2.0	0.2	1.1	4.2	5.3	1.6	4.3	4.5	1.7	6.5	5.5	5.1	5.9
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027602-200177424	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	10	"intestine: 38.7;liver: 36.1;pancreas: 100.4"	"Cell line enhanced"	"Detected in some"		"A549: 19.3;HAP1: 11.7;HMC-1: 5.1;HUVEC TERT2: 16.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.5"					"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	2.9	0.2	0.2	4.5	0.3	0.0	2.6	0.2	0.2	2.3	23.8	0.2	0.6	8.1	3.5	1.3	0.7	1.3	5.7	0.5	0.2	0.4	0.4	36.1	1.6	0.7	0.3	0.3	1.0	100.4	0.0	0.3	0.3	0.3	1.1	6.3	0.3	0.5	1.3	1.0	0.7	38.7	1.8	0.4	0.3	0.6	0.6	0.2	0.2	0.8	0.3	0.4	0.8	1.1	1.3	1.4	5.5	1.2	1.5	1.1	0.3	0.0	19.3	0.0	0.1	0.0	0.2	0.5	0.0	0.3	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.5	11.7	0.0	0.0	2.5	0.8	0.0	0.2	2.0	0.4	0.0	5.1	0.1	0.0	0.0	0.1	16.1	0.0	0.3	0.0	0.5	0.0	0.3	0.8	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	3.7	0.3	0.1	0.8	0.2	0.1	0.1	2.7	1.7	2.0	0.3	0.1	0.1	5.5	1.2	1.1	0.6	0.7	0.7	0.7	1.0	0.8	0.4	1.3	1.1	1.0	4.2	1.5	0.5	1.4	0.9	0.3	0.2	0.3	0.2	0.2	0.2	0.4	0.3	0.3	0.3	0.2
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 71.9"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.6"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA049152	Approved				"Secreted to blood"					"HPA049152: AB_2680655"			"prognostic favourable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.1	7.0	0.1	0.0	0.1	0.1	0.1	0.1	20.6	0.1	0.1	4.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.2	71.9	0.1	0.1	0.1	0.1	0.0	24.1	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	10	"intestine: 19.3"	"Cell line enhanced"	"Detected in single"		"Daudi: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA039931	Uncertain									"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.0	7.2	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	19.3	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TUBAL3	FLJ21665	ENSG00000178462	"Tubulin alpha like 3"	A6NHL2	10	5393098-5404830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"intestine: 41.5"	"Group enriched"	"Detected in some"	6	"HEL: 16.5;K-562: 5.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA045900, HPA063394"	Uncertain									"HPA045900: AB_10961130, HPA063394: AB_2685003"	"unprognostic (2.63e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.13e-2)"		"unprognostic (3.02e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.44e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.35e-4)"	"unprognostic (7.93e-4)"	0.2	0.0	0.3	0.7	0.4	0.0	0.2	0.1	0.9	0.1	16.1	0.1	0.1	18.0	0.4	0.1	0.3	0.1	0.3	0.5	0.2	0.2	4.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.7	0.2	8.1	0.1	0.8	0.1	0.1	0.4	41.5	0.1	0.4	0.1	0.1	1.2	0.2	0.1	0.1	1.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.7	0.9	0.0	1.6	0.0	0.4	0.0	0.9	0.0	0.0	0.0	16.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.1	0.9	0.2	0.2	0.2	0.1	0.7	0.2
AC004754.1		ENSG00000269881			16	249547-269943	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	9	"intestine: 15.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.5;ASC TERT1: 2.4;EFO-21: 5.1;HHSteC: 2.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"naive CD4 T-cell: 1.5"	"Low lineage specificity"	"Detected in single"											"HPA011651, HPA071871"	Uncertain		Uncertain	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"HPA011651: , HPA071871: AB_2732188"	"unprognostic (1.22e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.75e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.37e-2)"	"unprognostic (5.06e-2)"	"unprognostic (5.24e-3)"	"unprognostic (4.66e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.95e-2)"	0.5	0.0	0.7	0.0	1.1	0.0	0.0	0.3	0.6	0.6	0.2			15.3	0.3	0.3	0.1	0.2	0.0	0.9	0.4	1.4	0.3	0.1	0.0	0.0	0.7		0.1	1.7	0.0	0.2	0.0		0.2	0.0		0.0	0.3	1.0	0.1	7.4	0.2	0.7	0.0	0.1	0.9			0.1		0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.8	0.4	1.8	2.5	2.4	0.5	0.0	1.2	0.0	0.1	0.3	0.1	0.0	5.1	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	2.5	0.0	0.0	1.0	0.0	0.2	1.0	0.7	0.0	0.3	0.0	2.2	0.0	0.2	1.2	0.0	1.3	0.0	0.0	0.9	0.0	0.3	1.0	0.0	0.0	0.4	1.0	0.6	0.0	0.4	0.0	1.0	0.0	0.1	0.2	0.1	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.8	0.0	0.5	1.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0										
BCL2L15	"Bfk, C1orf178, FLJ22588"	ENSG00000188761	"BCL2 like 15"	Q5TBC7	1	113878168-113887547	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 84.0"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 22.6;EFO-21: 7.8;RPTEC TERT1: 6.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.6;neutrophil: 1.9"	"Group enriched"	"Detected in many"	6	"granulocytes: 1.9;T-cells: 1.6"	"Region enriched"	"Detected in single"	32	"cerebellum: 36.9"	"Low region specificity"	"Detected in all"			"HPA029732, HPA029733"	Enhanced									"HPA029732: AB_10599615, HPA029733: AB_10600422"	"unprognostic (5.96e-2)"	"unprognostic (6.41e-3)"	"unprognostic (5.82e-2)"	"prognostic favourable (5.63e-4)"	"unprognostic (2.16e-1)"	"unprognostic (6.23e-3)"	"unprognostic (4.97e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-7)"	"unprognostic (5.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (9.04e-3)"	"unprognostic (4.27e-2)"	0.4	0.2	0.4	3.8	0.4	5.7	0.4	0.9	0.4	2.6	30.5	0.4	0.7	25.4	0.6	2.4	2.3	0.5	4.9	0.4	0.4	0.2	1.3	0.4	0.7	0.4	0.4	0.4	0.6	9.4	0.0	0.4	0.4	0.4	0.5	18.8	0.4	0.4	0.4	0.4	0.2	84.0	0.4	0.4	0.5	9.4	0.6	0.4	0.4	0.4	0.9	0.6	0.8	0.6	0.0	0.0	1.9	0.3	0.0	1.6	0.4	0.0	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.1	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.4	0.0	2.1	0.3	0.2	0.0	0.0	0.0	0.3	0.5	6.7	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.4	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	1.2	0.5	0.0	0.0	0.2	0.0	1.9	0.0	0.3	0.0	0.0	0.4	0.4	0.4	0.9	0.4	0.4	0.2	0.4	0.4	0.4	0.4
BTNL8	"BTN9.2, FLJ21458"	ENSG00000113303	"Butyrophilin like 8"	Q6UX41	5	180899077-180950906	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	9	"blood: 57.9;intestine: 111.7"	"Cell line enriched"	"Detected in some"	23	"CACO-2: 28.6"	"Group enriched"	"Detected in some"	12	"colorectal cancer: 2.6;liver cancer: 1.5;pancreatic cancer: 2.8;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	13	"neutrophil: 57.9"	"Lineage enriched"	"Detected in single"	213	"granulocytes: 57.9"									HPA039738	Enhanced									"HPA039738: AB_2676656"	"unprognostic (4.31e-1)"	"unprognostic (6.85e-6)"	"unprognostic (6.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.91e-1)"	"unprognostic (6.27e-3)"	"unprognostic (6.07e-2)"	"unprognostic (3.08e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.02e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.17e-2)"	1.1	0.2	0.1	2.2	0.4	2.3	0.5	0.3	0.7	0.2	37.6	0.1	0.1	43.8	0.2	0.2	0.2	0.6	9.3	0.3	0.3	0.1	0.4	0.3	1.9	2.0	0.3	0.2	0.2	0.5	0.0	0.2	0.2	0.5	0.1	9.7	0.4	0.1	0.1	0.3	0.1	111.7	0.1	0.5	2.2	2.5	3.5	0.3	0.3	0.9	0.2	0.1	0.1	0.7	0.0	0.0	57.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.2	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.9	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.3	0.7	0.3	0.1	0.3	0.2	0.5	0.3
CLECL1	DCAL1	ENSG00000184293	"C-type lectin like 1"	Q8IZS7	12	9715860-9733299	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	9	"blood: 42.4;intestine: 11.5;lymphoid tissue: 20.6"	"Group enriched"	"Detected in some"	5	"HEL: 15.7;Karpas-707: 21.7;U-698: 55.5;U-937: 30.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 42.4"	"Lineage enriched"	"Detected in many"	5	"B-cells: 42.4"									HPA063928			Supported	"Plasma membrane,Centriolar satellite"				"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"HPA063928: "	"unprognostic (2.18e-2)"	"unprognostic (2.35e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.90e-3)"	"unprognostic (3.66e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.55e-4)"	"unprognostic (5.10e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-5)"	"unprognostic (3.31e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.10e-2)"	"unprognostic (7.39e-2)"	2.7	1.0	0.8	9.8	1.1	0.9	1.1	0.3	0.9	0.6	1.7	1.3	0.1	1.6	0.7	1.3	2.6	0.9	1.5	2.7	1.0	0.9	1.6	1.4	1.9	15.5	1.3	0.7	0.5	1.7	0.0	0.9	0.5	0.9	0.8	2.8	0.8	1.5	0.1	0.5	0.5	11.5	0.9	2.5	20.5	2.6	0.6	0.3	2.2	0.9	0.5	20.6	2.8	2.4	42.4	8.6	0.7	4.6	0.0	3.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	55.5	0.0	30.5	0.0	0.7	2.6	0.1	1.7	4.6	0.0	42.4	1.4	3.5	6.1	14.5	0.0	0.5	0.1	0.0	4.6	8.6	0.1	2.1	0.8	1.1	0.3	0.9	1.0	0.9	1.3	0.7	0.9	0.3
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"intestine: 161.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 15.8;PC-3: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	11.8	18.5	3.6	5.7	4.7	6.4	6.8	6.6	5.6	3.3	60.2	4.0	6.4	44.7	3.9	3.6	5.5	3.1	7.9	6.3	3.7	2.7	6.7	14.4	3.8	3.1	4.1	2.7	3.3	3.9	5.0	4.0	4.3	3.6	3.4	6.3	4.1	5.9	4.3	10.0	4.8	161.0	3.6	2.6	5.3	5.7	10.7	4.2	5.1	3.8	6.2	5.0	4.7	3.4	0.7	2.2	2.8	2.0	0.3	1.7	0.8	3.8	4.1	1.9	3.6	3.2	1.3	2.3	2.7	2.7	2.6	1.8	9.7	2.6	1.5	10.6	1.7	3.3	1.6	3.7	0.5	2.8	4.0	2.8	3.3	15.8	2.3	0.7	2.9	1.8	2.9	1.6	1.9	2.0	2.2	3.5	1.7	3.2	4.8	3.1	0.9	17.6	6.2	0.8	2.5	2.4	2.1	2.0	3.4	3.6	4.4	1.8	2.5	2.7	1.6	1.4	4.9	2.8	2.2	2.0	0.4	0.6	1.4	4.9	2.3	0.0	2.0	2.8	1.2	1.3	1.7	0.7	0.9	1.1	2.2	0.5	0.7	0.3	2.3	0.3	1.7	1.1	0.7	0.8	3.6	4.7	6.6	5.6	3.7	2.7	4.1	2.7	3.6	4.2
FAM151A	"C1orf179, MGC27169"	ENSG00000162391	"Family with sequence similarity 151 member A"	Q8WW52	1	54609182-54623556	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 45.8;kidney: 59.3"	"Cell line enriched"	"Detected in single"	45	"CACO-2: 40.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 2.3;renal cancer: 3.2;testis cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"eosinophil: 2.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016840	Approved									"HPA016840: AB_2669461"	"unprognostic (1.89e-1)"	"unprognostic (6.90e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.97e-6)"	"unprognostic (1.71e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.91e-3)"	"unprognostic (9.99e-2)"	"prognostic favourable (4.09e-5)"	"unprognostic (5.85e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.40e-3)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.8	0.1	0.1	0.6	0.1	0.1	0.2	0.0	0.1	0.8	0.1	0.0	59.3	5.6	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.0	45.8	0.1	0.1	0.5	0.0	0.3	0.1	0.3	0.1	0.1	0.9	0.1	0.1	0.0	0.4	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	40.7	0.4	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.8	0.2	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
LGALS4	GAL4	ENSG00000171747	"Galectin 4"	P56470	19	38801671-38813364	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;NB-4: 2.6;RT4: 6.9;SH-SY5Y: 2.5"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 1.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"CAB025653, HPA031184, HPA031185, HPA031186"	Enhanced		Uncertain	"Plasma membrane"		92000	92000	"Plasma membrane"	"Plasma membrane"	"CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778"	"unprognostic (1.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.57e-3)"	"unprognostic (7.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-2)"	"unprognostic (5.01e-2)"	"unprognostic (5.34e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavourable (2.28e-4)"	"unprognostic (1.69e-1)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-2)"	"prognostic favourable (3.21e-4)"	0.3	0.2	0.2	83.5	0.2	0.0	0.3	0.3	0.2	0.3	190.6	0.3	0.3	65.5	0.3	0.5	0.6	0.5	157.1	0.2	0.2	0.2	0.4	20.3	1.5	0.2	0.2	0.2	0.3	8.3	0.0	0.2	0.2	0.2	0.8	75.8	0.3	0.3	0.4	0.3	0.3	326.8	4.9	0.2	0.6	10.5	0.2	0.2	0.3	0.4	0.3	0.2	2.7	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.1	0.6	0.2	0.0	0.7	0.1	2.1	0.0	0.0	0.1	0.1	3.0	0.5	0.5	0.4	0.2	0.0	0.0	0.0	0.0	0.7	0.1	0.5	0.3	0.0	0.3	0.0	0.3	0.0	2.1	0.0	0.0	0.1	0.1	0.2	0.0	0.6	0.3	2.6	0.0	0.0	0.3	0.2	2.1	0.2	6.9	0.3	2.5	0.2	0.2	0.1	0.4	2.3	0.0	0.0	0.6	1.7	0.1	0.7	0.4	0.2	0.0	0.2	0.3	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2
LRRC19	FLJ21302	ENSG00000184434	"Leucine rich repeat containing 19"	Q9H756	9	26993136-27005693	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 61.3;kidney: 50.0"	"Cell line enhanced"	"Detected in some"		"A-431: 2.4;RPTEC TERT1: 4.1"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 6.0;renal cancer: 5.8;stomach cancer: 1.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									96000	96000				"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.16e-2)"	"unprognostic (9.21e-5)"	"unprognostic (1.87e-2)"	"unprognostic (4.48e-2)"	"prognostic favourable (7.08e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.32e-2)"	0.2	0.2	0.2	5.9	0.2	0.0	0.2	0.2	0.2	0.2	23.4	0.1	0.1	11.9	0.2	1.3	0.2	0.2	2.9	0.1	0.2	0.2	50.0	0.8	0.2	0.1	0.2	0.1	0.2	0.6	0.0	0.2	0.1	0.1	0.2	17.0	0.1	0.2	0.1	0.1	0.2	61.3	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.2	2.0	0.9	1.1	0.7	0.4	0.8	0.0	2.4	0.6	0.3	0.4	0.0	0.4	0.9	0.7	0.0	0.0	0.0	0.6	0.3	0.3	0.7	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.6	1.0	0.5	0.0	0.6	0.8	0.1	0.5	0.0	0.3	0.0	0.3	1.0	0.0	0.3	0.5	1.5	1.7	1.0	0.5	0.4	0.6	4.1	0.4	0.6	0.2	1.6	0.3	0.1	0.3	0.5	1.2	0.7	0.4	1.6	0.5	0.3	0.3	0.1	0.2	0.6	0.2	1.0	0.7	0.6	0.5	0.6	0.4	0.6	0.8	0.4	0.5	2.0	0.8	0.7	1.1	0.4	0.6	0.9	0.6	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
PYY	PYY1	ENSG00000131096	"Peptide YY"	P10082	17	43952738-44004469	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 40.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 7.8"	"Group enriched"	"Detected in many"	8	"endometrial cancer: 7.9;ovarian cancer: 15.2;testis cancer: 18.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"			"HPA010973, CAB016734"	Enhanced				"Secreted to blood"					"CAB016734: AB_876471, HPA010973: AB_1855194"	"unprognostic (8.17e-3)"	"unprognostic (5.41e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.48e-4)"	"unprognostic (5.26e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.69e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"	0.1	0.8	0.1	2.0	0.2	0.0	0.2	0.1	0.1	0.1	40.0	0.1	0.1	1.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.5	0.1	20.6	0.1	0.1	0.3	0.1	0.0	24.8	0.1	0.1	0.1	0.1	1.0	0.1	4.2	0.2	0.1	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.0	0.4	0.0	0.2	0.5	0.7	1.2	1.0	1.7	0.2	1.2	0.3	1.4	0.8	1.2	0.9	0.7	1.6	1.4	0.7	1.1	0.4	0.9	3.1	0.6	1.8	0.5	0.2	1.2	0.5	7.8	2.2	0.4	1.3	0.6	0.3	0.4	1.3	1.2	1.6	0.5	1.0	1.5	0.7	0.3	0.3	0.2	2.1	0.1	1.3	0.3	0.7	0.0	2.0	1.2	0.1	1.3	1.5	1.4	0.3	1.1	0.1	1.2	0.2	1.8	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.5	0.1
SEC16B	"LZTR2, PGPR-p117, RGPR, Sec16S"	ENSG00000120341	"SEC16 homolog B, endoplasmic reticulum export factor"	Q96JE7	1	177923956-177984303	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 43.4;liver: 47.4"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 8.4;CAPAN-2: 8.8;EFO-21: 6.7;HDLM-2: 6.8;RPMI-8226: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA054292, HPA072913"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane,Actin filaments"				"Endoplasmic reticulum, Plasma membrane"	"Endoplasmic reticulum, Plasma membrane"	"HPA054292: AB_2682439, HPA072913: AB_2732213"	"unprognostic (2.31e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.78e-3)"	"unprognostic (6.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.34e-4)"	"unprognostic (6.67e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-1)"	1.4	1.8	1.1	3.2	0.9	0.0	1.5	0.9	2.3	1.7	19.6	0.9	0.9	14.3	1.3	0.9	0.9	1.6	2.5	2.2	0.9	0.4	2.5	47.4	0.9	0.9	0.9	0.9	1.8	4.8	0.1	1.4	0.9	1.0	0.9	1.6	0.9	1.4	0.9	3.9	0.9	43.4	0.9	0.9	2.7	4.0	0.9	0.9	0.9	1.4	0.9	1.0	0.9	1.0	0.0	0.7	0.0	0.7	0.0	0.0	0.2	2.3	1.9	0.1	1.9	2.4	8.4	0.1	1.9	0.6	0.1	0.8	1.2	8.8	0.7	6.7	1.5	0.0	0.4	0.2	0.1	6.8	0.1	0.0	0.0	4.1	0.2	0.1	0.0	4.9	0.6	0.3	0.1	2.6	0.0	6.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	7.7	0.1	0.2	0.8	1.5	0.1	0.2	1.0	0.1	1.6	0.9	1.3	0.2	0.8	0.0	1.9	0.8	0.1	3.3	0.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	1.1	0.9	0.9	2.3	0.9	0.4	0.9	0.9	1.0	0.9
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781191	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"gallbladder: 14.9;intestine: 24.6;liver: 27.2;pancreas: 14.2"	"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 5.7"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"							HPA055564	Approved									"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.2	0.0	0.2	1.8	0.2	0.0	0.2	0.2	0.2	0.2	12.8	0.2	0.2	14.8	0.2	0.4	0.2	0.1	14.9	0.2	0.2	0.1	2.2	27.2	0.2	0.2	0.2	0.2	0.2	14.2	0.0	0.2	0.2	0.2	0.2	14.2	0.2	0.2	0.2	0.2	0.0	24.6	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	1.3	0.1	0.1	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.1	0.7	5.7	0.0	0.2	0.3	0.1	0.2	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.0	0.3	0.0	0.1	1.3	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416895	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 77.7"	"Group enriched"	"Detected in some"	11	"CAPAN-2: 17.3;Hep G2: 44.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favourable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.2	0.0	0.5	1.1	0.2	0.1	0.2	0.2	1.1	0.2	73.9	0.2	0.2	42.1	0.2	0.4	0.2	0.3	0.7	0.2	0.2	0.0	8.3	0.4	1.3	0.2	0.2	0.2	1.5	0.6	0.0	0.3	0.4	0.2	0.4	0.1	0.2	0.5	0.2	0.2	0.0	77.7	0.2	0.2	0.2	1.2	0.4	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.1	17.3	0.0	0.5	0.0	0.1	0.0	0.0	0.0	2.9	0.4	0.7	0.1	44.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	0.9	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.2	0.2	1.1	0.2	0.0	0.2	0.2	0.2	0.2
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383075	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Group enriched"	"Detected in some"	9	"intestine: 6.2;lymphoid tissue: 2.4;smooth muscle: 1.9"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.1;SCLC-21H: 2.3"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.2	0.0	0.0	6.2			0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.0	0.0	0.1	0.0	0.0		0.3	3.1		0.0	0.0	0.0	0.0	1.5	1.9	0.0	0.0	0.3	0.1			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SMIM32		ENSG00000271824	"Small integral membrane protein 32"		5	136191468-136193134	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Group enriched"	"Detected in some"	9	"brain: 7.8;gallbladder: 9.8;intestine: 12.3;kidney: 26.2"	"Group enriched"	"Detected in some"	7	"HaCaT: 2.2;SCLC-21H: 6.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 12.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"														"unprognostic (2.35e-5)"	"unprognostic (3.08e-1)"	"unprognostic (7.74e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.11e-2)"	"unprognostic (9.13e-2)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.86e-2)"		"unprognostic (1.75e-2)"	"prognostic favourable (6.13e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.85e-3)"	"unprognostic (8.05e-2)"	0.0	0.0	0.0	1.2	2.2	0.0	0.0	0.0	7.8	0.0	5.1	0.0	0.0	12.3	0.0	0.0	0.0	0.0	9.8	0.0	0.6		26.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.4	0.1	0.0	0.0	0.2	0.0	8.3	0.0	0.0	0.0	1.5	0.0	1.4	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	6.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0										
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	9	"intestine: 80.9;liver: 69.8"	"Group enriched"	"Detected in some"	14	"CACO-2: 24.3;Hep G2: 42.1"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"non-classical monocyte: 1.1"	"Lineage enriched"	"Detected in single"	5	"monocytes: 1.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"				"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	45.1	0.1	0.1	50.5	0.1	0.2	0.1	0.1	7.0	0.1	0.1	0.1	3.1	69.8	0.1	0.1	0.1	0.1	0.1	0.9	4.1	0.1	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.1	80.9	0.1	0.1	0.1	8.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	24.3	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	42.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
XPNPEP2		ENSG00000122121	"X-prolyl aminopeptidase 2"	O43895	X	129738974-129769538	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"intestine: 145.6;kidney: 49.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 6.2;ASC TERT1: 32.6;HSkMC: 16.5"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.3;liver cancer: 18.3;stomach cancer: 3.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"gdTCR: 7.3;intermediate monocyte: 2.1;MAIT T-cell: 2.2;memory CD4 T-cell: 2.4;memory CD8 T-cell: 4.8;naive CD8 T-cell: 3.6;non-classical monocyte: 4.4;T-reg: 2.2"	"Group enriched"	"Detected in many"	7	"monocytes: 4.4;T-cells: 7.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA000339, CAB025136, CAB025269, HPA064568"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	8900000	8900000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB025136: , CAB025269: , HPA000339: AB_1858894, HPA064568: "	"unprognostic (7.95e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.54e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.26e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.07e-1)"	"unprognostic (9.28e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.26e-3)"	4.7	0.5	0.0	1.1	0.1	0.0	3.2	0.0	0.1	1.7	57.4	0.1	0.8	37.0	1.2	1.7	4.2	3.4	1.3	2.6	0.0	0.0	49.7	8.0	1.0	1.2	0.0	0.0	3.5	0.9	0.0	0.0	0.6	0.1	3.6	2.0	0.7	0.7	0.3	1.6	2.1	145.6	2.5	0.1	0.2	1.7	1.2	0.0	0.1	0.9	1.4	0.3	4.0	10.7	0.4	0.8	0.2	4.4	0.0	7.3	1.3	0.0	0.0	0.4	0.0	6.2	32.6	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	7.3	2.1	2.2	0.0	2.4	4.8	0.3	0.4	0.7	3.6	0.2	0.0	4.4	0.8	2.2	1.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 59.9"	"Cell line enhanced"	"Detected in some"		"HEL: 15.6;HMC-1: 6.5;K-562: 17.9;SH-SY5Y: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"HPA062621, HPA065947"	Enhanced		Approved	"Nuclear bodies,Vesicles,Plasma membrane"				"Nuclear bodies, Vesicles, Plasma membrane"	"Nuclear bodies, Vesicles, Plasma membrane"	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	36.0	0.0	0.0	37.2	0.2	0.3	0.1	4.3	0.5	0.7	0.4	0.0	0.0	0.1	2.2	0.4	0.1	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.3	59.9	0.0	0.0	2.7	0.3	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0
BCO1	"BCDO, BCDO1, BCMO, BCMO1, FLJ10730"	ENSG00000135697	"Beta-carotene oxygenase 1"	Q9HAY6	16	81238448-81291142	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 28.1;retina: 62.0"	"Cell line enhanced"	"Detected in some"		"A549: 12.5;EFO-21: 9.5;HAP1: 3.6;NTERA-2: 5.1;RPTEC TERT1: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043811			Uncertain	"Actin filaments,Centriolar satellite"				"Actin filaments, Centriolar satellite"	"Actin filaments, Centriolar satellite"	"HPA043811: "	"unprognostic (2.78e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.61e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.05e-2)"	"unprognostic (8.01e-4)"	"unprognostic (1.65e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.58e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.09e-1)"	0.1	0.0	1.3	0.2	1.4	0.0	0.2	0.2	1.6	0.3	28.1	0.3	1.4	11.0	0.7	0.5	0.7	0.6	1.4	0.1	1.7	1.9	4.2	2.5	0.3	0.1	0.8	0.1	2.0	0.4	0.0	1.9	0.1	5.9	1.3	3.6	62.0	1.3	2.8	0.6	0.3	16.9	0.4	0.4	0.1	2.3	0.2	0.3	0.3	0.2	0.5	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	2.5	0.0	9.5	0.0	0.1	3.6	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	5.1	0.0	0.0	0.0	0.0	9.6	0.3	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.2	1.6	1.7	1.9	0.8	0.1	5.9	0.3
C6orf222	DKFZp779B1540	ENSG00000189325	"Chromosome 6 open reading frame 222"	P0C671	6	36315757-36336885	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 46.7"	"Group enriched"	"Detected in some"	4	"CACO-2: 3.1;Daudi: 3.4;REH: 3.3;RT4: 1.6;U-937: 3.6"	"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA038407, HPA058189"	Uncertain									"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.1	0.0	0.1	0.7	0.1	0.0	0.1	0.1	0.2	0.1	14.0	0.1	0.1	19.8	0.1	0.1	0.1	0.0	1.2	0.1	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.1	0.1	4.7	0.0	0.1	0.1	0.1	0.1	4.6	0.1	0.1	0.1	0.1	0.2	46.7	0.1	0.1	0.1	5.8	1.4	0.1	0.3	0.1	0.1	0.1	0.1	0.1	1.3	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	3.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.6	0.0	1.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.3	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CHP2		ENSG00000166869	"Calcineurin like EF-hand protein 2"	O43745	16	23754627-23758951	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 105.8;skin 1: 36.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 9.2;NB-4: 10.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.4"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB072806	Approved									"CAB072806: "	"unprognostic (4.82e-1)"	"unprognostic (3.40e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.54e-1)"		"unprognostic (4.54e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.31e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.44e-5)"	"unprognostic (2.21e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.84e-2)"	"unprognostic (9.01e-2)"	0.3	0.0	0.3	8.8	0.5	0.0	0.5	0.4	0.7	2.3	37.4	0.7	0.8	54.8	0.4	0.6	0.4	0.1	0.3	0.3	0.3	0.1	0.5	0.3	0.5	0.3	1.2	0.3	0.3	0.3	0.0	0.3	0.8	0.8	1.4	26.2	0.4	0.6	0.5	0.3	36.8	105.8	0.9	0.9	0.3	0.0	2.9	0.6	0.5	0.3	0.5	0.4	6.2	1.4	1.5	1.3	2.5	0.9	0.4	0.9	0.1	1.2	2.7	0.9	0.8	1.7	1.7	1.6	3.6	1.4	0.6	1.3	0.8	2.9	0.6	1.2	3.1	1.8	0.6	3.5	0.8	0.8	0.3	0.6	5.1	2.1	2.1	0.5	0.9	1.2	1.1	3.2	9.2	1.5	1.5	1.3	1.6	0.2	0.1	10.6	0.5	2.6	0.3	0.2	1.7	1.4	1.5	0.8	1.0	1.1	0.3	0.1	0.3	0.2	1.6	0.7	1.0	1.0	0.2	0.6	0.2	0.3	0.0	0.7	0.7	1.2	0.9	0.2	0.9	0.5	0.5	0.7	0.6	0.7	0.4	1.5	0.9	0.8	2.5	0.4	0.5	1.3	0.3	0.1	0.3	0.5	0.4	0.7	0.3	0.1	1.2	0.3	0.8	0.6
ERICH4	"C19orf69, LOC100170765"	ENSG00000204978	"Glutamate rich 4"	A6NGS2	19	41443158-41444765	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 78.1"	"Group enriched"	"Detected in some"	12	"CACO-2: 4.7;Hep G2: 10.8;THP-1: 3.0"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA042632, HPA048484"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA042632: AB_2678090, HPA048484: AB_2680415"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-1)"	"unprognostic (9.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-1)"		"unprognostic (4.03e-5)"	"unprognostic (8.53e-2)"		"unprognostic (7.54e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.16e-1)"		0.6	0.0	0.2	0.2	0.3	0.0	0.6	0.2	0.3	0.4	21.0	0.2	0.2	27.1	0.4	0.4	0.2	0.4	0.5	1.3	0.2	0.0	10.0	0.2	1.2	0.2	0.3	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.9	0.0	78.1	0.2	0.3	0.2	0.1	0.8	0.2	0.2	0.3	0.2	0.2	0.3	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.3	0.2	0.2	0.2
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791664-52803910	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adrenal gland: 119.4;intestine: 202.4;kidney: 79.7;liver: 214.4;testis: 78.2"	"Cell line enriched"	"Detected in some"	13	"Hep G2: 87.7"	"Group enriched"	"Detected in many"	6	"liver cancer: 555.4;renal cancer: 135.0"	"Region enriched"	"Detected in single"	6	"basal ganglia: 4.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: "	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favourable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavourable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.6	119.4	0.6	0.7	4.2	0.0	0.6	0.6	0.7	0.8	64.3	4.3	0.6	59.9	0.6	1.2	0.7	6.9	16.4	0.6	0.6	0.0	79.7	214.4	7.1	0.6	0.6	0.6	8.5	16.9	0.0	0.7	0.9	0.7	1.8	0.2	1.0	2.6	0.8	0.6	0.1	202.4	0.6	0.6	0.6	10.7	78.2	0.6	0.7	0.6	2.1	4.4	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	87.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.7	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	4.2	0.6	0.7	0.6	0.0	0.6	0.6	0.7	0.6
HOXB13		ENSG00000159184	"Homeobox B13"	Q92826	17	48724763-48729178	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 18.6;prostate: 38.3"	"Cell line enriched"	"Detected in some"	13	"PC-3: 57.6"	"Cancer enriched"	"Detected in many"	17	"prostate cancer: 187.6"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB004438, HPA062852, HPA065019"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB004438: AB_627744, HPA062852: AB_2684880, HPA065019: AB_2685406"	"unprognostic (4.81e-2)"	"unprognostic (2.57e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.85e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.17e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.73e-11)"	"unprognostic (1.39e-2)"	"unprognostic (4.50e-2)"		"unprognostic (1.12e-1)"	0.3	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	2.4	10.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	1.4	0.1	38.3	18.6	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	3.6	2.4	0.1	0.2	1.3	0.1	0.1	0.1	0.0	0.6	2.0	0.0	4.5	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.8	1.0	0.0	1.0	0.0	0.0	2.9	0.0	0.0	0.3	1.4	0.9	0.6	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.0	57.6	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.9	0.0	1.4	0.0	0.2	0.0	0.2	1.7	1.7	0.4	0.0	0.0	0.0	0.0	0.0	1.4	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
LGALS2	HL14	ENSG00000100079	"Galectin 2"	P05162	22	37570246-37582616	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 129.0;gallbladder: 91.7;intestine: 43.0;kidney: 35.3;pancreas: 87.3"	"Group enriched"	"Detected in some"	13	"CACO-2: 45.9;Hep G2: 25.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 54.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	31	"classical monocyte: 129.0;intermediate monocyte: 47.0;myeloid DC: 100.5"	"Group enriched"	"Detected in many"	51	"dendritic cells: 100.5;monocytes: 129.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA003536, CAB025198"	Enhanced		Approved	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB025198: , HPA003536: AB_1078936"	"unprognostic (1.37e-3)"	"unprognostic (4.11e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.91e-3)"	"unprognostic (3.19e-1)"	"unprognostic (9.92e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (6.15e-2)"	"unprognostic (5.19e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.70e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.21e-1)"	3.1	0.4	0.6	4.3	0.5	1.8	0.6	0.4	0.5	0.5	12.6	0.5	0.4	6.1	1.0	1.9	0.8	0.6	91.7	0.7	0.4	0.4	35.3	1.0	2.3	7.9	0.5	0.4	0.6	87.3	0.0	0.4	0.9	0.5	0.5	13.0	0.5	1.8	0.4	0.4	0.9	43.0	0.4	0.5	8.3	1.5	0.6	0.4	4.5	0.5	1.0	9.6	0.7	0.6	0.6	100.5	2.2	129.0	0.1	0.2	70.1	1.1	0.6	0.4	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	45.9	0.0	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	25.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.4	0.2	0.1	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.7	0.8	1.0	0.7	0.7	2.7	0.9	0.4	1.8	0.3	0.0	0.1	0.1	1.2	0.0	0.5	0.6	129.0	0.6	0.1	47.0	0.2	0.6	0.1	0.2	100.5	0.2	0.2	0.1	2.2	0.1	2.9	0.8	0.2	70.1	0.6	0.5	0.4	0.5	0.4	0.4	0.5	0.4	0.5	0.4
PIGY	MGC14156	ENSG00000255072	"Phosphatidylinositol glycan anchor biosynthesis class Y"	Q3MUY2	4	88521573-88521789	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	8	"blood: 38.4;intestine: 10.6"	"Group enriched"	"Detected in some"	6	"AF22: 8.8;hTEC/SVTERT24-B: 10.7;MOLT-4: 18.3"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA059018	Uncertain									"HPA059018: AB_2683884"																		1.4	2.9	0.5	1.1	1.2	1.1	1.2	1.8	1.4	2.0	10.6			1.1	2.1	1.1	1.7	1.1	1.1	1.6	0.1	0.3	1.1	1.7	1.1	1.1	1.1		1.3	1.4	1.1	1.2	1.1		1.1	1.1		1.1	1.1	3.1	1.1	1.1	1.1	2.3	1.2	1.3	1.1			1.5		1.1	1.4	1.3	24.8	38.4	21.0	26.6	24.3	33.1	35.9	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.8	0.0	16.3	26.0	21.0	27.3	26.6	28.5	24.8	27.9	27.5	38.4	19.8	30.1	29.1	4.5	24.3	21.6	14.2	33.1	35.9										
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752654	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"intestine: 134.9"	"Group enriched"	"Detected in some"	6	"CAPAN-2: 29.5;SK-BR-3: 29.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	1.1	51.7	0.2	0.3	42.7	1.9	2.2	0.9	0.1	16.6	0.1	0.1	0.1	6.3	8.2	0.2	0.1	0.1	0.1	0.2	7.1	4.3	0.3	1.0	0.3	0.9	0.5	0.2	0.3	0.3	0.1	9.9	134.9	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.2	0.7	0.4	0.5	1.9	1.1	1.1	2.3	0.7	1.2	0.9	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.8	29.5	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.6	1.7	0.6	0.1	0.3	0.0	29.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.7	0.7	0.9	0.3	0.8	0.8	0.7	0.7	0.2	1.1	0.9	0.8	2.2	1.2	0.4	1.1	0.6	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996348-171026750	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 77.4;liver: 172.8"	"Group enriched"	"Detected in some"	68	"CACO-2: 7.1;Hep G2: 23.7"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favourable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	27.9	0.0	0.0	10.8	0.1	0.2	0.1	0.1	3.8	0.1	0.1	0.1	15.3	172.8	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	77.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	23.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SPIB	SPI-B	ENSG00000269404	"Spi-B transcription factor"	Q01892	19	50418938-50431313	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"blood: 83.3;intestine: 22.3;lymphoid tissue: 73.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 44.3;HDLM-2: 28.3;Karpas-707: 14.2;U-698: 61.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	57	"memory B-cell: 47.4;naive B-cell: 39.9;plasmacytoid DC: 83.3"	"Group enriched"	"Detected in many"	105	"B-cells: 47.4;dendritic cells: 83.3"									HPA018523	Uncertain									"HPA018523: AB_1857443"	"prognostic favourable (4.76e-5)"	"unprognostic (1.06e-5)"	"unprognostic (9.15e-3)"	"unprognostic (3.70e-2)"	"unprognostic (9.72e-3)"	"prognostic favourable (2.14e-5)"	"unprognostic (2.33e-1)"	"unprognostic (4.79e-3)"	"unprognostic (1.18e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.96e-8)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.75e-1)"	"unprognostic (7.33e-2)"	0.6	0.4	0.4	73.2	0.4	1.9	0.5	0.4	0.4	0.4	18.9	0.1	0.1	4.6	0.4	0.0	2.3	0.5	0.7	0.6	0.4	0.4	1.1	0.5	3.7	33.0	0.4	0.0	0.4	1.5	0.0	0.5	0.2	0.3	1.1	6.7	0.4	7.7	0.0	0.6	0.4	22.3	0.0	1.2	26.9	2.4	0.6	0.0	9.3	1.0	1.5	53.7	2.2	0.6	47.4	83.3	0.4	0.0	0.6	0.0	2.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	44.3	0.0	0.0	0.0	0.3	0.0	0.0	28.3	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.1	14.2	0.0	0.1	0.0	0.1	0.4	0.0	3.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.2	0.0	0.8	0.0	0.0	1.3	0.9	61.6	0.0	0.6	0.0	0.4	0.0	0.1	0.0	0.0	0.0	47.4	0.0	0.0	1.0	39.9	0.0	0.0	0.4	0.6	0.0	83.3	0.0	2.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.3	0.0
SSUH2	"C3orf32, fls485, ssu-2"	ENSG00000125046	"Ssu-2 homolog (C. elegans)"	Q9Y2M2	3	8619400-8745040	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	8	"intestine: 45.1"	"Cell line enriched"	"Detected in some"	20	"Hep G2: 23.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049777	Approved									"HPA049777: AB_2680876"	"unprognostic (2.49e-1)"	"unprognostic (7.62e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.46e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.09e-1)"	"unprognostic (7.97e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.15e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.65e-2)"	"unprognostic (4.96e-2)"	"unprognostic (7.50e-2)"	0.7	0.3	0.3	0.4	0.6	0.0	0.6	0.3	0.4	0.7	37.3	0.3	0.2	8.5	1.0	0.2	0.3	0.7	1.4	2.8	0.3	0.3	1.1	0.5	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.3	0.5	0.5	0.4	0.3	0.3	1.7	0.2	0.3	0.2	45.1	0.8	0.2	2.0	0.4	5.6	0.2	0.2	1.1	1.5	0.5	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	23.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.4	0.3	0.3	0.2	0.3	0.5	0.2
TREH	"MGC129621, TRE, TREA"	ENSG00000118094	Trehalase	O43280	11	118657316-118679690	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"intestine: 51.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.3;Hep G2: 2.1;RPMI-8226: 1.9;SiHa: 1.8;U-2 OS: 2.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA039913, HPA042045"	Enhanced				"Intracellular and membrane"	12000000	12000000			"HPA039913: AB_10674988, HPA042045: AB_2677817"	"unprognostic (1.29e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.01e-2)"	"unprognostic (5.22e-4)"	"unprognostic (2.52e-1)"	"unprognostic (9.83e-2)"	"prognostic favourable (3.76e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.63e-2)"	"prognostic favourable (2.33e-6)"	"unprognostic (2.09e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.15e-1)"	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.1	24.1	0.0	0.0	28.9	0.1	3.3	0.6	0.1	3.7	0.1	0.1	0.1	6.1	2.6	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.1	0.1	51.8	0.0	0.1	0.1	0.6	0.3	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	5.3	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.2	0.9	1.8	0.2	1.4	0.7	0.0	0.8	0.1	2.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.0
UGT2B15	UGT2B8	ENSG00000196620	"UDP glucuronosyltransferase family 2 member B15"	P54855	4	68646630-68670628	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"gallbladder: 22.4;intestine: 50.7;liver: 65.4"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;HL-60: 2.1;RH-30: 1.2;RPMI-8226: 1.1"	"Cancer enriched"	"Detected in many"	10	"liver cancer: 120.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 2.7"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.7"									HPA045108	Approved									"HPA045108: AB_2679218"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.86e-1)"		"unprognostic (1.94e-1)"	"prognostic favourable (9.82e-4)"	"unprognostic (6.73e-2)"			"unprognostic (3.49e-2)"	"unprognostic (7.84e-2)"	"unprognostic (5.81e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.38e-2)"		"prognostic favourable (4.50e-4)"	0.1	0.0	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	48.0	0.1	0.1	5.4	0.1	0.1	0.2	0.0	22.4	0.1	0.1	0.0	0.1	65.4	0.1	0.1	0.1	0.1	0.1	5.3	0.0	0.1	0.1	0.1	0.2	1.6	0.1	0.1	0.1	0.1	0.0	50.7	0.1	0.1	0.1	5.7	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	2.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.2	0.1	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.2	0.4	0.1	0.5	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 32.5;liver: 99.7"	"Group enriched"	"Detected in some"	23	"CACO-2: 13.5;Hep G2: 35.0"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 18.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA037779: AB_10670529, HPA044079: AB_2678800"	"unprognostic (3.87e-3)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.73e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.38e-3)"		"unprognostic (1.30e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.50e-4)"	0.1	0.1	0.1	1.7	0.1	0.0	0.1	0.1	0.1	0.1	14.4	0.0	0.0	8.7	0.1	0.6	0.1	0.1	3.0	0.1	0.1	0.1	9.5	99.7	0.1	0.0	0.1	0.0	0.1	5.6	0.0	0.1	0.0	0.1	0.1	3.8	0.0	0.1	0.0	0.1	0.1	32.5	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	1.6	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
AC005551.1		ENSG00000284638			19	3482804-3483446	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	7	"intestine: 15.0;retina: 22.4"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.7;CAPAN-2: 1.2;HEL: 1.1;PC-3: 1.7;U-937: 2.9"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																																			0.0	0.0	0.0	0.8	0.0	2.6	0.0	0.0	0.0	0.3	6.0	0.0	1.3	15.0	0.0	1.9	0.0	0.0	0.6	0.0	0.1		1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	22.4	0.0	0.6	0.0	0.0	8.9	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AGMO	"FLJ16237, TMEM195"	ENSG00000187546	"Alkylglycerol monooxygenase"	Q6ZNB7	7	15200318-15562015	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 41.9;liver: 57.9"	"Cell line enhanced"	"Detected in some"		"HSkMC: 4.0;Karpas-707: 8.5;NTERA-2: 3.8;SCLC-21H: 3.6;TIME: 4.3;WM-115: 16.8"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 15.7"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 3.6;neutrophil: 3.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA057900			Uncertain	Vesicles				Vesicles	Vesicles	"HPA057900: "	"unprognostic (2.82e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.44e-4)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.35e-1)"	"unprognostic (4.18e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	6.8	0.2	0.8	1.0	1.2	0.1	3.7	0.3	0.5	0.3	16.5	1.1	0.1	4.6	0.3	7.3	0.3	0.3	4.7	0.9	0.7	0.6	5.3	57.9	0.4	0.5	1.1	0.8	0.3	0.3	0.0	0.7	0.4	0.7	0.4	0.3	0.0	0.4	0.1	0.5	0.5	41.9	0.1	1.1	0.3	0.3	1.8	2.0	0.0	0.7	0.1	0.1	1.0	0.4	0.2	0.1	3.6	0.1	0.6	0.1	0.0	0.0	2.4	0.0	2.1	0.2	3.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	1.2	0.0	0.7	3.6	0.0	0.0	0.0	0.0	0.0	0.0	4.3	1.5	0.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	16.8	3.6	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.1	3.1	0.6	0.0	0.1	0.0	0.0	0.8	1.2	0.3	0.4	0.7	0.6	1.1	0.8	0.7	2.0
CASP5	ICE(rel)III	ENSG00000137757	"Caspase 5"	P51878	11	104994235-105023168	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 22.3;intestine: 31.0;lymphoid tissue: 12.3"	"Cell line enriched"	"Detected in some"	7	"HHSteC: 9.1"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 3.9;stomach cancer: 1.3"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	13	"intermediate monocyte: 10.5;neutrophil: 7.8;non-classical monocyte: 22.3"	"Group enriched"	"Detected in many"	14	"granulocytes: 7.8;monocytes: 22.3"																				"unprognostic (4.30e-2)"	"unprognostic (8.86e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.22e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (4.38e-3)"	"unprognostic (7.39e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.82e-9)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.50e-1)"	0.6	0.3	0.3	11.8	1.0	0.0	0.3	0.2	0.8	0.2	13.3	0.2	0.0	8.2	0.2	0.2	0.3	0.5	0.1	0.4	2.9	0.3	0.4	1.2	2.7	10.5	0.4	0.2	0.2	0.3	0.0	0.9	0.5	2.0	0.4	11.3	0.2	0.3	0.0	0.8	0.2	31.0	1.4	2.1	12.3	0.4	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	1.0	7.8	22.3	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.8	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	9.1	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.0	10.5	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	7.8	0.0	22.3	0.3	0.0	0.6	0.3	1.0	0.2	0.8	2.9	0.3	0.4	0.2	2.0	0.3
CD79A	"IGA, MB-1"	ENSG00000105369	"CD79a molecule"	P11912	19	41877120-41881372	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood: 125.3;intestine: 43.5;lymphoid tissue: 119.2"	"Group enriched"	"Detected in some"	24	"Daudi: 155.5;REH: 48.3;U-698: 135.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 106.4;naive B-cell: 125.3"	"Lineage enriched"	"Detected in many"	41	"B-cells: 125.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB000019	Enhanced									"CAB000019: AB_2244527"	"prognostic favourable (8.45e-5)"	"unprognostic (1.63e-3)"	"unprognostic (4.13e-3)"	"unprognostic (1.31e-3)"	"unprognostic (2.02e-1)"	"prognostic favourable (1.18e-5)"	"unprognostic (1.23e-2)"	"unprognostic (8.11e-3)"	"unprognostic (9.41e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.32e-1)"	"prognostic unfavourable (2.15e-5)"	"unprognostic (6.08e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	1.3	0.6	0.5	103.8	0.5	5.4	1.3	0.5	0.5	1.8	6.3	0.1	0.1	4.9	0.6	0.2	4.4	1.0	2.3	0.8	0.5	0.5	2.3	0.9	4.3	114.9	0.5	0.1	0.6	0.6	0.0	0.5	0.5	0.1	1.0	3.4	1.8	13.6	1.2	0.5	0.5	43.5	0.2	0.5	108.1	9.7	0.8	0.1	32.0	2.4	1.9	119.2	6.8	1.0	125.3	3.0	0.7	0.3	0.2	2.3	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.9	0.0	0.0	48.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.7	0.1	135.4	0.0	4.6	0.0	0.7	0.1	0.5	0.1	0.1	0.0	106.4	0.3	0.1	0.2	125.3	0.4	2.3	0.4	0.2	0.3	3.0	0.8	4.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.1	0.1	0.1
CDHR2	"FLJ20124, FLJ20383, PC-LKC, PCDH24, PCLKC"	ENSG00000074276	"Cadherin related family member 2"	Q9BYE9	5	176542511-176595974	"Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 179.8"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 21.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 9.1;liver cancer: 5.7;pancreatic cancer: 11.7;renal cancer: 8.6;stomach cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"hypothalamus: 2.5"	"Low region specificity"	"Detected in many"			"HPA012569, HPA017053"	Enhanced					3600000	3600000			"HPA012569: AB_1845298, HPA017053: AB_1845297"	"unprognostic (1.34e-2)"	"unprognostic (8.90e-4)"	"unprognostic (3.82e-2)"	"unprognostic (8.51e-2)"	"unprognostic (5.10e-4)"	"unprognostic (4.24e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.75e-1)"	"prognostic favourable (9.29e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.42e-1)"	0.1	0.0	0.1	2.5	0.3	0.0	0.1	0.1	0.3	0.1	80.0	0.1	0.1	67.2	0.1	0.8	0.1	0.2	7.1	0.1	0.1	0.4	3.0	26.6	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	2.9	0.5	0.1	0.1	0.1	0.1	179.8	0.1	0.1	0.1	2.8	1.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.8	0.3	0.0	0.1	0.1	0.0	0.2	0.3	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.5	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.3	1.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.3	0.0	0.0	0.1	0.1	0.3	0.1	0.3	0.1	0.4	0.1	0.1	0.1	0.1
CDHR5	"FLJ20219, MU-PCDH, MUCDHL, MUPCDH"	ENSG00000099834	"Cadherin related family member 5"	Q9HBB8	11	616565-626078	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 296.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;CACO-2: 6.6;RPMI-8226: 3.7"	"Group enriched"	"Detected in many"	17	"colorectal cancer: 33.2;liver cancer: 61.6;pancreatic cancer: 12.7;renal cancer: 35.4;stomach cancer: 26.7"	"Region enriched"	"Detected in single"	7	"pons and medulla: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA009081, HPA009173, CAB025004"	Enhanced				"Intracellular and membrane"	170000000	170000000			"CAB025004: , HPA009081: AB_1079428, HPA009173: AB_1079429"	"unprognostic (7.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.56e-3)"	"unprognostic (4.89e-2)"	"unprognostic (3.85e-2)"	"unprognostic (5.75e-2)"	"unprognostic (6.36e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.01e-2)"	"unprognostic (3.90e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.14e-2)"	0.1	0.3	0.1	8.1	0.1	0.0	0.1	0.1	0.1	0.1	118.7	0.4	0.0	34.3	0.1	0.8	0.1	0.2	12.1	0.1	0.2	0.1	10.9	43.8	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.2	0.0	1.6	0.1	21.3	5.1	0.1	0.0	0.1	0.1	296.7	0.8	0.1	0.1	1.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	0.0	2.4	0.0	0.0	0.0	0.0	6.6	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	1.5	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.1	0.7	0.8	0.0	0.1	0.1	3.7	0.0	0.3	0.0	1.6	0.0	0.2	0.0	0.0	0.2	0.6	0.1	0.1	0.3	1.1	0.0	0.3	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.0	1.6	0.0
CIDEB		ENSG00000136305	"Cell death-inducing DFFA-like effector b"	Q9UHD4	14	24305096-24311430	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 123.9;liver: 215.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 14.9;HEL: 7.6;Hep G2: 16.7;HL-60: 10.7;Karpas-707: 7.7;U-266/84: 9.9;U-937: 12.6"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001272	Approved									"HPA001272: AB_2666255"	"unprognostic (2.62e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.62e-3)"	"unprognostic (9.35e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.48e-4)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (3.39e-3)"	"unprognostic (2.36e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.04e-2)"	"unprognostic (5.15e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.64e-1)"	2.3	5.6	0.9	1.9	1.2	3.9	2.2	3.1	0.9	2.7	43.4	1.1	1.9	26.0	2.2	2.7	7.1	2.5	3.1	1.2	1.0	0.6	24.2	215.9	2.0	3.3	1.2	0.9	5.5	3.9	0.5	2.5	0.8	1.3	3.1	1.3	2.4	2.8	2.2	0.6	4.0	123.9	1.5	1.0	19.5	1.4	0.9	0.9	0.8	1.4	3.2	4.5	1.3	3.8	0.7	7.1	8.7	7.1	6.3	4.9	2.5	0.0	0.0	0.0	0.0	1.0	0.5	0.1	0.3	0.1	0.1	0.0	1.0	0.3	0.0	0.0	0.4	1.4	0.0	0.1	0.0	14.9	0.0	7.6	0.0	16.7	0.0	10.7	0.0	0.4	0.0	0.0	0.0	3.5	0.0	7.7	0.0	0.0	0.0	5.0	0.0	0.0	1.2	0.1	3.8	0.0	0.5	3.3	0.0	4.2	0.1	0.0	0.0	3.7	0.1	0.0	0.0	0.0	0.0	6.1	9.9	0.1	0.0	12.6	0.0	0.9	7.1	8.7	4.9	2.4	4.5	0.7	3.2	3.1	7.1	0.6	2.0	2.6	4.1	6.3	1.2	1.7	1.6	2.5	0.9	1.2	3.1	0.9	1.0	0.6	1.2	0.9	1.3	0.9
CPO		ENSG00000144410	"Carboxypeptidase O"	Q8IVL8	2	206939554-206969474	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 71.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 2.9;BEWO: 1.7;hTCEpi: 2.2;NB-4: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"basophil: 10.3"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.3"					"Low region specificity"	"Detected in many"								"Intracellular and membrane"						"unprognostic (9.39e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.95e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.89e-2)"	0.2	0.4	0.2	0.1	0.9	0.0	0.3	0.1	0.4	0.2	0.6	0.1	1.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.2	0.5	0.5	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.6	0.5	0.1	0.1	0.3	0.1	0.1	0.3	0.3	0.2	0.1	71.1	0.2	0.1	0.1	0.1	0.3	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	10.3	0.0	0.0	0.2	0.0	0.0	0.3	0.3	0.0	2.9	1.0	1.7	0.4	0.0	0.0	0.1	0.3	0.2	0.1	0.7	0.0	0.0	0.3	0.2	0.1	0.2	0.5	0.0	0.0	0.2	0.0	0.7	0.2	0.9	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.0	0.2	0.6	0.1	0.0	0.2	1.5	0.1	0.3	0.0	0.0	0.3	0.0	0.2	0.6	0.0	0.0	1.0	0.7	0.4	0.1	0.9	0.0	0.0	0.3	0.5	10.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.2	0.5	0.2	0.1	0.1	0.1
CYP4F2		ENSG00000186115	"Cytochrome P450 family 4 subfamily F member 2"	P78329	19	15878023-15898120	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 69.1;liver: 102.9"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 8.8"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 29.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"basophil: 8.5"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 8.5"									"HPA014048, HPA017265, HPA058960"	Supported				"Intracellular and membrane"					"HPA014048: AB_1847452, HPA017265: AB_1847451, HPA058960: AB_2683862"	"unprognostic (7.46e-3)"	"unprognostic (3.58e-1)"	"unprognostic (3.01e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.55e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.64e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.69e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.89e-1)"		"unprognostic (7.79e-3)"	0.1	0.1	0.2	0.5	0.1	0.0	0.2	0.1	0.2	0.2	10.1	0.2	0.1	24.5	0.1	8.8	0.2	0.1	1.8	0.1	0.2	0.1	11.9	102.9	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.2	1.9	0.0	0.1	0.1	0.2	0.1	0.5	69.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.1	0.4	0.3	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.3	0.7	0.1	0.3	0.1	0.0	0.6	0.0	0.3	0.0	0.0	0.1	0.0	0.2	8.8	0.0	0.9	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.1	0.1	0.3	0.6	0.8	0.1	0.4	0.4	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.2	0.1
DDC	AADC	ENSG00000132437	"Dopa decarboxylase"	P20711	7	50458436-50565457	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 90.1;kidney: 68.1"	"Group enriched"	"Detected in some"	8	"CACO-2: 17.4;Hep G2: 15.3;SCLC-21H: 44.0;SH-SY5Y: 45.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"midbrain: 7.9;pons and medulla: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"midbrain: 90.4;pons and medulla: 40.7"	HPA017742	Enhanced		Approved	"Actin filaments"		380000	380000	"Actin filaments"	"Actin filaments"	"HPA017742: AB_1847832"	"unprognostic (1.04e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.57e-2)"	"unprognostic (3.49e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (5.15e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.44e-2)"	"unprognostic (9.36e-3)"	"unprognostic (5.24e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.55e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.16e-1)"	0.3	10.9	0.3	3.0	0.7	0.0	0.3	0.3	0.4	0.3	36.7	0.4	0.3	33.5	0.3	1.8	0.3	0.0	0.7	0.3	0.3	1.3	68.1	11.7	0.7	0.3	7.9	0.3	0.4	9.8	0.0	0.3	0.3	3.4	0.4	8.1	0.4	0.3	0.3	0.3	0.1	90.1	0.3	0.3	0.3	4.3	0.6	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	44.0	45.7	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.7	0.3	0.4	0.3	1.3	7.9	0.3	3.4	0.5
FABP1	L-FABP	ENSG00000163586	"Fatty acid binding protein 1"	P07148	2	88122982-88128116	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 453.2;liver: 370.7"	"Group enriched"	"Detected in some"	7	"CACO-2: 25.6;Hep G2: 81.3"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 175.1;liver cancer: 437.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	23	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002305, HPA028275"	Enhanced		Approved	Nucleoplasm,Cytosol		32000000	32000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB002305: AB_563728, HPA028275: AB_10600909"			"unprognostic (1.91e-1)"		"unprognostic (7.91e-3)"		"unprognostic (5.47e-2)"			"unprognostic (1.96e-1)"	"unprognostic (2.03e-2)"		"unprognostic (2.35e-1)"	"unprognostic (7.99e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.29e-1)"		0.4	0.1	0.4	33.9	0.4	0.0	0.4	0.4	0.5	0.4	153.5	0.4	0.4	137.9	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.2	57.6	370.7	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	97.7	0.4	0.5	0.4	0.4	0.1	453.2	6.7	0.4	0.4	0.2	0.5	0.4	0.4	0.5	0.5	0.4	0.4	0.4	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	25.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	81.3	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	7.0	0.1	0.0	0.0	1.4	7.5	0.0	0.1	0.8	5.6	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.1	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.5	0.4	0.2	0.4	0.4	0.4	0.4
FAM129C	"BCNP1, FLJ39802"	ENSG00000167483	"Family with sequence similarity 129 member C"	Q86XR2	19	17523301-17553839	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 37.2;bone marrow: 12.1;intestine: 12.3;lymphoid tissue: 37.9;salivary gland: 9.9"	"Group enriched"	"Detected in some"	22	"Daudi: 29.1;REH: 14.6;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	226	"memory B-cell: 10.9;naive B-cell: 19.5;plasmacytoid DC: 37.2"	"Group enriched"	"Detected in many"	284	"B-cells: 19.5;dendritic cells: 37.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA043277	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043277: AB_10794391"	"unprognostic (6.55e-5)"	"unprognostic (3.03e-7)"	"unprognostic (3.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-4)"	"unprognostic (3.79e-3)"	"unprognostic (1.69e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.47e-4)"	"unprognostic (8.42e-2)"	"unprognostic (5.51e-5)"	"unprognostic (3.39e-1)"	"unprognostic (9.03e-3)"	"unprognostic (6.08e-2)"	"unprognostic (7.56e-3)"	0.5	0.2	0.2	37.9	0.2	12.1	0.2	0.3	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.6	0.2	0.2	0.5	0.3	0.9	17.4	0.2	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.5	0.0	0.4	9.9	0.2	0.1	0.2	12.3	0.0	0.3	28.5	0.4	0.5	0.0	2.5	0.5	0.4	35.4	3.0	0.4	19.5	37.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	37.2	0.0	0.7	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FAM25C	bA164N7.4	ENSG00000276430	"Family with sequence similarity 25 member C"	B3EWG5	10	47995355-47999791	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"breast: 5.7;esophagus: 4.9;intestine: 5.0;lymphoid tissue: 2.8;skin 1: 10.3"	"Cell line enriched"	"Detected in some"	6	"SK-BR-3: 18.7"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 1.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044808	Uncertain									"HPA044808: AB_2679096"		"unprognostic (2.93e-1)"				"unprognostic (2.21e-1)"												0.0	0.0		0.0		0.0	5.7		0.0	0.0	0.0			0.0	0.0	0.0	4.9	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.7	10.3	5.0	0.0		0.0	0.0	0.0			0.0		2.8	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCRL2	"CD307b, FCRH2, IRTA4, SPAP1"	ENSG00000132704	"Fc receptor like 2"	Q96LA5	1	157745733-157777132	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 20.2;intestine: 14.9;lymphoid tissue: 27.0"	"Group enriched"	"Detected in some"	4	"Daudi: 14.7;U-698: 11.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	50	"memory B-cell: 20.2;naive B-cell: 10.8"	"Lineage enriched"	"Detected in single"	65	"B-cells: 20.2"																				"unprognostic (3.94e-3)"	"unprognostic (1.47e-3)"	"unprognostic (3.49e-2)"	"unprognostic (3.69e-3)"		"unprognostic (5.11e-5)"	"unprognostic (1.67e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.19e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.19e-2)"	"unprognostic (4.60e-7)"	"unprognostic (2.89e-1)"	"unprognostic (2.29e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.48e-1)"	0.4	0.2	0.2	22.6	0.2	1.5	0.2	0.1	0.2	0.2	1.3	0.1	0.1	1.2	0.3	0.1	1.4	0.2	0.4	0.2	0.2	0.2	0.5	0.9	0.7	15.6	0.3	0.1	0.5	0.2	0.0	0.2	0.1	0.2	0.4	1.7	0.6	2.8	0.7	0.1	0.2	14.9	0.1	0.2	27.0	0.8	0.2	0.1	0.3	0.5	0.1	23.3	1.4	0.2	20.2	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	14.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	3.1	0.0	11.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.3	0.1	0.2	0.1
GIMD1		ENSG00000250298	"GIMAP family P-loop NTPase domain containing 1"	P0DJR0	4	106357485-106368825	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	7	"intestine: 24.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.8;HBF TERT88: 1.0;HEL: 1.0;NB-4: 1.2;U-138 MG: 1.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"																															0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	23.5	0.0	0.0	0.0	0.0	3.5	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
HTR4	5-HT4	ENSG00000164270	"5-hydroxytryptamine receptor 4"	Q13639	5	148451032-148677235	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 18.1;heart muscle: 7.2;intestine: 14.6;pituitary gland: 5.9"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 18.1"	"Cell type enriched"	"Detected in single"	8	"T-reg: 1.5"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA040591	Enhanced									"HPA040591: AB_2677028"	"unprognostic (1.12e-1)"	"unprognostic (4.60e-2)"	"unprognostic (7.74e-2)"		"unprognostic (2.37e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.77e-2)"	"unprognostic (4.68e-2)"			"unprognostic (1.10e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.49e-2)"	"unprognostic (8.83e-5)"	0.4	1.4	1.9	1.1	18.1	0.1	0.2	0.1	3.2	0.6	4.3	0.0	0.0	8.0	0.3	0.1	0.3	0.4	1.5	7.2	5.2	0.6	0.1	0.2	0.3	0.2	0.5	1.3	0.2	0.1	0.1	5.9	0.1	0.1	0.1	4.9	0.0	0.2	0.2	0.2	0.2	14.6	1.1	0.3	0.2	0.2	0.2	2.4	0.0	0.2	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	1.9	18.1	0.1	3.2	5.2	0.6	0.5	1.3	0.1	2.4
LRRC66		ENSG00000188993	"Leucine rich repeat containing 66"	Q68CR7	4	51993702-52017620	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 50.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.5;CAPAN-2: 5.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA014549, HPA027839"	Uncertain									"HPA014549: AB_1853062, HPA027839: AB_10602705"	"unprognostic (1.10e-1)"	"unprognostic (4.87e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.57e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.93e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.61e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-1)"	"unprognostic (4.06e-1)"	0.5	0.1	0.8	2.6	1.0	0.0	0.5	1.4	0.9	0.5	11.3	0.5	0.5	19.6	0.5	0.5	0.5	0.5	1.6	0.6	0.8	0.8	0.9	0.5	0.5	0.5	0.8	0.5	0.5	0.5	0.5	3.1	0.5	0.5	0.5	5.2	0.5	0.5	0.5	6.7	0.0	50.2	0.5	0.6	0.5	4.6	0.7	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.2	0.4	0.7	1.9	4.5	0.2	0.7	1.1	0.4	0.8	0.2	5.7	0.0	0.1	1.1	0.0	0.3	0.3	0.3	1.8	0.7	0.0	0.2	0.0	0.2	0.1	0.1	1.7	1.0	0.9	0.3	0.4	0.0	0.0	2.2	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.2	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.7	0.4	1.2	0.1	0.7	0.5	0.7	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.0	1.4	0.9	0.8	0.8	0.8	0.5	0.5	0.5
MOGAT3	"DC7, DGAT2L2, MGAT3"	ENSG00000106384	"Monoacylglycerol O-acyltransferase 3"	Q86VF5	7	101195007-101201021	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 61.6;liver: 16.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 4.7;Hep G2: 15.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.0;liver cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"											HPA011940	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA011940: AB_1854057"		"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.14e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.20e-1)"	"unprognostic (9.54e-3)"		"unprognostic (9.36e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.05e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.66e-2)"	"unprognostic (1.65e-1)"		"unprognostic (2.59e-2)"	0.2	0.1	0.2	2.6	0.2	0.4	0.2	0.2	0.2	0.2	17.3	0.2	0.2	19.7	0.2	0.5	0.2	0.1	0.2	0.2	0.2	0.1	0.9	16.0	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	7.1	0.2	0.2	0.2	0.2	0.1	61.6	0.4	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	1.7	1.2	5.3	0.9	1.9	1.2	0.3	0.6	0.2	0.2	0.5	0.0	0.1	0.4	0.6	0.0	0.0	0.0	4.7	1.1	0.3	0.6	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.6	0.6	15.8	0.2	0.5	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.6	0.1	0.3	0.3	0.5	0.2	0.6	0.3	0.1	0.4	0.7	0.6	0.3	0.3	0.3	0.6	0.1	0.3	0.3	0.8	0.9	0.2	1.0	0.5	0.4	0.2	0.1	1.7	0.6	1.4	2.2	0.9	1.1	1.0	0.7	0.7	1.0	0.8	0.7	0.5	1.7	0.9	1.2	5.3	1.9	0.6	1.2	0.5	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
MUC12	MUC11	ENSG00000205277	"Mucin 12, cell surface associated"	Q9UKN1	7	100969623-101018949	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 35.6"	"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.7"	"Cancer enriched"	"Detected in some"	7	"colorectal cancer: 13.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA023835	Enhanced									"HPA023835: AB_1854199"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.84e-4)"	"unprognostic (4.40e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.33e-7)"	"unprognostic (8.42e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.54e-2)"	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	25.2			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		5.0	35.6		0.0	0.0	0.0	0.0	1.8	0.3	0.0	0.0	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0										
NKX6-3	FLJ25169	ENSG00000165066	"NK6 homeobox 3"	A6NJ46	8	41645178-41650669	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	7	"brain: 13.8;intestine: 10.8;stomach 1: 33.7"	"Group enriched"	"Detected in some"	7	"Daudi: 10.8;THP-1: 4.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 0.9;pancreatic cancer: 3.1;stomach cancer: 3.9;testis cancer: 1.6"	"Region enriched"	"Detected in some"	10	"cerebellum: 13.8"	"Cell type enriched"	"Detected in single"	17	"naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.7"																				"unprognostic (1.87e-1)"	"unprognostic (9.91e-3)"		"unprognostic (4.04e-1)"	"unprognostic (5.73e-2)"			"unprognostic (1.98e-1)"		"unprognostic (1.65e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.13e-1)"		"unprognostic (2.17e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.78e-1)"		0.2	0.0	0.4	0.2	0.5	0.0	0.2	13.8	1.3	0.2	4.6	0.2	0.2	10.8	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.8	2.9	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	33.7	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	13.8	1.3	0.2	0.2	0.2	0.2	0.2	0.2
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818485	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 7.1;intestine: 15.4;liver: 22.2"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 17.3"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"					"Cell type enriched"	"Detected in single"	18	"NK-cell: 7.1"	"Lineage enriched"	"Detected in single"	18	"NK-cells: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.6			15.4	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	22.2	0.0	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.5		0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.1	0.7	0.0			0.0		0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.3	0.1										
P2RY4	"NRU, P2P, P2Y4, UNR"	ENSG00000186912	"Pyrimidinergic receptor P2Y4"	P51582	X	70258170-70259764	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	7	"intestine: 14.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB022644	Uncertain									"CAB022644: "	"unprognostic (4.59e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.10e-2)"		"unprognostic (1.69e-1)"	"unprognostic (9.53e-4)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (8.89e-3)"	"unprognostic (2.90e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.89e-1)"	0.3	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	2.1	2.9	0.2	0.2	0.7	0.2	0.6	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.3	1.6	0.2	0.6	0.2	0.2	2.1	14.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.2	0.4	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.8	0.3	0.5	0.0	0.2	0.4	0.1	0.3	0.1	0.6	0.0	0.0	0.3	0.0	0.2	0.3	0.0	0.5	1.8	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.0	1.0	0.3	0.8	0.2	0.6	0.1	0.3	0.7	0.3	0.0	0.0	0.4	0.1	0.7	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.8	1.1	0.1	1.2	0.3	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
PLB1	"FLJ30866, PLB"	ENSG00000163803	"Phospholipase B1"	Q6P1J6	2	28457145-28643788	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 66.7"	"Cell line enhanced"	"Detected in some"		"AF22: 4.7;BEWO: 7.2;CACO-2: 4.7;RT4: 5.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	14	"classical monocyte: 3.1;eosinophil: 3.3;intermediate monocyte: 4.9;myeloid DC: 6.4;neutrophil: 9.9;non-classical monocyte: 5.2"	"Group enriched"	"Detected in many"	40	"dendritic cells: 6.4;granulocytes: 9.9;monocytes: 5.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"														"unprognostic (2.18e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.91e-3)"	"unprognostic (4.74e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.61e-9)"	"unprognostic (2.48e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.99e-2)"	"unprognostic (8.03e-2)"	0.9	3.3	0.7	1.0	2.1	2.9	1.0	0.6	0.7	0.9	0.8	0.6	0.6	0.2	0.8	1.7	1.3	0.7	0.9	1.4	0.6	0.9	0.8	0.6	0.7	0.6	0.8	0.6	0.6	0.6	0.0	0.7	1.3	0.7	1.0	1.1	0.7	0.6	0.9	0.9	5.2	66.7	1.7	0.8	2.8	0.5	1.2	0.6	0.6	1.2	0.9	0.6	0.9	0.6	0.0	6.4	9.9	5.2	0.0	0.1	1.1	0.8	0.1	4.7	0.1	1.0	0.7	7.2	0.2	1.9	0.5	0.4	4.7	0.5	0.5	0.5	0.7	1.0	0.0	3.8	0.4	0.3	0.1	0.4	0.7	0.8	1.6	0.8	0.3	0.8	2.2	0.7	1.2	1.2	0.0	0.1	1.3	0.0	0.0	0.6	0.2	1.0	0.0	0.8	0.0	2.1	5.3	2.1	0.4	0.2	0.3	0.4	0.0	2.5	0.5	0.5	1.4	0.2	0.2	1.0	0.2	0.0	1.7	3.6	0.1	0.0	3.1	3.3	0.0	4.9	0.0	0.0	0.1	0.0	6.4	0.0	0.0	0.0	9.9	0.0	5.2	0.3	0.1	1.1	0.7	2.1	0.6	0.7	0.6	0.9	0.8	0.6	0.7	0.6
REP15	RAB15EP	ENSG00000174236	"RAB15 effector protein"	Q6BDI9	12	27696519-27697596	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 27.2;stomach 1: 35.4"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA040448, HPA059868"	Approved									"HPA040448: AB_10964206, HPA059868: AB_2684148"	"unprognostic (4.13e-2)"	"unprognostic (4.32e-3)"	"prognostic favourable (9.43e-5)"	"unprognostic (7.29e-2)"	"unprognostic (7.42e-5)"	"unprognostic (4.63e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-1)"	"unprognostic (5.13e-3)"	"unprognostic (3.00e-1)"	"unprognostic (5.30e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.27e-5)"	"unprognostic (1.77e-1)"	0.8	0.6	0.6	4.2	0.6	0.0	0.6	0.6	0.6	0.6	16.2	0.6	0.6	6.0	0.6	0.6	0.6	0.3	3.5	2.2	0.7	0.2	0.8	1.3	1.0	0.6	0.6	0.6	1.6	0.6	0.0	0.7	0.6	0.6	1.1	27.2	0.6	0.6	0.6	0.6	0.3	26.1	0.6	0.6	1.4	35.4	0.7	0.6	0.6	1.0	0.6	0.6	0.6	0.6	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.7	1.4	1.2	2.7	2.5	3.9	2.2	4.0	1.9	1.7	1.5	5.5	1.0	0.7	1.3	5.1	1.4	1.3	2.5	4.2	1.8	1.0	1.6	1.7	1.4	0.4	0.6	0.9	2.0	2.6	5.0	1.4	5.3	0.6	0.2	7.6	0.7	2.6	0.3	3.9	3.6	0.4	2.6	5.4	4.7	0.7	0.2	0.3	1.2	0.6	2.0	0.3	0.9	4.9	9.2	4.2	1.0	3.5	0.0	0.0	0.0	6.8	0.8	9.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.6	0.6	0.6	0.7	0.2	0.6	0.6	0.6	0.6
SOWAHA	ANKRD43	ENSG00000198944	"Sosondowah ankyrin repeat domain family member A"	Q2M3V2	5	132813587-132816797	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 52.0;intestine: 35.0"	"Group enriched"	"Detected in some"	8	"SCLC-21H: 11.2;T-47d: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"amygdala: 59.1;basal ganglia: 89.2;cerebral cortex: 40.5;hippocampal formation: 66.1"	"Low region specificity"	"Detected in all"			HPA064621	Approved									"HPA064621: AB_2685302"	"unprognostic (1.59e-1)"	"unprognostic (5.58e-2)"	"unprognostic (3.75e-3)"	"unprognostic (5.34e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.18e-1)"	"unprognostic (5.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.65e-2)"	"prognostic favourable (4.03e-4)"	"unprognostic (3.92e-2)"	"prognostic favourable (9.38e-5)"	"unprognostic (4.36e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.53e-3)"	"unprognostic (1.42e-1)"	0.7	1.2	27.5	1.0	52.0	0.4	0.9	5.1	16.3	0.7	7.9	3.4	2.2	33.4	0.5	6.5	0.5	1.8	2.0	0.4	20.1	3.1	5.1	2.1	0.5	0.5	6.0	11.1	0.6	2.3	2.4	0.8	0.6	2.8	2.9	6.7	0.7	3.4	3.3	0.4	0.5	35.0	0.5	3.7	0.4	5.2	0.6	11.0	0.1	1.6	0.0	0.5	1.1	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	1.2	0.0	0.6	0.0	0.0	2.1	0.3	0.0	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	11.2	0.4	0.1	0.0	0.0	26.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.5	52.0	5.1	16.3	20.1	3.1	6.0	11.1	2.8	11.0
UGT2A3	FLJ21934	ENSG00000135220	"UDP glucuronosyltransferase family 2 member A3"	Q6UWM9	4	68928463-68951791	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 150.5;kidney: 43.2"	"Cell line enriched"	"Detected in some"	9	"Hep G2: 20.5"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 46.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	10	"eosinophil: 5.3"	"Lineage enriched"	"Detected in single"	53	"granulocytes: 5.3"									HPA045108	Supported									"HPA045108: AB_2679218"			"prognostic favourable (3.31e-4)"				"unprognostic (3.97e-3)"				"unprognostic (8.87e-3)"		"prognostic favourable (6.07e-7)"	"unprognostic (2.10e-2)"				0.1	0.1	0.1	4.3	0.1	0.0	0.7	0.1	0.1	0.1	63.8	0.1	0.1	31.9	0.1	1.7	0.1	0.1	14.6	0.3	0.1	0.1	43.2	9.6	0.1	0.1	0.1	0.1	0.1	12.0	0.0	0.1	0.1	0.1	0.1	8.6	0.1	0.1	0.1	0.1	0.1	150.5	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ZNF488	FLJ32104	ENSG00000265763	"Zinc finger protein 488"	Q96MN9	10	47365496-47384273	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	7	"brain: 29.7;intestine: 25.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 23.1;HDLM-2: 33.5;RT4: 18.6"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035957, HPA035958"			Supported	Nucleoplasm,Cytosol	"Intracellular and membrane"			"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA035957: AB_10672234, HPA035958: AB_2674887"	"unprognostic (3.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.49e-4)"	"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.60e-3)"	"unprognostic (2.13e-2)"	"unprognostic (3.11e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavourable (4.02e-7)"	"unprognostic (3.60e-1)"	"unprognostic (6.62e-5)"	"unprognostic (2.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.18e-2)"	0.4	0.4	5.7	0.4	18.5	0.3	1.2	2.9	14.2	0.5	3.2	17.0	0.0	25.8	0.5	2.3	0.9	0.5	0.6	0.4	15.1		1.1	0.3	0.5	0.3	19.8	6.0	0.7	0.3	0.3	0.0	4.1	21.4	0.6	1.1	0.0	0.6	0.4	0.3	2.2	12.5	0.4	29.7	0.3	0.6	1.2	12.8	0.0	0.3	0.0	0.9	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.3	6.7	1.1	0.3	0.0	0.0	0.1	0.2	0.3	0.4	0.4	2.6	6.2	0.1	0.4	0.0	23.1	0.6	2.5	0.3	33.5	0.7	0.1	0.7	0.2	0.0	0.0	0.3	0.0	6.1	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.1	1.7	0.6	0.0	2.9	0.0	0.1	18.6	5.5	1.0	1.6	0.2	0.0	0.5	0.0	0.0	0.0	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC243967.1		ENSG00000267881			19	41708612-41761282	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"esophagus: 79.7;intestine: 34.3;lymphoid tissue: 77.4;tongue: 22.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.9;HaCaT: 1.8;MCF7: 1.9;RT4: 4.1;U-2 OS: 1.2"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA011041	Approved									"HPA011041: AB_1078481"			"unprognostic (1.55e-2)"								"unprognostic (1.15e-2)"			"unprognostic (9.59e-3)"				0.4	0.3	0.3	60.6	0.4	0.2	0.5	0.6	0.4	9.2	34.3	0.0	0.0	0.5	0.3	0.1	79.7	0.3	0.5	0.5	0.4	0.3	0.4	0.7	1.4	0.1	0.3	0.0	0.5	0.6	0.3	0.5	0.1	0.0	0.5	0.4	0.0	0.7	0.1	0.4	0.5	6.1	0.7	0.3	0.6	0.8	0.6	0.0	0.0	0.4	22.3	77.4	1.0	8.0	0.1	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.0	0.0	0.0
ACY1		ENSG00000243989	"Aminoacylase 1"	Q03154	3	51983278-51989202	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"intestine: 53.3;kidney: 91.6;liver: 77.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											"CAB003695, HPA036174, HPA036175"	Enhanced					28000000	28000000			"CAB003695: AB_425286, HPA036174: AB_2674988, HPA036175: "	"unprognostic (4.28e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.15e-1)"	"unprognostic (6.51e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.05e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.36e-2)"	"unprognostic (2.70e-2)"	"prognostic favourable (2.93e-4)"	"unprognostic (3.57e-1)"	"unprognostic (3.75e-1)"	"unprognostic (7.88e-2)"	"prognostic favourable (6.77e-4)"	4.4	8.5	2.5	3.9	3.0	1.5	4.4	1.5	3.3	3.2	24.9	4.1	9.8	34.5	1.9	7.9	3.8	3.0	8.4	4.1	2.3	1.8	91.6	77.8	3.5	6.3	2.8	2.9	2.1	9.0	6.2	1.9	4.3	2.9	3.7	6.2	6.6	9.4	9.2	7.6	2.6	53.3	2.1	3.5	3.4	4.9	1.5	1.7	0.6	5.9	6.7	4.1	3.3	2.5	5.0	12.1	3.8	10.0	12.1	6.4	4.5	3.9	8.0	3.9	10.9	9.0	12.2	12.9	4.2	7.9	9.3	5.1	12.5	20.9	2.5	3.6	7.3	4.9	4.0	25.7	3.7	7.0	5.1	9.0	4.6	38.5	16.7	6.0	5.8	14.0	21.3	8.2	22.2	3.5	13.5	8.0	9.1	11.2	0.0	11.0	5.7	13.6	3.1	3.3	22.6	24.4	15.1	5.5	5.0	5.3	17.6	9.3	14.2	7.9	1.7	6.7	6.4	8.3	5.0	21.0	4.9	3.8	7.9	12.6	8.1	3.8	10.0	0.2	6.4	9.0	3.6	5.0	2.0	2.8	12.1	4.0	3.3	4.0	0.0	12.1	3.4	1.9	2.7	4.5	2.5	3.0	1.5	3.3	2.3	1.8	2.8	2.9	2.9	1.7
APOA4		ENSG00000110244	"Apolipoprotein A4"	P06727	11	116820700-116823306	"Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 593.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.9;CACO-2: 8.0;Hep G2: 7.5;NB-4: 7.3;RPMI-8226: 11.7;SH-SY5Y: 10.8"	"Cancer enriched"	"Detected in some"	29	"liver cancer: 291.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001352, HPA002549, CAB068250, CAB068251, CAB068252"	Enhanced		Approved	Vesicles	"Secreted to blood"	140000000000	140000000000	Vesicles	Vesicles	"CAB068250: AB_2665657, CAB068251: AB_2665659, CAB068252: , HPA001352: AB_1078179, HPA002549: AB_1078177"							"unprognostic (8.81e-2)"				"unprognostic (2.12e-2)"			"unprognostic (1.75e-2)"	"unprognostic (7.91e-2)"			0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	293.8	0.0	0.0	175.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	93.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	593.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	3.2	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARL14	"ARF7, FLJ22595"	ENSG00000179674	"ADP ribosylation factor like GTPase 14"	Q8N4G2	3	160677159-160678452	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 44.5;intestine: 49.1;stomach 1: 24.5"	"Group enriched"	"Detected in some"	6	"A-431: 6.8;CAPAN-2: 26.2;HaCaT: 6.5;RT4: 12.7"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 6.6;pancreatic cancer: 26.0;stomach cancer: 14.3;urothelial cancer: 8.1"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"memory B-cell: 5.1"	"Lineage enriched"	"Detected in single"	52	"B-cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"														"unprognostic (2.65e-1)"	"unprognostic (7.26e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.70e-3)"		"unprognostic (6.36e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavourable (2.64e-5)"	"unprognostic (2.30e-1)"	"unprognostic (8.67e-2)"	"prognostic unfavourable (6.71e-4)"	"unprognostic (4.74e-2)"	"unprognostic (4.91e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-2)"	0.2	0.2	0.2	6.9	0.2	0.0	0.2	0.2	0.2	0.5	26.3	0.3	0.2	16.4	0.2	0.2	0.8	0.2	44.5	0.2	0.2	0.1	0.3	1.5	0.2	0.2	0.2	0.2	0.2	6.7	0.0	0.2	0.2	0.2	1.7	11.8	0.2	0.2	0.2	0.2	0.2	49.1	0.7	0.2	0.2	24.5	0.4	0.2	0.5	0.2	0.6	1.1	6.5	1.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	26.2	0.0	0.6	0.0	6.5	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.2	2.1	12.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
B3GALT1	beta3Gal-T1	ENSG00000172318	"Beta-1,3-galactosyltransferase 1"	Q9Y5Z6	2	167868948-167874041	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 2.4;brain: 5.1;intestine: 5.8;skeletal muscle: 7.1"	"Cell line enriched"	"Detected in some"	8	"AN3-CA: 27.9"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"					"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.23e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.94e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (2.30e-3)"	"unprognostic (8.34e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.79e-1)"	0.1	0.6	0.5	0.0	1.6	0.0	0.3	0.9	5.1	0.2	5.6			0.0	0.2	0.3	0.0	0.8	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.3		0.1	0.2	0.0	0.8	0.0		0.1	5.8		0.1	0.9	7.1	0.0	0.1	0.0	0.1	0.0	0.0	0.5			0.1		0.0	0.0	0.1	1.4	0.8	2.0	0.5	1.0	2.4	0.4	0.0	0.0	2.2	27.9	0.2	0.0	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.1	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.1	0.0	0.4	0.0	1.8	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.6	0.0	0.5	0.0	2.6	2.0	0.5	0.3	0.6	0.3	0.7	1.1	0.7	0.7	0.2	1.4	2.4	1.3	1.5	1.0	0.3	0.8	0.6	0.4										
BANK1	"BANK, FLJ20706"	ENSG00000153064	"B cell scaffold protein with ankyrin repeats 1"	Q8NDB2	4	101411286-102074812	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 61.4;intestine: 18.0;lymphoid tissue: 67.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 10.2;HEL: 8.0;HL-60: 7.1;U-266/70: 24.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	15	"memory B-cell: 61.4;naive B-cell: 46.2"	"Lineage enriched"	"Detected in many"	17	"B-cells: 61.4"	"Low region specificity"	"Detected in many"							HPA037002	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA037002: AB_10672383"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.73e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.97e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.89e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.75e-2)"	"unprognostic (6.09e-3)"	"unprognostic (1.75e-1)"	3.3	2.9	0.7	45.4	0.9	2.0	1.9	2.1	0.7	0.7	1.3	0.7	1.4	0.7	0.4	1.2	6.0	1.0	1.6	0.9	0.8	0.7	2.0	0.5	4.9	30.3	0.7	0.2	0.9	0.6	0.0	3.7	0.5	0.6	2.2	1.1	0.5	7.7	1.8	0.4	0.6	18.0	0.3	0.8	67.0	2.5	1.3	0.7	4.8	5.5	0.4	42.3	6.5	1.1	61.4	2.0	3.6	0.3	0.2	0.0	2.1	0.0	2.2	0.0	0.0	2.7	1.1	0.0	0.1	0.0	0.3	0.5	0.0	3.5	10.2	1.0	0.0	0.1	0.1	1.1	0.3	0.0	0.0	8.0	2.1	0.0	0.1	7.1	0.0	0.5	0.3	0.0	0.0	0.1	0.0	3.1	0.4	0.4	0.0	0.4	0.0	4.3	0.1	0.4	0.0	0.3	4.7	2.0	0.0	0.2	0.1	0.0	0.4	1.8	1.0	0.0	0.4	0.0	0.0	24.5	0.0	1.6	0.1	4.1	0.0	1.5	0.3	3.6	0.0	0.1	0.0	61.4	0.0	0.0	2.0	46.2	0.0	0.0	0.1	0.2	0.0	1.0	0.0	2.1	0.7	0.9	2.1	0.7	0.8	0.7	0.7	0.2	0.6	0.7
CA1	Car1	ENSG00000133742	"Carbonic anhydrase 1"	P00915	8	85327608-85379014	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 156.0;intestine: 203.6"	"Cell line enriched"	"Detected in single"	1206	"HEL: 165.2"	"Group enriched"	"Detected in some"	10	"colorectal cancer: 3.4;stomach cancer: 0.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006558, CAB025790"	Enhanced					7800000000	7800000000			"CAB025790: , HPA006558: AB_1845989"	"unprognostic (1.44e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.57e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.03e-2)"		"unprognostic (1.73e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.61e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	1.8	0.4	0.5	11.5	0.5	156.0	0.4	0.3	0.4	0.3	95.4	1.5	0.0	0.0	0.3	0.0	0.6	0.7	0.0	17.6	0.5	0.4	0.8	2.9	32.2	0.2	0.9	0.0	0.8	0.5	0.0	1.0	24.0	0.6	1.1	203.6	2.6	0.3	0.1	3.1	0.2	0.4	3.2	0.5	14.3	0.3	0.3	0.0	0.2	7.5	0.0	0.2	4.5	16.0	0.7	0.7	0.0	0.3	0.0	0.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	7.5	0.5	0.5	0.3	0.4	0.5	0.4	0.9	0.0	0.6	0.0
CCK		ENSG00000187094	Cholecystokinin	P06307	3	42257825-42266207	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 95.1;intestine: 71.6"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 8.7;RPTEC TERT1: 22.7"	"Group enriched"	"Detected in many"	5	"glioma: 4.0;pancreatic cancer: 1.8;prostate cancer: 3.5;stomach cancer: 1.0"	"Group enriched"	"Detected in many"	5	"amygdala: 59.0;basal ganglia: 29.8;cerebral cortex: 95.1;hippocampal formation: 35.8;olfactory region: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 565.3"	"HPA045039, HPA069515"	Enhanced	Supported			"Secreted to blood"					"HPA045039: , HPA069515: AB_2732135"	"unprognostic (3.36e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"		"unprognostic (2.39e-3)"		"unprognostic (1.97e-2)"	"unprognostic (3.91e-1)"	"unprognostic (8.77e-2)"		"unprognostic (1.35e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.10e-2)"	0.9	1.1	59.0	1.1	29.8	0.8	0.9	0.2	95.1	0.8	11.3	1.4	0.0	71.6	0.8	0.8	0.9	0.9	0.9	0.9	35.8	10.8	0.8	0.9	1.1	0.8	8.0	26.9	0.8	1.1	0.8	4.1	9.4	1.3	13.5	0.9	0.0	0.8	1.0	0.8	0.9	10.5	1.0	1.3	0.8	1.7	1.7	0.5	0.0	0.8	0.0	0.8	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	22.7	0.1	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.0	29.8	0.2	95.1	35.8	10.8	8.0	26.9	1.3	0.5
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931939-28939346	"CD markers, Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 47.6;intestine: 16.7;lymphoid tissue: 40.3"	"Cell line enhanced"	"Detected in some"		"Daudi: 52.1;REH: 27.6;U-698: 11.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"memory B-cell: 36.0;naive B-cell: 47.6"	"Lineage enriched"	"Detected in single"	106	"B-cells: 47.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB016110	Enhanced									"CAB016110: AB_626952"	"unprognostic (3.27e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.63e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.11e-5)"	"unprognostic (2.61e-1)"	"unprognostic (6.96e-3)"	"unprognostic (1.29e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.41e-6)"	"unprognostic (2.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.07e-1)"	0.4	0.2	0.2	37.0	0.2	2.3	0.2	0.1	0.2	0.2	0.9	0.1	0.0	0.2	0.2	0.1	1.4	0.3	0.2	0.2	0.2	0.2	0.7	0.3	1.4	32.0	0.2	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.4	0.5	0.1	5.9	0.0	0.1	0.1	16.7	0.0	0.2	40.3	1.3	1.9	0.0	2.4	0.7	0.2	38.7	1.8	0.3	47.6	0.0	0.4	0.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	36.0	0.0	0.0	0.0	47.6	0.1	0.0	0.3	0.0	0.1	0.0	0.0	1.8	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.0	0.0
CHST6	MCDC1	ENSG00000183196	"Carbohydrate sulfotransferase 6"	Q9GZX3	16	75472052-75495384	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 7.2;brain: 22.6;cervix, uterine: 18.6;intestine: 16.8;salivary gland: 20.1"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 12.1;CAPAN-2: 13.3;NTERA-2: 6.4;SK-MEL-30: 5.3;U-2 OS: 8.1;WM-115: 7.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (2.28e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.93e-3)"	"unprognostic (3.30e-2)"	"unprognostic (4.02e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-7)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.80e-4)"	0.8	7.2	10.1	1.1	17.4	0.8	0.7	8.3	11.6	18.6	5.9	22.6	0.0	16.8	1.4	1.1	2.5	2.9	0.8	2.3	9.4	5.5	1.1	0.6	1.4	0.8	17.6	4.9	0.7	0.7	1.1	1.4	0.8	18.5	1.3	5.9	0.4	20.1	1.0	0.9	0.9	15.5	1.3	19.5	0.9	1.3	1.3	13.6	0.0	0.8	0.0	0.8	0.9	0.5	1.2	0.8	2.5	0.5	1.4	0.7	0.2	0.2	0.6	0.8	12.1	0.2	0.5	0.2	0.1	0.0	0.0	0.1	0.2	13.3	0.1	1.8	0.1	0.1	1.1	0.2	0.1	0.0	0.3	0.0	0.2	1.2	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	6.4	0.2	0.0	0.0	0.1	1.1	0.1	0.3	0.1	0.0	0.1	5.3	0.1	0.4	0.2	0.1	8.1	0.1	0.0	0.3	0.2	3.1	0.4	0.0	7.0	2.5	0.5	0.4	0.6	0.3	0.5	0.8	0.4	0.4	0.1	1.2	0.5	0.7	2.0	1.4	0.3	0.8	0.3	0.2	10.1	17.4	8.3	11.6	9.4	5.5	17.6	4.9	18.5	13.6
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500289	"Predicted secreted proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 242.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;K-562: 1.7;NB-4: 5.2;RPMI-8226: 5.6;SH-SY5Y: 4.0;U-2197: 3.3"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	70000	70000			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favourable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			0.2	0.2	0.2	41.7	0.2	0.0	0.2	0.2	0.2	0.2	100.0	0.1	0.1	80.7	0.2	0.1	0.2	0.3	4.4	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.2	98.0	0.2	0.2	0.1	0.2	0.2	242.9	1.1	0.2	0.2	0.2	0.3	0.1	0.1	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.6	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 182.1;intestine: 64.2"	"Cell line enriched"	"Detected in single"	964	"RT4: 96.4"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	210000	210000	"Plasma membrane"	"Plasma membrane"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favourable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favourable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.2	0.1	2.2	8.8	3.0	0.1	0.6	0.0	2.0	12.3	64.2	2.0	0.0	0.1	0.3	0.1	182.1	0.1	0.1	0.1	2.2	0.6	0.1	0.1	0.1	0.1	3.2	1.6	0.1	0.0	0.1	0.0	0.1	3.0	1.8	38.4	0.0	5.9	0.1	0.1	4.5	6.1	0.8	2.4	0.1	0.1	0.1	5.0	0.0	0.1	8.6	21.5	9.0	13.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	96.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.0	0.0	2.0	2.2	0.6	3.2	1.6	3.0	5.0
DMBT1	"Gp-340, GP340, hensin, muclin, SALSA, vomeroglandin"	ENSG00000187908	"Deleted in malignant brain tumors 1"	Q9UGM3	10	122560665-122643736	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 122.3;salivary gland: 130.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 4.5;LHCN-M2: 9.0;RH-30: 20.9"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 47.6;lung cancer: 18.0;pancreatic cancer: 33.3;stomach cancer: 76.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA040778	Enhanced		Approved	"Centriolar satellite"	"Secreted in other tissues"	7500000	7500000	"Centriolar satellite"	"Centriolar satellite"	"HPA040778: AB_2677132"	"unprognostic (3.32e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.47e-2)"	"prognostic favourable (1.43e-4)"	"unprognostic (8.77e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.70e-1)"	"unprognostic (7.97e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.08e-9)"	"unprognostic (2.26e-1)"	"unprognostic (2.92e-4)"	"unprognostic (2.00e-3)"	"unprognostic (2.22e-1)"	0.1	0.1	0.2	2.4	0.2	0.0	0.1	0.1	0.2	1.1	34.8	0.1	0.1	122.3	0.2	0.1	0.3	0.3	2.7	0.1	0.3	0.2	0.1	0.1	13.1	0.1	0.6	0.1	0.2	1.2	0.0	0.1	0.1	0.1	0.5	1.5	0.1	130.0	0.1	0.2	0.2	68.3	0.9	1.1	0.1	0.2	0.3	0.1	0.1	0.1	19.7	14.7	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	0.3	0.2	4.5	0.0	0.0	0.0	9.0	0.0	0.0	0.7	0.0	0.0	0.0	20.9	2.4	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.5	2.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.2	0.3	0.2	0.6	0.1	0.1	0.1
GAGE12B		ENSG00000236737	"G antigen 12B"		X	49529869-49529985	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	6	"intestine: 5.4;testis: 21.5"	"Group enriched"	"Detected in some"	16	"PC-3: 7.4;U-2197: 4.0"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in many"																																							0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0			5.4	0.8	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0		0.8	0.0	0.0	0.0	0.0		0.0	0.0		2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	21.5			0.0		0.0	0.0	0.1	0.0	0.3	2.0	0.5	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	1.8	0.7	0.0	0.0	0.1	0.8	2.0	0.0	0.5	0.3	1.8	0.2										
GAL3ST1	CST	ENSG00000128242	"Galactose-3-O-sulfotransferase 1"	Q99999	22	30554635-30574587	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 28.7;gallbladder: 13.4;intestine: 25.1;kidney: 13.3;stomach 1: 7.2"	"Cell line enhanced"	"Detected in some"		"A549: 22.6;CACO-2: 6.2;EFO-21: 12.3;K-562: 5.2"	"Cancer enriched"	"Detected in many"	6	"renal cancer: 38.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001220	Approved		Approved	Vesicles	"Intracellular and membrane"			Vesicles	Vesicles	"HPA001220: AB_1078933"	"unprognostic (2.69e-2)"	"unprognostic (3.12e-4)"	"unprognostic (5.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.50e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.89e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavourable (1.79e-4)"	"unprognostic (2.33e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.56e-2)"	0.8	0.6	8.4	0.7	9.6	1.2	0.8	1.4	12.3	1.4	11.3	25.8	0.0	24.2	1.3	2.3	0.8	2.2	13.4	0.5	12.1	8.3	13.3	1.6	1.5	0.9	14.0	2.6	1.2	2.9	0.6	0.5	1.3	12.4	1.2	2.8	0.3	1.0	1.9	1.9	2.1	25.1	0.7	28.7	0.7	7.2	2.5	7.8	0.0	0.6	0.0	0.4	1.0	0.7	2.3	2.8	2.3	0.7	0.3	0.8	0.0	0.1	22.6	0.4	0.2	0.0	0.0	1.7	0.0	0.1	0.0	0.0	6.2	3.1	0.3	12.3	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.3	0.2	4.1	0.5	0.1	0.3	0.2	0.0	0.1	0.1	0.0	5.2	0.6	0.0	0.1	0.3	0.8	3.2	0.3	0.2	0.1	0.6	0.9	0.1	0.3	1.5	0.0	0.4	0.2	0.1	0.1	0.6	0.2	0.1	0.2	0.0	2.0	1.2	0.3	0.1	0.1	0.2	0.9	0.7	0.1	0.4	0.5	0.7	1.8	0.7	0.8	0.2	2.3	0.5	0.8	2.3	0.3	0.3	2.8	0.1	0.0	8.4	9.6	1.4	10.3	12.1	8.3	14.0	2.6	12.4	7.8
GALNT8	GALNAC-T8	ENSG00000130035	"Polypeptide N-acetylgalactosaminyltransferase 8"	"Q9NY28, P17658"	12	4720341-4851927	"Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 12.7;intestine: 33.2;testis: 18.5"	"Group enriched"	"Detected in some"	4	"Karpas-707: 26.3;NTERA-2: 9.3;U-266/84: 7.5"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in single"			"HPA012638, HPA073461"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"			"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA012638: AB_2294503, HPA073461: AB_2686604"	"unprognostic (2.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.75e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.72e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.06e-5)"	"unprognostic (1.16e-2)"	"unprognostic (6.67e-5)"	"unprognostic (5.18e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.33e-2)"	1.1	2.2	5.3	2.2	6.5	0.5	3.1	1.4	12.7	1.0	15.5	9.4	0.0	7.2	0.9	0.4	0.7	1.2	1.1	3.7	8.0	1.7	1.2	0.8	0.9	1.0	5.7	9.6	1.6	0.9	0.2	3.7	0.5	6.0	1.1	33.2	0.1	1.0	0.9	0.7	0.9	14.7	2.1	3.5	1.2	1.3	18.5	11.5	0.0	0.8	0.5	0.9	1.2	0.9	1.0	0.7	0.1	0.1	0.9	3.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	26.3	0.0	0.0	0.2	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.3	7.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	0.4	0.3	0.7	1.2	0.0	1.0	0.0	0.1	0.1	0.9	0.0	0.7	3.0	0.0	5.3	6.5	1.4	12.7	8.0	1.7	5.7	9.6	6.0	11.5
GALR2	GALNR2	ENSG00000182687	"Galanin receptor 2"	O43603	17	76074794-76077541	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.5;intestine: 13.1;lymphoid tissue: 9.8;smooth muscle: 6.4"	"Cell line enhanced"	"Detected in some"		"HaCaT: 3.1;NTERA-2: 4.6;THP-1: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA044513	Approved									"HPA044513: AB_10962510"	"unprognostic (1.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.54e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.39e-1)"	"unprognostic (9.32e-5)"	"unprognostic (2.31e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.04e-2)"	"unprognostic (8.14e-2)"	0.3	0.1	0.0	9.8	0.1	3.5	0.0	0.0	0.3	0.3	13.1	0.0	0.0	0.6	0.0	0.0	1.1	0.1	0.5	0.1	1.4	0.8	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.1	0.4	0.6	0.2	0.1	0.0	0.1	0.0	0.0	0.3	9.0	6.4	1.4	0.2	0.4	0.3	0.0	0.0	0.0	1.1	1.2	1.0	0.2	0.0	1.1	1.4	0.9	0.5	0.4	0.7	0.2	1.9	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.3	0.0	2.1	0.4	0.6	0.3	0.0	3.1	0.0	0.1	0.0	0.3	2.5	0.0	1.5	2.8	0.3	0.6	0.5	0.0	0.0	0.3	0.0	0.1	0.1	0.5	0.1	1.1	0.2	0.3	4.6	2.9	0.1	0.6	0.8	0.0	0.2	0.2	0.1	1.7	0.7	0.3	0.6	6.8	0.2	0.2	0.6	0.2	0.4	0.7	0.4	2.6	0.0	0.1	0.0	0.0	0.9	0.0	0.4	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.4	0.5	0.4	1.1	0.0	0.7	0.0	0.1	0.0	0.3	1.4	0.8	0.2	0.0	0.6	0.0
GPA33	A33	ENSG00000143167	"Glycoprotein A33"	Q99795	1	167052836-167166479	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 101.1"	"Cell line enhanced"	"Detected in some"		"HL-60: 1.9;MOLT-4: 2.3;NB-4: 1.1;NTERA-2: 4.0;RPMI-8226: 2.9;THP-1: 1.1"	"Cancer enriched"	"Detected in many"	6	"colorectal cancer: 84.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 17.8;T-reg: 13.0"	"Lineage enriched"	"Detected in many"	7	"T-cells: 17.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018858, CAB025943"	Enhanced									"CAB025943: , HPA018858: AB_1849909"	"unprognostic (2.41e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (8.39e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.10e-2)"	"unprognostic (9.44e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.13e-1)"	"unprognostic (9.68e-3)"	"unprognostic (2.96e-3)"	0.2	0.2	0.2	12.1	0.2	0.0	0.2	0.2	0.2	0.2	46.9	0.2	0.1	31.6	0.2	0.1	0.3	0.2	0.3	0.2	0.2	0.2	0.2	0.2	1.2	1.6	0.2	0.1	0.2	0.2	0.0	0.2	0.3	0.2	0.2	43.5	0.2	0.3	0.1	0.2	0.2	101.1	1.4	0.2	0.6	0.2	0.2	0.1	0.6	0.2	0.1	0.6	0.2	0.2	1.7	1.7	0.1	2.5	0.1	17.8	4.6	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.1	4.0	0.1	0.0	0.0	2.9	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	2.5	1.1	0.1	7.6	3.9	1.7	1.7	17.8	2.4	0.1	0.1	1.6	0.0	13.0	4.6	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.1
HTR3E		ENSG00000186038	"5-hydroxytryptamine receptor 3E"	A5X5Y0	3	184097064-184106995	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	6	"intestine: 7.0"	"Cell line enriched"	"Detected in single"	6	"RH-30: 5.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA049764	Enhanced									"HPA049764: AB_2680869"		"unprognostic (4.12e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.15e-1)"		"unprognostic (4.57e-4)"		"unprognostic (3.61e-3)"		"unprognostic (1.15e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.47e-1)"		"unprognostic (3.32e-1)"	"unprognostic (2.67e-1)"		"unprognostic (4.16e-2)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium voltage-gated channel subfamily J member 13"	O60928	2	232766464-232776568	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 22.9;intestine: 49.5;retina: 70.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.8;CACO-2: 2.7;U-2197: 4.7"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Region enriched"	"Detected in some"	7	"pons and medulla: 22.9"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.2	0.2	0.5	0.0	0.7	0.1	0.3	0.4	0.9	0.2	10.1	7.0	1.3	4.3	0.2	0.3	0.2	0.1	1.6	0.2	3.2	0.5	1.9	0.3	0.2	0.0	0.4	0.4	0.3	0.4	8.5	0.3	0.0	22.9	0.3	0.0	70.3	0.3	1.6	0.2	1.8	49.5	0.0	0.6	0.2	1.1	0.5	0.1	0.0	3.8	0.0	0.0	0.3	0.3	1.1	0.8	5.4	1.1	1.1	2.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.1	0.0	0.5	0.0	0.3	0.2	0.9	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.0	0.3	1.1	0.2	0.3	0.0	0.1	0.0	4.7	0.4	1.4	0.1	0.8	0.8	0.4	0.0	5.4	1.1	0.9	1.0	0.2	1.2	0.8	1.8	0.7	0.4	1.1	2.1	1.1	0.8	1.1	1.0	0.8	2.7	0.1	0.5	0.7	0.4	0.9	3.2	0.5	0.4	0.4	22.9	0.1
KHK		ENSG00000138030	Ketohexokinase	P50053	2	27086747-27100772	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 60.2;kidney: 38.4;liver: 67.0"	"Cell line enhanced"	"Detected in many"		"HEL: 18.5;Hep G2: 26.9"	"Group enriched"	"Detected in all"	7	"liver cancer: 62.2;renal cancer: 32.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007040	Enhanced		Approved	Cytosol		320000	320000	Cytosol	Cytosol	"HPA007040: AB_1079185"	"unprognostic (8.44e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.70e-1)"	"prognostic unfavourable (7.62e-8)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.02e-2)"	0.9	1.9	2.1	1.2	2.7	0.7	1.9	5.2	3.9	1.1	22.3	1.9	0.2	40.0	1.5	0.9	1.1	1.6	0.6	0.6	2.2	2.2	38.4	67.0	0.7	0.8	3.5	1.9	1.8	4.2	0.6	0.7	0.4	3.0	0.9	0.6	0.6	1.7	0.7	1.4	1.0	60.2	0.9	1.8	0.8	1.0	1.6	3.6	0.0	0.5	1.2	0.6	0.7	0.9	5.1	7.3	0.6	6.6	5.4	8.8	6.0	13.9	10.6	1.6	6.4	1.2	0.3	1.4	0.9	0.6	1.3	0.8	5.1	3.0	2.1	3.4	0.0	6.2	5.5	1.8	0.4	4.9	10.0	18.5	2.8	26.9	0.6	2.5	2.2	0.1	0.8	1.6	0.1	1.2	3.3	3.5	0.1	9.1	3.0	2.0	2.3	4.2	10.6	0.8	11.8	1.6	1.7	6.0	9.3	2.0	3.6	3.9	1.6	1.1	1.1	0.4	2.1	0.9	3.7	4.4	7.8	3.6	1.8	6.0	1.0	0.0	6.6	0.4	5.4	3.8	7.4	5.1	8.8	7.8	6.1	5.1	6.4	7.8	0.6	5.4	1.6	7.3	5.5	6.0	2.1	2.7	5.2	3.9	2.2	2.2	3.5	1.9	3.0	3.6
KRT20	"CK20, K20, MGC35423"	ENSG00000171431	"Keratin 20"	P35900	17	40875941-40885227	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 232.0"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;BEWO: 2.6;NB-4: 2.3;RPMI-8226: 2.8;RT4: 7.2;SH-SY5Y: 2.2"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 159.5;stomach cancer: 52.7;urothelial cancer: 99.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.7"	"Low region specificity"	"Detected in all"			"CAB000032, HPA024309, HPA024684, HPA027236"	Enhanced		Supported	Cytosol		34000000	34000000	Cytosol	Cytosol	"CAB000032: AB_2133718, HPA024309: AB_1852220, HPA024684: AB_1852222, HPA027236: AB_1852224"	"unprognostic (3.49e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.71e-1)"	"unprognostic (6.38e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.66e-3)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (2.63e-2)"			"unprognostic (4.87e-3)"	"unprognostic (2.37e-2)"	"prognostic unfavourable (1.32e-4)"	"unprognostic (5.71e-2)"	"unprognostic (6.30e-2)"		"unprognostic (7.27e-2)"	0.2	0.1	0.2	38.0	0.2	0.0	0.2	0.2	0.2	0.2	75.5	0.2	0.2	40.4	0.2	0.2	0.3	0.3	3.9	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.3	45.0	0.2	0.3	0.2	0.2	0.2	232.0	2.7	0.2	0.2	13.6	0.2	0.2	0.2	0.2	0.3	0.2	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.0	0.1	0.0	0.0	2.8	0.0	7.2	0.4	2.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.3	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
LEFTY1	"LEFTB, LEFTYB"	ENSG00000243709	"Left-right determination factor 1"	O75610	1	225886282-225911382	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 12.1;epididymis: 19.0;intestine: 26.6;pancreas: 46.5"	"Cell line enriched"	"Detected in some"	6	"NTERA-2: 33.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.8"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	35	"basophil: 12.1"	"Lineage enriched"	"Detected in single"	35	"granulocytes: 12.1"									"HPA047883, HPA056210"	Approved				"Secreted in other tissues"					"HPA047883: AB_2680200, HPA056210: AB_2683067"	"unprognostic (2.81e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.76e-2)"	"unprognostic (6.13e-2)"	"prognostic unfavourable (2.48e-6)"	"unprognostic (2.78e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.61e-2)"	0.2	0.0	0.6	4.5	1.1	0.0	0.2	1.2	0.9	0.6	26.6	0.2	1.5	0.0	0.7	19.0	0.4	0.1	0.2	0.2	0.6	0.7	3.6	0.2	0.3	0.2	0.2	0.2	2.0	46.5	0.0	0.3	0.3	0.2	0.6	15.1	0.3	0.5	1.6	0.2	0.0	0.8	0.4	0.2	0.2	0.4	2.1	0.2	0.3	0.2	0.2	0.2	0.9	0.2	0.0	0.0	12.1	0.0	0.3	0.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.5	0.3	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	1.7	0.6	1.1	1.2	0.9	0.6	0.7	0.2	0.2	0.2	0.2
MISP	"C19orf21, Caprice, DKFZp686H18209, MISP1"	ENSG00000099812	"Mitotic spindle positioning"	Q8IVT2	19	751126-764318	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"gallbladder: 24.6;intestine: 63.8"	"Cell line enhanced"	"Detected in some"		"A549: 37.1;HaCaT: 27.5;hTCEpi: 25.8;MCF7: 18.9;SK-BR-3: 41.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 133.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049511, HPA062232"	Enhanced		Enhanced	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA049511: AB_2680798, HPA062232: AB_2684719"	"unprognostic (7.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.78e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.56e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.29e-1)"	"unprognostic (4.80e-1)"	"unprognostic (5.27e-2)"	0.5	0.1	0.3	7.9	0.3	0.0	0.7	0.2	0.2	1.5	42.8	0.2	0.2	45.9	0.7	0.8	0.4	2.4	24.6	0.2	0.5	0.2	6.9	0.4	6.8	0.2	0.3	0.3	2.2	2.0	0.0	4.2	2.1	0.2	2.2	13.0	0.2	0.5	0.5	0.2	0.3	63.8	0.7	0.2	0.2	5.8	0.2	0.2	0.3	0.2	0.8	0.2	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	37.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	12.7	13.6	3.2	3.6	0.0	27.5	0.0	11.5	0.0	0.0	0.0	0.0	14.6	3.9	0.0	0.0	0.5	0.0	25.8	0.1	1.4	0.0	0.0	0.1	0.0	18.9	0.0	0.2	0.0	7.6	0.0	0.1	0.3	9.3	10.3	0.4	0.1	13.1	41.8	0.0	9.1	0.0	0.0	0.0	4.7	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.2	0.5	0.2	0.3	0.3	0.2	0.2
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455752-60470760	"CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1"	"Group enriched"	"Detected in some"	25	"Daudi: 120.0;U-698: 60.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	105	"memory B-cell: 77.7;naive B-cell: 77.7"	"Lineage enriched"	"Detected in single"	105	"B-cells: 77.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favourable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	1.6	0.3	0.3	79.0	0.3	3.6	0.6	0.3	0.3	0.5	2.0	0.0	0.0	0.2	0.4	0.5	7.0	0.4	1.3	0.7	0.3	0.3	2.0	0.9	2.7	81.2	0.3	0.1	0.3	0.4	0.0	0.4	0.4	0.1	1.1	1.7	0.6	14.5	0.2	0.3	0.3	46.1	0.1	0.4	90.7	2.6	0.6	0.0	15.7	2.5	2.7	134.1	6.4	0.8	77.7	0.0	0.2	0.0	0.7	0.6	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	77.7	0.3	0.6	0.0	77.7	0.0	0.2	0.2	0.7	0.0	0.0	0.0	3.5	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.0
MS4A8	"CD20L5, MS4A4, MS4A8B"	ENSG00000166959	"Membrane spanning 4-domains A8"	Q9BY19	11	60699574-60715811	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	6	"fallopian tube: 36.8;intestine: 123.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.7;CAPAN-2: 1.7;HDLM-2: 1.6;NB-4: 2.5;RPMI-8226: 4.4;SCLC-21H: 3.2;SH-SY5Y: 1.7"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA007318, HPA007319"	Enhanced									"HPA007318: AB_1854139, HPA007319: AB_1854138"	"unprognostic (7.28e-3)"	"unprognostic (2.11e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.52e-2)"			"unprognostic (9.41e-2)"	"unprognostic (4.89e-3)"	"unprognostic (9.33e-2)"	"unprognostic (7.97e-3)"	"unprognostic (2.40e-1)"	"unprognostic (2.40e-9)"	"unprognostic (2.46e-1)"	"unprognostic (3.02e-2)"		"unprognostic (1.59e-3)"	0.1	0.2	1.4	2.0	0.2	0.0	0.1	0.2	0.6	7.1	43.9	0.4	0.6	46.6	2.5	5.9	0.3	36.8	8.9	0.3	0.6	0.3	0.2	0.1	8.6	0.1	0.1	0.5	4.2	1.2	0.0	4.7	0.1	1.0	2.3	4.0	0.2	0.4	10.9	0.8	0.1	123.9	0.1	0.1	0.1	12.7	0.7	0.1	0.2	0.1	0.1	0.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	4.4	0.0	0.0	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.2	0.2	0.6	0.6	0.3	0.1	0.5	1.0	0.1
MUC3A	MUC3	ENSG00000169894	"Mucin 3A, cell surface associated"	Q02505	7	100949555-100968346	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"gallbladder: 84.4;intestine: 138.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 12.0;CAPAN-2: 4.0;MCF7: 2.6;U-2 OS: 2.3"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 29.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA010871	Uncertain				"Intracellular and membrane"					"HPA010871: AB_1854201"	"unprognostic (1.12e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.91e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.50e-3)"	"unprognostic (8.73e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.51e-2)"	0.1	0.0	0.0	1.6	0.0	0.0	0.4	0.0	0.0	0.0	31.4	0.0	0.0	23.3	0.0	0.0	0.0	0.0	84.4	0.8	0.0		0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.5	6.7	0.0	0.0	0.0	2.4	0.0	138.0	0.1	0.0	0.0	1.4	0.0	0.0	19.3	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	4.0	0.0	0.1	0.0	0.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	2.6	0.0	0.0	1.8	0.0	0.0	0.0	0.3	0.6	0.0	0.9	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MYO7B		ENSG00000169994	"Myosin VIIB"	Q6PIF6	2	127535802-127637729	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 124.3"	"Cell line enriched"	"Detected in some"	18	"MOLT-4: 77.4"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 17.2;pancreatic cancer: 5.4;renal cancer: 3.7;stomach cancer: 9.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 7.2;naive B-cell: 9.1"	"Group enriched"	"Detected in many"	24	"B-cells: 9.1;dendritic cells: 3.3;monocytes: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039131	Enhanced									"HPA039131: AB_10672771"	"unprognostic (4.10e-3)"	"unprognostic (3.81e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.23e-4)"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.76e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.03e-1)"	"prognostic favourable (1.25e-4)"	"unprognostic (2.80e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.88e-1)"	0.2	0.2	0.2	8.4	0.3	2.0	0.2	0.2	0.3	0.2	67.2	0.0	0.7	41.3	0.2	7.2	0.3	0.3	21.0	0.2	0.3	0.3	8.9	0.4	0.5	2.0	0.5	0.0	0.2	0.3	0.0	0.2	0.3	0.0	0.2	9.2	0.0	0.2	0.0	0.3	0.2	124.3	0.2	0.4	7.3	0.2	0.9	0.0	3.0	0.2	0.0	0.5	0.2	0.2	9.1	3.3	0.2	7.2	0.0	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	4.1	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	77.4	0.2	0.0	0.5	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.1	2.4	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.1	0.0	2.7	0.0	1.2	0.0	0.0	3.3	9.1	0.0	0.2	0.2	0.0	1.7	0.8	0.0	2.7	0.2	0.3	0.2	0.3	0.3	0.3	0.5	0.0	0.0	0.0
PLA2G12B	PLA2G13	ENSG00000138308	"Phospholipase A2 group XIIB"	Q9BX93	10	72935170-72954778	"Plasma proteins, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 47.8;liver: 42.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.8;Hep G2: 19.6"	"Cancer enriched"	"Detected in many"	8	"liver cancer: 35.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA057745, HPA059562"	Approved				"Secreted to blood"					"HPA057745: AB_2683514, HPA059562: AB_2684064"			"unprognostic (1.11e-2)"				"unprognostic (2.66e-2)"	"unprognostic (2.02e-3)"			"unprognostic (3.41e-1)"		"unprognostic (1.68e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.14e-2)"		0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	25.6	0.0	0.0	15.4	0.1	0.3	0.1	0.1	0.0	3.5	0.1	0.1	8.0	42.8	0.9	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.7	0.1	0.1	0.0	0.1	0.1	47.8	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	19.6	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
PRAP1	UPA	ENSG00000165828	"Proline rich acidic protein 1"	Q96NZ9	10	133347146-133352683	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 196.7;liver: 112.7"	"Cell line enriched"	"Detected in some"	4	"Hep G2: 44.3"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 72.9;liver cancer: 348.8"	"Region enriched"	"Detected in single"	4	"pons and medulla: 1.1"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9;NK-cell: 3.6"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.9;NK-cells: 3.6"									"HPA038713, HPA052451"	Supported				"Secreted to digestive system"	330000000	330000000			"HPA038713: AB_10673117, HPA052451: AB_2681839"	"unprognostic (1.63e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.90e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-1)"	"unprognostic (4.35e-3)"	"unprognostic (4.91e-2)"	"unprognostic (8.23e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.22e-3)"	0.1	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.2	0.1	145.3	0.2	0.4	111.1	0.1	2.4	0.1	0.2	3.4	0.1	0.1	0.1	24.4	112.7	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.1	1.1	0.1	3.1	3.6	0.2	0.1	0.1	0.1	196.7	0.1	0.1	0.2	0.1	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.8	0.7	2.9	0.2	3.6	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	10.4	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	44.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.3	1.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.2	0.2	0.3	0.0	0.0	0.0	2.9	0.2	0.2	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.8	0.4	0.4	1.8	3.6	0.1	0.7	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	1.1	0.1
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	6	"intestine: 13.5;pancreas: 35.3"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 8.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"					"Cell type enhanced"	"Detected in some"		"basophil: 3.8"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 3.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	12	"midbrain: 1.2;pons and medulla: 1.3;thalamus: 1.5"	HPA007269	Uncertain									"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0			13.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.2	4.1	0.0	0.0		0.0	35.3	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.9	0.2			0.2		0.0	0.0	0.0	0.5	0.1	3.8	0.3	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.8	0.0	0.5	0.1	0.0	0.0	0.0	0.6	0.0	0.0	8.0	0.7	0.5	0.1	0.0	0.8	0.0	0.1	0.0	1.4	0.3	0.5	0.0	0.3	0.0	0.3	0.0	0.0	1.1	0.0	0.0	0.3	0.6	0.0	0.9	0.3	0.1	0.0	0.0	0.1	3.8	0.3	0.9	0.3	0.2	0.4	0.3	0.3	0.0	0.0	0.5	0.3	0.2	1.2	0.3	0.3	0.1	0.4	0.0										
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 beta subunit"	Q86UW2	15	65045370-65053396	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 85.0"	"Group enriched"	"Detected in some"	10	"CACO-2: 16.5;EFO-21: 11.1;Hep G2: 13.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria				Mitochondria	Mitochondria	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favourable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.4	0.5	0.4	3.8	0.6	0.0	0.4	0.4	0.8	14.0	34.9	0.4	0.4	28.1	0.9	3.3	0.4	1.0	0.5	0.4	0.5	0.6	7.5	2.4	1.6	0.4	0.6	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.8	9.5	0.4	0.4	0.8	0.4	0.1	85.0	0.4	0.4	0.4	0.2	4.1	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.0	0.0	0.7	0.1	0.0	0.5	0.3	0.0	1.4	0.2	0.7	0.0	0.1	0.4	0.0	0.0	0.2	0.0	16.5	0.0	0.1	11.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	13.8	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.4	0.0	0.3	0.4	0.4	0.0	0.0	0.8	0.4	0.0	0.6	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.1	0.1	0.2	0.3	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.0	0.5	0.0	0.3	0.2	0.0	0.0	0.1	0.3	0.7	0.0	0.1	0.0	0.0	0.3	0.4	0.6	0.4	0.4	0.5	0.6	0.6	0.4	0.4	0.4
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225117	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 167.3"	"Group enriched"	"Detected in some"	6	"BEWO: 14.2;HEL: 17.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced									"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favourable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	55.3	0.0	0.0	44.6	0.1	0.0	0.1	0.1	30.0	0.1	0.1	0.1	28.7	0.5	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.5	1.7	0.0	0.1	0.0	0.1	0.1	167.3	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SULT1B1	ST1B2	ENSG00000173597	"Sulfotransferase family 1B member 1"	O43704	4	69721162-69787961	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 137.6"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 47.5;TIME: 15.4;U-2197: 13.7"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 7.6;liver cancer: 2.6;pancreatic cancer: 5.5;stomach cancer: 5.5"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 21.9"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 21.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002107	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA002107: AB_2666542"	"unprognostic (9.58e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.06e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.46e-2)"	1.2	0.6	0.9	9.3	1.8	1.3	1.1	0.5	1.5	1.1	38.6	0.5	0.7	31.8	0.8	0.6	1.0	1.5	1.2	1.2	0.9	0.9	1.1	24.8	2.4	12.9	1.2	0.7	0.7	0.5	0.0	0.4	0.6	2.0	0.6	20.3	1.3	0.6	0.2	0.4	0.4	137.6	1.4	3.6	13.3	13.9	0.5	0.7	2.0	0.6	0.3	2.0	0.7	1.2	0.2	1.8	21.9	3.2	1.8	3.6	1.6	0.3	0.2	0.3	0.4	0.8	0.9	0.6	0.4	0.2	0.1	0.1	0.3	0.3	0.5	0.3	0.4	0.5	0.0	0.1	0.3	0.6	0.4	0.5	0.4	0.2	1.2	0.6	0.7	5.5	0.0	0.1	0.2	47.5	0.2	1.1	0.4	0.3	0.3	0.5	0.4	0.2	0.2	1.6	0.3	0.1	0.8	0.7	0.4	0.2	0.2	0.2	0.7	0.3	15.4	0.4	0.8	13.7	0.3	0.8	0.4	0.2	0.2	1.4	0.6	5.8	3.2	0.8	0.7	1.9	0.2	0.1	1.1	0.3	1.8	0.2	3.6	1.7	21.9	1.8	2.2	0.2	0.5	1.6	0.9	1.8	0.5	1.5	0.9	0.9	1.2	0.7	2.0	0.7
TBC1D10C	"Carabin, EPI64C, FLJ00332"	ENSG00000175463	"TBC1 domain family member 10C"	Q8IV04	11	67403915-67410089	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 55.4;bone marrow: 16.0;intestine: 14.5;lymphoid tissue: 35.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;HEL: 6.2;MOLT-4: 23.1;NB-4: 27.8;U-937: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA069743	Enhanced		Approved	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"HPA069743: AB_2686186"	"prognostic favourable (3.83e-4)"	"prognostic favourable (4.20e-4)"	"unprognostic (9.23e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.28e-3)"	"prognostic favourable (1.86e-5)"	"unprognostic (6.22e-3)"	"unprognostic (1.17e-2)"	"unprognostic (3.65e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.28e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (4.35e-7)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.81e-2)"	1.3	0.4	0.7	20.8	0.8	16.0	0.7	0.4	0.4	0.9	3.0	0.4	0.7	2.4	0.5	0.6	1.6	1.3	1.5	0.8	1.1	0.3	1.9	1.5	5.2	22.4	0.5	0.8	0.6	0.5	0.0	0.4	0.7	0.4	1.1	0.4	1.4	3.6	0.2	0.4	0.4	14.5	0.2	0.8	35.0	3.1	0.7	0.9	27.1	4.6	1.0	27.8	1.8	1.8	39.1	13.1	52.5	30.6	25.9	55.4	49.2	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.4	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	23.1	27.8	0.0	0.0	2.6	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	5.0	0.0	11.5	0.0	33.2	10.0	52.5	51.1	23.7	36.2	37.6	44.5	44.7	13.1	39.1	46.8	42.3	49.1	25.9	30.6	11.0	55.4	49.2	0.7	0.8	0.4	0.4	1.1	0.3	0.5	0.8	0.4	0.9
TLR10	CD290	ENSG00000174123	"Toll like receptor 10"	Q9BXR5	4	38772239-38782990	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"blood: 23.5;brain: 11.3;intestine: 11.2;lymphoid tissue: 31.6"	"Group enriched"	"Detected in some"	55	"Daudi: 37.3;REH: 12.5;U-698: 13.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"memory B-cell: 23.5;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	6	"B-cells: 23.5"					"Low region specificity"	"Detected in all"			HPA066755			Approved	Centrosome,Cytosol				Cytosol	Cytosol	"HPA066755: "	"unprognostic (5.41e-5)"	"unprognostic (2.41e-4)"	"unprognostic (1.91e-3)"	"unprognostic (8.22e-4)"	"unprognostic (6.48e-2)"	"unprognostic (9.98e-4)"	"unprognostic (9.31e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.08e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.76e-2)"	"unprognostic (6.90e-2)"	"unprognostic (2.98e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.88e-2)"	0.8	0.5	4.2	24.5	9.4	0.9	0.6	0.6	3.5	0.6	1.0	2.5	0.0	0.9	0.5	0.3	1.7	0.9	1.0	0.5	3.2	1.8	0.8	0.7	1.2	27.0	5.5	0.5	0.5	0.6	0.1	0.7	0.2	4.8	0.8	1.4	0.0	2.6	0.3	0.5	0.5	11.2	0.3	11.3	24.4	1.8	0.4	7.4	2.7	0.9	0.0	31.6	3.2	0.6	23.5	4.0	0.7	1.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.1	0.2	0.4	0.0	1.5	0.0	23.5	0.0	0.0	3.6	14.9	0.0	0.0	0.7	0.0	1.8	4.0	0.0	0.9	4.2	9.4	0.6	3.5	3.2	1.8	5.5	0.5	4.8	7.4
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149473974-149503281	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"gallbladder: 196.0;intestine: 126.4;liver: 81.8"	"Group enriched"	"Detected in some"	6	"A549: 15.9;RPTEC TERT1: 24.6"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.3"	"Lineage enriched"	"Detected in single"	13	"monocytes: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	0.3	0.2	0.2	0.2	0.0	0.3	0.2	0.2	0.2	68.2	0.0	0.0	70.3	0.2	0.1	0.3	0.3	196.0	0.2	0.2	0.2	0.4	81.8	0.3	0.0	0.2	0.0	0.2	24.2	0.0	0.3	0.1	0.0	0.2	0.0	0.1	0.2	0.0	0.2	0.2	126.4	0.0	0.2	0.3	2.3	0.3	0.0	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.4	0.2	0.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.6	0.1	0.0	0.0	0.3	0.9	24.6	0.0	0.5	0.9	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"intestine: 108.7"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 38.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavourable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.7	0.3	0.3	4.8	0.3	0.1	5.6	0.3	0.7	3.8	66.1	0.6	0.6	19.1	2.1	16.9	1.4	1.9	15.9	0.4	0.4	0.3	0.3	1.8	17.6	0.2	0.3	0.4	1.8	5.4	4.5	1.0	3.7	1.0	8.4	9.8	1.7	18.9	0.2	0.3	0.8	108.7	0.3	0.2	0.3	19.5	2.6	0.2	0.2	0.8	1.7	4.1	1.5	1.1	0.5	0.7	2.2	0.6	0.9	0.8	0.3	3.6	6.0	0.0	0.1	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	38.9	0.0	0.2	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.1	1.4	1.7	0.0	0.0	1.4	0.1	0.1	0.4	0.1	0.0	1.2	0.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.6	0.2	0.3	0.3	0.2	0.4	0.8	0.3	0.2	0.5	0.2	0.3	2.2	0.9	0.4	0.7	0.1	0.3	0.3	0.3	0.3	0.7	0.4	0.3	0.3	0.4	1.0	0.2
TPH1	"TPH, TPRH"	ENSG00000129167	"Tryptophan hydroxylase 1"	P17752	11	18017564-18042426	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.2;intestine: 16.2;pituitary gland: 5.4;stomach 1: 13.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 4.5"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 4.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"							"CAB010767, HPA022483"	Approved		Uncertain	Cytosol				Cytosol	Cytosol	"CAB010767: AB_261587, HPA022483: AB_1858378"	"unprognostic (2.14e-4)"	"unprognostic (9.97e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.26e-5)"	"unprognostic (1.73e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.19e-4)"	"unprognostic (6.72e-2)"	"unprognostic (5.40e-8)"	"unprognostic (3.76e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.46e-5)"	0.7	0.0	0.7	0.7	0.7	0.6	0.9	0.7	4.2	0.7	7.1	0.7	0.7	8.2	0.7	0.7	0.7	1.5	0.7	0.7	0.7	0.3	0.7	0.7	0.7	0.7	0.7	0.7	1.0	0.7	0.0	5.4	0.7	0.7	1.3	16.2	0.7	0.7	0.7	0.7	1.0	9.1	0.7	0.7	1.0	13.3	0.9	0.7	0.7	0.7	0.7	0.7	0.7	0.7	1.4	0.8	1.5	0.5	0.9	1.6	0.2	0.4	0.1	1.7	1.5	0.1	0.0	0.6	0.6	0.5	0.2	1.1	1.8	0.3	1.4	0.3	0.0	0.6	0.4	1.5	0.7	1.3	3.1	2.2	0.8	3.5	0.0	4.5	1.2	0.0	1.8	0.2	0.6	0.7	0.9	0.8	0.1	0.5	1.0	0.7	0.5	0.3	1.7	0.3	0.0	0.0	1.0	1.3	0.9	0.2	0.4	0.9	0.3	2.9	0.2	0.4	1.3	0.5	1.7	0.2	0.3	1.1	0.2	1.0	1.4	1.5	0.4	0.4	1.6	0.2	0.8	0.5	0.5	0.4	0.1	1.4	0.6	0.6	1.5	0.9	0.5	0.8	0.6	0.2	0.7	0.7	0.7	4.2	0.7	0.3	0.7	0.7	0.7	0.7
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136108-30148735	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 13.5;placenta: 39.4"	"Cell line enriched"	"Detected in single"	50	"HEL: 5.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	19	"thalamus: 3.4"	"Low region specificity"	"Detected in all"			HPA043818	Uncertain									"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	4.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	39.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A10	UGT1J	ENSG00000242515	"UDP glucuronosyltransferase family 1 member A10"	Q9HAW8	2	233636454-233773305	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 9.4;gallbladder: 8.4;intestine: 31.1;stomach 1: 12.4"	"Cell line enriched"	"Detected in single"	142	"RT4: 106.4"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 9.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"								"unprognostic (9.33e-2)"			"unprognostic (7.64e-2)"	"unprognostic (2.45e-3)"	"unprognostic (1.73e-1)"			"prognostic unfavourable (4.55e-4)"		"unprognostic (1.49e-10)"	"unprognostic (2.90e-1)"	"unprognostic (1.50e-1)"		"unprognostic (3.59e-3)"	0.3	0.0	0.3	2.6	0.3	0.0	0.3	0.3	0.3	0.3	19.2	0.3	0.3	31.1	0.3	0.3	9.4	0.1	8.4	0.3	0.3	0.0	0.3	1.4	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3	14.3	0.3	0.9	0.3	0.3	0.3	20.2	0.5	0.3	0.3	12.4	1.0	0.3	0.3	0.3	0.3	1.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
VIL1	"D2S1471, VIL"	ENSG00000127831	"Villin 1"	P09327	2	218419092-218453295	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 129.3"	"Group enriched"	"Detected in some"	106	"CACO-2: 122.1;Hep G2: 57.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	6	"neutrophil: 2.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB002452, HPA006884, HPA006885"	Enhanced		Enhanced	"Plasma membrane"		41000000	41000000	"Plasma membrane"	"Plasma membrane"	"CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564"	"unprognostic (1.28e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.36e-1)"	"unprognostic (3.03e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.90e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.65e-2)"	0.3	0.2	0.6	5.7	0.8	0.0	0.3	0.7	0.4	0.3	36.6	0.3	0.3	68.9	0.3	1.2	0.3	0.2	22.6	0.3	0.5	0.5	4.6	6.1	0.3	0.3	0.5	0.3	0.3	7.2	0.0	0.4	0.3	0.3	0.3	32.6	0.3	0.5	0.3	0.3	0.3	129.3	1.2	0.5	0.4	0.9	0.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	2.5	0.1	0.1	0.1	7.8	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	122.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.5	0.1	0.0	0.4	0.0	7.8	0.6	0.8	0.7	0.4	0.5	0.5	0.5	0.3	0.3	0.3
VPREB3	8HS20	ENSG00000128218	"V-set pre-B cell surrogate light chain 3"	Q9UKI3	22	23752743-23754468	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"blood: 90.4;epididymis: 27.9;intestine: 32.7;lymphoid tissue: 77.9"	"Group enriched"	"Detected in some"	45	"Daudi: 56.9;REH: 67.3;U-698: 17.7"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	730	"memory B-cell: 79.9;naive B-cell: 90.4"	"Lineage enriched"	"Detected in single"	775	"B-cells: 90.4"	"Not detected"	"Not detected"							HPA003041	Supported				"Intracellular and membrane"					"HPA003041: AB_1080577"	"unprognostic (2.06e-3)"	"unprognostic (4.75e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.21e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.79e-2)"	"unprognostic (6.63e-3)"	"unprognostic (9.15e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.84e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.87e-1)"	"unprognostic (4.12e-1)"	0.5	9.2	0.7	62.6	0.9	7.5	0.3	0.7	0.8	0.3	1.3	0.3	0.2	0.2	0.3	27.9	2.3	0.1	0.7	0.4	0.6	0.7	1.1	0.9	1.2	77.9	0.8	0.2	0.3	0.3	0.1	1.4	0.3	0.2	0.6	0.9	0.4	4.8	0.2	0.8	0.4	32.7	0.2	0.5	31.6	1.4	1.4	0.2	1.6	0.8	1.0	36.0	3.1	0.2	90.4	0.0	0.1	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	56.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.2	0.0	0.2	67.3	0.1	1.0	0.0	0.0	0.1	0.2	0.0	0.1	0.8	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.3	0.0	17.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.9	0.0	0.0	0.0	90.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.7	0.9	0.7	0.8	0.6	0.7	0.8	0.2	0.2	0.2
ZG16	"hZG16, JCLN, JCLN1, ZG16A"	ENSG00000174992	"Zymogen granule protein 16"	O60844	16	29778240-29782973	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 84.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 1.8;SK-BR-3: 6.9"	"Cancer enriched"	"Detected in some"	6	"colorectal cancer: 21.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							"HPA052066, HPA052512"	Enhanced				"Secreted to digestive system"	250000	250000			"HPA052066: AB_2681716, HPA052512: AB_2681857"	"unprognostic (1.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.60e-3)"	"unprognostic (8.20e-2)"		"unprognostic (3.50e-2)"	"unprognostic (1.93e-2)"	"unprognostic (5.14e-2)"		"unprognostic (1.65e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.27e-1)"		"unprognostic (2.56e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.42e-1)"	0.2	0.0	0.2	13.3	0.2	0.0	0.2	0.2	0.2	0.2	67.8	0.2	0.2	9.9	0.2	0.2	0.2	0.1	0.4	0.2	0.2	0.0	0.2	3.6	0.2	0.2	0.2	0.2	0.2	8.9	0.0	0.2	0.2	0.2	0.2	84.6	0.2	0.2	0.2	0.2	0.0	51.6	2.3	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.7	0.2	0.4	0.7	1.1	1.0	0.1	0.7	0.2	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.2	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.0	1.2	0.1	0.1	0.0	0.1	0.7	0.0	0.3	0.2	0.4	0.0	6.9	0.0	0.4	0.0	0.1	0.0	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.7	0.1	0.5	0.3	0.6	0.3	0.6	0.5	0.0	0.7	0.9	1.0	0.4	1.1	0.3	0.2	0.5	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
ACE	"ACE1, CD143, DCP1"	ENSG00000159640	"Angiotensin I converting enzyme"	P12821	17	63477061-63498380	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 205.6"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 35.9;HUVEC TERT2: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 3.7"	"Group enriched"	"Detected in many"	23	"B-cells: 3.7;monocytes: 2.0;T-cells: 1.9"									"CAB002426, CAB002921, HPA029298, HPA069790"	Enhanced		Approved	Vesicles	"Secreted to blood"	92000000	92000000	Vesicles	Vesicles	"CAB002426: AB_442052, CAB002921: , HPA029298: AB_10960255, HPA069790: "	"unprognostic (4.72e-2)"	"unprognostic (4.16e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.06e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.66e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-2)"	6.8	2.0	0.5	2.4	4.2	0.0	2.9	0.5	1.1	5.3	83.2	0.7	37.7	46.4	4.5	5.1	1.7	1.5	4.4	4.7	0.6	0.7	2.6	1.4	16.3	2.2	0.4	0.7	1.4	3.0	3.6	3.6	3.6	0.8	3.4	1.4	1.7	2.5	20.1	3.6	1.3	205.6	2.4	0.6	1.4	1.9	32.6	1.3	0.5	6.9	3.1	2.2	1.7	1.6	3.7	0.1	0.0	2.0	0.0	1.9	0.4	0.0	0.0	0.0	0.0	1.5	35.9	0.4	1.3	2.6	0.0	0.0	0.5	3.1	0.7	1.0	6.1	0.0	1.7	0.0	0.0	0.0	0.7	3.4	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	18.3	3.0	0.0	0.0	0.6	0.0	0.7	0.2	0.3	0.1	0.2	0.5	0.0	0.0	4.5	3.2	0.0	0.0	0.0	1.6	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.4	0.6	0.9	3.7	1.9	1.4	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.4	0.5	4.2	0.5	1.1	0.6	0.7	0.4	0.7	0.8	1.3
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15561033-15602148	"Enzymes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 122.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.4;HaCaT: 4.1;Hep G2: 2.4;NB-4: 2.2;RPMI-8226: 2.0;RT4: 2.4;SH-SY5Y: 2.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174"	Enhanced				"Secreted to blood"	85000	85000			"CAB026174: , HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favourable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favourable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	4.5	0.4	0.2	0.8	0.2	0.0	2.3	0.2	0.2	0.4	49.1	0.2	2.3	46.0	0.4	2.7	1.2	0.6	16.4	10.5	0.2	0.1	23.2	1.2	0.8	0.6	0.2	0.2	1.3	1.6	0.0	0.2	1.0	0.2	0.5	1.3	0.2	1.1	1.2	0.7	0.2	122.0	0.3	0.2	0.2	0.5	17.9	0.2	0.2	4.5	0.5	0.2	0.4	0.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.4	0.0	0.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.6	0.0	4.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.0	0.0	2.0	0.4	2.4	0.6	2.8	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
ACSL5	"ACS2, ACS5, FACL5"	ENSG00000197142	"Acyl-CoA synthetase long chain family member 5"	Q9ULC5	10	112374018-112428380	"Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 278.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 42.4;RT4: 43.4;U-937: 21.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007162, CAB035986, CAB062546"	Enhanced		Supported	Nucleoplasm,Mitochondria		22000	22000	Mitochondria	Mitochondria	"CAB035986: AB_941506, CAB062546: AB_2665614, HPA007162: AB_2667761"	"unprognostic (5.75e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.08e-2)"	"prognostic favourable (1.13e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.92e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.18e-3)"	"unprognostic (7.40e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (5.92e-3)"	"unprognostic (1.08e-3)"	10.0	1.4	3.1	12.7	3.5	2.2	6.4	1.2	3.1	9.3	84.6	1.6	3.8	64.5	8.7	41.8	4.2	8.0	11.2	3.1	3.3	3.1	3.2	56.5	10.8	7.1	4.0	1.2	5.0	1.6	0.1	1.2	2.1	3.9	7.0	21.5	8.4	2.4	4.0	2.6	1.3	278.7	2.6	3.8	12.4	7.7	2.3	2.5	6.3	3.1	2.7	7.2	17.4	6.7	10.8	19.4	16.3	17.0	16.2	25.1	11.7	11.4	0.2	0.2	0.0	0.8	0.1	1.0	0.3	2.2	0.0	0.1	10.4	42.4	14.0	2.6	0.5	0.1	0.0	0.0	0.2	11.6	0.0	10.9	0.4	18.1	2.8	16.9	18.5	1.9	0.0	0.2	0.0	0.8	0.0	6.3	0.0	0.0	0.0	7.8	0.0	0.4	3.8	0.0	8.5	1.1	43.4	0.0	0.2	16.9	6.5	0.0	0.0	9.5	12.3	0.1	0.1	0.7	0.7	4.6	0.0	6.8	0.3	21.2	0.0	14.5	9.3	16.3	16.7	17.0	16.6	10.8	13.7	18.4	19.4	8.2	9.5	14.5	2.5	16.2	15.9	6.2	25.1	11.7	3.1	3.5	1.2	3.1	3.3	3.1	4.0	1.2	3.9	2.5
ADA		ENSG00000196839	"Adenosine deaminase"	P00813	20	44619522-44652233	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 64.0;intestine: 142.2;lymphoid tissue: 99.0"	"Cell line enriched"	"Detected in many"	8	"MOLT-4: 197.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 64.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001399, CAB004307, HPA023884"	Enhanced		Supported	"Plasma membrane,Cytosol"		650000	650000	"Plasma membrane"	"Plasma membrane"	"CAB004307: AB_626634, HPA001399: AB_1078099, HPA023884: AB_1844573"	"unprognostic (4.30e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.96e-2)"	"prognostic unfavourable (1.23e-7)"	"unprognostic (9.33e-2)"	"unprognostic (9.07e-3)"	"prognostic unfavourable (6.77e-5)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.66e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavourable (2.94e-14)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.82e-1)"	8.1	3.2	2.5	5.4	6.5	5.3	5.1	0.9	5.0	2.8	7.4	5.0	1.8	142.2	1.7	3.4	4.6	2.4	3.0	9.2	2.7	0.8	1.3	2.1	2.8	8.9	3.6	2.3	1.2	2.4	0.8	0.3	1.8	3.9	1.8	1.5	0.7	2.6	1.3	2.0	2.8	5.0	2.1	1.3	9.5	19.7	1.6	6.1	99.0	2.8	2.1	7.6	3.6	2.6	1.3	41.6	0.5	64.0	16.9	10.3	9.6	1.4	3.9	2.0	1.3	3.9	5.4	3.3	1.4	0.8	1.4	1.0	1.8	1.5	4.0	1.7	1.8	0.2	1.4	5.8	0.8	0.3	1.8	0.8	0.7	1.4	1.6	0.6	2.1	26.1	2.5	0.5	0.9	5.4	2.0	3.3	0.6	3.4	197.1	2.9	0.5	1.4	10.6	2.8	9.8	0.2	0.0	0.0	0.9	2.1	0.4	2.5	0.4	1.9	1.7	1.0	2.0	2.2	0.2	4.3	2.7	8.3	0.3	3.3	0.9	0.0	1.8	0.2	8.7	30.7	5.7	1.3	7.3	10.3	6.8	1.0	5.7	8.1	0.5	16.9	64.0	41.6	5.3	9.6	2.5	6.5	0.9	5.0	2.7	0.8	3.6	2.3	3.9	6.1
AMN	amnionless	ENSG00000166126	"Amnion associated transmembrane protein"	Q9BXJ7	14	102922656-102933596	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 97.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.0;Hep G2: 10.8;U-698: 5.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA000817	Approved									"HPA000817: AB_1078146"	"unprognostic (2.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.94e-3)"	"unprognostic (7.39e-3)"	"unprognostic (9.32e-2)"	"unprognostic (1.88e-3)"	"unprognostic (8.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.97e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (9.62e-5)"	"unprognostic (8.02e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.66e-1)"	0.4	0.0	0.1	3.3	0.1	0.0	0.7	0.1	0.1	0.6	44.3	0.1	0.2	19.3	0.2	3.1	2.6	0.6	10.4	0.2	0.1	0.0	17.2	17.8	1.8	0.5	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.1	0.4	2.1	0.2	0.7	0.0	0.0	0.9	97.6	0.1	0.0	0.6	3.9	0.3	0.1	0.7	0.7	0.1	1.1	0.5	1.0	0.3	1.8	0.0	0.0	0.0	0.7	0.1	0.6	0.1	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.0	11.0	0.3	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	10.8	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.9	1.6	0.2	0.0	0.2	0.1	0.2	0.0	0.0	1.0	0.7	0.1	0.1	0.1	0.0	1.4	0.0	0.0	0.0	0.2	0.0	1.0	0.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.7	0.6	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1
AOC1	"ABP1, DAO"	ENSG00000002726	"Amine oxidase, copper containing 1"	P19801	7	150824627-150861504	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 108.6;placenta: 240.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.0;HaCaT: 4.9;NB-4: 4.8;RPMI-8226: 5.8;THP-1: 20.9"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 61.3;endometrial cancer: 39.1;pancreatic cancer: 26.9;renal cancer: 69.4;stomach cancer: 43.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"eosinophil: 20.3"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 20.3"					"Low region specificity"	"Detected in all"			"HPA031032, HPA031033"	Approved				"Secreted in other tissues"	800000	800000			"HPA031032: AB_10670150, HPA031033: AB_10669670"	"unprognostic (1.73e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.84e-2)"	"unprognostic (6.31e-3)"	"unprognostic (8.31e-3)"	"unprognostic (9.07e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.11e-1)"	"prognostic favourable (1.71e-4)"	"unprognostic (5.32e-3)"	"unprognostic (3.62e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.64e-1)"	0.3	0.3	0.3	6.7	0.3	0.0	0.3	0.3	0.3	0.9	68.3	0.2	1.2	30.2	0.3	3.9	1.7	0.3	4.4	0.3	0.3	0.3	37.9	1.5	0.3	0.6	0.3	0.1	0.3	0.6	0.0	0.3	240.4	0.1	1.3	15.5	0.1	0.4	0.2	0.3	0.8	108.6	0.2	0.3	0.4	2.7	1.8	0.1	0.7	0.3	0.1	1.0	0.4	0.4	0.0	1.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.5	16.0	0.0	2.2	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	4.8	0.2	0.0	0.0	0.0	5.8	0.2	0.1	1.8	2.1	0.0	0.7	0.0	0.6	20.9	0.5	0.2	0.1	0.4	0.0	0.2	0.1	0.1	0.1	0.8	0.0	0.1	0.1	20.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.1	0.1
ARHGAP45	"HA-1, HMHA1, KIAA0223"	ENSG00000180448	"Rho GTPase activating protein 45"	Q92619	19	1065923-1086628	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 32.1;bone marrow: 35.2;intestine: 23.4;lung: 17.5;lymphoid tissue: 50.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 30.7;THP-1: 27.4;U-266/70: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA019816	Enhanced					2200000	2200000			"HPA019816: AB_1853923"	"unprognostic (1.34e-1)"	"unprognostic (5.13e-3)"	"unprognostic (5.17e-3)"	"prognostic favourable (6.02e-4)"	"unprognostic (2.26e-1)"	"prognostic favourable (7.82e-4)"	"unprognostic (1.59e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.59e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.33e-2)"	4.9	2.8	2.8	28.3	3.8	35.2	4.3	0.9	2.2	2.1	4.8	3.8	0.6	4.4	2.1	2.6	3.2	3.3	5.4	2.7	3.0	2.2	4.6	3.5	17.5	42.2	5.4	1.2	1.2	1.5	0.5	2.5	5.8	3.9	3.2	1.7	3.2	6.7	1.5	1.2	2.0	23.4	2.0	4.9	50.4	6.1	1.7	4.6	45.0	4.3	1.8	38.4	4.3	4.3	9.3	9.4	15.7	9.2	11.3	32.1	21.0	3.2	0.6	0.0	3.6	0.0	0.0	8.6	0.0	0.0	0.0	0.0	8.7	4.2	21.9	0.9	0.0	2.9	0.6	0.1	0.0	16.0	0.3	2.9	6.0	1.0	0.1	14.2	17.3	0.0	0.9	0.0	0.0	0.0	1.9	30.7	0.0	0.2	15.8	12.7	2.3	1.6	15.3	0.1	21.7	0.0	0.0	0.1	0.0	5.0	0.0	1.3	1.0	27.4	1.4	0.0	0.6	0.0	0.0	40.4	17.3	17.5	0.1	21.4	1.6	2.7	9.2	9.8	20.4	9.0	17.8	7.3	23.2	24.2	9.4	9.3	32.1	23.3	15.7	11.3	8.4	5.6	18.2	21.0	2.8	3.8	0.9	2.2	3.0	2.2	5.4	1.2	3.9	4.6
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	268727-283010	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"brain: 60.4;intestine: 31.7;pancreas: 45.3"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.1;HEK 293: 18.4;MCF7: 23.6;SCLC-21H: 8.3;SH-SY5Y: 10.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	3.7	3.1	37.3	1.8	15.6	1.0	1.1	43.3	60.4	1.0	1.8	3.7	0.0	31.7	1.1	2.3	1.1	1.0	0.9	3.6	29.0	27.4	1.0	0.9	1.0	1.0	21.2	21.4	1.0	45.3	0.9	1.7	2.4	12.7	1.1	1.2	0.6	1.3	1.3	2.0	0.9	12.0	1.3	8.6	1.0	9.3	2.0	2.0	0.0	0.9	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.6	0.1	0.3	0.0	0.3	0.0	0.3	0.1	0.0	0.6	0.4	0.1	5.1	0.0	0.0	0.0	18.4	0.0	0.3	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.2	1.2	0.2	0.0	23.6	0.0	0.3	2.5	0.0	0.0	0.0	0.4	0.0	0.0	8.3	10.3	0.1	0.1	0.0	1.8	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	37.3	15.6	43.3	43.8	29.0	27.4	21.2	21.4	12.7	2.0
ATOH1	"bHLHa14, HATH1, MATH-1, Math1"	ENSG00000172238	"Atonal bHLH transcription factor 1"	Q92858	4	93828753-93830964	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	5	"intestine: 29.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 3.6;HL-60: 2.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																"prognostic favourable (3.26e-5)"								"unprognostic (5.20e-1)"	"unprognostic (2.69e-1)"		"unprognostic (1.26e-1)"	"unprognostic (2.70e-1)"			0.0	0.0	0.1	6.4	0.1	0.0	0.1	0.1	0.1	0.1	22.5	0.0	0.0	8.8	0.1	0.0	0.1	0.1	2.7	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	15.0	0.0	0.1	0.0	0.0	0.1	29.5	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	2.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.8	0.5	0.0	0.2	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
B3GNT6	B3Gn-T6	ENSG00000198488	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6"	Q6ZMB0	11	77034398-77041973	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.8;lymphoid tissue: 17.5;stomach 1: 17.9"	"Cell line enhanced"	"Detected in some"		"MCF7: 2.0;RPMI-8226: 1.5"	"Group enriched"	"Detected in some"	14	"colorectal cancer: 6.3;lung cancer: 3.9;pancreatic cancer: 5.1;prostate cancer: 5.0;stomach cancer: 4.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 2.3;neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA039805	Enhanced				"Intracellular and membrane"					"HPA039805: AB_2676690"		"unprognostic (1.71e-1)"	"prognostic favourable (2.31e-4)"	"unprognostic (4.79e-2)"	"unprognostic (5.42e-2)"	"unprognostic (7.64e-2)"		"unprognostic (1.95e-1)"		"unprognostic (2.72e-1)"	"unprognostic (1.23e-2)"	"unprognostic (7.77e-2)"		"unprognostic (2.19e-1)"		"unprognostic (9.30e-2)"	"unprognostic (1.71e-1)"	0.2	0.2	0.3	6.6	0.4	0.0	0.2	0.3	0.4	0.5	15.8	0.0	0.0	3.7	0.2	0.0	2.5	0.2	0.9	0.2	0.3	0.3	0.2	0.2	1.4	0.0	0.3	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	12.4	0.0	1.6	0.0	0.2	0.2	9.4	0.0	0.2	0.2	17.9	0.6	0.0	0.0	0.2	3.4	17.5	0.2	0.3	0.4	0.3	2.3	0.2	0.8	0.5	0.2	0.1	0.0	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.5	0.1	1.1	0.2	0.7	0.3	0.0	0.0	0.1	0.6	0.1	0.3	0.2	0.2	0.1	0.2	0.0	0.6	0.2	0.5	0.4	0.0	0.0	0.0	0.2	0.6	0.0	2.0	0.2	0.5	0.7	0.0	0.0	0.1	1.5	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.1	0.3	0.4	0.5	0.3	0.1	0.2	0.2	2.3	0.2	0.3	0.4	0.2	0.5	0.2	0.2	0.2	0.0	0.4	0.3	0.3	2.2	0.8	0.0	0.3	0.1	0.2	0.3	0.4	0.3	0.4	0.3	0.3	0.3	0.0	0.0	0.0
BAIAP2L2	"FLJ22582, pinkbar"	ENSG00000128298	"BAI1 associated protein 2 like 2"	Q6UXY1	22	38084889-38110670	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 59.1;intestine: 80.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 9.5;RPTEC TERT1: 18.4;SK-MEL-30: 23.0;WM-115: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"gdTCR: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in many"		"olfactory region: 4.5"	"Low region specificity"	"Detected in many"			HPA003043	Approved									"HPA003043: AB_2227864"	"unprognostic (2.15e-1)"	"unprognostic (4.23e-2)"	"unprognostic (9.82e-2)"	"unprognostic (5.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.37e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.77e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (4.23e-2)"	"unprognostic (4.51e-2)"	0.8	0.3	2.0	8.1	1.7	0.3	0.7	1.6	3.9	1.3	39.7	0.3	0.1	48.6	0.8	3.4	10.6	0.6	59.1	0.3	2.0	0.8	15.1	1.4	0.3	0.6	0.7	2.6	0.5	0.9	0.2	1.4	1.1	0.2	0.8	7.1	0.3	1.4	0.3	0.6	1.0	80.9	0.6	0.7	0.5	4.7	2.2	0.1	0.1	1.2	1.4	3.5	0.4	1.3	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.3	7.9	0.1	0.1	0.2	1.1	2.3	2.1	0.0	0.0	0.1	7.8	1.1	0.2	3.7	2.0	1.4	0.0	0.2	0.0	0.4	1.2	0.7	0.2	9.5	0.4	0.0	1.3	0.2	0.4	4.1	0.6	0.0	0.4	0.5	0.1	1.3	0.4	0.3	0.8	0.1	0.6	0.0	0.5	18.4	1.4	0.5	0.3	0.4	3.2	23.0	2.4	0.2	0.1	0.1	1.3	0.1	0.0	3.9	0.5	0.2	0.0	0.1	18.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	2.0	1.7	1.6	3.9	2.0	0.8	0.7	2.6	0.2	0.1
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44787705	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 34.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.3;U-698: 5.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA058564	Uncertain									"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.5	1.1	0.6	1.4	2.5	0.4	0.5	2.1	0.7	1.2	32.7	0.5	0.5	8.8	0.7	2.6	0.5	7.2	0.5	0.5	1.0	3.2	0.5	0.5	1.1	0.5	0.5	0.5	0.5	0.5	0.4	1.8	0.5	0.5	0.5	15.9	0.5	0.5	0.5	0.5	1.8	34.3	0.5	0.5	0.5	0.2	0.5	0.5	0.5	0.5	0.5	0.5	0.5	0.5	3.0	0.9	0.7	0.1	0.9	2.8	0.4	0.2	0.6	1.1	1.2	0.4	0.4	3.4	0.8	0.4	0.3	0.1	0.4	1.5	0.3	1.5	0.4	1.6	0.2	0.2	0.4	0.7	0.7	0.2	1.8	7.3	0.4	0.0	0.9	0.7	0.9	0.4	0.7	1.0	0.2	0.6	0.2	0.2	0.0	0.5	2.4	0.2	0.4	0.3	0.6	0.5	0.1	2.5	0.9	0.3	0.2	0.3	1.2	0.1	1.7	0.5	0.5	0.5	0.5	1.2	0.3	5.2	1.2	0.3	0.2	0.1	0.1	0.5	1.1	0.1	2.7	3.0	1.9	2.8	0.0	2.0	1.0	1.8	0.7	0.9	0.0	0.9	2.2	0.4	0.6	2.5	2.1	0.7	1.0	3.2	0.5	0.5	0.5	0.5
BTNL3	"BTN9.1, BTNLR"	ENSG00000168903	"Butyrophilin like 3"	Q6UXE8	5	180988845-181006727	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 82.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;CACO-2: 2.4;HMC-1: 1.0;RPMI-8226: 2.4;U-266/84: 2.4"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 5.5;pancreatic cancer: 1.2;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	178	"neutrophil: 17.8"	"Lineage enriched"	"Detected in single"	178	"granulocytes: 17.8"																						"unprognostic (4.07e-2)"		"unprognostic (3.64e-2)"	"unprognostic (9.21e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.00e-1)"		"unprognostic (1.10e-1)"	"unprognostic (5.57e-2)"		"unprognostic (2.19e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-1)"		0.1	0.0	0.1	2.1	0.1	0.0	0.1	0.1	0.1	0.1	32.5	0.1	0.1	44.2	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	9.4	0.1	0.1	0.1	0.1	0.0	82.5	0.1	0.1	0.5	0.4	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.4	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
C3orf85	FLJ22763	ENSG00000241224	"Chromosome 3 open reading frame 85"		3	109118252-109150514	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	5	"intestine: 50.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.2;CACO-2: 4.9;RPMI-8226: 1.4;SH-SY5Y: 1.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"unprognostic (9.10e-2)"				"unprognostic (9.48e-3)"						"unprognostic (3.80e-4)"	"unprognostic (1.15e-1)"	"unprognostic (6.70e-2)"			0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	36.2	0.0	0.6	0.0	0.0	0.0	0.4	0.0		6.8	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	4.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CA7		ENSG00000168748	"Carbonic anhydrase 7"	P43166	16	66844379-66854153	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 37.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 1.2;HAP1: 1.8;NTERA-2: 1.5;REH: 3.3;SCLC-21H: 2.7;THP-1: 5.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047237	Uncertain									"HPA047237: AB_2679994"	"unprognostic (8.77e-4)"	"unprognostic (5.23e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.16e-2)"		"unprognostic (7.90e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.84e-2)"	"unprognostic (9.62e-2)"	"unprognostic (1.69e-2)"	"unprognostic (7.12e-3)"	"unprognostic (8.47e-2)"	"unprognostic (5.20e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.46e-2)"	0.2	0.2	3.2	0.4	7.5	0.2	0.2	3.9	7.7	0.2	37.2	0.3	0.0	4.8	0.3	0.9	0.3	0.2	0.2	0.2	6.3	0.5	0.2	0.2	0.2	0.2	0.7	2.9	0.2	0.2	0.2	0.0	0.2	1.8	0.2	32.0	0.0	1.1	0.4	0.2	0.2	22.8	1.0	0.1	0.2	0.2	0.5	1.3	0.1	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	3.3	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	7.5	3.9	7.7	6.3	0.5	0.7	2.9	1.8	1.3
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 30.7;intestine: 9.9;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"MAIT T-cell: 30.7;memory B-cell: 23.8;memory CD4 T-cell: 11.9;naive B-cell: 28.2;T-reg: 20.9"	"Group enriched"	"Detected in many"	5	"B-cells: 28.2;T-cells: 30.7"	"Region enriched"	"Detected in single"	8	"basal ganglia: 0.9"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved									"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.3	1.0	24.4	1.5	1.3	1.1	0.3	1.1	0.6	3.0	0.1	0.0	1.4	0.3	0.8	2.1	0.5	3.1	0.3	0.9	0.9	1.0	0.5	3.3	27.3	0.6	0.0	0.3	0.3	0.0	0.4	0.5	0.2	0.5	1.2	0.3	5.0	0.8	0.3	1.1	9.9	0.0	0.4	23.4	2.2	2.7	0.1	3.7	0.6	2.1	33.7	4.8	0.4	28.2	5.4	0.2	0.0	0.4	30.7	2.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.2	1.3	0.3	0.0	0.0	0.3	0.2	0.1	2.6	0.7	0.1	0.3	14.1	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.2	0.4	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.3	0.5	0.3	0.4	0.0	0.2	0.6	0.0	0.0	0.1	1.6	0.0	30.7	23.8	11.9	4.7	5.4	28.2	0.1	0.0	0.2	0.4	0.0	0.6	20.9	2.5	1.0	1.5	0.3	1.1	0.9	0.9	0.6	0.0	0.2	0.1
CD40LG	"CD154, CD40L, gp39, hCD40L, HIGM1, IMD3, TNFSF5, TRAP"	ENSG00000102245	"CD40 ligand"	P29965	X	136648193-136660390	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 29.2;intestine: 8.7;lymphoid tissue: 33.7"	"Cell line enriched"	"Detected in single"	72	"MOLT-4: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 9.4;MAIT T-cell: 22.9;memory CD4 T-cell: 29.2;naive CD4 T-cell: 28.1"	"Lineage enriched"	"Detected in single"	58	"T-cells: 29.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045827	Enhanced				"Secreted to blood"					"HPA045827: AB_10959606"	"unprognostic (1.94e-5)"	"unprognostic (1.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-3)"	"unprognostic (4.71e-2)"	"unprognostic (3.56e-5)"	"unprognostic (3.66e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.70e-4)"	"unprognostic (2.15e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.36e-3)"	"unprognostic (2.92e-2)"	2.0	0.5	0.3	22.4	0.3	1.4	1.2	0.3	0.3	2.0	3.3	0.1	0.0	1.7	1.5	1.3	1.6	1.6	2.6	1.1	0.4	0.4	1.6	1.1	4.0	14.6	0.4	0.0	0.7	0.6	0.0	0.4	0.2	0.3	1.0	3.1	1.0	4.9	1.3	0.4	1.1	8.7	0.5	0.6	9.9	1.7	0.6	0.1	33.7	1.4	2.0	26.1	3.0	1.4	0.0	0.0	0.5	0.0	0.2	29.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	9.4	0.0	22.9	0.0	29.2	4.1	0.0	0.0	28.1	0.2	0.5	0.2	0.0	0.0	3.3	4.7	0.3	0.3	0.3	0.3	0.4	0.4	0.4	0.0	0.3	0.1
CLEC17A	FLJ45910	ENSG00000187912	"C-type lectin domain containing 17A"	Q6ZS10	19	14583084-14611157	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 30.9;intestine: 8.5;lymphoid tissue: 25.1"	"Group enriched"	"Detected in some"	10	"Daudi: 9.9;U-698: 18.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"memory B-cell: 14.7;naive B-cell: 30.9"	"Lineage enriched"	"Detected in many"	16	"B-cells: 30.9"					"Low region specificity"	"Detected in all"														"unprognostic (4.71e-5)"	"unprognostic (1.34e-2)"	"unprognostic (9.64e-4)"	"unprognostic (5.02e-3)"	"unprognostic (3.90e-1)"	"unprognostic (9.00e-4)"	"unprognostic (3.18e-3)"	"unprognostic (1.60e-3)"	"unprognostic (1.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.65e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.23e-1)"	0.4	0.3	0.8	23.2	2.2	1.3	0.3	0.3	1.3	0.3	0.6	3.3	0.0	0.4	0.3	0.0	0.4	0.3	0.6	0.3	2.2	1.1	0.6	0.3	0.4	18.7	1.3	0.0	0.3	0.3	0.1	0.5	0.1	1.7	0.4	0.6	0.4	4.7	0.0	0.3	0.3	8.5	0.0	3.7	17.0	0.7	1.4	2.0	1.0	0.5	0.0	25.1	1.5	0.3	30.9	1.8	0.7	0.3	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.2	0.0	14.7	0.0	0.0	1.8	30.9	0.0	0.0	0.7	0.1	0.1	0.2	0.0	1.3	0.8	2.2	0.3	1.3	2.2	1.1	1.3	0.0	1.7	2.0
CMBL	FLJ23617	ENSG00000164237	"Carboxymethylenebutenolidase homolog"	Q96DG6	5	10275875-10308026	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"gallbladder: 21.6;intestine: 71.4;kidney: 81.7;liver: 83.7;skeletal muscle: 70.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 30.2;K-562: 30.7;PC-3: 29.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036571	Uncertain					590000	590000			"HPA036571: AB_10670114"	"unprognostic (1.81e-2)"	"unprognostic (2.55e-1)"	"unprognostic (8.10e-3)"	"unprognostic (2.53e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.20e-1)"	"unprognostic (8.64e-2)"	"prognostic favourable (1.99e-4)"	"unprognostic (1.76e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.44e-1)"	5.7	13.9	8.1	6.1	7.7	2.0	13.1	4.1	7.8	5.6	38.3	2.9	5.2	47.0	4.3	6.1	3.0	5.1	21.6	11.4	7.8	5.1	81.7	83.7	5.5	2.1	5.8	7.6	10.6	6.5	13.9	6.0	1.3	5.1	8.6	17.8	4.8	3.5	8.4	70.6	1.4	71.4	5.0	7.0	1.4	14.4	3.9	4.1	1.3	7.3	10.5	1.6	6.4	4.8	0.8	0.6	3.0	1.2	0.7	2.1	0.8	3.6	4.3	5.0	12.6	20.1	23.1	27.4	6.2	6.7	2.0	2.8	1.7	18.7	0.0	10.4	4.5	0.1	11.7	7.9	2.4	0.2	8.8	16.4	19.7	14.1	6.2	0.1	0.1	30.2	5.2	4.1	3.8	6.0	30.7	0.2	7.0	0.7	0.1	0.6	7.7	29.6	3.6	0.0	0.4	18.5	2.3	4.0	6.2	14.8	1.3	0.4	10.3	0.6	1.7	3.0	3.9	4.8	0.0	0.1	0.0	0.0	4.9	0.0	0.0	2.1	1.2	0.5	1.5	0.5	2.1	0.3	1.7	0.7	0.6	0.8	0.8	1.6	3.0	0.7	0.3	0.5	0.2	0.8	8.1	7.7	4.1	7.8	7.8	5.1	5.8	7.6	5.1	4.1
CUBN	"gp280, IFCR, MGA1"	ENSG00000107611	Cubilin	O60494	10	16823964-17129831	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 28.9;kidney: 79.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 17.8;ASC TERT1: 4.5;SK-MEL-30: 3.3;WM-115: 6.7"	"Cancer enriched"	"Detected in some"	15	"renal cancer: 24.3"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA004133, HPA043854"	Enhanced				"Intracellular and membrane"	240000	240000			"HPA004133: AB_2732398, HPA043854: AB_2732510"	"unprognostic (1.75e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.12e-3)"	"unprognostic (8.61e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.88e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.47e-1)"	"prognostic favourable (1.12e-4)"	"unprognostic (6.24e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.93e-1)"	0.3	0.3	0.3	0.3	0.6	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.3	0.0	0.4	11.5	0.3	1.6	0.3	0.3	0.3	0.3	79.7	0.3	0.3	0.4	0.3	0.3	2.0	0.3	0.6	1.7	1.1	0.3	0.6	0.1	0.3	0.3	0.3	0.3	0.3	28.9	0.3	0.3	0.5	0.1	1.2	0.3	0.3	3.1	0.3	0.3	0.3	0.3	0.8	1.2	0.9	0.2	0.6	1.4	0.0	0.0	0.1	1.8	17.8	0.6	4.5	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.6	0.2	1.8	0.1	0.3	0.2	0.0	0.3	0.2	0.3	0.1	0.1	0.4	0.0	0.6	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.1	1.8	0.1	0.2	0.3	0.2	0.6	0.1	0.0	0.5	0.1	6.7	0.9	0.2	0.0	0.8	0.0	1.0	0.4	0.4	0.2	0.0	0.8	0.8	1.4	0.6	0.6	0.0	1.2	0.7	0.0	0.3	0.6	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.3
CYP3A5	"CP35, P450PCN3, PCN3"	ENSG00000106258	"Cytochrome P450 family 3 subfamily A member 5"	P20815	7	99648194-99680026	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 72.9;liver: 73.4;stomach 1: 21.3"	"Cell line enhanced"	"Detected in some"		"A549: 3.1;CACO-2: 12.1;CAPAN-2: 8.1;Hep G2: 8.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 38.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA072245			Uncertain	Cytosol				Cytosol	Cytosol	"HPA072245: "	"unprognostic (2.13e-1)"	"unprognostic (4.36e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.73e-1)"	"prognostic favourable (3.72e-5)"	"unprognostic (1.37e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.85e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-4)"	"unprognostic (6.58e-3)"	1.0	3.3	0.4	2.0	0.5	0.0	1.3	0.6	0.6	1.9	32.6	0.6	1.0	30.3	0.7	0.5	5.2	0.5	8.2	0.4	0.4	0.0	6.8	73.4	2.4	0.8	0.4	0.4	0.6	12.1	0.0	1.8	0.6	0.8	4.9	5.1	0.4	0.6	1.3	0.4	4.3	72.9	0.6	0.5	0.4	21.3	0.7	0.4	0.5	0.4	2.2	4.0	3.0	2.7	0.0	0.2	0.1	0.6	0.0	0.7	0.2	0.0	3.1	0.0	0.0	0.5	0.8	0.1	0.0	0.0	0.0	0.0	12.1	8.1	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.4	0.1	0.1	0.2	0.0	2.6	0.0	0.1	0.0	2.6	0.2	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.0	0.8	0.7	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.4	0.5	0.6	0.6	0.4	0.0	0.4	0.4	0.8	0.4
EFNA2	"ELF-1, EPLG6, LERK6"	ENSG00000099617	"Ephrin A2"	O43921	19	1286154-1300237	"Cancer-related genes, Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"gallbladder: 10.0;intestine: 30.3;liver: 14.2"	"Cell line enhanced"	"Detected in some"		"AF22: 4.8;BEWO: 4.9;Hep G2: 9.3;NTERA-2: 5.4;REH: 7.1;SH-SY5Y: 16.8;U-2 OS: 5.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067567			Approved	Mitochondria,Cytosol	"Intracellular and membrane"			"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA067567: AB_2732771"	"unprognostic (1.98e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.96e-2)"	"unprognostic (4.04e-2)"	"unprognostic (3.90e-1)"	"unprognostic (7.19e-2)"	"unprognostic (2.34e-3)"	"unprognostic (3.58e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.82e-4)"	"unprognostic (1.94e-1)"	0.2	0.1	1.5	3.4	2.2	0.2	0.1	1.5	2.0	0.1	10.7	2.0	0.0	12.0	0.2	0.1	0.4	0.1	10.0	0.1	1.0	1.6	0.3	14.2	0.1	0.1	1.2	0.5	0.1	0.1	0.1	0.3	0.2	1.1	0.1	2.3	1.9	0.1	0.2	0.2	0.1	30.3	0.2	0.9	0.2	0.6	0.6	0.7	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.8	1.7	0.0	0.0	4.9	0.2	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	2.2	0.0	0.0	0.1	2.1	0.0	0.0	9.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.4	0.0	7.1	0.6	0.0	0.0	0.1	0.0	16.8	0.2	0.0	0.1	0.2	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.2	1.5	2.0	1.0	1.6	1.2	0.5	1.1	0.7
ENPP7	"alk-SMase, NPP7"	ENSG00000182156	"Ectonucleotide pyrophosphatase/phosphodiesterase 7"	Q6UWV6	17	79730919-79742222	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.1"	"Group enriched"	"Detected in some"	5	"Hep G2: 2.8;Karpas-707: 5.1;U-266/70: 6.9"	"Cancer enriched"	"Detected in some"	6	"liver cancer: 6.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA024603	Approved				"Intracellular and membrane"	440000	440000			"HPA024603: AB_1848174"	"unprognostic (4.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.01e-1)"		"unprognostic (8.45e-4)"	"unprognostic (4.83e-2)"		"unprognostic (1.18e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.80e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.6	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	14.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.7	1.3	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ENTPD8	"NTPDase-8, UNQ2492"	ENSG00000188833	"Ectonucleoside triphosphate diphosphohydrolase 8"	Q5MY95	9	137434364-137441816	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 48.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.0;RPMI-8226: 8.7;T-47d: 4.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA021509	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA021509: AB_1848185"	"unprognostic (3.85e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.46e-3)"	"unprognostic (8.70e-2)"	"unprognostic (3.87e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.08e-5)"	"prognostic favourable (7.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.78e-1)"	0.4	0.0	0.4	2.6	0.4	0.0	0.4	0.4	0.4	0.4	19.2	0.4	0.4	18.5	0.4	0.4	0.4	0.3	2.2	0.4	0.5	0.0	2.1	9.8	0.8	0.4	0.4	0.4	0.4	1.8	0.0	4.2	0.5	0.4	0.4	7.5	0.8	4.1	0.4	0.4	0.0	48.1	0.4	0.4	0.4	6.1	0.4	0.4	0.6	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	2.0	9.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	1.5	0.2	0.0	0.6	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	1.6	0.0	0.2	0.1	0.4	0.0	0.0	8.7	1.4	0.0	0.3	0.9	0.2	0.0	0.1	4.7	0.2	0.1	0.0	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.5	0.0	0.4	0.4	0.4	0.4
EPS8L3	"FLJ21522, MGC16817"	ENSG00000198758	"EPS8 like 3"	Q8TE67	1	109750080-109764027	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 30.0;intestine: 115.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.5;CAPAN-2: 10.9;EFO-21: 4.5;Hep G2: 25.9"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 52.5;pancreatic cancer: 29.7;stomach cancer: 26.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	22	"NK-cell: 2.1"	"Lineage enriched"	"Detected in single"	22	"NK-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA030998	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA030998: AB_2673691"	"unprognostic (1.73e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (4.13e-5)"	"unprognostic (5.55e-3)"		"unprognostic (3.71e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.33e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (5.87e-3)"	"unprognostic (3.89e-1)"		"prognostic favourable (1.82e-4)"	0.2	0.1	0.2	11.0	0.2	0.0	0.2	0.2	0.2	0.5	88.2	0.2	0.2	41.3	0.2	0.2	0.3	0.2	30.0	0.2	0.2	0.1	0.3	0.3	0.2	0.2	0.2	0.2	0.2	0.5	0.0	0.2	0.2	0.2	0.3	22.1	0.2	0.2	0.3	0.2	0.1	115.1	0.5	0.2	0.2	15.1	1.2	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	11.5	10.9	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
EXOC3L4	C14orf73	ENSG00000205436	"Exocyst complex component 3 like 4"	Q17RC7	14	103100144-103110559	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 15.3;liver: 26.4"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.8;HEL: 7.0;Hep G2: 4.9;RPMI-8226: 4.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA043661	Approved									"HPA043661: AB_10965693"	"unprognostic (8.71e-2)"	"unprognostic (7.42e-3)"	"prognostic unfavourable (1.43e-5)"	"unprognostic (8.20e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.98e-2)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.81e-4)"	0.4	0.2	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.4	1.5			15.3	0.1	0.0	0.3	0.2	2.0	0.4	0.0	0.0	2.4	26.4	1.1	4.4	0.0		0.2	0.8	0.0	0.1	0.3		0.8	0.7		0.2	0.0	0.0	0.1	7.4	0.0	0.0	3.5	3.2	0.1			0.1		1.9	0.2	0.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	2.0	1.2	0.3	0.3	0.0	0.2	0.0	0.0	0.0	6.8	0.0	7.0	0.1	4.9	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.0	4.7	0.0	0.1	0.2	0.0	0.0	1.7	0.0	0.3	1.2	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
FCGBP	FC(GAMMA)BP	ENSG00000275395	"Fc fragment of IgG binding protein"		19	39863323-39934626	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Group enriched"	"Detected in many"	5	"cervix, uterine: 13.9;gallbladder: 46.6;intestine: 43.3;stomach 1: 17.0;thyroid gland: 20.9"	"Cell line enhanced"	"Detected in some"		"A549: 9.7;Daudi: 3.0;RH-30: 10.9;RPMI-8226: 3.8;U-266/70: 3.6"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA003517, HPA003564"	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytokinetic bridge"				"Plasma membrane"	"Plasma membrane"	"HPA003517: AB_1078838, HPA003564: AB_2231648"	"unprognostic (1.65e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.04e-2)"	"prognostic favourable (1.28e-5)"	"prognostic unfavourable (4.74e-5)"	"unprognostic (1.36e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavourable (9.70e-6)"	"unprognostic (9.44e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.92e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.82e-1)"	"prognostic unfavourable (4.27e-4)"	"unprognostic (2.08e-1)"	1.7	0.6	1.7	5.9	1.8	0.0	2.7	0.2	1.6	13.9	43.3	0.8	0.7	15.2	0.2	0.4	0.2	0.0	46.6	0.7	0.6		0.6	0.2	0.6	0.2	0.9	0.6	0.6	0.2	0.0	1.2	1.5	1.1	0.4	16.7	0.3	1.3	1.2	0.2	2.8	16.9	0.2	2.1	0.2	17.0	0.4	0.9	0.5	20.9	0.2	0.5	0.2	0.2	0.6	2.3	0.0	0.9	1.3	3.2	0.6	0.0	9.7	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.3	0.1	0.3	1.0	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.4	2.8	1.2	0.3	0.7	0.2	10.9	3.8	0.2	1.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	3.6	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.9	0.3	0.0	0.7	1.4	2.3	0.6	0.9	3.2	0.0	1.3	0.5	0.0	0.2	0.6										
FCMR	"FAIM3, TOSO"	ENSG00000162894	"Fc fragment of IgM receptor"	O60667	1	206904386-206923247	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 99.6;intestine: 30.1;lymphoid tissue: 84.9"	"Group enriched"	"Detected in some"	5	"RPMI-8226: 51.7;U-266/70: 26.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 99.6;T-cells: 60.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA003910	Approved		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"	"Secreted to blood"	2400000	2400000	"Focal adhesion sites, Cytosol"	"Focal adhesion sites, Cytosol"	"HPA003910: AB_1078798"	"prognostic favourable (4.23e-4)"	"unprognostic (1.16e-3)"	"unprognostic (7.48e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.15e-1)"	"unprognostic (4.85e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.15e-3)"	"unprognostic (8.06e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.05e-3)"	15.5	0.6	0.5	42.9	0.5	2.9	1.5	0.4	0.4	0.8	2.5	0.4	0.3	1.2	1.2	0.8	3.4	1.3	2.6	1.0	0.5	0.5	2.4	1.5	3.9	77.2	0.5	0.0	1.3	0.7	0.0	0.9	0.8	0.2	1.4	2.3	1.3	10.1	0.3	1.9	0.6	30.1	0.4	0.6	78.8	2.8	0.5	0.0	51.8	1.8	1.2	84.9	8.5	1.2	99.6	1.4	5.3	0.4	18.4	60.0	28.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.1	0.0	0.0	3.3	0.0	0.1	0.1	0.0	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.6	0.0	0.0	7.2	0.0	0.1	1.0	0.1	0.0	0.0	1.6	0.2	51.7	0.0	0.1	0.0	0.0	1.0	0.2	4.8	0.1	0.0	0.2	0.0	0.2	0.0	0.0	26.1	1.9	7.2	0.3	0.0	0.2	0.5	0.2	0.2	20.3	0.4	26.4	80.3	28.1	26.2	0.2	99.6	49.5	33.3	5.3	18.4	0.3	1.4	60.0	28.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.0	0.2	0.0
GPR35		ENSG00000178623	"G protein-coupled receptor 35"	Q9HC97	2	240605431-240631259	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 109.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.1;CAPAN-2: 27.9;HDLM-2: 9.3;Hep G2: 17.7;HMC-1: 17.6;NB-4: 8.6;U-937: 9.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	12	"classical monocyte: 16.4;eosinophil: 16.8;intermediate monocyte: 22.7;myeloid DC: 14.5;non-classical monocyte: 6.1"	"Group enriched"	"Detected in many"	14	"dendritic cells: 14.5;granulocytes: 16.8;monocytes: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.71e-2)"	"prognostic unfavourable (5.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavourable (2.59e-5)"	"unprognostic (7.03e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-3)"	0.8	0.2	1.5	7.0	1.8	2.4	1.4	2.4	2.2	1.6	50.4	1.0	0.5	27.2	1.7	1.8	1.1	3.4	24.1	0.8	1.5	1.5	2.2	0.7	3.1	6.6	1.6	0.8	2.5	0.5	0.3	3.2	0.7	1.8	1.8	11.2	0.6	0.8	0.7	3.9	1.2	109.6	1.3	1.4	8.9	10.8	2.0	1.6	1.9	1.2	0.9	2.4	1.0	1.0	0.0	14.5	16.8	22.7	0.3	1.3	5.5	0.0	0.2	0.1	0.6	0.5	0.0	0.2	0.0	0.2	0.0	0.1	11.1	27.9	0.1	0.1	0.1	0.2	0.0	0.0	0.0	9.3	0.3	4.6	0.2	17.7	0.2	0.2	17.6	0.1	0.1	0.3	0.1	0.0	0.2	1.6	0.0	0.3	0.2	8.6	0.4	0.1	1.0	0.0	0.2	0.1	0.1	1.1	0.4	0.0	0.1	0.2	0.1	3.1	0.4	0.1	0.1	0.7	0.1	1.9	0.8	0.1	0.0	9.7	0.2	0.0	16.4	16.8	0.7	22.7	1.3	0.0	0.4	0.4	14.5	0.0	0.2	0.5	0.2	0.3	6.1	0.3	0.1	5.5	1.5	1.8	2.4	2.2	1.5	1.5	1.6	0.8	1.8	1.6
GZMA	"CTLA3, HFSP"	ENSG00000145649	"Granzyme A"	P12544	5	55102648-55110252	"Enzymes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 92.3;intestine: 31.0;lymphoid tissue: 40.9"	"Cell line enriched"	"Detected in some"	4	"HL-60: 9.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	13	"gdTCR: 92.3;MAIT T-cell: 90.8;memory CD4 T-cell: 25.4;memory CD8 T-cell: 89.3;naive CD8 T-cell: 50.5;NK-cell: 61.9"	"Group enriched"	"Detected in many"	38	"NK-cells: 61.9;T-cells: 92.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054134	Approved				"Secreted to blood"					"HPA054134: AB_2682395"	"prognostic favourable (7.27e-4)"	"unprognostic (7.29e-3)"	"unprognostic (1.50e-2)"	"prognostic favourable (6.44e-6)"	"unprognostic (2.96e-3)"	"unprognostic (1.85e-3)"	"unprognostic (8.30e-3)"	"unprognostic (1.15e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.09e-1)"	"prognostic unfavourable (1.26e-6)"	"unprognostic (5.91e-2)"	"unprognostic (5.57e-1)"	"unprognostic (5.73e-3)"	"unprognostic (3.33e-3)"	4.3	1.8	1.1	16.3	1.2	10.0	2.5	0.7	0.8	3.9	12.5	0.9	1.3	10.3	5.2	2.9	2.9	2.9	9.6	4.5	1.1	1.1	4.6	5.2	11.8	20.3	1.7	0.9	3.0	5.8	0.0	1.9	5.8	1.5	3.4	6.3	4.5	5.1	1.3	2.6	1.2	31.0	2.5	2.6	40.9	3.9	1.1	0.6	1.9	3.1	4.2	11.1	6.6	2.9	0.2	0.2	2.0	0.3	61.9	92.3	52.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	92.3	0.2	90.8	0.2	25.4	89.3	0.2	0.1	5.2	50.5	2.0	61.9	0.3	0.2	2.9	52.0	1.1	1.2	0.7	0.8	1.1	1.1	1.7	0.9	1.5	0.6
HIST1H4G	"H4/l, H4FL"	ENSG00000275663	"Histone cluster 1 H4 family member g"	Q99525	6	26246681-26246977	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"intestine: 2.1"	"Group enriched"	"Detected in some"	20	"AF22: 1.0;CAPAN-2: 1.2;PC-3: 3.3;SCLC-21H: 1.7;THP-1: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported									"HPA042201: AB_2677898"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.3			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.7		0.0	0.0	0.0	0.0	2.1	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.3	0.0	0.4	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0										
HKDC1	"FLJ22761, FLJ37767"	ENSG00000156510	"Hexokinase domain containing 1"	Q2TB90	10	69220303-69267559	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 77.4"	"Cell line enhanced"	"Detected in some"		"A549: 14.7;CACO-2: 20.9;CAPAN-2: 41.4;EFO-21: 12.8;Hep G2: 12.1;RPTEC TERT1: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 8.3;T-reg: 6.6"	"Lineage enriched"	"Detected in single"	29	"T-cells: 8.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 12.2"	"Low region specificity"	"Detected in all"			"HPA011956, HPA064198, HPA064230"	Approved		Enhanced	Mitochondria				Mitochondria	Mitochondria	"HPA011956: AB_1850758, HPA064198: AB_2685210, HPA064230: "	"unprognostic (1.29e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.47e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.31e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.23e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.19e-1)"	0.2	0.0	0.9	1.2	1.6	0.0	0.2	0.8	1.4	0.5	29.8	0.5	0.2	29.9	0.5	1.0	0.3	2.5	11.2	0.2	0.5	0.6	15.6	4.6	1.3	0.3	0.3	0.2	1.0	4.7	0.0	0.5	0.2	0.4	0.2	2.3	12.0	0.2	0.2	0.2	0.0	77.4	0.2	0.2	0.2	0.4	0.6	0.2	0.2	5.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.2	8.3	1.6	0.4	14.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	20.9	41.4	0.0	12.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	12.1	1.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	30.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.7	0.0	4.4	1.4	0.0	0.0	8.3	3.2	0.0	0.2	0.0	0.0	6.6	1.6	0.9	1.6	0.8	0.4	0.5	0.6	0.3	0.2	0.4	0.2
HOXB9	"HOX2, HOX2E"	ENSG00000170689	"Homeobox B9"	P17482	17	48621159-48626356	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ductus deferens: 27.3;epididymis: 42.8;intestine: 16.6;kidney: 15.3;seminal vesicle: 23.5"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 77.4;HEK 293: 29.8;HMC-1: 30.6;K-562: 32.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031463			Approved	Nucleoplasm,Mitochondria				"Nucleoplasm, Mitochondria"	"Nucleoplasm, Mitochondria"	"HPA031463: "	"unprognostic (2.16e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavourable (4.47e-4)"	"unprognostic (1.38e-4)"	"prognostic unfavourable (6.64e-5)"	"unprognostic (3.15e-2)"	"unprognostic (1.60e-3)"	"unprognostic (6.30e-3)"	"unprognostic (3.41e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.85e-1)"	"unprognostic (6.00e-2)"	0.5	0.8	0.1	1.9	0.2	0.0	0.4	0.1	0.3	5.3	16.6	0.1	27.3	0.0	1.4	42.8	0.1	0.4	0.1	0.1	0.1	0.1	15.3	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.4	0.3	0.5	0.2	1.1	10.4	0.1	0.1	23.5	0.2	0.2	11.3	1.0	3.5	0.2	0.2	2.0	0.1	0.1	0.1	0.1	0.1	2.0	2.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	4.0	1.3	0.0	7.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	1.6	0.0	8.3	0.2	0.0	1.3	0.0	0.0	77.4	29.8	13.5	0.5	0.0	0.5	0.2	30.6	0.0	0.0	0.0	0.8	0.0	32.8	0.0	1.3	0.0	0.0	0.1	0.0	1.2	0.0	5.2	0.4	13.5	0.0	0.0	0.0	1.0	0.0	8.5	0.1	0.0	0.1	0.0	7.7	0.0	2.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.2	0.1
IGSF23		ENSG00000216588	"Immunoglobulin superfamily member 23"	A1L1A6	19	44613630-44636781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"blood: 6.0;intestine: 19.9;liver: 20.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 13.7;Hep G2: 8.1;SiHa: 6.3"	"Cancer enriched"	"Detected in some"	10	"liver cancer: 12.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 6.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.0"									"HPA051811, HPA054591"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"				Nucleoplasm	Nucleoplasm	"HPA051811: AB_2681621, HPA054591: AB_2682535"	"unprognostic (1.54e-1)"	"unprognostic (1.84e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.53e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.11e-1)"	"prognostic favourable (7.20e-6)"	"unprognostic (7.35e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-8)"	"unprognostic (1.26e-1)"	"unprognostic (6.38e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.85e-1)"	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.8	0.1	0.1	12.2	0.1	0.5	0.1	0.1	0.1	0.6	0.1	0.1	0.4	20.6	0.1	0.1	0.1	0.1	0.1	3.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.9	0.1	0.1	0.0	19.9	0.1	0.6	0.1	0.0	1.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	6.0	1.2	0.0	0.0	0.2	0.4	0.8	0.0	0.5	0.0	0.0	0.7	0.5	0.6	0.0	0.6	13.7	0.4	0.0	1.0	0.4	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.3	8.1	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	6.3	2.2	0.0	0.3	0.0	2.5	0.4	0.5	0.6	0.0	1.2	0.0	0.0	0.1	0.3	0.0	0.0	1.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
IL7R	CD127	ENSG00000168685	"Interleukin 7 receptor"	P16871	5	35852695-35879603	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 70.3;intestine: 34.0;lung: 52.6;lymphoid tissue: 133.1"	"Cell line enhanced"	"Detected in many"		"BJ: 21.7;fHDF/TERT166: 40.7;HBF TERT88: 37.4;REH: 84.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 19.2;MAIT T-cell: 70.3;memory CD4 T-cell: 39.9;memory CD8 T-cell: 28.0;naive CD4 T-cell: 34.5;naive CD8 T-cell: 22.5;NK-cell: 19.1"	"Group enriched"	"Detected in many"	33	"NK-cells: 19.1;T-cells: 70.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			CAB010215			Supported	"Plasma membrane,Centriolar satellite"	"Intracellular and membrane"	180000	180000	"Plasma membrane, Centriolar satellite"	"Plasma membrane, Centriolar satellite"	"CAB010215: AB_673727"	"unprognostic (2.93e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.82e-3)"	"unprognostic (5.58e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-3)"	"unprognostic (5.53e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.27e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.78e-1)"	6.7	3.6	0.7	34.0	0.7	3.1	4.8	0.5	0.6	4.8	20.6	0.3	0.9	3.5	1.8	2.9	6.6	3.7	8.5	1.9	0.7	0.7	7.0	2.7	52.6	133.1	0.8	0.1	2.5	1.7	0.0	1.5	1.2	0.8	3.3	5.4	1.7	13.2	1.8	0.9	1.8	34.0	1.2	1.5	32.3	7.8	3.0	0.4	130.9	5.1	5.3	42.9	12.6	4.6	0.4	0.3	1.3	0.2	19.1	70.3	12.7	0.1	0.0	0.1	0.1	0.1	0.1	0.2	21.7	11.0	19.6	11.6	0.1	0.1	2.1	0.0	40.7	3.5	0.0	1.3	37.4	1.8	0.2	0.6	2.3	0.0	0.3	0.1	1.5	0.3	0.0	4.2	0.9	0.5	0.1	0.3	15.4	0.0	0.5	0.2	0.1	1.0	84.6	1.1	0.1	0.0	1.2	0.0	0.0	3.6	0.3	0.0	0.1	0.0	1.5	7.7	13.1	3.3	2.8	0.1	0.0	2.4	3.9	2.0	5.9	0.5	0.2	0.1	19.2	0.2	70.3	0.2	39.9	28.0	0.1	0.4	34.5	22.5	1.3	19.1	0.2	0.3	6.7	12.7	0.7	0.7	0.5	0.6	0.7	0.7	0.8	0.1	0.8	0.4
ITLN1	"FLJ20022, hIntL, HL-1, ITLN, LFR"	ENSG00000179914	"Intelectin 1"	Q8WWA0	1	160876539-160885170	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adipose tissue: 119.2;heart muscle: 48.6;intestine: 157.9;lymphoid tissue: 40.1"	"Cell line enhanced"	"Detected in some"		"HEL: 4.3;HHSteC: 1.9;HL-60: 3.1;RPMI-8226: 1.7;U-937: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 61.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"intermediate monocyte: 6.9;non-classical monocyte: 17.3"	"Lineage enriched"	"Detected in many"	15	"monocytes: 17.3"	"Not detected"	"Not detected"							"CAB012652, HPA063275, HPA067326"	Enhanced				"Secreted to blood"	160000000	160000000			"CAB012652: , HPA063275: AB_2684974, HPA067326: "	"unprognostic (9.69e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.31e-3)"	"unprognostic (2.28e-1)"		"unprognostic (1.79e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.70e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.38e-1)"	"unprognostic (9.96e-2)"	"unprognostic (3.67e-1)"	"unprognostic (8.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.34e-2)"	119.2	0.0	0.2	40.1	0.2	0.0	0.2	0.2	0.2	0.4	52.5	0.2	1.0	31.9	0.5	8.8	0.7	1.2	8.7	48.6	0.2	0.0	0.5	2.6	13.9	0.2	0.2	0.3	4.3	0.2	0.0	0.4	0.4	0.3	3.0	157.9	0.2	2.6	0.6	1.5	0.1	48.6	0.8	0.2	0.6	1.9	2.7	0.2	0.4	0.2	1.4	1.5	1.6	0.8	0.0	1.1	0.1	17.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.0	0.0	1.9	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	11.9	0.0	0.0	0.3	0.0	0.0	6.9	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.3	0.3	0.2
KIR2DL4	"103AS, 15.212, CD158D"	ENSG00000189013	"Killer cell immunoglobulin like receptor, two Ig domains and long cytoplasmic tail 4"	Q99706	19	54803535-54814517	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"blood: 5.6;intestine: 7.3;lymphoid tissue: 13.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	56	"NK-cell: 5.6"	"Lineage enriched"	"Detected in single"	56	"NK-cells: 5.6"														"Intracellular and membrane"						"unprognostic (1.98e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.70e-4)"	"unprognostic (2.23e-1)"	"unprognostic (5.95e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.92e-5)"	"unprognostic (5.15e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.53e-8)"	"unprognostic (6.47e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.10e-4)"	"unprognostic (3.59e-3)"	0.2	0.3	0.0	2.8	0.0	0.3	0.1	0.0	0.2	0.1	3.8	0.0	0.0	0.1	1.4	0.2	0.2	0.2	0.3	0.9	0.1	0.0	0.2	0.3	1.2	0.3	0.0	0.0	1.1	0.1	0.1	0.1	1.7	0.0	0.2	0.3	0.0	0.1	0.8	0.1	0.1	7.3	0.1	0.0	13.9	0.3	0.3	0.0	0.4	0.5	0.0	1.5	0.8	0.1	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0
LCN15	"PRO6093, UNQ2541"	ENSG00000177984	"Lipocalin 15"	Q6UWW0	9	136759634-136766255	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 4.9;ductus deferens: 12.0;intestine: 16.5;seminal vesicle: 5.3"	"Cell line enriched"	"Detected in some"	7	"Hep G2: 19.2"	"Cancer enriched"	"Detected in some"	19	"colorectal cancer: 23.0"	"Group enriched"	"Detected in some"	6	"amygdala: 2.4;cerebral cortex: 4.9;hippocampal formation: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			HPA060584	Enhanced				"Secreted in other tissues"					"HPA060584: AB_2684327"			"unprognostic (5.24e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.14e-1)"					"unprognostic (3.67e-1)"		"unprognostic (3.45e-2)"		"unprognostic (3.28e-2)"	"unprognostic (2.39e-1)"		"unprognostic (1.83e-1)"	0.1	0.0	2.4	0.1	0.4	0.0	0.1	0.1	4.9	0.1	12.8	0.1	12.0	16.5	0.1	2.0	0.1	0.0	0.1	1.9	1.7	0.1	0.1	0.1	2.0	0.1	0.5	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	2.6	0.1	0.1	5.3	1.3	0.0	5.2	0.1	0.7	0.3	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	19.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.4	0.1	4.9	1.7	0.1	0.5	0.1	0.1	0.1
LRRC75A	"C17orf76, FAM211A, FLJ35696"	ENSG00000181350	"Leucine rich repeat containing 75A"	Q8NAA5	17	16441577-16492153	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 42.3"	"Cell line enhanced"	"Detected in some"		"HEL: 11.8;HUVEC TERT2: 3.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028528, HPA065840"	Uncertain		Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoplasm	Nucleoplasm	"HPA028528: AB_10600755, HPA065840: "	"unprognostic (1.09e-1)"	"unprognostic (5.60e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.85e-5)"	"unprognostic (3.93e-2)"	"unprognostic (3.23e-2)"	"unprognostic (3.44e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.74e-2)"	"unprognostic (2.84e-1)"	"prognostic favourable (7.46e-5)"	"unprognostic (8.36e-2)"	"unprognostic (4.28e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-3)"	"unprognostic (2.06e-1)"	1.0	8.9	5.2	2.8	3.7	1.7	0.6	0.7	6.3	2.2	26.3	1.5	1.4	15.0	1.9	0.5	0.4	0.9	0.5	0.4	4.1	2.4	0.8	0.2	1.6	1.9	1.6	3.2	1.8	1.6	3.7	4.1	1.5	2.1	1.1	10.4	1.9	0.3	1.7	0.4	0.4	42.3	3.0	0.8	6.4	1.3	8.5	0.4	0.5	1.2	0.0	1.9	1.3	0.7	0.8	0.0	0.3	0.6	0.3	0.6	0.2	1.1	1.0	1.2	0.8	0.3	0.5	0.1	0.3	0.8	2.7	2.2	1.1	0.3	0.0	0.8	0.1	0.4	0.3	0.2	0.1	0.4	0.9	11.8	0.6	0.0	0.4	0.2	0.9	0.0	0.0	0.6	0.0	3.8	0.5	0.2	0.0	1.9	1.9	0.8	0.2	0.1	0.6	0.7	0.1	0.5	0.2	2.3	0.6	0.0	0.2	2.8	0.2	0.1	0.0	0.3	1.4	0.9	1.5	1.5	0.3	0.2	0.1	0.7	1.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.6	0.3	0.3	0.6	0.0	0.0	0.2	5.2	3.7	0.7	6.3	4.1	2.4	1.6	3.2	2.1	0.4
MGAM2		ENSG00000257743	"Maltase-glucoamylase 2 (putative)"	Q2M2H8	7	142111749-142222324	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 61.2;pancreas: 15.6;salivary gland: 35.4"	"Cell line enriched"	"Detected in single"	7	"RH-30: 5.0"	"Group enriched"	"Detected in some"	11	"colorectal cancer: 3.5;pancreatic cancer: 2.5;stomach cancer: 9.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 1.1"					"Low region specificity"	"Detected in all"			HPA055697	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA055697: AB_2682890"	"unprognostic (1.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-4)"	"unprognostic (7.11e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.71e-2)"	"unprognostic (9.33e-2)"	0.2	0.1	0.1	2.5	0.1	0.2	1.3	0.1	0.1	0.1	28.8	0.0	0.0	15.0	0.1	0.4	0.1	0.3	7.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.4	0.0	0.1	15.6	0.0	0.1	0.0	0.1	0.1	1.4	0.7	35.4	0.0	0.1	0.2	61.2	0.0	0.5	1.5	0.7	1.0	0.0	0.0	0.1	1.7	0.8	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	5.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.1	0.0
MT1G	"MT1, MT1K"	ENSG00000125144	"Metallothionein 1G"	P13640	16	56666731-56668065	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"intestine: 101.1;kidney: 210.7;liver: 396.4;pancreas: 217.1;thyroid gland: 278.4"	"Cell line enriched"	"Detected in some"	4	"U-937: 152.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																"Intracellular and membrane"						"unprognostic (1.62e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.97e-2)"	"unprognostic (2.49e-2)"	"unprognostic (4.21e-1)"	"prognostic unfavourable (1.67e-7)"	"unprognostic (1.42e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.92e-2)"	"unprognostic (2.26e-2)"	10.1	1.0	11.7	10.4	50.7	0.7	2.8	1.1	27.4	1.0	78.1	3.1	1.9	49.6	1.5	15.9	21.7	4.6	23.2	0.9	25.1	7.6	210.7	396.4	2.4	7.0	23.6	11.3	0.6	217.1	0.4	1.0	0.6	46.9	21.6	48.9	22.4	2.4	1.0	0.6	2.9	101.1	7.9	7.7	0.5	47.4	0.6	3.6	0.0	278.4	1.9	1.8	2.4	1.2	0.1	1.1	0.7	1.1	0.3	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.2	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.6	0.0	0.4	0.6	0.1	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.0	0.5	34.8	0.0	0.0	0.0	0.1	9.9	5.8	0.0	3.1	0.4	0.0	0.1	0.1	0.0	15.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	152.3	0.0	0.7	1.1	0.3	1.5	1.1	1.4	0.1	1.7	2.6	1.1	0.0	1.6	2.9	0.1	0.3	0.5	0.3	2.8	1.5	11.7	50.7	1.1	27.4	25.1	7.6	23.6	11.3	46.9	3.6
NEU4		ENSG00000204099	"Neuraminidase 4"	Q8WWR8	2	241808825-241817413	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 27.1;liver: 42.9"	"Group enriched"	"Detected in some"	21	"Hep G2: 22.0;HMC-1: 30.7"	"Group enriched"	"Detected in some"	7	"colorectal cancer: 2.3;glioma: 6.0;liver cancer: 6.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037394	Enhanced									"HPA037394: AB_2675455"	"unprognostic (1.50e-1)"	"unprognostic (2.39e-3)"	"unprognostic (1.85e-1)"	"unprognostic (3.68e-4)"	"unprognostic (3.76e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.70e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.92e-1)"	"unprognostic (8.11e-4)"	"unprognostic (2.00e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.55e-2)"	0.6	0.5	6.5	0.7	5.3	5.7	0.3	1.9	7.0	0.6	13.9	4.9	0.0	9.3	0.3	0.3	0.7	1.1	2.6	0.6	6.4	5.8	1.4	42.9	0.4	0.5	6.9	4.4	0.4	0.3	0.3	0.4	0.4	3.8	0.5	6.1	0.0	0.4	0.4	3.6	0.3	27.1	0.4	4.1	0.5	0.5	0.6	2.3	0.0	0.4	2.8	0.3	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	5.3	1.9	4.0	6.4	5.8	6.9	4.4	3.8	2.3
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 93.0"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.1;TIME: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.8;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	14	"dendritic cells: 1.2;granulocytes: 1.0;monocytes: 3.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"				"Nuclear membrane"	"Nuclear membrane"	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	7.4	1.1	6.0	5.4	5.7	0.2	2.4	3.7	8.6	2.2	46.3	4.3	3.4	13.4	3.0	11.2	10.0	0.9	7.2	18.4	4.8	3.4	17.4	19.5	15.0	2.0	4.2	1.3	1.2	4.6	2.8	1.7	3.5	6.3	1.7	10.0	7.9	3.4	0.4	2.3	10.5	93.0	3.0	2.8	2.0	6.8	1.6	1.6	0.2	1.2	3.6	1.7	2.4	3.9	0.1	1.2	1.0	3.8	0.1	0.1	0.7	2.6	2.3	16.4	6.9	4.8	5.9	6.1	2.3	1.1	0.8	0.8	3.0	1.5	0.0	3.0	2.0	6.0	9.9	6.1	0.4	0.2	6.6	1.6	1.1	22.1	7.1	5.8	1.1	8.5	3.5	0.4	7.1	11.5	0.0	0.9	3.6	5.1	0.6	0.4	6.5	4.3	6.7	1.7	0.5	5.6	6.7	6.2	0.0	2.5	5.1	16.5	1.6	1.8	31.5	2.3	2.3	2.3	6.5	0.6	1.2	0.0	0.2	2.4	12.6	1.0	3.4	0.5	0.1	3.8	0.1	0.1	0.0	0.1	1.2	0.0	0.1	0.1	0.1	0.1	3.8	0.7	0.0	0.7	6.0	5.7	3.7	3.5	4.8	3.4	4.2	1.3	6.3	1.6
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541315	"FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 77.0;liver: 29.8"	"Group enriched"	"Detected in some"	7	"CACO-2: 6.7;Hep G2: 16.8;SCLC-21H: 14.4"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebral cortex: 0.7"	"Low region specificity"	"Detected in all"			"CAB070127, CAB070128"	Enhanced									"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.5	0.1	0.1	0.0	0.2	0.0	0.4	0.5	0.2	0.3	42.0	0.0	0.0	30.5	0.4	0.3	0.3	0.3	11.4	0.1	0.1	0.1	0.7	29.8	0.2	0.0	0.1	0.0	0.5	1.4	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.2	77.0	0.0	0.1	0.1	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.2	0.0	0.6	0.2	0.4	0.5	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	14.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.2	0.1	0.1	0.1	0.0	0.0	0.0
NTS		ENSG00000133636	Neurotensin	P30990	12	85874295-85882992	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 115.3"	"Cell line enriched"	"Detected in some"	5	"HEL: 32.5"	"Cancer enhanced"	"Detected in many"		"lung cancer: 155.1"	"Group enriched"	"Detected in many"	4	"hippocampal formation: 10.3;hypothalamus: 22.1;midbrain: 6.3;pons and medulla: 25.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 81.8"	HPA026664	Enhanced				"Secreted to digestive system"	120000	120000			"HPA026664: AB_2671936"	"unprognostic (3.63e-1)"	"prognostic favourable (9.94e-5)"	"unprognostic (8.18e-2)"	"prognostic unfavourable (5.10e-4)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.53e-3)"	"unprognostic (8.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (3.76e-2)"	"unprognostic (1.30e-6)"	"unprognostic (2.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.48e-2)"	2.9	0.6	3.9	1.4	3.2	0.1	2.5	0.3	0.4	0.5	5.2	2.5	0.0	2.8	0.2	1.6	2.5	0.5	0.8	0.8	10.3	22.1	0.9	0.7	2.0	15.1	6.3	0.1	0.7	0.4	0.1	15.0	0.3	25.0	0.4	0.7	0.0	1.6	0.5	0.1	0.1	115.3	0.5	2.7	0.2	18.8	0.3	0.4	0.1	0.9	0.8	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.7	32.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.2	2.7	0.0	1.1	0.0	0.0	0.0	3.6	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	3.2	0.3	0.4	10.3	22.1	6.3	0.1	25.0	0.4
PCK2	"PEPCK, PEPCK2"	ENSG00000100889	"Phosphoenolpyruvate carboxykinase 2, mitochondrial"	Q16822	14	24094053-24110598	"Citric acid cycle related proteins, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"intestine: 156.3;liver: 115.1"	"Cell line enhanced"	"Detected in many"		"HHSteC: 34.9;hTCEpi: 33.9;SK-MEL-30: 32.1"	"Cancer enhanced"	"Detected in all"		"liver cancer: 91.3"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018734, HPA051162, HPA053502"	Enhanced		Enhanced	Mitochondria		3300000	3300000	Mitochondria	Mitochondria	"CAB018734: AB_2160168, HPA051162: AB_2681368, HPA053502: AB_2682171"	"unprognostic (3.38e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.50e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (2.81e-4)"	"unprognostic (3.91e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.71e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.17e-1)"	8.2	2.5	1.0	4.9	1.9	1.0	4.3	1.3	1.3	1.3	69.7	1.4	6.9	51.8	1.3	8.5	4.5	1.2	4.2	2.6	1.5	1.0	26.4	115.1	6.0	4.4	1.7	1.2	1.8	8.5	3.4	1.7	1.2	1.8	2.0	5.4	1.9	11.5	4.9	1.0	2.7	156.3	1.1	1.7	6.7	3.3	3.9	1.3	1.3	5.8	1.9	4.6	2.8	1.9	8.8	10.8	2.4	15.1	1.5	6.5	3.9	5.4	3.1	0.9	5.8	3.6	3.7	14.8	6.8	8.2	5.7	9.3	5.1	6.3	13.9	0.8	10.5	8.0	6.0	8.8	4.7	7.1	0.2	2.5	1.7	27.2	34.9	4.8	11.0	4.3	33.9	3.6	8.8	4.6	7.1	25.8	2.2	23.7	1.2	2.4	1.0	4.1	2.8	3.4	7.9	1.7	8.5	3.7	5.9	5.2	6.8	32.1	9.1	7.5	0.8	1.2	6.6	1.8	1.9	17.7	5.5	3.4	3.5	7.7	3.0	0.1	8.2	2.4	3.1	15.1	3.4	8.8	3.5	3.5	10.8	6.1	2.2	2.0	1.0	1.5	14.4	1.9	6.5	3.9	1.0	1.9	1.3	1.3	1.5	1.0	1.7	1.2	1.8	1.3
PCSK5	"PC5, PC6, SPC6"	ENSG00000099139	"Proprotein convertase subtilisin/kexin type 5"	Q92824	9	75890644-76362339	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"blood: 157.6;intestine: 71.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.5;HaCaT: 21.8;RH-30: 14.4;RPTEC TERT1: 20.2;U-2 OS: 31.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"basophil: 157.6;neutrophil: 57.4"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 157.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031072	Approved		Supported	"Golgi apparatus"	"Secreted to blood"			"Golgi apparatus"	"Golgi apparatus"	"HPA031072: AB_10602190"	"unprognostic (3.28e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.13e-4)"	"unprognostic (4.08e-2)"	"unprognostic (7.43e-3)"	"unprognostic (3.17e-1)"	"unprognostic (2.07e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavourable (9.61e-5)"	"unprognostic (2.99e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.77e-5)"	15.8	3.8	2.9	13.7	2.8	1.5	9.5	2.4	3.2	8.5	51.8	2.9	4.5	19.7	6.5	13.9	9.6	7.8	22.9	6.7	3.8	2.4	3.7	1.9	7.7	5.6	2.3	3.1	17.2	3.4	9.5	3.2	7.7	3.5	4.5	6.7	3.3	5.0	5.8	4.0	4.8	71.5	6.9	3.5	2.5	3.3	5.1	2.4	18.0	6.4	14.2	4.5	7.1	11.4	11.7	12.2	157.6	4.4	12.6	12.7	0.8	1.1	0.8	2.4	1.6	1.5	0.5	15.5	2.1	0.2	0.1	0.0	8.2	0.9	0.3	0.6	0.2	21.8	1.1	0.6	0.1	0.2	1.9	2.8	1.6	0.7	0.4	0.8	1.3	2.9	0.2	0.5	0.2	4.5	3.2	1.0	1.5	5.1	3.2	4.9	10.6	0.9	0.6	14.4	0.8	20.2	1.2	0.2	0.2	3.3	0.7	0.2	1.2	3.5	3.5	0.7	31.5	1.8	0.9	0.2	0.1	0.4	2.4	1.2	12.0	157.6	4.2	16.2	9.7	2.3	8.3	8.8	9.8	8.9	1.9	11.7	9.9	12.7	57.4	12.6	4.4	12.2	8.4	0.8	2.9	2.8	2.4	3.2	3.8	2.4	2.3	3.1	3.5	2.4
PDX1	"IDX-1, IPF1, MODY4, PDX-1, STF-1"	ENSG00000139515	"Pancreatic and duodenal homeobox 1"	P52945	13	27920020-27926231	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 10.4;intestine: 33.0;pancreas: 24.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.2;CACO-2: 2.0;CAPAN-2: 2.4;HDLM-2: 6.8;HEK 293: 4.1;HeLa: 10.3"	"Group enriched"	"Detected in many"	11	"colorectal cancer: 8.4;liver cancer: 1.9;pancreatic cancer: 8.6;stomach cancer: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB025873, HPA059146"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB025873: , HPA059146: AB_2683927"		"unprognostic (2.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.75e-3)"			"unprognostic (7.10e-3)"			"unprognostic (3.83e-2)"	"unprognostic (1.65e-1)"		"unprognostic (1.04e-1)"	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	33.0	0.0	0.0	31.1	0.1	0.0	0.1	0.1	10.4	0.1	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.0	0.1	24.2	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	17.6	0.0	0.2	0.1	4.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	6.8	4.1	0.0	10.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
PLCB3		ENSG00000149782	"Phospholipase C beta 3"	Q01970	11	64251523-64269150	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"intestine: 77.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009257, HPA039279, HPA043907"	Enhanced		Enhanced	Nucleoplasm		94000	94000	Nucleoplasm	Nucleoplasm	"CAB009257: AB_654079, HPA039279: AB_2676425, HPA043907: AB_2678726"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.35e-1)"	"unprognostic (9.35e-2)"	"unprognostic (6.23e-3)"	"prognostic unfavourable (1.39e-4)"	"unprognostic (2.44e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.00e-2)"	"prognostic unfavourable (4.31e-5)"	"unprognostic (5.04e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-2)"	5.8	9.7	6.1	7.0	5.4	3.7	10.9	6.3	5.8	8.6	40.6	3.1	8.8	59.3	9.1	5.9	16.8	7.7	11.8	4.8	5.4	2.6	5.5	3.2	9.1	4.8	3.5	2.2	11.0	4.0	7.6	2.9	11.1	4.8	6.4	7.0	5.0	6.5	6.3	3.8	10.7	77.5	7.0	4.5	7.2	8.0	4.6	5.4	4.2	5.0	8.2	9.3	6.3	8.8	0.3	4.4	0.9	1.4	0.3	0.8	0.4	17.6	9.9	9.8	14.6	10.3	8.0	9.8	14.1	10.7	12.1	7.4	8.7	13.5	1.2	8.5	17.7	30.5	11.0	13.2	4.2	8.5	6.1	13.8	20.5	6.5	7.1	3.3	9.1	6.7	8.8	13.1	9.8	17.6	6.8	1.5	15.3	21.3	4.2	7.0	15.9	10.9	9.2	22.1	5.2	7.4	18.7	2.6	10.8	20.9	26.3	10.0	13.8	6.4	30.5	11.2	13.4	25.6	9.1	1.9	0.9	1.4	18.5	7.9	10.3	0.0	1.4	0.2	0.7	1.4	0.8	0.1	0.8	0.7	1.3	0.3	0.4	0.4	0.9	0.3	1.4	4.4	0.2	0.4	6.1	5.4	6.3	5.8	5.4	2.6	3.5	2.2	4.8	5.4
PPP1R14D	"CPI17-like, FLJ20251, GBPI-1, MGC119014, MGC119016"	ENSG00000166143	"Protein phosphatase 1 regulatory inhibitor subunit 14D"	Q9NXH3	15	40815445-40828709	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 71.3"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.5;RPMI-8226: 6.6;RT4: 4.2;SK-BR-3: 2.8;T-47d: 2.6;U-266/84: 4.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA041846	Uncertain									"HPA041846: AB_10794307"	"unprognostic (1.29e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.91e-3)"	"unprognostic (1.17e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.89e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.26e-3)"	"unprognostic (3.16e-2)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (3.55e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.74e-3)"	"unprognostic (3.11e-2)"	0.2	0.1	0.2	13.6	0.2	0.0	0.3	0.3	0.2	0.2	33.6	0.2	0.2	33.9	0.2	0.3	0.3	0.4	10.0	0.2	0.2	0.2	2.3	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.0	0.2	0.2	0.2	0.5	28.9	0.2	0.5	0.2	0.2	0.3	71.3	0.8	0.2	0.2	0.4	0.2	0.2	0.2	0.6	0.2	0.2	0.2	0.2	1.2	1.1	0.4	1.9	0.3	1.0	0.2	0.1	0.8	0.1	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	2.1	0.2	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.2	0.2	0.5	3.5	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	0.2	1.2	0.0	0.5	0.1	0.4	0.1	0.0	0.0	0.4	6.6	0.0	4.2	1.2	0.8	0.0	2.8	0.0	2.6	0.0	0.0	0.2	0.0	0.1	0.0	0.2	4.4	0.8	0.1	0.1	0.0	0.4	1.2	0.1	0.6	0.9	0.3	0.1	1.0	0.3	0.1	1.2	0.6	0.8	0.4	0.3	1.9	1.1	0.4	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2
PRAC1	"C17orf92, PRAC"	ENSG00000159182	"PRAC1 small nuclear protein"	Q96KF2	17	48721719-48722522	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 62.1;prostate: 40.3"	"Cell line enriched"	"Detected in some"	33	"PC-3: 90.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 291.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 2.2"	"Low lineage specificity"	"Detected in single"											HPA047871	Uncertain		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA047871: AB_2680195"			"unprognostic (7.59e-2)"									"unprognostic (2.43e-2)"			"unprognostic (2.04e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.6	2.0	30.8	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	40.3	62.1	0.1	0.1	0.1	0.1	0.0	0.1	1.5	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	9.9	5.1	0.8	0.0	2.2	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	90.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.2	0.5	0.0	0.2	0.5	0.0	0.4	0.0	0.8	0.1	0.1	2.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1
RNF186	FLJ20225	ENSG00000178828	"Ring finger protein 186"	Q9NXI6	1	19814029-19815278	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"epididymis: 25.8;intestine: 59.0;kidney: 44.0;pancreas: 30.5"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 6.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA034547, HPA035558"	Enhanced									"HPA034547: AB_10670975, HPA035558: AB_2674678"	"unprognostic (1.66e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-1)"	"unprognostic (5.93e-3)"			"unprognostic (1.77e-3)"	"unprognostic (3.23e-1)"			"unprognostic (3.05e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.40e-1)"		"unprognostic (8.60e-3)"	0.2	0.1	0.1	7.8	0.1	0.0	0.8	0.1	0.1	0.2	38.2	0.0	0.5	47.1	0.2	25.8	0.2	0.2	0.1	0.1	0.1	0.1	44.0	0.7	0.1	0.0	0.1	0.0	0.3	30.5	0.0	0.2	0.0	0.0	0.6	5.4	0.0	0.2	0.0	0.1	0.2	59.0	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	6.1	0.0	0.1	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SATB2	"FLJ21474, KIAA1034"	ENSG00000119042	"SATB homeobox 2"	Q9UPW6	2	199269500-199471266	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 26.1;intestine: 33.2;lymphoid tissue: 11.0"	"Cell line enhanced"	"Detected in many"		"HEL: 19.4;K-562: 21.2;THP-1: 28.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 10.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"amygdala: 7.9;cerebral cortex: 29.7;hippocampal formation: 19.7"	"Group enriched"	"Detected in many"	10	"cerebral cortex: 52.6;hippocampal formation: 45.2"	"HPA001042, CAB023669, HPA029543, CAB062562, CAB067751, CAB068229, CAB068230, CAB068231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB023669: AB_1129287, CAB062562: , CAB067751: AB_2665629, CAB068229: AB_2665628, CAB068230: AB_2665630, CAB068231: AB_2665631, HPA001042: AB_10601711, HPA029543: AB_10959737"	"unprognostic (1.77e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.53e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.39e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.54e-3)"	"unprognostic (8.26e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.37e-8)"	"unprognostic (1.14e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.95e-6)"	"unprognostic (1.08e-3)"	2.4	5.0	4.5	11.0	10.0	0.5	2.0	0.5	26.1	2.3	27.9	0.4	0.4	1.4	1.7	1.1	0.9	1.1	1.4	0.7	5.6	1.6	3.6	2.8	0.8	0.6	2.3	15.5	1.9	3.4	3.1	1.1	0.8	4.6	1.9	33.2	0.1	1.5	2.6	2.1	1.7	5.0	2.9	4.9	0.7	1.0	2.4	0.0	0.0	1.6	2.4	1.0	1.6	3.1	0.2	0.0	0.0	0.7	0.0	0.5	0.1	1.2	0.8	8.7	4.0	4.2	5.1	0.6	3.0	4.4	2.2	2.9	0.1	2.8	0.4	0.1	6.5	0.2	6.9	1.8	3.5	4.4	6.0	19.4	1.6	2.3	0.9	8.8	8.6	2.4	3.2	4.3	2.8	0.2	21.2	0.0	6.3	0.4	0.4	11.0	1.6	1.4	0.8	3.0	0.1	3.3	0.3	1.9	0.0	1.5	0.0	4.5	1.8	28.9	3.0	15.9	3.0	5.0	8.0	1.3	4.1	12.7	11.0	7.1	12.5	0.0	0.1	0.0	0.2	0.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	4.5	10.0	0.5	26.1	5.6	1.6	2.3	15.5	4.6	0.0
SFRP5	SARP3	ENSG00000120057	"Secreted frizzled related protein 5"	Q5T4F7	10	97766751-97771952	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 34.9;heart muscle: 27.1;intestine: 17.8;pancreas: 70.4;retina: 67.6"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 15.9;RPMI-8226: 5.7;SCLC-21H: 2.6"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 30.4"	"Group enriched"	"Detected in some"	5	"hypothalamus: 1.8;midbrain: 4.5;pons and medulla: 5.6"	"Cell type enriched"	"Detected in some"	5	"naive CD8 T-cell: 7.4"	"Lineage enriched"	"Detected in many"	5	"T-cells: 7.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"								"Secreted in other tissues"						"unprognostic (2.63e-4)"	"unprognostic (3.03e-3)"	"unprognostic (6.74e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.51e-9)"	"unprognostic (1.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.62e-1)"	0.9	5.1	0.0	1.3	0.8	0.4	0.6	0.5	0.4	1.8	10.9	1.1	9.1	14.7	1.1	2.8	4.3	0.6	34.9	27.1	0.7	1.8	0.2	3.2	1.9	0.4	4.5	0.1	0.3	70.4	0.2	0.1	0.2	5.6	1.9	0.5	67.6	9.2	2.4	0.4	0.9	17.8	1.0	1.9	0.3	3.4	0.4	0.3	0.0	0.2	1.6	0.3	1.3	1.4	0.0	1.5	0.0	0.0	0.0	7.4	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	5.7	0.0	0.0	2.6	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	7.4	0.0	0.0	0.0	1.5	0.0	0.5	0.0	0.8	0.5	0.3	0.7	1.8	4.5	0.1	5.6	0.3
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357079-100422059	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	5	"brain: 10.7;intestine: 12.4;lymphoid tissue: 3.9"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;RPTEC TERT1: 1.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB079058		Supported								"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.1	0.3	2.0	0.1	3.7	0.1	0.1	0.0	10.7	0.1	1.1	0.0	0.0	1.8	0.4	0.2	0.1	1.0	0.1	0.1	6.9	2.2	0.3	1.2	0.2	0.1	0.8	1.0	0.2	0.2	0.1	0.4	1.0	3.6	0.1	1.0	1.7	0.1	0.1	0.1	0.1	12.4	0.1	0.5	0.1	0.2	0.4	0.1	3.9	0.1	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.4	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	2.0	3.7	0.0	10.7	6.9	2.2	0.8	1.0	3.6	0.1
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40810111	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 26.0;liver: 66.4;pancreas: 24.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042146	Approved									"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favourable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favourable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavourable (5.46e-4)"	1.0	1.1	1.4	4.7	1.7	1.6	2.6	1.0	2.0	1.3	13.2	1.0	0.2	16.3	1.6	1.5	1.8	1.2	3.1	1.9	1.3	1.6	4.0	66.4	1.6	2.0	1.6	0.9	1.8	24.9	0.8	1.0	1.8	1.5	1.0	2.6	0.9	1.4	1.6	2.5	1.3	26.0	1.5	1.4	1.5	2.0	3.8	1.0	2.7	8.0	2.9	3.8	1.2	1.1	1.7	3.4	0.0	3.1	2.4	5.0	1.6	5.0	9.9	9.8	13.5	3.6	4.8	12.5	3.7	1.9	4.2	2.7	10.5	9.7	32.0	4.3	6.2	8.2	15.4	10.2	3.7	7.6	7.7	24.2	4.9	13.6	6.9	8.6	3.1	5.2	4.5	5.3	13.0	6.5	12.4	5.1	6.5	16.3	6.4	3.8	21.2	5.1	15.8	8.1	6.9	5.1	4.6	5.5	13.6	6.9	10.9	5.9	9.1	12.8	6.2	5.3	8.5	8.1	10.7	5.8	5.5	18.8	5.6	7.0	10.6	0.0	1.3	0.0	4.3	3.1	2.7	1.6	2.9	2.8	3.4	1.7	3.0	5.0	0.0	2.4	1.0	0.7	1.8	1.6	1.4	1.7	1.0	2.0	1.3	1.6	1.6	0.9	1.5	1.0
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"gallbladder: 53.5;intestine: 110.1;lymphoid tissue: 42.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.2;CACO-2: 1.8;NB-4: 1.5;RPMI-8226: 7.5"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA036055	Approved									"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	0.3	0.3	0.3	42.8	0.3	0.0	6.1	0.3	0.3	0.4	110.1	0.2	0.3	58.4	0.3	1.2	0.3	0.6	53.5	0.3	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.2	0.3	0.3	0.0	0.3	0.2	0.2	0.5	92.7	0.2	0.3	14.4	0.3	0.3	106.5	1.2	0.3	0.3	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	7.5	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.2	0.2
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252230-45277845	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"gallbladder: 28.7;intestine: 49.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.2;NB-4: 2.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA046068, HPA055623"	Enhanced									"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.2	0.1	0.2	0.0	0.2	0.2	0.2	0.8	18.5	0.2	0.1	25.7	0.4	0.1	0.3	0.2	28.7	0.1	0.2	0.2	1.0	0.3	0.2	0.1	0.2	0.1	0.2	0.2	0.0	0.2	1.6	0.1	0.2	13.8	0.1	0.1	0.1	0.1	0.2	49.3	0.1	0.2	0.1	8.5	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.6	0.2	1.3	0.5	0.6	0.7	0.0	0.1	0.3	0.1	0.1	0.0	0.1	4.2	0.2	0.0	0.0	0.0	0.0	0.1	0.6	0.3	0.0	0.6	0.2	0.0	0.0	0.7	0.0	0.1	0.2	0.6	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.1	0.3	2.2	0.2	0.3	0.2	0.4	1.3	0.0	0.2	1.1	1.6	0.0	0.1	0.3	0.2	0.6	0.3	0.4	0.5	1.2	0.2	0.7	0.2	0.3	0.4	0.6	0.2	1.3	0.2	0.1	0.4	0.1	0.2	0.5	0.3	0.1	0.2	0.6	0.4	0.7	0.2	0.6	0.5	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC6A20	"XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755450-45796535	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"gallbladder: 14.3;intestine: 25.5;retina: 51.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 5.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"pons and medulla: 6.1"	"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA029873	Uncertain									"HPA029873: "	"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favourable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.3	0.1	0.3	0.6	0.8	0.5	0.7	1.5	2.2	2.4	11.2	3.0	0.4	22.3	1.3	1.7	0.1	0.4	14.3	0.1	0.5	0.4	3.3	0.2	1.9	0.2	1.0	1.7	0.1	5.1	0.0	2.0	0.1	6.1	1.0	0.2	51.3	1.3	0.1	0.9	0.6	25.5	0.3	1.5	0.1	4.7	0.4	0.3	0.0	0.1	0.4	0.1	0.2	0.3	0.8	0.7	2.6	0.2	0.5	0.4	0.1	0.4	0.7	0.7	0.7	0.2	0.1	0.8	0.3	0.0	0.1	0.1	2.7	2.4	0.4	1.9	0.0	5.2	0.2	0.0	0.3	0.2	0.3	2.2	2.0	0.4	0.0	0.1	0.4	0.1	1.1	0.0	0.1	0.0	0.3	0.8	0.0	0.6	0.8	0.5	2.4	0.5	0.8	0.2	0.6	0.4	0.6	0.6	0.8	2.6	0.4	0.1	0.5	0.3	0.1	0.9	0.7	0.7	0.5	1.4	0.5	0.2	0.4	0.5	0.2	1.0	0.2	0.2	0.3	0.1	0.3	0.2	0.2	0.2	0.1	0.8	0.4	0.3	2.6	0.5	0.1	0.7	0.1	0.1	0.3	0.8	1.5	2.2	0.5	0.4	1.0	1.7	6.1	0.3
SST	SMST	ENSG00000157005	Somatostatin	P61278	3	187668906-187670399	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 102.8;intestine: 105.2;pancreas: 105.6;stomach 1: 90.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 15.2;U-2 OS: 28.3;U-251 MG: 4.7;U-698: 5.9"	"Group enriched"	"Detected in many"	7	"ovarian cancer: 249.9;pancreatic cancer: 1039.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000075, HPA019472, CAB034105"	Enhanced	Supported			"Secreted to blood"					"CAB000075: AB_2688022, CAB034105: AB_2271061, HPA019472: AB_1857360"		"unprognostic (2.44e-1)"	"unprognostic (2.05e-1)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (5.12e-3)"	"unprognostic (1.54e-2)"			"unprognostic (4.69e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.07e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.19e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.45e-1)"	2.0	13.0	28.6	1.9	53.8	1.7	0.7	0.1	47.9	0.7	45.1	1.8	21.9	105.2	0.9	0.7	1.1	0.7	1.0	0.9	17.5	102.8	2.5	0.7	0.7	1.0	6.2	15.4	0.8	105.6	0.7	1.5	0.7	16.1	1.5	7.4	0.4	0.7	7.5	0.7	3.1	36.1	1.4	18.4	0.7	90.4	0.7	8.6	0.0	0.9	0.0	0.7	4.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.3	0.3	4.7	0.0	1.6	5.9	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	53.8	0.1	47.9	17.5	102.8	6.2	15.4	16.1	8.6
SULT1A4		ENSG00000213648	"Sulfotransferase family 1A member 4"	P0DMN0	16	29459889-29464976	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	5	"blood: 16.7;intestine: 38.8"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 30.9;EFO-21: 25.6;HEL: 20.9;Hep G2: 67.7;Karpas-707: 40.4"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	13	"classical monocyte: 11.3;intermediate monocyte: 16.7;myeloid DC: 11.3;non-classical monocyte: 5.0"	"Group enriched"	"Detected in many"	16	"dendritic cells: 11.3;monocytes: 16.7"									"HPA049500, HPA051051"	Supported									"HPA049500: AB_2680796, HPA051051: AB_2681327"										"unprognostic (4.14e-2)"				"unprognostic (1.04e-1)"				2.7	0.7	3.3	2.0	1.6	0.9	2.0	4.3	2.6	3.0	8.1			38.8	1.2	0.0	0.3	1.7	1.6	1.7	2.8	1.6	2.8	1.7	3.4	2.9	1.5		0.9	0.6	0.0	1.8	2.4		2.2	7.6		1.8	0.0	0.7	5.2	25.9	2.7	1.1	3.3	3.2	1.1			3.4		2.1	0.1	1.0	0.6	11.3	0.8	16.7	0.2	0.6	2.4	4.0	4.0	1.2	0.1	0.1	1.4	1.7	0.4	0.7	0.1	0.1	2.3	30.9	0.2	25.6	0.2	4.4	1.7	0.4	0.1	1.5	2.3	20.9	2.7	67.7	0.6	0.7	2.9	0.0	0.0	2.0	0.0	4.8	4.2	40.4	0.1	2.0	0.4	3.1	0.9	0.7	1.7	0.6	1.1	2.9	2.8	0.9	2.2	0.0	6.2	0.0	1.3	0.0	8.4	0.8	0.4	1.2	0.7	1.7	13.7	0.4	1.9	3.7	0.2	0.2	11.3	0.0	0.6	16.7	0.1	0.6	0.3	0.1	11.3	0.5	0.3	0.1	0.8	0.2	5.0	0.2	0.3	2.4										
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	5	"intestine: 89.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 3.3;HHSteC: 4.9;LHCN-M2: 3.8;NTERA-2: 2.6;SH-SY5Y: 4.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA066026	Uncertain									"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.3	0.3	0.6	43.2	0.2	0.2	36.8	0.4	1.7	0.2	0.2	1.0	0.4	0.2	0.5	3.2	18.5	0.3	0.0	0.1	0.1	0.0	0.1	0.0	0.4	0.1	0.5	0.5	0.9	0.4	0.2	0.4	0.0	0.1	89.4	0.2	0.1	0.1	1.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.9	0.0	0.0	0.4	0.1	2.1	1.2	1.0	1.3	1.0	0.1	0.0	1.0	1.7	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.1	3.3	4.9	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.8	2.6	0.0	0.0	0.0	0.4	0.0	0.0	1.9	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.3	0.2	0.5	0.1	0.1	0.5	0.1
TMEM252	"C9orf71, MGC34760"	ENSG00000181778	"Transmembrane protein 252"	Q8N6L7	9	68536580-68540867	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	5	"intestine: 16.0;kidney: 64.2"	"Group enriched"	"Detected in some"	15	"EFO-21: 1.6;PC-3: 3.4;RH-30: 1.9;RPTEC TERT1: 6.3;SK-BR-3: 3.6"	"Cancer enriched"	"Detected in many"	17	"renal cancer: 35.7"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	8	"neutrophil: 7.6"	"Lineage enriched"	"Detected in single"	37	"granulocytes: 7.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (2.64e-1)"		"unprognostic (3.28e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.00e-2)"	"unprognostic (7.79e-3)"		"unprognostic (6.47e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.42e-2)"	"prognostic favourable (1.75e-7)"	"unprognostic (7.63e-2)"	"unprognostic (6.15e-2)"	"unprognostic (7.66e-2)"	"unprognostic (2.50e-1)"	0.5	2.0	0.4	0.6	0.4	0.0	0.4	0.9	0.4	0.6	5.6	0.4	0.4	1.0	4.3	0.8	4.3	2.7	0.7	3.0	0.4	0.0	64.2	0.9	0.4	0.4	0.4	0.4	0.6	0.4	0.0	0.4	2.6	0.4	1.8	0.0	0.4	0.4	0.4	0.7	0.2	16.0	0.9	0.4	0.4	1.7	0.6	0.4	0.4	0.4	0.4	0.5	6.0	0.6	0.0	0.1	7.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.4	0.0	1.9	0.0	6.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.9	0.4	0.4	0.0	0.4	0.4	0.4	0.4
UCN3	"SPC, UCNIII"	ENSG00000178473	"Urocortin 3"	Q969E3	10	5365009-5374692	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 14.9;pancreas: 10.6;pituitary gland: 5.6;stomach 1: 4.6"	"Cell line enriched"	"Detected in single"	8	"SCLC-21H: 5.4"	"Group enriched"	"Detected in many"	5	"lung cancer: 5.1;pancreatic cancer: 15.4;stomach cancer: 3.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 5.9"	"Region enriched"	"Detected in single"	7	"hypothalamus: 4.7"	HPA038281	Uncertain				"Secreted to blood"					"HPA038281: AB_10672408"			"unprognostic (2.00e-2)"	"unprognostic (2.31e-1)"				"unprognostic (1.60e-1)"		"unprognostic (2.10e-1)"	"unprognostic (3.18e-3)"	"unprognostic (8.42e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.91e-2)"				0.1	0.9	0.1	0.1	0.4	0.0	0.1	0.4	0.4	0.1	14.4	0.1	0.1	11.6	0.1	0.1	0.1	1.2	1.2	0.1	0.1	1.7	0.8	0.1	1.3	0.1	0.1	0.5	0.1	10.6	0.0	5.6	0.1	1.6	0.2	3.1	0.3	0.1	0.1	0.1	0.0	14.9	0.1	0.5	0.1	4.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	5.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.1	1.7	0.1	0.5	1.6	0.1
URAD	PRHOXNB	ENSG00000183463	"Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase"	A6NGE7	13	27977714-27988654	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	5	"breast: 8.8;intestine: 16.7"	"Group enriched"	"Detected in some"	13	"BEWO: 6.7;CACO-2: 6.1"	"Cancer enriched"	"Detected in some"	15	"colorectal cancer: 7.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038972	Uncertain									"HPA038972: AB_10671869"			"unprognostic (2.00e-1)"											"unprognostic (1.05e-1)"	"unprognostic (5.21e-2)"			2.8	0.0	0.1	1.5	0.1	0.0	8.8	0.6	0.1	0.1	16.7	0.1	0.1	8.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.9	0.1	0.1	0.1	0.1	0.0	16.0	0.2	0.1	0.1	0.0	0.2	0.1	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.1
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132681590-132714049	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 131.9;liver: 112.2"	"Cell line enhanced"	"Detected in some"		"A-431: 4.0;CAPAN-2: 4.2;EFO-21: 14.8;HBEC3-KT: 3.9;LHCN-M2: 4.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 13.4"	"Group enriched"	"Detected in many"	71	"dendritic cells: 4.9;granulocytes: 8.0;monocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064145	Uncertain				"Intracellular and membrane"	1100000000	1100000000			"HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavourable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	1.8	0.4	0.3	0.6	0.3	2.4	0.7	0.2	0.3	0.4	128.6	0.1	0.0	40.6	2.5	0.2	0.6	1.7	27.0	1.1	0.3	0.3	6.5	112.2	7.9	2.4	0.4	0.1	0.4	0.9	0.0	0.3	1.0	0.5	0.4	0.3	0.2	1.5	0.1	0.4	0.5	131.9	0.0	0.5	5.6	0.8	0.5	0.1	0.2	0.4	0.0	0.4	0.4	0.9	0.1	4.9	8.0	13.4	0.0	0.0	3.6	4.0	0.0	0.5	0.1	0.1	1.3	0.9	0.3	0.3	0.0	0.0	0.1	4.2	0.2	14.8	0.0	0.1	0.0	3.9	1.0	0.1	0.0	0.2	0.2	2.3	2.3	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.2	0.0	0.6	0.1	0.2	0.1	0.2	1.7	0.9	0.3	0.2	0.6	0.1	0.0	0.0	0.0	0.0	2.6	1.0	0.1	0.4	0.2	0.4	0.0	0.1	0.4	0.1	0.6	2.3	13.4	0.0	0.0	7.4	0.0	0.0	0.0	0.0	4.9	0.1	0.0	0.0	8.0	0.0	10.2	0.2	0.0	3.6	0.3	0.3	0.2	0.3	0.3	0.3	0.4	0.1	0.5	0.1
AC008397.1		ENSG00000284797			19	18249950-18255419	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"gallbladder: 19.9;intestine: 13.8;pancreas: 12.5"	"Cell line enriched"	"Detected in single"	29	"HaCaT: 2.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	1.5	13.8	0.0	0.0	0.0	0.0	0.0	3.4	0.2	19.9	0.0	0.0		0.3	0.0	0.4	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.2	0.0	0.0	0.7	0.0	1.7	0.0	0.0	0.0	9.4	0.2	0.0	0.0	1.7	1.1	0.0	0.0	0.1	0.5	3.5	0.4	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC233755.1		ENSG00000275063	"Immunoglobulin heavy variable 4-38-2 "	P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"blood: 75.1;intestine: 32.1;lymphoid tissue: 37.1;urinary bladder: 45.9"	"Cell line enriched"	"Detected in some"	8	"REH: 54.7"									"Group enriched"	"Detected in some"	363	"memory B-cell: 75.1;naive B-cell: 42.7"	"Lineage enriched"	"Detected in single"	463	"B-cells: 75.1"														"Secreted to blood"																							0.8	0.0		14.4		2.6	2.8		0.0	10.9	32.1			24.1	0.0	0.0	4.3	0.0	1.0	0.0			0.0	0.0	0.7	5.5			0.0	0.0	0.0		0.0		0.0	11.1		11.1	0.0	0.0	0.0	6.4	0.6		9.4	11.7	0.0			0.0		37.1	45.9		75.1	0.1	0.1	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	7.2	0.1	0.1	0.0	54.7	0.6	1.2	0.0	0.0	0.0	3.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	75.1	0.0	0.0	0.0	42.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	6.0										
ADH1C	ADH3	ENSG00000248144	"Alcohol dehydrogenase 1C (class I), gamma polypeptide"	P00326	4	99336492-99353027	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 47.1;liver: 149.4;stomach 1: 43.1"	"Group enriched"	"Detected in some"	4	"ASC TERT1: 5.1;HSkMC: 15.1"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 238.2"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA047814, HPA060902"	Supported		Supported	"Plasma membrane,Cytosol"		9700000	9700000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA047814: AB_2680163, HPA060902: AB_2684384"	"unprognostic (3.98e-2)"	"unprognostic (9.88e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.57e-1)"	"prognostic favourable (4.55e-4)"	"prognostic favourable (2.99e-4)"	"unprognostic (8.25e-2)"	"unprognostic (8.89e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.37e-2)"	4.7	0.0	0.0	18.5	0.0	0.0	1.1	0.0	0.0	1.1	37.9	0.0	1.1	43.4	0.3	1.2	1.7	0.0	12.0	2.0	0.0		8.3	149.4	1.1	0.0	0.2	0.0	1.1	11.4	0.0	0.0	0.0	0.0	2.5	13.6	0.0	1.1	0.8	6.0	0.0	47.1	0.9	0.5	0.0	43.1	1.6	0.0	0.0	0.5	2.0	0.2	1.3	0.7	0.2	0.2	0.3	0.1	0.1	0.3	0.1	0.0	2.2	0.0	0.1	1.7	5.1	1.1	0.0	0.6	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.1	0.5	1.4	0.3	15.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.9	0.4	0.1	0.1	0.9	2.1	0.9	0.0	0.4	1.6	0.7	0.8	0.0	0.2	0.0	0.1	0.0	0.6	0.3	0.2	0.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1										
AIFM3	"AIFL, FLJ30473"	ENSG00000183773	"Apoptosis inducing factor, mitochondria associated 3"	Q96NN9	22	20965108-20981360	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 21.7;intestine: 28.0"	"Cell line enhanced"	"Detected in some"		"Hep G2: 8.6;HMC-1: 12.9;T-47d: 6.2;THP-1: 8.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 7.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"classical monocyte: 2.2;intermediate monocyte: 5.7;myeloid DC: 3.8;non-classical monocyte: 3.4"	"Group enriched"	"Detected in many"	22	"dendritic cells: 3.8;monocytes: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001271			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA001271: "	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.49e-2)"	"unprognostic (9.99e-2)"	"unprognostic (6.79e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.28e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.13e-3)"	"unprognostic (5.13e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.78e-2)"	"unprognostic (1.47e-1)"	"unprognostic (3.37e-1)"	"prognostic favourable (7.13e-5)"	1.3	1.3	20.3	4.6	19.0	5.4	0.8	14.4	18.4	1.2	28.0	9.7	0.0	4.3	0.9	0.8	0.9	1.2	1.6	0.9	14.6	9.9	0.9	0.8	1.5	1.4	14.8	12.4	1.0	0.9	0.9	1.9	1.3	21.7	1.2	13.0	5.0	2.2	1.9	0.7	0.9	3.4	1.9	9.6	2.7	1.6	1.1	7.6	0.0	1.0	0.0	0.8	1.9	0.1	0.2	3.8	0.0	5.7	0.0	0.0	0.9	1.2	2.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	3.5	0.0	0.1	0.0	1.4	0.2	0.0	0.0	0.3	0.0	2.2	0.0	8.6	0.2	0.0	12.9	0.6	0.7	0.1	0.0	0.0	0.1	0.1	0.0	3.5	0.0	0.1	0.0	0.0	0.1	0.0	1.4	0.0	1.5	1.7	1.1	1.0	0.1	0.0	6.2	8.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	5.7	0.0	0.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.9	20.3	19.0	14.4	18.4	14.6	9.9	14.8	12.4	21.7	7.6
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610355	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 60.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 8.7;Hep G2: 14.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"B-cells: 2.0;NK-cells: 2.0;T-cells: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favourable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	14.5	4.2	0.8	3.5	0.6	1.1	5.0	4.8	0.6	22.4	2.1	0.7	24.7	0.8	1.2	0.5	0.9	2.4	0.7	2.5	4.5	5.2	13.9	0.6	0.9	3.4	3.4	9.3	3.6	0.9	1.8	3.5	3.4	3.9	2.1	3.8	0.8	0.7	1.0	1.0	60.1	0.6	1.5	1.0	2.3	7.4	1.7	0.0	1.6	0.2	0.4	0.8	0.6	2.0	0.1	0.3	0.1	2.0	2.3	0.8	1.1	3.6	1.5	2.4	3.5	0.9	1.6	1.9	0.8	1.8	0.8	8.7	1.7	1.8	0.9	0.8	1.1	0.6	0.1	0.9	5.3	1.5	1.4	1.2	14.4	1.1	3.0	1.7	0.9	0.3	1.0	0.2	0.3	0.9	1.1	2.0	1.8	1.1	2.0	1.6	3.4	1.6	3.9	0.6	1.0	1.4	1.5	1.1	2.4	0.5	0.9	1.8	0.4	1.0	1.4	4.6	2.8	1.2	1.2	0.8	1.4	0.5	0.2	2.0	0.0	0.0	0.3	1.9	0.0	1.3	0.3	0.8	1.5	0.1	2.0	2.3	0.7	0.0	2.0	0.1	0.1	0.1	0.8	4.2	3.5	5.0	4.8	2.5	4.5	3.4	3.4	3.4	1.7
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 25.2;retina: 28.7;skin 1: 11.7"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 3.5"	HPA046229	Approved									"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.1	0.2	4.1	0.2	1.8	0.3	0.2	1.3	0.4	25.2	0.2	0.2	0.0	0.2	0.7	0.2	0.2	0.3	0.2	0.2	0.1	0.2	0.2	0.2	2.2	0.2	0.2	0.4	0.2	0.4	0.2	0.2	0.2	0.2	12.8	28.7	0.6	0.2	0.2	11.7	11.5	0.5	0.2	0.2	0.1	0.3	0.2	0.2	0.4	1.5	5.2	0.2	1.0	3.1	2.7	2.2	0.8	1.7	2.1	1.2	0.9	0.7	2.3	3.5	0.0	0.4	1.6	1.0	0.0	0.5	0.7	2.6	3.6	2.9	0.9	1.2	1.8	0.0	0.5	0.6	3.3	1.5	2.4	3.2	0.9	0.4	1.1	5.1	0.5	0.3	0.4	0.3	0.3	0.6	1.5	0.5	3.0	0.8	1.9	3.0	2.6	0.4	1.3	0.5	1.0	1.2	1.9	1.9	1.5	0.7	0.6	1.8	0.9	2.6	0.9	1.0	1.6	2.1	0.9	1.3	1.1	1.3	2.7	1.8	1.7	0.5	0.4	1.4	0.8	1.1	2.2	1.0	0.8	0.2	3.1	2.1	2.1	2.2	1.7	0.5	2.7	0.7	1.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
CALML4	"MGC4809, NY-BR-20"	ENSG00000129007	"Calmodulin like 4"	Q96GE6	15	68190705-68206110	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 44.0;gallbladder: 28.4;intestine: 91.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"intermediate monocyte: 39.2;non-classical monocyte: 44.0"	"Lineage enriched"	"Detected in many"	10	"monocytes: 44.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA051109	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA051109: AB_2681346"	"unprognostic (1.69e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.97e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (4.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.19e-3)"	"unprognostic (6.24e-2)"	"unprognostic (3.85e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	2.4	2.5	1.8	12.0	1.1	0.8	2.2	2.6	1.0	3.2	40.3	2.2	7.7	34.0	1.5	7.8	5.1	7.3	28.4	1.4	2.6	0.7	12.6	12.3	3.1	2.6	0.9	1.3	2.3	5.3	0.0	3.1	2.1	8.4	4.3	21.8	3.1	1.9	6.7	1.4	1.7	91.6	2.7	1.0	5.3	5.4	2.4	0.6	1.1	1.5	1.3	1.3	1.9	2.0	0.0	4.5	1.8	44.0	0.0	0.0	2.8	2.5	7.7	5.7	3.4	0.6	1.0	4.0	1.6	1.5	2.6	2.6	14.9	16.0	2.5	2.0	1.1	10.8	12.8	2.3	1.0	2.1	12.4	4.1	13.2	5.2	2.3	3.5	5.5	1.1	3.4	1.5	2.2	2.9	3.8	2.9	0.6	7.2	5.6	7.7	4.9	2.3	8.4	5.6	5.1	0.9	4.3	2.9	3.3	2.5	2.3	6.7	1.7	3.4	2.4	3.8	3.5	6.6	6.3	10.6	6.2	7.0	2.4	6.9	1.3	0.0	6.5	0.0	0.0	39.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.0	44.0	0.2	0.0	2.8	1.8	1.1	2.6	1.0	2.6	0.7	0.9	1.3	8.4	0.6
CDHR1	"CORD15, KIAA1775, PCDH21, RP65"	ENSG00000148600	"Cadherin related family member 1"	Q96JP9	10	84194635-84219621	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 10.3;HEK 293: 5.3;HEL: 6.2;K-562: 4.4;NTERA-2: 4.5;RPTEC TERT1: 16.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.8"	"Region enhanced"	"Detected in many"		"basal ganglia: 31.2"	"Cell type enriched"	"Detected in single"	11	"NK-cell: 10.5"	"Lineage enriched"	"Detected in single"	11	"NK-cells: 10.5"	"Region enriched"	"Detected in some"	21	"olfactory region: 408.8"	"Low region specificity"	"Detected in all"			HPA036819	Enhanced				"Intracellular and membrane"					"HPA036819: AB_10671750"	"unprognostic (8.91e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.67e-1)"	"unprognostic (6.69e-4)"	"unprognostic (1.90e-1)"	"unprognostic (5.51e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-3)"	"unprognostic (5.07e-2)"	0.3	1.2	1.9	0.7	31.2	0.5	2.3	0.9	7.7	2.8	12.3	2.2	0.0	0.3	0.6	2.2	4.8	0.6	0.5	0.9	3.4	2.1	0.5	0.5	0.4	0.7	1.5	3.1	0.8	0.4	0.3	1.5	0.4	9.3	0.9	22.6	42.5	1.0	2.2	0.7	86.8	5.3	0.9	1.2	3.0	0.4	0.4	3.0	2.4	0.4	3.3	0.9	0.4	1.5	0.0	0.0	0.0	0.0	10.5	0.9	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	10.3	2.0	0.0	0.0	5.3	6.2	0.0	0.0	0.2	0.0	0.2	0.0	2.2	0.0	0.7	0.0	4.4	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.0	0.0	1.3	16.8	0.0	3.5	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.1	1.9	31.2	0.9	7.7	3.4	2.1	1.5	3.1	9.3	3.0
CDX1		ENSG00000113722	"Caudal type homeobox 1"	P47902	5	150166795-150184558	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 83.7"	"Cell line enriched"	"Detected in some"	5	"BJ hTERT+: 11.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 125.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"thalamus: 0.3"	"Group enriched"	"Detected in some"	10	"midbrain: 1.0;pons and medulla: 1.2;thalamus: 2.1"	HPA055196	Enhanced									"HPA055196: AB_2682734"	"unprognostic (2.50e-3)"	"unprognostic (3.90e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.09e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-7)"	"unprognostic (2.10e-1)"	"unprognostic (4.25e-1)"	"unprognostic (5.42e-3)"	"unprognostic (2.16e-3)"	0.2	0.1	0.1	18.6	0.2	0.0	0.2	0.1	0.2	0.2	63.6	0.2	0.1	19.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1	38.5	0.1	0.1	0.1	0.1	0.2	83.7	1.5	0.1	0.1	0.1	0.9	0.1	0.5	0.1	0.3	0.2	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.9	0.3	0.0	11.9	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CES2	"CE-2, CES2A1, iCE"	ENSG00000172831	"Carboxylesterase 2"	O00748	16	66934444-66945096	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"esophagus: 46.7;intestine: 146.9;liver: 78.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018897	Enhanced		Approved	"Golgi apparatus,Cytosol"		7500000	7500000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA018897: AB_1846558"	"unprognostic (8.15e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.74e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.31e-1)"	"unprognostic (6.93e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.66e-2)"	"prognostic favourable (1.50e-5)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.38e-1)"	5.8	15.3	8.5	8.8	11.7	2.4	5.1	13.0	15.9	9.5	42.3	12.1	11.2	146.9	7.0	11.9	46.7	6.1	14.5	15.2	7.4	6.6	22.5	78.6	6.7	4.6	8.2	10.7	8.4	12.0	10.0	6.8	7.3	10.3	9.7	42.6	13.0	12.7	7.9	11.6	8.9	117.3	10.4	5.6	7.8	10.9	8.5	8.2	9.0	11.7	14.1	12.1	7.6	11.6	6.9	8.9	5.0	10.6	7.9	10.7	5.2	6.8	9.0	9.5	12.7	9.4	8.8	7.2	7.8	12.6	9.2	11.7	9.7	11.4	8.0	7.8	10.2	17.8	6.9	19.7	7.2	7.1	9.6	7.9	5.1	18.2	13.3	10.3	13.8	12.7	37.3	13.0	21.9	6.8	11.0	5.9	15.5	4.3	9.1	8.6	5.1	9.1	10.8	9.6	9.4	26.1	12.0	6.2	8.1	25.5	6.4	6.6	11.1	12.8	8.4	12.1	6.5	7.5	5.9	11.9	14.2	9.5	18.7	8.1	9.1	4.7	10.4	4.7	10.1	7.8	9.2	6.1	7.7	10.7	8.9	6.9	9.5	8.6	5.0	7.9	10.6	7.7	6.8	5.2	8.5	11.7	13.0	15.9	7.4	6.6	8.2	10.7	10.3	8.2
CRYBA2		ENSG00000163499	"Crystallin beta A2"	P53672	2	218990189-218993421	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.6;intestine: 5.8;pancreas: 16.2;pituitary gland: 12.2;stomach 1: 6.1"	"Cell line enriched"	"Detected in some"	7	"BEWO: 39.9"	"Cancer enriched"	"Detected in some"	15	"pancreatic cancer: 16.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA062293	Supported									"HPA062293: AB_2732680"	"unprognostic (5.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.19e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-1)"		"prognostic favourable (7.62e-4)"	"unprognostic (2.91e-1)"		"unprognostic (1.90e-1)"	"unprognostic (2.19e-1)"			0.3	4.6	0.3	0.3	2.0	0.0	0.3	0.3	0.8	0.3	5.8	0.3	0.3	3.5	0.3	0.3	0.3	0.0	0.3	0.3	0.6	0.5	0.3	0.3	0.3	0.3	0.6	0.3	0.3	16.2	0.1	12.2	0.3	0.7	0.5	2.8	0.8	0.3	0.3	0.3	0.1	4.7	0.3	0.3	0.3	6.1	1.6	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	5.8	1.4	1.1	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.0	0.3	0.8	0.6	0.5	0.6	0.3	0.7	0.3
DHDH	HUM2DD	ENSG00000104808	"Dihydrodiol dehydrogenase"	Q9UQ10	19	48933682-48944969	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 32.4;kidney: 18.0"	"Cell line enhanced"	"Detected in many"		"U-266/70: 6.7;U-266/84: 5.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 5.8;naive CD4 T-cell: 4.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 5.8;T-cells: 4.8"					"Low region specificity"	"Detected in all"			HPA044131	Approved		Approved	"Nucleoplasm,Actin filaments"				"Nucleoplasm, Actin filaments"	"Nucleoplasm, Actin filaments"	"HPA044131: AB_10966968"	"unprognostic (1.54e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (9.91e-4)"	"unprognostic (3.33e-3)"	"unprognostic (1.45e-1)"	"unprognostic (5.81e-6)"	"unprognostic (1.56e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.30e-2)"	"unprognostic (5.08e-2)"	"prognostic favourable (3.15e-4)"	"unprognostic (2.93e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.54e-1)"	0.3	0.5	1.5	0.1	2.1	0.1	0.2	1.8	1.5	0.1	8.2	0.2	0.1	10.6	0.2	0.4	0.8	0.3	0.8	0.1	2.7	2.0	18.0	0.7	1.9	0.2	0.4	0.4	0.5	0.4	0.2	2.1	1.3	0.6	3.5	0.1	1.2	0.8	0.2	0.3	0.2	32.4	0.1	0.9	1.8	0.7	2.8	0.1	0.4	0.1	0.5	0.7	1.1	0.3	0.1	0.0	5.8	0.0	0.0	4.8	0.5	2.9	0.0	0.2	1.5	0.8	0.7	1.2	0.0	0.4	0.5	1.4	2.8	2.3	0.0	0.6	0.0	0.8	1.0	2.1	1.0	1.1	2.3	4.1	0.9	1.1	0.0	0.0	1.0	0.6	0.2	1.1	0.0	0.0	1.3	0.4	0.0	0.6	0.0	0.3	0.6	1.9	1.5	0.2	2.1	0.4	0.9	4.5	2.4	0.5	0.3	0.9	2.0	0.1	0.0	0.0	1.8	0.7	0.1	6.7	5.3	1.7	1.4	0.0	0.4	5.8	0.0	0.9	1.6	0.0	0.8	0.0	1.6	0.7	0.0	0.1	4.8	3.1	0.1	0.0	0.0	0.0	1.2	0.5	1.5	2.1	1.8	1.5	2.7	2.0	0.4	0.4	0.6	0.1
ESCO2	"EFO2, RBS"	ENSG00000171320	"Establishment of sister chromatid cohesion N-acetyltransferase 2"	Q56NI9	8	27771949-27812640	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 23.2;lymphoid tissue: 39.8;testis: 10.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA027243, HPA053679"			Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA027243: AB_2672175, HPA053679: AB_2682227"	"unprognostic (7.86e-2)"	"unprognostic (1.50e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (5.13e-3)"	"unprognostic (9.50e-2)"	"unprognostic (8.67e-3)"	"unprognostic (7.30e-4)"	"unprognostic (5.24e-3)"	"unprognostic (2.24e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.23e-1)"	"unprognostic (1.65e-14)"	"unprognostic (6.65e-3)"	"unprognostic (5.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (4.06e-1)"	1.0	1.7	0.5	7.1	0.5	5.5	1.0	0.4	0.6	1.2	9.6	0.1	0.5	11.9	0.6	1.0	5.0	0.3	1.8	1.1	0.7	0.5	1.6	1.4	1.1	4.2	0.5	0.6	0.6	1.0	0.3	0.3	1.5	0.5	0.5	4.5	0.1	1.4	1.4	0.4	1.1	23.2	0.4	0.8	4.7	2.4	10.3	0.2	39.8	0.5	5.3	5.7	1.0	1.8	1.3	1.9	0.8	1.5	0.9	4.6	0.8	24.8	18.9	8.5	10.3	1.1	1.8	4.7	15.0	6.3	13.9	15.9	6.7	4.9	9.2	7.9	3.9	13.8	10.3	4.1	21.2	7.1	4.4	10.9	8.5	7.0	0.1	5.5	10.2	0.3	0.4	8.1	2.0	5.1	8.7	14.1	8.0	4.8	22.3	2.5	5.7	6.4	9.9	25.4	6.7	4.5	15.1	3.7	5.4	7.5	9.1	3.8	6.2	6.1	2.2	8.6	17.8	17.3	11.7	1.9	5.0	11.4	4.7	9.3	11.9	0.1	0.7	0.4	0.3	1.5	0.1	1.3	0.7	1.0	1.9	0.1	0.5	0.4	0.8	0.9	0.4	0.2	4.6	0.8	0.5	0.5	0.4	0.6	0.7	0.5	0.5	0.6	0.5	0.2
FCRL4	"CD307d, FCRH4, IGFP2, IRTA1"	ENSG00000163518	"Fc receptor like 4"	Q96PJ5	1	157573749-157598080	"Cancer-related genes, CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 5.4;lymphoid tissue: 15.6"	"Cell line enriched"	"Detected in single"	102	"U-266/70: 10.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory B-cell: 1.1"	"Lineage enriched"	"Detected in single"	12	"B-cells: 1.1"					"Low region specificity"	"Detected in many"			HPA054030	Approved									"HPA054030: "	"unprognostic (6.06e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.57e-1)"	"unprognostic (5.08e-2)"		"unprognostic (4.69e-4)"		"unprognostic (2.06e-2)"			"unprognostic (6.38e-2)"			"unprognostic (1.99e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-1)"	"unprognostic (6.77e-2)"	0.1	0.1	0.1	15.6	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	5.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	2.5	0.0	0.1	0.1	5.4	0.0	0.1	2.2	0.3	0.1	0.0	1.1	0.1	1.9	14.9	0.4	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	4	"intestine: 15.8;lung: 11.7;pituitary gland: 39.2"	"Cell line enhanced"	"Detected in some"		"A549: 3.3;CACO-2: 2.7;HaCaT: 5.5;NB-4: 6.1"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042563			Uncertain	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	5.2	0.6	1.8	2.8	1.7	0.2	1.9	0.1	2.6	0.2	11.3	1.1	0.0	0.7	0.1	0.1	0.4	1.4	2.6	1.2	0.9	1.6	0.3	0.6	11.7	1.3	0.6	1.0	0.3	1.1	0.1	39.2	0.4	0.8	0.2	15.8	0.3	0.9	0.1	0.5	1.3	1.0	0.3	2.6	0.2	0.7	2.0	0.9	0.7	0.2	0.0	0.6	0.3	0.2	0.5	3.4	1.3	3.0	0.7	0.3	0.8	0.1	3.3	0.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	2.7	0.8	0.2	0.5	0.0	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	6.1	0.3	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.1	0.1	0.1	0.0	1.1	0.2	0.3	0.1	0.2	0.3	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.9	3.0	0.2	0.3	0.6	0.2	0.4	0.2	0.2	3.4	0.5	0.2	0.3	1.3	0.7	0.4	0.4	0.1	0.8	1.8	1.7	0.1	2.6	0.9	1.6	0.6	1.0	0.8	0.9
FMO5		ENSG00000131781	"Flavin containing monooxygenase 5"	P49326	1	147175351-147243050	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 61.1;liver: 119.4;stomach 1: 38.6"	"Cell line enhanced"	"Detected in some"		"Hep G2: 28.4;HMC-1: 6.4;THP-1: 7.2"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 43.0"	"Group enriched"	"Detected in many"	6	"basal ganglia: 5.5;cerebral cortex: 4.5;midbrain: 17.1;pons and medulla: 5.2;thalamus: 6.0"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012373	Enhanced		Supported	"Endoplasmic reticulum,Cytosol"				"Endoplasmic reticulum, Cytosol"	"Endoplasmic reticulum, Cytosol"	"HPA012373: AB_1848975"	"unprognostic (2.70e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.43e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.13e-1)"	"prognostic favourable (1.34e-6)"	"unprognostic (3.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.11e-2)"	1.1	2.4	1.1	1.9	5.5	0.2	8.6	0.6	4.5	1.3	61.1	1.5	0.8	12.5	1.0	1.3	0.7	1.1	8.5	1.0	1.3	0.5	9.0	119.4	17.0	0.8	17.1	0.5	1.0	11.9	8.8	4.9	0.6	5.2	1.9	8.2	0.5	9.7	0.6	0.4	4.2	53.6	0.9	7.1	1.2	38.6	1.2	6.0	0.2	1.1	1.5	0.5	1.9	0.8	9.2	4.9	6.2	12.1	1.0	2.0	3.6	0.1	0.7	0.5	0.0	1.9	0.5	0.6	0.4	0.3	0.2	0.6	0.4	1.5	0.3	0.5	0.4	0.3	0.0	0.0	0.0	1.0	0.1	1.1	0.0	28.4	0.6	0.9	6.4	0.9	0.1	0.3	0.0	0.4	0.1	0.1	1.1	0.9	0.2	0.5	2.0	0.5	0.3	0.3	0.2	2.4	0.4	0.4	0.2	0.6	1.9	0.9	1.4	7.2	0.7	0.0	0.2	0.6	0.0	0.2	0.0	0.2	0.7	0.3	0.2	6.2	12.1	3.5	2.0	5.6	0.3	3.6	0.5	0.6	4.9	9.2	0.3	1.3	1.2	1.0	1.6	2.4	1.4	3.6	1.1	5.5	0.6	4.5	1.3	0.5	17.1	0.5	5.2	6.0
GOLT1A	"CGI-141, FLJ42654, GOT1, MGC62027, YMR292W"	ENSG00000174567	"Golgi transport 1A"	Q6ZVE7	1	204198160-204214092	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 35.9;liver: 74.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.2;CAPAN-2: 10.6;Hep G2: 13.1;MCF7: 22.2;RT4: 14.6;SK-BR-3: 14.6"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 80.7"	"Group enriched"	"Detected in many"	5	"basal ganglia: 8.8;cerebellum: 3.8;hypothalamus: 3.8"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.5"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.5"					"Not detected"	"Not detected"														"unprognostic (3.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-3)"	"unprognostic (2.66e-2)"	"prognostic unfavourable (6.37e-4)"	"unprognostic (6.20e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (6.35e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.18e-3)"	"prognostic favourable (1.51e-4)"	0.3	0.0	1.2	0.8	8.8	0.0	1.7	3.8	0.8	3.5	13.7	0.4	1.7	15.5	0.3	3.6	0.3	1.0	3.4	0.3	1.0	3.8	5.9	74.9	3.1	0.3	0.8	0.4	0.4	12.5	7.1	8.7	1.0	0.9	2.9	1.6	0.5	1.0	3.7	0.6	0.0	35.9	1.6	0.6	0.3	1.9	0.5	0.3	0.4	0.6	0.3	0.4	10.9	2.5	0.1	0.0	0.0	0.0	0.0	1.5	0.6	0.2	4.3	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	9.2	10.6	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	22.2	0.0	0.0	2.1	0.1	0.0	0.0	0.2	4.5	14.6	0.7	1.0	0.4	14.6	0.0	4.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	1.4	1.4	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.6	1.2	8.8	3.8	0.8	1.0	3.8	0.8	0.4	0.9	0.3
GPR15		ENSG00000154165	"G protein-coupled receptor 15"	P49685	3	98531899-98533150	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 12.9;intestine: 27.1;lymphoid tissue: 26.3;urinary bladder: 9.4"	"Group enriched"	"Detected in some"	22	"HDLM-2: 10.9;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 4.4;memory CD4 T-cell: 12.9;memory CD8 T-cell: 6.1;T-reg: 12.9"	"Group enriched"	"Detected in many"	30	"B-cells: 4.4;T-cells: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA013775	Approved									"HPA013775: AB_1849264"	"unprognostic (8.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.66e-2)"	"unprognostic (9.48e-3)"	"unprognostic (5.60e-5)"	"unprognostic (5.17e-1)"	"unprognostic (6.77e-3)"	"unprognostic (3.96e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.83e-1)"	"unprognostic (4.04e-3)"	"unprognostic (4.23e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.54e-1)"	0.9	0.1	0.1	13.4	0.1	0.0	2.5	0.1	0.2	1.1	15.3	0.1	0.1	1.8	0.1	0.1	2.6	0.2	2.1	0.2	0.1	0.1	0.3	0.4	1.9	24.9	0.1	0.4	0.4	0.1	0.0	0.2	0.1	0.3	1.4	27.1	0.3	4.6	0.7	0.1	0.4	11.8	1.5	0.2	4.3	1.1	0.2	0.1	3.6	0.7	2.0	26.3	9.4	2.4	4.4	0.2	0.2	0.0	0.0	12.9	2.8	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	4.8	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.4	4.4	12.9	6.1	0.0	0.7	0.6	1.0	0.2	0.0	0.0	0.2	12.9	2.8	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.3	0.1
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 67.7;brain: 55.2;intestine: 21.7"	"Group enriched"	"Detected in many"	4	"A549: 21.8;HDLM-2: 57.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"plasmacytoid DC: 11.5"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008557	Approved		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments"				Nucleoli	Nucleoli	"HPA008557: AB_1079197"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavourable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.4	67.7	15.5	3.1	16.0	11.8	1.1	55.2	25.0	1.2	3.1	5.1	5.9	21.7	1.2	6.6	0.9	2.9	8.1	4.3	13.6	7.5	10.4	1.3	1.9	3.6	6.8	15.1	7.6	2.0	0.6	6.7	5.0	14.4	1.1	1.2	11.9	1.3	2.5	1.8	0.8	15.6	1.3	4.1	2.7	7.8	10.6	5.1	3.4	3.7	0.0	2.7	1.5	0.8	0.1	11.5	0.6	2.0	2.6	2.7	0.7	0.0	21.8	1.2	0.0	0.1	0.2	3.6	7.2	5.2	1.6	0.6	0.9	0.1	1.3	3.8	3.6	0.0	2.3	0.0	1.7	57.6	2.0	0.0	9.8	0.2	0.0	7.5	0.0	0.4	0.0	2.8	0.0	0.6	0.0	0.0	1.3	0.1	1.2	2.5	2.8	8.2	3.9	3.5	2.3	0.1	0.0	7.2	5.9	1.7	0.1	0.0	0.2	4.2	4.3	8.7	1.4	1.5	0.3	0.0	0.0	0.0	1.8	7.9	0.4	0.0	2.0	0.6	0.7	1.0	0.4	0.0	2.7	2.1	3.0	0.1	0.3	0.3	0.2	2.6	1.0	11.5	1.1	0.7	15.5	16.0	55.2	25.0	13.6	7.5	6.8	15.1	14.4	5.1
HAPLN4	"BRAL2, KIAA1926"	ENSG00000187664	"Hyaluronan and proteoglycan link protein 4"	Q86UW8	19	19255641-19262796	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 38.5;intestine: 24.3"	"Cell line enhanced"	"Detected in some"		"NB-4: 5.6;NTERA-2: 14.6;SCLC-21H: 3.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055856	Enhanced				"Secreted in brain"					"HPA055856: AB_2682946"					"unprognostic (3.36e-4)"													0.5	1.9	3.0	0.4	7.5	0.4	0.7	8.9	38.5	2.4	0.6	1.6	0.0	19.6	1.6	0.5	0.4	0.7	0.6	0.5	8.9	9.4	0.5	7.5	0.6	0.4	7.8	2.7	1.4	1.3	0.4	0.2	0.7	26.4	1.1	0.6	0.4	0.5	0.8	0.4	0.4	24.3	0.6	3.8	0.4	0.8	0.5	0.0	0.0	0.4	0.0	0.4	0.5	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.3	0.0	0.0	5.6	14.6	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	7.5	8.9	38.5	8.9	9.4	7.8	2.7	26.4	0.0
ITM2C	"BRI3, BRICD2C, E25, hRPC.1050_D_4, ITM3"	ENSG00000135916	"Integral membrane protein 2C"	Q9NQX7	2	230864639-230879248	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"blood: 187.0;brain: 138.3;intestine: 158.6"	"Cell line enhanced"	"Detected in many"		"EFO-21: 77.1;NB-4: 83.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"plasmacytoid DC: 187.0"	"Lineage enriched"	"Detected in many"	9	"dendritic cells: 187.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.50e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavourable (1.81e-4)"	"unprognostic (3.74e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (4.44e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.52e-2)"	9.7	21.5	113.6	23.9	138.3	21.7	6.6	15.9	122.4	18.2	158.6	41.9	3.9	18.4	19.4	9.9	20.2	12.7	12.7	11.5	81.8	96.8	29.5	7.7	8.2	15.9	97.3	63.4	19.7	18.5	23.1	39.6	24.8	51.4	24.7	124.0	26.1	17.1	27.4	5.1	4.3	41.7	22.5	68.1	18.1	18.3	4.4	44.3	29.6	12.7	1.9	16.4	27.5	10.8	14.9	187.0	21.1	0.2	3.6	4.5	3.6	4.7	9.6	31.8	25.0	4.0	2.3	10.2	25.0	28.1	13.7	21.6	12.8	6.8	0.0	77.1	18.0	2.4	19.1	3.6	8.6	47.2	15.7	6.3	5.1	16.3	14.5	11.3	27.1	19.7	3.6	12.3	1.2	0.5	6.0	16.1	5.1	7.5	8.3	83.1	38.7	8.7	12.3	5.3	67.6	18.2	28.4	1.7	49.1	12.3	1.5	28.9	2.4	65.6	0.4	5.9	17.1	10.3	7.1	0.1	1.2	0.6	18.6	10.0	49.0	4.6	0.2	21.1	1.0	0.1	2.7	14.9	3.2	2.6	5.2	6.9	3.2	2.5	0.5	3.6	0.0	187.0	4.5	3.6	113.6	138.3	15.9	93.6	81.8	96.8	97.3	63.4	51.4	44.3
ITPKA	"IP3-3KA, IP3KA"	ENSG00000137825	"Inositol-trisphosphate 3-kinase A"	P23677	15	41493393-41503551	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.8;intestine: 19.8;stomach 1: 10.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 12.3;basal ganglia: 21.2;cerebral cortex: 28.8;hippocampal formation: 10.4;olfactory region: 8.2"	"Cell type enriched"	"Detected in single"	8	"MAIT T-cell: 4.7"	"Lineage enriched"	"Detected in single"	13	"T-cells: 4.7"	"Group enriched"	"Detected in many"	13	"amygdala: 120.1;basal ganglia: 97.6;cerebellum: 62.9;cerebral cortex: 164.4;hippocampal formation: 162.9"	"Group enriched"	"Detected in many"	7	"amygdala: 12.1;basal ganglia: 40.8;cerebral cortex: 32.2;hippocampal formation: 28.6"	HPA040454	Enhanced	Approved	Approved	Vesicles				Vesicles	Vesicles	"HPA040454: AB_10672897"	"unprognostic (5.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.19e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavourable (6.77e-4)"	"unprognostic (2.25e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavourable (3.76e-9)"	"unprognostic (2.15e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.10e-2)"	0.4	3.0	12.3	1.1	21.2	0.8	0.4	3.0	28.8	0.6	8.5	0.3	0.0	19.8	0.6	0.5	0.4	0.6	0.6	0.7	10.4	0.9	0.4	0.8	0.4	0.4	1.6	8.2	0.6	2.5	1.7	0.0	0.7	0.3	0.8	3.4	0.0	2.1	0.8	1.4	0.4	19.7	0.7	0.2	0.4	10.7	3.5	0.6	0.0	0.4	0.0	0.4	0.4	0.2	0.0	0.0	0.0	0.0	0.3	4.7	0.0	4.8	1.3	0.2	5.6	0.0	1.8	10.2	3.0	2.4	2.0	2.1	11.2	0.2	0.0	2.5	0.2	0.5	2.4	0.2	0.1	4.5	3.0	6.8	3.0	22.7	9.2	2.3	0.3	0.1	0.1	1.9	0.6	0.1	8.6	1.3	0.7	3.2	0.2	4.4	0.6	4.0	1.1	1.0	0.4	0.2	0.3	0.5	1.1	2.2	0.0	0.2	0.6	3.4	0.2	4.9	5.1	5.5	8.1	0.7	7.1	0.0	9.1	9.0	1.6	0.0	0.0	0.0	0.3	0.0	4.7	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	12.3	21.2	3.0	28.8	10.4	0.9	1.6	8.2	0.3	0.6
LY75	"CD205, CLEC13B, DEC-205"	ENSG00000054219	"Lymphocyte antigen 75"	O60449	2	159803355-159904749	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 28.8;lymphoid tissue: 61.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 10.3;HDLM-2: 9.7;Karpas-707: 41.3;RT4: 14.0;THP-1: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB001450, HPA049108, HPA054073"	Enhanced		Approved	"Golgi apparatus"		960000	960000	"Golgi apparatus"	"Golgi apparatus"	"CAB001450: AB_563525, HPA049108: AB_2680635, HPA054073: "	"unprognostic (7.29e-3)"	"unprognostic (1.92e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.52e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.65e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.24e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.74e-3)"	"unprognostic (3.92e-1)"	"prognostic unfavourable (2.39e-5)"	"unprognostic (2.66e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.94e-2)"	"prognostic favourable (3.86e-4)"	3.5	1.8	1.9	21.4	2.6	4.9	6.1	1.2	1.8	4.5	9.3	2.0	1.0	10.8	2.1	1.9	4.5	5.0	10.7	2.8	1.8	1.7	2.8	1.2	10.3	33.9	2.5	1.1	1.6	2.3	0.2	1.9	0.8	2.4	2.0	7.2	1.3	7.2	1.3	0.8	6.5	28.8	1.3	3.4	17.2	3.8	1.1	3.0	61.9	10.7	3.6	17.1	6.9	3.8	5.8	4.3	5.9	2.6	7.5	8.0	2.3	1.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.1	10.3	7.1	0.3	0.0	0.2	0.0	0.0	0.0	9.7	0.0	2.0	0.0	0.0	0.2	1.6	0.0	0.1	0.0	0.2	0.1	5.3	0.0	41.3	0.0	0.0	0.0	2.6	0.2	0.0	2.7	0.0	1.7	3.1	14.0	0.0	0.0	3.3	2.4	0.0	0.0	10.4	7.9	0.0	0.0	0.0	0.0	6.3	1.0	1.4	0.0	3.6	0.0	3.4	2.0	3.5	6.5	2.6	7.1	5.8	5.9	7.5	4.3	4.5	6.7	8.0	5.9	7.5	1.0	1.5	4.3	2.3	1.9	2.6	1.2	1.8	1.8	1.7	2.5	1.1	2.4	3.0
LY9	"CD229, hly9, mLY9, SLAMF3"	ENSG00000122224	"Lymphocyte antigen 9"	Q9HBG7	1	160796074-160828261	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.8;intestine: 11.3;lymphoid tissue: 43.7;urinary bladder: 28.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.2;Karpas-707: 14.6;U-266/70: 37.2;U-266/84: 14.3"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 30.6;MAIT T-cell: 30.7;memory B-cell: 15.2;memory CD4 T-cell: 26.8;memory CD8 T-cell: 29.6;naive B-cell: 13.9;naive CD4 T-cell: 30.5;naive CD8 T-cell: 30.8;plasmacytoid DC: 18.6;T-reg: 19.7"	"Group enriched"	"Detected in many"	4	"B-cells: 15.2;dendritic cells: 18.6;T-cells: 30.8"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA050917	Approved					23000	23000			"HPA050917: AB_2681272"	"unprognostic (8.04e-4)"	"unprognostic (2.31e-5)"	"unprognostic (8.08e-3)"	"unprognostic (1.20e-3)"	"unprognostic (9.83e-3)"	"unprognostic (1.87e-5)"	"unprognostic (1.16e-2)"	"unprognostic (3.84e-3)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.69e-2)"	"unprognostic (9.47e-2)"	"unprognostic (3.49e-2)"	"unprognostic (6.88e-2)"	2.8	0.5	0.4	20.9	0.4	6.9	2.7	0.4	0.4	1.4	3.7	0.2	0.4	2.4	0.9	0.8	3.5	1.0	2.0	0.9	0.4	0.4	1.7	1.3	6.1	35.3	0.4	0.0	1.1	0.5	0.0	0.5	0.2	0.1	1.0	2.3	1.0	6.5	0.4	0.4	0.8	11.3	0.1	0.7	25.3	3.4	1.1	0.0	35.7	1.6	1.8	43.7	28.6	1.2	15.2	18.6	0.6	0.2	5.2	30.8	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	1.1	0.2	0.0	0.0	0.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	37.2	14.3	0.1	0.0	2.0	0.0	0.2	0.2	0.1	30.6	0.2	30.7	15.2	26.8	29.6	1.3	13.9	30.5	30.8	0.6	5.2	0.2	18.6	19.7	12.9	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.1	0.0
METTL7B	"ALDI, MGC17301"	ENSG00000170439	"Methyltransferase like 7B"	Q6UX53	12	55681546-55684611	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"epididymis: 35.7;heart muscle: 46.1;intestine: 44.7;liver: 82.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 11.8;CAPAN-2: 23.9;EFO-21: 17.9;Hep G2: 11.6;LHCN-M2: 19.8;THP-1: 17.5;U-87 MG: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 5.4;myeloid DC: 8.6;naive B-cell: 2.5;non-classical monocyte: 4.0"	"Group enriched"	"Detected in many"	56	"B-cells: 2.5;dendritic cells: 8.6;monocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038644	Enhanced		Supported	Vesicles,Microtubules				Microtubules	Microtubules	"HPA038644: AB_2676130"	"unprognostic (7.54e-2)"	"unprognostic (7.15e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.07e-3)"	"unprognostic (6.30e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (2.00e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.55e-1)"	"unprognostic (2.98e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.76e-2)"	"unprognostic (7.10e-2)"	"prognostic favourable (2.37e-4)"	"unprognostic (2.43e-1)"	1.3	0.9	1.2	2.1	0.9	0.1	0.5	0.5	2.2	0.4	15.2	3.0	0.0	15.2	0.4	35.7	0.3	0.7	8.1	46.1	4.6	0.6	12.6	82.4	0.8	0.8	1.8	1.5	0.3	1.2	0.0	1.3	4.3	3.2	0.3	6.0	1.4	0.4	0.1	2.7	0.5	44.7	0.4	1.0	3.1	1.0	0.4	0.6	0.0	1.0	0.1	0.0	0.3	0.3	2.5	8.6	0.0	5.4	0.0	0.0	0.4	0.2	9.1	0.0	0.2	1.9	6.7	0.1	0.3	1.3	0.1	0.6	11.8	23.9	4.8	17.9	0.5	0.0	1.7	0.1	0.3	0.0	2.3	0.4	1.5	11.6	0.0	0.2	0.0	1.7	0.0	0.4	0.0	0.0	0.1	0.0	19.8	8.2	0.0	0.1	2.4	1.1	0.0	0.6	1.1	0.2	0.0	0.0	0.1	0.9	0.0	1.6	1.6	17.5	0.0	1.3	1.6	0.2	1.2	0.0	0.2	1.4	18.2	4.1	0.1	0.0	1.0	0.0	0.0	5.4	0.0	0.7	0.0	0.0	8.6	2.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.4	1.2	0.9	0.5	2.2	4.6	0.6	1.8	1.5	3.2	0.6
MGAM	MGA	ENSG00000257335	Maltase-glucoamylase	O43451	7	141907813-142106747	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 155.5"	"Cell line enhanced"	"Detected in some"		"A549: 3.6;BJ hTERT+: 3.2;HL-60: 5.3;U-937: 8.5;WM-115: 2.0"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 4.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 14.1"	"Lineage enriched"	"Detected in single"	104	"granulocytes: 14.1"	"Region enriched"	"Detected in single"	12	"olfactory region: 3.1"					HPA002270	Enhanced					68000	68000			"HPA002270: AB_1079366"	"unprognostic (1.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.95e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (7.32e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.97e-1)"	"unprognostic (2.17e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.16e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.34e-3)"	"unprognostic (3.03e-1)"	0.9	0.2	0.3	0.8	0.2	6.9	0.3	0.2	0.2	0.2	59.4	0.1	7.6	25.2	0.2	36.0	0.2	1.0	0.1	0.3	0.2	0.2	8.7	0.4	2.1	0.1	0.3	0.1	0.2	0.2	0.0	0.2	0.1	0.1	0.6	0.0	0.1	0.2	3.2	0.2	0.1	155.5	0.1	0.3	8.3	0.7	4.3	0.1	0.1	0.2	0.1	0.1	0.2	0.2	0.0	0.0	14.1	0.1	0.0	0.0	0.0	0.0	3.6	0.2	0.1	0.0	0.0	0.4	0.1	3.2	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	1.0	0.4	0.1	0.3	0.0	0.1	0.0	8.5	2.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.2	0.2	0.2	0.3	0.1	0.1	0.1
MYO5B	KIAA1119	ENSG00000167306	"Myosin VB"	Q9ULV0	18	49822813-50195093	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 92.2"	"Cell line enhanced"	"Detected in many"		"A-431: 20.6;HaCaT: 32.6;RH-30: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA040593, HPA040902, HPA069773"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: AB_2686194"	"unprognostic (2.51e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.12e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.14e-1)"	"unprognostic (8.84e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.13e-2)"	"unprognostic (3.46e-1)"	"prognostic unfavourable (2.26e-5)"	"unprognostic (4.48e-2)"	"prognostic favourable (1.45e-11)"	"unprognostic (2.17e-3)"	"unprognostic (1.50e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.28e-1)"	2.0	1.2	1.1	12.7	1.3	0.0	5.2	0.4	2.5	7.5	56.9	1.0	13.7	23.5	1.8	10.4	20.3	4.6	20.6	2.0	1.8	1.2	19.1	13.9	9.4	0.6	0.7	1.5	1.7	16.4	9.3	10.5	13.5	2.1	6.0	17.5	8.4	21.6	8.7	0.6	14.5	92.2	0.8	0.7	0.9	13.1	5.5	0.3	2.4	16.3	14.9	17.4	4.0	11.8	1.0	0.1	0.0	0.0	2.4	0.6	0.0	20.6	5.6	0.1	0.1	0.0	0.0	11.3	0.1	0.8	0.4	0.0	14.6	8.8	0.0	5.2	0.0	32.6	7.4	8.8	0.4	0.0	2.2	0.0	2.5	10.3	0.0	0.0	0.0	0.0	7.8	0.2	5.4	0.7	0.1	8.1	0.8	8.0	0.0	0.0	1.5	2.3	0.0	50.5	3.5	18.6	4.2	11.2	0.2	7.9	9.3	0.0	5.5	0.0	0.4	0.0	11.4	0.1	2.1	5.5	3.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	1.0	0.4	0.1	0.0	0.0	0.2	0.4	0.0	2.4	0.0	0.1	0.1	0.0	1.1	1.3	0.4	2.5	1.8	1.2	0.7	1.5	2.1	0.3
NLRP6	"CLR11.4, NALP6, PAN3, PYPAF5"	ENSG00000174885	"NLR family pyrin domain containing 6"	P59044	11	278365-285359	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 63.8"	"Group enriched"	"Detected in some"	4	"REH: 4.3;U-266/70: 8.6"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"neutrophil: 14.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"HPA043681, HPA048500"	Supported									"HPA043681: AB_2678614, HPA048500: AB_2680422"	"unprognostic (6.37e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.42e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.18e-2)"	"prognostic favourable (4.23e-5)"	"unprognostic (8.82e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.11e-3)"	"unprognostic (4.96e-2)"	"unprognostic (2.14e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.69e-2)"	0.4	0.0	0.1	1.3	0.1	0.2	0.1	0.1	0.1	0.1	29.1	0.1	0.1	25.9	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.0	0.9	1.6	0.6	0.6	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	63.8	0.1	0.1	2.7	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.3	0.1	14.6	4.0	0.9	2.4	0.6	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	1.4	0.0	0.4	0.5	1.0	0.3	0.0	4.3	0.0	1.6	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.3	0.0	8.6	0.5	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.7	0.3	1.4	0.3	1.7	1.2	0.1	0.1	2.0	2.4	14.6	0.9	4.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74924275-74933912	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 20.4;testis: 5.1"	"Cell line enriched"	"Detected in single"	47	"HDLM-2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.4"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 1.4"	"Region enriched"	"Detected in single"	13	"olfactory region: 15.6"	"Low region specificity"	"Detected in all"			"HPA024524, HPA053090"	Uncertain									"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.1	0.0	0.1	2.9	0.1	0.0	0.1	0.1	0.1	0.1	20.4	0.1	0.1	0.2	0.5	0.1	1.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	10.9	0.1	0.1	0.1	0.1	0.2	11.3	0.2	0.1	0.1	0.0	5.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	1.4	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696404	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 30.4;intestine: 12.0;lymphoid tissue: 39.1;skeletal muscle: 11.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 24.0;Karpas-707: 15.5;RPMI-8226: 27.0;U-698: 22.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"memory B-cell: 28.1;naive B-cell: 30.4"	"Lineage enriched"	"Detected in many"	19	"B-cells: 30.4"									"HPA021948, HPA067827"	Supported		Supported	Cytosol				Cytosol	Cytosol	"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.6	0.3	2.2	32.0	4.9	4.8	0.5	4.1	5.1	0.3	1.4	0.0	0.4	0.9	0.2	0.2	2.4	0.2	0.8	4.9	1.8	3.0	0.8	0.4	1.0	39.1	1.5	2.1	0.2	0.8	0.1	1.2	0.2	1.7	0.5	1.2	0.0	5.4	0.1	11.4	0.2	12.0	0.4	0.6	29.6	1.8	0.6	0.2	9.3	0.5	1.9	27.6	2.2	0.3	30.4	0.1	0.7	0.0	0.0	1.6	1.6	3.8	3.2	0.0	0.0	0.1	0.6	0.0	4.0	1.8	0.4	1.3	2.4	4.7	24.0	2.4	1.9	2.0	8.6	0.0	0.8	0.4	1.5	1.2	8.5	2.9	0.6	1.6	2.1	1.0	0.9	0.1	5.6	0.0	0.2	15.5	8.7	0.0	10.8	3.6	2.4	9.7	0.4	0.0	27.0	0.1	2.9	2.0	0.0	3.3	1.1	1.8	1.0	1.5	0.0	0.0	2.2	0.1	0.7	5.5	11.7	22.3	0.0	2.3	0.2	0.0	0.0	0.7	1.1	0.0	1.6	28.1	1.0	0.8	0.1	30.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	1.6	2.2	4.9	4.1	5.1	1.8	3.0	1.5	2.1	1.7	0.2
PAX4	MODY9	ENSG00000106331	"Paired box 4"	O43316	7	127610292-127618114	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 3.9;testis: 3.6"	"Cell line enriched"	"Detected in single"	62	"SCLC-21H: 17.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"								"unprognostic (1.52e-1)"								"unprognostic (9.71e-2)"			"unprognostic (4.86e-3)"	"unprognostic (1.21e-1)"			0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	3.4	0.1	0.1	3.8	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	3.9	0.1	0.1	0.1	0.1	0.0	2.1	0.1	0.1	0.1	0.0	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
POU2F2	"OCT2, OTF2"	ENSG00000028277	"POU class 2 homeobox 2"	P09086	19	42086110-42196585	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 33.1;brain: 12.0;intestine: 10.8;lymphoid tissue: 43.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.1;Daudi: 38.2;hTEC/SVTERT24-B: 15.0;U-266/70: 26.6;U-266/84: 25.7;U-698: 30.3;U-87 MG: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 33.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002513, HPA049056, HPA062096, HPA064404"	Enhanced		Enhanced	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB002513: AB_442118, HPA049056: , HPA062096: AB_2684681, HPA064404: AB_2685259"	"unprognostic (2.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.39e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavourable (7.57e-11)"	"unprognostic (2.31e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.54e-1)"	1.9	2.0	5.6	43.1	7.4	4.8	1.2	12.0	5.7	0.9	3.2	2.5	0.0	2.1	0.9	1.7	1.4	1.5	2.3	4.8	5.7	5.9	1.6	1.4	3.1	31.4	6.8	1.5	0.7	1.6	0.4	2.1	2.5	6.6	2.5	2.1	1.4	2.1	2.3	0.7	1.2	10.8	1.9	6.5	22.7	3.1	6.0	6.2	1.9	1.3	0.6	30.0	4.3	1.0	13.9	8.0	1.7	33.1	0.6	2.7	4.5	0.3	0.5	0.6	0.0	0.0	1.0	0.1	2.8	18.1	1.8	3.5	0.1	0.5	38.2	1.0	1.0	0.3	0.2	2.9	8.2	0.1	0.1	0.9	0.1	0.0	0.2	0.3	0.7	0.8	0.5	15.0	1.0	1.1	0.4	8.8	0.4	0.2	0.1	2.0	0.1	0.2	0.4	0.0	0.1	0.0	0.2	0.6	0.3	0.1	0.2	0.2	0.0	4.8	1.4	7.8	0.8	0.0	0.3	26.6	25.7	30.3	14.6	0.9	1.0	1.0	10.7	0.1	1.2	19.3	1.1	11.0	1.8	1.6	8.0	13.9	0.9	1.3	1.7	0.6	33.1	1.3	2.7	4.5	5.6	7.4	12.0	5.7	5.7	5.9	6.8	1.5	6.6	6.2
PRAC2	"C17orf93, HOXB-AS5, HOXB13-AS1, NCRNA00253"	ENSG00000229637	"Prostate cancer susceptibility candidate 2"	D3DTV9	17	48723168-48724758	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	4	"intestine: 11.2;prostate: 12.8;urinary bladder: 3.4"	"Group enriched"	"Detected in some"	5	"PC-3: 31.3;REH: 12.2"	"Cancer enriched"	"Detected in many"	8	"prostate cancer: 26.6"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Intracellular and membrane"						"unprognostic (1.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.63e-2)"			"unprognostic (9.98e-2)"	"unprognostic (3.27e-2)"		"unprognostic (9.77e-2)"	"unprognostic (8.97e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.82e-1)"	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	5.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.8	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	31.3	12.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PRORY	CYorf17	ENSG00000183146	"Proline rich, Y-linked"	Q9H606	Y	21382954-21386360	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	4	"intestine: 5.4"	"Cell line enriched"	"Detected in some"	8	"U-266/84: 8.4"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"																																				"unprognostic (1.59e-1)"			0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.4	0.0	2.0			0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	1.6		0.0	0.0	0.1	0.4	5.4	0.0	0.0	0.1	0.0	0.7			0.0		0.0	0.0	0.0	0.9	0.3	1.2	0.4	0.3	0.9	0.2	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.2	0.1	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.2	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.5	0.1	0.5	0.6	0.0	0.2	0.4	0.9	0.0	0.9	8.4	0.2	0.2	0.7	0.1	0.6	0.2	0.5	0.7	0.4	0.5	0.4	0.4	0.7	0.2	0.9	0.7	0.9	1.2	0.3	0.4	0.3	0.0	0.2										
PTPRH	SAP-1	ENSG00000080031	"Protein tyrosine phosphatase, receptor type H"	Q9HD43	19	55181248-55209506	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"gallbladder: 29.6;intestine: 84.3;lymphoid tissue: 21.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 8.0;HHSteC: 10.4;K-562: 12.1;PC-3: 8.2;SK-MEL-30: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 1.5"	"Lineage enhanced"	"Detected in single"		"monocytes: 1.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042300			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA042300: "	"unprognostic (1.87e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.59e-1)"	"unprognostic (7.57e-3)"	"unprognostic (5.01e-3)"	"unprognostic (8.14e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.96e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.47e-11)"	"unprognostic (4.08e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.57e-1)"	0.5	8.9	0.5	5.2	0.7	0.0	0.5	0.5	1.0	0.7	39.9	0.6	0.5	30.1	0.5	0.5	0.6	0.0	29.6	0.5	1.3	1.6	0.6	7.8	0.6	0.5	3.0	0.5	0.6	2.8	0.0	3.0	0.6	0.5	1.0	9.6	0.6	0.5	0.5	0.5	0.0	84.3	0.7	6.9	21.2	10.2	0.5	0.5	0.5	0.5	1.0	0.8	1.1	2.4	0.0	0.7	0.0	1.5	0.0	0.0	0.0	5.6	3.5	0.0	1.4	1.1	3.1	0.1	0.1	3.0	0.6	1.2	1.5	8.0	0.0	0.3	0.5	0.0	0.0	0.0	0.7	0.0	0.1	0.4	0.1	4.0	10.4	0.0	4.1	0.8	2.5	2.0	3.1	0.1	12.1	0.5	0.0	0.0	0.0	0.2	0.0	8.2	0.0	0.0	0.4	0.0	0.0	0.3	0.8	0.0	3.6	18.2	0.0	1.6	0.0	0.8	1.2	0.4	0.0	0.0	3.0	0.0	0.9	0.1	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.5	0.7	0.5	0.5	1.3	1.6	3.0	0.5	0.5	0.5
RXFP4	"GPCR142, GPR100, RLN3R2, RXFPR4"	ENSG00000173080	"Relaxin/insulin like family peptide receptor 4"	Q8TDU9	1	155941710-155942949	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 1.8;bone marrow: 1.3;intestine: 5.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 1.6;NB-4: 2.1;SK-MEL-30: 2.0;T-47d: 2.2"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 2.4"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (4.90e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.17e-2)"	"unprognostic (4.73e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.86e-2)"	0.2	0.0	0.0	0.5	0.1	1.3	0.1	0.7	0.0	0.0	5.2			3.5	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0		0.0	0.1	0.0	0.0	0.0		0.0	5.4		0.1	0.1	0.0	0.0	2.8	0.0	0.0	0.2	0.0	0.2			0.0		0.0	0.6	0.0	0.6	0.4	1.8	1.4	0.7	0.8	0.2	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.4	1.2	0.0	0.9	0.0	0.3	0.0	0.0	0.3	0.6	0.2	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.1	2.1	0.3	0.0	0.2	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.0	2.0	2.2	0.0	0.6	0.1	0.0	0.0	0.0	0.1	1.2	0.7	1.2	0.2	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.5	0.8	0.4	0.6	0.0	0.1	1.1	0.7	1.4	0.0	0.0	0.2										
SCT		ENSG00000070031	Secretin	P09683	11	626431-627143	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"blood: 39.8;intestine: 52.3"	"Cell line enhanced"	"Detected in some"		"A549: 2.3;HSkMC: 5.4;U-266/70: 2.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	152	"plasmacytoid DC: 39.8"	"Lineage enriched"	"Detected in single"	152	"dendritic cells: 39.8"					"Low region specificity"	"Detected in many"			HPA050961	Enhanced				"Secreted to blood"					"HPA050961: AB_2681291"	"unprognostic (5.28e-2)"	"unprognostic (6.18e-2)"	"prognostic unfavourable (3.70e-4)"	"unprognostic (2.72e-1)"	"unprognostic (7.91e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.19e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.45e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.13e-1)"	0.2	0.1	0.2	0.4	0.3	0.5	0.2	0.5	0.4	0.2	52.3	0.3	0.2	30.4	0.3	0.5	0.2	0.1	0.2	2.3	0.3	0.4	0.4	0.4	3.1	1.1	0.3	0.2	0.3	0.2	0.0	2.6	0.5	0.4	1.0	0.1	3.6	1.4	0.2	11.5	0.1	10.5	0.2	0.5	3.9	0.7	3.5	0.2	0.2	0.6	1.6	0.7	0.4	0.2	0.0	39.8	0.0	0.0	0.2	0.0	0.1	0.4	2.3	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.9	0.6	0.5	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.5	0.0	0.7	0.0	0.2	5.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.9	0.2	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.7	0.6	0.2	0.0	0.0	0.6	1.0	0.0	0.4	2.9	1.0	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	39.8	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.4	0.3	0.2	0.4	0.2
SH2D6	FLJ35993	ENSG00000152292	"SH2 domain containing 6"	Q7Z4S9	2	85418721-85437029	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 4.2;pancreas: 1.7;testis: 6.4;thyroid gland: 2.4"	"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.5;RH-30: 2.4;SCLC-21H: 1.5"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA053873	Uncertain									"HPA053873: AB_2682286"	"unprognostic (4.70e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.06e-7)"	"unprognostic (2.54e-1)"	"unprognostic (8.65e-2)"	"unprognostic (1.23e-2)"	"unprognostic (5.65e-3)"	0.0	0.0	0.3	0.2	0.3	0.0	0.0	0.3	0.4	0.0	1.9			4.2	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.0	0.0	0.6		0.0	1.7	0.0	0.1	0.0		0.0	0.4		0.0	0.0	0.0	0.0	2.8	0.0	0.4	0.0	0.8	6.4			2.4		0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.6	0.3	0.0	0.1	0.6	0.1	0.3	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.0	0.2	6.5	0.0	0.0	0.0	0.1	0.4	0.1	2.4	0.0	0.7	0.0	1.5	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	1.2	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.3	0.1	0.0	0.5	0.6	0.0	0.0	0.3	0.0										
SHBG	"ABP, MGC126834, MGC138391, TEBG"	ENSG00000129214	"Sex hormone binding globulin"	P04278	17	7613946-7633383	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 14.2;liver: 51.1"	"Cell line enhanced"	"Detected in some"		"ASC diff: 7.7;Hep G2: 5.0;HSkMC: 7.5"	"Cancer enriched"	"Detected in some"	28	"liver cancer: 14.3"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"myeloid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"olfactory region: 0.4"										"Secreted to blood"	15000000000	15000000000				"unprognostic (3.35e-3)"	"unprognostic (6.47e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.58e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (7.83e-3)"	"unprognostic (4.35e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.06e-1)"	0.5	0.9	1.0	0.0	1.3	0.1	0.2	0.4	0.8	0.6	2.7	0.4	0.0	3.5	0.3	0.6	0.2	0.5	0.4	0.9	0.9	0.5	2.3	51.1	0.3	0.1	0.8	0.7	0.5	0.8	0.3	1.4	0.3	1.1	0.3	0.2	1.1	0.3	0.3	0.5	0.0	14.2	0.2	1.1	0.2	0.2	8.0	1.0	0.0	0.6	0.0	0.1	0.2	0.1	0.0	1.2	0.0	0.6	0.0	0.0	0.0	0.2	4.1	3.8	0.6	7.7	3.6	0.2	1.0	1.6	1.7	0.8	1.6	0.6	0.0	0.9	1.4	0.6	0.2	0.3	0.9	0.2	0.6	0.0	1.0	5.0	2.5	0.0	0.1	7.5	0.6	2.9	1.4	0.1	0.4	0.3	0.4	0.9	0.0	0.4	0.6	0.0	0.1	0.3	0.5	0.6	0.5	0.2	0.6	3.1	0.0	0.4	0.6	0.0	1.3	0.8	0.0	0.0	0.3	0.6	0.6	0.3	1.9	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.4	0.8	0.9	0.5	0.8	0.7	1.1	1.0
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066846	"Disease related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in some"	4	"intestine: 40.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HAP1: 2.4;NB-4: 1.2;U-2197: 1.1"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA004795	Approved									"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favourable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	2.4	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35G1	"C10orf60, FLJ33990, TMEM20"	ENSG00000176273	"Solute carrier family 35 member G1"	Q2M3R5	10	93893973-93956062	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 73.5;retina: 24.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 2.6;T-cells: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"														"unprognostic (1.94e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.90e-4)"	"unprognostic (8.89e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.30e-1)"	1.4	1.7	0.7	2.7	1.9	0.5	1.1	1.2	1.4	1.0	29.0	0.8	0.7	52.2	1.9	0.9	2.2	1.1	1.1	2.4	0.8	0.6	0.8	5.1	1.1	1.5	0.6	1.0	1.9	11.6	1.0	3.7	0.9	4.5	1.1	4.7	24.6	2.1	0.9	1.3	2.2	73.5	1.9	0.7	1.4	3.3	4.4	0.4	1.5	2.1	1.6	1.0	1.4	1.5	0.6	0.3	2.6	0.4	0.0	3.8	1.0	7.8	7.6	3.5	4.4	1.1	3.2	5.2	7.2	8.3	6.2	8.3	5.9	5.8	5.0	3.0	4.4	13.7	7.8	2.5	10.3	6.5	9.1	4.1	4.7	4.6	1.9	7.8	8.1	3.2	2.6	5.3	3.1	2.7	3.8	3.1	4.2	2.6	3.9	1.4	4.8	9.6	0.0	6.0	2.0	3.1	7.0	4.5	4.2	9.5	4.5	5.6	5.0	2.2	3.7	5.3	9.0	9.1	7.0	3.5	3.4	1.8	3.4	0.0	3.7	0.0	0.4	2.6	0.4	0.4	1.6	0.4	3.0	1.8	0.3	0.6	3.2	2.0	0.2	0.0	0.0	0.3	3.8	1.0	0.7	1.9	1.2	1.4	0.8	0.6	0.6	1.0	4.5	0.4
SLC52A1	"FLJ10060, GPCR42, GPR172B, hRFT1, PAR2, RFVT1"	ENSG00000132517	"Solute carrier family 52 member 1"	Q9NWF4	17	5032600-5052009	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 25.6;placenta: 34.6"	"Cell line enhanced"	"Detected in some"		"A549: 4.3;BEWO: 3.7;EFO-21: 3.5;HMC-1: 8.8;SK-BR-3: 5.0;T-47d: 3.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"																						"unprognostic (8.81e-3)"	"prognostic favourable (9.54e-4)"	"unprognostic (9.34e-2)"	"unprognostic (7.30e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.19e-2)"	"unprognostic (5.17e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.07e-2)"	"unprognostic (6.60e-2)"	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.3	0.6	1.0	20.0	0.2	0.6	24.4	0.5	0.1	1.5	0.8	0.1	0.1	0.1	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.2	0.1	1.0	0.1	34.6	0.3	1.4	0.1	0.1	0.5	0.3	0.1	7.4	25.6	0.1	0.1	0.6	0.0	0.7	0.1	0.6	0.2	0.4	0.7	2.5	1.0	1.4	0.6	3.7	0.6	1.4	1.2	0.3	0.2	4.3	0.1	0.2	0.1	0.2	3.7	0.0	0.0	0.6	0.6	0.1	0.2	0.3	3.5	0.1	0.4	0.0	0.3	0.1	0.1	0.2	0.0	0.7	0.3	0.1	0.1	8.8	0.1	0.1	0.2	0.1	0.2	0.1	1.2	0.0	0.3	0.4	0.4	0.4	0.2	0.1	0.0	0.3	0.1	1.4	0.1	0.3	0.8	5.0	0.0	3.0	1.3	0.6	0.3	1.1	0.1	0.2	0.3	0.1	0.3	0.2	0.1	0.5	2.6	0.6	0.9	0.7	0.4	0.6	0.6	0.9	1.2	0.2	1.4	1.1	0.8	3.7	1.4	0.4	0.6	0.5	0.3	0.1	0.2	0.3	0.6	0.1	0.1	0.1	0.1	0.3	0.1
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667019-26723427	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 60.8;kidney: 90.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.1;NTERA-2: 4.4;T-47d: 3.3;U-266/70: 2.7"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.2"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA060904	Enhanced									"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.0	0.1	0.0	11.3	0.0	0.2	1.7	0.0	18.5	0.0	0.0	0.0	3.4	0.1	0.1	90.3	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.8	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.8	1.0	0.7	0.9	0.7	0.1	0.5	0.1	0.3	0.7	0.2	0.0	0.6	0.1	0.0	0.0	0.0	0.7	0.3	0.7	1.0	0.3	0.3	0.2	0.1	0.1	0.0	0.0	0.1	0.9	0.2	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.5	6.1	0.1	0.3	0.2	0.6	4.4	0.1	0.1	0.0	0.7	0.1	1.3	2.3	0.4	2.0	0.3	0.0	3.3	0.6	0.7	0.5	0.2	0.5	0.3	2.7	0.8	0.3	0.3	0.1	0.0	1.0	0.5	0.1	0.6	0.7	0.4	1.1	0.4	0.4	0.5	1.5	0.7	0.6	0.4	0.9	0.6	0.8	0.1	0.1	0.1	1.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869766	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"intestine: 63.3;kidney: 26.4"	"Group enriched"	"Detected in some"	17	"BEWO: 4.8;CACO-2: 11.1;Hep G2: 10.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced									"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.3	0.2	0.2	20.1	0.1	0.1	30.5	0.1	1.1	0.1	0.2	0.1	0.1	0.1	0.1	26.4	11.0	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.1	0.1	63.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	4.8	0.0	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1
SMIM31	LINC01207	ENSG00000248771	"Small integral membrane protein 31"		4	164754064-164803795	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enriched"	"Detected in some"	4	"intestine: 42.7"	"Cell line enhanced"	"Detected in some"		"A549: 3.2;RPTEC TERT1: 4.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted - unknown location"						"unprognostic (2.84e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.87e-4)"			"unprognostic (2.95e-2)"	"unprognostic (1.78e-1)"			"unprognostic (4.17e-2)"	"unprognostic (4.82e-1)"		"unprognostic (9.47e-2)"			"unprognostic (5.63e-3)"	0.0	0.0	0.1	4.0	0.0	0.2	0.6	0.0	0.0	3.1	25.4	0.0	0.0	13.7	0.7	0.2	0.1	0.0	6.9	0.0	0.0		0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	9.8	9.8	0.0	2.1	0.0	0.0	0.0	42.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.1	1.4	3.1	0.5	1.3	0.5	0.0	0.4	3.2	0.2	0.8	0.2	0.4	0.8	0.3	0.1	0.3	0.3	1.2	0.4	0.6	0.3	0.2	0.7	0.1	0.4	0.1	0.3	0.4	0.0	0.4	0.2	0.4	0.6	0.9	0.3	0.3	0.2	0.2	0.0	0.5	1.4	0.0	0.6	0.3	1.4	0.4	0.1	0.6	0.2	1.4	4.4	0.6	0.5	0.2	0.4	0.5	0.6	0.4	0.7	0.4	0.4	0.2	0.8	0.5	1.7	0.4	0.7	0.7	0.7	1.2	3.1	0.5	0.6	0.4	0.3	0.4	0.4	0.4	0.4	0.2	1.1	0.5	0.5	2.8	1.3	0.4	1.4	0.3	0.0										
SOX11		ENSG00000176887	"SRY-box 11"	P35716	2	5692667-5701385	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"blood: 3.1;brain: 12.3;heart muscle: 5.3;intestine: 3.3;testis: 3.7"	"Cell line enhanced"	"Detected in some"		"AF22: 25.9;NTERA-2: 12.7;REH: 9.2;RH-30: 9.9;SCLC-21H: 15.9;SH-SY5Y: 24.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 2.0;glioma: 8.5;ovarian cancer: 1.8;testis cancer: 2.8"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA000448, HPA000536, CAB056152, CAB056153"	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB056152: AB_2665567, CAB056153: AB_2665568, HPA000448: , HPA000536: AB_1080060"	"unprognostic (2.17e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-2)"	"unprognostic (7.35e-6)"	"unprognostic (2.79e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.04e-8)"	"unprognostic (2.79e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.35e-3)"	"unprognostic (2.42e-1)"	"unprognostic (8.45e-8)"	"unprognostic (1.35e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.50e-3)"	"unprognostic (7.47e-2)"	0.5	0.5	4.2	0.5	7.1	0.6	0.6	0.3	12.3	0.4	3.3	5.8	0.0	0.6	0.7	0.6	0.5	0.5	0.6	5.3	4.4	5.1	0.5	0.5	0.6	0.5	3.3	5.0	0.5	0.4	0.5	0.7	0.5	4.5	0.5	0.8	0.0	0.9	0.4	1.0	0.6	0.7	1.3	6.3	1.0	0.6	3.7	3.6	0.0	0.6	0.0	0.6	0.5	0.1	1.1	0.8	3.1	1.5	1.6	1.1	0.5	0.0	0.0	25.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	12.7	0.0	9.2	9.9	0.3	0.0	0.0	15.9	24.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.8	0.3	0.6	0.0	0.0	6.0	3.1	0.5	1.0	0.5	0.8	1.1	1.1	0.6	0.7	0.6	0.7	0.9	0.9	1.6	1.6	1.5	0.8	0.9	0.5	4.2	7.1	0.3	6.4	4.4	5.1	3.3	5.0	4.5	3.6
STAP1	"BRDG1, STAP-1"	ENSG00000035720	"Signal transducing adaptor family member 1"	Q9ULZ2	4	67558728-67607337	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 36.8;ductus deferens: 12.3;intestine: 9.3;kidney: 20.0;lymphoid tissue: 30.4"	"Group enriched"	"Detected in some"	5	"Daudi: 62.1;U-698: 27.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 13.0"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 3.2"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 28.1;naive B-cell: 36.8"	"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Low region specificity"	"Detected in many"			HPA038529	Enhanced		Uncertain	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA038529: AB_10673011"	"unprognostic (1.14e-4)"	"unprognostic (1.49e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.30e-4)"	"unprognostic (1.95e-3)"	"unprognostic (6.95e-3)"	"unprognostic (5.18e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (8.43e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.49e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.40e-1)"	0.7	0.3	0.4	27.8	0.3	2.9	0.6	0.3	0.4	0.7	2.1	0.0	12.3	0.8	0.6	1.2	2.4	0.4	0.7	0.4	3.2	0.3	20.0	0.5	2.7	23.9	0.4	0.0	0.3	0.6	0.0	0.4	0.1	0.2	1.0	1.3	0.3	2.6	5.1	0.4	0.5	9.3	0.1	0.4	26.5	1.1	2.1	0.0	5.9	0.7	0.7	30.4	4.6	0.6	36.8	1.7	7.7	0.0	12.6	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	7.9	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	8.9	0.0	1.2	0.0	7.7	0.3	0.0	0.7	28.1	0.7	0.3	0.4	36.8	2.9	0.1	0.3	12.6	0.0	1.7	0.1	1.7	0.4	0.3	0.3	0.4	3.2	0.3	0.4	0.0	0.2	0.0
TIAM2	STEF	ENSG00000146426	"T cell lymphoma invasion and metastasis 2"	Q8IVF5	6	154832697-155257723	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 11.3;brain: 21.1;intestine: 27.4;testis: 15.6;thyroid gland: 7.8"	"Cell line enhanced"	"Detected in many"		"AF22: 34.4;HDLM-2: 14.7;RH-30: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 11.3"	"Group enriched"	"Detected in many"	4	"B-cells: 3.3;granulocytes: 8.3;monocytes: 11.3"	"Group enriched"	"Detected in many"	5	"amygdala: 20.4;basal ganglia: 31.5;cerebral cortex: 23.6;hippocampal formation: 19.4;olfactory region: 70.6"	"Low region specificity"	"Detected in many"			"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoplasm, Nucleoli fibrillar center"	"Nucleoplasm, Nucleoli fibrillar center"	"HPA011134: , HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.6	2.1	5.3	1.7	9.4	0.7	1.5	7.9	21.1	1.5	11.6	0.7	0.1	11.0	1.2	0.8	1.0	1.2	4.0	3.5	4.7	2.0	0.7	0.7	0.9	2.0	1.7	9.5	0.9	1.8	0.2	1.8	0.8	0.6	3.0	1.1	1.3	2.4	3.6	3.0	1.0	27.4	1.4	0.9	1.2	4.0	15.6	1.9	0.0	7.8	0.0	2.5	2.3	1.2	3.3	0.9	8.3	11.3	0.8	1.8	0.4	4.3	0.8	34.4	4.0	1.5	4.2	0.4	1.8	1.1	1.7	2.9	0.5	2.5	1.0	1.8	3.1	0.6	1.2	0.0	1.2	14.7	1.9	0.2	0.6	2.0	0.9	0.3	1.0	2.8	0.1	0.6	0.1	2.4	0.5	0.1	3.8	0.4	0.4	0.9	2.5	0.9	4.4	22.4	0.4	0.1	0.2	0.9	7.9	0.1	0.4	0.2	0.3	0.5	0.8	0.3	8.7	0.3	0.9	0.2	1.7	0.2	0.1	0.5	2.2	0.4	0.2	3.1	0.2	3.2	0.3	3.3	0.5	0.3	0.9	1.0	0.6	0.4	8.3	0.8	11.3	0.3	1.8	0.4	5.3	9.4	7.9	21.1	4.7	2.0	1.7	9.5	0.6	1.9
TMEM156	FLJ23235	ENSG00000121895	"Transmembrane protein 156"	Q8N614	4	38966744-39032922	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 30.6;brain: 12.7;intestine: 8.3;lymphoid tissue: 23.7"	"Cell line enhanced"	"Detected in some"		"Daudi: 16.1;HBEC3-KT: 34.4;hTERT-HME1: 27.1;NB-4: 14.0;PC-3: 15.3;U-698: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 30.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"														"prognostic favourable (4.09e-4)"	"unprognostic (7.36e-3)"	"unprognostic (3.31e-3)"	"unprognostic (4.17e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (4.10e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.45e-3)"	"unprognostic (5.17e-2)"	"unprognostic (8.73e-4)"	"unprognostic (3.89e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.92e-4)"	"unprognostic (9.06e-2)"	0.9	1.7	5.8	11.8	6.6	1.7	1.1	0.7	4.1	0.6	1.7	6.1	0.0	1.7	0.6	0.3	2.0	1.0	1.9	0.6	4.1	2.6	1.4	2.6	1.6	20.2	6.2	0.8	0.5	0.8	0.3	0.7	0.2	5.3	0.9	2.0	0.0	2.0	0.6	0.6	0.5	8.3	0.5	12.7	17.3	2.3	0.6	4.2	7.4	1.0	0.3	23.7	4.5	0.8	30.6	5.0	18.8	0.3	4.8	9.0	3.6	0.9	9.7	0.1	0.1	0.0	0.3	0.1	0.0	2.6	0.0	0.0	0.1	0.1	16.1	0.1	0.0	0.1	0.1	34.4	0.1	0.2	0.0	0.9	3.3	0.2	5.7	6.6	0.1	0.0	1.8	0.7	27.1	3.0	2.3	0.1	1.2	0.1	1.2	14.0	0.0	15.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.5	7.3	1.2	0.2	0.0	0.3	0.0	0.0	18.4	2.1	6.2	0.0	5.4	0.3	18.8	5.2	0.1	6.1	30.6	9.0	5.2	3.3	21.9	3.5	4.6	0.8	4.8	0.1	5.0	6.0	3.6	5.8	6.6	0.7	4.1	4.1	2.6	6.2	0.8	5.3	4.2
TMEM82		ENSG00000162460	"Transmembrane protein 82"	A0PJX8	1	15742422-15747982	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 35.6;liver: 30.1"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 8.2"	"Cancer enhanced"	"Detected in some"		"liver cancer: 10.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060282	Uncertain		Uncertain	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA060282: AB_2684241"	"unprognostic (2.46e-2)"		"unprognostic (7.96e-2)"	"unprognostic (4.88e-2)"			"unprognostic (1.40e-2)"	"unprognostic (6.45e-2)"		"unprognostic (6.90e-2)"	"unprognostic (4.80e-2)"		"prognostic favourable (3.80e-7)"	"unprognostic (1.41e-1)"	"unprognostic (5.80e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-1)"	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	18.9	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	7.5	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	35.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM92	FLJ33318	ENSG00000167105	"Transmembrane protein 92"	Q6UXU6	17	50271406-50281485	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 74.7"	"Group enriched"	"Detected in some"	4	"A549: 9.7;CACO-2: 16.5;CAPAN-2: 15.9;EFO-21: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 5.5"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 5.5"					"Low region specificity"	"Detected in all"			"HPA063009, HPA069820"	Approved		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA063009: AB_2684921, HPA069820: AB_2686208"	"unprognostic (3.54e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.63e-1)"	"prognostic unfavourable (8.35e-4)"	"unprognostic (4.37e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.39e-1)"	"unprognostic (3.88e-3)"	"unprognostic (2.97e-2)"	"prognostic unfavourable (1.14e-6)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.81e-2)"	0.2	0.1	0.3	1.9	0.3	0.4	0.3	0.3	0.3	3.3	27.9	0.3	0.1	23.3	1.2	0.3	1.0	0.7	11.7	0.1	0.8	0.3	0.4	10.2	6.1	0.1	0.3	0.2	2.4	1.2	0.0	0.1	0.3	0.9	1.2	1.8	1.1	4.3	1.2	0.1	0.2	74.7	0.4	0.4	0.3	17.9	0.5	0.3	0.1	0.1	0.4	1.6	2.2	3.7	0.1	0.2	5.5	0.1	0.0	0.0	0.0	1.0	9.7	0.2	0.0	0.0	0.4	2.1	0.2	0.3	0.0	0.0	16.5	15.9	0.0	33.0	0.7	0.1	0.2	1.8	0.1	2.6	0.1	0.0	1.0	1.6	0.1	0.1	0.1	0.1	1.9	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.0	0.2	3.6	4.3	0.2	0.0	4.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.5	0.0	0.1	2.3	0.0	0.0	0.0	0.2	0.1	0.2	1.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.3	0.8	0.3	0.3	0.2	0.9	0.3
TRABD2A	"C2orf89, TIKI1"	ENSG00000186854	"TraB domain containing 2A"	Q86V40	2	84821650-84907008	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 29.3;intestine: 26.6;lymphoid tissue: 24.7;ovary: 23.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.3;HDLM-2: 18.3;HSkMC: 13.0;hTEC/SVTERT24-B: 10.7;SiHa: 10.4"	"Group enriched"	"Detected in many"	9	"colorectal cancer: 14.4;stomach cancer: 3.0"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 29.3"	"Lineage enriched"	"Detected in many"	17	"T-cells: 29.3"									HPA045817	Approved				"Intracellular and membrane"					"HPA045817: AB_2679460"	"unprognostic (7.49e-3)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-1)"	"unprognostic (3.29e-2)"	"unprognostic (3.82e-5)"	"unprognostic (2.46e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.47e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.37e-1)"	1.8	0.5	0.7	24.7	1.6	2.1	6.3	0.6	3.7	0.5	23.2	0.9	0.0	2.4	0.5	0.4	0.5	1.3	0.2	0.7	0.9	0.8	0.9	0.9	3.0	11.3	0.9	3.1	23.7	0.4	0.4	0.6	2.0	0.2	0.5	26.6	1.2	3.3	0.0	0.3	1.2	9.3	1.8	0.9	3.1	0.6	0.6	0.0	6.4	0.7	0.0	6.3	0.7	0.7	1.7	0.6	0.5	0.1	1.3	29.3	5.3	0.7	0.6	0.2	0.1	7.2	7.8	24.3	1.2	1.9	3.5	6.4	0.3	2.7	0.0	0.3	3.8	0.0	1.7	0.3	5.2	18.3	0.4	0.0	5.1	0.0	0.8	0.0	0.0	13.0	0.0	10.7	4.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	10.4	0.0	0.1	0.0	0.1	0.2	3.4	0.4	0.0	1.2	2.2	0.0	0.0	3.0	2.0	0.0	0.0	0.1	0.0	3.3	0.1	4.0	0.3	13.1	5.0	0.6	1.7	29.3	18.2	0.5	1.3	0.0	0.6	8.5	5.3	0.7	1.6	0.6	3.7	0.9	0.8	0.9	3.1	0.2	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172696	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"gallbladder: 12.1;intestine: 29.3;liver: 14.1"	"Cell line enriched"	"Detected in single"	24	"HEL: 19.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 14.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA047527	Uncertain		Approved	"Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	8.6	0.0	0.2	0.2	0.0	12.1	0.0	0.0	0.0	4.3	14.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	29.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TSPAN8	"CO-029, TM4SF3"	ENSG00000127324	"Tetraspanin 8"	P19075	12	71125085-71441898	"Cancer-related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"intestine: 235.3"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.9;HeLa: 18.0;PC-3: 57.3;RPTEC TERT1: 11.0;RT4: 13.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 283.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB026009, HPA044337"	Enhanced		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB026009: , HPA044337: AB_2678899"	"unprognostic (1.64e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.40e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.01e-3)"	"unprognostic (2.93e-1)"	"prognostic unfavourable (9.66e-5)"	"unprognostic (1.88e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.97e-2)"	"prognostic favourable (7.36e-5)"	1.9	0.8	0.7	24.1	2.3	0.0	1.1	0.6	1.3	2.0	139.5	2.8	1.5	83.2	1.2	1.5	1.1	1.3	30.8	1.0	0.7	0.7	7.6	3.7	5.1	1.0	4.7	1.0	6.9	9.9	0.0	0.8	0.7	3.5	14.2	79.5	2.6	11.7	1.0	12.5	2.4	235.3	3.4	9.7	0.6	55.5	1.6	2.7	0.6	1.8	3.1	5.0	3.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.7	0.2	0.9	0.0	0.0	0.0	0.0	14.9	1.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	18.0	1.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	1.0	0.1	57.3	0.0	0.0	1.5	11.0	13.2	1.3	2.7	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.3	0.6	1.3	0.7	0.7	4.7	1.0	3.5	2.7
AADAC	"CES5A1, DAC"	ENSG00000114771	"Arylacetamide deacetylase"	P22760	3	151814037-151828488	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 66.2;intestine: 81.7;liver: 123.1"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;ASC diff: 4.4;EFO-21: 6.3;HBEC3-KT: 5.6"	"Cancer enriched"	"Detected in many"	22	"liver cancer: 153.4"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA002911	Approved									"HPA002911: AB_1078074"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.11e-2)"	"unprognostic (4.41e-2)"		"unprognostic (9.23e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (5.58e-6)"	"prognostic unfavourable (5.02e-4)"			"prognostic unfavourable (2.19e-4)"	"unprognostic (1.22e-1)"		"unprognostic (1.27e-1)"	3.9	66.2	0.1	0.1	1.6	0.0	2.1	0.1	0.1	0.1	26.1	0.5	0.4	29.6	0.1	0.3	0.3	0.2	4.3	0.2	0.1	0.0	0.1	123.1	1.7	0.1	0.1	0.1	0.1	22.7	0.0	0.1	1.7	0.2	0.3	0.0	0.1	0.3	0.1	0.2	1.7	81.7	0.1	0.1	0.1	7.3	0.3	0.1	0.1	0.2	4.8	1.3	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	4.4	0.2	0.3	0.0	0.0	0.1	0.0	1.1	0.1	0.2	6.3	0.0	0.4	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.7	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.2	0.3	0.2	0.4	2.1	0.0	2.2	0.2	1.9	0.3	0.1	0.0	0.0	0.0	2.5	0.0	2.4	1.3	0.0	0.4	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81117295-81166077	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.3;intestine: 28.7"	"Group enriched"	"Detected in some"	6	"CACO-2: 29.6;SH-SY5Y: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	2.8	4.7	14.3	3.2	16.6	3.7	0.9	19.0	29.0	1.2	3.3	16.5	0.0	28.7	1.0	1.1	1.7	1.2	2.7	2.3	23.6	13.9	1.2	1.2	9.7	1.5	20.1	13.6	1.0	17.9	3.6	6.4	2.6	11.0	2.4	1.1	4.1	5.6	3.6	1.1	1.9	20.3	1.3	35.3	5.9	4.5	1.3	9.8	0.0	1.3	0.0	1.0	1.3	1.1	0.0	0.0	3.6	0.1	0.0	0.0	0.0	0.0	0.2	0.3	2.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	29.6	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.6	1.1	1.4	1.8	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.1	0.0	0.1	0.5	0.1	1.3	2.4	0.2	0.0	0.0	2.8	10.2	0.2	0.0	1.4	0.3	0.8	1.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	14.3	16.6	19.0	22.3	23.6	13.9	20.1	13.6	11.0	9.8
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503633-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 57.8;intestine: 49.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 29.4;HEK 293: 9.0;HEL: 16.3;Hep G2: 8.1;RPTEC TERT1: 11.3;SH-SY5Y: 36.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 19.2"	"Group enriched"	"Detected in many"	8	"NK-cells: 11.4;T-cells: 19.2"									"CAB001716, HPA002199"	Enhanced		Approved	"Nucleoplasm,Focal adhesion sites,Cytosol"				"Nucleoplasm, Focal adhesion sites, Cytosol"	"Nucleoplasm, Focal adhesion sites, Cytosol"	"CAB001716: , HPA002199: AB_1844428"	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favourable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favourable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	57.8	9.4	3.2	11.5	1.2	3.4	5.1	10.5	5.5	22.7	3.8	2.0	14.4	9.4	3.5	2.0	3.2	9.0	1.8	9.2	6.6	19.1	15.6	3.8	2.2	9.4	5.7	2.2	1.5	1.7	1.3	3.1	11.1	2.7	10.7	7.6	1.5	2.1	1.1	1.3	49.6	5.7	9.0	2.4	1.7	1.3	8.6	0.1	2.4	1.4	2.2	2.6	5.9	1.9	0.0	0.1	0.0	11.4	19.2	1.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	29.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	9.0	16.3	1.9	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	11.3	0.0	0.4	36.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.4	3.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	7.8	0.0	19.2	0.4	2.0	4.7	0.0	1.9	1.2	4.8	0.1	11.4	0.0	0.0	0.0	1.5	9.4	11.5	5.1	10.5	9.2	6.6	9.4	5.7	11.1	8.6
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782732-99852192	"Cancer-related genes, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 28.4;kidney: 25.6;liver: 74.3"	"Group enriched"	"Detected in some"	5	"A549: 59.0;Hep G2: 58.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 24.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 4.1"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 4.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004860, CAB037271"	Enhanced									"CAB037271: AB_2221326, HPA004860: AB_1844433"	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavourable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	0.8	0.3	0.1	0.1	0.1	0.1	1.1	0.3	0.1	0.2	13.4	0.1	0.1	16.1	0.3	0.5	0.2	0.4	13.7	0.2	0.1	0.1	25.6	74.3	0.3	0.1	0.1	0.1	0.2	0.6	0.0	0.1	1.2	0.1	0.3	0.0	0.1	0.3	0.1	0.6	0.6	28.4	0.1	0.2	0.8	0.4	0.4	0.1	0.1	0.3	0.4	0.1	0.7	0.3	0.3	0.7	4.1	0.2	0.1	0.5	0.0	0.0	59.0	0.9	2.9	4.5	3.5	1.0	0.1	0.3	0.1	0.2	12.6	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.2	58.8	0.1	0.0	0.2	0.5	4.1	0.4	0.4	0.1	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.9	7.3	0.0	0.1	0.1	0.1	0.1	0.3	0.1	0.2	0.0	0.0	4.8	0.9	0.3	4.1	0.2	0.3	0.3	0.0	0.4	0.2	0.3	0.1	0.3	0.3	0.3	0.1	1.3	0.1	0.1	0.7	0.5	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.1	0.1
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724868-153744762	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.2"	"Cell line enhanced"	"Detected in many"		"EFO-21: 32.4;PC-3: 22.9;SK-BR-3: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavourable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	13.8	20.3	2.1	6.0	2.7	5.0	8.9	1.1	2.5	6.2	15.9	2.7	12.7	12.5	21.4	9.7	4.7	6.1	8.8	10.4	2.0	2.0	7.0	14.3	7.5	10.1	3.0	1.9	6.0	11.7	2.2	6.5	23.1	2.0	7.1	2.3	9.3	6.1	7.3	14.7	3.0	46.2	8.3	2.7	9.1	4.6	24.0	1.7	12.1	3.8	6.5	4.9	7.8	9.8	1.9	4.8	4.1	5.4	1.4	7.7	3.4	5.8	1.8	1.2	5.1	3.5	1.5	15.8	2.8	3.1	1.9	3.4	1.1	3.2	1.5	32.4	3.9	0.7	0.7	0.6	0.2	5.2	0.9	4.6	18.2	15.0	4.6	2.8	10.4	2.9	0.8	2.2	0.2	3.0	2.6	5.7	2.7	2.0	1.9	2.7	1.5	22.9	3.4	2.9	2.5	1.4	0.6	1.3	5.3	7.4	22.7	11.6	1.7	4.8	3.5	2.6	3.5	6.6	3.1	5.7	2.4	3.7	3.2	9.7	3.6	0.7	4.8	4.1	1.6	5.4	7.7	1.9	1.9	2.3	4.8	1.5	2.1	1.5	3.1	1.4	4.7	3.0	0.6	3.4	2.1	2.7	1.1	2.1	2.0	2.0	3.0	1.9	2.0	1.7
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090264-88231322	"Cancer-related genes, CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 49.6;intestine: 56.6;seminal vesicle: 61.0"	"Cell line enhanced"	"Detected in many"		"A549: 19.9;BEWO: 34.7;MCF7: 11.5;RPMI-8226: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.7"	"Low lineage specificity"	"Detected in many"											"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.8	2.5	11.6	0.8	14.8	1.2	2.4	4.3	9.7	13.6	12.5	8.4	49.6	24.9	14.4	4.2	1.5	6.1	3.3	2.0	16.0	12.2	2.3	19.7	3.0	0.8	17.6	5.6	5.6	0.6	3.2	7.0	12.3	17.0	5.5	8.1	6.9	2.9	61.0	0.4	0.6	56.6	11.8	15.7	0.9	1.2	1.9	5.5	0.0	3.8	0.8	1.3	2.0	3.1	1.2	0.5	0.0	0.2	2.4	5.7	0.7	0.7	19.9	5.9	0.0	0.2	0.0	34.7	0.7	0.6	1.0	1.7	4.4	0.2	0.0	0.2	0.1	5.8	0.2	0.6	1.5	5.6	0.9	0.2	0.1	5.9	0.0	0.3	0.0	0.1	2.4	2.3	0.1	1.8	0.4	0.0	0.6	11.5	2.7	0.1	2.0	0.0	1.3	0.0	17.4	0.0	4.2	0.1	0.2	4.1	0.4	0.5	0.1	0.0	0.0	0.8	0.7	0.2	0.0	5.5	2.1	0.0	1.5	0.0	0.8	0.0	0.0	0.0	1.9	0.0	5.7	0.1	0.7	0.6	0.0	1.2	0.7	0.3	0.0	2.4	0.2	0.5	1.7	0.7	11.6	14.8	4.3	9.7	16.0	12.2	17.6	5.6	17.0	5.5
ABO	"A3GALNT, A3GALT1"	ENSG00000175164	"ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase"		9	133250401-133275219	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 28.2"	"Group enriched"	"Detected in some"	6	"K-562: 19.9;RT4: 7.8"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	8	"basophil: 2.1;eosinophil: 3.0;naive B-cell: 2.2"	"Group enriched"	"Detected in many"	8	"B-cells: 2.2;granulocytes: 3.0"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (2.78e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.51e-2)"	"unprognostic (9.30e-3)"	"unprognostic (7.23e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.34e-1)"	"unprognostic (9.04e-2)"	1.6	1.0	0.1	5.8	0.1	0.3	0.4	0.0	0.6	1.0	15.0	0.0	2.3	1.7	1.6	0.8	3.0	0.3	7.6	0.3	0.0		10.7	0.3	3.6	0.3	0.0	0.0	3.2	2.6	0.3	0.0	0.3	0.2	1.5	2.4	1.0	2.2	0.3	1.4	0.3	28.2	0.6	0.0	0.3	0.3	2.0	0.0	0.0	10.1	4.2	5.8	1.0	1.4	2.2	0.1	3.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	3.0	0.0	0.3	0.0	0.0	0.2	0.0	0.1	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.2										
AC007325.2		ENSG00000277196			Unmapped	138082-161852	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 12.8;skin 1: 12.6"	"Cell line enriched"	"Detected in some"	9	"RPTEC TERT1: 63.3"									"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.4"									HPA020361	Uncertain									"HPA020361: AB_10963116"																		0.0	0.0		0.0		0.0	0.6		6.4	0.0	0.0			11.1	0.0	0.0	2.1	0.0	0.0	2.8			4.5	1.6	7.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.3	3.0	12.6	12.8	0.0		0.0	0.0	0.0			1.1		1.8	0.5		0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	2.8	0.1	0.8	1.8	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.6	0.0	0.1	0.0	3.4	6.4	0.1	0.0	0.0	0.2	0.0	0.0	0.3	1.3	0.0	0.0	0.1	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	6.0	0.0	0.0	0.0	0.0	63.3	0.2	0.1	0.1	0.0	2.4	0.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC008397.2		ENSG00000285188	"CAMP-specific 3',5'-cyclic phosphodiesterase 4C "	Q08493	19	18207961-18255419	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.4;intestine: 15.6;pancreas: 14.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.6;U-2197: 1.6;U-87 MG: 4.7"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA048975	Uncertain									"HPA048975: AB_2680581"																		0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	1.2	1.9	15.6	0.0	0.0	1.3	1.1	3.6	4.0	1.0	22.4	0.6	0.0		0.6	0.0	2.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.8	0.0	0.0	1.7	0.0	2.1	1.1	3.7	0.0	8.0	0.6	0.0	0.4	7.1	0.2	0.0	0.0	0.4	0.8	4.1	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	3.6	0.1	0.0	0.0	0.2	0.0	0.3	0.3	0.3	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.1	0.2	0.9	0.0	0.0	0.2	0.4	0.0	0.8	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	1.6	0.0	0.3	0.2	0.1	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC008403.1		ENSG00000268465			19	48465837-48472431	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.7;intestine: 3.6;testis: 4.7"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.9;LHCN-M2: 3.6;NB-4: 3.7;U-698: 5.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA060662			Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA060662: AB_2732652"																		0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.5	0.1	3.6			0.0	2.7	0.0	0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.2		0.3	0.0	0.0	0.1	0.0		0.3	0.0		0.1	0.0	0.3	0.1	1.6	0.0	0.2	0.1	0.5	4.7			0.1		0.0	0.0	0.0	1.0	0.5	0.7	0.4	0.0	1.0	0.0	0.0	0.0	0.0	2.9	2.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.6	2.3	1.3	0.0	2.2	0.0	0.0	1.2	0.0	0.0	0.3	0.0	3.6	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.2	0.0	1.5	0.1	0.0	0.0	0.0	0.9	1.8	0.0	0.0	0.9	0.9	5.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.3	0.2	1.0	0.3	0.4	0.3	0.0	0.6	0.1	0.0	0.0	0.4	0.5	1.0	0.0										
AC020909.1		ENSG00000142539			19	50415799-50428409	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"blood: 5.3;intestine: 2.6;lymphoid tissue: 6.0"	"Cell line enhanced"	"Detected in some"		"REH: 6.8;U-2 OS: 2.6;U-266/70: 3.7;U-698: 5.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"memory B-cell: 2.5;naive B-cell: 1.3;plasmacytoid DC: 5.3"	"Group enriched"	"Detected in many"	21	"B-cells: 2.5;dendritic cells: 5.3"									HPA018523	Uncertain									"HPA018523: AB_1857443"																		0.0	0.0	0.0	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0			2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	2.0	0.0		0.0	0.2	0.0	0.0	0.0		0.0	0.0		1.2	0.0	0.0	0.0	1.1	0.0	0.0	6.0	0.1	0.1			0.0		0.0	0.0	0.0	2.5	5.3	0.1	0.0	0.0	0.0	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.4	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.3	1.2	0.0	0.0	0.1	0.6	0.0	0.0	6.8	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.6	0.4	0.0	3.7	0.6	5.5	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.7										
AC068987.5		ENSG00000284730			12	51813940-51814926	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.4;intestine: 1.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.6;SiHa: 1.8"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							2.4	0.0		0.0		0.0	0.0		0.3	0.0	0.2			1.7	0.0	0.0	0.0	0.0	0.0	0.0			0.5	1.5	0.0	0.0			0.0	0.2	1.1		0.0		0.0	0.0		0.2	0.5	0.0	0.0	0.3	0.0		0.7	1.6	1.2			0.0		0.0	0.0		0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC092017.3		ENSG00000283952			1	211082872-211188533	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"intestine: 1.2;testis: 2.8"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;HSkMC: 1.4;hTEC/SVTERT24-B: 1.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.3	0.0		0.0		0.1	0.0		0.0	0.8	0.2			1.2	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	2.8			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.4	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC097662.2		ENSG00000284629			2	227387683-227387949	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"intestine: 1.0"	"Cell line enriched"	"Detected in single"	9	"PC-3: 5.0"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	1.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.7		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
AC136616.2		ENSG00000277761			Unmapped	1167457-1257196	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 17.8;intestine: 15.5;stomach 1: 13.5"	"Group enriched"	"Detected in some"	9	"HaCaT: 2.6;RH-30: 2.0;U-251 MG: 1.1;U-937: 2.6"									"Group enriched"	"Detected in some"	92	"memory B-cell: 17.8;naive B-cell: 4.7"	"Lineage enriched"	"Detected in single"	145	"B-cells: 17.8"																																					0.0	9.5		5.0		0.4	4.3		0.0	0.0	15.5			6.6	0.0	1.0	0.0	0.0	0.4	0.0			0.0	0.0	1.4	0.1			4.7	0.0	0.0		0.0		0.0	6.8		11.1	0.0	0.0	0.0	7.1	0.0		3.9	13.5	0.0			0.0		11.0	10.4		17.8	0.0	0.0	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6										
AC136616.3		ENSG00000278782			Unmapped	1157687-1240349	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 6.6;breast: 4.8;cervix, uterine: 6.8;intestine: 5.2;lymphoid tissue: 7.7"	"Cell line enriched"	"Detected in single"	16	"U-251 MG: 1.6"									"Cell type enriched"	"Detected in some"	6	"naive B-cell: 6.6"	"Lineage enriched"	"Detected in single"	66	"B-cells: 6.6"																																					0.0	0.0		0.1		0.4	4.8		0.0	6.8	2.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	2.5		1.6	0.0	0.0	0.0	5.2	0.0		2.0	0.0	0.0			0.0		7.7	3.6		6.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2										
AC141272.1		ENSG00000277836			Unmapped	1270984-1271271	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 15.4;intestine: 16.4;lymphoid tissue: 22.4;urinary bladder: 14.5"	"Cell line enhanced"	"Detected in some"		"Daudi: 1.8;K-562: 2.1;RH-30: 1.7;RPMI-8226: 5.9;SCLC-21H: 1.6"									"Group enriched"	"Detected in some"	113	"memory B-cell: 15.4;naive B-cell: 7.0"	"Lineage enriched"	"Detected in single"	155	"B-cells: 15.4"																																					0.0	0.0		6.5		1.5	1.0		0.0	2.9	16.2			16.4	0.0	0.0	1.3	0.0	0.0	0.0			0.0	0.0	0.0	3.2			0.0	0.0	0.0		0.0		0.0	5.2		10.9	0.0	0.0	0.0	8.3	0.0		4.3	11.6	0.0			0.0		22.4	14.5		15.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	5.9	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
AC233755.2		ENSG00000277856			Unmapped	26241-26534	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 20.4;intestine: 14.5;lymphoid tissue: 33.2;stomach 1: 13.5"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 11.9;REH: 3.7;RH-30: 1.9;SH-SY5Y: 4.0;TIME: 2.6"									"Group enriched"	"Detected in some"	180	"memory B-cell: 15.5;naive B-cell: 20.4"	"Lineage enriched"	"Detected in single"	205	"B-cells: 20.4"																																					0.3	0.0		4.2		2.9	1.1		0.0	0.7	14.5			14.1	0.0	0.0	1.9	0.0	0.0	0.0			0.0	0.0	0.0	11.8			0.0	0.0	0.0		0.0		0.0	2.4		5.5	0.0	0.0	0.0	4.2	0.0		4.7	13.5	0.0			0.0		33.2	11.3		20.4	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.9	0.7	0.0	0.0	3.7	1.9	0.0	0.0	0.0	0.7	4.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	20.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6										
ACKR4	"CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1"	ENSG00000129048	"Atypical chemokine receptor 4"	Q9NPB9	3	132597237-132618967	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 35.6;salivary gland: 29.0"	"Cell line enriched"	"Detected in some"	6	"BJ hTERT+: 86.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	4	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.8"	"Group enriched"	"Detected in some"	7	"cerebellum: 5.3;pons and medulla: 1.6"	"Low region specificity"	"Detected in all"			HPA054926			Approved	Vesicles,Mitochondria				"Vesicles, Mitochondria"	"Vesicles, Mitochondria"	"HPA054926: "	"unprognostic (1.50e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.62e-2)"	"unprognostic (8.27e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.55e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.20e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.69e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.22e-1)"	13.9	1.9	0.3	2.9	0.4	0.5	10.9	0.4	0.4	3.7	8.7	0.2	4.5	16.2	5.6	7.1	5.7	2.6	9.8	7.1	0.6	0.6	6.6	2.0	10.0	2.7	0.6	0.2	2.1	3.0	0.0	8.2	0.7	0.6	5.2	1.2	1.3	29.0	2.0	3.1	10.7	35.6	5.0	0.4	1.5	10.5	3.4	0.1	0.8	1.8	12.8	1.5	8.2	4.5	0.2	0.0	1.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	6.2	3.4	0.0	14.2	86.6	0.8	2.4	0.0	0.1	0.9	0.0	8.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.4	0.6	0.6	0.6	0.2	0.6	0.1
ACTG2	"ACTA3, ACTL3, ACTSG"	ENSG00000163017	"Actin, gamma 2, smooth muscle, enteric"	P63267	2	73892314-73919865	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 404.6;smooth muscle: 581.1;urinary bladder: 568.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.4;BJ hTERT+: 13.4;BJ hTERT+ SV40 Large T+: 53.0;HHSteC: 13.8;U-251 MG: 57.0"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 255.0;stomach cancer: 237.2"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	9	"T-reg: 10.9"	"Lineage enriched"	"Detected in single"	17	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in many"	6	"midbrain: 17.0"	"HPA041264, HPA041271"	Supported									"HPA041264: AB_2677383, HPA041271: AB_2677386"	"unprognostic (5.79e-3)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.56e-3)"	"unprognostic (2.50e-1)"	"unprognostic (8.05e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.93e-1)"	"unprognostic (7.23e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavourable (3.95e-7)"	"unprognostic (9.30e-3)"	"unprognostic (6.84e-2)"	"unprognostic (2.29e-2)"	"unprognostic (7.57e-3)"	8.7	1.2	0.3	57.4	0.4	0.0	6.8	0.3	0.4	90.0	404.6	0.8	187.4	15.9	188.2	76.1	348.3	45.5	122.5	5.6	0.3	0.3	2.9	0.6	7.0	3.6	0.4	0.6	25.9	1.1	0.0	0.4	10.0	0.9	160.8	52.4	2.8	9.4	271.2	2.4	4.7	80.2	581.1	0.4	0.9	134.9	14.5	0.1	0.1	1.8	2.0	2.3	568.2	35.2	0.2	0.5	0.4	0.6	0.2	10.9	2.3	0.1	0.0	5.4	0.0	0.0	0.0	16.4	3.5	13.4	53.0	9.9	1.7	0.0	0.0	0.2	0.0	0.0	9.5	0.0	7.6	0.0	0.0	0.0	0.8	0.1	13.8	0.0	0.1	0.1	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	2.1	0.0	0.0	0.0	0.1	0.8	0.1	3.5	0.1	0.6	0.0	0.7	0.3	0.0	0.0	0.0	0.3	0.6	0.6	57.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.5	0.4	0.4	0.4	0.2	0.2	1.1	0.4	0.5	0.2	0.6	0.7	0.2	0.2	0.6	0.2	10.9	2.3	0.3	0.4	0.3	0.4	0.3	0.3	0.4	0.6	0.9	0.1
ACY3	"ACY-3, HCBP1, MGC9740"	ENSG00000132744	"Aminoacylase 3"	Q96HD9	11	67642555-67650659	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 72.2;kidney: 28.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 6.0;CAPAN-2: 9.4;Daudi: 34.2;RPMI-8226: 5.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"non-classical monocyte: 21.1"	"Group enriched"	"Detected in many"	6	"dendritic cells: 5.9;monocytes: 21.1"	"Low region specificity"	"Detected in all"							"HPA039219, HPA048187"	Enhanced									"HPA039219: AB_10671872, HPA048187: AB_2680306"	"unprognostic (8.37e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.04e-1)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.43e-1)"	"unprognostic (7.37e-4)"	"unprognostic (2.44e-3)"	"unprognostic (1.15e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.63e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.24e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.48e-3)"	0.1	0.1	3.4	1.8	5.5	0.6	0.5	0.8	7.8	5.5	13.0	15.3	0.2	38.2	0.3	2.1	0.7	0.4	6.1	0.1	3.1	2.9	28.9	18.3	0.2	3.1	4.6	5.1	0.1	11.2	0.0	0.3	0.1	7.1	0.4	2.2	0.3	1.2	0.2	0.1	0.1	72.2	0.1	5.2	0.9	5.9	0.1	2.8	0.7	0.2	0.0	4.2	0.2	0.2	1.1	5.9	0.0	21.1	2.3	0.9	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	9.4	34.2	0.4	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.2	1.5	0.0	0.0	1.1	0.0	5.9	0.0	0.0	0.0	0.1	0.2	0.8	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.8	0.3	0.0	0.5	0.0	0.1	4.9	0.5	1.0	0.2	0.1	2.6	1.1	0.9	0.6	0.0	2.3	21.1	5.9	0.0	1.2	3.4	5.5	0.8	7.8	3.1	2.9	4.6	5.1	7.1	2.8
ADAP1	"CENTA1, GCS1L"	ENSG00000105963	"ArfGAP with dual PH domains 1"	O75689	7	897901-955407	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.8;intestine: 30.8"	"Cell line enhanced"	"Detected in many"		"A-431: 35.6;CAPAN-2: 25.7;HaCaT: 16.3;HMC-1: 24.6;THP-1: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007033, HPA012049"	Enhanced		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA007033: AB_1846529, HPA012049: AB_1846527"	"unprognostic (2.45e-1)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (5.25e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (9.13e-4)"	"unprognostic (3.06e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.69e-1)"	"prognostic favourable (4.13e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.79e-2)"	3.0	2.1	32.9	8.9	25.9	8.1	1.2	13.8	41.8	3.6	30.8	30.3	1.7	16.7	2.6	1.3	4.5	4.2	6.2	3.9	36.1	17.7	6.5	1.6	5.8	3.3	28.0	20.1	0.7	5.4	3.7	1.3	3.0	19.3	1.9	20.6	0.9	3.0	3.1	0.8	2.0	22.8	7.7	36.1	7.4	16.3	1.1	19.3	0.0	4.8	0.4	2.3	5.1	1.0	1.3	5.5	3.4	11.7	1.6	6.8	3.7	35.6	1.3	0.0	1.2	0.5	0.0	0.4	1.1	0.0	0.3	0.1	14.2	25.7	0.0	3.5	0.2	16.3	1.9	2.7	0.1	0.2	1.5	0.0	2.2	8.0	0.6	0.2	24.6	0.6	7.6	0.0	0.0	0.0	0.1	0.0	0.0	11.4	0.0	9.6	1.1	0.0	4.8	0.0	0.1	1.9	8.6	1.1	0.3	1.1	0.4	0.1	9.2	41.9	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	7.5	1.3	1.1	7.6	3.4	6.8	8.1	3.3	1.3	2.0	6.1	5.5	1.1	0.6	3.1	3.4	1.6	11.7	0.4	0.9	3.7	32.9	25.9	13.8	33.4	36.1	17.7	28.0	20.1	19.3	19.3
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 48.3;intestine: 61.2;retina: 38.0;seminal vesicle: 48.0"	"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 10.3;HUVEC TERT2: 35.2;RPMI-8226: 13.3;TIME: 19.0;U-138 MG: 12.7;U-266/84: 14.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"pons and medulla: 12.4"	"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 10.5;T-reg: 9.8"	"Lineage enriched"	"Detected in many"	7	"T-cells: 10.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavourable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.8	0.4	0.6	10.6	0.8	0.0	0.9	0.3	2.1	0.4	21.8	1.5	48.3	22.4	0.4	4.0	0.9	0.5	0.3	0.5	1.2	0.4	3.8	1.0	3.9	2.0	0.4	1.1	0.4	0.6	0.8	0.3	0.3	12.4	1.7	16.2	38.0	0.7	48.0	0.4	12.7	61.2	0.5	0.4	1.0	11.4	14.1	0.1	0.8	0.7	0.6	3.2	2.7	0.5	0.2	0.2	1.4	0.3	0.1	10.5	1.5	1.6	0.0	0.0	0.0	0.2	0.3	0.0	0.5	0.3	0.4	0.3	1.5	0.8	0.0	0.7	0.3	0.7	0.0	4.7	0.6	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.1	0.0	8.7	3.5	10.3	35.2	8.5	0.0	1.2	0.0	0.0	0.2	0.1	2.4	0.0	0.1	13.3	0.7	0.1	0.0	0.1	0.6	0.0	0.3	0.0	0.3	19.0	12.7	0.9	0.3	1.0	0.5	14.9	0.0	2.6	0.5	0.1	1.4	0.1	0.0	0.0	0.3	2.3	0.2	2.8	0.2	0.1	0.1	10.5	0.8	0.2	0.1	0.2	0.2	9.8	1.5	0.6	0.8	0.3	2.1	1.2	0.4	0.4	1.1	12.4	0.1
AGMAT	FLJ23384	ENSG00000116771	Agmatinase	Q9BSE5	1	15572353-15585110	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3;kidney: 54.7;liver: 66.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.6;Hep G2: 45.0;RPMI-8226: 11.2"	"Group enriched"	"Detected in all"	5	"colorectal cancer: 18.5;liver cancer: 25.3;renal cancer: 11.2;stomach cancer: 11.1"	"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 4.6;T-cells: 10.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA026443, HPA028321"	Enhanced					250000	250000			"HPA026443: AB_1844644, HPA028321: AB_10600779"	"unprognostic (2.27e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.60e-2)"	"unprognostic (8.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-1)"	"prognostic favourable (5.13e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.45e-2)"	0.7	0.8	0.7	2.8	0.5	0.1	0.4	0.2	1.0	0.2	14.9	0.3	0.0	7.1	0.3	1.2	0.5	0.2	3.6	0.3	0.6	0.8	54.7	66.1	0.2	1.3	0.7	0.3	0.2	1.1	1.3	0.4	0.2	0.6	0.3	2.8	0.1	9.6	0.0	12.3	0.2	21.3	0.1	0.3	1.0	0.5	0.5	0.1	1.0	0.3	1.7	1.5	0.4	0.2	4.6	0.4	1.4	0.3	0.4	10.5	2.8	3.9	3.2	0.2	0.1	0.0	0.4	0.1	0.7	0.7	0.4	0.2	18.6	2.6	0.0	0.1	0.5	0.0	0.0	0.0	0.5	3.8	0.0	2.4	2.6	45.0	0.5	1.9	0.0	0.5	0.2	1.3	0.0	0.4	0.0	5.3	1.0	4.2	0.0	1.8	4.2	1.8	0.0	0.0	11.2	0.1	1.0	0.7	0.5	5.4	0.2	0.6	0.7	3.8	0.4	0.1	0.1	1.0	0.0	0.1	3.0	2.5	0.2	0.0	0.0	0.9	0.3	0.2	2.4	0.3	3.1	4.6	5.7	3.0	0.2	3.2	10.5	5.9	1.4	0.4	0.2	0.4	7.1	2.8	0.7	0.5	0.2	1.0	0.6	0.8	0.7	0.3	0.6	0.1
AGR3	"BCMP11, hAG-3, HAG3, PDIA18"	ENSG00000173467	"Anterior gradient 3, protein disulphide isomerase family member"	Q8TD06	7	16859405-16881987	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 40.5;intestine: 99.1"	"Cell line enriched"	"Detected in some"	41	"T-47d: 86.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 104.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 5.6"					HPA053942	Enhanced		Supported	"Endoplasmic reticulum,Vesicles"	"Intracellular and membrane"	31000	31000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA053942: AB_2682317"	"unprognostic (2.18e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.59e-2)"	"unprognostic (3.32e-3)"	"unprognostic (3.08e-2)"		"unprognostic (1.49e-1)"		"unprognostic (1.46e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.56e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.96e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.57e-1)"	0.6	0.0	0.6	7.5	0.7	0.0	13.1	0.7	0.6	4.4	45.8	0.6	0.6	29.2	1.2	5.4	0.9	40.5	11.8	0.6	0.6	0.3	1.5	0.6	26.3	0.6	0.6	0.6	5.1	1.9	0.0	12.9	2.8	1.9	1.1	38.9	0.6	9.4	0.6	0.6	0.3	99.1	1.2	0.8	0.6	17.1	1.0	0.6	0.6	1.4	1.9	3.9	4.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	2.0	0.0	0.3	0.1	0.0	0.1	0.0	86.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.6	0.6	0.3	0.6	0.6	1.9	0.6
AHCYL2	KIAA0828	ENSG00000158467	"Adenosylhomocysteinase like 2"	Q96HN2	7	129225023-129430211	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 72.4"	"Cell line enriched"	"Detected in all"	8	"HDLM-2: 71.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053128	Uncertain		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA053128: AB_2682050"	"unprognostic (1.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (8.52e-3)"	"unprognostic (1.71e-3)"	"unprognostic (7.44e-3)"	"prognostic favourable (4.17e-4)"	"unprognostic (8.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.79e-3)"	"prognostic favourable (1.08e-7)"	"unprognostic (4.70e-3)"	"unprognostic (2.46e-1)"	"unprognostic (7.21e-2)"	"unprognostic (2.62e-1)"	4.3	6.6	12.8	5.9	20.3	1.5	4.3	7.2	16.9	7.1	61.8	13.3	5.1	23.1	6.1	3.3	5.7	4.4	22.7	3.4	16.5	9.6	11.9	3.4	26.1	4.2	10.7	14.9	5.7	5.8	9.1	12.8	5.1	19.8	5.0	72.4	24.3	15.0	3.3	20.7	9.8	15.0	5.3	11.4	2.9	16.5	8.1	9.6	4.6	24.1	4.0	4.0	5.4	4.7	0.9	1.3	2.0	2.5	3.3	5.0	0.5	2.6	4.2	8.1	4.8	2.2	3.2	1.7	2.1	2.9	2.4	2.1	2.4	1.8	1.6	2.2	2.3	1.8	4.0	3.3	2.7	71.8	5.0	3.8	4.6	1.9	1.3	2.8	4.9	3.0	4.3	1.9	2.9	4.7	1.7	9.1	3.1	2.5	4.1	3.6	4.0	3.0	2.7	2.2	4.3	4.8	3.5	3.7	2.3	4.8	2.0	2.8	1.9	2.0	2.7	2.0	1.2	5.4	2.2	3.8	4.3	2.2	5.3	3.0	3.1	0.1	1.2	2.0	0.9	2.5	1.2	0.9	1.5	0.7	1.3	0.5	1.3	0.5	0.4	3.3	1.2	0.4	5.0	0.5	12.8	20.3	7.2	16.9	16.5	9.6	10.7	14.9	19.8	9.6
AKR1B10	"AKR1B11, AKR1B12, ALDRLn, ARL-1, ARL1, HIS, HSI"	ENSG00000198074	"Aldo-keto reductase family 1 member B10"	O60218	7	134527592-134541408	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 41.5;intestine: 99.7;stomach 1: 68.6"	"Group enriched"	"Detected in some"	82	"A549: 252.0;Hep G2: 69.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 353.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.8"	"Low lineage specificity"	"Detected in single"											"HPA020280, CAB070163, HPA073633"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Secreted in other tissues"	68000000	68000000	Cytosol	Cytosol	"CAB070163: AB_10008614, HPA020280: AB_10602228, HPA073633: AB_2686620"	"unprognostic (1.29e-2)"	"unprognostic (1.50e-1)"	"prognostic favourable (1.91e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.18e-2)"	"unprognostic (4.65e-3)"	"unprognostic (1.54e-1)"	"prognostic unfavourable (4.80e-9)"	"unprognostic (2.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.25e-1)"	0.6	0.8	0.6	2.2	0.6	0.0	0.6	0.6	0.6	13.1	11.5	0.6	0.6	99.7	0.6	0.9	41.5	0.0	28.9	0.6	0.6	0.0	4.0	6.3	2.0	0.6	0.6	0.6	0.6	0.6	0.0	2.5	0.6	0.6	2.0	7.3	1.3	6.1	0.6	0.6	1.0	54.1	7.1	0.6	0.6	68.6	0.8	0.6	0.9	0.7	28.6	3.6	16.3	22.9	0.4	0.1	1.8	0.2	0.4	0.2	0.1	0.0	252.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.1	69.9	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.1	0.2	1.8	0.4	0.1	0.1	0.1	0.1	0.6	0.6	0.6	0.6	0.6	0.0	0.6	0.6	0.6	0.6
AKR1C3	"DDX, HAKRB, HSD17B5, KIAA0119, PGFS"	ENSG00000196139	"Aldo-keto reductase family 1 member C3"	P42330	10	5035354-5107686	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 50.1;intestine: 52.3"	"Cell line enhanced"	"Detected in many"		"A549: 149.2;AN3-CA: 43.6;ASC diff: 85.8;HeLa: 46.2;Hep G2: 62.6;RT4: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 50.1;gdTCR: 26.7"	"Low lineage specificity"	"Detected in many"											"CAB010874, HPA068265"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Endoplasmic reticulum,Cytosol"		11000000	11000000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"CAB010874: AB_476751, HPA068265: AB_2685966"	"unprognostic (4.20e-3)"	"unprognostic (2.70e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.81e-3)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.41e-1)"	"unprognostic (6.74e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.33e-2)"	"prognostic unfavourable (1.22e-4)"	"unprognostic (4.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.79e-3)"	"unprognostic (4.24e-3)"	16.6	6.6	3.2	3.2	3.9	3.5	12.8	3.2	3.9	3.2	17.3	3.2	3.2	52.3	3.2	3.2	6.0	4.5	32.2	4.8	4.4	1.0	20.1	34.4	5.5	3.2	3.2	3.2	3.2	4.2	1.8	3.2	3.2	4.2	3.2	11.4	3.2	4.4	3.2	13.0	2.6	31.1	4.2	3.2	3.2	28.6	3.2	3.2	3.2	3.2	3.2	3.2	12.3	3.2	0.1	9.6	50.1	0.7	4.6	26.7	9.7	0.0	149.2	0.1	43.6	85.8	30.9	0.0	0.0	2.1	0.0	0.1	4.4	2.5	0.0	8.1	2.0	1.2	0.1	2.9	0.0	0.3	0.0	0.2	46.2	62.6	0.4	0.0	0.0	17.1	6.1	2.0	0.0	2.8	0.9	0.0	3.9	0.3	1.0	0.2	0.0	0.4	0.3	0.9	4.4	14.7	58.9	0.0	0.3	21.4	0.0	0.0	0.0	0.0	20.8	0.5	0.4	9.0	0.3	0.0	0.0	0.0	5.0	5.9	0.4	50.1	0.7	1.1	26.7	0.2	1.7	0.0	5.0	4.8	0.5	0.1	3.2	2.4	1.9	4.6	0.3	9.6	4.9	9.7	3.2	3.9	3.2	3.9	4.4	1.0	3.2	3.2	4.2	3.2
AKR7A3		ENSG00000162482	"Aldo-keto reductase family 7 member A3"	O95154	1	19282558-19289250	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 48.5;liver: 27.4;pancreas: 59.0;stomach 1: 35.5"	"Cell line enriched"	"Detected in some"	5	"SK-BR-3: 19.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"									HPA064638			Approved	Cytosol		1000000	1000000	Cytosol	Cytosol	"HPA064638: AB_2685307"	"unprognostic (7.78e-2)"	"unprognostic (5.07e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.10e-2)"	"unprognostic (8.84e-2)"	"unprognostic (3.85e-3)"	"unprognostic (7.70e-3)"	"unprognostic (2.72e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.98e-1)"	"prognostic favourable (8.80e-7)"	"unprognostic (4.53e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.35e-1)"	0.7	0.4	0.7	0.7	0.7	0.0	0.7	0.7	0.9	0.7	5.1	0.7	0.7	48.5	0.7	1.3	0.7	0.0	6.9	0.7	0.7	0.2	13.4	27.4	0.7	0.7	0.7	0.7	1.0	59.0	0.0	0.7	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.7	0.2	27.0	0.7	0.7	0.7	35.5	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.7	0.3	1.9	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.6	0.4	0.4	0.2	1.9	0.1	0.1	0.2	0.1	0.5	1.5	0.2	0.4	0.3	0.7	0.0	0.0	0.0	0.2	0.6	0.2	0.6	0.9	0.2	0.1	0.3	0.3	0.3	0.4	0.0	0.0	0.2	0.3	0.1	0.6	0.4	1.5	0.3	0.7	0.7	0.1	1.5	0.0	0.3	0.9	1.4	0.3	19.3	0.4	3.5	0.4	0.3	0.3	0.2	1.0	0.3	1.4	0.3	0.3	0.5	0.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.2	0.7	0.7	0.7	0.7
AL032819.3		ENSG00000284395			16	1431035-1433397	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"intestine: 4.1;prostate: 5.2;salivary gland: 2.5;stomach 1: 4.5"	"Cell line enriched"	"Detected in single"	30	"SCLC-21H: 27.1"									"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																																			0.2	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.0	2.0	0.7	0.0	0.0	0.0	1.3	0.0	0.0		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.2	0.0	0.4	2.5	0.0	0.2	0.3	2.1	1.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	27.1	0.2	0.0	0.0	0.1	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0										
ANKDD1B		ENSG00000189045	"Ankyrin repeat and death domain containing 1B"	A6NHY2	5	75611459-75671846	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 5.6;intestine: 4.5"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 6.5;RPTEC TERT1: 2.7;SH-SY5Y: 1.9"	"Low cancer specificity"	"Detected in many"							"Group enriched"	"Detected in some"	7	"NK-cell: 3.2;T-reg: 1.8"	"Group enriched"	"Detected in many"	11	"NK-cells: 3.2;T-cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059722	Uncertain									"HPA059722: AB_2684112"	"unprognostic (5.11e-3)"	"unprognostic (2.46e-2)"	"unprognostic (3.06e-2)"	"unprognostic (6.16e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.84e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.41e-1)"	"unprognostic (7.36e-2)"	"unprognostic (1.62e-1)"	"prognostic favourable (2.30e-7)"	"unprognostic (1.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.27e-2)"	0.2	0.6	0.4	0.6	0.8	0.0	0.5	0.0	0.1	0.9	3.3			0.5	0.4	1.1	0.1	5.6	0.5	0.0	0.8	0.8	3.8	0.1	1.2	0.0	0.1		0.1	0.8	2.6	0.7	0.4		0.9	4.5		0.1	0.0	0.0	1.0	0.7	0.5	0.2	0.3	2.5	0.8			0.5		0.3	0.8	0.6	0.0	0.2	0.2	0.1	3.2	1.8	0.7	0.3	0.3	0.0	0.5	0.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.3	1.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	6.5	2.7	0.1	0.8	1.9	0.0	0.1	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.2	0.5	0.4	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.2	3.2	0.1	0.0	1.8	0.7										
ANKS4B	"FLJ38819, HARP"	ENSG00000175311	"Ankyrin repeat and sterile alpha motif domain containing 4B"	Q8N8V4	16	21233665-21253845	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 64.5;kidney: 16.2;liver: 15.0"	"Group enriched"	"Detected in some"	4	"HDLM-2: 5.3;Hep G2: 12.7"	"Group enriched"	"Detected in many"	8	"colorectal cancer: 12.2;liver cancer: 5.1;pancreatic cancer: 3.2;renal cancer: 3.3;stomach cancer: 5.0"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 2.0"	HPA043523	Approved		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA043523: AB_10966687"	"unprognostic (1.35e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.42e-3)"	"unprognostic (8.61e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.08e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.75e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.88e-1)"	"unprognostic (4.77e-2)"		"unprognostic (4.34e-3)"	0.1	0.1	0.1	4.3	0.2	0.0	0.1	0.9	0.1	0.1	26.9	0.0	0.0	9.3	0.1	1.5	0.1	0.1	9.2	0.1	0.1	0.1	16.2	15.0	0.1	0.0	0.1	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.1	7.6	0.0	0.1	0.0	0.5	0.1	64.5	0.1	0.1	0.1	1.6	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.8	0.6	2.0	0.4	1.1	0.4	0.1	0.0	0.5	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.3	0.1	0.0	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	1.5	0.4	0.4	0.3	0.3	0.2	0.5	0.3	0.2	0.1	0.8	0.4	0.4	2.0	1.1	0.2	0.6	0.3	0.1	0.1	0.2	0.9	0.1	0.1	0.1	0.1	0.0	0.0	0.0
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;prostate: 44.7;stomach 1: 15.1"	"Group enriched"	"Detected in some"	5	"BEWO: 6.0;Hep G2: 5.8"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"NK-cell: 2.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"							HPA078464	Enhanced				"Intracellular and membrane"					"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.2	0.0	0.3	6.5	0.4	1.7	0.2	0.2	0.4	0.3	17.3	0.3	0.2	5.3	0.2	0.2	0.2	0.1	1.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	44.7	4.9	0.2	2.3	0.2	0.2	0.0	17.3	0.5	0.3	0.2	15.1	0.2	0.2	0.2	0.2	0.7	1.0	0.3	0.2	0.0	0.0	0.0	0.8	2.2	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	6.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.5	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	1.1	0.2	0.3	0.0	0.0	1.1	0.0	0.0	0.4	0.5	0.0	0.1	0.3	0.3	0.0	1.0	0.0	0.0	1.1	0.6	0.2	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.1	0.3	0.4	0.2	0.4	0.2	0.2	0.2	0.2	0.2	0.2
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 6.8;CAPAN-2: 20.8;HaCaT: 12.1;RPMI-8226: 14.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	41	"B-cells: 2.2;NK-cells: 3.9;T-cells: 7.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favourable (8.81e-4)"	0.7	0.1	0.1	17.4	0.2	0.9	1.4	0.1	0.2	1.4	32.1	0.1	1.3	21.5	0.8	4.7	6.8	1.2	6.2	0.4	0.2	0.1	4.8	0.4	5.8	6.3	0.4	0.1	0.5	5.6	0.0	1.6	0.7	0.3	2.6	5.4	0.6	6.2	0.6	0.1	14.4	69.4	0.5	0.5	4.8	4.4	0.4	0.1	11.3	2.2	6.1	17.2	3.4	2.7	2.2	0.1	0.0	0.0	3.9	7.9	1.5	2.0	0.3	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	1.9	20.8	1.5	1.0	0.0	12.1	0.0	4.9	0.0	1.6	0.0	0.0	0.3	2.8	0.0	0.3	0.0	0.0	3.3	0.0	0.8	0.0	0.1	1.3	0.0	2.4	0.3	0.1	0.0	0.0	0.1	0.0	14.6	3.2	3.0	0.9	0.1	0.2	5.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.6	2.2	6.8	3.2	0.1	1.0	3.9	2.9	0.0	3.9	0.0	0.0	7.9	1.5	0.1	0.2	0.1	0.2	0.2	0.1	0.4	0.1	0.3	0.1
ANPEP	"CD13, gp150, LAP1, p150, PEPN"	ENSG00000166825	"Alanyl aminopeptidase, membrane"	P15144	15	89784889-89815401	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 195.3;kidney: 78.7;pancreas: 93.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 59.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 59.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"CAB002417, HPA004625"	Enhanced		Supported	"Plasma membrane"		1500000000	1500000000	"Plasma membrane"	"Plasma membrane"	"CAB002417: AB_563491, HPA004625: AB_2667199"	"unprognostic (6.31e-2)"	"unprognostic (7.94e-3)"	"unprognostic (6.91e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.50e-1)"	"unprognostic (7.73e-2)"	"unprognostic (5.28e-3)"	"unprognostic (3.96e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.01e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.99e-2)"	21.3	1.1	0.6	2.9	0.8	9.5	17.0	1.0	1.3	8.2	21.2	0.8	0.5	195.3	1.4	8.4	3.6	1.4	27.7	3.7	0.4	0.3	78.7	37.7	9.7	9.3	0.9	0.9	1.8	93.9	0.0	0.7	14.7	1.3	8.6	4.7	4.0	6.6	1.8	1.6	4.9	155.8	4.3	1.2	7.2	0.8	4.7	0.2	5.6	1.5	4.2	3.8	4.7	3.0	0.0	6.9	59.4	12.8	0.0	0.0	5.5	0.0	4.9	0.0	0.0	60.1	77.0	0.5	76.7	109.7	9.4	8.3	0.5	0.0	0.0	0.9	65.8	0.0	0.5	0.0	3.7	0.0	0.0	14.5	0.4	11.4	35.4	1.0	69.8	67.4	0.1	29.7	0.0	85.8	0.4	0.1	3.6	0.0	0.0	34.1	0.2	5.2	0.0	0.0	0.8	42.9	0.0	0.1	0.7	0.0	0.1	0.0	0.0	6.7	85.8	41.4	0.0	93.5	0.0	0.0	0.0	0.0	0.1	0.0	2.2	5.7	12.8	10.4	0.0	7.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	59.4	0.0	12.0	0.1	0.0	5.5	0.6	0.8	1.0	1.3	0.4	0.3	0.9	0.9	1.3	0.2
ANXA13	ANX13	ENSG00000104537	"Annexin A13"	P27216	8	123680794-123737407	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 41.9;gallbladder: 38.7;intestine: 108.6"	"Group enriched"	"Detected in some"	13	"A549: 23.3;HDLM-2: 12.0"	"Group enriched"	"Detected in many"	13	"colorectal cancer: 7.8;liver cancer: 8.5;pancreatic cancer: 6.1;renal cancer: 7.0;stomach cancer: 7.3"	"Region enhanced"	"Detected in single"		"midbrain: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA018535, HPA019569, HPA019650, CAB025135"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB025135: , HPA018535: AB_1844854, HPA019569: AB_1844855, HPA019650: AB_1844856"	"unprognostic (6.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.66e-2)"	"unprognostic (4.05e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.86e-3)"	"unprognostic (2.06e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.79e-2)"	0.2	0.1	0.3	0.7	0.5	0.0	0.4	0.1	0.4	0.2	30.3	0.4	41.9	66.5	1.1	2.6	0.2	13.3	38.7	0.1	0.5	0.6	2.1	4.3	0.1	0.1	3.0	0.1	0.9	0.3	0.0	0.1	0.1	0.7	1.1	8.1	0.2	0.2	20.7	0.1	0.1	108.6	0.4	8.0	0.1	0.7	2.3	0.3	0.1	0.1	0.1	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.1	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.5	0.6	3.0	0.1	0.7	0.3
ARHGAP11B		ENSG00000285077	"Rho GTPase activating protein 11B"	Q3KRB8	15	30624494-30638805	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"esophagus: 2.6;intestine: 2.7;stomach 1: 1.9"	"Cell line enhanced"	"Detected in many"		"HeLa: 17.6"									"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA064479	Uncertain		Uncertain	Vesicles				Vesicles	Vesicles	"HPA064479: AB_2685272"																		0.2	0.0		0.0		0.3	0.0		0.0	0.0	1.1			1.1	0.0	0.0	2.6	0.1	0.0	0.0			0.0	0.1	0.1	1.6			0.0	0.0	0.0		1.0		0.0	2.7		0.0	0.0	0.0	0.3	0.1	0.0		0.3	1.9	0.4			0.0		0.9	0.3		1.0	0.8	0.0	0.0	0.0	1.3	0.0	2.8	0.4	0.0	1.7	0.6	0.6	1.6	0.2	1.0	1.3	0.5	4.6	3.0	0.0	1.4	1.0	5.2	4.1	0.1	2.4	4.0	0.4	0.0	17.6	1.4	0.4	0.8	0.2	0.4	0.1	0.5	1.1	1.5	1.3	7.6	3.8	0.2	2.4	0.6	0.9	0.2	0.8	1.8	1.1	1.3	4.5	2.7	1.0	1.1	1.3	0.6	1.5	3.3	1.3	4.7	2.6	0.1	3.0	2.9	2.1	1.4	1.1	3.6	4.9	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.3	0.9	0.8	1.0	0.3	0.6	0.0	0.0	0.0	0.3	0.2	0.0										
ARHGAP27	"CAMGAP1, FLJ43547, SH3D20, SH3P20"	ENSG00000159314	"Rho GTPase activating protein 27"	Q6ZUM4	17	45393902-45434421	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 38.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 12.6;HMC-1: 11.9;RT4: 19.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023919, HPA053053"	Approved		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA023919: AB_2059402, HPA053053: AB_2682027"	"unprognostic (9.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (7.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (4.66e-1)"	"unprognostic (2.69e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.89e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.96e-3)"	"unprognostic (5.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.92e-2)"	"prognostic favourable (3.21e-4)"	6.0	3.1	4.9	21.9	8.7	15.0	5.5	5.2	6.3	9.3	23.1	6.4	2.7	14.9	3.2	7.8	35.0	4.5	17.4	7.0	7.5	3.2	11.0	2.4	10.5	24.1	8.2	2.4	2.4	3.5	4.3	4.0	9.7	7.5	6.1	13.0	3.8	13.6	9.1	2.6	11.6	38.8	3.8	10.2	28.6	8.8	2.9	8.0	29.4	6.3	5.8	34.1	8.0	15.0	4.1	7.8	10.4	11.2	1.9	3.1	3.5	4.4	4.4	0.1	1.3	0.6	0.3	12.6	0.0	0.2	0.3	0.1	3.9	8.9	4.0	8.6	0.3	2.8	0.6	0.8	0.2	8.1	2.7	0.2	1.7	2.5	0.1	0.0	11.9	0.6	3.6	0.0	1.3	2.7	1.0	7.4	0.3	3.0	3.8	1.3	0.2	3.7	3.1	0.2	1.4	2.9	19.2	0.6	0.4	0.5	3.7	0.2	2.9	7.4	4.2	0.0	1.1	0.0	0.4	9.1	5.9	0.9	0.2	1.1	0.0	1.0	4.7	4.2	2.8	9.3	1.8	4.1	1.7	3.1	4.5	3.4	1.4	1.4	10.4	1.9	11.2	7.8	2.3	3.5	4.9	8.7	5.2	6.3	7.5	3.2	8.2	2.4	7.5	8.0
ARHGEF16	"GEF16, NBR"	ENSG00000130762	"Rho guanine nucleotide exchange factor 16"	Q5VV41	1	3454426-3481113	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.6;intestine: 45.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.2;MCF7: 16.5;SK-BR-3: 18.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"olfactory region: 5.8"	"Low region specificity"	"Detected in some"			HPA010609	Approved									"HPA010609: AB_1845004"	"unprognostic (1.28e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.83e-2)"	"unprognostic (4.31e-1)"	"unprognostic (2.09e-2)"	"prognostic unfavourable (1.82e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (5.39e-2)"	"unprognostic (9.16e-2)"	"prognostic favourable (1.24e-10)"	"unprognostic (6.46e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.29e-2)"	1.8	0.1	0.5	7.5	1.0	0.0	2.9	1.1	0.8	2.5	30.4	1.2	11.5	24.8	1.0	4.6	11.4	1.3	28.6	0.5	1.1	0.9	11.7	4.3	3.1	0.5	1.3	0.5	0.9	7.0	4.8	7.7	9.0	2.2	5.7	6.8	1.5	10.1	13.7	0.7	3.4	45.9	1.0	1.9	0.5	15.8	2.3	0.7	0.9	9.0	5.9	5.3	5.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	3.5	0.9	0.1	0.0	0.0	6.3	0.1	0.2	0.2	0.7	10.6	29.2	0.0	7.0	0.0	9.2	1.5	6.2	0.0	0.0	3.1	0.0	4.4	8.2	0.3	0.0	0.0	0.1	6.0	0.6	0.3	0.0	1.1	0.0	0.0	16.5	0.0	0.2	7.1	0.2	0.0	0.0	1.3	7.4	4.7	4.8	0.9	1.7	18.1	0.4	8.0	0.3	0.0	0.1	2.1	0.1	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	1.1	0.8	1.1	0.9	1.3	0.5	2.2	0.7
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"intestine: 27.5"	"Cell line enhanced"	"Detected in many"		"PC-3: 19.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"HPA061171: AB_2684442"	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	2.8	8.3	6.5	3.3	10.7	2.3	4.6	4.4	14.5	4.0	4.5	1.5	3.8	27.5	5.1	6.2	4.4	4.8	4.3	7.8	7.2	9.0	7.3	12.2	3.7	2.9	5.7	8.3	5.6	7.6	8.8	12.8	2.1	7.4	6.3	5.3	7.0	6.6	4.4	5.7	3.0	16.0	4.4	3.9	3.0	6.4	5.2	2.0	2.7	5.6	6.8	4.8	3.8	3.4	1.4	3.2	0.5	0.1	0.7	6.0	1.5	1.9	2.0	3.1	5.1	1.0	2.6	2.5	9.5	5.2	5.8	4.8	6.7	4.9	0.1	3.6	2.0	2.0	3.5	4.1	4.8	3.6	4.0	1.3	5.8	4.4	3.8	1.7	1.9	3.2	4.8	5.6	8.5	1.2	6.1	2.5	4.7	4.2	2.7	0.2	4.0	19.0	0.1	7.2	2.4	3.4	7.1	5.9	11.9	3.2	4.0	3.3	6.8	1.2	6.3	2.5	11.4	5.2	11.2	2.9	0.4	0.0	12.6	0.0	4.2	0.5	0.1	0.0	2.2	0.0	6.0	0.7	3.5	2.5	0.0	1.4	4.9	4.5	0.4	0.7	0.1	3.2	3.9	1.5	6.5	10.7	4.4	14.5	7.2	9.0	5.7	8.3	7.4	2.0
ATP10B	"ATPVB, FLJ21477, KIAA0715"	ENSG00000118322	"ATPase phospholipid transporting 10B (putative)"	O94823	5	160563120-160852214	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.8;intestine: 35.4"	"Cell line enriched"	"Detected in single"	23	"WM-115: 17.4"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 19.0;pancreatic cancer: 4.2;stomach cancer: 8.6"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA034574	Uncertain									"HPA034574: AB_10669992"	"unprognostic (1.47e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.47e-4)"	"unprognostic (3.99e-2)"	"unprognostic (6.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.38e-3)"	"unprognostic (5.13e-2)"	"unprognostic (2.56e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.14e-1)"	0.5	0.4	4.3	4.1	9.4	0.4	0.7	5.1	10.0	1.7	33.8	27.8	1.5	18.9	0.4	11.4	8.2	0.7	12.8	0.5	5.5	2.8	0.5	0.4	0.5	0.4	13.8	6.8	0.4	4.2	0.4	0.4	0.4	13.1	0.5	35.4	0.0	2.8	1.0	0.4	8.4	21.1	1.6	20.2	0.4	4.1	0.7	14.0	0.0	0.5	0.0	2.5	1.8	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	9.4	5.1	10.0	5.5	2.8	13.8	6.8	13.1	14.0
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 195.4;parathyroid gland: 194.4"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 248.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					380000	380000			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favourable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavourable (4.01e-4)"	17.4	25.6	22.4	16.2	40.3	10.5	26.9	74.2	67.4	17.8	121.9	14.2	56.1	92.3	13.1	38.3	34.9	17.7	65.8	41.1	26.1	18.7	162.7	34.6	35.1	9.6	19.2	27.6	17.4	78.6	194.4	25.0	19.2	34.1	22.1	65.7	24.1	84.4	53.7	19.0	40.5	195.4	17.7	20.7	13.7	25.0	17.0	13.9	9.1	101.2	13.7	16.2	14.2	23.1	10.3	22.0	6.4	29.7	10.4	30.2	17.2	32.9	12.2	12.7	6.3	25.5	24.7	65.2	19.8	39.4	24.4	34.7	48.7	23.7	26.1	28.0	23.4	43.1	25.0	41.7	35.5	9.6	27.7	15.2	23.0	41.1	19.5	38.1	21.4	27.5	69.9	28.4	37.5	29.9	25.0	25.3	21.6	65.6	15.4	13.8	29.8	24.5	14.9	29.6	23.1	88.1	34.0	12.5	11.0	30.7	58.4	248.8	15.3	22.1	26.3	13.9	19.5	35.9	40.0	12.2	9.5	20.1	42.7	22.0	81.6	6.4	13.3	6.1	23.2	20.9	24.8	10.3	26.4	24.9	22.0	5.3	30.2	22.0	1.6	10.4	29.7	11.1	20.3	17.2	22.4	40.3	74.2	67.4	26.1	18.7	19.2	27.6	34.1	13.9
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.0;salivary gland: 35.8"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.3;MCF7: 16.3;RT4: 12.9;SK-BR-3: 22.7;T-47d: 7.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	24	"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane, Focal adhesion sites"	"Plasma membrane, Focal adhesion sites"	"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favourable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.3	0.0	2.1	8.0	1.5	6.1	2.5	0.2	2.0	3.5	23.0	0.5	1.9	16.3	1.8	1.9	2.7	4.0	18.8	0.4	1.8	1.9	2.6	0.2	21.9	0.2	1.3	0.7	1.3	0.5	0.0	2.9	4.8	0.7	7.9	21.9	1.0	35.8	0.2	0.9	15.2	14.5	0.5	0.6	0.2	3.4	0.4	0.4	0.3	8.2	2.2	8.1	4.8	7.8	0.0	0.0	2.7	0.0	0.0	0.1	0.0	4.1	0.3	0.5	0.0	0.0	0.0	4.4	0.1	0.0	0.0	0.0	3.9	3.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	12.9	3.3	0.0	0.0	22.7	0.2	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.2	2.0	1.8	1.9	1.3	0.7	0.7	0.4
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803101	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 27.1;HBF TERT88: 24.3;RT4: 57.5"	"Low cancer specificity"	"Detected in all"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA018673, HPA018674"	Enhanced		Approved	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favourable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favourable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	3.8	2.3	0.0	1.8	0.0	0.0	3.4	0.0	0.3	4.5	21.3			8.9	2.4	0.8	6.7	2.6	4.8	1.8	0.2	0.0	2.1	3.0	3.6	0.0	0.1		0.7	10.7	2.7	1.1	1.3		6.0	19.3		5.8	2.8	0.4	3.6	11.1	2.0	0.2	1.2	13.3	0.0			5.7		0.2	12.8	5.4	6.0	2.0	4.7	2.1	0.7	1.3	0.3	10.1	3.4	0.1	0.1	3.5	6.4	4.9	19.6	19.1	20.6	12.9	2.6	8.8	0.7	5.9	27.1	15.0	0.1	4.1	24.3	0.2	0.4	0.1	0.9	0.9	1.1	0.2	0.1	1.0	3.7	6.2	10.9	10.8	0.1	0.4	11.9	4.8	0.2	0.2	0.2	1.0	0.1	0.1	0.2	2.8	57.5	0.4	0.3	0.4	12.1	0.1	3.7	0.6	12.4	16.8	0.6	2.7	4.5	0.2	0.1	0.2	0.4	0.2	0.9	0.8	2.1	0.5	1.3	0.9	1.0	2.7	1.0	0.7	0.5	6.0	0.9	1.0	4.7	0.7	1.2	2.0	0.4	0.3										
AVIL	"ADVIL, DOC6, FLJ12386, p92"	ENSG00000135407	Advillin	O75366	12	57797376-57818704	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;RH-30: 12.6"	"Cancer enhanced"	"Detected in all"		"glioma: 9.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 9.8"	"Cell type enhanced"	"Detected in many"		"neutrophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058864	Approved									"HPA058864: AB_2683838"	"unprognostic (3.86e-2)"	"unprognostic (9.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.36e-1)"	"unprognostic (7.79e-4)"	"unprognostic (1.42e-1)"	"unprognostic (7.44e-2)"	"unprognostic (9.13e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.57e-4)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (3.29e-1)"	"prognostic favourable (2.71e-4)"	1.0	4.0	0.9	1.9	1.4	0.2	1.1	9.8	1.2	0.9	13.6	0.9	0.9	3.0	0.9	3.4	0.9	1.3	2.6	1.2	0.9	0.6	1.4	1.3	2.2	0.9	0.9	0.9	2.0	3.9	0.0	2.1	1.0	1.9	1.6	1.3	1.4	1.4	1.0	9.3	6.0	21.4	0.9	1.5	1.1	1.0	0.9	1.3	0.9	3.4	0.9	0.9	1.7	1.1	2.3	1.3	9.0	1.4	0.6	2.0	0.1	0.5	0.6	4.3	3.0	1.1	2.0	0.3	0.4	0.2	0.0	0.3	0.1	1.5	6.6	0.6	0.6	2.3	0.1	0.0	0.5	0.0	2.0	0.7	1.4	1.3	0.4	2.7	0.1	1.4	1.1	0.2	0.6	0.6	0.5	2.8	0.0	0.6	0.0	2.8	0.3	1.4	0.1	12.6	0.4	0.2	1.2	0.9	0.1	0.5	0.4	1.5	0.9	0.0	0.3	1.9	0.2	1.4	0.0	1.3	4.7	0.8	0.7	0.5	0.5	0.4	1.4	2.3	1.2	0.6	1.3	1.2	2.0	1.0	0.6	2.3	1.9	1.4	9.0	0.6	1.0	1.3	0.6	0.1	0.9	1.4	9.8	1.2	0.9	0.6	0.9	0.9	1.9	1.3
B3GALT5	"B3GalT-V, B3T5, beta3Gal-T5, GLCT5"	ENSG00000183778	"Beta-1,3-galactosyltransferase 5"	Q9Y2C3	21	39556442-39673137	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;intestine: 27.1;lymphoid tissue: 14.8"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 18.1;RPTEC TERT1: 21.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 15.8"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054092, HPA054684"	Approved				"Intracellular and membrane"					"HPA054092: AB_2682375, HPA054684: AB_2682573"	"unprognostic (1.40e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.52e-1)"	"prognostic favourable (6.36e-4)"	"unprognostic (9.23e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.25e-2)"	"unprognostic (7.86e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.09e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.55e-3)"	0.1	0.3	0.5	3.1	15.8	0.1	1.8	0.3	1.5	3.0	16.2	0.6	0.0	19.4	1.4	1.6	2.3	1.0	12.9	0.2	1.3	1.5	0.6	0.3	0.2	0.1	0.7	0.1	0.7	6.2	0.1	7.9	0.7	2.2	1.0	27.1	2.2	5.5	0.1	0.2	1.1	23.4	0.7	2.0	0.2	3.8	0.6	3.6	1.8	1.1	0.8	14.8	1.1	5.9	0.2	0.2	1.0	0.2	0.3	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.1	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	4.9	0.5	0.0	2.1	0.1	21.5	1.3	3.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.1	0.8	0.0	0.0	0.0	0.9	0.0	0.2	0.3	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.3	0.0	0.2	0.0	0.0	0.5	15.8	0.3	1.5	1.3	1.5	0.7	0.1	2.2	3.6
B3GNT3	"B3GN-T3, B3GNT-3, beta3Gn-T3, HP10328, TMEM3"	ENSG00000179913	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 3"	Q9Y2A9	19	17794828-17813082	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 69.9;intestine: 61.6;placenta: 56.0"	"Cell line enhanced"	"Detected in some"		"A-431: 17.8;BEWO: 17.6;CAPAN-2: 47.7;EFO-21: 12.2;RT4: 17.1;SK-BR-3: 16.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory CD4 T-cell: 2.7;memory CD8 T-cell: 1.1;naive CD4 T-cell: 3.2"	"Lineage enriched"	"Detected in single"	32	"T-cells: 3.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA024298	Enhanced				"Intracellular and membrane"					"HPA024298: AB_1845236"	"unprognostic (1.10e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.84e-3)"		"unprognostic (1.10e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (4.25e-5)"	"unprognostic (3.26e-1)"	"unprognostic (4.64e-2)"	"prognostic unfavourable (2.16e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.57e-2)"	0.4	0.2	0.2	8.7	0.3	0.0	1.8	0.2	0.3	3.5	25.3	0.0	12.0	16.6	0.4	1.2	15.1	0.6	69.9	0.5	0.2	0.3	11.4	2.5	1.0	1.2	0.2	0.0	0.3	9.1	0.0	0.3	56.0	0.0	4.4	22.4	0.3	24.4	12.8	0.3	2.0	61.6	1.9	0.2	0.3	21.8	0.3	0.0	0.3	0.4	2.6	18.3	10.2	5.4	0.0	0.0	0.0	0.0	0.0	3.2	0.6	17.8	4.7	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.2	47.7	0.0	12.2	0.0	1.7	0.0	5.7	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.1	7.7	0.0	0.0	0.4	10.6	17.1	0.0	0.0	0.0	16.2	0.0	0.7	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.1	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.2	0.3	0.2	0.3	0.2	0.0	0.0	0.0
B3GNT5	"B3GN-T5, beta3Gn-T5"	ENSG00000176597	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 5"	Q9BYG0	3	183253244-183298504	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.2"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 25.8;hTCEpi: 31.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 9.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.0"	"Region enriched"	"Detected in single"	12	"cerebellum: 16.5"	"Low region specificity"	"Detected in many"			HPA017292	Uncertain		Approved	Nucleoli				Nucleoli	Nucleoli	"HPA017292: AB_1845237"	"unprognostic (2.17e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.08e-2)"	"prognostic unfavourable (5.09e-4)"	"unprognostic (7.10e-3)"	"unprognostic (7.78e-2)"	"unprognostic (8.48e-2)"	"prognostic unfavourable (7.23e-6)"	"unprognostic (4.20e-1)"	"prognostic unfavourable (1.30e-7)"	"unprognostic (1.18e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.53e-2)"	"unprognostic (8.10e-3)"	8.6	1.4	2.2	6.1	2.3	31.6	4.3	1.2	2.5	6.4	29.8	5.4	2.1	17.5	3.2	5.4	23.5	5.4	10.1	3.3	3.0	2.9	3.5	3.0	11.2	5.1	4.0	0.7	4.2	3.5	1.8	5.1	19.8	4.5	3.9	9.2	3.2	8.7	2.5	6.6	8.0	80.2	2.9	6.3	2.3	5.1	2.9	2.3	1.0	4.6	18.9	8.9	5.0	10.6	0.1	1.1	9.0	1.5	0.0	0.3	0.4	16.4	1.6	8.9	5.4	7.4	22.0	8.0	0.2	0.4	1.7	1.4	3.3	8.7	0.0	1.0	0.0	7.6	9.1	25.8	1.4	0.0	5.6	0.8	0.7	0.0	9.5	8.3	4.1	10.3	31.4	1.4	23.5	16.0	9.4	0.0	14.1	0.0	0.0	2.7	3.7	14.3	2.6	4.5	0.0	5.4	4.6	0.4	8.5	4.6	0.0	1.9	0.0	10.1	23.6	0.4	3.5	0.5	4.0	0.0	0.0	0.0	3.3	19.6	8.8	0.0	1.5	1.5	0.0	0.3	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.3	0.4	2.2	2.3	1.2	2.5	3.0	2.9	4.0	0.7	4.5	2.3
B3GNT7	beta3GnT7	ENSG00000156966	"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7"	Q8NFL0	2	231395543-231401164	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 93.7;intestine: 41.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.9;HEL: 11.7;THP-1: 10.4;WM-115: 18.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"NK-cell: 19.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA035625, HPA035626"	Enhanced				"Intracellular and membrane"	2100000	2100000			"HPA035625: AB_10601118, HPA035626: AB_2674707"	"unprognostic (2.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.77e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.96e-2)"	"unprognostic (1.18e-1)"	"prognostic favourable (6.00e-4)"	"unprognostic (3.57e-1)"	3.0	10.3	5.3	2.3	4.9	5.5	1.9	0.9	3.2	1.2	28.0	3.8	0.8	12.2	1.6	3.5	1.9	3.6	93.7	26.8	4.2	4.4	1.4	1.3	17.7	1.8	4.0	2.0	13.0	18.9	6.7	8.9	10.7	3.2	1.6	35.5	2.0	4.0	2.3	0.4	2.4	41.2	1.1	1.9	6.7	17.1	1.6	2.2	1.2	4.2	1.7	3.9	1.2	0.6	7.1	4.2	0.4	0.3	19.9	2.0	0.5	0.5	2.1	0.2	0.4	0.1	0.2	0.7	0.2	0.8	0.0	0.1	1.0	14.9	1.6	4.5	0.2	3.8	0.2	0.0	0.1	0.2	0.4	11.7	0.3	0.7	0.1	0.1	0.6	0.1	1.1	0.1	0.2	0.2	0.3	0.3	0.1	0.6	0.1	0.5	4.8	2.5	0.2	0.0	0.2	0.5	1.3	0.4	0.6	0.2	1.3	0.5	0.5	10.4	0.2	0.3	0.3	0.2	0.1	1.8	0.6	0.5	0.3	0.1	18.0	0.3	0.0	0.4	2.0	0.3	0.4	7.1	0.0	0.2	4.2	5.1	0.1	0.5	0.1	19.9	0.3	2.1	0.1	0.5	5.3	4.9	0.9	3.2	4.2	4.4	4.0	2.0	3.2	2.2
B4GALNT2	"Cad, GALGT2, Sda"	ENSG00000167080	"Beta-1,4-N-acetyl-galactosaminyltransferase 2"	Q8NHY0	17	49132460-49176840	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.6;lymphoid tissue: 30.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA015721	Approved									"HPA015721: AB_1845245"	"unprognostic (4.39e-4)"	"unprognostic (3.18e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.03e-4)"		"unprognostic (1.72e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.67e-2)"	"unprognostic (7.67e-2)"	"unprognostic (4.06e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-1)"	"prognostic favourable (1.29e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.15e-1)"	0.3	0.8	0.4	30.9	0.5	2.2	0.4	0.3	0.5	0.3	19.6	0.3	0.3	0.7	0.3	0.3	0.5	0.4	4.0	0.3	0.3	0.3	8.3	0.3	1.1	0.8	0.3	0.3	0.3	0.5	0.0	0.4	0.7	0.6	0.3	7.9	0.4	1.7	0.3	0.3	1.8	11.9	1.3	1.1	0.8	5.3	0.7	0.3	0.3	10.3	0.3	0.8	0.3	1.4	2.0	1.2	2.3	0.6	0.6	1.6	0.2	1.5	2.9	2.9	5.1	0.1	0.1	1.5	2.2	1.6	0.1	0.2	6.0	2.4	3.5	3.5	0.1	1.6	1.1	0.1	0.4	3.0	3.2	3.8	7.2	3.5	0.1	1.9	6.1	0.3	2.1	0.6	0.3	0.0	2.1	5.8	0.1	1.8	2.5	2.6	3.6	1.5	4.2	1.3	1.1	8.2	2.4	2.7	2.6	1.0	1.3	1.1	3.1	2.5	1.1	3.7	2.3	2.3	1.1	4.4	1.4	3.7	1.3	2.6	1.5	2.3	0.6	0.9	1.1	0.5	0.6	1.3	1.2	0.8	0.5	2.0	1.6	1.5	1.2	0.6	0.3	1.2	0.6	0.2	0.4	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.6	0.3
BCAS1	"AIBC1, NABC1"	ENSG00000064787	"Breast carcinoma amplified sequence 1"	O75363	20	53936777-54070594	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 134.0;intestine: 40.3;stomach 1: 85.5"	"Group enriched"	"Detected in some"	6	"RT4: 41.0;SK-BR-3: 85.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033558, HPA051816, HPA054745"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB033558: AB_2274632, HPA051816: AB_2681623, HPA054745: AB_2682590"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.75e-1)"	"unprognostic (7.77e-3)"	1.3	1.0	49.8	3.8	63.4	0.9	2.8	5.4	37.2	5.1	36.9	97.6	0.0	10.7	1.6	2.1	4.7	1.7	5.4	0.9	51.6	35.6	1.7	0.9	2.4	1.1	75.3	14.7	0.9	1.0	0.8	0.3	0.9	69.7	19.1	40.3	0.0	2.9	1.0	0.9	1.1	17.1	2.4	134.0	1.1	85.5	2.5	49.2	0.0	0.8	0.0	4.1	21.8	1.1	1.6	0.2	1.0	0.2	0.3	5.7	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	41.0	0.0	0.0	0.0	85.9	0.0	2.8	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.5	0.2	0.1	0.5	0.2	3.0	1.6	1.0	0.3	0.0	0.5	0.2	0.1	1.0	0.3	0.2	0.2	5.7	0.2	49.8	63.4	5.4	32.3	51.6	35.6	75.3	14.7	69.7	49.2
BCL2L14	"BCL-G, BCLG"	ENSG00000121380	"BCL2 like 14"	Q9BZR8	12	12049844-12211084	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 40.1;testis: 29.8"	"Group enriched"	"Detected in some"	5	"CAPAN-2: 5.5;NTERA-2: 4.2;RT4: 5.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.0"	"Lineage enhanced"	"Detected in single"		"T-cells: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA040665	Enhanced		Uncertain	Cytosol				Cytosol	Cytosol	"HPA040665: AB_10964282"	"unprognostic (3.65e-4)"	"unprognostic (4.95e-3)"	"unprognostic (1.68e-2)"	"unprognostic (2.02e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.70e-4)"	"unprognostic (1.10e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.24e-2)"	"unprognostic (4.59e-5)"	"unprognostic (1.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.79e-6)"	"unprognostic (3.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.73e-8)"	0.1	0.1	0.1	5.3	0.2	0.0	0.3	0.1	0.1	0.3	17.6	0.1	0.1	11.5	0.1	0.4	0.4	0.2	7.7	0.1	0.1	0.1	0.3	0.3	1.3	1.6	0.1	0.1	0.4	11.2	0.0	0.1	0.1	0.1	1.6	13.3	0.1	0.8	0.1	0.1	0.1	40.1	0.1	0.1	0.9	7.8	29.8	0.1	4.1	0.1	0.3	1.2	2.5	0.2	0.9	0.0	0.1	0.2	0.0	3.0	0.3	0.2	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	1.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.3	5.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.7	0.9	1.4	0.7	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	3.0	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
BIRC3	"API2, c-IAP2, cIAP2, hiap-1, MALT2, MIHC, RNF49"	ENSG00000023445	"Baculoviral IAP repeat containing 3"	Q13489	11	102317450-102339403	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.0;lymphoid tissue: 46.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.5;Daudi: 33.0;HDLM-2: 31.2;hTERT-HME1: 32.8;U-266/70: 22.0;U-266/84: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 32.9;naive B-cell: 32.9"	"Group enriched"	"Detected in many"	10	"B-cells: 32.9;T-cells: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002317	Enhanced	Approved	Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA002317: AB_1846748"	"prognostic favourable (3.60e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (9.35e-4)"	"unprognostic (3.28e-2)"	"prognostic unfavourable (7.28e-4)"	"unprognostic (5.83e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.88e-3)"	"unprognostic (9.62e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavourable (3.03e-4)"	"unprognostic (3.21e-1)"	"prognostic unfavourable (6.66e-6)"	"unprognostic (6.42e-2)"	"unprognostic (6.23e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.85e-2)"	6.9	3.3	1.4	43.9	2.3	5.1	5.4	0.5	2.0	5.3	13.1	0.5	2.8	6.8	2.9	3.7	8.4	3.9	13.9	6.0	2.2	1.3	10.8	12.5	21.8	46.3	2.8	1.2	3.4	7.0	1.1	14.5	0.9	2.2	8.7	6.2	1.1	9.2	4.7	2.2	5.5	46.0	7.3	3.0	34.9	15.9	3.2	2.7	34.2	3.0	4.1	34.0	12.6	6.2	32.9	0.8	2.0	2.6	2.5	17.1	2.8	6.3	5.1	0.0	0.1	0.1	0.7	0.6	0.5	4.3	0.6	0.7	0.9	37.5	33.0	17.0	0.3	3.6	0.0	0.9	2.1	31.2	0.1	0.1	1.5	0.2	6.5	0.5	0.7	0.7	4.6	2.1	32.8	0.1	0.1	0.0	0.8	0.0	2.2	0.3	0.1	0.2	0.0	0.3	1.6	8.5	3.3	0.0	0.1	0.5	0.5	0.3	1.6	0.3	1.7	7.2	0.7	0.4	6.5	22.0	18.8	11.6	1.3	1.8	0.8	2.0	0.9	0.4	1.4	2.2	2.5	32.9	10.7	3.5	0.8	32.9	7.5	2.2	0.5	2.5	2.6	0.3	17.1	2.8	1.4	2.3	0.5	2.0	2.2	1.3	2.8	1.2	2.2	2.7
BMP3		ENSG00000152785	"Bone morphogenetic protein 3"	P12645	4	81030965-81057531	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;lung: 21.0;urinary bladder: 18.7"	"Group enriched"	"Detected in some"	4	"AF22: 10.3;Daudi: 15.7;RT4: 13.1;SK-BR-3: 5.9"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 7.5"	"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.5"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"						"unprognostic (5.21e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.36e-2)"		"unprognostic (2.73e-3)"		"unprognostic (9.11e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.16e-4)"	"unprognostic (2.26e-2)"	"unprognostic (3.86e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.22e-2)"	2.4	0.5	1.4	3.8	0.6	0.8	4.5	0.8	0.7	0.9	15.0	0.0	0.3	3.5	0.2	0.3	4.2	1.1	2.5	0.2	0.7	1.0	0.3	0.2	21.0	0.5	0.3	0.4	3.0	1.0	0.0	0.4	0.0	0.5	3.7	7.9	2.9	6.9	0.0	0.6	0.7	11.2	1.5	0.9	0.2	2.2	0.3	0.0	0.0	0.3	1.6	2.3	18.7	10.5	3.5	0.0	0.6	0.1	1.2	0.1	0.2	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	0.0	0.0	1.9	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	13.1	0.1	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	3.5	0.1	0.0	0.5	1.2	0.0	0.0	0.0	0.2	1.4	0.6	0.8	0.7	0.7	1.0	0.3	0.4	0.5	0.0
BMP8B	"BMP8, OP-2"	ENSG00000116985	"Bone morphogenetic protein 8b"	P34820	1	39757182-39788861	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"intestine: 21.9;thyroid gland: 26.8"	"Cell line enhanced"	"Detected in many"		"THP-1: 46.4;U-266/70: 14.0;U-266/84: 20.0;WM-115: 22.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"																"Secreted to blood"						"unprognostic (1.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.64e-3)"	"unprognostic (8.79e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.72e-4)"	"unprognostic (1.79e-2)"	"unprognostic (3.15e-1)"	"unprognostic (9.67e-2)"	"unprognostic (8.68e-3)"	"unprognostic (4.82e-1)"	2.8	8.1	5.5	2.4	6.7	1.4	1.6	2.5	4.1	3.8	13.2	6.9	8.2	7.5	2.6	14.2	3.5	2.3	2.1	1.6	5.0	3.3	1.6	1.0	3.1	3.6	6.1	5.5	1.4	9.9	6.6	5.8	2.3	2.8	5.1	4.0	3.6	3.6	4.7	1.2	3.2	21.9	2.1	3.6	2.4	3.0	3.1	6.2	0.4	26.8	3.4	3.1	2.1	3.3	1.7	0.2	0.8	0.7	2.6	1.9	0.3	1.0	1.9	0.1	1.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	2.1	0.0	0.7	0.0	0.2	1.6	0.0	0.0	0.4	2.3	1.9	1.5	0.1	0.4	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	7.4	0.1	1.5	0.0	1.0	0.3	0.7	1.1	6.3	2.4	1.6	1.0	5.3	1.3	1.7	0.1	5.1	1.3	46.4	0.0	0.0	0.1	1.6	0.1	14.0	20.0	0.8	0.0	1.4	22.4	0.8	0.7	0.1	0.5	0.3	0.6	1.7	0.2	1.9	0.1	0.7	0.3	0.4	0.6	2.6	0.3	0.2	0.1	0.3	5.5	6.7	2.5	4.1	5.0	3.3	6.1	5.5	2.8	6.2
BRINP3	"DBCCR1L, DBCCR1L1, FAM5C"	ENSG00000162670	"BMP/retinoic acid inducible neural specific 3"	Q76B58	1	190097662-190478404	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.4;intestine: 18.6"	"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 17.7"	"Group enriched"	"Detected in some"	14	"breast cancer: 3.4;glioma: 8.6;prostate cancer: 3.5"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054693	Uncertain				"Secreted in other tissues"					"HPA054693: AB_2682575"	"unprognostic (3.18e-2)"		"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.40e-1)"			"unprognostic (1.72e-1)"			"unprognostic (8.25e-2)"	"unprognostic (3.65e-1)"		"unprognostic (2.38e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.84e-2)"	"unprognostic (4.58e-3)"	0.7	2.4	11.3	1.0	11.9	0.3	2.0	18.4	30.4	0.5	7.2	2.1	0.0	5.3	0.6	3.7	2.2	0.9	2.0	5.6	8.9	12.2	2.8	0.4	1.6	0.3	6.0	12.7	0.4	0.3	0.4	0.4	0.3	7.4	7.8	7.6	0.0	1.6	6.3	0.4	0.4	18.6	1.0	6.8	0.3	0.7	3.7	2.7	0.0	2.4	0.0	0.5	1.1	0.3	0.1	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	11.3	11.9	18.4	19.1	8.9	12.2	6.0	12.7	7.4	2.7
BST1	CD157	ENSG00000109743	"Bone marrow stromal cell antigen 1"	Q10588	4	15702950-15738313	"CD markers, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 59.5;bone marrow: 54.9;intestine: 61.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 36.3;TIME: 20.0;U-937: 23.7;WM-115: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 52.7;neutrophil: 59.5"	"Group enriched"	"Detected in many"	105	"dendritic cells: 16.6;granulocytes: 59.5;monocytes: 52.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050121	Uncertain				"Intracellular and membrane"	170000000	170000000			"HPA050121: AB_2681025"	"unprognostic (2.95e-1)"	"unprognostic (3.61e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.06e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.94e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.95e-1)"	14.3	2.0	1.1	5.6	2.0	54.9	6.6	0.8	1.5	7.2	33.8	1.5	2.1	20.4	6.4	7.0	4.6	5.6	10.3	14.5	1.8	0.8	6.6	3.7	9.4	9.6	1.3	1.9	5.5	1.0	0.4	1.3	8.0	1.3	7.5	4.0	5.4	2.8	2.2	3.4	3.5	61.3	7.9	1.5	13.6	2.4	2.4	1.2	2.8	3.5	2.9	1.8	7.5	16.1	0.4	16.6	59.5	52.7	0.1	0.3	19.6	0.2	5.4	0.5	0.4	13.2	3.1	0.7	10.3	0.9	9.4	10.6	0.1	5.6	0.3	0.9	5.2	0.1	1.5	0.2	8.0	0.3	0.2	2.4	0.3	0.2	3.4	3.2	7.1	2.7	0.7	6.0	0.5	1.4	0.3	0.2	5.5	0.1	1.0	1.9	1.2	1.1	0.3	0.7	0.2	0.3	0.3	0.7	2.0	0.2	0.3	6.8	0.2	36.3	20.0	0.3	0.4	3.7	0.4	0.2	0.0	0.2	1.3	23.7	21.6	7.6	52.7	3.9	0.2	19.8	0.3	0.4	0.1	0.1	16.6	0.2	0.2	0.1	59.5	0.1	13.6	5.5	0.2	19.6	1.1	2.0	0.8	1.5	1.8	0.8	1.3	1.9	1.3	1.2
BTC		ENSG00000174808	Betacellulin	P35070	4	74744759-74794686	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 16.1;MCF7: 5.7;RPTEC TERT1: 9.7;SK-BR-3: 6.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	17	"plasmacytoid DC: 1.7"	"Lineage enriched"	"Detected in single"	17	"dendritic cells: 1.7"	"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (7.36e-2)"	"unprognostic (4.99e-2)"	"unprognostic (7.04e-2)"	"unprognostic (7.76e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.05e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.68e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (5.35e-1)"	"prognostic favourable (6.10e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (2.31e-3)"	3.0	1.2	1.0	5.2	2.2	0.0	3.7	0.3	2.8	2.2	23.5	1.2	3.1	3.0	2.4	5.6	9.9	6.1	10.3	2.5	1.3	1.3	3.7	0.8	3.4	0.2	0.8	1.0	3.6	2.9	5.2	4.5	0.9	2.1	3.7	5.9	7.0	6.8	3.6	0.6	12.4	11.3	8.3	0.6	0.4	6.9	0.8	0.9	0.4	5.2	1.9	2.3	5.6	3.3	0.0	1.7	0.0	0.0	0.0	0.0	0.0	3.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.0	1.1	0.0	16.1	0.0	3.4	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.6	0.0	0.2	0.0	0.0	0.0	1.2	0.3	0.1	0.1	0.0	0.1	0.4	5.7	0.1	0.0	0.0	2.4	0.0	0.0	0.0	9.7	4.6	0.2	0.0	2.3	6.4	0.0	0.4	0.0	0.0	0.3	0.1	0.3	2.8	0.3	0.0	0.0	2.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	1.0	2.2	0.3	2.8	1.3	1.3	0.8	1.0	2.1	0.9
C10orf99	"AP-57, CSBF, FLJ21763, RLLV1833, UNQ1833"	ENSG00000188373	"Chromosome 10 open reading frame 99"	Q6UWK7	10	84173738-84185294	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 93.5;intestine: 66.0;lymphoid tissue: 48.4;tongue: 95.1"	"Cell line enriched"	"Detected in some"	5	"RT4: 31.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA050920	Enhanced				"Secreted in other tissues"					"HPA050920: AB_2681274"		"unprognostic (3.13e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.04e-2)"		"unprognostic (1.78e-2)"		"unprognostic (7.46e-3)"	"unprognostic (2.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (1.20e-5)"	"unprognostic (3.70e-1)"			"unprognostic (4.67e-2)"	0.1	0.0	0.0	48.4	0.0	0.0	0.1	0.0	0.1	22.5	63.5	0.0	0.2	0.0	2.6	0.0	93.5	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.7	66.0	0.0	5.9	0.7	0.0	8.8	5.4	3.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	95.1	21.6	17.0	26.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	31.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0
C11orf24	DM4E3	ENSG00000171067	"Chromosome 11 open reading frame 24"	Q96F05	11	68261335-68272001	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 65.7"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 62.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA012748	Uncertain		Uncertain	Nucleoplasm,Vesicles				Nucleoplasm	Nucleoplasm	"HPA012748: AB_1845526"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (7.38e-4)"	"unprognostic (2.31e-2)"	"unprognostic (7.91e-2)"	"prognostic unfavourable (6.05e-4)"	"unprognostic (1.56e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.55e-1)"	"prognostic unfavourable (1.60e-9)"	"unprognostic (2.18e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.67e-3)"	12.9	9.3	6.6	12.9	10.6	2.7	14.7	6.7	13.7	14.1	32.6	23.3	8.4	35.2	21.8	12.3	8.6	12.2	19.2	19.1	9.1	6.5	10.0	44.3	12.6	14.4	10.3	8.1	14.1	17.5	5.8	8.1	12.6	14.5	12.2	11.8	14.7	22.1	12.6	6.9	8.9	65.7	21.5	13.8	11.3	13.5	7.8	10.3	3.4	9.2	11.4	18.8	14.6	10.5	23.7	16.4	9.3	11.0	5.5	9.2	6.9	12.3	12.8	7.6	14.8	18.4	18.7	8.8	29.9	19.4	15.1	15.6	27.0	7.6	5.6	9.3	37.0	14.0	11.2	13.4	9.7	6.1	6.6	5.9	13.0	18.0	14.9	5.0	20.0	15.4	10.0	22.8	9.4	6.0	10.4	9.2	12.7	15.4	1.2	7.3	12.7	15.6	2.3	13.0	28.9	6.8	5.9	5.0	9.3	9.7	7.8	62.4	7.3	4.2	6.6	23.7	14.7	29.9	13.1	11.4	11.2	5.2	19.0	3.9	22.8	9.3	7.2	7.5	9.2	11.0	6.2	17.3	5.3	5.7	12.0	23.7	5.0	5.3	1.1	5.5	8.1	16.4	4.8	6.9	6.6	10.6	6.7	13.7	9.1	6.5	10.3	8.1	14.5	10.3
C15orf48	"MIR147BHG, NMES1"	ENSG00000166920	"Chromosome 15 open reading frame 48"	Q9C002	15	45430529-45448761	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 95.5;lymphoid tissue: 56.1;testis: 47.2"	"Cell line enhanced"	"Detected in some"		"A-431: 24.2;CAPAN-2: 45.6;HMC-1: 10.6"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"classical monocyte: 3.2;intermediate monocyte: 3.7;myeloid DC: 3.0;neutrophil: 2.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 3.0;granulocytes: 2.1;monocytes: 3.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA012943	Enhanced									"HPA012943: AB_2668774"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.17e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.48e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.95e-2)"	"unprognostic (8.86e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.66e-1)"	0.6	0.1	0.4	56.1	0.4	7.2	2.9	0.4	0.4	9.0	87.2	0.5	26.0	6.0	0.9	0.9	33.5	0.6	6.0	2.8	0.4	0.1	1.4	1.6	11.2	0.4	0.4	0.4	0.6	3.3	0.0	0.4	10.6	0.5	2.5	95.5	0.8	6.1	21.5	0.5	14.9	54.6	3.1	0.8	0.6	10.8	47.2	0.4	1.6	0.9	33.1	19.6	1.4	10.9	0.0	3.0	2.1	3.7	0.0	0.2	1.6	24.2	6.0	0.0	0.1	0.3	0.0	1.0	1.2	8.7	1.6	4.5	0.9	45.6	0.0	1.1	0.1	0.6	0.7	0.3	3.9	2.7	0.6	0.0	0.1	0.1	4.1	0.0	10.6	0.4	0.4	8.1	0.0	0.0	0.0	0.2	0.2	1.1	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	1.9	0.0	0.2	1.4	2.8	0.1	0.5	0.5	0.2	0.2	0.5	0.3	0.3	0.7	0.4	0.1	0.8	0.2	0.1	0.0	3.2	0.3	0.2	3.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	2.1	0.0	0.4	0.5	0.0	1.6	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.5	0.4
C19orf33	"H2RSP, IMUP, IMUP-1, IMUP-2"	ENSG00000167644	"Chromosome 19 open reading frame 33"	Q9GZP8	19	38304161-38305009	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 105.8;tongue: 78.5"	"Cell line enhanced"	"Detected in some"		"A-431: 69.7;A549: 107.5;CAPAN-2: 66.4;HBEC3-KT: 64.5;hTCEpi: 67.5;PC-3: 61.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	11	"myeloid DC: 15.1"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 15.1"									"HPA054406, HPA059696"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA054406: AB_2682478, HPA059696: AB_2684105"	"unprognostic (9.31e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.34e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (5.42e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavourable (5.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.63e-2)"	"unprognostic (6.01e-2)"	6.9	0.6	0.5	16.4	0.7	0.3	5.0	0.5	0.8	14.5	58.8	0.6	3.5	34.6	3.9	4.3	88.4	18.2	45.2	9.9	0.8	0.3	5.8	1.0	34.8	0.6	0.7	1.4	4.9	0.8	0.0	2.0	10.0	1.7	10.3	18.2	1.2	21.5	6.8	2.8	53.3	105.8	2.9	3.1	1.9	28.7	1.5	0.5	1.5	4.4	78.5	39.2	16.2	35.1	0.1	15.1	1.4	0.6	0.3	0.4	14.6	69.7	107.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	66.4	0.0	39.9	0.0	26.2	0.0	64.5	0.0	0.0	0.0	0.0	22.6	1.8	0.5	0.0	0.0	0.0	67.5	0.0	43.3	1.1	0.0	0.0	0.0	18.0	0.0	0.1	0.1	61.5	0.0	0.0	0.0	40.8	20.7	0.1	0.0	40.7	29.5	0.0	9.2	0.2	14.6	0.0	20.3	0.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.1	0.6	1.4	0.3	0.0	0.3	0.1	0.2	0.1	15.1	0.1	0.4	0.3	0.9	0.3	0.0	0.9	0.0	14.6	0.5	0.7	0.5	0.8	0.8	0.3	0.7	1.4	1.7	0.5
C1orf115	FLJ14146	ENSG00000162817	"Chromosome 1 open reading frame 115"	Q9H7X2	1	220689845-220699157	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"brain: 32.9;intestine: 32.1"	"Cell line enhanced"	"Detected in many"		"Hep G2: 23.2;HUVEC TERT2: 19.1;TIME: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive B-cell: 3.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.16e-2)"	"prognostic favourable (6.52e-4)"	"unprognostic (1.31e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.69e-3)"	"unprognostic (8.65e-2)"	"prognostic favourable (5.12e-5)"	"unprognostic (3.11e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.24e-1)"	"unprognostic (4.54e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.07e-1)"	12.4	1.6	16.2	3.2	27.0	0.0	8.9	3.1	32.9	3.9	8.1	2.1	2.4	30.6	3.1	5.8	2.9	3.8	4.6	4.7	9.6	2.9	14.4	27.6	6.2	1.7	2.5	17.8	4.9	3.9	8.5	6.2	19.0	5.7	8.6	6.2	3.3	20.2	2.8	3.3	2.6	32.1	3.2	1.1	12.7	5.5	2.8	3.7	1.0	5.5	1.1	2.2	2.1	2.3	3.6	0.2	0.0	0.6	0.0	0.9	0.3	0.6	2.7	0.1	3.9	0.0	0.0	11.3	0.7	3.1	1.6	7.2	2.7	2.9	0.0	1.2	0.2	0.0	6.5	1.3	1.5	0.0	6.5	0.1	0.6	23.2	3.7	0.0	0.1	0.5	2.2	0.1	0.8	19.1	1.7	0.0	0.1	2.5	0.0	0.1	4.8	2.0	0.0	0.0	0.2	3.5	3.7	2.0	2.9	0.0	4.7	11.4	7.7	0.1	35.6	0.0	0.0	0.1	0.6	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.8	0.0	0.3	1.9	0.9	0.2	0.2	3.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	16.2	27.0	3.1	32.9	9.6	2.9	2.5	17.8	5.7	3.7
C1orf210	"MGC52423, TEMP"	ENSG00000253313	"Chromosome 1 open reading frame 210"	Q8IVY1	1	43281883-43285617	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell line enhanced"	"Detected in some"		"A-431: 7.9;BEWO: 8.8;CACO-2: 8.2;CAPAN-2: 26.6;SK-BR-3: 9.3;T-47d: 10.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013788	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA013788: AB_1845637"	"unprognostic (1.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.01e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (7.57e-3)"	"unprognostic (3.94e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.61e-2)"	0.3	0.1	0.3	6.5	0.3	0.0	7.4	0.3	0.3	3.9	28.6	0.4	7.4	20.6	1.0	10.9	11.2	2.6	20.7	0.3	0.3	0.1	25.2	3.3	13.5	0.3	0.3	0.3	1.0	29.8	3.0	9.6	6.1	0.4	4.4	14.4	0.4	25.8	7.2	0.3	10.6	64.0	0.5	0.3	0.3	14.6	1.1	0.3	1.0	32.1	7.8	7.7	3.4	5.2	0.1	0.3	5.4	0.3	0.4	0.2	0.0	7.9	0.0	0.0	0.1	0.0	0.0	8.8	0.0	0.0	0.0	0.0	8.2	26.6	0.0	0.2	0.0	6.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	5.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	5.1	3.2	0.2	0.0	9.3	0.0	10.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.4	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.1	0.3	0.3	0.4	0.3
C1orf226	FLJ13137	ENSG00000239887	"Chromosome 1 open reading frame 226"	A1L170	1	162366908-162386818	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6"	"Cell line enhanced"	"Detected in many"		"A-431: 13.2;HEL: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA052251	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA052251: AB_2681775"	"prognostic favourable (2.60e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.59e-2)"	"unprognostic (6.71e-3)"	"unprognostic (9.80e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-3)"	"prognostic favourable (4.44e-5)"	"unprognostic (9.34e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.51e-1)"	"prognostic favourable (1.13e-4)"	1.5	8.2	1.5	3.4	1.5	1.2	7.1	4.8	2.0	3.7	18.0	1.5	1.5	4.9	1.9	1.6	4.4	2.5	3.2	1.5	1.6	2.4	5.2	15.2	3.0	1.5	1.8	1.5	2.0	3.5	1.4	6.9	18.9	1.5	3.2	8.3	2.0	8.2	7.6	1.5	3.3	28.6	2.4	2.3	2.2	5.8	2.7	1.5	1.5	1.5	7.4	5.1	2.2	1.5	0.0	0.0	0.8	0.7	0.0	0.0	0.2	13.2	0.7	10.9	8.3	0.3	0.0	0.2	1.2	1.1	0.8	0.4	1.5	6.1	0.0	9.1	0.2	9.7	3.1	0.7	0.5	0.2	4.4	16.9	0.5	7.4	0.2	0.0	0.1	1.2	0.8	0.0	0.6	3.3	1.4	0.1	0.2	4.3	0.6	0.0	6.8	6.1	0.2	1.7	0.0	9.3	5.4	4.7	3.2	4.5	1.2	2.6	4.9	0.7	2.3	0.0	1.4	0.2	3.3	6.3	0.0	0.0	1.6	0.2	0.7	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	1.5	1.5	4.8	2.0	1.6	2.4	1.8	1.5	1.5	1.5
C1QTNF12	"ADIPOLIN, C1QDC2, CTRP12, FAM132A, MGC105127"	ENSG00000184163	"C1q and TNF related 12"	Q5T7M4	1	1242446-1246722	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 11.0;skin 1: 7.8"	"Group enriched"	"Detected in some"	5	"EFO-21: 8.1;U-2 OS: 8.1"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in some"		"neutrophil: 2.6;NK-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024107	Uncertain		Approved	Vesicles	"Secreted to blood"			Vesicles	Vesicles	"HPA024107: AB_2101207"	"unprognostic (1.10e-2)"	"unprognostic (5.68e-3)"	"unprognostic (3.45e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.01e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.02e-3)"	"unprognostic (1.10e-2)"	"unprognostic (9.68e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.20e-1)"	1.0	0.0	0.5	0.2	0.0	0.0	0.5	0.2	0.2	0.1	3.4			11.0	0.1	0.0	1.2	0.2	0.1	0.2	0.0	1.0	3.1	0.2	0.1	0.0	0.1		0.0	0.0	0.0	0.1	0.3		0.0	1.2		0.4	0.0	0.1	7.8	10.4	0.1	0.2	0.0	0.3	2.4			0.2		0.1	0.0	0.4	0.3	0.6	2.6	0.3	2.2	0.4	0.2	0.3	0.0	0.0	0.6	0.4	0.1	1.5	1.1	0.0	0.1	0.0	0.6	0.4	0.1	8.1	0.3	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.1	0.3	0.0	0.3	0.0	0.0	0.5	0.3	0.1	0.8	0.1	0.3	0.0	1.3	0.0	0.0	1.2	0.3	0.0	0.0	0.7	0.6	0.1	0.0	0.0	8.1	0.1	0.0	1.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.2	0.2	0.0	0.6	0.3	0.4	0.0	2.6	2.2	0.3	0.0	0.0	0.2										
C2orf88	"MGC13057, smAKAP"	ENSG00000187699	"Chromosome 2 open reading frame 88"	Q9BSF0	2	189879609-190203484	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.6;testis: 40.7"	"Group enriched"	"Detected in some"	6	"HEL: 40.9;K-562: 34.1;RT4: 22.5"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 16.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.7;naive B-cell: 1.8;neutrophil: 7.0;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	8	"B-cells: 2.7;dendritic cells: 2.6;granulocytes: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049549	Approved					230000	230000			"HPA049549: AB_2680812"	"unprognostic (1.20e-4)"	"unprognostic (9.17e-2)"	"unprognostic (4.50e-2)"	"prognostic favourable (4.97e-4)"	"unprognostic (6.09e-3)"	"unprognostic (4.55e-2)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"prognostic unfavourable (9.39e-4)"	"unprognostic (5.29e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.18e-1)"	"prognostic favourable (7.79e-4)"	"unprognostic (2.64e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-3)"	2.3	5.0	6.7	6.1	8.4	4.7	5.3	1.8	5.7	29.8	21.7	13.0	4.0	20.0	9.7	2.7	3.1	12.5	2.4	9.8	7.0	5.2	6.6	3.2	2.5	1.9	14.0	4.9	2.6	9.8	4.5	2.3	5.5	8.5	5.0	22.8	2.4	16.1	6.1	7.1	3.4	55.6	2.4	14.6	3.3	3.3	40.7	13.3	0.0	6.1	8.9	3.0	3.3	8.1	2.7	2.6	7.0	0.5	0.1	0.1	14.9	0.0	0.1	0.3	0.1	1.4	4.7	0.3	0.1	0.2	0.0	0.4	1.3	0.1	0.2	5.6	0.4	0.1	1.1	0.0	0.5	0.2	0.7	40.9	0.1	2.5	0.1	0.2	0.0	2.1	0.1	2.2	0.1	0.1	34.1	2.7	0.6	0.1	0.1	0.3	0.1	0.0	0.1	1.6	0.2	0.8	22.5	0.3	0.9	0.0	0.0	4.3	0.0	0.4	0.3	0.3	0.3	0.1	0.1	0.2	0.7	0.8	0.4	0.2	0.1	0.0	0.5	0.7	0.0	0.0	0.0	2.7	0.0	0.1	0.1	1.8	0.0	0.0	7.0	0.1	0.0	2.6	0.0	14.9	6.7	8.4	1.8	5.1	7.0	5.2	14.0	4.9	8.5	13.3
C3orf80		ENSG00000180044	"Chromosome 3 open reading frame 80"	F5H4A9	3	160225496-160228213	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 25.0;intestine: 8.6"	"Cell line enriched"	"Detected in some"	5	"HMC-1: 55.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA047439	Uncertain									"HPA047439: AB_10965171"	"unprognostic (5.34e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.92e-3)"	"unprognostic (6.70e-3)"	"unprognostic (4.28e-3)"	"unprognostic (1.69e-1)"	"unprognostic (4.64e-3)"	"unprognostic (1.51e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (6.09e-10)"	"unprognostic (1.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.11e-3)"	"unprognostic (5.00e-2)"	1.3	0.4	5.2	1.6	9.3	1.4	0.7	5.4	25.0	0.5	8.6	0.1	0.0	1.8	1.2	0.5	5.7	0.3	1.4	0.6	4.3	2.0	0.6	0.8	2.0	0.3	1.7	9.3	0.3	0.4	1.4	0.7	0.3	1.2	1.8	3.3	0.0	0.6	0.8	0.2	0.2	1.3	1.8	0.5	2.7	2.5	1.3	0.0	0.0	0.5	0.0	0.4	2.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	1.1	0.7	4.6	1.3	0.0	0.0	0.9	55.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.5	0.0	0.0	0.1	11.4	0.0	0.0	0.2	0.0	1.4	0.1	0.0	0.0	0.4	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.2	9.3	5.4	25.0	4.3	2.0	1.7	9.3	1.2	0.0
C8orf86	FLJ43582	ENSG00000196166	"Chromosome 8 open reading frame 86"	Q6ZUL3	8	38510834-38528662	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 2.3;intestine: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA025066	Uncertain									"HPA025066: AB_1848937"	"unprognostic (9.54e-2)"			"unprognostic (9.14e-3)"	"unprognostic (2.38e-2)"					"unprognostic (2.47e-1)"		"unprognostic (5.63e-2)"		"unprognostic (2.69e-2)"	"unprognostic (2.21e-1)"			0.5	0.2	0.6	0.1	0.4	0.6	0.2	1.5	0.9	0.2	0.2			3.9	0.2	0.2	0.3	0.4	0.6	0.1	0.7	0.7	0.5	0.8	0.0	0.0	0.5		0.2	0.3	0.0	1.1	0.0		0.2	0.1		0.3	0.0	1.0	0.6	1.8	0.0	0.3	0.2	0.7	0.5			0.0		0.0	0.3	0.1	1.3	0.7	2.3	0.6	1.4	0.7	0.2	0.1	0.0	0.2	0.6	0.7	2.1	0.3	1.7	0.4	0.1	0.1	0.5	0.3	0.5	0.3	0.0	1.0	0.1	0.0	0.2	0.9	0.3	0.0	1.0	0.0	0.5	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.7	0.0	1.4	0.1	1.5	0.0	0.4	0.0	0.0	0.0	1.3	0.5	0.3	0.5	0.3	0.3	1.2	0.0	0.7	0.6	0.5	1.2	0.1	0.6	1.0	0.6	0.4	0.3	0.1	2.0	0.6	0.4	0.5	0.3	0.5	0.9	0.5	0.5	0.3	1.3	0.7	0.7	2.3	1.4	0.4	0.7	0.4	0.2										
C9orf152	bA470J20.2	ENSG00000188959	"Chromosome 9 open reading frame 152"	Q5JTZ5	9	110190048-110208189	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9;salivary gland: 34.3;stomach 1: 20.7"	"Group enriched"	"Detected in some"	6	"SK-BR-3: 9.7;T-47d: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA050769	Approved		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA050769: AB_2681230"	"unprognostic (1.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-1)"	"prognostic favourable (7.22e-5)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.09e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.57e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.06e-2)"	0.4	0.0	0.4	1.7	0.4	0.0	6.1	0.4	0.4	5.3	16.1	0.5	10.5	9.1	1.0	0.4	2.4	1.5	7.1	0.4	0.4	0.0	0.4	0.5	3.6	0.4	0.4	0.4	0.4	3.9	0.0	0.8	0.4	0.4	11.6	20.9	0.4	34.3	17.0	0.4	3.8	7.0	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	1.6	5.2	1.3	0.4	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.0	1.4	0.1	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.6	0.1	0.1	0.0	9.7	0.0	18.7	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
CA13	"CAXIII, FLJ37995, MGC59868"	ENSG00000185015	"Carbonic anhydrase 13"	Q8N1Q1	8	85220587-85284073	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 56.7"	"Cell line enhanced"	"Detected in many"		"HEL: 16.1;RPTEC TERT1: 8.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA024689, CAB025567"	Enhanced		Uncertain	Nucleoplasm,Nucleoli,Vesicles		100000	100000	Nucleoli	Nucleoli	"CAB025567: , HPA024689: AB_1846004"	"unprognostic (1.12e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.16e-5)"	"unprognostic (2.21e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.39e-2)"	"unprognostic (7.90e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.13e-1)"	"prognostic favourable (9.40e-4)"	"unprognostic (7.59e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.55e-2)"	"unprognostic (3.00e-1)"	2.6	2.6	2.0	1.9	3.1	0.5	2.9	2.4	2.4	3.2	18.2	0.8	0.0	14.2	1.8	1.7	6.7	1.4	25.6	5.8	1.6	1.9	10.4	17.1	9.5	2.4	2.0	0.1	2.2	1.6	9.3	6.5	1.0	5.7	2.6	3.7	1.9	7.0	1.0	1.9	7.1	56.7	1.9	5.2	2.2	7.0	0.9	0.9	0.4	10.3	3.9	5.6	2.9	5.2	0.8	2.1	3.2	2.5	0.5	0.5	1.0	0.3	0.4	0.9	0.1	0.6	0.7	0.4	1.1	1.1	0.1	3.1	7.5	5.8	0.4	0.5	1.3	2.4	2.3	3.0	0.2	1.6	1.0	16.1	2.1	6.9	1.6	0.2	0.7	2.4	0.5	0.2	1.3	1.7	4.1	3.2	2.7	0.1	0.3	0.2	0.5	0.5	0.2	2.4	0.2	8.7	0.3	0.3	0.1	0.5	0.0	1.6	0.6	0.8	1.6	3.0	4.3	0.1	1.6	1.3	0.6	2.0	6.3	2.3	2.8	3.2	2.5	1.3	0.4	0.7	0.2	0.2	0.2	0.1	2.1	0.8	0.3	0.5	0.9	0.5	0.8	0.9	0.1	1.0	2.0	3.1	2.4	2.4	1.6	1.9	2.0	0.1	5.7	0.9
CA2	"CA-II, CAII, Car2"	ENSG00000104267	"Carbonic anhydrase 2"	P00918	8	85463852-85481493	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 108.1;stomach 1: 171.5"	"Cell line enhanced"	"Detected in some"		"HaCaT: 33.1;HEK 293: 139.1;THP-1: 58.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"basophil: 20.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001550, CAB010102"	Enhanced					790000000	790000000			"CAB010102: AB_626796, HPA001550: AB_1078393"	"unprognostic (6.78e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.57e-1)"	"unprognostic (9.89e-2)"	"prognostic favourable (5.57e-6)"	"unprognostic (2.45e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.49e-3)"	1.6	2.2	24.4	21.5	32.6	32.4	6.9	4.3	23.2	1.3	108.1	28.9	42.0	46.9	0.9	2.2	5.6	0.9	33.0	4.3	29.1	14.5	53.5	43.0	10.2	1.3	49.0	14.2	0.5	9.1	3.1	2.0	3.5	65.0	0.8	105.6	7.0	14.0	54.2	9.2	13.3	7.6	6.0	27.5	2.5	171.5	5.1	58.3	0.0	3.8	2.4	1.1	1.0	1.4	1.9	8.0	20.3	8.2	0.0	4.4	17.5	0.5	0.3	1.5	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	1.9	0.1	0.0	1.2	0.0	33.1	4.8	1.6	0.0	0.0	139.1	4.3	2.4	0.0	0.0	3.0	0.6	0.0	8.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.4	0.0	2.7	0.1	0.0	0.4	1.1	0.0	0.0	0.7	0.0	0.0	0.0	58.3	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	20.3	3.1	4.4	0.1	8.2	4.4	0.6	0.0	0.4	8.0	1.9	0.0	0.0	6.8	0.0	7.1	0.8	0.0	17.5	24.4	32.6	4.3	23.2	29.1	14.5	49.0	14.2	65.0	58.3
CA4	"CAIV, Car4, RP17"	ENSG00000167434	"Carbonic anhydrase 4"	P22748	17	60149936-60170899	"Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.7"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.4;HUVEC TERT2: 1.7;NTERA-2: 3.9;RPMI-8226: 1.5;RPTEC TERT1: 2.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"cerebellum: 50.1"	"Cell type enriched"	"Detected in some"	7	"neutrophil: 37.0"	"Lineage enriched"	"Detected in single"	370	"granulocytes: 37.0"	"Region enriched"	"Detected in all"	5	"cerebellum: 336.9"	"Low region specificity"	"Detected in many"			"HPA011089, HPA017258"	Enhanced		Supported	Vesicles		190000	190000	Vesicles	Vesicles	"HPA011089: AB_1845996, HPA017258: AB_1845997"	"unprognostic (2.07e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.78e-3)"	"unprognostic (8.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.19e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.76e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.68e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-2)"	32.2	0.9	3.4	9.8	4.4	5.7	46.4	50.1	11.8	2.3	81.7	2.0	31.5	1.4	2.3	17.4	0.9	1.7	12.2	8.8	4.7	2.6	12.0	0.3	33.3	2.4	3.5	5.2	1.9	9.5	3.3	5.1	3.2	3.0	2.4	54.9	20.3	4.8	24.0	10.0	1.0	3.2	1.1	2.1	4.9	2.5	1.2	0.3	0.2	23.1	5.0	0.2	1.7	7.9	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.5	0.9	0.0	0.3	0.0	0.0	0.4	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.3	3.9	0.0	0.0	0.2	1.5	2.2	0.0	0.8	0.4	0.2	0.0	0.0	0.0	0.6	0.0	0.2	0.9	0.5	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.0	0.0	0.0	0.0	0.0	0.0	3.4	4.4	50.1	11.8	4.7	2.6	3.5	5.2	3.0	0.3
CAPN13	FLJ23523	ENSG00000162949	"Calpain 13"	Q6MZZ7	2	30722771-30820542	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 67.3;pancreas: 20.4;stomach 1: 17.6"	"Group enriched"	"Detected in some"	5	"RT4: 8.8;SK-BR-3: 21.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029496, HPA029497, HPA030034"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029496: AB_2673072, HPA029497: AB_2673073, HPA030034: AB_2673281"	"unprognostic (7.42e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.17e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.32e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.28e-3)"	0.2	0.0	0.5	0.5	0.4	0.0	4.8	0.2	0.2	6.2	39.6	0.3	0.2	13.0	1.1	0.6	1.1	0.5	7.4	0.2	0.8	0.4	2.0	0.2	9.4	0.2	0.7	0.3	0.4	20.4	0.6	1.2	0.2	0.2	5.2	16.0	0.2	1.0	0.2	0.2	0.1	67.3	1.6	1.0	0.2	17.6	0.2	0.2	0.2	0.2	0.5	1.0	3.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	8.8	0.1	0.4	0.0	21.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.2	0.2	0.8	0.4	0.7	0.3	0.2	0.2
CAPN5	"ADNIV, HTRA3, nCL-3, VRNI"	ENSG00000149260	"Calpain 5"	O15484	11	77066932-77126155	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 49.5;intestine: 47.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 18.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"gdTCR: 4.8"	"Lineage enriched"	"Detected in single"	5	"T-cells: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033237, HPA072319"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB033237: AB_2069673, HPA072319: AB_2686512"	"unprognostic (6.81e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.36e-2)"	"prognostic unfavourable (2.16e-6)"	"unprognostic (3.47e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.30e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.21e-2)"	"unprognostic (5.35e-3)"	"unprognostic (4.64e-1)"	"unprognostic (3.17e-3)"	"unprognostic (8.58e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.30e-3)"	3.9	7.1	5.6	19.5	5.4	1.5	3.9	6.3	10.8	7.4	34.1	6.0	4.8	32.7	6.3	8.3	18.3	6.6	49.5	4.4	5.4	4.6	8.7	26.8	2.8	1.2	3.7	7.0	15.4	3.2	0.7	3.3	2.6	10.2	9.3	27.9	7.4	4.7	7.5	1.8	1.9	47.8	9.3	4.1	2.2	29.3	22.0	2.3	0.6	3.1	4.6	7.3	9.8	6.3	0.2	0.7	0.0	0.9	0.0	4.8	2.1	0.4	6.7	4.5	4.4	17.0	16.4	0.4	6.8	11.8	7.0	5.1	3.9	2.0	0.2	4.9	11.7	0.3	1.8	0.5	3.0	0.4	0.4	1.3	0.2	0.4	4.2	0.1	0.4	8.1	0.7	11.2	2.7	8.1	0.1	0.1	12.9	9.4	1.1	0.2	3.8	5.3	1.0	15.2	0.2	2.3	8.5	0.3	8.1	1.6	1.3	3.0	1.0	0.0	16.7	13.6	8.0	18.7	0.8	0.4	0.9	0.0	7.0	0.2	3.1	0.0	0.7	0.0	4.8	0.9	0.4	0.0	0.5	1.6	0.7	0.2	2.4	2.5	0.0	0.0	0.2	0.3	0.0	2.1	5.6	5.4	6.3	10.8	5.4	4.6	3.7	7.0	10.2	2.3
CAPN9	"GC36, nCL-4"	ENSG00000135773	"Calpain 9"	O14815	1	230747384-230802003	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.6;lung: 19.8;stomach 1: 35.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 18.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	17	"naive CD4 T-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA020398, CAB033483"	Enhanced									"CAB033483: AB_1119945, HPA020398: AB_2670429"	"unprognostic (2.64e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.97e-5)"	"unprognostic (1.51e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.60e-2)"	"unprognostic (2.16e-1)"	0.2	0.7	0.4	7.0	0.3	0.0	0.2	0.3	0.5	0.4	10.4	0.4	0.2	3.9	0.2	0.2	0.7	1.5	12.7	0.2	0.5	0.2	0.2	0.2	19.8	0.2	0.6	0.2	0.3	0.2	0.0	0.6	0.2	0.2	0.8	13.7	0.2	8.1	0.2	1.3	0.0	17.6	0.2	1.1	0.2	35.8	0.2	0.2	0.2	0.2	1.0	7.1	3.7	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.1	18.3	0.0	0.0	0.6	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.3	0.4	0.5	0.2	0.6	0.2	0.2	0.2
CARD10	"BIMP1, CARMA3"	ENSG00000100065	"Caspase recruitment domain family member 10"	Q9BWT7	22	37490362-37519542	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.6"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 23.6;U-2197: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029359, HPA055612"	Approved		Approved	"Vesicles,Intermediate filaments,Cytosol"				"Vesicles, Intermediate filaments"	"Vesicles, Intermediate filaments"	"HPA029359: AB_10601354, HPA055612: AB_2682861"	"unprognostic (9.12e-3)"	"unprognostic (2.28e-1)"	"unprognostic (7.51e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (4.54e-1)"	"unprognostic (2.70e-2)"	"prognostic unfavourable (7.73e-6)"	"unprognostic (3.66e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.34e-1)"	"unprognostic (4.31e-2)"	"unprognostic (9.69e-2)"	8.1	6.8	3.5	4.5	2.3	0.0	10.2	1.5	2.7	5.7	16.4	2.4	4.1	23.7	9.8	6.4	6.8	5.9	14.1	7.6	1.7	1.1	14.0	10.5	7.0	2.4	1.6	1.3	6.8	8.9	1.6	1.7	4.9	3.8	5.6	6.2	5.6	12.6	3.2	8.0	7.3	33.6	4.1	1.3	3.3	7.0	11.1	1.3	0.7	5.6	13.5	3.9	4.9	9.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	12.8	9.4	1.7	1.3	0.0	3.8	8.5	1.2	2.8	5.5	4.3	5.8	9.2	0.0	4.6	2.2	18.2	2.1	23.6	1.7	0.0	5.1	0.3	5.9	9.0	2.3	0.2	0.8	1.3	4.9	10.5	13.5	11.0	1.3	0.0	4.1	4.4	0.0	0.8	3.1	5.7	0.0	16.9	1.3	8.2	2.2	0.6	1.0	9.0	4.0	0.9	4.3	0.7	14.6	4.1	12.1	35.4	6.7	0.0	0.0	0.0	13.1	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	3.5	2.3	1.5	2.7	1.7	1.1	1.6	1.3	3.8	1.3
CASP10	MCH4	ENSG00000003400	"Caspase 10"	Q92851	2	201182881-201229406	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 17.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB003780, HPA017059"	Approved		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus"	"Golgi apparatus"	"CAB003780: AB_289592, HPA017059: AB_1846040"	"unprognostic (4.01e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.54e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.68e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (6.05e-7)"	"unprognostic (3.23e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.38e-2)"	16.0	3.3	3.4	10.1	3.4	14.9	7.6	1.9	3.3	7.0	17.7	4.4	4.3	18.6	8.3	8.2	10.4	4.9	7.2	4.8	3.6	3.0	10.3	7.8	14.2	10.4	4.1	1.4	3.4	6.1	1.4	2.1	8.5	4.7	5.0	11.9	4.1	6.9	6.9	3.6	5.4	42.4	4.8	5.6	26.1	8.7	2.1	2.5	17.1	6.8	8.2	17.9	9.4	6.1	7.8	6.0	4.7	15.4	7.1	7.1	5.8	2.9	2.3	0.1	0.2	0.1	0.2	5.1	0.5	3.4	0.3	1.3	3.1	6.8	0.2	4.9	1.7	1.9	0.1	1.6	0.9	1.4	3.3	8.2	2.4	10.2	1.1	5.4	8.9	0.3	1.4	3.7	0.3	17.7	9.8	12.1	0.3	0.1	10.5	5.1	0.3	1.5	5.7	0.3	12.1	6.2	4.1	0.1	0.1	2.8	0.1	1.3	0.0	5.2	7.1	0.2	0.5	2.3	0.1	13.2	7.8	0.3	3.3	4.2	0.1	4.7	9.6	0.6	6.2	13.5	5.2	7.8	5.2	3.4	5.3	5.0	7.1	6.0	1.9	7.1	15.4	6.0	1.0	5.8	3.4	3.4	1.9	3.3	3.6	3.0	4.1	1.4	4.7	2.5
CASP6	MCH2	ENSG00000138794	"Caspase 6"	P55212	4	109688622-109703583	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 42.8"	"Cell line enhanced"	"Detected in all"		"Karpas-707: 38.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003775, HPA011337, HPA024303"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB003775: AB_562064, HPA011337: AB_1846053, HPA024303: AB_1846052"	"unprognostic (1.07e-1)"	"unprognostic (1.91e-1)"	"prognostic favourable (2.64e-5)"	"unprognostic (1.45e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.03e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.59e-3)"	"unprognostic (1.15e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.44e-1)"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.41e-1)"	"prognostic favourable (9.93e-4)"	8.1	6.1	3.6	6.7	4.3	5.3	14.3	2.8	3.8	6.9	25.5	2.8	4.5	23.4	5.9	4.3	8.7	5.3	11.7	4.9	4.0	2.0	11.0	14.3	5.6	8.5	5.0	1.6	7.0	13.0	2.3	6.4	4.3	4.5	8.1	19.5	3.4	8.0	10.3	3.4	6.5	42.8	14.0	6.6	9.1	9.2	2.7	4.3	14.5	11.2	3.3	8.4	8.2	12.7	4.4	8.0	8.5	7.0	5.6	21.3	8.0	12.4	4.0	8.3	7.5	6.1	6.0	12.3	7.0	4.8	6.2	6.8	6.7	25.6	1.3	8.1	7.1	5.8	9.9	11.0	5.0	19.7	6.5	10.9	3.6	5.9	4.9	10.9	7.7	6.6	8.2	6.0	1.5	11.8	14.1	38.8	10.1	7.0	28.1	6.9	6.3	7.3	9.8	5.3	6.8	20.6	11.8	8.8	6.6	7.4	13.3	4.1	5.7	4.0	10.0	6.9	7.4	3.3	7.9	5.7	10.3	1.4	9.0	13.1	3.5	8.5	5.3	6.3	4.9	4.8	5.3	4.1	17.8	9.3	6.0	4.4	21.3	11.8	1.1	5.6	7.0	8.0	16.4	8.0	3.6	4.3	2.8	3.8	4.0	2.0	5.0	1.6	4.5	4.3
CASP7	"CMH-1, ICE-LAP3, MCH3"	ENSG00000165806	"Caspase 7"	P55210	10	113679162-113730907	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 64.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB025563	Approved									"CAB025563: "	"prognostic favourable (2.11e-4)"	"unprognostic (3.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.63e-3)"	"unprognostic (3.96e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.35e-2)"	"prognostic unfavourable (5.90e-4)"	"unprognostic (5.45e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.33e-3)"	16.5	7.8	8.6	12.3	8.7	3.4	22.1	4.7	11.3	13.3	35.5	5.9	9.8	30.8	12.6	6.1	12.0	9.5	7.8	9.0	7.6	3.9	14.1	15.7	16.2	12.2	7.3	2.7	11.0	18.4	5.7	9.6	10.2	9.1	11.9	28.5	5.8	21.8	10.5	9.7	10.9	64.8	9.3	12.4	12.3	21.0	4.3	8.0	12.0	8.4	8.1	11.3	10.6	36.6	9.6	8.6	14.6	17.1	5.4	12.2	7.4	10.8	11.7	9.6	5.1	17.6	15.5	6.7	12.6	19.7	22.5	28.3	8.7	18.8	11.5	7.5	11.4	9.6	11.8	9.5	16.0	17.8	15.9	7.4	8.7	14.5	11.8	7.9	9.8	10.0	6.4	12.8	5.3	29.7	1.9	15.7	8.3	14.6	18.7	6.2	1.7	7.2	19.1	39.1	6.9	17.8	8.0	0.7	5.7	9.7	14.1	6.6	16.7	7.0	14.2	5.0	9.6	5.2	10.3	11.6	7.3	0.3	5.1	14.9	5.6	14.6	12.5	9.4	9.6	17.1	8.4	9.6	8.3	12.2	8.6	7.3	6.5	8.7	2.1	5.4	14.0	1.1	11.1	7.4	8.6	8.7	4.7	11.3	7.6	3.9	7.3	2.7	9.1	8.0
CBLC	"CBL-3, CBL-SL, RNF57"	ENSG00000142273	"Cbl proto-oncogene C"	Q9ULV8	19	44777869-44800634	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.8"	"Cell line enhanced"	"Detected in some"		"A-431: 19.0;BEWO: 13.1;CACO-2: 12.8;CAPAN-2: 26.3;HaCaT: 18.4;HBEC3-KT: 16.0;hTCEpi: 12.2;RT4: 16.0;SK-BR-3: 14.6;T-47d: 10.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB008087, HPA035266"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB008087: AB_2228531, HPA035266: AB_2674542"	"unprognostic (1.58e-1)"	"unprognostic (2.25e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.82e-1)"	"unprognostic (7.39e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.85e-1)"	"prognostic favourable (3.11e-6)"	"unprognostic (3.50e-1)"	"unprognostic (8.25e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.21e-3)"	0.1	0.0	0.5	8.5	0.2	0.0	4.8	0.1	0.4	4.4	39.5	0.1	3.2	29.5	1.7	1.7	22.0	1.4	18.8	0.1	0.6	0.0	4.9	15.1	1.3	0.1	0.1	0.3	0.8	18.1	0.9	0.7	4.1	0.2	6.9	6.9	0.5	11.4	5.2	0.1	20.8	66.8	0.4	0.1	0.1	10.2	1.6	0.1	0.5	1.9	13.2	15.7	7.6	8.9	0.0	0.0	0.0	0.0	0.0	0.8	0.0	19.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	12.8	26.3	0.0	0.0	0.0	18.4	0.0	16.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	16.0	0.1	0.0	0.0	14.6	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.4	0.6	0.0	0.1	0.3	0.2	0.1
CBR1	"CBR, SDR21C1"	ENSG00000159228	"Carbonyl reductase 1"	P16152	21	36069941-36073166	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 176.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA018433	Enhanced		Approved	Nucleoplasm,Cytosol		12000000	12000000	Nucleoplasm	Nucleoplasm	"HPA018433: AB_1846109"	"prognostic favourable (2.18e-4)"	"unprognostic (9.78e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.14e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.20e-2)"	"unprognostic (4.00e-1)"	"prognostic favourable (4.75e-4)"	"unprognostic (2.37e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.13e-3)"	"unprognostic (2.47e-2)"	9.6	22.9	31.7	8.4	41.6	3.7	8.5	12.0	35.8	14.6	63.4	75.9	6.5	176.1	9.3	17.1	40.2	9.6	15.1	7.8	37.7	24.7	35.2	77.2	11.7	8.5	57.3	25.2	10.4	8.0	8.9	7.9	11.7	51.6	16.7	16.8	10.4	23.1	15.0	8.7	34.4	118.1	11.6	48.1	10.0	41.4	5.7	41.9	3.6	11.3	29.8	14.3	12.4	17.1	17.0	29.9	17.1	51.4	19.1	29.2	37.0	25.4	39.2	4.8	12.4	25.2	25.5	0.2	28.5	20.5	15.6	18.7	14.4	15.0	6.4	18.8	26.6	18.7	9.8	28.0	12.0	31.6	23.2	19.2	22.8	9.8	14.4	10.6	17.7	12.4	35.3	15.1	6.6	16.6	0.0	4.7	14.3	25.2	5.3	11.1	0.0	28.6	0.0	0.1	17.7	41.5	12.7	14.0	12.6	27.6	40.1	32.4	19.0	14.8	16.7	17.5	7.4	44.5	20.6	32.1	58.1	0.1	32.2	10.6	25.4	1.8	36.6	17.1	18.1	51.4	15.3	17.0	22.7	16.9	29.9	15.6	29.2	21.4	2.5	19.1	38.6	10.4	22.7	37.0	31.7	41.6	12.0	35.8	37.7	24.7	57.3	25.2	51.6	41.9
CCDC68	SE57-1	ENSG00000166510	"Coiled-coil domain containing 68"	Q9H2F9	18	54901509-54959508	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.1"	"Cell line enhanced"	"Detected in some"		"A-431: 7.9;HHSteC: 10.7;HSkMC: 11.7;RT4: 7.9;TIME: 21.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040865, HPA048197"	Supported		Approved	"Golgi apparatus,Cytosol"				"Golgi apparatus"	"Golgi apparatus"	"HPA040865: AB_2677176, HPA048197: AB_2680310"	"unprognostic (1.36e-2)"	"prognostic unfavourable (4.50e-4)"	"unprognostic (1.47e-3)"	"unprognostic (7.38e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.91e-2)"	"unprognostic (2.65e-2)"	"unprognostic (6.29e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (1.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (2.38e-1)"	5.6	3.0	1.2	7.7	2.4	0.3	5.8	0.6	4.7	5.5	20.7	0.8	3.1	14.8	4.5	2.5	2.1	2.6	9.1	5.7	1.7	1.7	5.6	9.9	15.2	2.3	2.0	4.7	15.4	2.8	0.5	15.7	23.9	4.4	5.2	13.9	9.3	2.2	13.0	7.7	1.0	40.1	2.1	1.6	5.8	10.5	7.4	0.1	0.0	3.5	2.1	1.0	3.0	4.2	0.8	0.6	1.1	2.2	0.5	1.0	0.5	7.9	2.5	0.0	0.0	2.3	6.6	0.0	0.2	3.2	0.5	0.5	4.4	4.7	0.0	5.9	0.0	0.1	0.5	5.1	0.4	0.0	1.2	0.6	2.9	0.9	10.7	0.0	0.0	11.7	0.0	2.4	0.1	3.7	0.0	0.1	0.3	0.6	0.0	0.1	0.0	2.7	0.2	0.0	0.2	0.9	7.9	0.0	1.9	2.5	0.8	0.1	0.0	0.0	21.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	0.7	0.7	0.4	0.8	0.6	0.6	0.6	0.5	0.4	0.8	0.9	1.0	0.7	0.5	2.2	0.6	0.5	0.5	1.2	2.4	0.6	4.7	1.7	1.7	2.0	4.7	4.4	0.1
CCL1	"I-309, P500, SCYA1, SISe, TCA3"	ENSG00000108702	"C-C motif chemokine ligand 1"	P22362	17	34360328-34363231	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7;lymphoid tissue: 6.7;tongue: 3.2"	"Cell line enriched"	"Detected in some"	41	"HMC-1: 125.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 2.5"	"Group enriched"	"Detected in some"	4	"classical monocyte: 2.0;intermediate monocyte: 1.2"	"Lineage enriched"	"Detected in single"	20	"monocytes: 2.0"					"Region enriched"	"Detected in some"	4	"hippocampal formation: 2.2"	HPA049861	Uncertain				"Secreted to blood"					"HPA049861: AB_2680919"		"unprognostic (6.52e-2)"				"unprognostic (4.81e-3)"		"unprognostic (5.84e-2)"	"unprognostic (5.01e-1)"	"unprognostic (6.04e-1)"				"unprognostic (2.71e-1)"	"unprognostic (1.37e-1)"			0.1	0.0	0.2	0.2	2.5	0.0	0.1	0.1	0.9	0.1	0.5	0.1	0.1	0.0	0.1	0.8	0.1	0.2	0.4	0.1	0.5	0.3	0.1	0.1	0.4	0.1	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	7.7	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	1.8	0.1	6.7	0.1	3.2	0.5	0.1	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	125.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	2.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	2.5	0.1	0.8	0.5	0.3	0.2	0.1	0.1	0.1
CCL11	"eotaxin, MGC22554, SCYA11"	ENSG00000172156	"C-C motif chemokine ligand 11"	P51671	17	34285668-34288334	"Cancer-related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 31.0;intestine: 29.6;lymphoid tissue: 29.2"	"Cell line enriched"	"Detected in single"	21	"BJ hTERT+: 13.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"Secreted to blood"						"unprognostic (4.61e-2)"	"unprognostic (1.45e-1)"	"prognostic favourable (8.70e-4)"	"unprognostic (8.18e-2)"		"prognostic favourable (1.99e-4)"	"unprognostic (9.91e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.64e-8)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	2.6	0.4	0.2	29.2	0.2	0.0	0.2	0.2	0.2	4.5	29.6	0.4	0.6	17.3	3.5	0.0	20.7	0.8	12.0	31.0	0.2	0.2	7.0	1.2	7.3	0.3	0.2	0.0	2.6	11.6	0.2	1.1	0.0	0.2	16.1	8.0	0.0	0.2	0.3	0.5	0.2	18.7	10.2	0.2	1.2	18.2	0.6	0.0	0.7	0.4	0.0	0.8	12.1	5.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	13.9	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.0
CCL15	"HCC-2, HMRP-2B, Lkn-1, MIP-1d, MIP-5, NCC-3, SCYA15, SCYL3"	ENSG00000275718	"C-C motif chemokine ligand 15"	Q16663	17	35996440-36002038	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 36.4;liver: 17.9"	"Cell line enriched"	"Detected in some"	14	"Hep G2: 26.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.8"					"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											HPA058608			Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	7900000	7900000	"Golgi apparatus"	"Golgi apparatus"	"HPA058608: AB_2683776"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.40e-1)"			"unprognostic (8.88e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.63e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.07e-2)"	"prognostic favourable (3.02e-4)"	0.0	0.0	0.0	6.1	0.0	0.0	0.6	0.0	0.0	0.1	18.0	0.0	0.0	11.6	0.0	0.4	0.0	1.1	7.4	0.8	0.0		6.4	17.9	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	15.8	0.0	0.0	0.0	0.0	0.4	36.4	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.7	1.0	2.2	0.3	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	26.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.3	0.2	0.2	0.3	0.3	0.5	0.0	0.7	0.4	0.2	2.2	0.9	0.1	1.0	0.3	0.0										
CCL24	"Ckb-6, eotaxin-2, MPIF-2, MPIF2, SCYA24"	ENSG00000106178	"C-C motif chemokine ligand 24"	O00175	7	75811665-75823356	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 33.1;lung: 23.3;lymphoid tissue: 63.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.8;EFO-21: 2.6;HMC-1: 2.7;RH-30: 3.4;U-2 OS: 9.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 67.6"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"intermediate monocyte: 3.3"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.3"	"Low region specificity"	"Detected in many"												"Secreted to blood"						"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"prognostic favourable (5.41e-4)"	"unprognostic (1.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.73e-2)"	8.2	0.5	0.3	5.7	0.3	0.0	0.8	0.3	0.3	0.6	12.2	0.3	0.2	9.4	0.4	0.6	1.0	0.4	1.1	0.5	0.3	0.3	0.6	3.8	23.3	21.2	0.3	0.2	0.6	0.4	0.0	0.4	0.3	0.3	0.5	33.1	0.6	0.6	0.5	0.4	0.7	26.8	0.5	0.3	63.3	1.0	1.0	0.2	1.2	0.5	0.9	2.8	13.4	0.7	0.0	0.6	0.0	3.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.1	0.0	8.8	0.2	2.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.7	0.2	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.3	0.0	0.0	9.3	0.0	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.5	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.2	0.3	0.2
CD160	"BY55, NK1, NK28"	ENSG00000117281	"CD160 molecule"	O95971	1	145719471-145739288	"CD markers, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.9;brain: 15.2;intestine: 19.9;lymphoid tissue: 17.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"cerebellum: 15.2"	"Group enriched"	"Detected in many"	9	"gdTCR: 33.9;MAIT T-cell: 14.4;memory CD8 T-cell: 22.9;naive CD8 T-cell: 27.3;NK-cell: 23.2"	"Group enriched"	"Detected in many"	11	"NK-cells: 23.2;T-cells: 33.9"	"Not detected"	"Not detected"												"Intracellular and membrane"						"unprognostic (6.54e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.33e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.25e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.49e-3)"	"unprognostic (3.48e-5)"	"unprognostic (4.05e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-4)"	0.6	0.2	2.2	3.6	2.6	5.1	0.6	15.2	3.1	0.8	9.3	0.4	0.3	5.6	0.8	1.4	0.9	0.6	1.2	0.6	1.6	2.2	0.5	5.9	3.8	6.0	1.6	0.3	1.1	2.2	0.0	0.4	1.8	0.6	1.3	1.0	0.9	3.0	0.4	1.0	1.1	19.9	1.4	1.0	17.4	0.8	0.8	0.3	2.9	0.4	0.3	3.1	0.7	0.3	0.2	0.3	2.7	0.4	23.2	33.9	20.2	1.3	1.0	1.6	0.9	0.0	0.3	0.3	0.1	0.0	0.2	0.1	0.6	0.1	1.7	1.3	0.2	1.6	0.2	0.2	0.1	3.5	1.6	3.1	4.6	1.2	0.1	2.0	3.2	0.2	0.4	0.1	0.3	0.0	0.8	1.5	0.1	1.5	1.2	4.0	1.1	2.8	0.3	0.2	1.0	0.0	0.6	1.2	1.5	0.9	1.3	0.6	1.5	2.0	1.8	1.3	0.6	0.7	3.0	2.3	1.6	0.6	0.7	2.4	0.2	2.7	0.1	0.1	33.9	0.1	14.4	0.2	0.4	22.9	0.0	0.2	0.2	27.3	1.7	23.2	0.4	0.3	0.0	20.2	2.2	2.6	15.2	3.1	1.6	2.2	1.6	0.3	0.6	0.3
CD163L1	"CD163B, M160, SCARI2, WC1"	ENSG00000177675	"CD163 molecule like 1"	Q9NR16	12	7346685-7479897	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 31.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.2;HUVEC TERT2: 8.8;TIME: 8.3;U-87 MG: 19.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA015663	Enhanced		Approved	Nucleoplasm,Centrosome,Cytosol	"Intracellular and membrane"	170000	170000	"Centrosome, Cytosol"	"Centrosome, Cytosol"	"HPA015663: AB_2072575"	"unprognostic (1.25e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.46e-3)"	"unprognostic (2.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (9.39e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.26e-6)"	"unprognostic (8.59e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-1)"	5.0	1.7	1.2	19.1	1.2	0.0	2.5	0.8	1.6	1.4	9.2	0.3	1.0	5.5	1.2	8.5	1.8	1.3	2.6	3.2	1.2	1.0	1.7	1.5	2.8	14.6	1.1	0.7	1.0	1.0	0.1	1.4	6.8	3.3	1.4	15.1	2.7	2.5	1.4	1.1	1.4	18.4	1.8	1.0	31.2	2.6	4.6	0.2	9.5	1.7	6.4	12.9	4.3	1.2	0.2	0.7	0.7	0.8	0.0	0.0	0.2	0.2	0.4	0.2	0.0	1.0	0.3	0.0	0.8	1.8	0.2	0.8	0.0	1.4	0.0	0.3	0.8	0.0	0.0	1.1	1.4	8.2	0.0	0.0	0.4	1.2	0.0	0.5	0.0	0.3	0.0	0.2	3.3	8.8	0.1	4.7	5.2	0.0	0.0	6.5	0.2	0.0	1.5	1.5	1.8	0.0	0.0	1.2	5.5	4.3	6.8	0.0	0.0	5.4	8.3	3.0	2.7	0.3	0.0	0.1	0.1	0.0	19.4	0.4	5.7	0.0	0.8	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.2	1.2	0.8	1.6	1.2	1.0	1.1	0.7	3.3	0.2
CD177	"HNA2A, NB1, PRV1"	ENSG00000204936	"CD177 molecule"		19	43353659-43363172	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"bone marrow: 67.6;intestine: 43.5;lymphoid tissue: 33.9;vagina: 30.8"	"Cell line enriched"	"Detected in some"	24	"RPMI-8226: 44.9"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 27.6"					"Cell type enriched"	"Detected in some"	7	"neutrophil: 11.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 11.3"									"HPA041820, HPA046601"	Enhanced				"Intracellular and membrane"					"HPA041820: AB_2677691, HPA046601: AB_2679716"	"unprognostic (4.32e-2)"	"prognostic favourable (3.66e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-3)"	"unprognostic (1.61e-1)"	"unprognostic (3.89e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (1.24e-1)"	1.0	0.0	0.0	8.3	0.0	67.6	0.7	0.0	0.9	2.3	39.5	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	17.3	0.0		0.0	2.1	16.6	26.6	0.1	0.0	2.0	1.0	0.0	0.0	0.4	1.9	17.3	43.5	0.9	0.0	0.0	0.0	0.0	0.0	0.6	4.8	33.9	0.0	1.1	0.0	2.0	1.3	7.2	2.3	0.8	30.8	0.0	0.0	11.3	1.6	0.0	0.9	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.6	0.3	0.3	0.0	0.0	0.0	1.2	0.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.6	0.1	0.0	0.0	44.9	0.7	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	1.6	0.0	0.9	0.0										
CDC42EP5	"Borg3, CEP5"	ENSG00000167617	"CDC42 effector protein 5"	Q6NZY7	19	54465026-54473264	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.7"	"Cell line enhanced"	"Detected in some"		"AF22: 1.5;ASC TERT1: 1.8;BEWO: 1.4;CACO-2: 2.6;HBEC3-KT: 1.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA043449	Approved									"HPA043449: AB_10961041"	"unprognostic (7.67e-2)"	"unprognostic (1.24e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.36e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.49e-2)"	"unprognostic (4.13e-2)"	"prognostic unfavourable (2.79e-5)"	"unprognostic (1.73e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.37e-3)"	"prognostic favourable (1.36e-4)"	11.0	1.8	0.0	9.6	0.1	1.8	8.1	0.0	1.8	12.9	32.7	0.4	2.7	1.8	6.1	4.5	7.3	4.1	7.2	7.2	0.0	0.0	4.2	1.8	9.4	10.4	0.7	0.0	5.9	3.8	1.8	1.1	5.8	0.4	17.0	1.8	4.4	9.8	2.9	4.7	2.7	29.4	6.3	0.9	4.8	6.1	7.9	0.0	4.4	2.8	5.3	6.5	17.7	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	1.8	1.4	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.7	0.0	0.4	0.0
CDCA3	"GRCC8, TOME-1"	ENSG00000111665	"Cell division cycle associated 3"	Q99618	12	6844793-6852066	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.6;lymphoid tissue: 51.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 8.8"	"Cell type enhanced"	"Detected in many"		"T-reg: 7.7"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA026587			Approved	Cytosol				Cytosol	Cytosol	"HPA026587: AB_1846386"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavourable (6.51e-5)"	"prognostic unfavourable (9.77e-5)"	"unprognostic (3.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-3)"	"unprognostic (8.81e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.94e-2)"	1.6	1.9	1.0	19.2	1.8	9.9	1.9	8.8	2.2	2.0	17.3	1.2	1.2	15.5	2.3	2.0	6.9	1.0	2.9	2.2	1.1	1.6	1.3	0.9	1.9	10.8	1.3	0.7	3.7	0.6	0.3	6.9	4.7	1.2	2.2	5.3	0.7	2.4	0.4	0.7	4.3	34.6	2.0	1.4	5.2	2.4	18.2	1.1	51.0	1.3	8.5	15.1	1.6	2.8	1.6	2.3	0.5	0.6	0.8	7.7	0.9	29.8	21.6	22.1	13.4	1.3	2.0	25.6	19.7	12.1	32.4	22.6	32.0	25.7	16.5	2.5	14.8	20.5	14.1	13.6	32.2	24.8	15.7	14.8	14.4	20.8	0.2	11.0	14.2	0.9	1.1	17.4	9.5	13.7	12.3	10.8	30.8	23.3	16.0	12.7	25.7	16.7	16.2	19.2	9.3	10.7	8.4	3.4	6.6	17.8	16.6	6.1	6.5	10.7	6.0	15.8	20.5	10.3	33.0	5.5	5.6	25.8	7.4	13.7	27.8	0.0	0.6	0.0	0.5	0.3	0.8	1.6	1.3	1.9	0.7	0.8	0.6	1.2	0.5	0.8	0.5	2.3	7.7	0.9	1.0	1.8	8.8	2.2	1.1	1.6	1.3	0.7	1.2	1.1
CDH1	"CD324, UVO, uvomorulin"	ENSG00000039068	"Cadherin 1"	P12830	16	68737225-68835548	"Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 125.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 105.6;CACO-2: 35.5;CAPAN-2: 49.6;HaCaT: 47.9;hTCEpi: 33.8;MCF7: 29.3;RT4: 36.5;T-47d: 31.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	12	"myeloid DC: 2.8;plasmacytoid DC: 8.5"	"Lineage enriched"	"Detected in single"	18	"dendritic cells: 8.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000087, HPA004812, CAB028364, CAB072855, CAB072856, CAB072857"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		22000000	22000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB000087: AB_2533003, CAB028364: AB_2076812, CAB072855: , CAB072856: AB_2665699, CAB072857: AB_2665700, HPA004812: AB_1078369"	"unprognostic (3.95e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.04e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.61e-1)"	"prognostic favourable (2.06e-4)"	"unprognostic (1.21e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.51e-1)"	"unprognostic (5.92e-2)"	1.1	0.7	1.3	14.8	1.5	0.5	15.3	0.8	1.1	14.4	63.8	1.8	42.4	25.5	4.7	18.6	48.5	9.7	48.9	0.8	1.5	1.0	24.2	64.9	24.4	0.5	1.8	0.9	5.6	71.5	62.2	13.2	55.2	2.8	28.9	25.9	11.8	66.6	43.7	0.8	30.5	125.5	1.5	1.1	3.5	21.6	2.1	1.8	11.7	83.0	26.2	32.6	16.8	21.7	0.0	8.5	0.0	0.0	0.3	0.4	0.1	21.3	2.2	0.0	0.0	0.0	0.0	105.6	0.0	0.0	0.0	0.0	35.5	49.6	0.0	0.4	0.0	47.9	0.0	23.8	0.0	4.1	0.6	0.0	0.1	7.6	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	29.3	0.0	0.1	0.8	0.1	0.0	0.0	0.3	8.7	36.5	1.3	0.1	0.2	0.0	9.0	31.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	2.8	0.0	0.0	0.0	0.0	0.3	0.0	8.5	0.1	0.1	1.3	1.5	0.8	1.1	1.5	1.0	1.8	0.9	2.8	1.8
CDKN2B	"CDK4I, INK4B, MTS2, P15, p15INK4b, TP15"	ENSG00000147883	"Cyclin dependent kinase inhibitor 2B"	P42772	9	22002903-22009363	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 14.6;ASC TERT1: 20.1;HaCaT: 17.4;HeLa: 16.4;SiHa: 22.0;SK-MEL-30: 15.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"classical monocyte: 4.6;intermediate monocyte: 3.9;non-classical monocyte: 10.9"	"Lineage enriched"	"Detected in single"	16	"monocytes: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB000349, HPA052838, HPA063327"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB000349: , HPA052838: , HPA063327: AB_2684987"	"unprognostic (2.30e-1)"	"unprognostic (9.23e-2)"	"unprognostic (2.19e-1)"	"prognostic unfavourable (4.47e-6)"	"unprognostic (2.10e-1)"	"unprognostic (7.40e-2)"	"prognostic unfavourable (1.49e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (1.03e-4)"	"unprognostic (9.14e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.28e-2)"	22.4	1.4	1.4	7.3	1.1	0.0	25.1	0.8	1.2	6.6	35.4	1.4	1.5	14.1	2.6	0.8	27.0	1.2	1.4	1.4	1.6	0.8	0.5	0.6	9.9	2.3	2.0	0.8	0.8	1.0	3.9	7.8	3.7	3.4	3.1	13.4	0.7	5.1	3.2	6.5	8.6	47.0	3.2	1.0	4.4	3.9	3.3	1.3	1.1	0.8	9.8	12.5	2.8	16.6	0.0	0.6	0.0	10.9	0.0	0.4	1.3	0.0	0.0	0.1	1.0	14.6	20.1	0.3	0.7	0.0	2.3	6.4	1.6	4.4	0.0	1.8	1.0	17.4	0.4	3.4	2.7	1.1	5.4	0.0	16.4	0.7	7.4	0.5	2.9	4.1	0.0	2.9	12.9	2.2	0.0	7.8	3.6	1.3	0.0	0.0	0.8	10.1	0.0	1.0	0.3	4.9	0.0	2.8	0.0	22.0	5.7	15.8	1.2	0.0	5.6	0.0	0.4	0.0	0.0	7.4	4.2	0.1	0.0	0.5	0.0	0.0	4.6	0.0	0.1	3.9	0.0	0.0	0.4	0.3	0.6	0.0	0.0	0.1	0.0	0.0	10.9	0.0	0.1	1.3	1.4	1.1	0.8	1.2	1.6	0.8	2.0	0.8	3.4	1.3
CDS1		ENSG00000163624	"CDP-diacylglycerol synthase 1"	Q92903	4	84582979-84651338	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.6;hTCEpi: 25.8;SK-BR-3: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	5	"myeloid DC: 2.1"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036187, HPA064546"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA036187: AB_10601797, HPA064546: AB_2732714"	"unprognostic (8.74e-2)"	"unprognostic (7.11e-2)"	"prognostic favourable (5.22e-4)"	"unprognostic (2.73e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.10e-3)"	"unprognostic (3.11e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.67e-2)"	"prognostic favourable (0.00e+0)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.06e-1)"	0.9	4.6	7.4	2.5	10.4	0.4	6.7	13.3	12.9	4.3	16.7	3.3	9.3	24.8	2.0	19.1	17.4	20.5	8.8	0.5	7.4	8.4	11.9	0.6	10.6	0.8	6.4	4.7	5.5	4.5	19.3	7.1	19.7	14.1	6.1	13.6	4.2	11.2	4.3	0.2	12.9	48.0	0.8	2.4	1.0	11.5	5.1	2.3	0.9	19.3	7.9	6.1	3.5	7.4	0.0	2.1	0.0	0.0	0.0	0.4	0.0	11.5	0.2	0.6	0.1	0.0	0.0	12.1	0.0	0.1	0.3	0.2	4.9	20.6	0.0	0.9	0.0	12.1	3.8	10.2	0.1	0.8	5.7	0.0	1.8	1.1	0.0	0.3	0.8	0.1	25.8	0.0	3.7	0.0	0.0	0.0	0.0	8.1	0.1	0.0	1.7	0.8	0.0	0.0	2.4	5.8	8.8	4.8	0.1	1.3	28.0	0.0	8.5	0.2	0.0	0.0	0.7	1.3	1.5	0.0	0.0	0.0	1.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.4	10.4	13.3	12.9	7.4	8.4	6.4	4.7	14.1	2.3
CEACAM1	"BGP, BGP1, CD66a"	ENSG00000079385	"Carcinoembryonic antigen related cell adhesion molecule 1"	P13688	19	42507304-42561234	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 58.7;liver: 46.1;lymphoid tissue: 46.5"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 12.5;Hep G2: 35.4;RT4: 23.3;SK-MEL-30: 26.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"eosinophil: 20.6;neutrophil: 12.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.6"									"CAB002146, HPA011041"	Enhanced				"Intracellular and membrane"	180000000	180000000			"CAB002146: AB_563614, HPA011041: AB_1078481"	"unprognostic (7.13e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.67e-2)"	"prognostic favourable (6.32e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.45e-2)"	"unprognostic (4.43e-1)"	"unprognostic (5.46e-3)"	"unprognostic (4.87e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.55e-2)"	"unprognostic (5.52e-3)"	5.3	5.0	0.4	30.2	0.7	15.8	5.3	0.5	0.5	7.7	58.7	0.9	2.5	11.8	3.5	1.5	35.6	1.7	4.3	3.8	0.5	0.5	24.0	46.1	5.4	8.6	1.8	0.0	2.5	1.0	0.0	3.7	16.8	1.0	8.8	35.6	1.7	20.7	5.4	0.9	1.7	54.9	3.0	1.5	5.5	3.6	1.3	0.7	1.2	2.3	18.5	46.5	7.8	12.7	1.9	0.1	20.6	1.8	0.0	1.5	0.3	0.1	2.3	0.1	0.1	0.0	0.0	6.0	0.0	0.1	0.4	0.2	0.9	12.5	0.7	5.0	0.0	0.3	0.0	3.4	0.1	0.0	0.2	0.1	0.1	35.4	0.7	0.0	5.1	0.0	0.0	0.0	0.0	0.3	0.0	1.6	0.0	0.4	0.1	0.0	0.1	0.7	0.7	0.0	0.5	0.2	23.3	0.1	0.0	0.0	0.0	26.2	0.1	0.0	0.8	0.1	0.2	0.1	0.1	0.7	0.0	1.3	0.0	0.1	0.1	0.4	0.0	20.6	0.0	0.9	0.2	1.9	0.5	0.2	0.1	0.3	0.4	0.1	12.7	0.0	1.8	0.0	1.5	0.3	0.4	0.7	0.5	0.5	0.5	0.5	1.8	0.0	1.0	0.7
CEACAM5	"CD66e, CEA"	ENSG00000105388	"Carcinoembryonic antigen related cell adhesion molecule 5"	P06731	19	41708585-41729798	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 17.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 1007.1"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											"CAB000021, CAB000022, HPA011041, HPA019758"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	19000000	19000000	"Plasma membrane"	"Plasma membrane"	"CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326"	"unprognostic (1.54e-2)"	"unprognostic (7.59e-2)"	"unprognostic (5.49e-3)"	"unprognostic (1.80e-1)"		"unprognostic (1.38e-2)"		"unprognostic (2.22e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.67e-9)"	"unprognostic (2.92e-1)"	"unprognostic (2.71e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.85e-1)"	0.1	0.1	0.1	78.8	0.1	0.0	0.1	0.1	0.2	12.5	117.1	0.2	0.1	2.5	0.9	0.1	103.5	0.3	1.2	0.1	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.1	0.2	0.2	0.0	0.2	0.5	0.1	0.3	118.2	0.2	6.8	0.1	0.1	0.6	12.8	3.3	0.1	0.1	20.1	0.2	0.1	0.6	0.2	29.4	100.6	2.0	14.1	0.6	0.6	1.8	0.7	0.6	0.5	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	2.6	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.2	0.0	0.4	1.4	0.3	0.0	0.1	0.0	0.5	0.9	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	1.2	0.3	0.8	0.3	0.2	0.1	0.5	0.2	0.3	0.6	0.6	0.4	0.5	1.8	0.6	0.7	0.5	0.3	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1
CEACAM7	"CEA, CGM2"	ENSG00000007306	"Carcinoembryonic antigen related cell adhesion molecule 7"	Q14002	19	41673307-41706976	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 100.5;lymphoid tissue: 60.9"	"Cell line enhanced"	"Detected in some"		"HaCaT: 2.8;U-2 OS: 1.4;U-266/84: 2.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 66.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA069621	Supported				"Intracellular and membrane"					"HPA069621: AB_2686162"	"unprognostic (5.24e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.64e-2)"	"unprognostic (6.03e-2)"		"unprognostic (2.07e-2)"		"unprognostic (4.30e-2)"			"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"		"unprognostic (4.66e-2)"	"unprognostic (1.86e-1)"		"unprognostic (3.14e-1)"	0.1	0.1	0.1	60.9	0.1	0.0	0.1	0.1	0.1	9.2	90.0	0.1	0.1	0.0	0.6	0.1	21.1	0.3	5.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	2.0	0.0	0.1	0.3	0.1	0.3	100.5	0.2	1.5	0.1	0.1	0.5	0.2	0.7	0.1	0.1	0.2	0.1	0.1	0.1	0.1	12.1	19.4	6.1	13.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.0	2.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.8	0.1	2.3	0.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1
CES3	"ES31, FLJ21736"	ENSG00000172828	"Carboxylesterase 3"	Q6UWW8	16	66961237-66975148	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.8;liver: 26.7"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 8.9;Daudi: 9.8;U-937: 8.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA041008, HPA041307"	Approved		Approved	"Nuclear membrane,Endoplasmic reticulum"	"Intracellular and membrane"	1200000	1200000	"Nuclear membrane, Endoplasmic reticulum"	"Nuclear membrane, Endoplasmic reticulum"	"HPA041008: AB_2677247, HPA041307: AB_2677400"	"unprognostic (3.91e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.94e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.32e-2)"	"unprognostic (7.84e-4)"	"prognostic favourable (7.26e-5)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.75e-1)"	"unprognostic (3.31e-2)"	"unprognostic (7.41e-2)"	0.5	0.1	0.8	13.3	1.3	0.2	1.0	1.6	1.3	0.6	40.7	0.7	1.4	16.8	0.4	0.7	2.2	1.5	3.0	0.7	1.5	1.0	6.8	26.7	0.9	0.2	0.8	1.1	0.5	7.8	0.0	1.1	0.4	2.2	0.4	17.9	1.1	5.9	0.6	12.9	0.5	41.8	0.5	0.9	0.2	4.6	0.9	0.6	0.5	0.4	2.4	0.5	0.4	0.3	0.7	0.6	2.7	0.6	0.3	0.9	0.2	0.5	3.5	0.4	8.9	0.3	0.2	1.4	0.3	0.2	0.4	0.6	0.5	4.4	9.8	3.0	0.0	0.7	1.4	0.7	0.2	1.6	6.5	4.9	1.4	2.9	0.1	1.1	0.7	0.4	1.1	1.0	0.2	0.0	3.1	2.1	0.4	1.4	1.6	1.7	1.5	0.6	1.5	0.8	1.5	0.1	0.5	0.5	1.0	0.3	6.7	0.2	5.9	7.5	0.4	0.5	2.8	0.8	0.2	1.1	4.0	1.4	0.3	8.3	0.3	0.6	0.6	2.7	0.3	0.3	0.5	0.5	0.6	0.4	0.6	0.7	0.9	0.6	2.0	0.3	0.4	0.3	0.9	0.2	0.8	1.3	1.6	1.3	1.5	1.0	0.8	1.1	2.2	0.6
CGN	KIAA1319	ENSG00000143375	Cingulin	Q9P2M7	1	151510510-151538692	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 15.0;CACO-2: 37.3;CAPAN-2: 24.6;RT4: 18.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB017193, HPA027586, HPA027587, HPA027657"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		24000000	24000000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB017193: , HPA027586: AB_10600208, HPA027587: AB_10601884, HPA027657: AB_10611527"	"unprognostic (1.57e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (8.38e-2)"	"unprognostic (4.61e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.96e-3)"	"unprognostic (7.10e-2)"	"prognostic favourable (5.84e-10)"	"unprognostic (2.66e-1)"	"unprognostic (3.00e-1)"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-2)"	3.9	0.3	2.1	8.5	5.1	0.0	4.1	11.9	3.5	2.2	18.0	3.7	15.5	23.9	1.0	3.5	5.9	6.1	11.9	0.5	1.4	1.4	10.7	15.0	12.4	0.2	5.0	1.0	1.4	25.3	22.1	4.7	1.9	4.8	4.6	11.6	1.8	19.8	14.4	0.2	11.6	44.1	1.8	1.9	0.2	13.6	6.4	4.3	0.9	3.6	2.3	4.3	6.9	3.8	1.2	0.9	2.6	1.0	1.6	2.4	0.1	11.7	1.3	1.1	1.9	0.0	0.0	15.0	0.0	0.0	0.3	0.4	37.3	24.6	0.5	4.0	0.0	11.2	3.6	2.1	0.2	7.0	2.5	1.0	0.5	0.8	0.0	0.2	1.6	0.0	0.4	0.5	0.3	0.1	0.5	3.6	0.0	10.8	2.0	0.2	9.6	1.0	2.2	1.2	1.7	7.9	18.1	3.8	1.9	0.7	11.4	0.4	14.1	0.1	0.2	0.1	3.6	0.2	0.5	3.3	3.3	2.1	0.1	1.3	0.9	1.1	1.0	0.4	2.4	0.4	0.7	0.7	0.7	0.5	0.1	1.2	0.8	1.4	2.6	1.6	0.5	0.9	0.7	0.1	2.1	5.1	11.9	3.5	1.4	1.4	5.0	1.0	4.8	4.3
CHMP4C	"MGC22825, Shax3, VPS32C"	ENSG00000164695	"Charged multivesicular body protein 4C"	Q96CF2	8	81732434-81759515	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.3"	"Cell line enhanced"	"Detected in many"		"A-431: 16.7;CAPAN-2: 19.3;hTCEpi: 24.4;hTERT-HME1: 19.9;RPTEC TERT1: 17.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"NK-cell: 5.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023799	Enhanced									"HPA023799: AB_1846670"	"unprognostic (3.98e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.19e-2)"	"unprognostic (3.12e-2)"	"unprognostic (2.45e-2)"	"unprognostic (5.75e-2)"	"prognostic unfavourable (9.33e-5)"	"unprognostic (7.54e-2)"	"unprognostic (8.08e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.99e-2)"	"prognostic favourable (1.96e-6)"	"unprognostic (3.29e-3)"	"unprognostic (4.95e-1)"	"unprognostic (2.67e-1)"	"prognostic favourable (6.45e-4)"	1.3	5.0	0.5	3.4	1.2	0.1	8.2	0.3	0.7	4.4	26.4	0.4	17.4	21.1	1.5	10.9	16.9	4.2	14.5	4.1	0.6	0.5	12.8	11.7	7.0	0.7	0.6	0.8	1.3	31.8	6.1	13.8	17.5	3.0	8.2	7.4	2.6	30.7	16.1	0.4	21.5	45.3	1.1	0.7	5.6	11.9	1.9	0.4	1.1	20.5	11.5	8.0	6.5	10.2	1.3	0.4	1.4	0.4	5.3	0.2	0.3	16.7	3.5	0.0	0.1	0.0	0.0	7.8	0.9	1.0	0.0	0.0	6.5	19.3	0.0	13.7	0.0	10.3	0.1	7.3	0.0	0.0	8.4	0.3	4.9	6.2	0.3	0.0	0.0	0.0	24.4	0.0	19.9	0.0	4.5	5.8	0.0	8.3	0.0	0.1	0.0	7.0	0.0	0.0	3.7	17.2	10.1	3.7	0.0	4.6	7.7	0.0	11.2	0.1	0.0	0.0	4.2	0.0	0.1	3.1	1.9	0.0	0.0	0.1	0.0	1.4	0.4	0.2	0.2	0.1	0.2	1.3	0.2	0.1	0.1	0.6	0.2	0.2	1.2	5.3	0.2	0.4	0.1	0.3	0.5	1.2	0.3	0.7	0.6	0.5	0.6	0.8	3.0	0.4
CHN2	"ARHGAP3, RhoGAP3"	ENSG00000106069	"Chimerin 2"	P52757	7	29146569-29514328	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 89.2;intestine: 44.3"	"Cell line enhanced"	"Detected in many"		"HEL: 18.2;HMC-1: 35.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA018989	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA018989: AB_1846681"	"unprognostic (3.88e-2)"	"unprognostic (2.36e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.71e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.58e-3)"	2.7	4.4	7.9	3.3	21.8	1.4	2.1	89.2	14.7	6.6	14.1	19.2	0.3	44.3	2.7	2.1	1.9	5.0	4.8	6.9	10.5	7.0	8.2	22.0	3.7	2.0	34.7	6.9	13.4	13.9	0.5	1.9	6.4	16.5	5.3	5.9	4.6	1.6	2.9	2.7	1.5	36.3	3.0	16.5	5.1	4.2	2.3	29.2	0.8	4.7	0.0	1.7	3.5	4.0	0.3	8.5	3.9	11.2	9.3	2.5	2.6	0.1	0.4	1.6	0.0	0.0	0.0	9.4	0.0	0.0	0.4	0.0	5.0	1.5	0.5	3.1	0.1	2.6	5.0	0.0	0.0	8.9	1.6	18.2	0.8	9.7	0.1	0.0	35.5	0.0	3.3	0.0	0.7	1.9	0.7	0.2	0.1	0.2	4.9	0.2	0.6	1.7	0.4	0.0	0.9	9.2	6.2	9.5	0.7	2.2	3.3	5.8	0.3	1.0	0.2	0.5	0.1	0.0	0.2	1.8	7.0	0.0	0.1	1.1	0.7	3.9	10.5	0.1	2.5	11.2	1.8	0.3	0.4	2.2	8.5	0.2	0.5	1.0	0.6	9.3	6.4	1.0	0.0	2.6	7.9	21.8	89.2	14.7	10.5	7.0	34.7	6.9	16.5	29.2
CHRM4		ENSG00000180720	"Cholinergic receptor muscarinic 4"	P08173	11	46385098-46386608	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 11.7;intestine: 8.0;lymphoid tissue: 17.2"	"Cell line enhanced"	"Detected in some"		"RH-30: 4.9;SCLC-21H: 14.2;U-2 OS: 4.1"	"Low cancer specificity"	"Detected in single"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"amygdala: 26.8;basal ganglia: 65.9;cerebral cortex: 30.5;hippocampal formation: 26.4;olfactory region: 36.4"	"Group enriched"	"Detected in many"	7	"amygdala: 5.5;basal ganglia: 15.3;cerebral cortex: 8.6;hippocampal formation: 7.6;olfactory region: 20.1"	"CAB022444, HPA072083"	Enhanced		Uncertain	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"CAB022444: , HPA072083: "	"unprognostic (7.11e-2)"	"unprognostic (3.79e-1)"	"unprognostic (5.31e-2)"	"unprognostic (7.38e-2)"	"unprognostic (8.63e-3)"	"unprognostic (1.38e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.96e-3)"	"unprognostic (4.08e-3)"	"unprognostic (5.02e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.56e-1)"	"unprognostic (5.08e-2)"	0.0	0.5	1.1	0.2	11.7	1.6	0.0	0.0	6.0	0.0	0.6			3.7	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.6	0.0	0.0	0.2	0.0	0.2		0.0	0.2	0.0	0.5	0.0		0.0	0.1		0.0	0.0	0.0	1.2	8.0	0.1	0.0	17.2	0.8	4.1			0.0		0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	3.0	0.0	0.1	0.2	0.1	1.4	0.2	0.3	0.3	0.0	0.1	1.8	0.1	0.0	2.1	0.3	0.5	0.2	0.0	0.2	0.5	0.6	0.0	0.0	0.1	0.1	0.1	0.6	0.2	0.0	1.0	0.2	0.2	0.6	0.2	0.0	4.9	0.0	0.0	0.1	14.2	0.3	0.4	0.1	0.1	0.1	2.4	0.0	0.4	4.1	0.0	0.1	0.7	0.5	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2										
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.2"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.2;RT4: 12.0;SH-SY5Y: 6.7;SK-BR-3: 13.2;U-2 OS: 10.9"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA029422, CAB033624"	Enhanced									"CAB033624: AB_784835, HPA029422: "	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.8	12.9	4.4	1.5	3.4	2.3	2.0	0.9	8.4	1.1	12.2	1.0	1.1	7.9	1.4	0.8	0.8	0.7	4.6	1.2	2.5	5.6	0.9	0.4	1.2	2.0	3.8	2.7	2.9	4.9	1.8	2.0	0.4	11.8	2.2	4.0	11.7	2.1	1.2	0.8	0.7	27.2	0.9	3.1	5.2	11.2	5.1	0.6	0.1	4.3	0.9	1.4	3.1	2.0	0.3	1.2	3.1	1.1	1.8	0.7	0.4	0.0	1.4	2.3	6.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	2.9	0.0	0.0	0.0	1.8	0.4	0.0	1.8	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.2	1.1	0.0	0.0	3.7	0.2	0.2	12.0	0.5	6.7	0.2	13.2	0.0	0.0	0.0	0.7	0.0	10.9	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	1.5	1.1	3.1	0.7	0.4	0.2	0.3	0.4	0.1	1.2	0.2	0.2	0.3	0.7	1.8	0.6	0.7	0.5	0.4	4.4	3.4	0.9	8.4	2.5	5.6	3.8	2.7	11.8	0.6
CIB2	"DFNB48, KIP2, USH1J"	ENSG00000136425	"Calcium and integrin binding family member 2"	O75838	15	78104606-78131544	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 45.5;intestine: 48.5"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.0;HAP1: 18.4;NTERA-2: 15.3;SCLC-21H: 19.0;SH-SY5Y: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	51	"plasmacytoid DC: 16.1"	"Lineage enriched"	"Detected in single"	51	"dendritic cells: 16.1"	"Low region specificity"	"Detected in all"							HPA036697	Approved									"HPA036697: AB_10672475"	"unprognostic (5.77e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.81e-2)"	"prognostic unfavourable (7.05e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.73e-3)"	"unprognostic (1.66e-1)"	"unprognostic (9.94e-3)"	"unprognostic (3.18e-1)"	"unprognostic (7.49e-2)"	"prognostic favourable (6.16e-4)"	"unprognostic (9.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.64e-3)"	5.8	8.8	9.7	3.4	6.7	1.2	6.0	5.1	8.2	9.6	11.0	3.5	2.8	16.0	6.1	3.2	4.2	4.3	3.2	45.5	7.2	6.8	7.0	0.8	1.9	3.3	6.9	4.9	6.9	13.0	9.2	7.1	4.8	9.1	7.9	6.3	4.2	6.8	8.2	6.3	4.2	48.5	7.5	4.1	3.7	2.7	13.4	2.0	35.0	3.0	1.9	5.4	6.0	7.9	0.0	16.1	0.1	0.0	0.0	0.3	0.1	1.8	4.1	11.8	21.0	0.5	0.7	9.0	1.2	0.4	1.0	2.1	0.0	4.6	0.2	2.4	5.4	1.0	18.4	3.6	0.3	10.4	13.2	1.2	0.7	0.6	2.1	0.0	1.7	1.1	1.6	1.7	1.0	2.1	4.2	0.1	1.9	0.3	0.5	0.2	15.3	0.1	7.8	0.0	0.5	1.3	0.4	19.0	20.0	3.1	1.5	1.6	0.3	1.2	0.1	0.0	10.2	1.1	0.1	0.2	0.2	3.4	0.5	0.0	2.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	16.1	0.0	0.1	9.7	6.7	5.1	8.2	7.2	6.8	6.9	4.9	9.1	2.0
CKMT1A	CKMT1	ENSG00000223572	"Creatine kinase, mitochondrial 1A"	P12532	15	43692886-43699222	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.2;esophagus: 19.9;intestine: 25.5"	"Cell line enhanced"	"Detected in many"		"HaCaT: 42.6;hTCEpi: 19.3;SCLC-21H: 15.1;SK-BR-3: 33.5;T-47d: 29.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043491	Uncertain				"Intracellular and membrane"	2100000	2100000			"HPA043491: AB_2678510"	"unprognostic (2.04e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-1)"	"unprognostic (7.44e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.78e-9)"	"unprognostic (3.52e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.73e-3)"	0.0	0.7	4.8	1.9	6.3	0.0	2.1	17.2	12.6	1.8	25.5			24.7	0.0	0.0	19.9	0.4	3.0	0.0	5.6	7.9	0.9	0.0	0.0	0.0	5.0		0.0	0.1	2.1	1.4	2.5		0.5	24.1		7.2	0.0	0.0	13.0	21.7	0.9	1.1	0.0	7.8	0.0			0.6		4.4	1.4	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.0	0.3	0.0	10.6	0.0	0.0	0.0	0.0	2.2	7.3	0.0	0.4	0.0	42.6	6.1	12.5	0.0	0.0	4.7	0.0	0.7	0.2	0.0	0.0	2.0	0.0	19.3	0.0	3.3	0.0	1.9	0.0	0.0	9.9	0.0	0.0	3.0	2.3	0.0	0.0	1.9	2.0	1.5	15.1	5.9	0.0	33.5	2.2	29.9	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CKMT1B	"CKMT, CKMT1, UMTCK"	ENSG00000237289	"Creatine kinase, mitochondrial 1B"	P12532	15	43593054-43604901	"Enzymes, FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 52.7;intestine: 28.1"	"Cell line enhanced"	"Detected in many"		"HaCaT: 40.4;HBEC3-KT: 15.5;hTCEpi: 20.8;SCLC-21H: 15.6;SK-BR-3: 49.7;T-47d: 28.9"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA043491	Uncertain				"Intracellular and membrane"	2100000	2100000			"HPA043491: AB_2678510"	"unprognostic (3.47e-2)"	"unprognostic (9.73e-3)"	"unprognostic (3.10e-1)"	"prognostic unfavourable (2.55e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (3.64e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.26e-8)"	"unprognostic (1.71e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.43e-2)"	"unprognostic (4.36e-2)"	0.0	0.3	5.4	1.6	8.8	0.0	1.6	52.7	13.6	0.7	28.1			22.4	0.0	0.0	13.8	0.2	2.8	0.0	6.8	7.4	0.9	0.0	0.0	0.0	5.4		0.0	0.2	1.4	1.3	3.7		0.6	23.1		4.8	0.0	0.0	7.6	16.2	1.2	1.8	0.0	10.0	0.0			1.7		4.1	1.7	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	2.3	6.9	0.0	0.3	0.0	40.4	8.1	15.5	0.0	0.1	4.7	0.0	1.0	1.0	0.0	0.0	2.3	0.0	20.8	0.0	1.8	0.0	2.6	0.0	0.0	9.8	0.0	0.0	3.2	4.3	0.0	0.0	0.2	0.7	1.0	15.6	5.5	0.2	49.7	2.9	28.9	0.0	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361651	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 21.0;intestine: 20.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol				Cytosol	Cytosol	"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavourable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.6	5.4	4.9	2.6	8.3	1.3	1.6	8.8	6.3	2.8	20.2	16.9	5.1	11.6	4.5	5.0	1.7	2.8	21.0	1.5	6.3	3.1	3.7	1.8	1.3	1.0	15.3	4.1	6.1	5.9	4.4	4.0	1.5	8.9	2.6	14.0	15.6	3.7	9.0	1.2	2.2	11.8	2.4	10.8	1.6	2.7	11.9	9.8	0.1	3.2	1.3	1.3	2.2	2.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	7.9	2.8	2.3	6.1	2.1	1.8	5.3	2.8	1.6	2.8	1.8	14.9	2.7	2.8	7.9	1.4	13.8	3.3	3.1	0.8	2.5	4.0	2.5	5.8	6.3	1.3	1.0	2.5	3.4	2.5	2.4	2.8	2.7	0.9	1.4	0.9	4.4	0.8	1.3	3.4	4.3	4.9	2.2	9.5	3.5	6.0	3.8	2.3	2.9	10.4	4.7	8.4	1.1	1.3	1.4	4.3	7.0	6.9	3.7	4.8	1.7	2.5	4.8	6.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	8.3	8.8	6.3	6.3	3.1	15.3	4.1	8.9	9.8
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.4;thyroid gland: 91.6"	"Cell line enhanced"	"Detected in some"		"MCF7: 65.0;PC-3: 13.9;RPMI-8226: 11.1;SCLC-21H: 17.2;T-47d: 30.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"cerebellum: 3.1;pons and medulla: 3.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA014361	Enhanced		Supported	"Cell Junctions"		15000	15000	"Cell Junctions"	"Cell Junctions"	"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favourable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.3	0.1	0.1	11.5	0.1	0.2	7.1	3.1	0.2	3.8	77.9	1.6	21.8	24.3	2.8	8.8	0.3	9.4	11.3	0.1	0.2	0.4	20.7	16.0	6.0	0.2	0.0	0.0	4.3	38.0	0.2	7.4	3.1	3.0	14.6	8.0	1.9	31.1	32.1	0.1	2.1	100.4	0.5	0.0	0.1	0.7	1.2	0.0	2.2	91.6	0.9	3.6	0.8	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.5	0.7	1.0	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.2	10.3	0.0	2.9	0.0	0.3	0.1	0.0	0.0	0.0	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.1	0.3	0.6	13.9	0.0	0.0	11.1	0.6	0.0	17.2	0.2	0.0	9.9	0.0	30.9	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	3.1	0.2	0.2	0.4	0.0	0.0	3.0	0.0
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 166.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 26.6;CACO-2: 27.7;CAPAN-2: 53.9;HaCaT: 113.3;MCF7: 39.4;SK-BR-3: 47.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"				Vesicles	Vesicles	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favourable (8.96e-11)"	"prognostic favourable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favourable (1.85e-4)"	"unprognostic (1.62e-1)"	1.6	2.0	0.4	28.0	0.4	0.0	9.5	0.4	0.4	9.9	71.4	0.4	47.6	47.2	2.4	49.3	73.4	13.4	47.2	0.7	0.4	0.3	30.0	12.1	32.3	0.8	0.4	0.4	3.4	70.9	12.3	7.3	25.0	0.4	9.8	42.5	0.7	40.9	42.2	0.9	2.9	166.7	1.8	0.5	1.4	1.2	1.8	0.4	1.5	40.5	28.3	45.6	12.2	19.3	3.8	1.6	0.0	3.0	2.2	6.7	2.3	3.2	0.3	0.0	0.0	0.0	0.2	26.6	0.0	0.0	0.0	0.0	27.7	53.9	0.0	1.0	0.1	113.3	0.0	3.4	0.0	0.0	0.6	0.0	0.7	0.0	2.1	0.0	0.2	0.5	5.4	0.0	0.2	2.5	0.3	0.1	0.0	39.4	0.0	0.3	0.1	1.0	0.0	0.0	0.7	0.0	0.0	6.5	0.1	0.3	47.2	0.0	17.2	0.4	5.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	2.2	3.0	4.8	0.5	1.5	3.3	1.6	3.8	3.7	6.7	0.0	2.2	0.1	0.2	0.9	2.3	0.4	0.4	0.4	0.4	0.4	0.3	0.4	0.4	0.4	0.4
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 65.6;intestine: 46.2;skeletal muscle: 99.9"	"Group enriched"	"Detected in some"	8	"CAPAN-2: 13.3;EFO-21: 9.4;HDLM-2: 4.9;REH: 11.4;U-266/70: 12.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 8.8"	"Lineage enriched"	"Detected in single"	23	"T-cells: 8.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		1000000	1000000	"Plasma membrane"	"Plasma membrane"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	7.4	0.6	0.8	3.2	1.5	0.0	2.3	0.6	1.1	6.0	10.2	0.3	0.4	5.6	0.8	2.5	2.2	1.2	2.1	65.6	0.9	1.2	17.5	0.5	32.8	0.4	1.1	1.4	0.7	0.7	0.4	1.3	22.0	0.8	0.9	7.5	7.8	2.0	0.4	99.9	0.7	46.2	1.4	0.9	16.1	0.9	1.0	0.0	0.2	4.8	18.8	1.5	1.0	4.3	0.3	0.0	0.0	0.0	0.3	8.8	0.8	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.3	0.0	9.4	0.0	0.3	0.0	0.1	0.0	4.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.3	0.0	11.4	0.3	0.1	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.6	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	8.8	0.3	3.6	2.2	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	1.6	0.8	0.8	1.5	0.6	1.1	0.9	1.2	1.1	1.4	0.8	0.0
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892947	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 69.3;kidney: 14.7;liver: 25.6"	"Cell line enriched"	"Detected in some"	6	"CACO-2: 7.0"	"Group enriched"	"Detected in many"	10	"colorectal cancer: 45.3;liver cancer: 9.4;pancreatic cancer: 10.7;renal cancer: 30.0;stomach cancer: 16.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA014482	Approved									"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favourable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.4	0.2	0.3	3.1	0.2	0.0	0.2	0.2	0.3	0.2	27.5	0.3	0.2	23.7	0.2	1.3	0.2	0.1	9.5	0.2	0.3	0.2	14.7	25.6	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	23.5	0.2	0.2	0.2	0.2	0.1	69.3	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	1.4	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.2	7.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.0	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.4	0.0	0.1	0.3	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.2	0.2
CORO2A	"IR10, WDR2"	ENSG00000106789	"Coronin 2A"	Q92828	9	98120975-98192640	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 36.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 33.9;SK-BR-3: 22.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"granulocytes: 10.9;monocytes: 7.0;T-cells: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041161, HPA041302"	Enhanced		Approved	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041161: AB_10795537, HPA041302: AB_10794195"	"unprognostic (4.49e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.39e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.50e-3)"	"unprognostic (2.85e-1)"	"prognostic unfavourable (6.56e-4)"	"unprognostic (4.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.40e-3)"	1.6	0.8	1.2	6.9	1.8	8.1	2.9	9.3	2.4	3.9	22.0	0.7	1.3	20.8	2.0	2.2	13.6	2.7	27.7	1.5	1.3	3.0	1.4	2.9	7.5	1.6	2.6	1.3	1.5	1.4	2.8	5.2	3.5	3.3	9.0	7.9	1.2	5.4	1.9	0.9	6.3	36.1	1.9	0.6	3.8	6.6	11.4	0.6	5.6	1.1	3.6	6.6	7.7	6.2	0.6	0.7	10.9	7.0	1.5	11.1	1.4	4.1	1.4	0.3	1.0	0.6	0.7	33.9	0.3	0.3	1.0	1.6	9.4	0.7	0.0	4.8	0.6	11.5	3.8	6.3	0.7	3.3	0.9	0.1	5.8	8.3	1.4	3.8	0.3	0.2	7.8	0.5	9.5	0.3	3.2	1.9	0.1	3.1	0.7	3.8	4.3	1.1	2.9	0.0	0.1	0.7	11.6	0.8	1.2	2.1	22.8	0.8	2.7	6.3	0.3	0.1	5.0	0.1	1.2	0.3	1.9	0.3	0.2	1.2	1.4	7.7	1.5	10.9	2.4	3.0	5.5	0.6	4.1	3.8	0.5	0.6	2.7	3.5	1.1	1.5	7.0	0.7	11.1	1.4	1.2	1.8	9.3	2.4	1.3	3.0	2.6	1.3	3.3	0.6
CPA6	CPAH	ENSG00000165078	"Carboxypeptidase A6"	Q8N4T0	8	67422038-67746385	"Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2;prostate: 10.6;retina: 13.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.0;CACO-2: 6.2;EFO-21: 3.5;Hep G2: 9.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	10	"olfactory region: 15.5"	"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"						"unprognostic (2.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.23e-2)"	"unprognostic (6.99e-2)"	"unprognostic (3.57e-4)"	"unprognostic (9.61e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.09e-2)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	9.8	0.1	0.2	0.2	0.1	0.1	9.4	16.2	0.7	0.8	0.2	8.3	1.7	3.7	0.2	0.3	0.1	0.2	0.1	0.3	0.1	0.7	0.1	0.2	0.0	0.1	0.1	0.1	0.2	0.3	0.3	10.6	7.2	13.0	0.1	0.7	0.1	0.2	1.3	3.4	0.7	0.3	0.5	1.3	0.0	0.0	0.2	1.5	0.6	4.1	5.5	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	6.2	0.0	0.0	3.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.3	0.0
CTSE		ENSG00000196188	"Cathepsin E"	P14091	1	206009264-206023909	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 57.9;intestine: 47.3;stomach 1: 153.0"	"Group enriched"	"Detected in some"	7	"BEWO: 14.8;RT4: 28.1"	"Group enriched"	"Detected in many"	8	"lung cancer: 68.8;pancreatic cancer: 297.4;stomach cancer: 200.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA012940, CAB032687"	Enhanced				"Intracellular and membrane"					"CAB032687: AB_637901, HPA012940: AB_2668773"	"unprognostic (1.17e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.72e-2)"		"unprognostic (1.35e-2)"	"unprognostic (2.52e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.61e-2)"	"prognostic favourable (5.26e-5)"	0.2	0.1	0.1	3.7	0.1	3.0	0.1	0.1	0.1	0.1	47.3	0.3	0.8	29.3	0.1	0.7	0.6	0.5	57.9	0.3	0.1	0.1	0.2	0.2	24.9	0.0	0.1	0.0	0.1	2.2	0.0	0.5	0.0	0.1	1.3	3.2	0.0	0.1	0.0	0.1	0.1	29.7	0.0	0.1	0.2	153.0	0.1	0.0	0.3	4.2	0.0	1.1	1.8	0.4	0.2	0.7	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.5	0.6	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.6	0.0	0.7	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.9	0.5	0.0	0.2	0.0	0.5	0.6	28.1	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0
CXADR	CAR	ENSG00000154639	"CXADR, Ig-like cell adhesion molecule"	P78310	21	17512382-17593579	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"CACO-2: 31.7;Hep G2: 20.5;NTERA-2: 36.7;RT4: 35.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"											"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	11000	11000	"Plasma membrane, Cell Junctions"	"Plasma membrane, Cell Junctions"	"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	4.0	3.1	6.4	3.2	9.4	1.3	5.8	2.0	15.4	6.3	27.1	12.5	9.0	24.9	3.3	9.3	15.0	6.5	17.2	10.8	7.9	5.5	5.1	28.6	9.9	4.2	9.2	5.6	1.1	12.0	5.2	11.1	0.3	11.6	9.2	15.4	3.7	16.3	15.8	0.6	30.0	41.4	2.1	13.0	1.4	17.6	8.5	6.9	0.9	13.1	4.9	3.8	14.7	10.0	0.8	0.4	2.6	0.5	0.9	2.7	0.9	5.5	3.1	15.2	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.9	31.7	4.9	2.0	6.8	0.0	9.6	7.6	2.0	0.3	3.1	6.5	0.0	9.1	20.5	0.9	0.6	0.0	0.0	8.3	0.4	0.1	3.0	0.1	0.1	0.0	0.3	1.2	0.0	36.7	0.0	0.0	5.1	3.9	12.7	35.4	6.1	4.1	3.6	4.1	2.1	8.4	0.1	0.1	0.0	9.1	0.1	2.2	1.5	2.5	0.1	1.2	0.0	0.2	2.6	0.5	0.4	0.5	0.2	1.0	0.3	2.6	0.6	0.1	0.8	2.7	0.8	1.4	0.9	0.2	0.4	0.5	0.9	6.4	9.4	2.0	15.4	7.9	5.5	9.2	5.6	11.6	6.9
CYP2C18	"CPCI, CYP2C, CYP2C17, P450IIC17"	ENSG00000108242	"Cytochrome P450 family 2 subfamily C member 18"	P33260	10	94683621-94736190	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 62.9;liver: 56.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.2;EFO-21: 1.5;hTCEpi: 2.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 18.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	11	"basophil: 1.7"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.7"														"Intracellular and membrane"						"unprognostic (2.40e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.10e-2)"		"unprognostic (1.32e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.78e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.22e-3)"		"unprognostic (1.62e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.08e-1)"		"unprognostic (6.81e-3)"	0.2	0.0	0.2	0.8	0.2	0.0	0.2	0.2	0.2	2.4	29.2	0.3	0.2	30.2	0.2	0.2	13.5	0.0	6.7	0.2	0.2	0.0	0.2	56.1	0.5	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.5	0.2	0.2	0.5	0.2	2.4	0.2	0.2	1.7	62.9	0.2	0.2	0.2	19.0	0.2	0.2	0.3	0.2	5.0	3.8	0.2	3.7	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.3	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.1	0.1	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.0	0.6	0.2	0.4	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.0	0.1	0.2	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
CYP2J2		ENSG00000134716	"Cytochrome P450 family 2 subfamily J member 2"	P51589	1	59893308-59926790	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 44.9;intestine: 46.6;liver: 74.6"	"Group enriched"	"Detected in some"	6	"RT4: 35.6;SK-BR-3: 9.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"naive CD4 T-cell: 6.0;naive CD8 T-cell: 5.2"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"								"Intracellular and membrane"						"unprognostic (3.53e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.84e-2)"	"unprognostic (7.29e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavourable (5.54e-7)"	"unprognostic (4.96e-1)"	"unprognostic (8.45e-2)"	"unprognostic (4.25e-1)"	"unprognostic (9.70e-2)"	0.8	0.9	8.8	1.2	12.0	0.7	5.8	7.9	8.5	1.2	13.1	22.1	0.0	17.9	1.2	1.1	7.2	1.1	1.7	44.9	9.1	6.9	2.2	74.6	1.4	0.8	13.2	6.3	0.7	1.8	0.6	0.7	11.9	12.3	2.4	12.0	0.5	7.2	1.0	12.2	5.3	46.6	1.6	10.1	0.7	3.0	0.9	15.5	0.0	0.7	0.5	2.3	5.8	1.8	1.8	1.2	0.0	0.0	0.7	6.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.7	0.2	1.6	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.9	1.6	0.0	3.8	0.0	1.9	35.6	0.5	2.3	0.0	9.6	0.3	2.4	0.0	0.0	1.2	1.5	0.0	0.5	1.1	0.1	0.0	0.3	0.0	4.0	0.0	0.0	0.0	0.2	0.0	1.2	1.8	0.7	0.4	0.1	0.9	6.0	5.2	0.0	0.7	0.0	1.2	0.0	1.0	8.8	12.0	7.9	8.5	9.1	6.9	13.2	6.3	12.3	15.5
CYP2S1		ENSG00000167600	"Cytochrome P450 family 2 subfamily S member 1"	Q96SQ9	19	41193049-41207539	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 33.1;gallbladder: 29.1;intestine: 62.7;stomach 1: 45.9"	"Cell line enhanced"	"Detected in many"		"A549: 37.2;CACO-2: 19.2;HaCaT: 19.9;NTERA-2: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"classical monocyte: 9.5;myeloid DC: 33.1"	"Group enriched"	"Detected in many"	121	"dendritic cells: 33.1;monocytes: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049227, HPA069248"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA049227: AB_2680681, HPA069248: AB_2732128"	"unprognostic (1.49e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavourable (1.60e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.66e-2)"	1.2	0.8	0.8	2.3	1.0	0.5	0.6	0.1	1.0	1.7	18.3	1.2	0.5	37.6	0.3	0.9	10.1	2.4	29.1	1.0	1.4	1.6	0.9	2.1	3.8	3.3	5.6	0.4	0.8	0.6	0.0	0.9	1.6	4.5	0.9	7.2	1.1	3.8	0.3	0.1	2.0	62.7	0.6	1.1	4.0	45.9	0.5	1.2	2.6	0.4	15.8	21.0	3.2	2.7	0.0	33.1	0.0	9.5	0.0	0.1	3.9	1.4	37.2	0.0	0.0	0.0	0.0	1.8	0.2	0.3	0.4	0.1	19.2	5.4	0.1	4.4	0.2	19.9	6.5	10.1	0.1	0.0	0.1	5.0	2.0	6.9	7.9	0.0	0.1	0.3	0.5	0.5	0.3	0.3	2.2	0.1	0.0	0.7	0.1	0.1	28.2	4.8	0.1	0.0	0.3	0.6	7.9	0.0	0.2	3.7	0.0	0.0	4.9	1.9	4.2	0.0	1.6	0.7	0.0	0.2	0.0	0.0	0.2	0.8	0.0	0.0	9.5	0.0	0.0	2.3	0.1	0.0	0.0	0.0	33.1	0.0	0.0	0.0	0.0	0.0	1.2	1.3	0.0	3.9	0.8	1.0	0.1	1.0	1.4	1.6	5.6	0.4	4.5	1.2
CYP2W1	"FLJ20359, MGC34287"	ENSG00000073067	"Cytochrome P450 family 2 subfamily W member 1"	Q8TAV3	7	983199-989640	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 18.0;intestine: 9.1;skin 1: 12.1"	"Group enriched"	"Detected in some"	7	"CACO-2: 8.8;Hep G2: 32.0"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 25.3;stomach cancer: 15.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA012753	Uncertain				"Intracellular and membrane"					"HPA012753: AB_1847444"	"unprognostic (7.09e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.72e-5)"	"unprognostic (7.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavourable (5.85e-4)"	0.8	18.0	0.0	1.3	0.0	0.0	0.1	0.0	0.3	0.8	1.4	0.0	0.0	9.1	0.0	0.0	3.6	0.2	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.0	2.4	0.3	0.0	0.3	6.1	0.3	1.9	0.7	1.7	0.3	2.2	0.0	12.1	5.0	0.0	0.7	0.4	0.9	2.4	0.0	0.0	0.0	2.3	0.7	1.1	3.2	0.4	0.1	1.5	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.4	2.8	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.2	0.5	0.2	0.3	0.1	0.2	0.2	0.1	0.4	0.2	0.3	1.5	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.3	0.0
CYP4F12		ENSG00000186204	"Cytochrome P450 family 4 subfamily F member 12"		19	15672757-15697174	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 53.0;liver: 24.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.5;HaCaT: 22.0;Hep G2: 6.1;Karpas-707: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	39	"basophil: 5.3;eosinophil: 13.2"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 13.2"									HPA058960	Approved									"HPA058960: AB_2683862"	"unprognostic (4.30e-4)"	"prognostic favourable (1.21e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.37e-2)"	"unprognostic (5.32e-3)"	"unprognostic (1.84e-3)"	"unprognostic (9.13e-2)"	"unprognostic (9.11e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.45e-2)"	"unprognostic (3.17e-1)"	"prognostic favourable (2.33e-4)"	1.9	0.7	1.6	6.1	0.9	0.6	3.5	0.0	1.9	3.9	24.6	5.6	1.4	24.6	1.4	1.8	11.5	2.1	10.8	1.7	1.9	0.3	1.1	24.2	0.9	0.3	3.0	3.5	1.9	0.2	0.1	0.3	0.4	2.7	4.4	5.1	1.4	3.0	1.5	0.4	12.9	53.0	5.1	0.8	0.7	8.0	0.4	4.8	0.2	0.6	8.9	6.3	10.1	6.5	0.0	0.0	13.2	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.4	0.0	0.0	22.0	0.0	0.0	0.0	1.2	0.0	0.0	0.9	6.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	4.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	13.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	1.9	1.9	0.3	3.0	3.5	2.7	4.8
DAB1		ENSG00000173406	"DAB1, reelin adaptor protein"	O75553	1	56994778-58546734	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.4;intestine: 20.8"	"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 29.3;HeLa: 10.5;NTERA-2: 13.0;RT4: 17.3;WM-115: 14.6"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	5	"cerebellum: 31.4"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 5.5"	"Group enriched"	"Detected in many"	16	"granulocytes: 1.4;T-cells: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032329, HPA052033, HPA067495"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"CAB032329: AB_638973, HPA052033: , HPA067495: AB_2685852"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.09e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.30e-4)"	"unprognostic (3.90e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.06e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.67e-2)"	1.8	1.7	5.8	0.3	3.8	0.0	0.7	31.4	6.2	1.7	1.0	1.8	0.5	15.0	1.0	1.0	0.6	1.6	0.8	1.8	5.3	1.4	0.7	7.5	0.8	0.2	1.1	4.2	1.2	0.7	0.0	0.7	0.0	2.0	4.0	0.3	2.9	5.2	10.2	0.6	0.6	20.8	0.3	1.1	0.6	1.0	0.9	0.7	0.0	0.8	0.0	0.1	1.9	1.0	0.0	0.0	1.4	0.0	0.2	5.5	0.1	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	29.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	13.0	0.0	3.2	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	1.4	0.5	0.0	5.5	0.0	2.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.1	5.8	3.8	31.4	6.2	5.3	1.4	1.1	4.2	2.0	0.7
DCANP1	"C5orf20, DCNP1"	ENSG00000251380	"Dendritic cell associated nuclear protein"	Q8TF63	5	135444214-135447348	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.0;lymphoid tissue: 3.0;skin 1: 2.2"	"Cell line enriched"	"Detected in some"	4	"THP-1: 6.5"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.9;plasmacytoid DC: 1.0"	"Low lineage specificity"	"Detected in many"											HPA048308	Uncertain									"HPA048308: AB_2680349"																		0.2	0.0	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.6			0.0	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.0	0.2	0.2	0.5	3.0	0.2		0.0	0.3	0.0	0.0	0.0		0.1	0.4		0.2	0.1	0.1	2.2	2.0	0.0	0.2	2.7	0.1	0.0			0.2		1.6	0.1	0.2	0.0	1.0	0.1	1.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.5	0.0	1.0	0.0	0.0										
DEGS2	"C14orf66, DES2, FADS8"	ENSG00000168350	"Delta 4-desaturase, sphingolipid 2"	Q6QHC5	14	100143957-100160163	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.5;skin 1: 30.6"	"Cell line enriched"	"Detected in some"	20	"T-47d: 48.0"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 22.9"	"Cell type enhanced"	"Detected in many"		"memory B-cell: 11.9"	"Group enriched"	"Detected in many"	5	"B-cells: 11.9;granulocytes: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046644			Approved	Nucleoplasm,Nucleoli				"Nucleoplasm, Nucleoli"	"Nucleoplasm, Nucleoli"	"HPA046644: AB_2797231"	"unprognostic (8.18e-2)"	"unprognostic (3.83e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.38e-1)"	"prognostic favourable (7.94e-7)"	"unprognostic (1.03e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.66e-4)"	0.4	0.3	2.0	2.3	4.6	0.5	5.8	22.9	6.4	5.3	20.2	1.8	0.6	20.8	3.4	4.6	20.9	1.9	13.3	0.3	2.0	1.5	8.7	17.2	2.6	0.8	2.4	1.4	0.8	13.0	0.3	1.6	0.6	2.7	2.5	4.2	0.8	4.5	2.3	0.5	30.6	44.5	0.7	1.9	0.5	17.9	0.7	0.7	0.0	2.4	7.3	11.1	7.1	5.2	11.9	0.7	6.4	0.5	0.2	1.8	0.8	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	1.8	0.1	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.7	2.4	0.0	0.0	1.4	0.0	48.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.7	0.5	6.4	1.8	0.0	0.0	11.9	0.1	0.8	0.7	5.9	0.0	1.2	0.2	0.2	0.0	0.1	0.0	0.8	2.0	4.6	22.9	6.4	2.0	1.5	2.4	1.4	2.7	0.7
DEPDC7		ENSG00000121690	"DEP domain containing 7"	Q96QD5	11	33015864-33033582	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 51.8;liver: 42.2"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 26.7;RH-30: 20.2;SiHa: 18.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 9.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA015800			Approved	Nucleoplasm,Nucleoli,Cytosol				Nucleoli	Nucleoli	"HPA015800: AB_1847610"	"unprognostic (2.34e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.26e-2)"	"prognostic favourable (7.26e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.89e-2)"	"unprognostic (9.30e-2)"	"unprognostic (8.09e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.94e-2)"	0.6	0.5	2.0	1.4	4.1	0.9	2.0	0.5	2.6	1.7	15.3	4.3	1.2	14.1	1.2	1.4	3.1	0.8	3.1	0.9	2.6	1.4	10.9	42.2	0.7	0.4	4.0	1.5	1.3	2.7	3.5	0.8	1.2	2.8	1.4	3.1	1.2	1.7	1.0	3.3	3.4	51.8	1.0	3.2	0.5	2.2	15.6	3.3	1.8	0.6	2.0	0.9	0.9	2.4	0.0	4.4	9.0	0.7	3.0	3.1	0.6	4.5	2.5	3.7	1.6	1.9	1.9	2.4	8.0	2.7	4.9	6.6	6.5	0.4	0.0	1.8	7.9	4.6	5.3	1.9	5.8	0.0	7.4	1.2	7.8	9.2	1.6	4.3	5.5	2.3	2.9	2.8	2.1	0.0	2.9	0.0	26.7	0.5	0.0	7.0	2.4	0.0	0.0	20.2	0.0	1.6	0.6	0.8	2.1	18.4	3.3	15.9	0.8	2.3	0.0	3.2	5.3	17.1	5.1	0.0	0.0	0.0	1.1	0.0	15.6	4.0	0.7	9.0	0.3	0.2	0.0	0.0	0.6	0.3	4.4	0.0	2.9	3.1	0.0	3.0	0.0	1.8	0.0	0.6	2.0	4.1	0.5	2.6	2.6	1.4	4.0	1.5	2.8	3.3
DHRS9	"3alpha-HSD, RDH15, RDHL, RETSDR8, SDR9C4"	ENSG00000073737	"Dehydrogenase/reductase 9"	Q9BPW9	2	169064789-169096167	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 40.0;blood: 53.1;heart muscle: 32.2;intestine: 30.9"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 8.8;NB-4: 14.4;THP-1: 42.2;TIME: 18.8;U-2197: 13.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 16.6"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 53.1;eosinophil: 23.9;neutrophil: 19.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 53.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA036491, HPA036667"	Approved				"Intracellular and membrane"					"HPA036491: AB_10673498, HPA036667: AB_10670237"	"unprognostic (1.15e-1)"	"unprognostic (3.82e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.80e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.62e-4)"	"prognostic unfavourable (2.73e-4)"	"unprognostic (2.72e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.41e-1)"	40.0	0.1	1.3	14.9	1.0	3.3	2.2	0.3	1.9	4.0	30.9	1.1	0.8	0.6	1.3	0.9	12.8	0.6	2.3	32.2	1.2	0.8	0.4	1.0	9.6	8.0	2.5	1.1	1.2	1.4	0.0	0.3	4.9	1.1	3.5	20.9	0.6	2.9	0.3	1.0	1.5	2.7	3.5	2.4	4.0	4.6	12.3	0.6	0.9	0.5	23.2	12.0	3.7	4.6	1.7	5.4	53.1	6.1	0.0	0.1	1.3	0.0	0.3	0.0	0.0	1.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.4	0.1	0.2	0.5	2.6	8.8	0.4	0.0	0.0	0.0	0.0	14.4	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	42.2	18.8	0.0	0.1	13.9	0.1	0.0	0.0	0.0	0.3	7.5	0.0	53.1	5.4	23.9	0.0	6.1	0.1	1.7	0.0	0.0	5.4	1.0	0.0	0.0	19.5	0.0	1.2	0.4	0.0	1.3	1.3	1.0	0.3	0.7	1.2	0.8	2.5	1.1	1.1	0.6
DIABLO	"DFNA64, DIABLO-S, FLJ10537, FLJ25049, SMAC"	ENSG00000284934	"Diablo IAP-binding mitochondrial protein"	Q9NR28	12	122207662-122227534	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.7;intestine: 5.3;lymphoid tissue: 3.8"	"Cell line enriched"	"Detected in some"	11	"SH-SY5Y: 20.8"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA001825	Uncertain		Approved	Mitochondria		21000	21000	Mitochondria	Mitochondria	"HPA001825: AB_1857247"																		0.1	8.7	0.0	3.8	0.0	0.0	0.0	0.0	0.5	0.2	5.3	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.1	0.0		0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.5	0.0	2.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.9	2.4	0.0	1.2	0.6	1.1	0.6	0.6	2.3	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.5	0.4	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.1	0.7	0.0	0.4	1.8	20.8	0.4	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.2	0.0	0.7	0.5	0.3	1.4	0.6	1.0	0.3	1.0	2.3	0.6	1.2	0.3	1.3	1.1	0.6	0.2	0.4	2.2	0.5										
DNAJC22	"FLJ13236, wus"	ENSG00000178401	"DnaJ heat shock protein family (Hsp40) member C22"	Q8N4W6	12	49346917-49357546	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 10.0;intestine: 10.0;liver: 18.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.2;CACO-2: 17.5;CAPAN-2: 11.0;EFO-21: 18.9;MCF7: 15.4;T-47d: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"midbrain: 1.4"	"Low region specificity"	"Detected in many"			HPA039953			Approved	Vesicles				Vesicles	Vesicles	"HPA039953: AB_2676770"	"unprognostic (5.23e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.01e-2)"	"prognostic favourable (4.56e-5)"	"unprognostic (4.77e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-2)"	"prognostic unfavourable (7.54e-4)"	"unprognostic (6.14e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.18e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-2)"	1.1	0.3	0.5	0.4	1.0	0.0	0.4	0.4	2.2	1.5	5.4	0.8	0.4	10.0	2.2	1.3	0.4	0.8	10.0	0.4	0.7	0.5	5.2	18.9	0.4	0.4	1.0	1.2	0.4	5.2	2.7	0.4	0.9	4.6	0.4	5.2	0.8	1.2	0.4	0.4	0.2	8.3	0.4	0.8	0.4	4.4	0.6	0.4	0.4	6.6	0.4	0.4	0.4	0.7	0.7	0.8	2.7	0.5	0.5	0.5	0.4	1.6	10.4	0.0	11.2	0.0	0.0	3.7	0.4	3.3	1.1	2.4	17.5	11.0	0.0	18.9	0.4	0.1	1.6	0.0	1.9	0.1	2.5	0.3	0.2	8.7	2.7	0.0	1.9	0.1	0.0	1.7	0.3	1.6	0.1	0.3	0.8	15.4	0.0	0.0	0.0	5.4	0.0	5.4	0.1	0.3	0.0	1.8	0.9	0.3	0.5	3.5	13.9	0.2	0.2	1.2	3.5	0.1	1.5	0.0	0.0	0.0	2.6	0.0	2.3	2.3	0.5	0.5	0.5	0.3	0.3	0.4	0.4	0.3	0.1	0.7	0.3	0.3	2.7	0.5	0.4	0.8	0.2	0.4	0.5	1.0	0.4	2.2	0.7	0.5	1.0	1.2	4.6	0.4
DNASE1	DNL1	ENSG00000213918	"Deoxyribonuclease 1"	P24855	16	3611728-3680143	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 26.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA010703	Enhanced		Supported	Vesicles	"Secreted in other tissues"	160000	160000	Vesicles	Vesicles	"HPA010703: AB_10600806"	"unprognostic (5.18e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.69e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.45e-1)"	"prognostic favourable (1.14e-4)"	1.5	1.4	1.5	2.6	1.6	1.7	1.5	3.8	2.5	2.2	12.2	1.8	1.5	14.9	1.5	2.2	3.4	1.2	2.5	1.5	1.5	1.2	11.4	1.5	1.5	4.4	1.5	1.5	2.0	13.7	1.6	12.2	1.9	3.1	5.1	2.1	1.5	3.3	1.5	1.5	3.9	26.7	1.5	1.5	2.3	6.0	2.7	1.5	1.5	1.6	2.6	3.8	1.9	2.3	4.5	2.2	9.2	2.0	1.9	3.4	1.0	2.4	5.7	10.0	5.2	2.9	2.5	4.8	4.0	0.7	3.2	4.7	6.8	6.0	10.5	3.2	0.6	4.2	3.6	1.1	3.5	4.6	5.5	3.7	8.5	4.5	1.5	2.6	8.5	2.0	4.2	4.3	1.0	2.1	9.2	4.7	2.7	10.2	5.2	11.3	6.1	3.1	12.4	4.6	5.1	2.7	2.1	7.1	6.6	2.9	9.1	1.6	9.0	6.5	2.9	6.0	4.5	3.8	2.2	4.2	6.0	18.2	1.7	4.8	5.8	4.3	2.0	5.3	3.0	1.3	1.9	2.5	2.3	2.4	1.0	4.5	2.7	3.4	9.2	1.9	1.2	2.2	2.4	1.0	1.5	1.6	3.8	2.5	1.5	1.2	1.5	1.5	3.1	1.5
DPP4	"ADCP2, CD26, DPPIV"	ENSG00000197635	"Dipeptidyl peptidase 4"	P27487	2	161992241-162074542	"CD markers, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 133.1;parathyroid gland: 75.5"	"Cell line enhanced"	"Detected in some"		"ASC diff: 41.8;ASC TERT1: 42.4;BJ hTERT+: 38.9;RPTEC TERT1: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 26.7"	"Lineage enriched"	"Detected in many"	10	"T-cells: 26.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			CAB045970	Enhanced				"Secreted in other tissues"	170000000	170000000			"CAB045970: AB_11140529"	"unprognostic (4.47e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.58e-1)"	"unprognostic (4.73e-1)"	"unprognostic (2.36e-1)"	"prognostic unfavourable (1.98e-4)"	"prognostic favourable (1.35e-6)"	"unprognostic (4.68e-2)"	"unprognostic (6.33e-2)"	"prognostic favourable (4.99e-4)"	"unprognostic (1.21e-2)"	9.5	2.9	0.3	3.2	0.5	0.0	5.0	0.3	1.4	2.2	50.0	0.2	36.9	19.1	2.2	3.5	1.2	1.2	5.2	2.1	0.4	0.3	29.1	12.2	5.4	2.1	0.4	0.2	2.7	1.8	75.5	0.3	24.0	0.2	21.1	2.8	0.6	46.9	38.8	2.4	4.4	133.1	0.9	0.8	5.0	1.2	0.6	0.1	6.2	1.0	1.4	1.1	1.0	2.6	0.1	2.1	0.3	0.0	2.6	26.7	2.5	0.0	0.0	0.1	0.0	41.8	42.4	0.1	7.7	38.9	2.1	7.6	7.8	0.2	0.0	2.9	13.4	0.2	0.1	0.0	1.3	2.4	0.1	0.0	0.0	11.7	17.1	0.0	0.0	4.8	0.0	13.1	0.1	1.2	0.0	0.0	0.7	0.0	0.7	0.1	0.4	16.0	0.0	0.0	0.1	56.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.9	4.5	0.2	0.2	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	3.2	0.0	26.7	0.1	8.3	5.2	0.6	0.0	8.3	3.3	0.3	2.6	0.0	2.1	0.9	2.5	0.3	0.5	0.3	1.4	0.4	0.3	0.4	0.2	0.2	0.1
DSG2	CDHF5	ENSG00000046604	"Desmoglein 2"	Q14126	18	31498043-31549008	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 37.2;HaCaT: 58.0;HBEC3-KT: 43.0;hTERT-HME1: 46.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	7	"pons and medulla: 6.9"	"Cell type enriched"	"Detected in single"	10	"basophil: 9.5"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA004896, CAB025122"	Enhanced		Supported	"Cell Junctions"		94000000	94000000	"Cell Junctions"	"Cell Junctions"	"CAB025122: , HPA004896: AB_1078643"	"unprognostic (1.56e-3)"	"prognostic unfavourable (8.22e-4)"	"prognostic favourable (7.81e-4)"	"unprognostic (8.77e-3)"	"unprognostic (3.53e-4)"	"prognostic unfavourable (5.63e-4)"	"unprognostic (2.86e-3)"	"prognostic unfavourable (2.43e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (4.94e-5)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.14e-10)"	"unprognostic (1.76e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.72e-1)"	"unprognostic (8.57e-3)"	17.3	1.1	0.6	11.6	0.7	0.0	21.1	0.7	0.7	3.9	50.2	1.3	4.0	18.1	3.8	5.6	6.3	4.9	14.2	15.7	0.7	0.6	22.4	10.8	7.0	2.4	0.6	0.9	8.8	15.5	39.9	2.7	39.8	6.9	10.4	23.8	4.5	27.3	1.5	2.2	5.3	70.7	3.1	0.5	0.6	17.3	2.3	0.5	13.6	20.8	3.2	5.8	18.5	7.7	0.1	0.9	9.5	0.0	0.0	0.3	0.0	24.8	9.6	0.8	0.0	0.1	1.6	31.3	0.0	0.0	0.0	0.0	6.7	37.2	0.0	14.1	0.0	58.0	11.8	43.0	0.0	0.0	7.3	0.0	11.1	7.5	4.5	3.1	0.0	2.2	29.9	0.9	46.9	0.0	9.8	0.0	0.0	6.5	6.6	0.4	12.0	5.0	11.0	0.0	15.9	14.4	12.4	5.2	0.0	18.9	13.4	0.0	9.6	2.7	0.0	0.0	5.6	0.0	6.1	1.2	0.0	0.0	4.4	0.0	5.4	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.6	0.7	0.7	0.7	0.7	0.6	0.6	0.9	6.9	0.5
EDN2	ET2	ENSG00000127129	"Endothelin 2"	P20800	1	41478775-41484673	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 27.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.4;EFO-21: 21.2;HeLa: 7.2;SCLC-21H: 10.2;SK-BR-3: 25.2;U-2 OS: 9.8"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 24.0"	"Region enriched"	"Detected in single"	12	"pons and medulla: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 1.0"	HPA028459	Uncertain		Approved	Cytosol	"Secreted to blood"			Cytosol	Cytosol	"HPA028459: AB_10602490"	"unprognostic (2.71e-2)"	"unprognostic (5.64e-2)"	"unprognostic (8.39e-2)"	"prognostic unfavourable (2.85e-4)"	"unprognostic (1.47e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-2)"	"unprognostic (5.61e-2)"	"prognostic unfavourable (5.81e-4)"	"unprognostic (5.59e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.14e-2)"	"unprognostic (3.85e-1)"	0.5	0.2	0.0	0.9	0.2	0.3	2.2	0.0	0.1	15.1	13.6	0.4	1.4	4.5	1.8	6.3	17.4	2.3	0.4	1.9	0.0	0.0	4.0	0.8	18.4	0.1	0.0	0.0	0.8	3.2	0.1	1.1	0.4	2.6	9.7	1.3	1.4	4.3	1.0	0.9	8.9	27.8	0.2	0.0	0.1	0.9	0.7	0.1	0.0	1.3	4.0	13.7	1.2	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.5	8.4	0.0	21.2	0.0	1.0	0.0	0.0	0.0	2.4	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.4	0.0	0.0	0.8	4.9	5.7	0.4	10.2	0.0	0.2	25.2	0.0	0.5	0.0	0.0	0.0	9.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.1
EDN3	ET3	ENSG00000124205	"Endothelin 3"	P14138	20	59300427-59325992	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.8;retina: 86.8;salivary gland: 37.0;vagina: 37.8"	"Cell line enriched"	"Detected in single"	5	"SH-SY5Y: 3.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	17	"memory CD4 T-cell: 2.1;T-reg: 1.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.1"	"Low region specificity"	"Detected in all"												"Secreted to blood"						"unprognostic (4.64e-3)"	"unprognostic (7.87e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.88e-3)"	"prognostic favourable (1.73e-4)"	"unprognostic (1.58e-1)"		"unprognostic (1.78e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.08e-2)"	"unprognostic (4.48e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.40e-2)"		0.0	1.2	1.1	0.7	2.5	0.0	3.7	0.8	3.3	22.7	21.7	2.1	0.2	20.7	2.6	3.2	9.2	0.0	1.3	0.0	2.3	1.6	0.2	0.0	0.2	0.0	1.8	1.7	0.6	5.1	0.0	20.8	0.2	3.2	3.2	8.9	86.8	37.0	0.4	0.6	0.8	35.8	1.3	1.7	3.6	0.8	1.1	0.4	0.1	33.2	1.3	0.6	0.2	37.8	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	1.1	2.5	0.8	3.3	2.3	1.6	1.8	1.7	3.2	0.4
ELF3	"EPR-1, ERT, ESE-1, ESX"	ENSG00000163435	"E74 like ETS transcription factor 3"	P78545	1	202007945-202017188	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 100.8"	"Cell line enhanced"	"Detected in some"		"A549: 40.4;CAPAN-2: 57.6;RT4: 41.4;SK-BR-3: 79.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA003316, HPA003479"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA003316: AB_1078757, HPA003479: AB_1078756"	"unprognostic (9.90e-3)"	"unprognostic (1.72e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.05e-3)"	"unprognostic (7.67e-3)"	"unprognostic (7.07e-2)"	"unprognostic (9.92e-3)"	"unprognostic (4.03e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-3)"	0.3	0.1	0.1	16.0	0.2	0.0	34.0	0.2	0.2	13.2	80.7	0.2	12.5	34.4	3.8	8.9	59.3	8.6	67.7	1.1	0.1	0.1	38.1	33.3	24.6	0.1	0.1	0.1	5.8	38.4	1.1	1.7	16.7	0.3	39.9	31.3	0.7	37.9	11.3	0.7	3.5	100.8	9.5	0.3	0.2	29.9	1.9	0.1	0.6	5.7	25.5	43.5	44.7	22.7	0.3	0.8	2.0	0.3	0.2	0.3	0.0	10.5	40.4	0.0	0.0	0.0	0.0	12.6	0.0	1.5	0.0	0.0	9.0	57.6	0.0	4.7	0.0	10.5	0.0	0.0	0.0	1.2	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.1	0.6	3.4	0.0	0.0	0.5	15.3	41.4	0.0	0.0	0.4	79.9	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.8	0.3	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.8	0.3	0.2	0.1	2.0	0.2	0.3	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.1	0.3	0.1
ELL3	FLJ22637	ENSG00000128886	"Elongation factor for RNA polymerase II 3"	Q9HB65	15	43772600-43777543	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 13.3;lymphoid tissue: 24.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 7.8;U-698: 18.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"memory B-cell: 5.3;naive B-cell: 8.5"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.5"	"Region enriched"	"Detected in single"	11	"olfactory region: 2.4"	"Low region specificity"	"Detected in all"			HPA028938	Approved		Supported	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA028938: AB_10795352"	"unprognostic (2.59e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.59e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.42e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.24e-2)"	0.7	1.1	1.0	24.2	0.6	0.4	2.5	4.7	0.6	2.3	10.6	0.5	1.6	4.8	1.0	1.0	5.5	1.3	0.9	0.6	1.0	0.6	1.8	0.5	0.9	7.5	1.3	0.0	1.3	0.7	0.6	1.2	0.8	2.6	2.1	1.8	0.8	2.0	0.7	1.0	7.0	13.3	0.9	0.6	1.5	1.1	12.3	0.5	0.8	1.1	2.8	16.7	1.3	1.7	8.5	1.0	0.1	0.1	0.1	1.2	0.6	0.6	0.1	0.6	0.2	1.6	0.1	0.1	0.2	0.5	0.8	1.2	0.1	0.5	7.8	0.1	0.7	2.8	0.3	0.0	0.5	0.7	3.3	0.3	2.6	0.8	0.5	0.0	0.0	0.0	0.5	0.2	0.1	0.3	0.3	0.0	0.0	1.2	0.2	0.8	0.0	0.8	0.8	0.1	0.1	0.2	0.0	3.5	0.2	0.3	1.5	0.3	3.5	0.2	0.1	0.2	0.0	0.3	0.2	0.0	0.0	18.8	0.2	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.2	5.3	0.5	0.2	0.0	8.5	1.2	0.3	0.1	0.1	0.0	1.0	0.3	0.6	1.0	0.6	4.7	0.6	1.0	0.6	1.3	0.0	2.6	0.5
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 43.3;intestine: 42.2;lymphoid tissue: 44.1"	"Cell line enhanced"	"Detected in many"		"THP-1: 68.9;U-937: 29.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"														"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	15.0	16.4	1.7	21.7	2.0	43.3	8.4	1.1	2.9	2.7	18.9	1.4	0.5	21.7	1.6	5.6	6.5	4.7	6.1	16.7	2.2	4.7	4.2	1.9	10.6	44.1	3.8	1.4	2.7	1.8	15.2	8.0	6.6	4.5	9.5	3.6	4.0	7.4	6.9	2.7	15.9	42.2	2.5	3.3	20.6	3.7	10.5	1.8	15.9	13.7	3.6	17.0	5.3	2.9	9.9	11.4	16.4	14.7	16.4	26.1	16.1	8.4	0.7	1.6	0.0	0.7	2.3	0.1	0.4	0.0	0.7	0.0	0.0	22.3	16.9	0.4	0.8	12.9	3.8	10.9	0.1	5.2	8.6	8.0	2.7	0.0	0.1	16.0	0.0	0.1	6.0	1.8	7.3	0.0	0.0	22.6	13.3	9.8	9.9	9.5	6.4	4.3	15.8	0.0	22.1	0.0	7.6	5.1	4.6	0.0	2.5	0.2	1.0	68.9	0.0	0.0	8.2	0.0	0.0	0.2	0.0	14.0	0.0	29.9	2.0	3.7	14.7	16.4	21.5	1.9	26.1	9.9	19.4	19.3	9.7	6.5	11.5	15.5	13.7	16.4	0.6	11.4	23.4	16.1	1.7	2.0	1.1	2.9	2.2	4.7	3.8	1.4	4.5	1.8
ENPEP	"CD249, gp160"	ENSG00000138792	"Glutamyl aminopeptidase"	Q07075	4	110365733-110565285	"CD markers, Enzymes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 165.1;kidney: 63.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HEK 293: 12.1;MOLT-4: 2.9"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 41.0"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005128	Enhanced					37000000	37000000			"HPA005128: AB_1844795"	"unprognostic (2.73e-3)"	"unprognostic (2.84e-3)"	"unprognostic (5.16e-3)"	"unprognostic (3.48e-1)"	"unprognostic (2.90e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.93e-1)"	"unprognostic (9.47e-2)"	"unprognostic (4.49e-3)"	"unprognostic (3.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.49e-3)"	5.8	1.0	0.4	0.4	0.6	0.0	2.8	0.3	1.0	1.1	54.4	0.4	0.7	11.1	5.3	2.4	0.8	1.4	1.1	2.3	0.5	0.3	63.8	14.5	2.7	0.5	0.4	0.3	1.0	1.0	33.3	0.8	4.4	0.5	1.4	0.0	0.8	0.6	0.5	2.3	0.4	165.1	3.1	0.5	4.7	0.7	0.4	0.4	1.4	2.4	2.0	0.4	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.1	0.0	0.1	0.3	4.5	0.6	0.0	0.2	0.4	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.1	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	2.9	0.5	0.5	0.0	0.2	0.0	0.5	0.0	0.5	0.1	0.3	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.3	1.0	0.5	0.3	0.4	0.3	0.5	0.4
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ductus deferens: 29.0;intestine: 45.4;seminal vesicle: 70.7"	"Group enriched"	"Detected in some"	18	"HEL: 5.0;Hep G2: 16.6;HMC-1: 7.4"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	74	"basophil: 18.2"	"Lineage enriched"	"Detected in single"	74	"granulocytes: 18.2"	"Low region specificity"	"Detected in some"							HPA043772	Enhanced				"Secreted - unknown location"	480000	480000			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	0.8	7.9	0.5	2.0	0.5	0.0	4.0	2.1	0.4	19.0	18.5	0.2	29.0	9.3	6.2	7.2	0.5	2.3	1.8	0.2	0.4	0.7	11.9	2.7	1.7	0.2	0.5	0.2	0.9	0.2	0.0	0.5	0.4	0.2	3.7	4.8	0.6	14.9	70.7	0.2	0.8	45.4	1.9	0.4	0.5	0.7	1.0	0.2	4.1	0.5	1.2	0.5	0.9	1.2	0.0	0.0	18.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	5.0	0.0	16.6	0.0	0.1	7.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.5	2.1	0.4	0.4	0.7	0.5	0.2	0.2	0.2
ENTPD5	"CD39L4, NTPDase-5, PCPH"	ENSG00000187097	"Ectonucleoside triphosphate diphosphohydrolase 5"	O75356	14	73958010-74019399	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.0;kidney: 43.1;liver: 71.4"	"Cell line enhanced"	"Detected in all"		"RT4: 33.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 39.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 15.0;eosinophil: 8.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 15.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002927	Enhanced		Approved	Cytosol	"Secreted to blood"	5000000	5000000	Cytosol	Cytosol	"HPA002927: AB_1078744"	"unprognostic (4.19e-1)"	"unprognostic (9.63e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.34e-1)"	"unprognostic (6.01e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.55e-1)"	"prognostic favourable (3.95e-5)"	"unprognostic (1.25e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.76e-1)"	"unprognostic (6.92e-3)"	3.0	3.6	2.8	9.4	3.8	1.7	3.5	3.0	4.0	2.4	25.8	5.8	3.1	19.3	3.0	2.7	4.5	2.4	6.6	2.6	2.8	2.3	43.1	71.4	2.3	1.3	3.5	2.3	3.3	5.9	1.8	2.7	2.2	5.5	10.2	29.6	3.2	4.7	1.5	3.8	2.7	52.0	3.9	5.5	3.2	11.8	4.5	2.5	2.1	2.7	3.0	3.3	9.5	3.0	1.6	1.6	15.0	2.1	0.6	2.5	1.2	5.3	4.3	4.9	9.1	9.8	9.3	5.7	5.6	4.6	3.7	4.3	3.3	6.4	6.0	2.8	7.6	6.3	4.9	8.1	4.2	5.1	2.3	4.5	3.2	17.8	9.5	2.7	5.3	7.6	8.2	5.3	11.0	7.5	5.0	9.3	5.5	7.6	3.0	3.3	1.5	9.4	3.5	4.7	2.9	6.6	33.8	3.5	3.7	9.5	7.5	5.4	10.9	2.4	6.2	7.6	7.9	4.5	4.1	6.0	9.4	4.9	4.8	5.0	6.8	15.0	1.2	8.3	2.5	2.1	1.3	1.3	1.3	1.7	1.6	1.6	2.1	2.1	0.2	0.6	1.3	0.8	1.4	1.2	2.8	3.8	3.0	4.0	2.8	2.3	3.5	2.3	5.5	2.5
ENTPD7	"FLJ30978, LALP1"	ENSG00000198018	"Ectonucleoside triphosphate diphosphohydrolase 7"	Q9NQZ7	10	99659506-99706240	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 46.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014351	Uncertain		Approved	Nucleoplasm		24000	24000	Nucleoplasm	Nucleoplasm	"HPA014351: AB_1848183"	"unprognostic (1.82e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.01e-3)"	"unprognostic (6.22e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.99e-2)"	"unprognostic (3.39e-1)"	3.1	5.6	2.2	5.1	2.1	6.4	2.7	2.4	3.3	4.4	15.7	1.3	11.3	18.6	3.9	5.7	9.1	3.1	9.1	3.2	2.0	1.7	6.0	14.5	4.2	7.1	1.4	1.9	3.2	23.9	3.6	8.6	8.5	1.5	5.6	4.9	3.4	9.0	13.2	1.6	4.4	46.1	5.6	1.4	5.4	5.1	3.5	0.5	2.5	3.5	6.0	6.3	11.4	5.0	0.9	7.7	3.7	2.2	2.7	2.2	1.3	5.1	6.0	8.0	14.7	4.0	4.0	9.6	9.8	20.5	12.8	10.8	10.9	5.9	4.5	5.7	13.2	13.8	6.7	4.0	10.5	1.9	5.3	3.3	4.7	10.0	5.9	11.9	7.8	3.7	6.8	16.1	15.3	12.9	6.4	4.4	5.1	4.6	2.4	2.5	4.7	2.6	0.0	6.1	2.4	14.0	16.9	3.3	6.3	6.8	2.6	8.6	7.1	6.1	8.1	11.1	7.1	7.1	8.2	4.5	7.4	4.1	10.8	3.6	3.0	0.3	2.2	3.7	2.2	2.2	2.0	0.9	0.8	1.8	5.0	0.3	1.4	0.9	2.0	2.7	1.2	7.7	0.6	1.3	2.2	2.1	2.4	3.3	2.0	1.7	1.4	1.9	1.5	0.5
EPCAM	"17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1"	ENSG00000119888	"Epithelial cell adhesion molecule"	P16422	2	47345158-47387601	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 303.2"	"Cell line enhanced"	"Detected in many"		"A-431: 58.3;CACO-2: 75.6;CAPAN-2: 106.4;RPTEC TERT1: 45.4;SCLC-21H: 41.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB003809, HPA026761, CAB030012, CAB055098, HPA067463"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: AB_2685846"	"unprognostic (6.79e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.40e-1)"	"prognostic favourable (3.30e-4)"	"unprognostic (5.27e-2)"	"unprognostic (3.28e-2)"	"prognostic favourable (1.04e-6)"	"unprognostic (6.38e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.45e-3)"	"unprognostic (6.08e-2)"	0.4	2.1	1.8	49.8	3.0	0.2	8.9	0.6	1.0	10.8	155.8	0.7	31.5	66.8	4.4	35.2	2.8	10.2	41.6	0.4	1.7	2.7	60.2	1.2	22.6	0.4	1.2	0.4	3.8	54.1	19.8	38.7	2.2	0.9	9.0	70.5	0.7	47.2	25.0	0.5	2.0	303.2	1.7	1.4	0.5	15.3	5.5	0.9	1.7	83.6	4.2	4.1	4.1	2.1	0.2	1.9	0.4	0.2	0.0	0.0	0.6	58.3	0.6	0.0	0.1	0.0	0.0	37.0	0.0	0.0	0.0	0.0	75.6	106.4	0.0	16.4	0.1	27.5	0.5	6.9	0.2	0.0	6.7	0.0	0.3	29.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	17.4	0.0	0.0	29.8	0.0	2.8	19.1	3.8	0.0	0.0	14.8	45.4	25.8	41.1	0.3	0.4	21.7	0.0	18.3	0.1	0.0	0.0	0.7	0.2	0.1	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.6	1.8	3.0	0.6	1.0	1.7	2.7	1.2	0.4	0.9	0.9
EPHA10	"FLJ16103, FLJ33655"	ENSG00000183317	"EPH receptor A10"	Q5JZY3	1	37713880-37765133	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.6;intestine: 12.6;testis: 24.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 5.1;HDLM-2: 19.2;SCLC-21H: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"											HPA027497	Uncertain				"Intracellular and membrane"					"HPA027497: AB_10601158"	"unprognostic (9.27e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.24e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.50e-1)"	"unprognostic (8.81e-5)"	"unprognostic (2.55e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	0.4	1.1	5.8	1.7	15.6	0.7	1.9	1.3	10.5	0.6	12.6	3.6	0.2	5.8	0.5	6.8	0.8	1.8	2.1	0.4	4.6	7.4	0.5	0.4	0.5	0.6	3.5	5.0	0.4	5.1	1.1	10.8	0.4	6.4	1.4	10.3	1.6	2.4	0.7	0.4	0.6	7.3	1.0	2.3	0.5	5.3	24.8	2.1	0.0	1.0	0.0	0.5	0.6	0.3	0.4	0.3	1.5	0.3	0.8	0.7	0.1	1.5	1.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.6	2.8	0.0	0.4	0.0	0.1	0.1	0.0	0.0	19.2	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	1.0	0.0	0.2	0.7	0.6	0.0	0.0	0.4	0.3	1.7	8.9	0.4	1.1	0.0	0.0	2.8	0.1	0.0	0.0	1.0	0.1	0.0	1.7	1.2	0.0	0.0	0.0	0.0	1.4	0.2	0.1	0.7	0.1	0.4	0.4	0.3	0.3	0.1	0.4	0.6	0.7	1.5	0.8	0.3	0.3	0.2	0.1	5.8	15.6	1.3	10.5	4.6	7.4	3.5	5.0	6.4	2.1
EPHB2	"DRT, EPHT3, ERK, Hek5, Tyro5"	ENSG00000133216	"EPH receptor B2"	P29323	1	22710839-22921500	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.8;HUVEC TERT2: 31.1;TIME: 30.7;U-251 MG: 26.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.7"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 2.5;intermediate monocyte: 2.1"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB013647, HPA071200"	Approved		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	290000	290000	"Plasma membrane"	"Plasma membrane"	"CAB013647: , HPA071200: AB_2686360"	"unprognostic (2.47e-2)"	"unprognostic (2.43e-2)"	"prognostic favourable (4.98e-4)"	"prognostic unfavourable (1.05e-5)"	"unprognostic (3.99e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.07e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.46e-2)"	3.7	2.9	3.4	15.4	5.4	0.9	2.5	1.9	8.2	3.8	23.9	16.2	4.6	21.6	2.5	3.2	1.1	5.4	4.4	5.4	5.6	6.5	3.5	1.1	3.0	5.5	12.7	3.8	17.9	5.4	6.1	5.4	12.0	8.2	3.3	25.0	2.2	6.6	4.0	0.7	1.8	22.6	4.0	12.1	3.3	2.3	2.9	9.3	0.1	8.4	1.0	2.1	5.3	3.3	0.1	0.6	0.3	2.5	0.1	0.1	0.4	16.7	7.1	6.8	10.9	0.6	0.6	0.0	3.9	0.2	11.8	2.5	2.4	6.7	0.2	8.4	1.7	15.8	4.6	22.8	3.1	0.0	1.6	0.0	0.7	0.0	7.1	0.0	1.7	2.3	7.3	21.1	0.1	31.1	0.6	0.0	2.3	2.5	0.3	0.1	1.6	4.6	2.0	7.0	0.3	5.8	1.6	7.4	7.8	6.8	0.2	0.1	0.4	0.2	30.7	4.7	12.4	11.9	26.8	0.0	0.1	0.0	8.8	0.3	0.1	0.3	2.5	0.1	0.1	2.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.4	3.4	5.4	1.9	8.2	5.6	6.5	12.7	3.8	8.2	9.3
EPHX2		ENSG00000120915	"Epoxide hydrolase 2"	P34913	8	27490779-27545564	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.9;liver: 87.6"	"Cell line enhanced"	"Detected in many"		"K-562: 28.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive CD4 T-cell: 39.2"	"Lineage enriched"	"Detected in many"	24	"T-cells: 39.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023094, HPA023660"	Approved		Enhanced	Cytosol		720000	720000	Cytosol	Cytosol	"HPA023094: AB_1848214, HPA023660: AB_1848215"	"unprognostic (1.30e-1)"	"prognostic favourable (2.45e-4)"	"unprognostic (2.99e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.30e-3)"	"unprognostic (1.26e-3)"	"unprognostic (3.31e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.55e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.98e-1)"	"prognostic favourable (1.98e-10)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.26e-1)"	4.8	25.1	4.8	14.3	6.0	0.4	8.3	5.6	3.3	7.6	56.2	6.1	21.8	29.8	10.3	15.1	15.2	11.3	9.4	7.8	4.1	4.8	44.2	87.6	4.6	5.0	5.8	3.2	11.4	25.3	11.6	14.6	2.9	10.5	17.9	15.6	13.3	18.0	22.7	8.5	11.5	83.9	13.1	4.5	3.5	6.7	5.4	3.9	45.7	7.5	13.2	11.7	7.0	7.4	1.6	0.0	0.0	0.0	1.4	39.2	7.6	8.4	5.7	3.6	4.7	0.2	0.0	2.7	0.7	0.5	0.4	0.1	4.5	5.8	0.0	3.4	2.1	6.1	0.6	1.4	0.3	0.0	2.7	12.5	0.6	13.7	2.0	0.0	2.6	5.1	6.2	0.0	0.7	0.3	28.2	0.1	0.0	2.6	8.1	0.3	5.8	9.9	0.0	0.0	0.2	5.1	1.2	3.0	9.4	6.9	8.2	8.2	12.5	2.3	0.1	0.0	2.3	1.0	0.1	7.3	5.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	2.9	0.0	4.0	1.6	12.5	4.5	0.0	0.9	39.2	18.0	0.0	1.4	0.0	0.0	9.4	7.6	4.8	6.0	5.6	3.3	4.1	4.8	5.8	3.2	10.5	3.9
EPS8L2	"FLJ21935, FLJ22171, MGC3088"	ENSG00000177106	"EPS8 like 2"	Q9H6S3	11	694438-727727	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 73.3"	"Cell line enhanced"	"Detected in many"		"A-431: 45.8;BEWO: 45.3;CAPAN-2: 43.2;SK-BR-3: 53.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	8	"plasmacytoid DC: 6.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 6.4"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in single"	10	"cerebellum: 13.6"	HPA041143	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA041143: AB_10794985"	"unprognostic (1.39e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavourable (2.31e-4)"	"unprognostic (6.87e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.19e-1)"	"unprognostic (2.79e-1)"	"unprognostic (5.03e-2)"	1.7	3.0	2.0	6.4	3.3	0.0	12.4	6.9	2.5	11.6	31.5	1.2	23.9	38.7	4.6	10.1	53.3	5.3	21.7	1.0	1.3	1.6	30.4	38.3	18.0	0.4	1.7	0.5	3.9	11.6	1.8	4.3	39.6	3.6	8.4	6.0	2.7	26.2	17.6	0.7	22.8	73.3	2.4	2.4	0.5	18.0	7.2	1.5	0.9	29.5	29.4	33.7	6.9	19.2	0.2	6.4	0.7	0.1	0.1	0.1	0.1	45.8	14.0	0.0	0.3	0.5	3.1	45.3	4.0	4.2	6.0	2.6	10.5	43.2	0.1	16.8	4.3	24.3	0.1	24.3	1.4	0.1	0.9	0.0	5.2	18.8	3.4	0.0	0.0	1.6	16.3	1.7	4.2	0.0	0.3	0.2	0.6	14.7	0.1	0.2	0.5	4.5	0.1	0.1	0.3	21.2	11.4	0.1	0.1	14.3	53.0	0.1	20.0	0.0	0.3	2.4	5.7	1.5	0.3	0.1	0.2	0.1	1.3	0.1	0.1	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	6.4	0.0	0.1	2.0	3.3	6.9	2.5	1.3	1.6	1.7	0.5	3.6	1.5
ESPN	DFNB36	ENSG00000187017	Espin	B1AK53	1	6424776-6461367	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.4;liver: 54.9"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.7;Hep G2: 26.5;SK-BR-3: 54.3;T-47d: 18.1"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	6	"cerebellum: 6.0"	"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.6;memory CD4 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	37	"T-cells: 3.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 4.8"	"HPA028674, HPA060220"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA028674: AB_10601316, HPA060220: AB_2684224"	"unprognostic (5.06e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-2)"	"unprognostic (7.48e-3)"	"unprognostic (5.53e-2)"	"unprognostic (6.26e-3)"	"unprognostic (5.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.17e-2)"	0.6	1.4	0.6	2.5	0.8	6.7	2.9	6.0	0.7	13.3	44.8	0.6	9.2	27.1	1.2	19.7	9.9	6.3	1.2	0.6	1.0	0.1	14.3	54.9	1.6	0.6	0.6	0.6	2.4	0.6	12.9	12.1	1.3	0.6	2.6	1.7	19.5	2.9	4.7	0.6	27.1	70.4	1.0	0.6	0.6	0.4	37.7	0.6	1.2	0.7	2.4	3.2	0.8	5.9	0.0	0.0	0.0	0.0	0.0	3.6	0.3	4.5	0.2	0.2	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	9.9	0.5	0.1	2.2	0.0	10.8	0.8	0.0	0.0	0.6	0.2	0.1	0.2	26.5	0.0	0.2	0.9	0.0	0.2	0.0	0.0	0.0	5.6	0.0	0.0	9.2	0.0	0.3	0.2	4.1	0.0	0.1	3.5	0.0	0.0	7.1	0.3	1.3	54.3	1.6	18.1	2.4	5.2	0.0	0.2	0.2	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	3.6	0.0	1.2	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.6	0.8	6.0	0.7	1.0	0.1	0.6	0.6	0.6	0.6
ETHE1	"HSCO, YF13H12"	ENSG00000105755	"ETHE1, persulfide dioxygenase"	O95571	19	43506719-43527244	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 80.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 57.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028360, HPA029028, HPA029029"	Enhanced		Enhanced	Mitochondria		13000	13000	Mitochondria	Mitochondria	"HPA028360: AB_10599297, HPA029028: AB_10602092, HPA029029: AB_10601998"	"unprognostic (8.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.58e-1)"	"prognostic unfavourable (9.58e-4)"	"unprognostic (7.75e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.47e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.27e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.72e-3)"	"unprognostic (2.73e-2)"	7.7	10.5	5.2	28.3	6.3	13.1	8.8	4.5	6.7	10.9	80.7	4.6	9.6	27.4	7.1	12.2	28.2	7.1	18.4	8.9	4.4	4.1	19.0	21.3	11.4	15.5	5.6	4.9	7.4	12.7	3.0	7.2	16.7	5.1	12.0	72.1	5.6	18.5	6.7	9.4	9.1	40.3	11.8	4.5	11.0	13.2	3.3	4.7	12.0	26.2	23.3	24.4	10.9	13.3	7.9	35.8	7.4	24.3	9.9	20.2	15.1	13.4	17.7	3.6	12.6	19.8	13.5	1.4	20.9	57.0	18.0	18.5	5.3	13.8	0.0	15.7	20.0	11.0	5.2	31.5	4.8	6.7	1.7	3.4	7.7	14.7	9.0	5.0	4.7	13.8	24.8	6.9	19.5	13.3	2.2	22.6	8.8	9.1	5.8	4.6	0.9	8.6	6.6	1.6	3.0	39.1	28.0	0.0	4.5	5.3	19.2	12.5	5.8	8.4	11.2	2.9	12.4	3.5	3.8	6.4	5.0	0.3	12.6	20.8	15.0	7.4	24.3	0.6	17.2	12.7	20.0	7.9	20.2	16.3	35.8	3.4	15.6	14.8	0.7	9.9	8.5	7.1	19.4	15.1	5.2	6.3	4.5	6.7	4.4	4.1	5.6	4.9	5.1	4.7
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 15.7;BJ hTERT+ SV40 Large T+: 8.2;BJ hTERT+ SV40 Large T+ RasG12V: 15.7;HDLM-2: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 15.4"	"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA029033, HPA049689"	Uncertain		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA029033: AB_10601375, HPA049689: AB_2732556"	"unprognostic (1.67e-2)"	"prognostic favourable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favourable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favourable (2.95e-6)"	2.3	2.5	1.7	7.9	1.7	0.9	1.8	0.9	1.5	2.3	15.1	0.9	2.1	14.4	2.0	2.1	4.7	1.9	7.5	0.9	0.9	1.0	3.0	3.6	7.5	4.2	1.1	1.7	3.7	2.4	3.1	9.9	7.2	3.0	5.3	2.2	3.0	8.1	1.5	0.8	15.1	22.2	4.5	1.5	3.3	5.5	1.1	1.3	3.7	5.3	5.5	8.0	4.3	9.8	2.8	0.7	15.4	4.4	0.4	12.0	1.8	2.1	0.3	0.5	1.3	0.0	0.1	15.7	0.2	5.1	8.2	15.7	1.1	4.6	0.7	0.8	0.1	2.6	0.2	0.9	0.4	32.6	0.6	1.1	0.3	1.2	1.0	0.5	0.6	0.7	1.4	0.4	0.1	0.2	0.2	0.9	0.2	0.4	0.7	0.6	1.2	0.1	3.4	0.3	0.3	0.1	1.2	0.8	0.5	0.8	1.8	0.5	2.8	0.9	0.6	0.8	0.9	0.4	0.5	0.3	0.5	0.7	0.3	1.8	0.9	0.0	2.9	0.2	1.4	4.4	3.3	2.8	4.5	1.8	0.7	1.1	0.9	1.2	15.4	0.4	1.4	0.0	12.0	1.8	1.7	1.7	0.9	1.5	0.9	1.0	1.1	1.7	3.0	1.3
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.1"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 23.6;PC-3: 34.4;RPTEC TERT1: 57.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"pons and medulla: 7.8"	"Cell type enriched"	"Detected in many"	4	"neutrophil: 24.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 24.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favourable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavourable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavourable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favourable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	0.6	1.1	1.0	7.2	1.4	0.1	2.9	0.4	0.8	2.4	34.0	1.1	25.3	17.4	1.0	2.2	6.4	2.9	13.6	3.6	1.1	0.9	28.9	7.4	2.8	3.7	0.8	0.4	1.2	16.6	1.3	3.2	2.8	7.8	6.0	21.4	1.1	7.1	23.7	0.3	24.8	64.1	0.7	1.5	3.5	16.8	0.8	0.5	0.6	9.6	5.8	3.1	5.3	3.9	0.3	2.7	24.9	5.7	0.3	2.3	2.0	8.6	14.3	1.2	0.0	0.4	1.1	9.2	0.4	4.7	0.2	0.7	12.3	22.4	0.0	19.3	1.0	14.9	7.5	6.6	0.4	0.0	7.0	0.2	0.3	8.7	3.1	0.0	0.0	1.6	19.0	2.2	14.2	23.6	0.1	0.0	0.0	4.7	1.0	0.0	1.5	34.4	0.0	0.0	0.2	57.0	16.1	0.6	0.1	3.4	3.4	0.0	1.4	0.0	15.6	0.0	9.0	0.0	0.0	1.3	0.2	0.0	5.1	0.0	0.4	4.6	5.7	1.0	0.3	1.9	1.2	0.3	2.3	1.2	2.7	0.1	2.2	1.3	24.9	0.3	0.3	0.3	0.6	2.0	1.0	1.4	0.4	0.8	1.1	0.9	0.8	0.4	7.8	0.5
FADS6		ENSG00000172782	"Fatty acid desaturase 6"		17	74877299-74893781	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"brain: 13.2;epididymis: 22.6;intestine: 20.0"	"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in some"		"liver cancer: 2.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 5.3"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016802	Uncertain									"HPA016802: AB_2669448"	"unprognostic (2.41e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.64e-1)"	"unprognostic (4.68e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.41e-2)"	"unprognostic (6.98e-4)"	"unprognostic (3.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.27e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.79e-1)"	0.4	6.3	1.7	0.7	3.3	1.7	0.7	13.2	5.9	0.5	9.7	0.4	1.2	9.2	0.4	22.6	2.7	0.3	0.2	0.4	1.7	3.4	1.4	5.2	0.3	0.7	4.5	1.9	0.4	0.6	0.6	0.1	0.4	12.5	0.6	1.0	0.6	2.3	0.5	0.7	6.5	20.0	0.3	0.8	4.7	0.4	1.0	0.4	0.3	0.6	2.2	1.1	1.7	0.9	1.1	0.8	5.3	2.9	1.3	0.5	0.0	0.6	0.7	1.8	1.6	0.0	2.7	2.9	3.2	0.2	0.4	0.8	2.3	1.3	1.1	0.5	1.5	1.0	2.4	0.0	0.4	0.4	0.1	1.3	3.8	1.6	0.9	1.3	1.5	1.0	0.2	3.3	1.2	0.0	1.5	4.2	2.0	2.1	0.9	3.0	1.1	1.5	0.7	1.0	1.5	0.9	0.7	1.6	1.2	2.5	1.0	0.5	1.0	2.0	1.0	1.7	2.4	1.9	1.6	1.6	0.7	1.3	3.3	1.1	2.1	2.1	1.3	1.0	0.4	1.2	0.2	0.4	0.3	0.4	0.2	1.1	0.4	0.5	5.3	1.3	2.9	0.8	0.3	0.0	1.7	3.3	13.2	5.9	1.7	3.4	4.5	1.9	12.5	0.4
FAM109A	"FLJ32356, IPIP27A, SES1"	ENSG00000198324	"Family with sequence similarity 109 member A"	Q8N4B1	12	111360651-111369121	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 37.6"	"Cell line enhanced"	"Detected in many"		"Hep G2: 28.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 6.1"	"Group enriched"	"Detected in many"	4	"B-cells: 2.5;dendritic cells: 6.1;monocytes: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.26e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.42e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (1.15e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.80e-3)"	5.3	8.5	4.3	6.3	4.4	1.2	11.0	4.6	4.9	7.8	14.4	4.7	5.2	23.8	6.9	3.0	6.7	4.8	12.2	7.3	2.4	2.9	5.4	8.1	6.7	6.1	4.1	2.0	9.0	25.9	2.4	2.7	11.3	4.5	5.4	4.6	3.9	5.1	3.4	5.4	9.9	37.6	3.7	3.5	12.7	14.8	6.3	3.6	1.7	4.4	5.3	3.4	4.1	4.7	2.5	6.1	0.4	3.9	0.8	0.9	1.4	5.5	5.0	4.2	6.5	6.0	5.3	11.3	3.6	3.2	2.9	1.5	7.8	3.8	0.1	7.9	5.5	3.0	2.3	2.3	1.2	2.2	5.1	3.8	1.7	28.4	3.5	0.7	5.1	4.3	6.0	4.3	1.4	4.3	8.7	0.4	3.5	5.3	0.9	4.4	6.6	11.9	3.6	2.9	1.6	3.0	3.2	1.0	12.8	5.7	8.8	2.4	5.9	1.4	5.1	4.3	8.7	4.9	2.8	3.6	3.1	0.6	4.3	2.5	4.8	0.1	2.3	0.4	0.6	3.9	0.9	0.5	0.2	0.2	6.1	2.5	0.1	0.8	0.0	0.8	3.7	0.7	0.0	1.4	4.3	4.4	4.6	4.9	2.4	2.9	4.1	2.0	4.5	3.6
FAM3B	"2-21, C21orf11, C21orf76, D21M16SJHU19e, ORF9, PANDER, PRED44"	ENSG00000183844	"Family with sequence similarity 3 member B"	P58499	21	41304212-41357431	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.8;pancreas: 120.3;salivary gland: 67.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 9.3;CAPAN-2: 5.9;Hep G2: 15.2;RPMI-8226: 42.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 40.3"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"eosinophil: 3.0;neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015885, HPA029777"	Approved		Approved	Vesicles	"Secreted to blood"	57000	57000	Vesicles	Vesicles	"HPA015885: AB_1848396, HPA029777: AB_2673194"	"unprognostic (2.88e-1)"	"unprognostic (3.31e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.62e-1)"	"unprognostic (6.32e-3)"	"unprognostic (1.41e-1)"	"unprognostic (8.79e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.65e-1)"	"unprognostic (3.78e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.55e-3)"	0.6	0.2	0.2	4.5	0.4	0.0	4.3	0.2	0.3	1.8	38.5	0.4	29.9	38.2	0.2	8.8	17.4	4.5	6.9	0.4	0.2	0.2	5.2	0.6	2.0	0.7	0.3	0.2	0.7	120.3	0.0	1.9	7.9	0.4	10.0	0.0	0.2	67.9	36.0	0.2	0.9	83.8	2.0	0.3	0.5	30.8	2.0	0.2	2.3	3.9	7.4	17.6	17.5	4.7	0.2	1.3	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	9.3	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	42.1	0.0	2.8	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	3.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	6.9	0.0	0.6	1.3	0.0	0.0	0.2	0.4	0.2	0.3	0.2	0.2	0.3	0.2	0.4	0.2
FAM3D	"EF7, OIT1"	ENSG00000198643	"Family with sequence similarity 3 member D"	Q96BQ1	3	58633946-58666848	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 61.2;intestine: 69.2;salivary gland: 146.0;seminal vesicle: 88.6"	"Cell line enhanced"	"Detected in some"		"HUVEC TERT2: 3.4;RT4: 2.8;T-47d: 2.3;U-266/70: 1.8"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 151.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	4	"neutrophil: 6.7"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 6.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013844	Approved				"Secreted to digestive system"	8200	8200			"HPA013844: AB_2668897"	"prognostic favourable (7.51e-4)"	"unprognostic (1.07e-1)"	"unprognostic (2.08e-2)"	"unprognostic (9.67e-2)"	"unprognostic (5.51e-2)"	"prognostic favourable (1.89e-4)"	"unprognostic (7.97e-2)"	"unprognostic (6.54e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.97e-4)"	"unprognostic (2.34e-2)"	0.3	0.2	0.3	8.5	0.3	0.0	2.2	0.2	0.2	4.4	48.2	0.3	26.1	11.2	0.5	0.3	61.2	0.3	20.0	0.2	0.2	0.2	0.5	0.2	1.5	0.2	0.3	0.2	0.2	0.8	0.0	0.3	0.5	0.3	3.3	69.2	0.3	146.0	88.6	0.4	0.8	26.1	0.8	0.2	0.3	9.5	0.3	0.2	0.3	0.6	15.2	47.1	2.2	13.1	0.0	0.7	6.7	1.6	0.0	0.0	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	3.4	0.3	0.0	0.0	1.3	0.3	1.4	0.7	0.0	0.3	0.5	1.0	0.1	2.8	0.2	1.3	0.0	0.0	0.0	2.3	0.0	0.5	0.1	0.7	0.9	0.6	1.8	1.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	6.7	0.0	0.5	0.0	0.0	0.9	0.3	0.3	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.2
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54942022	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 32.7;intestine: 24.6;tongue: 30.1"	"Cell line enhanced"	"Detected in some"		"A-431: 12.3;HaCaT: 13.8;HBEC3-KT: 7.5;hTCEpi: 13.9;hTERT-HME1: 18.3;RT4: 15.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA031464, HPA031465"	Enhanced									"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavourable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavourable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavourable (1.86e-5)"	0.4	0.4	0.4	6.9	0.4	0.0	1.6	0.4	0.4	8.8	16.4	0.0	1.9	6.5	0.4	2.9	32.7	1.4	7.0	1.6	0.4	0.4	6.3	0.5	0.5	0.0	0.4	0.0	0.5	3.7	0.0	0.4	15.6	0.0	5.5	8.2	0.0	5.5	1.7	3.5	22.3	24.6	1.3	0.4	0.4	3.6	0.9	0.0	4.3	11.0	30.1	8.5	4.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	5.3	2.8	0.0	0.0	0.0	13.8	0.0	7.5	0.0	0.0	1.7	0.0	2.3	0.0	0.0	0.0	0.0	0.0	13.9	0.0	18.3	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.7	15.8	0.1	0.0	2.4	0.4	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.0	0.0
FAM83E	FLJ20200	ENSG00000105523	"Family with sequence similarity 83 member E"	Q2M2I3	19	48600810-48614854	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.5;intestine: 17.8;salivary gland: 15.6;stomach 1: 23.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 8.1;NTERA-2: 3.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA049305	Uncertain									"HPA049305: AB_2680705"	"unprognostic (1.36e-1)"	"unprognostic (9.81e-3)"	"unprognostic (3.83e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.56e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.71e-1)"	"unprognostic (8.00e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.05e-8)"	"unprognostic (5.17e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.70e-1)"	"unprognostic (8.90e-3)"	0.4	0.0	0.4	8.2	0.4	0.0	0.7	0.4	0.5	5.0	15.3	0.5	1.2	17.0	1.9	0.4	4.3	2.7	29.5	0.4	0.4	0.0	0.5	0.4	5.3	0.4	0.4	0.4	0.7	2.1	0.0	0.4	0.8	0.6	1.8	5.6	0.5	15.6	1.2	0.4	0.9	17.8	0.4	0.4	0.4	23.9	1.0	0.4	0.4	0.4	2.6	2.9	1.2	1.9	2.2	0.1	2.1	0.7	0.1	1.3	0.1	0.8	0.6	0.2	1.7	0.2	0.3	1.4	0.3	0.0	0.1	0.2	0.7	8.1	1.7	0.6	0.6	0.7	0.4	0.2	0.0	1.2	0.6	0.3	0.6	0.2	0.1	0.3	0.9	0.4	0.4	0.0	0.2	0.1	0.2	0.6	0.0	1.5	0.1	2.0	3.1	1.9	0.7	0.3	0.8	0.0	0.5	1.3	0.7	0.1	0.5	0.4	0.5	0.2	0.2	0.0	1.4	0.4	0.0	0.7	1.2	0.1	0.5	0.5	0.1	0.3	0.2	0.0	0.3	0.4	0.6	2.2	0.3	0.8	0.1	0.4	0.3	1.3	2.1	0.1	0.7	0.1	0.4	0.1	0.4	0.4	0.4	0.5	0.4	0.0	0.4	0.4	0.6	0.4
FAM84A	"FLJ35392, NSE1"	ENSG00000162981	"Family with sequence similarity 84 member A"	Q96KN4	2	14632686-14650814	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.0;hTCEpi: 11.8;RT4: 31.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047703	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047703: AB_2680123"	"unprognostic (1.05e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.24e-3)"	"unprognostic (1.13e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.36e-1)"	0.9	1.8	22.0	9.1	14.8	0.6	2.7	3.1	31.8	9.9	34.0	1.7	0.9	22.4	3.0	29.0	22.6	2.8	5.6	2.1	7.7	7.7	3.3	1.8	5.6	0.8	3.6	11.2	7.9	3.3	2.0	3.0	5.9	2.4	11.1	31.9	1.6	15.9	2.5	1.3	14.4	21.3	3.0	2.5	0.8	3.0	20.0	3.9	0.6	2.2	10.4	3.8	9.5	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	1.6	0.4	0.3	0.0	0.2	0.0	0.0	0.2	6.0	0.6	2.6	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.4	11.8	0.0	3.9	0.0	0.0	0.0	0.8	4.8	0.0	0.1	0.5	2.5	0.0	0.0	0.1	4.5	31.2	2.8	1.3	0.0	1.2	0.0	0.0	0.0	1.8	5.4	0.4	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	14.8	3.1	31.8	7.7	7.7	3.6	11.2	2.4	3.9
FAT1	"CDHF7, CDHR8, FAT"	ENSG00000083857	"FAT atypical cadherin 1"	Q14517	4	186587783-186726722	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.4"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 63.5;LHCN-M2: 46.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001869, HPA023882"	Enhanced				"Intracellular and membrane"	120000	120000			"HPA001869: AB_1078818, HPA023882: AB_1848429"	"unprognostic (1.98e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavourable (4.22e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.15e-3)"	"unprognostic (6.80e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.03e-3)"	"unprognostic (9.41e-2)"	"unprognostic (6.25e-3)"	"unprognostic (4.27e-2)"	15.5	1.3	7.9	12.3	9.8	0.4	15.4	11.9	8.4	15.9	40.4	11.8	8.1	17.9	20.6	14.0	9.7	9.6	28.2	21.1	10.0	6.0	29.1	13.3	10.9	1.4	11.4	6.2	9.7	13.8	7.5	10.5	14.6	24.7	15.9	22.9	5.0	13.9	18.2	3.0	13.1	76.4	18.3	12.8	1.7	11.5	7.0	11.2	1.3	10.5	10.2	6.7	17.5	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	18.6	18.4	0.0	18.5	22.3	4.5	24.8	41.0	12.1	7.7	11.0	11.0	0.0	6.0	63.5	9.0	7.2	30.6	16.5	0.0	2.9	0.0	6.6	11.1	9.2	8.0	6.6	8.0	11.1	22.5	14.7	0.2	0.1	0.0	46.6	5.9	14.3	0.0	4.1	3.1	0.0	5.1	0.3	18.2	17.5	1.9	7.4	4.3	7.3	2.9	0.0	2.9	5.3	34.6	13.4	0.4	15.4	0.1	0.0	0.1	7.9	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.8	11.9	8.4	10.0	6.0	11.4	6.2	24.7	11.2
FEV	Pet-1	ENSG00000163497	"FEV, ETS transcription factor"	Q99581	2	218981087-218985657	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 6.9;intestine: 7.0;pituitary gland: 5.4;stomach 1: 6.1"	"Group enriched"	"Detected in some"	6	"HMC-1: 18.7;SH-SY5Y: 23.9"	"Group enriched"	"Detected in some"	10	"pancreatic cancer: 3.0;prostate cancer: 9.9;stomach cancer: 2.4"	"Region enhanced"	"Detected in many"		"pons and medulla: 6.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"midbrain: 2.3;pons and medulla: 0.9"	"Group enriched"	"Detected in some"	34	"midbrain: 7.3;pons and medulla: 3.9"	HPA067679		Supported	Supported	"Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA067679: AB_2685884"			"unprognostic (4.58e-1)"		"unprognostic (1.60e-1)"					"unprognostic (7.21e-2)"	"prognostic favourable (4.85e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.15e-1)"			0.1	4.1	0.0	1.2	3.5	0.0	0.0	0.0	2.6	0.0	2.0	0.7	0.0	7.0	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.2	0.0	5.4	0.0	6.9	4.0	3.2	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	6.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	23.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	2.6	1.1	0.2	0.2	0.0	6.9	1.0
FGF4	"HBGF-4, HST, HST-1, HSTF1, K-FGF, KFGF"	ENSG00000075388	"Fibroblast growth factor 4"	P08620	11	69771016-69775403	"Cancer-related genes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;intestine: 1.6;testis: 2.4;tongue: 2.0"	"Cell line enriched"	"Detected in single"	93	"NTERA-2: 18.6"	"Cancer enriched"	"Detected in some"	5	"testis cancer: 13.9"	"Group enriched"	"Detected in some"	19	"midbrain: 2.6;pons and medulla: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011209	Uncertain				"Secreted in other tissues"					"HPA011209: AB_1848527"			"unprognostic (1.47e-2)"	"unprognostic (6.22e-2)"										"unprognostic (7.77e-2)"	"unprognostic (8.56e-2)"			0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.4	0.0	1.2	0.8	0.1	2.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	1.2	0.0
FKBP1B	"FKBP12.6, FKBP1L, FKBP9, OTK4, PPIase"	ENSG00000119782	"FK506 binding protein 1B"	P68106	2	24049701-24063681	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 31.1;intestine: 24.9"	"Cell line enhanced"	"Detected in many"		"Hep G2: 22.8;NTERA-2: 22.2;SH-SY5Y: 16.1;TIME: 19.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"T-reg: 5.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA045572, HPA051798"	Uncertain		Approved	Vesicles				Vesicles	Vesicles	"HPA045572: AB_2732521, HPA051798: AB_2681615"	"unprognostic (3.01e-3)"	"unprognostic (3.35e-1)"	"unprognostic (7.05e-2)"	"unprognostic (9.89e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.90e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.45e-1)"	2.9	5.9	25.0	2.8	30.7	1.9	5.9	15.7	23.1	5.1	7.2	1.6	7.4	24.9	3.6	4.2	4.5	4.5	7.1	3.4	31.1	14.0	4.4	4.6	9.0	2.2	13.0	19.7	4.6	4.9	6.4	2.8	5.6	7.9	5.1	4.6	2.4	3.3	9.2	1.1	3.6	6.7	4.0	5.2	1.8	13.3	1.6	4.4	0.6	5.0	1.1	3.2	7.1	3.5	1.5	2.2	4.4	0.8	0.3	5.4	1.1	0.1	1.0	8.9	0.0	5.6	2.2	3.1	3.0	3.1	1.3	1.9	0.6	1.0	0.0	2.2	5.2	3.4	13.1	10.2	0.8	1.5	8.4	3.0	0.1	22.8	2.1	0.0	7.3	2.1	2.4	3.0	0.6	8.3	0.7	0.0	2.9	0.1	0.9	0.0	22.2	1.5	1.5	0.7	0.0	1.0	0.6	2.2	16.1	0.1	0.0	2.8	0.6	1.1	19.4	0.0	2.8	0.1	0.7	0.5	0.2	0.0	3.2	0.0	0.7	1.3	0.8	4.4	0.3	0.7	0.0	0.3	0.6	0.5	2.2	1.5	0.0	0.2	0.1	0.3	0.0	0.4	5.4	1.1	25.0	30.7	15.7	23.1	31.1	14.0	13.0	19.7	7.9	4.4
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA"	ENSG00000162769	"Feline leukemia virus subgroup C cellular receptor 1"	Q9Y5Y0	1	212858255-212899363	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Cell line enhanced"	"Detected in all"		"NTERA-2: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favourable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavourable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	3.2	3.8	4.6	4.5	7.2	7.8	4.8	11.3	5.9	4.4	12.9	4.7	3.3	13.5	4.0	7.5	3.2	3.6	3.6	2.5	5.0	7.5	3.5	3.1	3.7	4.1	5.3	5.9	4.0	5.1	7.0	16.8	3.5	7.2	5.3	4.4	4.0	2.9	4.3	1.6	4.3	40.6	3.8	4.8	4.2	7.1	4.0	5.5	5.4	3.6	2.1	3.3	4.0	5.0	1.2	1.6	4.7	0.8	0.7	1.4	0.2	4.7	6.3	9.9	3.0	1.7	2.0	18.5	1.4	1.0	2.8	1.7	9.2	8.8	5.2	2.6	1.0	7.2	10.6	3.1	2.8	3.0	4.6	3.1	6.2	8.4	1.9	8.1	5.0	1.6	2.1	3.0	3.9	2.2	8.1	4.4	1.9	1.8	2.3	4.0	32.4	4.5	5.1	9.0	6.0	3.5	4.6	10.7	7.5	6.5	6.5	5.9	10.6	3.8	1.3	1.4	3.4	4.5	6.3	2.7	5.4	6.2	2.0	4.7	1.7	1.6	0.8	4.7	0.8	0.6	0.9	0.9	1.2	1.0	0.5	1.2	1.2	1.1	2.6	0.7	0.8	1.6	1.4	0.2	4.6	7.2	11.3	5.9	5.0	7.5	5.3	5.9	7.2	5.5
FLVCR2	"C14orf58, FLJ20371, MFSD7C"	ENSG00000119686	"Feline leukemia virus subgroup C cellular receptor family member 2"	Q9UPI3	14	75578617-75663214	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 45.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.5;ASC TERT1: 11.5;BEWO: 35.4;MCF7: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"classical monocyte: 11.3;intermediate monocyte: 12.1;myeloid DC: 6.2;non-classical monocyte: 8.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 6.2;monocytes: 12.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037984	Enhanced									"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favourable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.6	11.6	1.4	6.5	2.6	3.0	2.4	0.7	2.4	2.5	24.1	1.9	0.9	12.5	1.4	2.9	2.4	2.0	2.6	3.0	1.7	1.0	8.3	19.0	11.5	7.7	4.8	0.7	2.4	0.8	0.8	4.1	25.6	5.0	2.3	5.2	30.9	8.7	2.5	7.6	5.1	45.7	2.8	6.0	17.5	1.1	15.6	2.6	1.1	3.2	5.6	3.3	2.2	4.2	0.1	6.2	0.5	12.1	0.3	1.3	3.0	1.7	1.3	0.4	1.9	26.5	11.5	35.4	0.3	1.4	1.5	1.2	2.9	0.2	0.0	0.1	0.1	0.2	4.6	0.1	0.6	8.9	0.3	0.0	1.3	6.1	2.1	0.0	0.3	5.3	3.7	1.9	1.1	0.3	0.1	0.2	4.8	12.2	0.0	0.9	0.8	2.1	0.0	1.2	0.0	1.7	2.4	0.0	0.0	0.9	3.9	0.7	2.1	4.7	4.1	1.9	0.7	1.0	0.0	0.3	0.5	0.0	5.5	1.1	0.3	0.0	11.3	0.5	0.3	12.1	1.0	0.0	0.9	0.3	6.2	0.1	0.7	0.1	0.3	0.3	8.9	0.1	1.3	3.0	1.4	2.6	0.7	2.1	1.7	1.0	4.8	0.7	5.0	2.6
FOLH1	"FOLH, GCP2, GCPII, NAALAD1, NAALAdase, PSM, PSMA"	ENSG00000086205	"Folate hydrolase 1"	Q04609	11	49146635-49208670	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 37.7;intestine: 111.2;prostate: 33.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 5.3;RPMI-8226: 3.7;SK-BR-3: 4.4;TIME: 2.8;WM-115: 5.3"	"Cancer enriched"	"Detected in many"	27	"prostate cancer: 142.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001451, HPA010593"	Enhanced									"CAB001451: AB_563979, HPA010593: AB_1079685"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (5.24e-5)"	"unprognostic (2.55e-1)"	"unprognostic (8.31e-2)"	"prognostic favourable (4.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.67e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavourable (1.30e-6)"	"unprognostic (4.81e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.04e-1)"	1.2	1.0	10.4	0.9	16.4	0.8	2.5	1.4	12.7	1.4	67.6	37.7	0.0	111.2	1.3	0.8	1.2	2.1	5.0	0.7	16.9	8.7	6.1	15.7	1.1	0.9	19.0	9.1	1.0	0.7	0.7	0.4	0.7	17.7	33.8	0.8	0.6	20.7	0.8	0.6	1.2	61.1	1.0	33.0	1.5	1.0	0.9	16.2	0.0	1.0	0.0	0.8	1.2	0.5	0.9	0.1	0.3	0.8	1.4	1.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.9	0.2	0.6	0.0	0.2	5.3	0.5	0.0	1.2	0.9	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	1.0	0.0	0.3	0.3	3.7	0.0	0.0	0.4	1.6	0.0	4.4	1.0	1.0	0.0	2.8	0.2	2.7	0.4	0.3	0.1	0.5	0.1	0.0	0.9	5.3	0.1	0.8	0.3	0.9	0.6	0.2	0.6	1.2	0.5	0.0	0.9	0.7	0.3	0.2	1.4	0.5	0.1	0.4	0.0	10.4	16.4	1.4	12.7	16.9	8.7	19.0	9.1	17.7	16.2
FOXD2	"FKHL17, FREAC9"	ENSG00000186564	"Forkhead box D2"	O60548	1	47436017-47440691	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 7.7"	"Group enriched"	"Detected in some"	5	"AN3-CA: 12.5;WM-115: 17.9"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (5.10e-2)"	"unprognostic (4.55e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.39e-2)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-3)"	"unprognostic (1.92e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.79e-12)"	"unprognostic (1.00e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.58e-2)"	"unprognostic (5.91e-2)"	0.5	1.2	0.0	0.9	0.0	0.0	0.3	0.0	0.1	2.1	7.7			0.8	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.1	3.2	0.9	0.4	0.3	0.0		0.0	0.2	0.0	2.0	0.1		2.4	5.7		0.3	0.2	0.1	0.2	0.6	0.0	0.1	1.1	1.1	0.5			0.2		0.0	0.2	0.8	0.8	0.2	1.5	0.6	0.3	2.1	0.2	0.9	0.4	0.0	12.5	0.0	0.1	1.1	0.5	0.1	0.0	0.1	1.2	0.2	1.1	0.6	0.0	0.6	0.3	0.0	0.0	1.9	2.0	0.7	0.8	0.2	0.0	0.7	1.5	0.0	0.4	0.0	0.0	0.0	0.9	0.9	0.0	0.6	0.7	0.7	0.0	0.6	2.6	1.8	0.6	0.0	0.9	2.1	0.0	0.7	0.6	1.3	2.5	0.8	0.5	0.7	3.3	0.3	1.0	1.2	0.9	1.1	0.5	1.6	17.9	0.6	0.5	1.4	2.1	0.6	1.5	0.8	0.8	1.6	0.2	0.6	0.6	1.3	1.5	0.3	0.5	0.2	0.5	0.2										
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 28.5;intestine: 24.0;retina: 58.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 39.2;HEK 293: 13.1;U-2197: 16.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.4	0.4	3.5	3.4	4.4	0.1	2.2	1.7	3.9	1.3	24.0	2.3	0.0	7.6	0.2	1.2	28.5	0.4	2.0	0.5	2.8	2.4	0.2	0.3	13.6	0.6	3.7	3.2	0.2	0.7	0.8	5.5	11.5	2.2	13.2	12.3	58.7	0.8	1.0	0.6	0.9	15.8	4.8	2.1	0.2	12.6	0.8	1.4	0.0	2.5	2.7	2.4	9.1	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.8	0.6	0.4	1.8	2.9	0.0	8.2	39.2	3.6	1.6	0.1	0.0	0.0	1.8	2.5	6.4	6.8	0.3	1.6	0.0	13.1	0.0	3.1	0.0	3.5	0.0	0.2	0.5	2.8	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	2.0	0.0	2.7	0.0	0.1	0.0	3.3	6.1	16.0	1.4	0.2	0.0	0.0	0.0	2.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	4.4	1.7	3.9	2.8	2.4	3.7	3.2	2.2	1.4
FOXH1	FAST1	ENSG00000160973	"Forkhead box H1"	O75593	8	144473412-144476335	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.5"	"Cell line enriched"	"Detected in some"	15	"NTERA-2: 21.4"	"Cancer enriched"	"Detected in some"	26	"testis cancer: 23.2"					"Cell type enhanced"	"Detected in some"		"gdTCR: 1.1;plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (1.62e-1)"	"unprognostic (8.26e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.23e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-1)"	"unprognostic (4.57e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.65e-8)"	"unprognostic (1.03e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.99e-1)"	"unprognostic (9.35e-3)"	0.1	0.2	0.4	0.8	1.9	0.0	0.2	1.0	0.5	0.0	2.1			3.2	0.0	0.1	0.4	0.0	1.5	0.0	0.4	0.5	0.5	0.5	0.2	0.1	0.1		0.0	0.0	0.2	1.0	0.0		0.7	0.9		0.6	0.4	0.0	2.6	3.5	0.0	0.0	0.3	1.8	2.2			0.4		0.0	0.7	0.0	0.0	1.1	0.1	0.3	0.0	1.1	0.0	0.4	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.1	0.2	1.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.2	21.4	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.2	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.3	1.1	0.0	0.0										
FP565260.2		ENSG00000276612			21	5116343-5133805	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.7;blood: 3.1;intestine: 2.6"	"Cell line enhanced"	"Detected in many"		"RH-30: 6.3;SK-MEL-30: 4.9;U-937: 4.8"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in some"		"NK-cell: 3.1;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	6	"monocytes: 3.0;NK-cells: 3.1;T-cells: 2.2"																																					1.2	2.7		0.0		0.0	0.0		1.1	0.0	0.0			2.6	0.4	0.0	0.1	0.7	0.0	0.4			0.1	0.7	0.0	0.0			0.1	0.0	0.0		0.0		0.1	0.0		0.0	0.0	1.4	0.1	0.0	1.0		1.1	0.0	0.0			0.0		0.1	0.0		0.2	0.5	0.0	3.0	3.1	2.2	0.2	0.0	1.5	0.5	2.0	4.6	1.0	0.5	0.6	0.0	0.8	0.4	2.1	0.0	0.0	0.1	0.0	0.0	2.9	2.6	0.6	1.8	0.3	4.6	1.0	1.0	2.7	0.0	0.5	1.0	0.0	3.0	3.0	1.2	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.5	6.3	2.1	0.0	0.0	3.7	0.3	0.9	0.0	4.9	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.6	0.1	1.3	0.5	4.8	1.4	0.0	0.3	0.0	1.1	0.0	0.0	0.1	2.2	0.4	0.0	0.2	0.6	1.0	0.0	3.1	3.0	0.5	0.2	0.2										
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060758	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.4"	"Cell line enhanced"	"Detected in many"		"RT4: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025217, HPA030479"	Approved		Supported	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB025217: , HPA030479: AB_2732457"	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favourable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	1.5	2.2	0.8	3.0	1.3	1.3	2.6	0.5	0.8	6.4	21.4	0.2	10.2	6.8	1.6	9.0	10.5	2.8	7.3	3.3	1.2	0.8	23.7	19.6	5.6	0.6	1.5	0.5	2.4	5.9	0.3	3.8	2.7	0.8	4.1	5.5	0.8	9.2	6.1	2.9	2.0	41.4	2.5	2.4	1.0	5.5	1.8	0.5	1.2	1.0	5.2	7.4	5.0	3.6	2.2	1.2	3.8	1.2	1.4	2.3	0.3	3.2	5.3	0.8	1.3	0.4	0.4	1.0	0.8	0.2	0.1	0.1	4.1	5.1	1.3	4.9	0.8	7.7	0.4	1.5	0.2	4.4	0.5	1.8	4.6	3.5	0.3	1.2	1.1	0.3	2.2	0.5	0.6	0.3	0.9	3.3	1.3	1.8	1.0	0.8	1.4	0.9	1.5	4.6	1.6	6.5	10.1	1.1	1.2	1.1	6.8	0.7	2.1	1.0	1.3	1.5	1.6	1.2	0.8	5.0	3.5	2.3	1.5	0.8	1.0	3.2	1.0	1.0	1.9	0.6	2.3	1.1	1.4	1.7	0.4	2.2	1.1	1.4	3.8	1.4	1.2	1.2	1.0	0.3	0.8	1.3	0.5	0.7	1.2	0.8	1.5	0.5	0.8	0.5
FSIP1	FLJ35989	ENSG00000150667	"Fibrous sheath interacting protein 1"	Q8NA03	15	39588357-39782830	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 17.8;pituitary gland: 11.8;testis: 13.9"	"Cell line enhanced"	"Detected in many"		"BJ: 7.2"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 6.6"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in many"			HPA041002	Uncertain		Uncertain	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA041002: AB_10796565"	"unprognostic (1.55e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.43e-3)"	"unprognostic (5.17e-3)"	"unprognostic (5.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.81e-1)"	0.8	0.7	2.9	0.7	9.3	1.1	1.9	1.0	5.7	0.8	11.7	1.5	0.8	0.5	1.4	2.5	0.6	2.3	0.7	0.8	3.1	3.0	1.6	0.7	0.9	0.5	1.2	4.1	0.7	0.6	1.7	11.8	0.8	4.5	0.8	17.8	0.6	0.5	0.7	0.9	1.7	0.6	0.9	1.1	0.6	1.1	13.9	1.4	0.5	1.0	0.0	0.5	1.0	0.9	1.0	1.0	1.8	1.3	1.5	3.4	1.4	0.6	2.3	6.1	0.8	1.1	2.1	0.1	7.2	1.5	1.2	2.2	1.7	0.6	0.5	0.5	2.1	1.5	1.0	1.2	1.9	2.5	0.6	4.4	1.7	0.1	0.6	0.9	4.9	1.4	5.1	2.8	1.2	1.3	0.2	0.6	1.8	0.3	0.6	0.4	0.7	1.2	0.6	1.2	0.1	2.4	2.7	1.5	4.6	1.5	0.2	0.3	2.1	0.5	1.0	3.0	1.7	1.6	0.8	1.2	2.6	0.3	6.1	1.6	1.4	1.8	1.3	1.5	3.4	0.8	2.7	0.8	1.8	2.1	1.0	1.0	1.1	0.9	1.1	1.5	1.0	0.0	0.4	1.4	2.9	9.3	1.0	5.7	3.1	3.0	1.2	4.1	4.5	1.4
FUT2	"SE, Se2, SEC2, sej"	ENSG00000176920	"Fucosyltransferase 2"	Q10981	19	48695971-48705950	"Blood group antigen proteins, Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.3;salivary gland: 58.1"	"Cell line enriched"	"Detected in some"	6	"CAPAN-2: 40.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"cerebellum: 8.7"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA014402	Uncertain		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA014402: AB_1849194"	"unprognostic (2.95e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.80e-3)"	"unprognostic (4.63e-3)"	"unprognostic (2.63e-1)"	"prognostic favourable (5.83e-4)"	"unprognostic (6.30e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (8.44e-2)"	"unprognostic (7.89e-2)"	"unprognostic (5.11e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	0.4	0.6	0.7	5.3	0.8	0.0	0.8	8.7	1.6	9.3	25.0	0.3	13.9	24.1	1.3	0.1	16.0	1.2	23.3	0.5	0.7	0.7	0.8	0.4	1.1	0.1	0.7	0.1	1.0	7.5	0.0	1.5	0.2	0.7	1.2	10.9	0.1	58.1	14.5	0.5	2.6	41.3	0.4	0.7	0.6	15.8	0.7	0.2	0.5	0.6	16.1	19.3	3.1	5.4	1.7	1.8	3.5	1.0	1.4	2.5	0.6	1.1	1.0	0.2	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	4.8	40.9	0.3	0.3	0.0	7.2	0.0	0.0	0.0	0.4	0.3	0.4	0.3	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.9	0.3	0.3	0.3	0.1	1.8	0.0	0.3	2.2	0.3	0.1	0.3	0.0	6.1	0.0	0.1	0.2	0.3	0.3	0.1	0.3	0.2	0.0	0.2	0.2	0.1	3.5	0.8	0.4	2.0	0.7	1.1	1.5	2.3	1.0	0.5	1.7	2.1	0.7	3.4	1.4	1.0	1.8	2.5	0.6	0.7	0.8	8.7	1.6	0.7	0.7	0.7	0.1	0.7	0.2
FUT3	"CD174, LE"	ENSG00000171124	"Fucosyltransferase 3 (Lewis blood group)"	P21217	19	5842888-5851474	"Blood group antigen proteins, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 53.6;intestine: 49.3;lymphoid tissue: 38.4"	"Group enriched"	"Detected in some"	4	"A-431: 30.2;RH-30: 10.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 41.4"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"plasmacytoid DC: 1.6"	"Low lineage specificity"	"Detected in single"											HPA046966	Supported									"HPA046966: AB_2679879"	"prognostic unfavourable (6.86e-4)"	"unprognostic (2.59e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.12e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.63e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.99e-1)"	"prognostic favourable (8.22e-7)"	"unprognostic (5.66e-3)"	"unprognostic (9.56e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.07e-1)"	0.2	0.1	0.2	14.5	0.2	0.0	0.4	0.2	0.2	10.9	40.4	0.2	32.5	18.8	0.4	0.5	53.6	0.7	21.5	0.1	0.2	0.2	3.8	0.9	5.1	0.1	0.2	0.1	0.5	4.7	0.0	0.3	0.6	0.1	1.0	18.1	0.2	27.5	31.6	0.1	1.0	49.3	1.0	0.2	0.1	8.1	1.3	0.1	0.3	0.1	14.9	38.4	2.9	16.1	0.2	1.6	0.8	0.6	0.0	0.5	0.0	30.2	0.0	0.1	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.4	0.0	1.3	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	4.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.2	1.0	0.0	0.5	0.0	0.1	0.0	4.8	0.1	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.8	0.0	0.0	1.6	0.5	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.1	0.1
FUT6	"FCT3A, FLJ40754, FT1A, FucT-VI"	ENSG00000156413	"Fucosyltransferase 6"	P51993	19	5830610-5839731	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.8;intestine: 44.4;lymphoid tissue: 33.9;salivary gland: 37.0"	"Group enriched"	"Detected in some"	7	"Hep G2: 14.6;RPMI-8226: 5.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"basophil: 3.7;neutrophil: 1.2;NK-cell: 2.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.7;NK-cells: 2.1"									"HPA043707, HPA046966"	Approved		Supported	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA043707: AB_2678628, HPA046966: AB_2679879"	"unprognostic (3.65e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.35e-2)"	"prognostic favourable (2.12e-4)"	"unprognostic (8.02e-2)"	"unprognostic (6.68e-3)"	"unprognostic (4.01e-2)"	"unprognostic (8.53e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.94e-2)"	"prognostic favourable (3.17e-8)"	"unprognostic (1.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	0.2	0.2	0.2	7.2	0.2	0.1	0.8	0.2	0.2	9.2	26.4	0.0	9.5	15.6	0.7	7.6	40.8	0.6	25.4	0.2	0.2	0.2	27.2	6.5	1.3	0.2	0.2	0.0	0.2	2.2	0.0	0.8	0.0	0.0	0.3	6.9	0.0	37.0	19.1	0.2	0.2	44.4	0.2	0.2	0.2	2.8	0.3	0.0	0.0	0.2	16.4	33.9	0.2	12.4	0.4	0.3	3.7	0.3	2.1	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.4	0.2	14.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	5.4	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.1	3.7	0.3	0.4	0.2	0.1	0.1	0.1	0.3	0.2	0.1	0.4	0.3	0.2	1.2	2.1	0.1	0.3	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 160.2;salivary gland: 141.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 88.3;hTCEpi: 160.7;RT4: 83.9;SK-BR-3: 82.6;WM-115: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 3.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 3.2"									HPA010856	Enhanced		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavourable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	0.4	0.1	1.6	29.5	2.3	0.0	20.4	1.7	2.1	30.0	133.2	1.1	2.3	8.6	3.9	2.9	82.1	9.0	56.6	0.8	1.4	0.3	2.1	0.5	35.8	0.3	2.1	0.8	1.9	28.9	0.0	3.7	41.9	2.2	58.4	160.2	15.8	141.7	3.5	0.5	64.2	36.4	7.5	1.8	0.4	50.6	0.7	1.0	2.5	0.5	93.2	49.8	48.7	42.5	0.3	3.2	0.6	0.1	0.0	0.2	0.5	15.9	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.5	23.2	0.0	0.0	0.0	88.3	0.0	33.3	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	160.7	0.0	0.0	0.0	0.0	0.1	0.0	29.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	83.9	19.7	0.2	0.1	82.6	6.1	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	59.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.6	0.0	0.0	3.2	0.0	0.5	1.6	2.3	1.7	2.1	1.4	0.3	2.1	0.8	2.2	1.0
FZD5	"C2orf31, DKFZP434E2135, HFZ5"	ENSG00000163251	"Frizzled class receptor 5"	Q13467	2	207762586-207769563	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.2;liver: 36.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 47.3;CACO-2: 11.5;Hep G2: 15.9;NTERA-2: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA052361	Approved									"HPA052361: AB_2681799"	"unprognostic (4.97e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.82e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.00e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.51e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.15e-3)"	5.3	5.9	1.7	5.8	3.9	3.3	6.5	0.6	2.0	4.3	25.4	7.2	8.5	17.5	2.8	1.0	3.9	1.6	5.3	1.9	1.7	2.2	12.1	36.5	12.4	0.9	3.9	1.4	4.5	20.8	1.2	6.1	6.5	2.6	6.4	14.4	6.6	3.7	3.9	2.5	1.4	35.2	2.5	1.9	2.8	10.8	0.8	4.2	1.3	18.5	1.8	2.9	2.6	3.4	0.3	1.4	0.5	1.1	0.2	0.4	0.4	1.4	2.6	0.1	1.4	1.2	0.0	47.3	0.2	0.3	0.3	0.3	11.5	2.7	0.2	3.2	0.1	2.1	4.0	1.7	0.3	0.1	3.1	3.3	1.2	15.9	0.9	0.6	0.9	0.1	1.7	0.5	1.3	0.4	6.5	0.5	0.3	1.0	0.3	0.8	13.8	0.9	0.8	1.5	0.6	3.3	5.0	2.2	0.3	0.6	0.2	0.6	0.7	0.6	0.1	0.7	1.3	1.4	1.0	0.7	1.7	0.5	0.9	0.7	0.2	0.3	1.1	0.2	0.1	0.8	0.4	0.1	0.0	0.0	1.4	0.3	0.1	0.2	0.5	0.2	0.4	0.1	0.1	0.4	1.7	3.9	0.6	2.0	1.7	2.2	3.9	1.4	2.6	4.2
GAL3ST2	GP3ST	ENSG00000154252	"Galactose-3-O-sulfotransferase 2"	Q9H3Q3	2	241776825-241804208	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 8.6;intestine: 16.0;lymphoid tissue: 11.6"	"Group enriched"	"Detected in some"	7	"CACO-2: 1.8;Hep G2: 6.4;HMC-1: 2.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 6.7;ovarian cancer: 4.9;stomach cancer: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA071809	Enhanced				"Intracellular and membrane"					"HPA071809: AB_2686450"	"unprognostic (5.22e-3)"	"unprognostic (6.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.04e-3)"	"unprognostic (3.04e-4)"	"unprognostic (3.45e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.13e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.87e-11)"	"unprognostic (4.32e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.49e-1)"	1.0	0.6	0.5	11.6	0.7	0.1	0.1	0.1	0.5	1.9	16.0	0.0	0.0	0.1	0.1	0.1	0.1	1.0	8.6	0.1	0.4	0.6	0.4	0.9	1.3	0.1	0.2	0.0	1.7	0.1	0.1	0.4	0.1	0.0	0.3	6.6	0.0	3.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.2	0.1	0.9	11.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.5	0.4	0.6	0.2	0.0	0.0	0.0
GATA4		ENSG00000136574	"GATA binding protein 4"	P43694	8	11676959-11760002	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 42.5;intestine: 29.9;ovary: 63.4;pancreas: 49.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 14.9;HHSteC: 17.4;SH-SY5Y: 16.8"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 21.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013125, HPA073899"	Uncertain		Supported	"Nuclear bodies"				"Nuclear bodies"	"Nuclear bodies"	"CAB013125: AB_2533804, HPA073899: AB_2686641"	"unprognostic (2.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.68e-4)"	"unprognostic (2.66e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.55e-3)"	"unprognostic (1.02e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.67e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.61e-1)"		"unprognostic (1.29e-2)"	0.1	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	16.8	0.1	0.0	13.4	0.5	0.4	0.1	1.0	15.4	42.5	0.0	0.0	0.0	26.5	0.1	0.8	0.0	0.0	63.4	49.9	0.0	0.1	4.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	0.0	0.0	13.8	18.3	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	14.9	17.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	1.3	16.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0
GATA5	"bB379O24.1, GATAS"	ENSG00000130700	"GATA binding protein 5"	Q9BWX5	20	62463497-62475970	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 22.1;intestine: 23.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 2.5;HEL: 4.9;K-562: 7.7;SiHa: 3.4;T-47d: 8.2"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA067583			Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA067583: AB_2685867"	"unprognostic (2.21e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.34e-2)"		"unprognostic (1.69e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.27e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	1.9	3.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	4.4	15.9	0.0	5.2	14.8	3.8	1.7	0.3	9.1	22.1	6.8	0.0	0.0	3.3	0.7	1.6	0.0	0.0	0.0	3.1	0.0	0.3	0.6	0.6	0.0	11.3	0.0	1.0	0.4	0.8	0.1	0.3	23.6	18.3	0.2	0.1	10.3	16.8	0.0	0.0	1.2	0.0	0.0	14.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	0.0	0.3	4.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.6	3.4	0.0	0.0	8.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GBP3	FLJ10961	ENSG00000117226	"Guanylate binding protein 3"	Q9H0R5	1	89006666-89022894	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 63.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 30.4;BJ hTERT+ SV40 Large T+ RasG12V: 21.8;LHCN-M2: 26.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA045657	Approved									"HPA045657: AB_10961631"	"unprognostic (1.14e-2)"	"unprognostic (2.23e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.18e-1)"	"unprognostic (4.39e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.44e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.70e-3)"	"unprognostic (3.06e-2)"	"unprognostic (5.06e-3)"	7.5	10.9	3.0	10.5	6.5	0.4	6.1	3.4	4.1	10.5	20.6	2.8	9.8	35.9	4.9	14.3	7.1	7.2	16.4	5.4	4.2	3.5	16.5	6.8	11.8	5.6	6.9	0.8	10.4	3.9	1.9	6.1	14.1	8.0	8.8	13.0	4.6	8.2	10.0	1.9	3.1	63.1	5.9	9.5	8.6	14.6	3.2	6.4	4.9	15.0	4.3	5.1	12.6	16.8	3.5	5.7	3.0	10.1	5.8	11.5	4.4	9.6	0.6	0.0	0.0	9.5	11.2	1.6	16.7	30.4	15.9	21.8	0.0	0.8	0.7	3.2	15.0	4.0	0.0	11.0	15.6	0.2	0.0	0.9	1.6	0.1	8.1	3.2	0.0	8.7	2.1	11.8	4.2	5.2	0.0	2.0	26.9	0.0	2.3	0.4	0.0	7.6	0.7	1.8	1.1	16.0	18.3	0.0	0.0	5.1	2.9	0.0	0.0	0.9	6.3	17.1	1.1	0.1	1.7	2.9	0.9	0.0	0.1	0.0	4.3	0.0	5.8	0.3	11.5	6.3	10.0	3.5	10.2	9.2	5.7	2.7	6.5	9.6	3.0	5.8	10.1	0.4	7.2	4.4	3.0	6.5	3.4	4.1	4.2	3.5	6.9	0.8	8.0	6.4
GCNT1	"C2GNT, NACGT2, NAGCT2"	ENSG00000187210	"Glucosaminyl (N-acetyl) transferase 1, core 2"	Q02742	9	76419850-76507416	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.0;parathyroid gland: 57.8"	"Cell line enhanced"	"Detected in many"		"HHSteC: 25.8;HSkMC: 21.9;U-2197: 18.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"eosinophil: 16.8"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"cerebellum: 8.2;olfactory region: 30.1"	"Low region specificity"	"Detected in all"			"HPA003522, HPA003523, HPA031151"	Uncertain		Supported	"Nuclear speckles"		72000	72000	"Nuclear speckles"	"Nuclear speckles"	"HPA003522: , HPA003523: , HPA031151: AB_10602904"	"unprognostic (3.14e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.19e-1)"	"prognostic favourable (8.44e-4)"	"unprognostic (5.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.02e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.80e-1)"	"prognostic unfavourable (4.96e-4)"	5.6	1.1	1.6	7.9	3.9	2.2	8.2	10.9	2.7	5.3	24.5	0.7	3.0	23.2	5.2	1.2	2.1	1.8	4.1	3.1	2.1	1.4	1.4	1.0	4.5	9.2	1.6	2.1	0.9	2.0	57.8	1.9	3.9	1.0	4.9	4.6	0.5	9.1	1.8	0.8	1.5	32.0	2.5	1.2	7.6	18.6	1.4	0.6	2.8	16.9	1.2	6.4	2.4	3.3	9.4	4.7	16.8	6.4	4.7	1.9	1.6	2.4	0.2	0.1	0.0	3.1	14.9	3.6	10.0	4.5	8.1	5.8	2.5	0.6	1.7	1.0	7.4	2.1	5.0	4.1	9.1	1.2	0.8	4.2	0.2	0.4	25.8	3.1	1.4	21.9	1.1	7.9	8.5	7.4	0.0	1.7	8.1	3.7	1.6	5.0	4.7	0.6	2.8	5.0	0.8	9.5	4.4	1.0	0.0	1.2	1.3	0.0	0.0	2.1	3.0	5.1	3.3	18.3	4.4	2.6	0.4	0.0	10.3	5.3	1.2	4.3	2.7	16.8	1.3	6.4	0.4	1.3	1.5	1.3	4.7	9.4	0.2	1.0	0.9	4.7	5.7	2.3	1.9	1.6	1.6	3.9	10.9	2.7	2.1	1.4	1.6	2.1	1.0	0.6
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 26.2;Hep G2: 10.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"basal ganglia: 54.8"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Supported	"Golgi apparatus"		560000	560000	"Golgi apparatus"	"Golgi apparatus"	"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	2.0	0.9	2.5	7.9	2.8	0.7	12.7	7.6	1.9	6.0	13.0	2.0	0.9	7.8	5.6	1.3	3.7	1.7	2.8	11.8	2.2	2.4	19.6	14.3	10.4	3.3	2.4	0.4	0.9	5.5	1.0	6.2	3.1	4.0	21.9	3.7	8.1	7.4	0.9	2.3	2.5	25.1	2.6	2.2	4.2	8.3	9.0	2.9	0.9	2.4	1.2	7.2	2.0	3.0	2.1	2.5	4.2	3.1	0.5	0.4	0.7	4.2	3.5	1.2	2.9	0.0	0.0	3.5	0.0	3.1	0.8	0.2	6.2	3.1	2.4	26.2	0.0	0.1	0.3	3.2	1.8	1.6	0.9	0.5	1.8	10.9	0.0	1.1	2.9	0.0	0.0	0.3	0.0	6.9	0.3	0.0	0.3	0.0	0.0	2.2	3.9	2.4	0.1	2.4	3.8	9.3	2.3	2.6	1.8	0.0	9.2	8.8	0.1	0.4	5.9	0.5	0.4	0.0	3.4	0.0	0.0	1.7	0.5	0.2	1.4	4.2	3.1	1.3	0.3	2.3	0.1	2.1	0.3	0.4	2.5	1.3	0.4	0.4	0.2	0.5	0.8	0.6	0.2	0.7	2.5	2.8	7.6	1.9	2.2	2.4	2.4	0.4	4.0	2.9
GCNT3	"C2/4GnT, C2GnT-M, C2GnT2"	ENSG00000140297	"Glucosaminyl (N-acetyl) transferase 3, mucin type"	O95395	15	59594875-59640239	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 29.6;intestine: 103.3;salivary gland: 27.4"	"Cell line enriched"	"Detected in some"	5	"A549: 55.8"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 29.8"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA011154	Enhanced		Approved	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA011154: AB_1078961"	"unprognostic (5.09e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.92e-2)"	"prognostic favourable (1.78e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.02e-2)"	"prognostic unfavourable (6.49e-5)"	"unprognostic (1.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.02e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.06e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.43e-1)"	0.3	0.5	0.3	8.8	0.4	0.0	0.3	0.3	0.3	5.3	37.6	0.3	0.3	25.4	1.3	0.4	8.7	0.7	29.6	0.3	0.3	0.2	9.9	0.4	0.7	0.3	0.3	0.3	1.1	1.7	0.0	0.4	1.0	0.5	1.0	33.4	0.3	27.4	0.3	0.3	0.2	103.3	0.9	0.3	0.3	6.5	1.7	0.3	0.5	0.7	5.2	15.5	0.7	14.0	1.2	1.4	3.4	0.8	1.1	0.7	0.1	0.0	55.8	0.0	0.0	0.0	0.4	0.0	0.0	2.9	0.0	0.0	2.3	2.3	0.2	9.6	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	11.2	0.0	0.1	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.2	3.9	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.1	0.1	0.2	3.5	0.1	0.0	2.6	0.8	0.6	0.7	0.4	0.4	0.6	0.5	0.3	0.2	1.2	0.4	0.6	3.4	1.1	0.4	1.4	0.5	0.1	0.3	0.4	0.3	0.3	0.3	0.2	0.3	0.3	0.5	0.3
GCNT4	C2GNT3	ENSG00000176928	"Glucosaminyl (N-acetyl) transferase 4, core 2"	Q9P109	5	75025346-75030899	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 13.6;intestine: 13.1;stomach 1: 10.4"	"Cell line enriched"	"Detected in some"	5	"RT4: 26.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in many"		"basophil: 13.6"	"Group enriched"	"Detected in many"	54	"granulocytes: 13.6;T-cells: 11.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA037431	Approved		Supported	"Nucleoplasm,Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA037431: AB_10670382"	"unprognostic (1.88e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-1)"	"unprognostic (4.98e-2)"	"unprognostic (4.11e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.20e-2)"	"unprognostic (4.49e-3)"	"unprognostic (6.04e-2)"	"prognostic favourable (1.93e-7)"	"unprognostic (8.39e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.06e-2)"	"unprognostic (5.82e-2)"	0.6	0.6	0.3	1.0	0.7	0.0	0.9	0.0	2.3	1.1	1.1			13.1	1.4	0.6	1.3	1.1	2.5	0.3	0.3	0.1	1.8	0.4	1.0	1.7	0.1		0.9	3.0	8.4	0.1	3.0		1.0	0.2		0.5	2.4	1.0	1.5	10.8	0.7	0.0	0.6	10.4	1.0			0.5		1.1	6.4	2.0	0.0	0.0	13.6	0.1	0.2	11.6	1.6	0.2	0.1	1.0	1.6	1.8	0.6	0.1	2.0	5.2	1.0	0.9	2.5	0.1	0.0	0.2	1.5	0.7	1.0	1.8	0.2	0.0	0.0	0.8	0.2	0.2	0.8	0.0	0.0	0.3	2.9	0.1	0.3	0.0	0.0	0.3	0.1	0.0	1.4	0.0	0.4	0.0	0.0	0.0	2.6	0.2	26.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	13.6	0.0	0.0	0.9	0.0	3.5	0.0	8.1	2.6	0.0	0.0	8.1	5.9	0.1	0.2	0.1	0.0	11.6	1.6										
GDA		ENSG00000119125	"Guanine deaminase"	Q9Y2T3	9	72114595-72257193	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.8;intestine: 54.5;liver: 27.6"	"Cell line enhanced"	"Detected in some"		"A-431: 12.7;BJ hTERT+: 9.2;EFO-21: 50.3;HeLa: 17.6;hTCEpi: 23.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"amygdala: 39.7;basal ganglia: 31.5;cerebral cortex: 63.2;hippocampal formation: 79.5;olfactory region: 28.4"	"HPA019352, HPA024099, HPA030387"	Enhanced		Approved	Nucleoplasm		1300000	1300000	Nucleoplasm	Nucleoplasm	"HPA019352: AB_1855593, HPA024099: AB_1855594, HPA030387: AB_10602351"	"unprognostic (2.64e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.35e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.56e-2)"	"prognostic favourable (2.66e-5)"	"unprognostic (2.23e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (8.30e-4)"	0.5	1.7	26.7	1.8	27.7	0.5	0.5	0.4	33.8	1.0	20.6	0.9	7.7	47.4	2.4	0.6	0.5	4.7	13.1	0.5	25.7	15.0	21.4	27.6	0.5	0.5	2.9	27.4	0.4	1.7	10.8	1.7	10.3	0.8	0.4	5.5	0.0	0.4	4.1	1.1	1.6	54.5	0.5	0.6	0.5	2.0	1.0	0.2	0.0	0.4	1.0	2.6	3.4	0.5	1.4	0.5	3.0	0.7	1.0	1.0	0.1	12.7	1.6	0.0	0.0	0.0	0.0	0.3	0.0	9.2	0.0	0.0	1.1	7.1	0.0	50.3	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	23.5	0.0	0.2	0.0	3.4	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	2.9	0.0	0.2	0.9	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	3.0	0.7	0.3	1.0	0.6	0.3	0.6	0.5	0.4	0.3	1.4	0.7	0.7	1.9	1.0	0.4	0.5	0.5	0.1	26.7	27.7	0.4	33.8	25.7	15.0	2.9	27.4	0.8	0.2
GDPD2	"FLJ20207, GDE3, OBDPF"	ENSG00000130055	"Glycerophosphodiester phosphodiesterase domain containing 2"	Q9HCC8	X	70423031-70433390	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 22.5;intestine: 19.5;lymphoid tissue: 37.5;skin 1: 33.2"	"Group enriched"	"Detected in some"	7	"AF22: 9.2;NTERA-2: 19.7"	"Cancer enhanced"	"Detected in many"		"glioma: 10.8"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"														"unprognostic (1.53e-3)"	"unprognostic (5.79e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.00e-7)"	"unprognostic (3.15e-3)"	"unprognostic (3.65e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.40e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.22e-1)"	"unprognostic (8.91e-2)"	0.4	0.4	6.8	0.6	5.7	0.4	1.0	1.1	4.0	0.3	13.0	8.2	8.3	8.0	0.4	22.5	0.4	0.5	0.5	0.8	7.6	4.0	0.6	0.3	0.4	0.4	4.3	5.6	0.4	0.4	0.3	2.6	0.4	8.4	0.3	3.0	0.2	1.1	0.6	0.6	33.2	19.5	0.4	1.5	37.5	1.6	0.3	4.9	0.0	0.4	0.6	0.3	1.0	0.3	0.4	0.1	1.4	0.2	0.1	0.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.2	19.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	0.4	0.1	0.1	1.4	0.1	0.1	0.1	0.0	0.0	6.8	5.7	1.1	4.0	7.6	4.0	4.3	5.6	8.4	4.9
GGT6	FLJ90165	ENSG00000167741	"Gamma-glutamyltransferase 6"	Q6P531	17	4556927-4560818	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;salivary gland: 52.7"	"Group enriched"	"Detected in some"	8	"RT4: 29.8;SK-BR-3: 10.2;T-47d: 31.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"basophil: 3.5"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023362, HPA027213"	Approved					33000	33000			"HPA023362: AB_1848955, HPA027213: AB_10601326"	"unprognostic (2.23e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.14e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.71e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.29e-1)"	"prognostic favourable (4.35e-4)"	"unprognostic (2.10e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.07e-2)"	"unprognostic (5.06e-2)"	"prognostic favourable (9.42e-7)"	"unprognostic (1.56e-1)"	"unprognostic (5.71e-2)"	"unprognostic (9.17e-2)"	"unprognostic (8.07e-3)"	0.3	0.4	0.3	12.7	0.3	0.0	3.2	0.3	0.4	4.1	24.9	0.4	1.0	17.0	0.9	15.9	25.2	3.0	7.7	0.3	0.3	0.1	18.8	0.6	4.2	0.3	0.3	0.3	1.5	28.6	0.0	1.0	0.4	0.4	5.7	12.7	0.4	52.7	3.7	0.3	25.2	40.4	2.8	0.3	0.3	8.7	0.8	0.3	1.0	0.7	19.6	18.8	16.5	8.2	0.6	0.7	3.5	0.5	0.6	0.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	29.8	0.1	0.1	0.0	10.2	0.0	31.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.5	0.2	0.4	0.3	0.2	0.3	0.5	0.3	0.1	0.6	0.5	0.4	1.9	0.6	0.5	0.7	0.4	0.0	0.3	0.3	0.3	0.4	0.3	0.1	0.3	0.3	0.4	0.3
GIPC2	"FLJ20075, SEMCAP-2"	ENSG00000137960	"GIPC PDZ domain containing family member 2"	Q8TF65	1	77979542-78138449	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 64.0"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.1;HaCaT: 4.8;Hep G2: 17.9;HUVEC TERT2: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 1.9;naive CD4 T-cell: 1.4"	"Lineage enriched"	"Detected in single"	17	"T-cells: 1.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051212, HPA062684"	Approved		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA051212: , HPA062684: AB_2684833"	"unprognostic (1.72e-2)"	"unprognostic (9.37e-2)"	"prognostic favourable (5.49e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.35e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.22e-1)"	"unprognostic (5.91e-2)"	"unprognostic (1.44e-1)"	"prognostic favourable (2.11e-6)"	"unprognostic (6.55e-2)"	"unprognostic (1.78e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.29e-1)"	6.4	17.0	0.8	3.2	0.9	0.0	4.0	0.4	1.0	2.6	27.0	0.3	0.2	19.6	5.4	4.5	5.7	1.4	8.1	3.1	0.5	0.5	21.3	10.4	3.2	2.2	0.5	0.3	3.7	24.7	3.3	2.5	1.6	1.3	2.1	7.8	1.5	6.9	1.0	1.8	2.7	64.0	1.4	0.6	22.7	3.0	2.2	0.4	0.1	1.5	4.9	1.4	2.5	5.1	0.1	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	2.0	5.1	0.0	0.8	0.0	0.4	0.9	4.0	2.6	1.2	0.0	0.4	4.8	0.0	0.0	2.6	0.1	0.0	0.6	0.0	17.9	1.0	0.0	0.0	0.8	0.0	2.8	0.1	18.9	0.0	0.1	2.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.9	0.0	1.0	0.6	0.0	0.1	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	1.0	0.5	0.5	0.5	0.3	1.3	0.4
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
GLOD5		ENSG00000171433	"Glyoxalase domain containing 5"	A6NK44	X	48761750-48773648	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.2;kidney: 10.2;liver: 7.8"	"Cell line enhanced"	"Detected in some"		"Hep G2: 2.2;K-562: 1.9;MCF7: 6.3;SCLC-21H: 1.3;T-47d: 1.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	13	"eosinophil: 1.2"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010667	Enhanced		Uncertain	Mitochondria				Mitochondria	Mitochondria	"HPA010667: AB_1078975"	"unprognostic (1.03e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.78e-2)"	"unprognostic (7.04e-2)"		"unprognostic (3.14e-1)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-2)"		"unprognostic (2.64e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.05e-8)"	"unprognostic (2.08e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (6.79e-4)"	0.2	0.0	0.2	0.2	0.2	0.0	0.4	0.2	0.2	0.4	14.7	0.2	0.2	10.3	0.4	5.6	0.3	1.6	3.5	0.2	0.2	0.0	10.2	7.8	1.5	0.2	0.2	0.2	0.4	1.1	0.0	0.6	0.2	0.2	0.4	5.7	1.5	0.6	0.2	0.2	0.1	25.2	0.2	0.2	0.2	1.3	0.7	0.2	0.4	1.9	0.2	0.5	0.2	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.3	0.3	0.4	0.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
GLTPD2		ENSG00000182327	"Glycolipid transfer protein domain containing 2"	A6NH11	17	4788959-4790390	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 13.0;kidney: 9.8;liver: 44.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 11.5;Hep G2: 15.1;MCF7: 5.3"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 25.5"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA058295, HPA065267"	Uncertain		Approved	Vesicles	"Secreted - unknown location"			Vesicles	Vesicles	"HPA058295: AB_2683671, HPA065267: AB_2685451"	"unprognostic (4.00e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.79e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.45e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.33e-2)"	"unprognostic (5.62e-4)"	"unprognostic (7.80e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.25e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.71e-4)"	"unprognostic (7.59e-3)"	0.2	0.3	0.5	0.2	0.7	0.8	0.2	0.8	1.8	0.2	8.0	0.3	0.2	8.6	0.3	0.2	0.4	0.3	0.2	0.2	0.5	0.7	9.8	44.4	0.6	0.2	0.5	0.4	0.2	0.5	0.2	0.5	0.2	0.4	0.2	0.0	0.5	0.8	0.2	0.8	1.4	13.0	0.2	0.4	0.8	0.9	0.2	0.2	0.4	0.2	1.6	0.3	0.4	0.3	0.0	0.5	0.0	3.2	0.0	0.2	0.2	0.6	2.5	0.2	2.0	0.0	0.0	4.6	0.4	0.0	0.0	0.0	11.5	0.9	1.2	1.3	0.0	2.2	0.0	0.1	0.0	2.2	1.7	0.1	1.0	15.1	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	5.3	0.2	0.2	0.2	1.0	0.9	0.6	0.3	0.0	0.9	1.5	1.0	2.2	0.4	0.6	1.3	0.1	2.4	0.8	0.9	0.5	0.4	0.2	0.6	0.1	0.3	0.6	0.9	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.2	0.0	0.0	3.2	0.0	0.0	0.2	0.5	0.7	0.8	0.7	0.5	0.7	0.5	0.4	0.4	0.2
GNA11	"FBH, FBH2, FHH2, HHC2"	ENSG00000088256	"G protein subunit alpha 11"	P29992	19	3094410-3124004	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 103.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 9.1"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048886	Approved									"HPA048886: AB_2680544"	"unprognostic (4.64e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.26e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.43e-1)"	"prognostic favourable (1.48e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	19.3	14.2	17.3	13.7	17.1	5.9	14.2	38.5	28.0	16.1	40.8	18.6	18.3	65.9	19.8	14.5	17.2	19.8	19.5	21.9	16.0	12.8	17.8	16.6	15.1	5.0	11.7	12.6	19.4	19.6	14.2	13.8	20.0	14.1	18.2	23.0	27.1	17.5	30.5	27.3	20.0	103.3	17.6	12.2	10.5	17.2	20.1	12.5	3.9	18.0	13.5	7.6	19.2	22.1	2.4	3.9	9.1	2.4	0.7	2.2	0.4	20.3	12.4	11.3	19.6	16.7	11.1	12.5	20.2	20.1	27.4	22.5	15.6	10.5	5.0	11.2	28.2	14.8	14.2	16.2	17.5	11.0	8.4	1.4	13.4	8.9	16.5	1.3	4.6	15.2	14.1	18.5	11.2	21.8	10.2	1.0	18.3	9.4	1.4	6.0	7.8	11.2	8.9	10.0	4.6	13.3	16.0	25.5	16.1	14.5	17.4	10.1	12.5	2.9	18.6	18.1	12.9	32.6	27.0	0.5	1.4	3.3	12.9	1.1	19.6	2.8	2.4	0.5	1.1	1.3	1.4	1.3	0.9	1.1	0.4	2.4	2.2	1.6	9.1	0.7	2.4	3.9	0.3	0.4	17.3	17.1	38.5	28.0	16.0	12.8	11.7	12.6	14.1	12.5
GPAT3	"AGPAT10, AGPAT9, HMFN0839, LPAAT-theta, MAG1, MGC11324"	ENSG00000138678	"Glycerol-3-phosphate acyltransferase 3"	Q53EU6	4	83535914-83605875	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.2;kidney: 43.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 54.5;HMC-1: 20.0;U-87 MG: 23.8;WM-115: 18.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"basophil: 42.0"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA029414, CAB033749"	Approved		Uncertain	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB033749: AB_2224941, HPA029414: AB_10601562"	"unprognostic (9.51e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.50e-3)"	"unprognostic (2.61e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"prognostic favourable (2.71e-9)"	"unprognostic (3.74e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.53e-3)"	"prognostic unfavourable (8.21e-4)"	7.9	0.7	0.7	5.2	1.4	5.2	17.5	4.2	2.9	3.7	18.0	1.2	1.3	20.2	3.0	2.1	5.1	2.1	6.0	24.8	1.2	2.2	43.7	9.0	3.2	4.5	1.9	0.8	12.9	1.7	11.8	5.8	1.2	9.5	2.6	5.7	1.3	3.6	1.9	35.9	1.9	47.2	3.7	3.0	4.3	7.4	4.6	1.4	0.9	26.6	14.6	3.4	4.5	7.2	0.0	23.2	42.0	9.7	0.5	1.8	2.9	10.4	10.3	0.0	0.1	0.5	1.3	0.2	0.8	1.5	0.2	0.2	0.7	54.5	0.0	1.1	2.0	2.3	4.9	0.9	0.1	0.7	2.3	0.0	3.2	10.0	1.4	2.9	20.0	0.7	0.0	0.4	1.2	5.1	8.3	8.2	0.2	1.0	0.7	0.7	0.2	4.4	0.1	2.3	3.9	10.3	0.7	0.2	0.0	2.0	2.1	5.7	0.4	0.5	0.2	2.5	4.4	2.4	9.8	0.4	0.7	0.0	23.8	5.9	18.2	42.0	9.7	1.0	0.2	7.7	1.8	0.0	1.0	0.6	23.2	0.0	0.7	0.3	26.4	0.5	6.1	0.1	0.6	2.9	0.7	1.4	4.2	2.9	1.2	2.2	1.9	0.8	9.5	1.4
GPR119	"GPCR2, hGPCR2"	ENSG00000147262	"G protein-coupled receptor 119"	Q8TDV5	X	130384440-130385447	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.5;pancreas: 8.0"	"Group enriched"	"Detected in some"	20	"CACO-2: 2.7;Hep G2: 5.8"	"Cancer enriched"	"Detected in single"	11	"pancreatic cancer: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"																								"prognostic favourable (6.93e-4)"							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR152	PGR5	ENSG00000175514	"G protein-coupled receptor 152"	Q8TDT2	11	67451301-67452729	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 1.6"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 3.4"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA035078	Uncertain									"HPA035078: AB_10670286"								"unprognostic (3.81e-2)"		"unprognostic (1.69e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"		"unprognostic (3.76e-3)"				0.1	0.0	0.0	0.6	0.0	0.6	0.0	0.1	0.0	0.1	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.4	0.6	0.0		0.0	0.0	0.3	0.0	0.0		0.1	0.0		0.2	0.0	0.3	0.1	1.7	0.0	0.1	1.6	0.7	0.0			0.0		0.0	0.1	0.0	0.2	0.1	1.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.1	0.5	0.0	1.0	0.0	0.3	0.0	0.0	0.0										
GPR171	H963	ENSG00000174946	"G protein-coupled receptor 171"	O14626	3	151197832-151203201	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.2;intestine: 19.5;lymphoid tissue: 33.0"	"Cell line enriched"	"Detected in single"	26	"U-266/70: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"MAIT T-cell: 45.2"	"Lineage enriched"	"Detected in many"	18	"T-cells: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA062429	Approved									"HPA062429: AB_2684760"	"unprognostic (6.82e-6)"	"unprognostic (4.90e-3)"	"unprognostic (7.10e-2)"	"unprognostic (6.85e-4)"	"unprognostic (2.80e-3)"	"unprognostic (1.04e-3)"	"unprognostic (4.19e-4)"	"unprognostic (6.09e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.01e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.72e-6)"	"unprognostic (1.31e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.02e-2)"	4.1	0.9	0.4	15.1	0.4	0.4	1.6	0.3	0.3	4.0	6.8	0.3	0.6	3.5	1.4	1.6	2.7	3.9	4.6	1.3	0.4	0.4	4.3	2.7	10.7	33.0	0.7	0.5	1.9	1.0	0.0	0.7	0.8	1.5	2.2	3.8	1.7	2.4	1.2	1.0	1.1	19.5	1.1	2.7	20.7	4.0	1.0	0.5	19.9	2.2	1.8	8.5	7.0	2.4	0.1	0.8	1.0	0.1	2.5	45.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.9	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.0	11.6	0.0	45.2	0.0	16.2	21.5	0.8	0.1	9.9	8.4	0.3	2.5	0.1	0.7	8.0	3.4	0.4	0.4	0.3	0.3	0.4	0.4	0.7	0.5	1.5	0.5
GPR42	"FFAR3L, GPR41L, GPR42P"	ENSG00000126251	"G protein-coupled receptor 42 (gene/pseudogene)"	O15529	19	35370929-35372962	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adipose tissue: 2.3;blood: 2.1;intestine: 2.1"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 1.1"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	5	"eosinophil: 1.9;neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.1"									HPA044681	Uncertain									"HPA044681: AB_2679043"											"unprognostic (1.73e-3)"			"unprognostic (1.31e-4)"				2.3	0.0	0.0	1.5	0.1	0.1	1.2	0.0	0.2	0.0	1.7			0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1		0.0	0.1	1.3	0.1	0.4		0.1	0.3		0.0	0.0	0.0	0.0	2.1	0.2	0.4	0.8	1.3	0.0			0.5		0.0	0.3	0.0	0.0	0.1	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	0.0	0.0	0.0	1.9	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.1	0.0	0.3	0.0	0.0	0.0										
GPR55		ENSG00000135898	"G protein-coupled receptor 55"	Q9Y2T6	2	230907318-230961066	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.8;intestine: 8.2;lymphoid tissue: 13.2;testis: 7.7"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 26.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in some"	6	"basal ganglia: 7.8"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"														"unprognostic (9.88e-4)"	"unprognostic (2.60e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.24e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.12e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.37e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.42e-2)"	"unprognostic (4.26e-1)"	0.4	0.1	0.4	6.9	7.8	0.2	0.7	0.1	1.2	0.6	4.8	0.7	0.1	2.1	0.9	0.5	0.8	0.2	1.6	0.1	0.5	0.7	0.9	0.1	0.8	8.8	0.2	0.1	0.1	0.1	0.1	0.5	0.1	0.3	1.2	1.5	0.1	1.9	2.1	0.1	0.6	8.2	0.1	0.3	6.6	0.9	7.7	0.1	7.0	0.4	1.2	13.2	2.2	0.4	3.0	1.9	0.5	0.2	2.2	3.1	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.6	26.4	0.0	0.0	0.2	0.7	0.5	0.8	0.0	0.0	2.5	0.0	0.0	1.0	0.0	0.0	0.0	4.8	0.0	1.8	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.0	0.0	0.1	0.0	0.0	0.1	0.3	1.2	1.2	0.9	0.4	3.0	0.5	2.3	0.5	2.2	0.2	1.9	3.1	4.6	0.4	7.8	0.1	1.2	0.5	0.7	0.2	0.1	0.3	0.1
GPRIN2	"KIAA0514, MGC15171"	ENSG00000204175	"G protein regulated inducer of neurite outgrowth 2"	O60269	10	46549044-46555530	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 8.9;lung: 10.5;skin 1: 13.8"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;A549: 27.8;SiHa: 5.2;SK-BR-3: 15.3"	"Low cancer specificity"	"Detected in many"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA038129	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA038129: AB_2675846"	"unprognostic (1.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.77e-2)"	"prognostic unfavourable (8.60e-8)"	"unprognostic (5.77e-2)"	"prognostic favourable (3.47e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.97e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.67e-3)"	0.0	0.0	0.0	0.6	0.2	0.0	1.1	6.5	0.0	0.2	5.7			6.6	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.2	1.7	0.0	10.5	0.0	1.2		0.0	4.1	0.0	3.0	0.0		1.6	4.0		4.2	1.5	0.0	13.8	8.9	0.0	0.2	0.0	5.1	1.3			2.3		0.3	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.3	0.0	1.1	0.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.5	0.4	0.6	0.1	5.2	15.3	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
GRTP1	"FLJ22474, TBC1D6"	ENSG00000139835	"Growth hormone regulated TBC protein 1"	Q5TC63	13	113324164-113364148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 39.2;liver: 37.4"	"Cell line enhanced"	"Detected in many"		"T-47d: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA046201	Approved									"HPA046201: AB_2679584"	"unprognostic (5.31e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.94e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.75e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.07e-3)"	"prognostic favourable (1.50e-5)"	"unprognostic (4.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.56e-2)"	"unprognostic (4.50e-3)"	2.1	7.2	1.9	7.0	2.2	1.5	8.6	1.1	1.9	7.6	25.9	1.3	14.6	28.2	6.4	7.4	10.5	4.8	16.7	1.2	3.3	1.0	10.8	37.4	2.9	2.4	1.8	2.4	6.6	11.5	2.8	1.4	8.7	4.1	8.7	8.2	9.0	12.1	8.3	5.5	14.4	39.2	4.5	3.2	3.7	7.5	9.4	3.1	1.8	1.9	5.0	6.2	6.5	8.0	3.3	2.8	6.7	2.5	1.6	2.4	1.9	5.8	2.1	4.3	7.4	0.7	1.0	13.4	1.0	0.0	0.3	0.1	12.1	13.1	0.3	1.0	0.4	8.6	3.6	1.0	0.0	0.3	5.0	7.4	6.1	11.9	1.2	0.8	3.0	0.3	1.6	0.9	0.2	0.0	4.5	0.6	0.0	10.9	0.2	1.3	11.8	1.7	0.8	0.2	0.3	1.0	6.9	0.5	3.8	0.4	6.4	1.4	30.4	0.8	0.5	0.3	1.7	1.1	0.4	2.3	2.5	1.0	4.8	1.8	2.5	4.0	2.5	2.2	1.3	1.4	1.0	2.8	1.6	1.0	0.9	3.3	2.4	1.6	6.7	1.6	2.2	2.8	0.5	1.9	1.9	2.2	1.1	1.9	3.3	1.0	1.8	2.4	4.1	3.1
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 71.3"	"Cell line enriched"	"Detected in some"	8	"SK-BR-3: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"memory CD4 T-cell: 2.8"	"Low lineage specificity"	"Detected in many"											"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favourable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavourable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favourable (5.91e-9)"	4.0	0.0	1.3	13.3	2.0	1.3	2.8	4.8	1.7	2.1	33.1	1.4	2.0	25.2	1.3	1.7	1.3	1.3	14.4	1.3	1.3	0.6	2.2	17.1	2.4	3.5	1.3	1.3	2.0	2.8	0.0	1.3	1.8	1.3	3.5	22.4	1.3	1.3	2.7	1.3	2.8	71.3	3.9	1.3	4.7	18.1	1.4	1.5	1.6	2.9	1.3	2.8	4.1	4.5	0.8	0.0	1.8	0.0	0.1	2.8	0.4	0.4	0.3	0.6	0.1	1.5	0.9	0.5	0.3	0.2	0.1	0.4	0.3	12.0	0.6	0.5	0.3	1.6	0.3	0.3	0.8	2.4	0.3	0.2	0.1	0.1	0.4	0.0	0.1	0.6	2.0	0.5	0.7	0.2	0.2	0.7	0.1	0.1	0.6	1.3	0.1	0.4	0.6	0.1	0.9	0.0	0.3	0.2	0.3	0.1	100.5	0.3	0.5	0.3	0.3	0.4	0.6	1.1	0.2	2.2	1.8	0.5	0.1	0.4	0.0	0.0	0.0	1.8	1.1	0.0	0.0	0.8	2.8	1.4	0.0	0.0	2.6	0.6	0.7	0.1	0.0	0.0	0.4	0.4	1.3	2.0	4.8	1.7	1.3	0.6	1.3	1.3	1.3	1.5
GSKIP	C14orf129	ENSG00000100744	"GSK3B interacting protein"	Q9P0R6	14	96363452-96387288	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA043054, HPA046782"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA043054: AB_2678293, HPA046782: AB_2679803"	"unprognostic (3.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.23e-3)"	"unprognostic (1.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.16e-3)"	"unprognostic (6.82e-2)"	"unprognostic (2.84e-1)"	"unprognostic (8.74e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.30e-1)"	6.6	7.1	11.2	8.0	21.9	7.1	6.7	5.1	14.6	6.6	29.5	5.4	6.7	23.5	5.5	6.4	20.8	5.5	7.0	5.2	12.0	9.6	12.8	36.4	5.3	8.7	9.2	9.7	3.6	6.1	4.0	10.8	11.1	10.7	7.1	28.3	8.7	7.8	5.2	5.5	8.5	63.0	8.0	10.4	6.6	11.3	26.4	7.2	9.0	5.8	10.7	10.7	8.2	9.0	20.1	11.2	27.5	16.6	17.8	34.1	14.8	9.4	13.6	15.2	10.3	11.5	13.4	25.8	17.7	13.5	11.7	13.0	10.0	16.1	9.1	10.8	13.4	10.5	9.9	10.6	17.1	21.6	9.4	3.8	7.8	7.6	10.7	9.7	6.6	10.8	16.9	15.0	15.1	15.2	8.2	8.3	14.8	23.5	7.1	7.9	16.9	17.2	7.2	14.2	8.2	27.5	35.5	5.4	17.4	20.0	18.9	15.4	14.2	6.3	16.7	5.4	7.0	11.5	5.5	9.8	27.9	7.7	13.9	7.0	8.6	27.5	10.8	24.3	15.5	12.6	24.0	20.1	21.7	18.3	11.2	16.6	21.4	19.8	21.7	17.8	16.6	9.6	34.1	14.8	11.2	21.9	5.1	14.6	12.0	9.6	9.2	9.7	10.7	7.2
GSTM4		ENSG00000168765	"Glutathione S-transferase mu 4"	Q03013	1	109656081-109674836	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	9	"eosinophil: 69.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.8"	"Low region specificity"	"Detected in all"							"HPA048652, HPA055972, HPA055973"	Approved		Approved	"Cytokinetic bridge,Cytosol"		660000	660000	Cytosol	Cytosol	"HPA048652: AB_2680478, HPA055972: AB_2682992, HPA055973: AB_2682993"	"prognostic favourable (9.96e-5)"	"unprognostic (1.96e-3)"	"unprognostic (7.49e-2)"	"unprognostic (9.92e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.76e-2)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.47e-2)"	12.5	17.6	14.0	12.3	20.2	3.6	10.9	12.9	24.7	12.6	33.2	18.0	9.4	85.3	12.1	15.3	15.9	11.0	14.5	14.7	13.7	12.3	27.2	22.0	7.4	10.1	14.8	16.9	31.4	12.2	23.1	9.9	5.1	15.8	14.7	23.2	20.5	15.4	26.3	47.4	10.6	77.2	19.0	16.1	16.2	14.7	11.8	14.0	4.0	14.9	14.5	12.8	22.2	14.2	3.6	7.8	69.8	3.0	2.5	3.1	2.3	5.3	2.4	4.3	32.5	9.7	15.0	5.5	1.7	14.0	4.1	5.4	17.1	0.6	5.0	6.7	7.7	5.5	11.1	5.8	2.6	7.4	0.0	10.8	10.0	15.3	15.8	3.7	13.2	9.4	5.8	5.2	0.0	3.3	5.0	7.5	2.8	4.9	3.1	16.4	3.3	12.9	6.6	2.4	7.3	16.0	3.8	3.0	7.2	0.0	28.1	21.7	7.6	8.0	1.4	4.7	18.7	5.2	2.5	11.2	19.6	0.4	15.5	5.5	13.3	2.0	2.9	69.8	2.7	3.0	1.6	3.6	2.0	3.1	7.8	2.8	2.0	2.3	0.4	2.5	0.7	2.7	2.8	2.3	14.0	20.2	12.9	24.7	13.7	12.3	14.8	16.9	15.8	14.0
H2AFB2		ENSG00000277858	"H2A histone family member B2"	P0C5Z0	X	155380787-155381134	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 2.3;pancreas: 2.4;salivary gland: 2.8"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;CAPAN-2: 3.2;HeLa: 4.2;NB-4: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.3		0.0		0.0	0.0		0.1	0.0	0.3			2.3	0.0	0.0	0.5	0.0	0.0	1.3			0.1	0.0	0.0	0.2			0.2	2.4	0.0		0.1		0.0	0.1		2.8	0.0	0.0	0.0	0.0	0.0		0.2	0.0	0.4			0.0		0.0	0.0		0.4	0.6	0.0	0.3	0.0	0.4	1.2	2.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.2	0.0	0.7	1.1	0.0	0.0	0.2	1.5	0.0	4.2	0.0	0.0	1.7	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	1.1	2.6	0.0	0.0	0.7	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.6	0.0	0.2	0.4	0.9	0.0	2.0	1.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.4	1.2										
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478264	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"heart muscle: 25.9;intestine: 35.1;smooth muscle: 14.2"	"Cell line enriched"	"Detected in some"	7	"SH-SY5Y: 50.8"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 0.6;testis cancer: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA040925	Approved		Uncertain	"Nucleoplasm,Nuclear membrane"				Nucleoplasm	Nucleoplasm	"HPA040925: AB_10796563"			"unprognostic (2.37e-2)"					"unprognostic (8.29e-2)"		"unprognostic (2.46e-3)"	"unprognostic (7.23e-2)"				"unprognostic (5.21e-2)"		"unprognostic (6.38e-3)"	0.2	6.0	0.1	9.7	0.1	0.0	0.1	0.1	0.1	0.1	35.1	0.0	0.0	4.4	0.1	0.0	0.1	0.1	5.3	25.9	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	3.6	0.0	5.4	2.6	0.1	0.1	0.0	0.1	0.1	20.8	14.2	0.1	0.1	0.1	0.2	0.0	0.7	0.1	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	50.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
HEPACAM2	FLJ38683	ENSG00000188175	"HEPACAM family member 2"	A8MVW5	7	93188586-93226524	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 43.4;kidney: 24.5;pituitary gland: 16.1"	"Cell line enriched"	"Detected in some"	37	"SCLC-21H: 61.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA012381			Supported	"Nucleoplasm,Vesicles,Mitotic spindle"		89000	89000	"Vesicles, Mitotic spindle"	"Vesicles, Mitotic spindle"	"HPA012381: "	"unprognostic (2.01e-3)"	"unprognostic (6.05e-2)"	"prognostic favourable (9.73e-5)"	"unprognostic (1.33e-2)"	"unprognostic (7.27e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.48e-2)"	"unprognostic (8.40e-3)"	"unprognostic (7.61e-2)"	"unprognostic (8.68e-2)"	"unprognostic (5.37e-3)"	"unprognostic (4.93e-2)"	"unprognostic (3.64e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.82e-1)"	"unprognostic (6.34e-2)"	0.1	0.2	0.2	8.5	0.2	0.6	3.4	0.1	0.1	0.1	29.4	0.1	5.3	11.8	0.1	0.4	0.2	0.1	0.8	0.3	0.2	0.2	24.5	0.2	0.4	0.1	0.2	0.1	0.1	5.5	0.0	16.1	0.4	0.2	0.7	38.9	0.1	4.1	1.2	0.1	0.1	43.4	0.4	0.2	0.2	4.0	1.4	0.1	0.3	0.1	0.1	2.1	0.3	0.1	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	61.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.1
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 68.7"	"Cell line enhanced"	"Detected in some"		"AF22: 14.0;HEL: 12.0;HSkMC: 18.2;K-562: 33.7;LHCN-M2: 13.9"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA000553, HPA005824"	Approved		Approved	"Nucleoplasm,Nuclear bodies"		1200000	1200000	"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"HPA000553: , HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	4.0	12.2	8.3	10.9	9.3	0.0	3.9	3.7	10.1	11.6	38.4	9.7	8.9	32.9	18.3	9.0	7.5	8.7	21.4	14.8	8.1	5.0	3.7	1.4	7.1	1.3	9.2	10.2	10.2	1.0	0.9	2.5	0.9	8.5	11.0	33.5	11.4	3.0	14.5	0.5	2.8	68.7	34.8	6.7	4.4	8.6	3.2	8.8	0.0	3.2	2.7	1.1	11.2	6.4	0.0	0.2	0.0	0.0	0.0	0.6	0.5	0.0	0.0	14.0	1.1	0.0	0.0	0.4	3.5	0.1	0.0	0.0	8.3	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	3.9	0.0	12.0	0.0	0.0	0.1	0.1	0.0	18.2	0.0	0.0	0.0	0.0	33.7	0.3	13.9	0.0	0.0	0.3	6.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	8.1	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	8.3	9.3	3.7	10.1	8.1	5.0	9.2	10.2	8.5	8.8
HMX3	NKX5-1	ENSG00000188620	"H6 family homeobox 3"	A6NHT5	10	123135962-123137741	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8;intestine: 5.7"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 5.4;HeLa: 5.0;K-562: 17.9;NB-4: 6.1;SiHa: 5.0"	"Low cancer specificity"	"Detected in single"			"Group enriched"	"Detected in some"	11	"hypothalamus: 6.8;pons and medulla: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.3"	"Group enriched"	"Detected in some"	5	"basal ganglia: 2.3;hypothalamus: 8.0"	HPA069659			Approved	"Nucleoplasm,Centriolar satellite"				Nucleoplasm	Nucleoplasm	"HPA069659: AB_2686165"			"unprognostic (1.79e-1)"								"unprognostic (9.65e-2)"			"unprognostic (6.07e-2)"				1.9	0.1	0.0	1.5	0.1	0.0	0.0	0.0	0.4	0.1	3.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.8	0.9	0.0	0.4	0.2	0.0	0.0	0.9	0.7	0.0	1.3	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	2.0	0.0	0.0	0.8	0.7	5.4	5.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.0	6.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.0	0.0	0.0	0.0	2.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	6.8	0.0	0.0	2.2	0.0
HNF1A	"HNF1, LFB1, MODY3, TCF1"	ENSG00000135100	"HNF1 homeobox A"		12	120978543-121002512	"Cancer-related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in some"		"intestine: 24.2;kidney: 17.2;liver: 15.6"	"Group enriched"	"Detected in some"	7	"A549: 6.2;CACO-2: 20.6;Hep G2: 22.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010430, HPA035231"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB010430: AB_2116746, HPA035231: AB_2674528"	"unprognostic (5.92e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.12e-3)"	"unprognostic (6.18e-3)"	"unprognostic (3.72e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.18e-2)"	"unprognostic (9.18e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.77e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.25e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.48e-1)"		"unprognostic (6.93e-3)"	0.1	0.0	0.1	0.8	0.1	0.0	0.1	0.1	0.1	0.1	17.3	0.1	0.1	13.7	0.1	1.5	0.1	0.8	5.1	0.1	0.1	0.0	17.2	15.6	0.1	0.1	0.1	0.1	0.2	6.3	0.0	0.1	0.1	0.1	0.1	2.1	0.1	0.1	0.1	0.1	0.0	24.2	0.5	0.1	0.1	3.6	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.5	0.5	1.8	0.3	0.3	0.4	0.2	0.0	6.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.3	0.2	0.2	0.3	0.2	0.3	0.4	0.4	0.1	0.5	0.4	0.4	1.6	0.3	0.3	0.5	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HNF4A	"HNF4, MODY, MODY1, NR2A1, TCF14"	ENSG00000101076	"Hepatocyte nuclear factor 4 alpha"	P41235	20	44355700-44434596	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 65.5;kidney: 30.5;liver: 57.3"	"Group enriched"	"Detected in some"	9	"CACO-2: 51.6;Hep G2: 37.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 48.2"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA004712, CAB019417"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"CAB019417: AB_2295208, HPA004712: AB_1079075"	"unprognostic (2.47e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.54e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.90e-2)"	"unprognostic (4.79e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.75e-2)"	"unprognostic (8.40e-3)"	"unprognostic (2.12e-1)"		"unprognostic (2.70e-2)"	0.2	0.2	0.2	13.4	0.2	0.0	0.2	0.2	0.3	0.2	54.0	0.2	0.1	33.0	0.2	6.2	0.2	0.4	15.7	0.2	0.2	0.2	30.5	57.3	0.3	0.1	0.2	0.1	0.3	22.7	0.0	0.2	0.1	0.2	0.2	14.4	0.2	0.2	0.1	0.2	0.2	65.5	0.3	0.2	0.2	7.1	0.4	0.1	0.1	0.2	0.1	0.1	0.2	0.4	0.4	0.6	1.2	0.8	0.8	0.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	51.6	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.4	0.4	0.4	0.7	0.8	0.8	0.6	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.1
HOXD12	HOX4H	ENSG00000170178	"Homeobox D12"	P35452	2	176099730-176101193	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 4.3;intestine: 3.5;seminal vesicle: 4.8;vagina: 3.7"	"Group enriched"	"Detected in some"	4	"REH: 7.1;SCLC-21H: 2.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	41	"basal ganglia: 4.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA059444	Uncertain									"HPA059444: AB_2684020"		"unprognostic (1.00e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.32e-2)"	"unprognostic (3.53e-2)"		"unprognostic (1.71e-2)"	"unprognostic (1.36e-2)"			"unprognostic (7.11e-2)"		"unprognostic (4.54e-2)"	"unprognostic (7.29e-2)"		"unprognostic (1.44e-2)"	0.1	0.0	0.1	0.1	4.3	0.0	0.1	0.1	0.1	1.4	3.5	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	1.8	3.4	0.1	0.1	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.2	1.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.1	1.1	0.5	0.1	7.1	0.0	0.0	0.0	0.1	2.0	0.2	0.6	0.0	0.9	0.9	0.0	0.0	0.1	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.3	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
HOXD13	"HOX4I, SPD"	ENSG00000128714	"Homeobox D13"	P35453	2	176092891-176095938	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 14.0;intestine: 13.1;prostate: 13.8;seminal vesicle: 19.0;vagina: 15.0"	"Group enriched"	"Detected in some"	4	"HAP1: 9.6;HEK 293: 27.6;HL-60: 30.7;NB-4: 18.3;SCLC-21H: 8.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064064			Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA064064: AB_2685186"	"unprognostic (2.04e-1)"	"unprognostic (1.13e-1)"	"prognostic unfavourable (6.95e-5)"	"unprognostic (2.52e-3)"	"unprognostic (7.25e-2)"	"unprognostic (2.08e-2)"		"unprognostic (4.62e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.66e-1)"		"unprognostic (1.01e-2)"	"unprognostic (2.82e-4)"	"unprognostic (4.95e-2)"	"unprognostic (3.70e-2)"		"unprognostic (9.98e-3)"	0.4	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	14.0	13.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	13.8	8.8	0.1	0.1	19.0	0.6	0.0	0.1	3.7	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	3.8	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	1.1	2.5	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	1.5	0.0	27.6	4.2	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	18.3	0.9	1.5	0.0	0.1	0.0	0.0	0.2	8.0	1.9	1.9	0.0	4.4	0.0	0.0	0.0	1.0	0.0	0.4	2.5	0.0	0.0	0.0	1.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.1
HRASLS2	FLJ20556	ENSG00000133328	"HRAS like suppressor 2"	Q9NWW9	11	63552770-63563383	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 16.1;intestine: 42.5"	"Cell line enriched"	"Detected in some"	8	"U-266/70: 53.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 16.1;naive B-cell: 5.3"	"Lineage enriched"	"Detected in many"	12	"B-cells: 16.1"									HPA058997	Approved		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA058997: AB_2683874"	"unprognostic (4.76e-2)"	"prognostic favourable (6.87e-4)"	"unprognostic (1.20e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.69e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavourable (5.27e-5)"	"unprognostic (1.56e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.57e-2)"	0.4	0.0	0.4	1.5	0.4	0.0	4.7	0.4	0.4	0.6	20.6	0.5	0.4	33.4	0.6	1.1	0.5	2.1	0.4	1.0	0.4	0.2	5.5	1.9	3.3	1.1	0.4	0.4	0.4	0.4	0.0	0.4	1.4	0.4	0.4	6.5	0.4	0.7	0.4	0.4	0.2	42.5	0.4	0.4	0.7	8.8	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	16.1	0.8	0.1	0.1	1.2	0.9	3.6	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	6.3	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	53.2	6.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.9	16.1	0.2	0.9	0.0	5.3	0.2	0.6	0.1	1.2	0.0	0.8	0.0	3.6	0.4	0.4	0.4	0.4	0.4	0.2	0.4	0.4	0.4	0.4
HSD11B2	SDR9C3	ENSG00000176387	"Hydroxysteroid 11-beta dehydrogenase 2"	P80365	16	67430652-67437553	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.8;kidney: 119.9;salivary gland: 66.0"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.7;RPMI-8226: 11.5;RT4: 11.6;SCLC-21H: 12.8;SK-BR-3: 11.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB032443, HPA042186, HPA056385"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"CAB032443: AB_2233199, HPA042186: AB_2677888, HPA056385: AB_2683110"	"unprognostic (2.87e-3)"	"unprognostic (5.24e-2)"	"unprognostic (7.10e-2)"	"unprognostic (6.55e-2)"	"unprognostic (9.29e-3)"	"unprognostic (3.14e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.25e-3)"	"unprognostic (3.27e-2)"	"unprognostic (2.34e-1)"	"prognostic favourable (9.51e-5)"	"unprognostic (7.20e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.84e-1)"	0.4	1.0	0.6	22.2	2.3	0.0	3.2	2.0	1.7	4.8	42.8	0.3	1.3	9.4	3.8	3.6	2.5	2.4	8.3	0.5	0.5	0.1	119.9	1.2	2.3	0.7	0.3	0.8	4.8	2.1	0.0	0.4	42.3	1.1	3.7	24.5	0.4	66.0	1.4	0.4	13.8	62.8	4.3	0.3	1.5	2.1	1.4	1.3	0.5	3.8	3.3	1.6	1.5	4.8	0.1	0.0	0.0	0.2	0.0	0.0	0.0	2.9	0.9	0.4	1.2	0.1	1.5	3.1	0.0	0.0	0.1	0.1	5.1	1.1	0.0	2.3	0.1	6.5	4.3	0.4	0.0	0.0	1.5	0.0	0.5	5.4	0.5	0.6	0.0	1.5	2.6	0.2	0.1	0.0	0.3	0.0	0.0	3.1	0.1	0.1	9.7	0.8	0.0	0.1	11.5	0.4	11.6	12.8	0.8	0.7	11.5	0.5	5.5	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	2.3	2.0	1.7	0.5	0.1	0.3	0.8	1.1	1.3
HSD17B11	"17-BETA-HSD11, 17-BETA-HSDXI, DHRS8, PAN1B, RetSDR2, SDR16C2"	ENSG00000198189	"Hydroxysteroid 17-beta dehydrogenase 11"	Q8NBQ5	4	87336610-87391386	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.1;intestine: 81.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"neutrophil: 100.1"	"Group enriched"	"Detected in all"	4	"granulocytes: 100.1;monocytes: 25.8"	"Low region specificity"	"Detected in all"							HPA021608	Enhanced		Supported	"Lipid droplets"	"Intracellular and membrane"	14000	14000	"Lipid droplets"	"Lipid droplets"	"HPA021608: AB_1847660"	"unprognostic (4.53e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.68e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.65e-3)"	"unprognostic (5.53e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.04e-2)"	22.0	23.8	11.1	15.5	8.4	23.6	18.9	23.8	12.8	19.6	58.3	7.2	9.5	53.0	19.1	15.7	6.5	14.6	26.3	9.0	10.1	6.4	18.1	57.4	25.3	14.7	14.2	7.9	18.0	24.5	3.0	12.6	11.4	9.7	15.5	36.2	5.7	6.7	9.0	6.4	6.2	81.3	15.2	14.2	12.2	11.6	11.6	10.6	15.8	8.1	8.4	8.2	21.0	15.9	7.7	14.2	100.1	25.8	10.4	10.3	18.7	0.2	10.6	5.2	13.0	16.0	22.1	7.4	5.7	9.1	3.8	7.0	8.8	68.2	0.0	11.2	5.9	0.2	15.1	1.2	4.2	16.8	3.2	14.7	5.9	29.8	9.1	26.1	27.3	15.6	0.4	5.2	1.8	7.3	15.2	7.6	6.9	0.4	5.3	32.0	8.9	1.7	14.6	4.8	17.2	10.5	16.3	1.7	16.7	11.3	0.3	19.4	0.0	25.5	6.1	2.6	11.7	10.4	2.9	3.7	1.5	1.6	4.8	18.5	17.7	61.0	25.8	55.9	8.7	18.4	10.3	7.7	8.8	9.0	14.2	6.6	8.1	9.0	100.1	10.4	15.2	4.8	9.9	18.7	11.1	8.4	23.8	12.8	10.1	6.4	14.2	7.9	9.7	10.6
HSD17B2	"HSD17, SDR9C2"	ENSG00000086696	"Hydroxysteroid 17-beta dehydrogenase 2"	P37059	16	82035004-82098534	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 83.1;liver: 52.9;placenta: 110.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 23.7;Hep G2: 18.8;hTERT-HME1: 11.3;RT4: 38.9;TIME: 21.8"	"Cancer enhanced"	"Detected in many"		"liver cancer: 10.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"midbrain: 2.6;pons and medulla: 3.5"	"Not detected"	"Not detected"			"HPA021826, HPA050235"	Enhanced		Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA021826: AB_10961148, HPA050235: AB_2681059"	"unprognostic (1.50e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.48e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.29e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.35e-2)"	"unprognostic (6.05e-3)"	"unprognostic (4.98e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.31e-4)"	"unprognostic (5.39e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"prognostic favourable (3.83e-4)"	0.7	0.1	0.2	4.1	0.2	0.0	3.9	0.2	0.3	0.7	41.3	0.3	0.2	71.3	0.6	0.2	1.7	0.2	13.3	0.2	0.2	0.2	2.8	52.9	1.0	0.2	0.2	0.2	0.2	16.0	0.0	0.6	110.8	0.4	3.1	9.4	21.3	9.4	0.2	0.3	1.8	83.1	1.5	0.2	0.2	3.2	0.2	0.2	0.2	0.2	1.1	1.3	21.4	6.6	1.3	1.4	3.6	1.1	1.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.3	0.0	23.7	0.0	0.0	4.3	0.7	0.0	4.7	0.0	0.2	0.0	0.9	0.0	0.1	0.0	0.1	0.1	18.8	0.1	0.1	0.1	0.0	1.2	0.0	11.3	0.3	0.0	0.2	3.5	0.1	0.0	0.4	0.1	8.6	0.0	0.0	0.5	0.4	38.9	0.2	0.6	0.0	1.1	0.1	0.0	0.0	21.8	0.2	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.0	1.6	1.1	0.6	0.7	0.5	0.4	0.6	0.4	0.4	0.3	1.3	0.4	0.6	3.6	1.0	0.6	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.2	0.2	0.2	0.4	0.2
HTR1D	"5-HT1D, HT1DA, HTRL, RDC4"	ENSG00000179546	"5-hydroxytryptamine receptor 1D"	P28221	1	23191895-23194729	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.9;intestine: 12.2"	"Cell line enhanced"	"Detected in some"		"A549: 8.7;CAPAN-2: 6.3;SiHa: 5.9;TIME: 22.0;U-2 OS: 7.4"	"Low cancer specificity"	"Detected in many"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"basal ganglia: 7.6"	"Low region specificity"	"Detected in many"														"unprognostic (1.73e-2)"	"unprognostic (8.69e-3)"	"unprognostic (8.86e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.65e-2)"	"unprognostic (5.97e-4)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (3.87e-3)"	"unprognostic (8.88e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavourable (5.30e-4)"	"unprognostic (3.17e-2)"	"unprognostic (3.28e-6)"	"unprognostic (9.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.45e-1)"	"unprognostic (8.02e-3)"	0.0	0.0	0.3	0.0	3.9	0.1	0.0	0.0	0.2	0.0	0.1			12.2	0.0	0.0	0.0	0.5	1.9	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.2		0.0	0.1	0.0	0.1	0.0		0.1	0.1		0.0	0.0	0.0	0.1	10.4	0.0	0.2	0.0	0.0	0.4			0.0		0.0	0.5	0.0	1.0	0.7	2.2	1.2	1.2	0.9	0.2	2.6	8.7	0.0	0.0	0.0	0.2	0.8	0.0	0.6	0.3	0.3	0.6	6.3	0.0	2.6	0.3	1.9	1.7	0.0	0.4	0.0	0.7	0.0	5.1	0.1	0.3	0.0	0.0	0.1	0.1	1.1	0.4	5.2	0.0	0.0	0.2	1.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.2	0.0	2.2	0.0	5.9	0.4	0.1	0.1	0.0	22.0	0.0	7.4	0.1	2.1	0.0	0.0	0.1	0.0	0.0	0.1	1.7	1.2	0.5	0.6	0.8	0.4	1.0	0.9	0.6	0.4	1.0	0.6	0.6	2.2	1.2	1.0	0.7	0.4	0.2										
IHH	"BDA1, HHG2"	ENSG00000163501	"Indian hedgehog"	Q14623	2	219054420-219060467	"Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.1;intestine: 42.8;lymphoid tissue: 20.2"	"Cell line enriched"	"Detected in some"	10	"CACO-2: 20.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	13000000	13000000				"unprognostic (1.05e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.63e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (4.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.33e-3)"	"unprognostic (1.81e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.91e-2)"	0.1	0.1	0.1	20.2	0.1	0.0	0.1	0.3	0.2	4.5	33.1	0.1	0.7	10.7	14.3	10.3	0.7	0.7	19.1	0.1	0.1	0.2	3.7	3.4	3.3	0.1	0.1	0.1	0.7	0.1	0.0	0.6	0.2	0.1	2.3	11.4	8.2	0.1	1.1	0.1	0.1	42.8	0.5	0.1	0.1	11.6	0.3	0.1	0.1	1.1	0.1	0.1	0.9	1.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1
IL17RE	FLJ23658	ENSG00000163701	"Interleukin 17 receptor E"	Q8NFR9	3	9902612-9916402	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 55.7"	"Cell line enhanced"	"Detected in some"		"ASC diff: 10.8;ASC TERT1: 26.5;BEWO: 9.9;hTCEpi: 10.9;T-47d: 12.6"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	4	"cerebellum: 19.0"	"Group enriched"	"Detected in some"	8	"basophil: 3.1;MAIT T-cell: 1.9;memory CD8 T-cell: 2.0"	"Group enriched"	"Detected in many"	19	"granulocytes: 3.1;T-cells: 2.0"	"Region enhanced"	"Detected in single"		"cerebellum: 1.7"					HPA019011	Uncertain				"Intracellular and membrane"					"HPA019011: AB_1851667"	"unprognostic (1.08e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.43e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.43e-2)"	"unprognostic (6.69e-2)"	"unprognostic (6.31e-2)"	"unprognostic (3.55e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.96e-2)"	"unprognostic (2.85e-2)"	7.6	0.9	0.6	6.9	4.3	0.0	7.8	19.0	0.7	4.5	39.3	0.0	1.9	15.5	2.4	4.0	10.4	1.9	18.3	1.4	0.7	0.8	3.4	1.0	13.5	0.5	0.7	0.1	0.9	12.7	3.6	1.7	4.6	2.5	4.7	10.5	2.6	17.7	3.9	1.0	16.8	55.7	1.2	0.7	1.3	12.4	0.6	0.4	5.1	4.8	6.8	5.3	2.1	4.4	0.0	0.0	3.1	0.0	0.1	2.0	0.0	1.9	0.2	0.0	0.0	10.8	26.5	9.9	1.5	0.9	0.2	0.6	1.9	1.4	0.0	0.5	1.8	4.4	0.0	4.0	0.0	0.0	0.1	0.5	0.3	4.5	0.3	0.0	1.9	1.8	10.9	0.1	0.0	0.0	0.0	0.0	0.5	2.1	0.3	7.9	0.4	0.4	0.0	0.0	0.0	1.9	2.3	0.4	0.1	0.0	4.2	0.0	12.6	0.5	0.6	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.2	4.8	0.1	3.1	0.0	0.0	0.0	0.0	1.9	0.0	0.3	2.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	4.3	19.0	0.7	0.7	0.8	0.7	0.1	2.5	0.4
IL2	"IL-2, TCGF"	ENSG00000109471	"Interleukin 2"	P60568	4	122451470-122456725	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 1.9;intestine: 2.4;lymphoid tissue: 1.9"	"Cell line enriched"	"Detected in single"	23	"MOLT-4: 2.3"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"memory CD4 T-cell: 1.9"	"Lineage enriched"	"Detected in single"	19	"T-cells: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB010310	Uncertain				"Secreted to blood"					"CAB010310: AB_649346"	"unprognostic (8.87e-5)"	"unprognostic (6.13e-3)"		"unprognostic (1.38e-3)"				"unprognostic (9.79e-3)"			"unprognostic (2.56e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.06e-5)"	"unprognostic (5.21e-3)"	"unprognostic (8.01e-2)"			0.6	0.0	0.0	0.6	0.0	0.4	0.5	0.0	0.0	0.9	0.3			0.5	0.1	0.0	0.8	0.6	0.5	0.0	0.0	0.0	0.2	0.3	0.7	1.1	0.0		0.1	0.0	0.0	0.0	0.0		0.4	1.9		0.1	0.0	0.0	0.4	2.4	0.0	0.2	0.8	0.3	0.0			0.4		1.9	0.8	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
IL7	IL-7	ENSG00000104432	"Interleukin 7"	P13232	8	78675743-78805523	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.5;lymphoid tissue: 26.3"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.8;HDLM-2: 12.9;HEL: 13.7;HMC-1: 20.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"memory B-cell: 10.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA019590	Approved				"Secreted to blood"					"HPA019590: AB_10794621"	"unprognostic (3.19e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.57e-3)"	"unprognostic (5.45e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavourable (2.69e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.11e-4)"	6.8	1.9	1.3	13.4	1.8	1.8	2.2	1.7	1.7	2.6	9.5	0.4	1.3	7.0	1.9	5.0	5.0	5.2	8.2	1.5	1.0	0.9	5.6	8.9	6.5	26.3	0.8	0.1	2.4	2.6	0.0	1.3	1.0	1.0	5.0	4.8	1.1	7.9	2.0	0.9	9.6	20.5	2.4	1.2	8.6	4.4	3.0	0.9	2.0	4.1	4.4	10.4	3.9	3.3	10.9	2.4	5.4	0.8	0.5	7.5	0.6	0.2	0.0	0.1	0.0	0.3	0.3	0.0	1.1	1.1	1.0	1.5	0.0	5.8	0.1	0.0	3.3	3.3	0.1	0.0	0.0	12.9	0.0	13.7	0.3	1.7	0.0	0.1	20.3	1.0	0.0	0.1	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	4.2	2.3	0.0	1.9	2.0	0.2	0.1	0.1	0.0	0.2	0.7	0.8	0.0	1.5	0.2	0.0	0.0	2.7	0.0	1.5	5.4	0.3	0.0	0.4	0.2	0.0	10.9	1.1	1.1	2.4	8.2	0.3	0.3	0.0	0.5	0.8	0.3	7.5	0.6	1.3	1.8	1.7	1.7	1.0	0.9	0.8	0.1	1.0	0.9
INAVA	"C1orf106, FLJ10901"	ENSG00000163362	"Innate immunity activator"	Q3KP66	1	200891048-200915735	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 62.3"	"Cell line enhanced"	"Detected in many"		"BEWO: 24.1;CACO-2: 19.4;CAPAN-2: 20.8;HaCaT: 28.5;RPMI-8226: 19.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA027499, HPA027511"	Uncertain									"HPA027499: AB_10599708, HPA027511: AB_10600334"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.98e-1)"	"prognostic unfavourable (1.78e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.74e-2)"	"unprognostic (6.62e-3)"	"unprognostic (2.84e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.73e-2)"	0.2	0.0	1.2	7.2	1.3	1.5	0.6	0.5	1.3	5.7	41.6	1.2	0.4	24.3	0.6	2.8	26.0	1.9	29.5	0.2	1.0	0.8	12.0	0.6	3.0	0.2	0.7	0.6	1.0	11.2	0.0	0.6	3.1	0.8	6.6	14.1	0.7	6.9	2.4	0.2	23.4	62.3	1.3	0.3	0.2	14.2	0.7	1.0	0.9	0.2	12.3	21.8	11.0	9.3	0.8	0.3	1.2	0.2	0.4	1.2	0.1	11.6	16.4	8.7	0.0	0.0	0.0	24.1	0.0	0.0	0.2	0.2	19.4	20.8	0.0	5.8	0.0	28.5	0.0	7.3	0.2	0.0	1.9	1.4	0.7	6.5	0.0	3.0	0.3	0.0	10.7	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.5	17.1	3.5	0.0	3.7	19.6	9.3	14.7	0.0	1.1	0.9	16.8	0.0	6.8	2.8	0.0	0.0	4.1	0.0	1.0	18.1	7.5	0.0	0.0	3.1	0.7	0.5	0.2	1.2	0.4	0.1	0.3	0.6	0.4	0.2	0.1	0.8	0.3	0.4	1.0	0.4	0.2	0.3	1.2	0.1	1.2	1.3	0.5	1.3	1.0	0.8	0.7	0.6	0.8	1.0
IQGAP3		ENSG00000183856	"IQ motif containing GTPase activating protein 3"	Q86VI3	1	156525405-156572604	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.8;intestine: 13.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA030142, HPA030143"	Uncertain		Approved	Nucleoplasm,Nucleoli				Nucleoli	Nucleoli	"HPA030142: AB_10600108, HPA030143: AB_10601104"	"unprognostic (9.99e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.55e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.69e-3)"	"prognostic unfavourable (8.94e-6)"	"unprognostic (1.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.35e-3)"	"unprognostic (1.03e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (4.46e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.30e-2)"	"unprognostic (6.81e-2)"	3.2	1.2	0.3	5.4	0.3	14.8	0.6	0.3	0.8	1.4	10.1	0.4	1.3	7.0	1.1	3.7	9.8	0.3	1.8	1.8	0.4	0.2	1.5	1.1	2.6	1.4	0.3	0.3	0.5	0.4	0.0	0.3	6.5	0.8	0.8	5.5	0.4	1.8	0.3	0.5	3.8	13.0	2.9	1.5	1.5	5.1	6.8	0.3	12.2	0.4	3.1	7.3	0.9	3.1	0.2	0.9	0.5	0.3	0.6	2.6	0.0	23.5	11.3	10.7	7.5	0.6	1.7	5.2	17.5	11.7	17.2	15.4	13.0	21.7	2.1	6.5	10.2	22.4	7.2	9.0	15.4	0.0	6.5	3.1	22.4	6.4	0.1	3.8	0.0	0.5	1.0	14.4	21.2	9.9	6.3	3.4	12.5	12.3	2.2	5.5	7.7	11.4	7.5	12.0	2.4	4.3	8.0	6.7	10.5	15.9	18.7	6.4	14.9	10.3	6.5	15.6	18.6	12.7	20.5	1.6	0.8	1.0	5.2	6.1	17.6	0.5	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.6	0.1	0.1	0.1	0.2	0.6	0.3	0.9	2.6	0.0	0.3	0.3	0.3	0.8	0.4	0.2	0.3	0.3	0.8	0.3
ITGAE	"CD103, HUMINAE"	ENSG00000083457	"Integrin subunit alpha E"	P38570	17	3714628-3801243	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.2;lung: 25.9;lymphoid tissue: 13.0"	"Cell line enriched"	"Detected in single"	21	"MOLT-4: 15.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 3.1;memory CD8 T-cell: 7.4;T-reg: 1.9"	"Lineage enriched"	"Detected in many"	7	"T-cells: 7.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB026461, HPA036313"	Approved					13000	13000			"CAB026461: , HPA036313: AB_10795355"	"unprognostic (9.81e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.86e-2)"	"prognostic favourable (1.04e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.10e-1)"	"prognostic favourable (5.78e-4)"	"unprognostic (3.34e-2)"	"prognostic unfavourable (1.13e-8)"	"unprognostic (8.40e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.82e-2)"	"prognostic favourable (3.56e-4)"	3.6	0.2	0.3	13.0	0.6	8.0	0.9	0.2	0.2	0.6	9.6	0.2	0.0	4.9	0.4	0.4	2.0	1.5	2.7	0.2	0.5	0.4	0.3	0.3	25.9	8.1	0.3	0.0	0.9	1.2	0.5	0.4	0.1	0.2	1.2	2.0	0.2	1.8	3.9	0.3	0.6	20.2	2.0	0.7	1.4	3.6	1.6	0.1	3.1	1.0	1.5	5.3	1.9	2.5	0.2	0.1	0.0	1.0	0.0	7.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	15.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.2	1.0	3.1	0.2	1.0	7.4	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.0	1.9	0.9	0.3	0.6	0.2	0.2	0.5	0.4	0.3	0.0	0.2	0.1
JCHAIN	"IGCJ, IGJ, JCH"	ENSG00000132465	"Joining chain of multimeric IgA and IgM"	P01591	4	70655541-70681817	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.0;intestine: 403.3;lymphoid tissue: 209.3;salivary gland: 220.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 158.7;Karpas-707: 84.7;RPMI-8226: 168.2;U-266/70: 358.1;U-266/84: 139.0;U-698: 206.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	118	"memory B-cell: 213.0;naive B-cell: 91.6;plasmacytoid DC: 160.7"	"Group enriched"	"Detected in many"	142	"B-cells: 213.0;dendritic cells: 160.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034436, HPA044132"	Enhanced				"Secreted to blood"	4200000000	4200000000			"CAB034436: AB_2233368, HPA044132: AB_2678826"	"prognostic favourable (1.81e-6)"	"unprognostic (1.45e-3)"	"unprognostic (7.44e-3)"	"unprognostic (1.82e-2)"	"unprognostic (4.23e-2)"	"prognostic favourable (7.56e-7)"	"unprognostic (2.37e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.30e-2)"	"unprognostic (2.64e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.34e-2)"	"prognostic unfavourable (1.40e-4)"	"unprognostic (3.43e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.96e-1)"	4.4	1.6	0.9	209.3	0.9	0.4	69.6	0.9	0.9	27.2	403.3	2.1	0.7	132.7	1.7	1.5	29.2	9.8	79.4	2.4	0.9	1.0	19.9	12.7	62.8	111.7	0.9	0.6	14.0	8.6	0.0	1.4	0.7	0.8	5.7	142.5	8.2	220.1	30.1	1.1	1.7	361.5	4.0	1.0	161.3	124.6	7.0	0.7	8.0	7.1	36.8	96.7	42.1	5.9	213.0	160.7	1.3	0.3	0.2	0.9	52.6	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	158.7	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.2	84.7	0.0	0.0	0.2	0.5	0.1	0.0	0.2	0.1	168.2	0.0	0.0	0.1	0.6	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.4	0.2	0.2	358.1	139.0	206.4	0.0	0.2	0.0	0.7	0.3	0.1	0.2	0.0	0.9	213.0	0.1	0.2	0.3	91.6	0.1	0.1	1.3	0.2	0.1	160.7	0.1	52.6	0.9	0.9	0.9	0.9	0.9	1.0	0.9	0.6	0.8	0.7
KCNH6	"erg2, HERG2, Kv11.2"	ENSG00000173826	"Potassium voltage-gated channel subfamily H member 6"	Q9H252	17	63523334-63548977	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 8.7;kidney: 15.4;pituitary gland: 7.6;retina: 7.6"	"Group enriched"	"Detected in some"	6	"SCLC-21H: 8.5;SH-SY5Y: 3.3"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 5.3"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"olfactory region: 4.7"	HPA061704	Approved									"HPA061704: "	"unprognostic (8.00e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.98e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.19e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.66e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.15e-2)"	0.0	0.2	0.3	0.7	1.1	0.3	0.0	0.1	1.2	0.0	4.2	0.0	0.0	3.9	0.0	0.5	0.0	0.3	0.1	0.6	0.3	2.8	15.4	0.0	0.9	0.1	1.1	0.5	0.1	2.4	0.1	7.6	0.6	1.0	6.2	0.4	7.6	0.1	0.0	0.2	0.3	8.7	0.0	0.7	0.1	1.7	1.4	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.8	0.4	1.7	0.5	0.7	0.5	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.1	0.2	0.7	0.2	0.1	0.1	0.0	0.0	0.3	8.5	3.3	0.0	0.2	0.1	0.3	0.2	0.0	0.3	1.0	0.2	0.1	0.2	0.1	0.2	0.1	0.1	0.2	1.2	0.5	0.4	0.4	0.3	0.1	0.6	0.2	0.2	0.2	0.8	0.5	0.4	1.7	0.7	0.3	0.4	0.2	0.4	0.3	1.1	0.1	1.2	0.3	2.8	1.1	0.5	1.0	0.3
KCNK10	"K2p10.1, PPP1R97, TREK-2, TREK2"	ENSG00000100433	"Potassium two pore domain channel subfamily K member 10"	P57789	14	88180103-88326907	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 12.2;brain: 14.1;intestine: 11.6"	"Cell line enhanced"	"Detected in some"		"AF22: 2.5;NTERA-2: 1.7;REH: 4.2;SCLC-21H: 7.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	67	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	123	"dendritic cells: 12.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030462	Approved									"HPA030462: AB_10601919"	"unprognostic (9.52e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.20e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.26e-3)"	0.4	1.1	7.4	1.2	6.9	0.9	0.5	14.1	11.2	0.4	3.2	5.6	0.0	11.6	0.3	0.3	2.2	0.4	0.5	0.4	7.2	4.5	5.7	0.4	0.6	0.7	5.0	5.7	0.4	3.5	0.4	0.9	0.3	6.4	0.5	2.1	0.0	0.5	0.3	0.4	0.4	5.7	0.5	5.0	0.6	6.7	1.3	2.3	0.0	0.4	0.5	1.3	0.5	0.4	0.0	12.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.7	0.2	4.2	0.1	0.0	0.1	0.1	7.7	0.3	0.1	0.1	0.0	0.0	1.0	0.1	0.1	1.4	0.2	0.5	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.1	7.4	6.9	14.1	11.2	7.2	4.5	5.0	5.7	6.4	2.3
KCNK5	"K2p5.1, TASK-2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188973-39229450	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 48.4;intestine: 74.2;kidney: 46.3"	"Cell line enhanced"	"Detected in many"		"CACO-2: 18.8;HEL: 19.3;HMC-1: 17.8;K-562: 17.9;T-47d: 14.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory CD8 T-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favourable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavourable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favourable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favourable (4.45e-4)"	2.2	1.3	0.3	4.5	0.4	4.5	3.9	0.4	0.5	4.3	25.5	0.8	2.6	16.1	5.6	4.0	4.3	1.4	48.4	1.5	0.3	0.0	46.3	12.6	3.6	1.1	0.8	0.4	4.0	15.3	1.2	1.0	15.2	0.8	2.3	4.7	3.6	16.0	1.6	0.5	15.8	74.2	1.3	0.6	1.2	9.4	0.9	0.3	2.0	9.0	2.2	4.1	2.2	3.8	0.0	0.9	0.2	0.1	0.0	1.4	0.5	3.4	3.2	4.3	1.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	18.8	7.8	0.0	5.7	0.0	7.2	3.3	0.1	0.0	0.0	2.4	19.3	1.5	0.1	0.0	3.9	17.8	0.0	0.0	0.1	0.0	0.0	17.9	0.0	0.0	6.0	8.7	4.3	7.9	0.0	0.0	0.8	7.2	3.0	2.9	1.0	0.8	3.1	4.0	0.0	14.3	6.5	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.9	1.4	0.0	0.0	0.1	0.4	0.2	0.0	0.1	0.9	0.2	0.5	0.3	0.4	0.4	0.5	0.3	0.0	0.8	0.4	0.8	0.3
KIAA1211		ENSG00000109265	KIAA1211	Q6ZU35	4	56049073-56328625	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.9;testis: 27.0"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 15.7;SH-SY5Y: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043249, HPA048148"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA043249: AB_2678388, HPA048148: AB_2680286"	"unprognostic (1.65e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.04e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.05e-6)"	"unprognostic (1.02e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.93e-1)"	1.0	2.1	4.5	4.2	3.7	3.0	0.8	4.2	6.8	2.3	12.6	3.3	3.2	11.8	3.7	3.9	1.0	2.7	14.4	1.6	5.7	7.0	1.6	1.0	1.4	1.8	5.3	3.0	2.2	1.6	7.6	1.9	2.3	13.4	1.6	7.2	4.7	0.9	5.5	0.7	0.9	39.9	4.0	4.8	2.1	2.4	27.0	1.5	0.2	0.8	0.0	1.6	1.5	2.2	1.2	0.3	0.0	0.0	0.0	0.0	0.5	0.0	1.7	6.6	0.5	0.2	0.0	2.4	0.0	0.2	0.3	0.7	1.9	0.2	5.7	0.1	0.0	0.0	5.5	0.1	0.2	0.5	3.2	3.2	2.9	0.3	0.9	2.7	0.4	0.2	0.1	0.0	0.1	3.1	0.0	5.7	0.0	0.8	3.9	0.2	3.5	4.2	3.8	3.6	0.1	0.0	1.4	15.7	33.5	0.6	0.2	4.0	1.4	0.3	1.2	0.1	1.7	0.4	1.5	5.7	3.8	0.0	1.7	0.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	3.7	4.2	6.8	5.7	7.0	5.3	3.0	13.4	1.5
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075099	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favourable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	6.1	9.7	13.1	8.5	11.5	5.3	6.9	25.0	15.2	7.6	35.0	10.2	8.1	35.1	8.5	12.3	5.6	9.3	15.2	12.2	13.8	10.8	13.6	47.2	8.2	5.8	12.2	13.7	11.2	9.1	17.6	13.3	5.9	12.1	8.6	17.4	9.0	11.4	8.4	9.9	8.7	55.7	7.4	9.2	6.6	16.0	22.6	13.2	6.7	10.9	4.5	5.4	10.2	9.9	5.6	12.2	9.0	3.7	6.1	7.0	3.3	4.2	3.9	10.3	12.4	10.2	10.1	9.2	3.4	5.7	6.3	9.7	6.3	7.5	6.3	12.7	8.3	7.5	10.3	9.7	5.1	6.3	12.6	7.4	10.9	27.8	9.8	3.5	5.8	13.1	12.2	7.6	7.5	8.0	4.9	8.4	5.2	8.6	9.4	7.7	4.1	5.2	7.5	5.8	12.1	9.6	4.3	16.9	8.3	6.7	5.9	13.2	10.9	9.0	5.7	7.2	8.5	3.6	3.5	16.7	5.9	15.4	3.9	5.3	2.5	2.6	3.7	4.4	4.0	3.6	5.1	5.6	5.5	3.9	4.2	4.3	7.0	4.8	9.0	6.1	3.6	12.2	6.4	3.3	13.1	11.5	25.0	15.2	13.8	10.8	12.2	13.7	12.1	13.2
KLF5	"BTEB2, CKLF, IKLF"	ENSG00000102554	"Kruppel like factor 5"	Q13887	13	73054976-73077542	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.4;intestine: 88.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.8;HaCaT: 34.2;HBEC3-KT: 29.8;hTCEpi: 42.6;RT4: 36.0;SiHa: 30.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	5	"basal ganglia: 22.2"	"Cell type enriched"	"Detected in single"	18	"basophil: 16.3"	"Lineage enriched"	"Detected in single"	106	"granulocytes: 16.3"	"Group enriched"	"Detected in many"	4	"amygdala: 5.6;basal ganglia: 9.3;cerebral cortex: 6.9;hippocampal formation: 8.8;hypothalamus: 4.3"	"Low region specificity"	"Detected in many"			HPA040398	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"				Nucleoplasm	Nucleoplasm	"HPA040398: AB_10673267"	"unprognostic (7.90e-3)"	"unprognostic (5.11e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.69e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.82e-1)"	"unprognostic (1.47e-2)"	"prognostic unfavourable (2.55e-4)"	"unprognostic (4.43e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.56e-3)"	"unprognostic (3.98e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.54e-2)"	2.3	1.5	4.1	24.3	22.2	12.9	8.1	0.7	1.2	19.6	74.4	0.4	4.3	28.7	4.8	3.7	88.4	8.3	48.4	1.3	1.4	1.2	3.9	1.2	12.8	0.1	0.9	1.1	5.0	3.5	0.0	7.3	22.8	4.3	17.6	32.9	1.8	26.4	5.4	10.0	59.4	88.1	4.1	2.4	0.8	17.9	12.2	1.4	3.0	20.7	64.4	61.8	23.4	34.1	0.0	0.0	16.3	0.0	0.0	0.1	0.0	5.7	8.1	0.0	0.1	0.3	0.4	9.2	3.4	7.9	1.5	1.9	7.4	29.8	0.1	18.1	3.0	34.2	10.4	29.8	2.4	0.2	2.7	0.1	17.0	0.7	2.1	2.7	0.5	2.2	42.6	0.4	16.7	0.0	0.4	0.6	6.8	2.0	0.5	0.2	0.3	11.5	0.5	7.6	0.6	23.6	36.0	0.7	0.3	30.4	4.9	2.1	0.6	0.6	0.0	2.1	6.2	0.0	1.4	0.9	0.4	1.0	2.9	0.5	2.5	16.3	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	22.2	0.7	1.2	1.4	1.2	0.9	1.1	4.3	1.4
KLK15	"ACO, HSRNASPH, prostinogen"	ENSG00000174562	"Kallikrein related peptidase 15"	Q9H2R5	19	50825289-50837213	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 5.7;salivary gland: 9.7"	"Cell line enriched"	"Detected in some"	5	"RPMI-8226: 7.2"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 3.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA019802	Uncertain				"Secreted to blood"					"HPA019802: AB_1852601"		"unprognostic (6.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (8.13e-2)"		"unprognostic (2.90e-1)"				"unprognostic (2.29e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.17e-1)"		"unprognostic (1.55e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.72e-2)"		0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.7			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0		1.4	2.1		9.7	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	2.1			1.7		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
KRT12	K12	ENSG00000187242	"Keratin 12"	Q99456	17	40861303-40867210	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.3;retina: 3.6;skin 1: 1.9"	"Cell line enriched"	"Detected in single"	6	"HeLa: 3.7"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA055217, HPA055835"	Enhanced									"HPA055217: AB_2682742, HPA055835: AB_2682935"	"unprognostic (1.89e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.52e-2)"	"unprognostic (9.41e-3)"	"unprognostic (3.49e-1)"	"unprognostic (1.73e-1)"		"unprognostic (3.94e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.31e-3)"	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.9	0.1	3.3	0.1	0.1	1.3	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	1.0	3.6	0.1	0.1	0.1	1.9	3.3	0.1	0.1	0.1	0.4	0.7	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	3.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.9	0.1	0.0	0.1	0.1	0.1	0.1
KRT19	"CK19, K19, K1CS, MGC15366"	ENSG00000171345	"Keratin 19"	P08727	17	41523617-41528308	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 205.3;intestine: 184.9;placenta: 179.4"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 100.7;HBEC3-KT: 151.7;MCF7: 111.9;RT4: 161.1;SK-BR-3: 284.6;T-47d: 191.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in single"	4	"NK-cell: 2.7"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 2.7"	"Not detected"	"Not detected"							"CAB000031, HPA002465"	Enhanced		Supported	"Intermediate filaments"		330000000	330000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000031: AB_2234418, HPA002465: AB_1079179"	"unprognostic (1.09e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.80e-2)"	"unprognostic (3.14e-1)"	"unprognostic (4.86e-2)"	"prognostic unfavourable (6.82e-5)"	"unprognostic (1.90e-2)"	"prognostic unfavourable (2.98e-5)"	"unprognostic (3.52e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.35e-2)"	9.8	1.6	0.7	22.8	0.9	0.0	50.1	2.9	0.8	37.4	126.7	1.0	38.0	37.8	9.9	53.0	102.1	19.5	205.3	2.3	0.8	0.2	35.0	2.1	50.6	0.7	0.8	0.8	16.7	7.5	1.2	2.6	179.4	1.3	39.2	40.1	1.8	103.0	46.3	0.7	15.8	184.9	11.7	0.6	0.6	69.1	6.4	0.7	33.3	4.9	21.2	89.2	77.0	35.4	0.0	0.0	0.0	0.0	2.7	0.6	0.2	0.1	17.6	0.0	0.3	0.0	0.0	61.6	21.2	0.0	0.6	0.1	50.6	100.7	0.0	20.8	10.1	53.9	0.0	151.7	0.1	0.0	0.5	0.0	11.4	34.6	1.6	0.0	4.3	0.0	27.6	0.4	0.0	1.3	7.3	0.1	0.0	111.9	0.2	0.1	0.9	25.6	0.1	0.0	0.3	69.5	161.1	2.1	0.0	0.1	284.6	0.0	191.7	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.2	0.7	0.9	2.9	0.8	0.8	0.2	0.8	0.8	1.3	0.7
KRT8	"CARD2, CK8, CYK8, K2C8, K8, KO"	ENSG00000170421	"Keratin 8"	P05787	12	52897187-52949954	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 102.9"	"Cell line enhanced"	"Detected in many"		"A549: 224.1;BEWO: 150.2;CACO-2: 278.9;CAPAN-2: 176.2;MCF7: 376.4;SK-BR-3: 191.3;T-47d: 160.9"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons and medulla: 13.7"	"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.9"	"Group enriched"	"Detected in many"	4	"dendritic cells: 4.9;granulocytes: 3.2;NK-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB000131, CAB001696, HPA049866"	Enhanced		Supported	"Intermediate filaments"		920000000	920000000	"Intermediate filaments"	"Intermediate filaments"	"CAB000131: AB_2281144, CAB001696: , HPA049866: AB_2680923"	"unprognostic (5.72e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.76e-2)"	"unprognostic (4.86e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (8.99e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.18e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.19e-2)"	13.4	4.8	2.0	11.0	1.5	0.0	13.9	2.7	1.3	15.1	90.2	2.1	29.8	87.2	11.1	18.3	19.3	10.4	20.3	17.6	1.1	0.2	28.8	55.8	20.1	18.4	1.4	1.2	10.6	75.9	4.0	31.8	28.9	13.7	25.2	45.0	12.1	36.9	46.0	3.7	5.0	102.9	5.2	3.3	14.3	61.8	5.1	1.2	2.9	27.6	9.2	11.6	27.1	10.5	0.7	4.9	3.2	0.7	1.6	0.6	0.5	99.5	224.1	0.0	0.2	0.0	0.1	150.2	0.4	1.7	0.2	0.2	278.9	176.2	0.0	42.6	0.5	34.8	0.6	27.6	0.2	0.1	4.8	0.1	46.7	79.7	8.1	0.0	0.0	0.3	0.4	0.5	1.9	0.6	17.1	0.0	0.0	376.4	0.2	0.3	15.6	4.9	0.1	0.0	0.5	44.4	49.4	4.8	0.1	39.0	191.3	0.3	160.9	0.3	0.6	0.2	16.9	0.3	0.3	0.0	0.2	0.2	0.1	0.0	0.4	3.2	0.5	0.6	0.6	0.7	0.4	0.3	0.4	0.3	2.1	0.7	0.4	0.5	1.4	1.6	0.3	4.9	0.5	0.5	2.0	1.5	2.7	1.3	1.1	0.2	1.4	1.2	13.7	1.2
KRTCAP3	KCP3	ENSG00000157992	"Keratinocyte associated protein 3"	Q53RY4	2	27442366-27446481	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.8"	"Cell line enhanced"	"Detected in some"		"A-431: 27.9;CAPAN-2: 32.0;HaCaT: 10.2;SCLC-21H: 15.0;SK-BR-3: 9.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"MAIT T-cell: 6.9;memory B-cell: 5.4;memory CD4 T-cell: 6.2;memory CD8 T-cell: 3.2;naive B-cell: 4.6;naive CD4 T-cell: 7.0;naive CD8 T-cell: 3.3;T-reg: 4.8"	"Group enriched"	"Detected in many"	19	"B-cells: 5.4;T-cells: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047136, HPA060203"	Enhanced		Approved	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA047136: AB_2679949, HPA060203: AB_2684221"	"prognostic favourable (2.67e-5)"	"unprognostic (5.93e-2)"	"unprognostic (5.03e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.43e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.73e-3)"	"unprognostic (3.79e-2)"	"unprognostic (8.21e-2)"	"unprognostic (9.42e-3)"	0.9	1.0	0.5	10.0	0.8	0.5	6.3	1.3	1.7	4.6	24.4	0.7	13.3	16.2	1.5	3.2	8.5	9.8	16.5	1.7	0.7	0.3	4.8	6.5	11.8	1.9	0.7	1.4	2.7	28.8	3.3	6.9	1.5	1.5	9.7	6.2	1.9	17.4	22.6	1.0	4.9	34.8	0.9	0.9	1.0	16.7	1.8	0.8	2.3	12.3	6.9	5.4	7.6	4.5	5.4	0.0	0.1	0.0	0.3	7.0	1.8	27.9	0.2	0.7	0.5	0.0	0.0	5.8	0.0	0.0	0.0	0.1	9.0	32.0	0.2	0.2	0.0	10.2	0.2	7.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.3	0.1	0.0	7.5	0.3	1.9	6.0	0.1	0.1	0.2	0.7	0.0	0.0	15.0	0.5	0.4	9.3	0.6	0.2	0.2	0.0	0.3	0.7	0.2	0.2	1.6	1.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.6	0.0	6.9	5.4	6.2	3.2	0.0	4.6	7.0	3.3	0.0	0.3	0.0	0.0	4.8	1.8	0.5	0.8	1.3	1.7	0.7	0.3	0.7	1.4	1.5	0.8
LASP1	"Lasp-1, MLN50"	ENSG00000002834	"LIM and SH3 protein 1"	Q14847	17	38869859-38921770	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 124.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012072, CAB022049"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		26000000	26000000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB022049: , HPA012072: AB_1852714"	"unprognostic (1.23e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.77e-1)"	"prognostic unfavourable (4.57e-4)"	"unprognostic (1.47e-1)"	"unprognostic (3.03e-2)"	"prognostic unfavourable (2.41e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.60e-2)"	"unprognostic (9.87e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.29e-3)"	"unprognostic (3.95e-2)"	"unprognostic (1.60e-3)"	"unprognostic (4.53e-2)"	51.2	20.0	23.8	40.3	22.4	45.4	35.5	15.5	25.7	23.6	57.4	16.3	18.7	54.4	23.4	24.1	22.4	20.8	48.3	15.2	18.4	23.3	33.1	47.5	33.3	44.2	20.0	14.3	28.4	30.1	10.1	17.6	40.0	16.1	18.9	38.6	24.2	22.4	24.1	10.7	18.3	124.5	21.3	12.2	43.1	39.5	13.9	12.9	40.5	18.3	18.7	33.7	22.0	28.3	6.4	13.9	34.0	19.9	17.3	16.5	13.1	34.8	72.7	21.3	18.8	31.3	34.0	36.7	43.9	42.9	46.3	34.0	21.7	38.0	15.9	36.7	67.8	55.6	9.6	33.4	40.5	11.6	5.2	7.6	21.0	37.7	29.7	17.5	23.1	30.1	11.7	39.2	11.1	31.0	12.9	5.3	64.3	11.5	20.8	27.0	10.6	18.2	11.8	11.3	20.1	56.8	30.7	3.2	7.8	26.1	27.4	22.7	43.3	21.4	54.1	27.8	40.5	32.4	26.6	13.7	18.1	12.3	29.3	15.8	33.4	9.9	14.8	16.8	16.5	17.1	11.3	6.4	8.4	11.0	13.9	6.3	7.2	10.9	34.0	17.3	19.9	10.7	10.7	13.1	23.8	22.4	15.5	25.7	18.4	23.3	20.0	14.3	16.1	12.9
LGALS9C		ENSG00000171916	"Galectin 9C"	Q6DKI2	17	18476737-18494945	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.9;esophagus: 15.8;intestine: 8.3;lymphoid tissue: 8.5;stomach 1: 15.4"	"Cell line enhanced"	"Detected in some"		"A-431: 1.1;CAPAN-2: 2.9;Daudi: 1.0;Karpas-707: 2.8;RPMI-8226: 1.5;U-937: 2.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 3.2;NK-cell: 8.9"	"Group enriched"	"Detected in many"	5	"granulocytes: 3.2;NK-cells: 8.9"									"HPA046876, HPA047218"	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA046876: AB_2679852, HPA047218: AB_2679988"	"unprognostic (4.47e-2)"	"unprognostic (1.43e-3)"	"unprognostic (3.17e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.92e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.27e-3)"	"unprognostic (9.84e-2)"	0.1	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	2.1	8.3	0.2	0.0	1.6	0.0	0.0	15.8	0.0	4.7	1.0	0.0	0.0	0.0	0.8	0.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.9	0.0	1.6	1.0	0.0	0.2	5.1	0.1	0.0	1.5	15.4	0.0	0.0	0.4	0.0	3.0	7.5	0.0	2.1	0.0	0.4	3.2	1.2	8.9	0.6	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	2.9	1.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.5	0.5	0.6	1.2	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.2	3.2	8.9	1.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LIPH	"LPDLR, mPA-PLA1, mPA-PLA1alpha, PLA1B"	ENSG00000163898	"Lipase H"	Q8WWY8	3	185506262-185552613	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.8;lung: 28.5;stomach 1: 27.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 37.3;RPTEC TERT1: 18.9;T-47d: 8.9;U-266/84: 8.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA049079	Approved				"Secreted to blood"					"HPA049079: AB_2680623"	"unprognostic (4.50e-3)"	"unprognostic (2.07e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavourable (9.40e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavourable (4.59e-4)"	"unprognostic (7.88e-2)"	"prognostic favourable (9.20e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.97e-1)"	"prognostic favourable (4.21e-4)"	"unprognostic (1.15e-1)"	0.3	0.5	0.5	5.1	1.2	0.0	2.1	0.3	1.4	2.5	20.4	0.6	3.1	6.2	0.2	5.1	12.9	0.5	16.5	0.6	0.4	0.7	8.5	0.5	28.5	0.0	0.3	0.0	0.7	13.6	0.0	2.1	0.9	1.8	10.7	21.9	2.1	15.7	3.0	0.3	6.1	28.8	1.6	0.3	0.5	27.0	6.2	0.0	0.2	0.4	4.1	14.9	8.8	5.0	0.9	0.4	2.4	0.9	0.6	0.7	1.7	5.0	6.7	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.1	0.1	0.6	37.3	0.0	3.8	0.1	1.8	2.8	0.0	0.2	0.0	0.8	0.9	0.9	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.6	0.2	0.0	0.3	0.5	0.0	0.0	0.4	18.9	4.6	0.0	0.0	0.5	6.2	0.1	8.9	0.1	0.0	0.0	0.5	0.0	0.1	0.6	8.9	0.0	0.0	0.0	0.0	2.2	0.9	0.4	0.5	0.2	0.3	0.4	0.5	0.4	0.2	0.9	0.7	0.6	2.4	0.6	0.4	0.4	0.3	1.7	0.5	1.2	0.3	1.4	0.4	0.7	0.3	0.0	1.8	0.0
LPCAT3	"C3F, MBOAT5, nessy, OACT5"	ENSG00000111684	"Lysophosphatidylcholine acyltransferase 3"	Q6P1A2	12	6976186-7018510	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 85.5;liver: 78.2"	"Cell line enhanced"	"Detected in all"		"RT4: 48.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (1.74e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.72e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.40e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.00e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-2)"	"prognostic favourable (4.89e-5)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.23e-1)"	16.4	24.4	4.2	8.8	5.0	8.1	15.1	15.7	5.4	7.9	37.5	6.1	8.1	43.4	8.2	7.8	13.6	9.1	11.3	20.2	4.1	2.7	37.3	78.2	20.3	17.9	5.2	5.3	13.9	38.7	4.6	9.4	29.0	4.8	13.7	17.2	8.3	22.2	8.2	19.4	13.3	85.5	12.4	4.9	11.3	22.8	7.6	4.0	14.1	14.6	10.3	13.7	15.7	8.5	5.3	13.9	32.3	33.7	11.5	10.8	12.4	6.2	11.5	5.0	13.9	35.0	16.5	10.7	3.6	15.3	9.9	16.9	24.4	32.3	6.7	2.0	5.8	15.7	5.9	13.2	7.7	16.5	7.2	13.6	10.2	21.9	7.5	7.0	14.5	26.1	7.7	9.5	4.7	9.2	7.2	4.9	6.4	9.4	8.5	8.6	16.6	6.7	9.0	7.1	6.9	12.1	48.4	4.3	4.2	21.7	33.5	2.4	3.4	9.8	3.8	6.2	9.2	10.7	2.6	6.1	4.3	9.9	7.7	7.4	5.3	13.9	20.8	32.3	8.6	30.0	10.0	5.0	9.0	9.7	13.9	5.3	8.5	8.7	20.0	11.5	33.7	7.9	10.8	12.4	4.2	5.0	15.7	5.4	4.1	2.7	5.2	5.3	4.8	4.0
LPIN3	"LIPN3L, SMP2"	ENSG00000132793	"Lipin 3"	Q9BQK8	20	41340920-41360582	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.1"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"NK-cell: 6.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 1.8;NK-cells: 6.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA051466, HPA052667, HPA070640"	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA051466: , HPA052667: AB_2681908, HPA070640: "	"unprognostic (2.31e-1)"	"unprognostic (4.73e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavourable (9.74e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.91e-3)"	"unprognostic (4.26e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavourable (1.74e-4)"	"unprognostic (4.29e-2)"	"unprognostic (7.79e-2)"	"prognostic unfavourable (1.14e-5)"	"unprognostic (5.60e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.37e-3)"	11.6	3.7	3.0	8.1	5.2	0.1	23.4	1.5	3.0	10.9	29.2	2.8	13.5	26.8	12.8	21.6	16.3	7.5	11.2	8.8	3.6	0.7	28.2	14.4	4.5	1.6	2.8	3.7	7.9	7.4	8.1	6.7	4.4	4.2	10.1	8.8	8.7	11.0	15.1	1.8	26.1	49.1	5.5	2.4	2.7	7.4	2.5	1.5	1.2	14.2	10.6	9.0	8.0	12.5	0.9	0.7	1.8	0.9	6.3	0.8	0.2	6.8	6.7	0.4	4.0	11.0	17.1	5.2	4.2	5.9	5.1	7.0	12.5	6.1	0.3	5.3	9.3	17.4	2.0	11.0	3.2	0.1	3.9	0.3	9.4	6.3	1.8	0.0	4.7	12.3	14.0	8.7	3.4	1.3	1.7	0.2	6.4	14.6	0.0	0.1	0.6	6.9	0.0	0.1	0.4	18.1	8.6	0.5	0.1	5.6	7.2	3.6	8.5	3.4	0.4	0.3	1.7	5.8	0.0	3.4	1.8	0.0	0.1	0.1	0.3	1.8	0.5	0.7	0.5	0.5	0.8	0.6	0.7	0.4	0.3	0.9	0.7	0.6	1.8	6.3	0.9	0.7	0.5	0.2	3.0	5.2	1.5	3.0	3.6	0.7	2.8	3.7	4.2	1.5
LRRC31	FLJ23259	ENSG00000114248	"Leucine rich repeat containing 31"	Q6UY01	3	169839179-169869930	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.3;salivary gland: 7.0;stomach 1: 7.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 5.1;HAP1: 3.6;RPTEC TERT1: 5.6;T-47d: 2.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (5.15e-2)"	"unprognostic (5.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.00e-1)"		"unprognostic (9.90e-2)"	"unprognostic (4.40e-2)"		"unprognostic (7.90e-3)"	"unprognostic (2.49e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.20e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.27e-1)"	"unprognostic (5.96e-3)"	0.3	0.0	0.3	1.2	0.3	0.0	0.3	0.3	0.3	0.9	14.2	0.3	0.3	6.4	0.3	0.3	0.3	0.0	1.0	0.3	0.3	0.0	0.3	3.9	0.6	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.5	17.3	0.3	7.0	0.3	0.3	0.0	10.5	0.3	0.3	0.3	7.6	0.3	0.3	0.3	0.3	0.3	1.3	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	5.1	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	5.6	0.1	0.1	0.0	0.0	0.6	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.3	0.3	0.0	0.3	0.3	0.3	0.3
LY75-CD302		ENSG00000248672	"LY75-CD302 readthrough"		2	159771851-159904710	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"intestine: 17.0;lymphoid tissue: 37.5"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.6;HDLM-2: 5.8;Karpas-707: 22.2;RT4: 9.4;TIME: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA049108	Uncertain									"HPA049108: AB_2680635"	"unprognostic (2.53e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.33e-1)"			"unprognostic (1.86e-1)"		"unprognostic (9.04e-2)"			"unprognostic (1.68e-4)"		"unprognostic (1.14e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.88e-1)"	1.1	1.2	0.9	12.5	1.0	5.9	2.1	1.0	1.0	1.1	5.0	0.5	0.0	4.5	0.9	0.4	1.3	1.1	5.8	1.1	1.0	1.1	1.0	1.0	5.6	20.2	0.9	0.0	1.0	1.1	0.0	1.0	0.4	0.7	1.0	3.6	0.0	2.7	0.0	1.0	1.3	17.0	0.2	1.2	9.9	1.1	1.0	1.1	37.5	4.6	1.5	9.8	1.5	1.2	1.7	10.0	6.9	4.2	0.9	2.7	3.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.6	2.6	0.7	0.2	0.1	0.0	0.0	0.0	0.0	5.8	0.0	3.3	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.3	0.0	2.6	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	9.4	0.0	0.0	2.4	0.5	0.0	0.0	0.7	5.3	0.0	0.0	0.0	0.0	1.9	0.4	0.7	0.0	1.3	0.0	3.0	3.7	4.4	1.7	4.2	2.7	1.5	1.6	2.0	10.0	1.7	1.9	1.4	6.9	0.9	1.8	2.0	1.8	3.1	0.9	1.0	1.0	1.0	1.0	1.1	0.9	0.0	0.7	1.1
MAB21L2		ENSG00000181541	"Mab-21 like 2"	Q9Y586	4	150581922-150584693	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 19.2;intestine: 59.8;smooth muscle: 15.2"	"Group enriched"	"Detected in some"	17	"HHSteC: 7.0;SH-SY5Y: 17.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 3.3"	"Region enriched"	"Detected in some"	18	"pons and medulla: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA049324, HPA059864"			Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (1.12e-1)"		"unprognostic (3.67e-2)"		"unprognostic (4.03e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.85e-2)"		"unprognostic (8.99e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.68e-1)"	0.6	3.1	0.2	8.6	0.4	0.0	0.1	0.2	0.2	0.2	59.8	0.1	0.0	6.8	0.1	0.9	0.9	0.2	0.5	0.7	0.2	0.6	0.1	0.5	0.1	0.6	1.0	0.0	0.1	0.2	0.0	0.3	0.0	19.2	0.2	8.1	9.0	2.2	0.0	0.3	0.2	14.7	15.2	4.5	0.1	0.3	0.1	0.0	0.2	1.4	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.2	0.2	0.2	0.6	1.0	0.0	19.2	0.0
MACC1	"7A5, SH3BP4L"	ENSG00000183742	"MACC1, MET transcriptional regulator"	Q6ZN28	7	20134655-20217404	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 29.5;kidney: 23.9"	"Cell line enhanced"	"Detected in some"		"A-431: 40.5;CAPAN-2: 9.5;HaCaT: 28.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA020081, HPA020103, HPA029476, CAB068194"	Supported		Approved	Mitochondria				Mitochondria	Mitochondria	"CAB068194: , HPA020081: AB_1844386, HPA020103: AB_1844387, HPA029476: AB_10610136"	"unprognostic (1.59e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.43e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.01e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.03e-1)"	"prognostic favourable (5.71e-9)"	"unprognostic (4.49e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (6.93e-3)"	4.8	2.6	0.5	5.6	0.4	0.7	4.5	0.4	0.5	8.3	13.7	0.0	4.4	10.1	0.7	6.1	14.1	0.9	9.6	0.5	0.5	0.5	23.9	1.0	13.3	1.1	0.4	0.0	1.3	11.3	0.1	4.0	1.6	0.1	3.9	3.3	0.1	11.4	6.0	0.5	4.5	29.5	0.1	0.8	6.0	5.0	0.8	0.0	1.7	1.5	16.0	13.6	4.0	5.1	2.3	1.0	1.4	1.0	0.8	0.6	0.5	40.5	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	9.0	9.5	5.7	0.4	0.0	28.5	0.1	0.3	0.0	0.0	0.1	5.4	0.1	0.0	0.0	2.2	0.1	0.0	0.3	0.0	0.0	0.0	5.8	2.8	0.0	3.4	0.0	0.5	0.4	0.0	0.0	0.3	4.4	7.2	2.8	0.1	0.2	0.0	3.2	0.0	1.7	0.1	0.1	0.1	0.0	0.0	0.1	8.7	0.4	2.1	0.0	0.3	0.0	1.0	0.6	0.3	0.3	0.7	0.6	2.3	0.2	0.5	0.3	2.0	0.3	0.3	1.4	0.8	1.0	1.0	0.2	0.5	0.5	0.4	0.4	0.5	0.5	0.5	0.4	0.0	0.1	0.0
MALL	BENE	ENSG00000144063	"Mal, T cell differentiation protein like"	Q13021	2	110083870-110116566	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 107.7;intestine: 142.1;lung: 72.9"	"Cell line enhanced"	"Detected in some"		"A-431: 40.0;A549: 39.2;CAPAN-2: 54.2;fHDF/TERT166: 59.5;HaCaT: 42.2;PC-3: 23.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 9.3"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 9.3"	"Low region specificity"	"Detected in single"							HPA051410	Uncertain									"HPA051410: AB_2681474"	"unprognostic (5.17e-1)"	"unprognostic (4.15e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.46e-2)"	"unprognostic (6.50e-2)"	"unprognostic (6.82e-2)"	"prognostic unfavourable (1.23e-4)"	"unprognostic (2.37e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.50e-3)"	5.5	1.0	0.9	11.1	2.1	0.1	7.7	0.4	1.1	22.5	46.4	0.2	1.3	41.2	6.0	2.7	107.7	2.8	6.7	10.8	1.7	1.0	1.9	1.1	72.9	3.7	1.1	0.2	1.6	2.9	49.8	1.0	3.7	3.6	5.5	19.0	1.6	11.2	1.5	2.1	11.1	142.1	5.1	4.2	2.0	1.8	2.2	0.4	0.6	5.6	45.8	63.8	7.8	35.4	0.9	0.7	9.3	0.7	2.1	1.0	0.5	40.0	39.2	0.0	0.1	0.0	0.0	0.1	7.7	0.4	0.0	0.0	6.4	54.2	0.1	19.7	59.5	42.2	0.0	2.3	0.0	0.1	0.0	0.3	1.1	0.0	0.3	0.0	0.1	0.9	2.1	0.1	0.0	19.4	0.0	0.0	0.0	1.4	0.0	0.1	0.0	23.9	0.0	0.0	0.1	5.1	2.2	0.1	0.0	0.0	1.4	0.1	0.0	0.2	19.9	0.0	0.1	0.1	0.1	0.0	0.0	4.6	0.0	0.0	0.0	9.3	0.7	1.0	0.4	0.4	0.4	0.7	0.8	0.7	0.3	0.9	0.5	1.0	4.4	2.1	0.2	0.7	0.6	0.5	0.9	2.1	0.4	1.1	1.7	1.0	1.1	0.2	3.6	0.4
MAP4K1	HPK1	ENSG00000104814	"Mitogen-activated protein kinase kinase kinase kinase 1"	Q92918	19	38587641-38618882	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.2;intestine: 16.9;lymphoid tissue: 39.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 20.5;HDLM-2: 20.3;Karpas-707: 21.1;REH: 11.2;RPMI-8226: 12.7;U-266/70: 16.6;U-266/84: 16.3;U-698: 25.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007419, CAB007754"	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane"				"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"CAB007754: AB_562299, HPA007419: AB_1853778"	"unprognostic (1.99e-3)"	"prognostic favourable (6.17e-5)"	"unprognostic (9.50e-3)"	"unprognostic (3.27e-1)"	"unprognostic (6.03e-2)"	"prognostic favourable (3.26e-4)"	"unprognostic (4.88e-3)"	"unprognostic (5.32e-3)"	"unprognostic (2.79e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.92e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavourable (7.99e-10)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.50e-2)"	1.6	0.9	1.2	31.4	2.3	6.3	1.1	1.0	1.2	1.0	3.1	1.7	0.1	2.1	0.9	1.4	2.6	1.2	2.9	0.9	1.1	1.4	2.2	1.6	3.9	23.0	2.3	0.7	0.8	1.2	0.2	1.2	1.4	2.1	1.6	1.9	2.0	4.4	0.8	0.5	1.2	16.9	0.7	3.4	34.4	2.3	0.9	1.3	19.1	1.9	1.4	39.2	3.1	1.3	16.2	15.9	1.3	6.2	3.7	14.6	7.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.3	0.0	0.0	0.0	0.0	0.0	20.3	0.1	4.3	0.0	0.0	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	21.1	0.0	0.1	4.9	5.1	0.6	0.0	11.2	0.0	12.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	4.6	0.0	0.0	0.1	0.0	0.0	16.6	16.3	25.8	0.0	5.8	0.0	1.3	3.2	1.2	13.4	6.2	12.4	16.2	11.2	14.0	15.9	10.7	6.2	8.7	0.3	3.7	3.4	14.0	14.6	7.3	1.2	2.3	1.0	1.2	1.1	1.4	2.3	0.7	2.1	1.3
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.9;pancreas: 34.5"	"Cell line enhanced"	"Detected in some"		"A-431: 11.5;BEWO: 17.3;CACO-2: 12.8;CAPAN-2: 12.4;HaCaT: 11.7;MCF7: 21.8;RT4: 10.2;SK-BR-3: 10.3;T-47d: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"				Vesicles	Vesicles	"HPA043514: , HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favourable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.4	0.3	0.4	12.5	0.3	0.0	5.0	0.7	1.2	2.0	35.7	0.3	5.2	17.3	1.3	8.6	4.1	2.1	15.4	0.5	0.5	0.4	14.2	4.3	3.3	0.5	0.3	0.1	1.0	34.5	5.4	1.2	5.3	2.4	6.5	10.5	2.4	10.4	4.3	0.3	3.0	52.9	0.7	0.4	0.4	2.1	1.2	0.1	1.3	8.3	2.3	4.6	3.0	3.4	1.5	1.4	4.1	0.8	1.5	0.8	0.2	11.5	0.4	0.2	0.5	0.0	0.1	17.3	0.0	0.0	0.0	0.0	12.8	12.4	0.1	1.3	0.0	11.7	1.0	5.6	0.0	0.0	6.7	0.0	0.1	3.3	0.0	0.1	0.1	0.5	7.0	0.0	0.1	0.0	0.2	0.1	0.0	21.8	0.1	0.2	1.9	0.1	0.0	0.0	4.6	0.2	10.2	2.1	0.1	0.2	10.3	0.0	14.6	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.1	4.1	0.8	0.8	0.7	0.5	0.4	0.8	0.8	0.6	0.3	1.5	0.7	0.7	4.0	1.5	0.5	1.4	0.7	0.2	0.4	0.3	0.7	0.5	0.5	0.4	0.3	0.1	2.4	0.1
MGAT3	GNT-III	ENSG00000128268	"Mannosyl (beta-1,4-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase"	Q09327	22	39457344-39492194	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.0;intestine: 27.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 28.7;HMC-1: 24.8;U-266/70: 32.2;U-266/84: 13.0;U-698: 13.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.5;eosinophil: 3.3;memory B-cell: 1.7;naive B-cell: 1.2"	"Group enriched"	"Detected in many"	9	"B-cells: 1.7;granulocytes: 3.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017598	Approved				"Intracellular and membrane"	78000	78000			"HPA017598: AB_1853853"	"unprognostic (1.41e-3)"	"unprognostic (5.98e-3)"	"unprognostic (4.79e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.71e-3)"	"unprognostic (8.92e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.35e-3)"	"unprognostic (6.77e-2)"	"unprognostic (8.12e-3)"	"unprognostic (8.74e-2)"	"prognostic unfavourable (5.04e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.89e-2)"	"unprognostic (4.92e-2)"	5.3	1.2	17.1	3.9	18.7	9.2	3.6	29.0	24.6	7.1	11.9	8.9	0.0	21.1	3.4	1.2	1.4	4.0	7.9	3.0	18.1	14.9	3.3	0.4	14.9	7.2	13.1	13.4	1.0	3.1	0.9	1.4	10.5	10.7	1.0	4.9	1.7	2.1	1.4	1.6	2.5	27.1	3.2	10.4	3.3	7.8	4.9	9.0	0.2	1.1	0.0	8.9	3.0	2.7	1.7	0.1	3.5	0.2	0.0	0.2	0.1	0.1	0.1	4.7	0.4	0.0	0.0	28.7	0.2	0.3	0.2	0.0	6.3	1.6	9.9	3.5	0.0	0.5	2.4	0.0	0.0	0.0	0.2	8.0	0.0	0.0	0.1	0.0	24.8	0.0	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.1	0.2	0.6	1.4	0.0	0.5	0.0	1.6	0.2	0.2	2.6	1.9	0.0	0.0	0.0	0.3	0.4	0.0	0.0	3.7	0.0	0.0	32.2	13.0	13.9	0.0	0.0	0.7	3.5	0.1	3.3	0.1	0.2	0.1	1.7	0.0	0.0	0.1	1.2	0.2	0.2	0.4	0.0	0.0	0.0	0.1	0.1	17.1	18.7	29.0	24.6	18.1	14.9	13.1	13.4	10.7	9.0
MGAT4B	GnT-Ivb	ENSG00000161013	"Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme B"	Q9UQ53	5	179797597-179806952	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 125.6;liver: 100.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	9	"eosinophil: 8.5"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052134	Uncertain				"Intracellular and membrane"					"HPA052134: AB_2681741"	"unprognostic (2.01e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.83e-2)"	"prognostic unfavourable (6.15e-5)"	"unprognostic (3.61e-3)"	"unprognostic (7.57e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.13e-2)"	"unprognostic (2.26e-2)"	"unprognostic (2.27e-2)"	"prognostic favourable (5.78e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.42e-1)"	13.2	22.8	9.1	19.5	8.2	9.5	18.7	15.3	13.5	8.7	77.3	5.9	10.1	61.7	9.2	10.4	16.8	10.7	26.0	20.6	9.5	5.4	31.9	100.0	17.1	15.6	6.3	5.2	9.1	13.4	10.3	8.3	14.4	6.3	8.8	30.9	10.1	19.2	8.2	8.4	12.1	125.6	7.5	4.9	12.5	22.3	11.2	5.6	7.0	16.6	14.6	10.0	9.5	13.7	0.9	0.6	8.5	0.7	0.0	0.6	0.2	21.9	22.2	10.9	25.3	33.6	18.0	19.0	13.0	26.2	11.9	9.4	24.3	61.1	3.7	33.5	30.0	16.6	16.0	29.3	9.0	30.6	8.5	11.2	20.1	21.2	23.7	14.2	3.5	19.5	20.6	12.0	15.0	24.4	7.3	10.1	20.0	24.4	2.1	11.8	6.7	8.9	5.5	8.7	10.4	35.6	42.6	18.0	10.6	19.5	20.2	35.1	13.8	14.4	29.7	30.0	13.3	16.8	20.8	8.6	9.9	9.3	36.0	17.8	21.6	0.0	0.7	8.5	0.3	0.1	0.1	0.0	0.5	0.2	0.6	0.9	0.4	0.6	0.3	0.0	0.5	0.5	0.0	0.2	9.1	8.2	15.3	13.5	9.5	5.4	6.3	5.2	6.3	5.6
MME	"CALLA, CD10, NEP"	ENSG00000196549	"Membrane metalloendopeptidase"	P08473	3	155024124-155183729	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.1;intestine: 136.0;kidney: 64.9"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 95.0;BJ hTERT+: 142.9;HSkMC: 92.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	129	"neutrophil: 61.1"	"Lineage enriched"	"Detected in single"	129	"granulocytes: 61.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 26.8"	"CAB000013, HPA052583, HPA056072"	Enhanced					99000	99000			"CAB000013: AB_563478, HPA052583: AB_2681872, HPA056072: AB_2683027"	"unprognostic (1.36e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.78e-2)"	"unprognostic (6.52e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.67e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.30e-3)"	"unprognostic (1.31e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.50e-1)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.37e-2)"	26.5	0.4	0.4	3.4	7.4	1.9	14.7	0.4	0.7	4.8	65.6	0.1	18.4	74.0	2.8	8.1	0.7	0.9	8.5	1.8	0.3	0.4	64.9	11.5	13.7	3.0	2.1	0.2	0.9	0.6	0.0	0.6	35.0	8.6	18.3	0.4	1.3	3.7	11.3	11.7	1.4	136.0	0.6	0.9	2.7	0.7	1.0	1.2	13.2	1.0	5.3	2.3	3.4	4.9	0.1	0.4	61.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	38.6	95.0	0.2	21.2	142.9	10.8	28.1	0.0	0.0	23.4	0.0	18.8	0.0	0.7	0.8	26.1	0.0	0.1	0.0	0.0	0.0	30.9	0.0	0.0	92.1	0.1	5.8	41.6	8.2	0.0	0.0	17.3	0.1	0.0	0.1	0.9	0.1	38.8	18.2	0.1	0.6	0.2	0.0	0.2	0.0	0.0	4.1	0.0	0.0	23.3	46.7	0.1	15.9	3.7	0.0	0.0	30.8	5.6	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	61.1	0.0	0.0	0.4	0.0	0.0	0.4	7.4	0.4	0.7	0.3	0.4	2.1	0.2	8.6	1.2
MMP15	"MT2-MMP, MTMMP2, SMCP-2"	ENSG00000102996	"Matrix metallopeptidase 15"	P51511	16	58025566-58046901	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 36.8;Hep G2: 19.1;SK-BR-3: 18.5;WM-115: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	30	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	30	"dendritic cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002611, HPA040390"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB002611: , HPA040390: AB_2676956"	"unprognostic (1.76e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.40e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.24e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.81e-1)"	"prognostic favourable (8.54e-8)"	"unprognostic (3.63e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.28e-1)"	"prognostic favourable (3.08e-4)"	5.9	2.3	2.0	5.5	3.0	0.1	7.7	3.7	7.2	3.3	19.5	4.2	16.3	22.6	2.9	1.7	2.5	3.6	15.9	17.6	2.3	3.7	8.4	26.4	6.1	2.0	2.5	2.2	2.1	10.3	7.3	5.2	28.5	10.4	3.6	8.2	9.5	4.7	14.7	3.4	2.3	43.2	3.4	3.4	5.2	14.7	28.0	2.1	1.1	26.8	2.5	2.2	3.3	4.2	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.7	4.3	2.3	11.8	2.4	0.1	36.8	0.5	0.3	2.1	0.4	3.4	14.8	0.0	7.0	0.6	8.1	1.9	1.7	0.6	0.0	3.9	0.0	1.9	19.1	3.1	0.1	7.7	1.2	3.0	0.3	0.9	1.4	4.7	0.0	0.7	2.8	0.2	0.9	6.7	1.2	2.8	0.3	3.1	6.5	2.1	0.6	4.1	7.7	18.5	3.5	2.0	3.1	1.3	0.1	3.7	1.4	0.5	0.0	0.0	0.1	0.7	0.9	30.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	2.0	3.0	3.7	7.2	2.3	3.7	2.5	2.2	10.4	2.1
MOCOS	"FLJ20733, HMCS, MOS"	ENSG00000075643	"Molybdenum cofactor sulfurase"	Q96EN8	18	36187519-36272157	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.0;liver: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;hTERT-HME1: 25.1;SiHa: 26.9;SK-MEL-30: 18.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA039412, HPA047958"	Uncertain		Supported	Mitochondria,Cytosol				Mitochondria	Mitochondria	"HPA039412: AB_2676496, HPA047958: AB_2680225"	"unprognostic (3.07e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.18e-3)"	"unprognostic (2.55e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavourable (3.55e-4)"	"unprognostic (5.84e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (1.29e-4)"	"unprognostic (2.91e-2)"	"prognostic unfavourable (3.03e-12)"	"unprognostic (8.98e-2)"	"unprognostic (2.37e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.35e-2)"	3.7	12.7	0.6	1.6	0.5	0.2	6.4	0.4	0.4	1.4	10.4	0.7	8.0	6.7	1.3	4.6	4.8	1.9	5.8	1.3	0.4	0.5	1.7	36.6	1.8	0.2	0.4	0.1	17.2	3.2	1.1	9.4	11.2	2.2	2.8	1.8	2.1	2.5	7.2	1.3	2.6	33.0	1.0	0.4	0.7	1.7	1.3	0.2	0.0	1.2	2.9	3.5	2.6	1.7	0.4	0.3	1.9	0.3	1.1	0.3	0.1	6.8	2.3	0.1	0.0	2.2	2.8	1.4	4.0	2.2	1.9	5.0	1.5	2.1	0.0	1.2	6.5	4.2	1.4	6.3	2.7	1.1	1.1	0.1	6.8	5.6	7.5	0.0	1.9	4.4	20.4	7.6	25.1	0.3	2.3	0.0	3.1	1.7	0.0	0.0	0.4	2.0	0.0	0.0	0.0	2.7	9.0	0.0	0.6	26.9	1.7	18.7	1.2	0.1	1.3	1.5	1.9	3.3	0.6	0.0	0.0	0.0	3.9	0.0	0.6	1.7	0.3	0.3	0.3	0.2	0.2	0.3	0.2	0.3	0.1	0.4	0.2	0.3	1.9	1.1	0.2	0.3	0.1	0.1	0.6	0.5	0.4	0.4	0.4	0.5	0.4	0.1	2.2	0.2
MRGPRD	mrgD	ENSG00000172938	"MAS related GPR family member D"	Q8TDS7	11	68980021-68980986	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 2.5"	"Cell line enhanced"	"Detected in single"		"U-2197: 1.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA031346	Uncertain									"HPA031346: AB_10602710"										"unprognostic (1.92e-1)"		"unprognostic (7.14e-2)"		"unprognostic (1.72e-1)"				0.4	0.4	0.0	0.3	0.0	0.5	0.1	2.0	0.0	0.9	2.5			0.0	1.8	0.0	0.9	0.9	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0		0.1	0.0	0.0	0.0	0.0		0.3	0.1		0.0	2.2	0.0	0.1	0.8	1.1	0.0	0.0	0.5	0.3			0.0		0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MS4A18		ENSG00000214782	"Membrane spanning 4-domains A18"	Q3C1V0	11	60729304-60744212	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"breast: 7.8;intestine: 21.9;testis: 4.3"	"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA045121	Approved									"HPA045121: AB_10969456"	"unprognostic (1.02e-1)"											"unprognostic (8.87e-2)"		"unprognostic (2.51e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0			21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0		0.0	0.0	0.0	0.1	0.0		0.1	0.0		0.0	0.0	0.0	0.2	3.1	0.0	0.0	0.0	0.0	4.3			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MST1R	"CD136, CDw136, PTK8, RON"	ENSG00000164078	"Macrophage stimulating 1 receptor"	Q04912	3	49887002-49903873	"CD markers, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 27.7;intestine: 34.3;skin 1: 28.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.3;HaCaT: 19.5;HBEC3-KT: 21.2;hTCEpi: 29.8;RT4: 22.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"MAIT T-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA007657, HPA008180, CAB008972"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"CAB008972: , HPA007657: AB_1079292, HPA008180: AB_1079291"	"unprognostic (3.84e-3)"	"unprognostic (3.86e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.33e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.32e-1)"	"unprognostic (8.07e-3)"	"unprognostic (1.54e-2)"	"unprognostic (4.12e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.28e-1)"	"unprognostic (8.08e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.00e-3)"	"prognostic favourable (2.33e-5)"	1.7	0.1	0.4	7.5	0.6	0.0	2.4	0.5	0.7	1.8	20.5	0.7	2.0	11.2	1.2	1.3	6.1	0.6	27.7	0.9	0.5	0.1	1.4	0.4	5.0	1.1	0.4	0.6	0.5	4.1	0.0	1.3	0.8	0.9	1.7	9.7	2.5	2.1	0.4	0.5	28.7	34.3	0.7	0.4	0.6	19.1	1.9	0.4	7.7	1.3	6.0	4.5	4.3	3.5	0.2	0.0	0.0	0.0	0.6	2.1	0.0	12.7	4.9	0.0	0.2	0.0	0.0	0.8	0.1	0.0	0.0	0.0	1.2	35.3	0.5	3.1	0.2	19.5	0.0	21.2	0.0	0.3	0.3	0.0	8.4	0.3	0.3	0.0	0.4	0.1	29.8	0.1	4.2	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.1	10.3	0.8	0.0	0.3	13.0	22.8	0.3	0.0	3.6	8.2	0.0	6.5	0.3	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.9	0.0	0.4	0.6	0.5	0.7	0.5	0.1	0.4	0.6	0.9	0.4
MT1H	MT1	ENSG00000205358	"Metallothionein 1H"	P80294	16	56669814-56671129	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 53.9;kidney: 88.1;liver: 134.0;pancreas: 50.2;thyroid gland: 60.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;EFO-21: 8.3;NB-4: 2.9;SCLC-21H: 2.1"	"Cancer enhanced"	"Detected in many"		"testis cancer: 173.4"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"intermediate monocyte: 1.6"	"Low lineage specificity"	"Detected in single"																						"unprognostic (1.32e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.51e-1)"	"unprognostic (8.65e-2)"	"prognostic unfavourable (2.37e-7)"	"unprognostic (8.48e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.04e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (5.77e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.34e-1)"	0.6	0.0	1.4	1.1	20.1	0.0	0.2	0.2	4.7	0.3	21.7	0.6	0.2	9.4	0.8	3.1	4.1	0.2	2.8	0.2	7.4	0.9	88.1	134.0	0.3	1.3	4.4	1.6	0.3	50.2	0.0	0.2	0.3	8.3	2.3	11.0	1.6	0.5	0.2	0.3	0.7	53.9	1.4	1.9	0.2	6.7	0.4	1.5	0.2	60.3	0.9	0.4	1.0	0.2	0.2	0.1	0.0	1.6	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.3	2.9	0.4	0.0	0.3	0.0	1.6	0.6	0.0	2.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.1	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.5	1.4	20.1	0.2	4.7	7.4	0.9	4.4	1.6	8.3	1.5
MTMR11	CRA	ENSG00000014914	"Myotubularin related protein 11"	A4FU01	1	149928651-149936869	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 49.9"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 11.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"classical monocyte: 1.9;intermediate monocyte: 3.2;myeloid DC: 4.2;non-classical monocyte: 3.0"	"Group enriched"	"Detected in many"	37	"dendritic cells: 4.2;monocytes: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030351	Approved		Approved	Centrosome				Centrosome	Centrosome	"HPA030351: AB_10602185"	"unprognostic (1.14e-1)"	"unprognostic (3.01e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.81e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.83e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.12e-2)"	3.2	12.0	4.9	15.0	8.4	0.0	5.4	1.5	3.9	9.5	36.8	2.7	5.8	15.9	10.0	6.2	4.4	7.2	17.0	3.1	2.6	2.8	9.7	1.8	3.4	1.5	2.0	2.8	14.5	2.2	5.8	6.3	9.6	5.2	5.5	20.8	4.5	2.1	6.5	1.1	7.4	49.9	11.4	5.0	1.8	4.0	4.9	2.5	0.0	1.6	4.0	1.5	5.8	6.8	0.0	4.2	0.0	3.2	0.0	0.0	0.5	2.6	6.4	2.8	2.3	8.4	9.5	5.2	2.7	9.2	3.6	4.5	0.1	11.6	0.0	6.3	9.4	3.7	0.3	4.6	2.0	0.2	0.0	0.0	1.9	0.8	2.1	0.0	0.0	5.8	1.5	3.6	6.0	4.3	0.1	0.1	7.0	8.6	0.0	0.1	0.6	2.3	0.0	1.0	0.1	5.4	0.8	0.1	0.2	1.6	2.5	0.9	2.8	0.0	2.9	3.9	4.9	3.3	2.1	0.3	1.1	0.0	3.7	0.0	0.3	0.0	1.9	0.0	0.0	3.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.5	4.9	8.4	1.5	3.9	2.6	2.8	2.0	2.8	5.2	2.5
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 3.8;intestine: 3.1;kidney: 5.7;testis: 2.5"	"Cell line enhanced"	"Detected in some"		"A549: 2.7;EFO-21: 2.0;HEK 293: 2.0;NTERA-2: 1.8;SCLC-21H: 1.5;SH-SY5Y: 3.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"																"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.1	1.2	0.1	0.0	0.0	3.8	0.2	0.0	3.1			0.3	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.1	5.7	0.0	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0		0.0	2.4		0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5			0.0		0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.3	0.5	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
MUC4		ENSG00000145113	"Mucin 4, cell surface associated"	Q99102	3	195746765-195812277	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.5;lymphoid tissue: 57.2"	"Cell line enhanced"	"Detected in single"		"BEWO: 1.5"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA005895, CAB013536"	Approved				"Secreted in other tissues"					"CAB013536: , HPA005895: AB_1079427"	"unprognostic (4.16e-3)"	"unprognostic (1.00e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.22e-3)"	"unprognostic (6.68e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (3.19e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.46e-3)"	"unprognostic (9.97e-3)"	0.4	0.4	0.0	28.7	0.0	0.4	0.4	0.0	0.4	13.4	21.5	0.0	0.0	0.4	1.4	0.4	13.0	1.7	0.4	0.4	0.0	0.0	0.4	0.4	10.3	0.4	0.0	0.0	0.5	0.4	0.4	0.0	6.2	0.2	10.0	1.9	0.0	5.5	0.4	0.4	0.4	1.7	0.4	0.0	0.4	2.4	0.5	0.0	0.5	0.4	6.1	57.2	6.5	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0
MYH14	"DFNA4, FLJ13881, KIAA2034, MHC16, MYH17"	ENSG00000105357	"Myosin heavy chain 14"	Q7Z406	19	50188186-50310544	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;skeletal muscle: 53.1"	"Cell line enhanced"	"Detected in some"		"A-431: 15.0;CAPAN-2: 19.0;HaCaT: 37.8;MCF7: 18.4;RT4: 46.9;SK-BR-3: 16.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062391, HPA067889, HPA070260"	Enhanced		Approved	Nucleoplasm		59000000	59000000	Nucleoplasm	Nucleoplasm	"HPA062391: AB_2684748, HPA067889: AB_2685917, HPA070260: AB_2686243"	"unprognostic (2.52e-1)"	"unprognostic (5.81e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.71e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"prognostic favourable (3.97e-8)"	"prognostic favourable (7.83e-4)"	"unprognostic (8.50e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.77e-1)"	5.5	0.5	6.1	8.4	6.1	0.1	2.7	4.6	9.4	3.4	63.9	10.5	3.5	38.7	1.1	4.6	14.7	7.5	9.2	16.2	6.4	5.4	4.3	8.7	11.5	0.2	8.5	3.9	1.1	7.5	7.3	4.5	0.7	7.8	3.2	9.4	4.6	12.0	3.1	53.1	20.3	78.6	0.8	11.1	0.2	21.0	0.7	4.2	0.4	16.7	11.4	9.5	4.9	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	1.5	0.0	8.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	10.4	19.0	0.0	9.9	0.0	37.8	0.0	0.0	0.0	0.0	2.7	0.0	0.0	7.9	0.0	0.0	5.6	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	18.4	0.0	0.1	0.2	0.2	0.0	9.6	0.2	0.0	46.9	0.0	0.0	0.9	16.8	0.0	3.1	0.5	0.0	0.0	3.9	0.0	0.0	0.3	3.3	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	6.1	4.6	9.4	6.4	5.4	8.5	3.9	7.8	4.2
NAGS	"AGAS, ARGA, NAT7"	ENSG00000161653	"N-acetylglutamate synthase"	Q8N159	17	44004546-44009063	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.4;liver: 30.2"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 6.3;HHSteC: 6.4;TIME: 7.9;U-87 MG: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027300			Supported	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA027300: AB_2672207"	"unprognostic (1.51e-3)"	"unprognostic (9.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.19e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.27e-1)"	0.6	0.6	0.5	0.4	2.4	0.0	1.0	0.7	1.5	0.3	7.2	0.5	5.6	16.4	0.5	2.6	0.9	0.3	0.3	0.9	0.7	1.5	4.4	30.2	2.5	0.2	1.8	0.6	0.5	0.3	3.6	0.4	0.4	1.2	0.8	0.4	0.1	0.9	6.5	0.1	0.6	13.4	0.3	2.0	0.5	0.3	0.4	1.1	0.2	2.9	0.0	0.1	0.8	0.8	1.5	2.0	2.3	2.7	1.0	3.5	1.3	3.4	0.2	0.0	0.5	0.0	6.3	0.1	0.6	0.0	0.2	0.0	2.2	0.8	0.0	1.3	0.0	1.4	0.0	1.2	0.1	0.3	0.8	0.1	0.2	2.6	6.4	0.0	0.0	2.7	0.1	0.2	0.0	1.2	0.2	0.0	0.0	0.1	0.0	0.0	0.4	2.6	0.1	0.2	0.0	0.0	0.0	2.6	0.0	1.2	0.0	0.0	0.2	0.1	7.9	3.0	0.8	0.2	0.7	0.2	0.2	0.2	11.9	0.1	0.4	1.8	1.4	2.3	3.5	1.5	2.8	1.2	2.2	2.9	2.0	1.5	1.1	1.7	0.8	1.0	2.7	0.3	1.7	1.3	0.5	2.4	0.7	1.5	0.7	1.5	1.8	0.6	1.2	1.1
NAT1	AAC1	ENSG00000171428	"N-acetyltransferase 1"	P18440	8	18170477-18223689	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.4"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	14	"breast cancer: 47.9"	"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											"CAB017782, HPA043704"	Approved									"CAB017782: , HPA043704: AB_2678625"	"unprognostic (1.31e-1)"	"unprognostic (1.05e-1)"	"prognostic favourable (5.07e-4)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-2)"	"unprognostic (8.25e-2)"	"unprognostic (5.20e-2)"	"unprognostic (6.53e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.60e-2)"	"unprognostic (7.44e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.15e-2)"	3.7	3.2	1.5	8.5	1.5	1.9	7.9	1.3	1.5	5.4	15.6	1.0	5.1	9.3	4.4	13.0	4.8	3.5	5.9	2.9	1.7	1.0	8.6	14.3	6.2	6.6	2.5	1.0	3.3	4.2	1.1	4.6	6.0	3.1	7.4	10.3	4.5	3.6	5.4	2.0	1.6	23.4	2.6	2.3	9.8	4.8	4.1	0.5	10.8	2.6	4.3	6.2	3.1	3.0	6.3	8.1	12.3	7.1	8.6	8.5	3.9	18.8	2.4	2.1	2.8	5.7	5.8	4.6	6.9	7.2	7.7	8.9	3.1	4.0	9.1	5.5	4.4	3.0	3.8	4.5	7.9	8.6	2.0	6.2	2.6	2.4	5.5	2.8	8.6	4.7	5.8	5.2	0.5	6.7	5.4	2.6	8.5	3.4	8.1	8.8	2.1	2.9	4.0	2.1	3.8	8.2	11.0	1.1	1.4	0.3	8.1	4.7	6.7	8.3	6.8	4.6	2.7	7.0	1.1	1.7	3.3	8.0	4.1	6.3	2.1	5.3	6.4	12.3	4.8	7.1	3.5	6.3	5.0	4.8	8.1	5.4	4.8	5.8	11.2	8.6	6.8	4.7	8.5	3.9	1.5	1.5	1.3	1.5	1.7	1.0	2.5	1.0	3.1	0.5
NBPF4	FLJ32833	ENSG00000196427	"NBPF member 4"	Q96M43	1	108223341-108244081	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 3.1;testis: 8.8"	"Group enriched"	"Detected in some"	4	"BEWO: 8.0;K-562: 11.5;Karpas-707: 3.4;MCF7: 13.6;THP-1: 4.1"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.9"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (6.33e-2)"		"unprognostic (2.08e-1)"						"unprognostic (2.18e-2)"					"unprognostic (8.29e-2)"	"unprognostic (2.90e-1)"		"unprognostic (8.73e-2)"	0.0	0.0	0.0	0.0	1.0	0.0	1.3	0.0	0.0	0.0	0.6			0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	1.5	1.4		0.0	0.8		0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	8.8			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.5	3.4	0.0	13.6	0.0	0.0	0.6	0.0	0.0	2.0	0.6	0.0	0.0	0.3	0.0	0.0	0.2	1.6	0.2	4.1	0.0	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NBPF6		ENSG00000186086	"NBPF member 6"	Q5VWK0	1	108450282-108471002	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 1.9;testis: 7.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;K-562: 13.6;SK-BR-3: 3.3;SK-MEL-30: 2.4"	"Cancer enriched"	"Detected in single"	6	"breast cancer: 0.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA045044, HPA046411, HPA047447, HPA058050"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA045044: AB_2679196, HPA046411: AB_2679657, HPA047447: AB_2680051, HPA058050: "	"unprognostic (4.36e-2)"		"unprognostic (5.87e-2)"						"unprognostic (4.62e-2)"					"unprognostic (2.39e-1)"	"unprognostic (2.61e-1)"		"unprognostic (8.02e-2)"	0.0	0.0	0.0	0.0	1.7	0.0	1.1	0.0	0.1	0.0	0.1			0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1		0.0	0.0	0.0	0.6	1.4		0.0	0.9		0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	7.1			0.0		0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	1.5	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	3.3	2.4	0.0	1.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NCKAP5	"ERIH1, ERIH2, NAP5"	ENSG00000176771	"NCK associated protein 5"	O14513	2	132671799-133568463	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.3;lung: 19.2"	"Cell line enriched"	"Detected in some"	6	"AF22: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	8	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.1"	"Low region specificity"	"Detected in all"							"HPA034639, HPA044859"	Uncertain		Approved	"Nucleoli,Golgi apparatus,Plasma membrane,Cytosol"				Nucleoli	Nucleoli	"HPA034639: AB_10669678, HPA044859: AB_2679114"	"unprognostic (2.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.13e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.06e-11)"	"unprognostic (4.56e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.03e-1)"	3.6	2.0	6.6	1.5	6.3	0.2	5.4	5.2	5.6	3.1	5.8	6.2	0.9	3.8	3.6	6.2	6.9	1.0	1.5	4.6	6.0	3.9	16.3	6.7	19.2	2.2	6.6	4.7	4.5	1.8	2.2	1.3	4.6	4.2	1.6	1.9	7.5	7.8	1.0	1.1	3.7	18.3	1.0	6.3	2.9	3.0	2.1	6.6	0.3	2.1	5.4	2.3	1.3	3.1	0.0	0.3	3.1	0.0	0.0	0.0	0.0	0.0	1.5	31.7	0.0	0.0	0.3	0.1	0.5	5.6	0.5	0.5	0.0	0.0	2.4	0.0	0.3	0.1	0.2	0.4	1.8	0.0	0.2	0.0	4.7	0.0	0.0	0.0	0.0	0.3	2.6	3.0	0.4	0.5	0.0	0.0	0.9	0.3	0.0	0.0	0.7	1.0	0.3	0.0	1.2	0.7	0.7	0.1	1.0	0.0	1.1	1.6	0.5	0.0	1.6	0.2	0.2	4.6	0.0	0.1	0.0	0.9	0.3	0.0	0.4	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	6.3	5.2	5.6	6.0	3.9	6.6	4.7	4.2	6.6
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335655-41350887	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 8.5;intestine: 3.3;lymphoid tissue: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 1.7;MOLT-4: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"NK-cell: 2.5;plasmacytoid DC: 8.5"	"Group enriched"	"Detected in many"	13	"dendritic cells: 8.5;NK-cells: 2.5"									HPA067249	Uncertain									"HPA067249: AB_2685811"		"unprognostic (5.81e-2)"				"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"		"unprognostic (2.12e-2)"				"unprognostic (1.65e-1)"				0.1	0.1	0.1	1.9	0.1	0.0	0.1	0.0	0.0	0.0	3.3	0.0	0.0	2.8	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.2	0.0	0.1	2.5	0.1	0.0	0.6	0.1	0.3	0.0	1.2	0.1	1.7	3.7	0.0	0.1	0.0	8.5	0.0	0.0	2.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	8.5	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0
NEUROG3	"Atoh5, bHLHa7, Math4B, ngn3"	ENSG00000122859	"Neurogenin 3"	Q9Y4Z2	10	69571698-69573238	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 7.5;intestine: 8.4"	"Cell line enriched"	"Detected in some"	5	"THP-1: 15.0"	"Cancer enhanced"	"Detected in some"		"stomach cancer: 1.4"	"Region enriched"	"Detected in single"	20	"hippocampal formation: 7.5"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.1;memory B-cell: 1.1"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;T-cells: 2.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA039785	Uncertain		Approved	"Nucleoplasm,Nuclear speckles"				"Nuclear speckles"	"Nuclear speckles"	"HPA039785: "	"unprognostic (1.22e-2)"		"unprognostic (7.33e-2)"		"unprognostic (3.04e-2)"			"unprognostic (2.42e-1)"		"unprognostic (1.10e-1)"	"unprognostic (1.65e-2)"		"unprognostic (5.85e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.19e-1)"			0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	7.6	0.0	0.0	8.0	0.0	0.0	0.9	0.0	1.8	0.0	7.5	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.1	0.1	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	1.1	0.0	0.4	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.3	7.5	0.1	0.1	0.0	0.0	0.0
NGEF	ARHGEF27	ENSG00000066248	"Neuronal guanine nucleotide exchange factor"	Q8N5V2	2	232878686-233013272	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.1;brain: 55.6;intestine: 23.2"	"Cell line enhanced"	"Detected in many"		"A-431: 25.0;HDLM-2: 21.1;PC-3: 27.5;T-47d: 15.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 177.2;basal ganglia: 332.1;cerebral cortex: 231.3;hippocampal formation: 147.2"	"Low region specificity"	"Detected in many"			HPA008160	Approved		Uncertain	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA008160: AB_1854450"	"unprognostic (3.92e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.66e-1)"	"unprognostic (5.25e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.39e-3)"	"unprognostic (5.41e-3)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.74e-1)"	0.8	29.1	15.8	1.4	55.6	0.3	1.4	0.8	53.8	1.4	7.9	1.6	0.0	23.2	2.8	2.6	5.3	3.1	2.0	0.9	7.0	5.1	4.2	9.7	0.6	0.3	3.2	26.7	1.5	1.8	7.9	0.9	0.4	5.4	1.3	6.1	0.0	0.8	0.7	0.7	16.5	16.6	4.0	1.4	0.5	6.2	2.3	12.0	0.0	0.8	1.0	0.4	0.9	1.6	0.0	0.5	0.5	0.3	0.0	0.0	0.0	25.0	7.3	0.2	0.1	0.1	4.1	0.4	0.4	0.0	0.2	0.0	0.3	2.5	0.0	7.5	5.1	3.3	5.6	1.4	0.2	21.1	1.8	0.0	10.2	7.8	0.1	0.0	0.1	0.0	0.1	1.7	0.3	0.9	0.1	0.1	0.2	1.8	0.0	0.0	0.6	27.5	0.0	0.0	0.0	0.5	0.6	0.9	0.2	3.1	1.6	0.0	15.5	0.2	0.0	0.2	2.3	0.1	0.5	0.2	0.1	0.0	1.8	0.0	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	15.8	55.6	0.8	53.8	7.0	5.1	3.2	26.7	5.4	12.0
NKX1-2	"bB238F13.2, C10orf121"	ENSG00000229544	"NK1 homeobox 2"	Q9UD57	10	124445239-124450184	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;intestine: 2.9;skin 1: 2.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.9;HEK 293: 2.7;hTCEpi: 6.7;NTERA-2: 13.3;SCLC-21H: 5.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA029367	Uncertain									"HPA029367: AB_2673011"	"unprognostic (2.43e-1)"	"unprognostic (7.85e-3)"		"unprognostic (6.81e-5)"	"unprognostic (1.55e-2)"	"unprognostic (3.61e-2)"		"unprognostic (5.40e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.20e-1)"		"unprognostic (3.73e-2)"		"unprognostic (2.69e-1)"	"unprognostic (1.71e-1)"		"unprognostic (8.68e-2)"	0.0	0.0	0.7	0.0	2.0	0.0	0.9	0.2	2.9	0.4	0.0	1.1	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.6	0.3	0.0	0.2	0.4	0.0	0.7	3.7	0.3	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	1.2	0.0	0.0	2.2	2.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	1.2	1.2	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	6.9	0.6	0.9	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.3	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.2	2.9	0.6	0.3	0.7	3.7	2.2	0.0
NKX2-3	"CSX3, NKX2.3, NKX2C, NKX4-3"	ENSG00000119919	"NK2 homeobox 3"	Q8TAU0	10	99532933-99536524	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.5;intestine: 21.6;lymphoid tissue: 36.8"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.1;NB-4: 4.7;REH: 6.0;THP-1: 1.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.8"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	12	"memory CD8 T-cell: 1.2"	"Lineage enriched"	"Detected in single"	12	"T-cells: 1.2"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"basal ganglia: 0.3"	HPA047561	Uncertain		Uncertain	Nucleoli,Cytosol				"Nucleoli, Cytosol"	"Nucleoli, Cytosol"	"HPA047561: AB_2680088"		"unprognostic (5.70e-2)"	"unprognostic (2.95e-1)"			"unprognostic (2.70e-4)"	"unprognostic (6.34e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.40e-2)"	"unprognostic (1.20e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.83e-1)"	0.8	0.0	0.1	17.2	0.1	0.0	0.1	0.1	0.1	0.3	21.6	0.1	0.1	10.4	0.2	0.1	0.5	0.0	12.5	0.1	0.1	0.0	0.1	0.2	0.1	1.1	0.1	0.1	0.1	6.4	0.0	0.1	0.1	0.1	0.1	4.6	0.1	9.0	0.5	0.1	0.0	19.1	3.1	0.1	36.8	1.8	0.1	0.1	0.2	1.0	0.7	3.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.7	0.0	0.0	6.0	0.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NKX3-2	"BAPX1, NKX3.2, NKX3B"	ENSG00000109705	"NK3 homeobox 2"	P78367	4	13540830-13545050	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 18.3;lymphoid tissue: 6.5"	"Cell line enhanced"	"Detected in some"		"HAP1: 4.5;NB-4: 12.4;NTERA-2: 7.1;THP-1: 7.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA027564	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA027564: AB_10601973"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-1)"	"unprognostic (7.42e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.72e-2)"	"unprognostic (2.24e-5)"	"unprognostic (3.49e-2)"	"unprognostic (1.12e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.93e-8)"	"unprognostic (5.81e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.15e-1)"	1.7	0.0	0.1	6.5	0.1	0.0	0.1	0.1	0.1	1.1	18.3	0.1	0.1	1.6	0.9	0.1	2.3	0.2	0.4	1.8	0.1	0.0	0.4	0.1	0.1	2.0	0.1	0.1	2.9	0.2	0.0	0.9	0.1	0.1	0.6	2.4	0.1	1.5	0.6	0.1	0.1	2.0	3.2	0.1	5.3	2.8	0.9	0.1	0.1	0.3	0.9	0.1	0.8	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	1.9	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.8	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.5	0.6	1.6	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.6	0.0	0.3	12.4	7.1	0.5	0.0	0.7	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	1.0	7.4	0.0	0.5	2.9	0.1	0.5	2.2	0.0	0.0	0.4	0.2	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
NOS2	"HEP-NOS, iNOS, NOS, NOS2A"	ENSG00000007171	"Nitric oxide synthase 2"	P35228	17	27756766-27800499	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.8;lymphoid tissue: 15.6"	"Group enriched"	"Detected in some"	8	"CACO-2: 16.6;SCLC-21H: 13.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 16.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB002014	Enhanced									"CAB002014: "	"unprognostic (1.95e-3)"	"unprognostic (3.08e-3)"	"unprognostic (4.75e-3)"	"unprognostic (4.42e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.09e-2)"	"unprognostic (9.91e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.02e-2)"	"unprognostic (3.68e-1)"	"unprognostic (8.69e-2)"	"unprognostic (4.03e-2)"	1.0	0.7	1.6	15.6	1.6	0.0	0.5	1.5	7.3	0.4	6.8	0.0	0.0	11.8	0.4	0.0	1.0	0.5	0.4	0.7	1.3	1.1	1.7	0.2	3.8	1.8	1.0	2.2	1.0	0.3	0.1	2.1	3.4	0.4	0.9	9.0	1.2	0.2	0.2	0.7	0.4	20.8	1.7	0.8	0.2	0.3	0.4	0.2	0.2	0.5	5.3	1.7	5.4	0.3	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.6	1.5	7.3	1.3	1.1	1.0	2.2	0.4	0.2
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874345	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ductus deferens: 15.0;intestine: 36.3;seminal vesicle: 18.0"	"Cell line enriched"	"Detected in some"	21	"CACO-2: 25.9"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"olfactory region: 1.8"												"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favourable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.1	0.1	0.2	8.8	0.2	0.0	0.1	0.2	0.2	0.2	28.3	0.0	15.0	0.1	0.3	0.0	0.1	0.1	0.2	0.1	0.2	0.2	0.1	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	36.3	0.0	0.1	18.0	0.1	0.8	1.7	0.7	0.1	0.1	0.1	0.4	0.0	0.4	0.1	0.0	0.1	0.6	0.1	0.2	0.7	0.9	0.6	0.8	1.5	0.2	0.4	0.9	0.4	0.3	0.2	0.0	0.3	0.3	0.0	0.0	0.0	25.9	0.3	0.3	0.6	0.0	0.6	0.0	0.0	0.0	0.3	1.2	0.4	0.6	0.7	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	1.1	1.0	0.7	0.9	0.6	0.6	0.4	0.0	0.9	0.4	0.5	0.6	0.3	0.6	0.2	0.8	0.2	0.3	0.2	0.5	0.6	0.3	0.6	0.3	0.7	1.1	0.2	0.9	0.3	0.3	0.5	0.3	0.3	0.2	1.1	0.2	0.1	0.1	1.5	0.6	0.1	0.8	0.6	0.7	1.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	0.0
NOXO1	"P41NOXA, P41NOXB, P41NOXC, SH3PXD5, SNX28"	ENSG00000196408	"NADPH oxidase organizer 1"	Q8NFA2	16	1978917-1984192	"FDA approved drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 10.5;lymphoid tissue: 10.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.6;HaCaT: 3.8;MOLT-4: 3.3;SCLC-21H: 3.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA071540	Enhanced									"HPA071540: AB_2686415"			"unprognostic (3.74e-1)"							"unprognostic (1.10e-1)"				"unprognostic (1.73e-2)"				0.5	0.0	1.1	10.6	3.1	0.3	0.5	7.0	2.0	0.9	10.5	0.5	0.5	4.6	0.5	1.5	2.2	0.2	2.8	0.5	1.0	0.9	0.5	2.2	1.0	0.5	0.6	0.5	0.5	0.5	0.3	0.8	0.5	0.5	0.5	8.6	0.5	4.9	0.5	0.5	0.6	4.2	0.6	0.5	0.5	0.3	4.8	0.5	1.4	0.5	0.5	4.1	1.1	0.5	0.7	0.2	1.3	0.0	0.0	0.3	0.0	0.4	1.0	1.1	0.3	0.6	0.0	0.0	0.1	0.3	0.9	0.5	0.8	6.6	0.6	0.5	0.0	3.8	0.0	0.3	0.0	1.2	0.0	0.0	1.9	0.0	0.1	0.0	0.6	1.1	0.2	1.0	0.4	0.0	0.3	0.0	0.0	0.3	3.3	0.1	0.0	0.0	0.5	1.0	0.1	0.8	0.0	3.5	0.0	1.4	1.3	0.2	2.6	1.0	0.0	0.7	0.1	0.0	1.6	0.2	0.6	1.5	0.6	0.1	0.4	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.0	1.1	3.1	7.0	2.0	1.0	0.9	0.6	0.5	0.5	0.5
NPY4R	"PP1, PPYR1, Y4"	ENSG00000204174	"Neuropeptide Y receptor Y4"	P50391	10	46461099-46465881	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 9.4;skin 1: 4.3"	"Cell line enriched"	"Detected in some"	5	"A549: 24.9"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.8"	"Group enriched"	"Detected in some"	5	"cerebellum: 1.6;cerebral cortex: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Approved									"HPA027863: AB_10602819"		"unprognostic (2.26e-6)"	"unprognostic (2.94e-1)"			"unprognostic (8.17e-2)"		"unprognostic (1.20e-1)"		"unprognostic (1.30e-1)"	"unprognostic (1.77e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.64e-3)"	"unprognostic (6.58e-2)"			"unprognostic (9.79e-2)"	0.2	0.0	0.2	0.7	0.2	0.0	0.2	1.6	1.2	0.3	7.4	0.2	0.2	2.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	1.9	9.4	0.2	0.2	0.2	0.2	4.3	2.6	1.4	0.2	0.2	2.4	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	24.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.2	0.1	0.0	0.7	0.0	5.1	0.0	0.4	0.1	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	1.6	1.2	0.2	0.2	0.2	0.2	0.2	0.2
NPY4R2	CH17-360D5.1	ENSG00000264717	"Neuropeptide Y receptor Y4-2"		10	47918739-47923524	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"breast: 4.2;intestine: 6.3;skin 1: 3.3"	"Cell line enriched"	"Detected in some"	11	"A549: 20.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027863	Uncertain									"HPA027863: AB_10602819"		"unprognostic (1.74e-2)"	"unprognostic (1.24e-2)"			"unprognostic (1.59e-1)"		"unprognostic (7.78e-2)"			"unprognostic (6.72e-3)"	"unprognostic (1.23e-1)"		"unprognostic (1.46e-2)"			"unprognostic (3.25e-1)"	0.2	0.0	0.0	0.3	0.0	0.0	4.2	0.0	0.4	0.0	6.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7		0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	4.7	0.0	0.0	0.0	0.0	3.3	3.4	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	20.7	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.5	0.0	1.8	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
NR0B2	SHP	ENSG00000131910	"Nuclear receptor subfamily 0 group B member 2"	Q15466	1	26911489-26913966	"Disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 47.2;liver: 49.4;pancreas: 52.8"	"Cell line enriched"	"Detected in some"	32	"Hep G2: 40.9"	"Group enriched"	"Detected in many"	5	"liver cancer: 52.3;stomach cancer: 11.1"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"naive B-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in single"	6	"cerebellum: 1.9"	"Low region specificity"	"Detected in all"														"unprognostic (2.99e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.68e-3)"	"unprognostic (9.21e-2)"	"unprognostic (8.22e-2)"	"unprognostic (3.97e-2)"	"unprognostic (2.44e-2)"		"unprognostic (1.83e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.10e-2)"	0.1	7.5	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.1	11.8	0.3	0.1	32.6	0.1	0.8	0.1	0.0	18.5	16.6	0.1	0.0	9.3	49.4	2.4	0.1	0.1	0.1	0.1	52.8	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.3	0.1	3.5	0.0	47.2	0.1	0.1	5.3	8.5	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	1.0	0.6	0.0	0.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	40.9	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	1.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.1	0.1	0.2	0.1
NRARP	MGC61598	ENSG00000198435	"NOTCH regulated ankyrin repeat protein"	Q7Z6K4	9	137300482-137302251	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 41.7"	"Cell line enhanced"	"Detected in many"		"HaCaT: 23.3;HEK 293: 11.7;NTERA-2: 17.1;T-47d: 11.9;TIME: 17.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA025729	Approved		Approved	Nucleoplasm,Cytosol				Cytosol	Cytosol	"HPA025729: AB_1854633"	"unprognostic (9.92e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.17e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.42e-2)"	"unprognostic (4.73e-2)"	"unprognostic (1.33e-1)"	"prognostic unfavourable (6.73e-6)"	"unprognostic (2.85e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.28e-3)"	7.9	1.6	6.5	8.4	7.8	1.7	13.8	3.9	11.7	5.6	41.7	6.1	1.1	17.1	5.2	1.9	17.4	3.2	26.0	7.1	5.0	6.5	3.2	2.9	7.0	1.8	6.0	3.0	5.6	14.2	3.1	7.1	8.9	7.4	11.8	22.8	5.6	1.9	2.8	4.4	19.7	15.7	4.5	3.2	7.7	8.7	6.0	3.4	2.3	4.2	14.0	14.4	7.6	10.2	0.2	0.0	0.0	0.3	0.4	0.0	0.0	2.5	0.5	3.5	4.2	0.0	0.0	1.6	0.1	0.1	0.0	0.0	2.7	1.4	0.0	6.4	0.0	23.3	6.4	0.2	0.1	0.2	11.7	0.7	1.0	2.6	0.4	0.9	2.3	0.0	1.1	0.0	0.2	5.3	6.9	0.1	0.0	7.7	0.1	2.7	17.1	3.5	4.6	0.7	8.4	0.6	0.2	2.4	4.4	0.7	1.2	0.0	11.9	1.9	17.0	0.0	0.0	0.1	0.9	0.1	0.1	1.4	0.0	2.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	6.5	7.8	3.9	6.8	5.0	6.5	6.0	3.0	7.4	3.4
NT5DC3	"FLJ11266, TU12B1-TY"	ENSG00000111696	"5'-nucleotidase domain containing 3"	Q86UY8	12	103770453-103841197	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.0"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041634			Approved	Mitochondria,Cytosol	"Secreted - unknown location"			"Mitochondria, Cytosol"	"Mitochondria, Cytosol"	"HPA041634: "	"unprognostic (2.61e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.72e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (4.31e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.45e-2)"	"unprognostic (5.43e-2)"	"unprognostic (2.95e-1)"	"prognostic unfavourable (5.72e-6)"	"unprognostic (8.60e-3)"	"unprognostic (7.42e-2)"	"unprognostic (2.14e-1)"	"prognostic unfavourable (8.11e-4)"	4.2	5.4	14.8	3.2	10.5	23.9	5.4	2.7	16.2	12.2	52.0	2.9	9.4	2.0	17.9	8.4	8.9	3.5	2.6	2.2	13.3	5.7	2.2	4.0	2.8	2.3	2.8	11.7	3.8	3.5	1.8	4.2	4.5	10.4	9.8	12.5	3.7	3.9	9.1	7.0	2.8	4.2	32.9	2.1	1.9	6.6	3.5	2.7	0.0	2.9	0.9	2.4	22.4	5.2	4.1	4.9	2.4	1.6	1.5	3.3	0.8	3.2	5.9	3.4	3.9	4.9	3.8	6.4	5.4	3.2	3.8	2.5	4.0	0.9	5.5	1.1	6.4	3.8	4.8	10.7	5.6	4.1	3.9	6.9	2.2	4.7	2.7	3.6	1.8	3.4	2.4	5.0	21.6	2.2	10.8	2.8	8.6	2.9	3.2	5.9	4.2	6.4	4.4	6.0	2.1	6.1	2.2	4.6	1.9	4.6	5.1	6.4	2.9	3.5	2.9	3.8	4.6	5.2	10.8	2.5	3.1	4.1	3.6	5.6	5.5	0.8	1.5	0.1	1.7	1.6	3.3	3.5	2.4	1.4	3.8	4.1	2.1	1.8	2.4	1.5	1.0	4.9	0.6	0.8	14.8	10.5	2.7	16.2	13.3	5.7	2.8	11.7	10.4	2.7
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708837-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.0;intestine: 15.1"	"Cell line enriched"	"Detected in some"	5	"PC-3: 35.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA050299			Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.3	0.1	3.7	2.5	3.6	3.8	0.1	0.1	7.0	0.1	15.1	0.0	0.0	0.4	0.2	0.1	0.1	0.1	1.4	0.1	2.0	1.1	0.6	0.2	0.3	0.3	3.3	1.0	0.4	0.1	0.2	0.3	0.2	1.4	0.2	0.5	1.2	0.3	0.1	0.2	0.2	1.5	0.8	0.8	0.6	0.5	0.5	0.0	0.0	0.1	0.3	0.1	0.3	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	1.2	6.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	1.6	0.1	1.5	0.2	35.0	1.0	0.0	5.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.3	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.7	3.6	0.1	7.0	2.0	1.1	3.3	1.0	1.4	0.0
OAT	HOGA	ENSG00000065154	"Ornithine aminotransferase"	P04181	10	124397303-124418976	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 208.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB033576, HPA040098, HPA064742"	Enhanced		Supported	Nucleoplasm,Mitochondria				Mitochondria	Mitochondria	"CAB033576: AB_2298892, HPA040098: AB_10793955, HPA064742: AB_2685343"	"unprognostic (1.61e-2)"	"unprognostic (1.70e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (4.43e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.45e-1)"	"unprognostic (7.62e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.72e-2)"	"unprognostic (2.00e-2)"	13.5	37.1	25.9	9.1	26.7	20.3	33.8	17.2	39.8	24.7	71.9	22.8	33.9	164.0	21.6	15.5	26.1	14.9	16.0	12.7	25.6	29.8	25.6	36.8	11.6	9.3	27.9	30.1	21.8	12.3	12.1	18.0	14.8	37.8	17.9	15.8	13.3	55.2	29.1	13.7	16.3	208.5	22.5	25.5	8.4	17.3	14.6	19.4	4.9	15.9	23.1	15.2	15.5	18.2	10.2	26.5	23.0	23.6	9.6	20.1	16.3	41.4	7.5	4.9	17.6	50.3	48.5	16.8	25.1	51.3	22.5	24.7	19.2	5.4	0.0	18.3	42.4	44.2	22.5	47.0	24.5	7.3	31.2	46.4	5.3	14.3	25.9	0.0	30.6	31.7	24.3	20.2	23.6	26.1	79.8	8.9	31.3	10.7	12.2	2.6	9.8	10.6	11.4	18.8	11.2	21.5	0.6	10.3	11.0	15.8	42.1	35.3	14.0	11.4	20.1	12.8	12.0	21.2	15.6	7.6	8.0	11.2	17.7	12.5	6.1	18.6	23.6	20.7	18.5	20.7	20.1	9.6	15.6	19.4	26.5	10.2	19.6	19.1	23.0	9.6	20.8	5.7	14.4	16.3	25.9	26.7	17.2	39.8	25.6	29.8	27.9	30.1	37.8	19.4
OLFM4	"GC1, GW112, OlfD"	ENSG00000102837	"Olfactomedin 4"	Q6UX06	13	53028759-53052057	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 280.2;pancreas: 105.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 4.4;BJ hTERT+: 15.2;HaCaT: 21.3;RPMI-8226: 4.7"	"Group enriched"	"Detected in many"	14	"colorectal cancer: 711.4;pancreatic cancer: 594.7;stomach cancer: 724.0"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.4"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA077718	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytokinetic bridge,Cytosol"	"Secreted in other tissues"			"Nucleoplasm, Plasma membrane"	"Nucleoplasm, Plasma membrane"	"HPA077718: AB_2732358"	"prognostic favourable (8.77e-4)"	"unprognostic (4.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (2.33e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.74e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.84e-3)"	0.3	0.0	0.3	18.1	0.3	11.4	2.5	0.3	0.5	50.3	132.5	0.4	0.2	121.4	0.8	3.3	0.5	0.9	6.0	1.1	0.3	0.1	7.5	0.3	1.6	0.4	0.3	0.2	0.7	105.8	0.0	0.2	0.9	0.3	16.2	58.9	0.2	2.9	0.2	0.3	0.1	280.2	5.6	0.2	2.2	2.4	1.4	0.3	1.8	0.3	0.4	0.3	18.4	40.9	0.0	0.0	1.4	0.6	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.0	4.4	1.9	15.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	21.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.7	4.7	0.1	0.0	0.9	1.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.5	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.6	0.0	0.0	0.9	0.3	0.3	0.3	0.5	0.3	0.1	0.3	0.2	0.3	0.3
OMP		ENSG00000254550	"Olfactory marker protein"	P47874	11	77102840-77103331	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.4;liver: 3.9"	"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.3;BJ hTERT+ SV40 Large T+: 2.9;CACO-2: 3.6;hTEC/SVTERT24-B: 2.0"	"Low cancer specificity"	"Detected in some"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	63	"olfactory region: 119.4"																	"unprognostic (2.22e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.53e-2)"	"unprognostic (3.54e-1)"		"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.52e-3)"	"unprognostic (2.10e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.23e-1)"	"unprognostic (5.33e-3)"	"unprognostic (3.94e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.17e-2)"	0.0	0.8	0.1	0.2	0.2	1.9	0.0	0.1	0.1	0.4	3.0			5.4	0.0	0.0	1.3	0.2	2.3	0.2	0.0	0.1	0.6	3.9	0.2	0.0	0.0		0.3	0.5	0.0	0.2	0.0		0.5	3.8		0.3	0.1	0.0	0.0	5.0	0.1	0.1	0.1	1.9	0.7			0.2		0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.2	0.0	0.0	1.2	0.0	2.9	0.5	3.6	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	1.4	0.2	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.8	0.0	0.0	1.6	0.3	1.2	1.2	0.0	1.5	0.5	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ONECUT2	OC-2	ENSG00000119547	"One cut homeobox 2"	O95948	18	57435685-57491297	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.6;gallbladder: 60.7;intestine: 18.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 18.2;HeLa: 11.6;RT4: 6.2;SCLC-21H: 9.5"	"Group enriched"	"Detected in many"	7	"liver cancer: 4.3;pancreatic cancer: 4.3;stomach cancer: 5.4"	"Region enhanced"	"Detected in many"		"basal ganglia: 18.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	5	"basal ganglia: 10.6;cerebellum: 9.9;cerebral cortex: 6.6;hippocampal formation: 4.3;hypothalamus: 4.3"	HPA057058	Enhanced		Supported	"Nucleoplasm,Actin filaments"				Nucleoplasm	Nucleoplasm	"HPA057058: AB_2683323"	"unprognostic (3.02e-2)"	"unprognostic (5.36e-2)"	"unprognostic (9.06e-3)"	"unprognostic (3.79e-5)"	"unprognostic (1.13e-2)"	"unprognostic (4.48e-4)"	"unprognostic (2.10e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.56e-3)"	"unprognostic (8.66e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.34e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.21e-1)"	0.3	0.4	0.3	0.3	18.6	0.2	0.3	3.0	3.7	0.2	16.5	0.0	0.0	15.0	0.3	0.3	0.3	0.2	60.7	0.2	0.5	0.9	0.3	12.8	0.3	0.3	0.5	0.9	0.3	4.3	3.2	5.1	0.2	1.1	0.3	0.3	0.7	0.3	0.3	0.3	0.3	18.0	0.3	0.3	0.3	0.5	0.6	6.6	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	1.1	2.9	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	3.2	0.0	0.1	18.2	2.9	0.7	11.6	2.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	3.5	0.6	0.0	0.4	1.7	0.0	0.1	0.7	0.0	1.1	0.0	1.6	6.2	9.5	1.6	0.1	0.0	0.2	0.4	0.6	0.0	1.0	1.2	0.2	0.2	0.3	2.7	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.6	3.0	3.7	0.5	0.9	0.5	0.9	1.1	6.6
OR8S1		ENSG00000284723	"Olfactory receptor family 8 subfamily S member 1"	Q8NH09	12	48525632-48528103	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"intestine: 1.2;ovary: 1.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;CAPAN-2: 1.5"									"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA045595	Uncertain		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA045595: AB_10964447"																		0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			1.2	0.1	0.0	0.0	0.0	0.5	0.0			0.0	0.0	0.0	0.0			1.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.7			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
PANK3	FLJ12899	ENSG00000120137	"Pantothenate kinase 3"	Q9H999	5	168548495-168579600	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 63.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062358			Approved	"Nucleoplasm,Golgi apparatus"				Nucleoplasm	Nucleoplasm	"HPA062358: AB_2684746"	"unprognostic (1.24e-2)"	"unprognostic (5.71e-2)"	"prognostic favourable (3.94e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.47e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.20e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.48e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.97e-3)"	"unprognostic (2.01e-1)"	9.1	16.6	11.6	17.5	10.4	10.5	17.6	22.8	11.9	8.9	23.9	9.0	8.5	28.0	10.2	8.8	12.8	7.8	6.9	7.4	11.7	9.1	13.2	39.2	12.5	8.2	8.4	7.5	10.7	8.8	14.6	11.2	9.4	10.8	9.1	17.9	6.7	11.0	9.6	8.2	11.9	63.0	8.0	10.3	9.6	10.9	10.2	11.0	10.2	10.5	13.4	8.2	9.9	11.6	4.1	2.7	3.5	4.7	0.9	2.5	1.1	13.8	7.8	32.3	17.2	12.1	14.1	13.7	8.3	8.9	11.2	16.5	12.9	12.9	21.3	13.7	11.7	10.0	21.6	16.7	20.1	19.8	10.5	10.9	7.4	9.5	14.1	14.7	14.8	11.2	22.6	14.0	15.8	13.1	10.0	21.6	15.2	7.7	14.6	6.7	13.8	5.7	10.7	22.1	8.7	14.0	20.5	15.1	32.3	9.6	15.8	23.6	20.6	18.6	13.4	15.1	21.2	8.9	17.7	15.1	20.7	15.9	8.9	15.0	11.7	3.5	3.2	1.6	1.9	3.8	2.5	4.1	1.9	1.9	2.0	1.6	1.3	2.3	1.3	0.9	4.7	2.7	2.4	1.1	11.6	10.4	22.8	11.8	11.7	9.1	8.4	7.5	10.8	11.0
PARP15	"FLJ40597, pART7"	ENSG00000173200	"Poly(ADP-ribose) polymerase family member 15"	Q460N3	3	122577602-122639047	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.9;lymphoid tissue: 40.4"	"Cell line enhanced"	"Detected in some"		"HEL: 10.7;REH: 5.0;THP-1: 5.1;TIME: 12.7"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"gdTCR: 9.3;MAIT T-cell: 6.5;memory B-cell: 11.2;memory CD4 T-cell: 5.0;memory CD8 T-cell: 6.4;naive B-cell: 11.9;naive CD4 T-cell: 4.3;naive CD8 T-cell: 5.9;NK-cell: 5.2;T-reg: 4.5"	"Group enriched"	"Detected in many"	6	"B-cells: 11.9;NK-cells: 5.2;T-cells: 9.3"					"Low region specificity"	"Detected in many"			HPA035757			Approved	Mitochondria	"Intracellular and membrane"			Mitochondria	Mitochondria	"HPA035757: AB_10669656"	"unprognostic (8.19e-3)"	"unprognostic (2.88e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (9.01e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.61e-1)"	"unprognostic (9.63e-2)"	"unprognostic (9.24e-7)"	"unprognostic (9.03e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.22e-2)"	2.4	0.9	0.5	24.5	0.4	9.8	1.3	0.3	0.8	1.2	2.8	1.2	0.5	1.0	1.5	2.3	1.9	1.4	2.8	1.5	0.6	0.5	1.5	1.9	5.6	20.3	0.6	0.6	1.1	2.7	0.0	1.0	1.0	0.6	1.3	2.1	1.8	5.5	0.2	2.6	0.7	22.9	0.9	0.9	40.4	1.7	1.7	0.4	9.4	1.9	1.7	34.8	3.6	1.2	11.9	1.2	1.3	0.6	5.2	9.3	2.7	0.6	0.2	0.5	0.5	0.2	0.3	0.6	0.3	0.2	0.1	0.1	0.3	1.0	0.8	0.6	0.2	0.6	0.1	0.0	0.0	1.9	0.2	10.7	0.8	0.5	0.2	0.7	0.5	2.2	0.1	0.4	0.2	2.4	0.3	2.1	0.0	0.5	3.2	0.7	0.7	0.3	5.0	0.4	0.6	0.0	1.0	0.8	0.5	0.3	0.2	0.3	0.8	5.1	12.7	0.4	1.1	0.5	0.4	1.0	0.7	2.4	0.7	0.3	0.2	1.3	0.2	0.1	9.3	0.5	6.5	11.2	5.0	6.4	0.9	11.9	4.3	5.9	0.7	5.2	0.6	1.2	4.5	2.7	0.5	0.4	0.3	0.8	0.6	0.5	0.6	0.6	0.6	0.4
PBLD	"FLJ14767, MAWBP, MAWDBP"	ENSG00000108187	"Phenazine biosynthesis like protein domain containing"	P30039	10	68282660-68333049	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 47.3;kidney: 74.5;liver: 91.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA038035, HPA038036"	Enhanced		Approved	Vesicles		420000	420000	Vesicles	Vesicles	"HPA038035: AB_10672470, HPA038036: AB_10675625"	"unprognostic (1.00e-1)"	"unprognostic (8.30e-2)"	"unprognostic (6.14e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.78e-1)"	"prognostic favourable (1.44e-4)"	"unprognostic (8.25e-2)"	"unprognostic (3.62e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.26e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.07e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.68e-2)"	5.0	5.9	3.6	2.4	6.4	2.5	2.9	2.3	8.0	4.1	9.4	11.8	6.8	47.3	4.5	5.1	1.5	2.3	2.9	3.3	3.9	3.1	74.5	91.4	2.3	2.8	6.7	5.6	2.3	17.9	2.4	2.4	7.0	8.4	2.6	8.0	9.4	2.2	6.2	2.3	1.8	39.3	6.5	4.9	1.6	15.0	2.1	6.2	2.5	1.9	4.3	1.6	4.1	1.6	1.7	5.6	6.4	5.8	3.3	2.3	2.5	3.4	6.9	6.7	4.6	6.1	3.5	3.1	13.9	8.8	5.3	5.5	6.2	8.8	3.9	5.4	9.6	5.3	3.1	3.6	4.6	1.8	5.0	3.1	7.5	5.6	3.0	4.5	3.1	6.2	4.3	3.2	4.0	3.2	2.7	8.6	8.3	5.3	4.1	7.9	1.9	3.0	7.2	8.8	6.3	10.6	5.0	3.9	5.2	9.3	5.4	6.3	18.7	5.4	10.0	5.3	3.8	2.5	2.2	5.2	3.7	5.7	6.3	2.5	1.3	4.2	5.8	2.9	0.9	2.9	1.8	1.7	1.4	0.9	5.6	1.6	2.3	1.6	6.4	3.3	1.7	2.4	2.3	2.5	3.6	6.4	2.3	8.0	3.9	3.1	6.7	5.6	8.4	6.2
PDSS1	"COQ1, TPRT, TPT"	ENSG00000148459	"Decaprenyl diphosphate synthase subunit 1"	Q5T2R2	10	26697659-26746798	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 22.4;lymphoid tissue: 31.8"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038032, HPA042741"	Uncertain		Approved	Cytosol				Cytosol	Cytosol	"HPA038032: AB_10670650, HPA042741: AB_2678139"	"unprognostic (1.41e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (6.79e-3)"	"unprognostic (5.43e-2)"	"prognostic unfavourable (1.25e-5)"	"unprognostic (2.47e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.99e-3)"	"unprognostic (2.93e-3)"	"unprognostic (8.85e-2)"	"unprognostic (9.83e-2)"	"unprognostic (6.36e-2)"	3.1	2.6	2.4	7.0	3.1	5.6	3.5	5.6	5.1	3.1	18.2	1.5	1.2	20.6	3.8	2.1	8.3	3.4	3.7	4.2	2.2	2.2	8.6	7.2	4.0	7.8	2.1	2.3	2.8	3.8	1.7	2.5	2.8	2.9	2.3	17.0	3.2	3.5	1.8	10.4	2.7	22.4	3.6	3.1	5.7	3.8	3.0	1.6	31.8	2.1	4.7	5.0	2.9	4.0	3.2	5.2	0.9	5.3	0.8	3.4	1.3	7.5	5.9	4.5	8.2	1.5	2.8	6.2	7.0	1.8	10.2	7.0	9.0	4.2	17.3	3.7	3.4	9.6	14.3	10.7	8.7	7.2	12.0	14.9	5.1	6.5	2.2	9.9	5.9	3.5	4.6	9.5	2.5	5.3	13.7	4.6	7.1	11.9	31.2	7.0	9.0	5.7	14.5	12.9	12.5	6.0	3.6	13.2	8.1	6.8	14.0	7.6	4.9	11.6	3.4	5.7	9.1	11.7	11.1	1.8	6.7	12.6	5.6	25.2	4.4	0.0	5.3	0.9	0.9	4.1	2.1	0.5	1.8	1.3	5.2	3.2	3.4	1.5	0.3	0.8	2.1	1.4	0.1	1.3	2.4	3.1	5.6	5.1	2.2	2.2	2.1	2.3	2.9	1.6
PDZD3	"FLJ22756, IKEPP, PDZK2"	ENSG00000172367	"PDZ domain containing 3"	Q86UT5	11	119185457-119190223	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 12.8;intestine: 44.2;kidney: 12.5"	"Cell line enriched"	"Detected in some"	4	"CACO-2: 4.3"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077887	Enhanced									"HPA077887: "	"unprognostic (2.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.65e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.07e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.58e-3)"	"unprognostic (9.00e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.38e-1)"	"unprognostic (3.41e-3)"	0.9	0.0	0.1	5.8	0.1	0.0	0.1	0.1	0.1	0.1	24.9	0.0	0.0	15.1	0.0	2.6	0.1	0.8	12.8	0.3	0.0	0.0	12.5	0.5	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	5.5	0.0	0.1	0.0	0.1	0.1	44.2	0.0	0.0	0.1	2.5	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0
PDZD7	"bA108L7.8, DFNB57, FLJ23209, PDZK7"	ENSG00000186862	"PDZ domain containing 7"	Q9H5P4	10	101007683-101032295	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 17.7;intestine: 25.3"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 11.9;THP-1: 17.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"neutrophil: 6.9"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							HPA074542			Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA074542: "	"unprognostic (1.46e-1)"	"unprognostic (2.85e-3)"	"unprognostic (3.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.38e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.87e-3)"	"unprognostic (3.54e-3)"	"unprognostic (3.89e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.80e-1)"	2.4	2.3	7.0	1.7	10.7	2.4	0.9	15.9	11.6	0.8	3.4	2.4	0.0	17.4	2.5	1.9	1.0	1.1	3.0	1.2	6.3	7.8	2.2	0.7	1.9	1.6	12.5	8.3	1.4	1.7	3.8	6.2	1.8	17.7	1.5	0.7	1.1	2.1	1.2	1.4	3.8	25.3	2.0	9.1	2.6	1.9	2.1	4.8	0.0	2.2	0.0	0.6	1.3	1.0	1.3	0.7	6.9	2.1	2.3	1.5	0.6	7.3	1.0	0.5	0.8	0.9	0.2	2.5	1.3	0.7	0.0	0.4	1.7	1.9	3.6	3.5	0.3	2.3	0.2	0.7	0.0	1.0	2.4	0.2	3.5	2.3	0.6	0.6	3.3	0.4	0.3	0.2	0.2	0.3	0.6	0.9	0.1	1.8	0.5	1.4	0.6	2.6	1.6	1.0	0.4	1.8	0.8	11.9	5.5	0.8	0.4	1.2	2.5	17.4	0.5	1.2	2.6	1.4	1.1	1.5	0.1	0.3	6.5	1.3	0.7	2.9	2.1	1.5	1.0	1.3	1.0	1.1	0.9	1.3	0.4	1.3	1.5	0.8	6.9	2.3	0.8	0.7	0.6	0.6	7.0	10.7	15.9	11.6	6.3	7.8	12.5	8.3	17.7	4.8
PDZK1	"NHERF3, PDZD1"	ENSG00000174827	"PDZ domain containing 1"	Q5T2W1	1	145670852-145708148	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 49.2;kidney: 124.3"	"Group enriched"	"Detected in some"	4	"RPTEC TERT1: 42.1;T-47d: 109.4"	"Group enriched"	"Detected in many"	12	"breast cancer: 8.9;liver cancer: 27.6;renal cancer: 44.3"	"Region enriched"	"Detected in single"	17	"cerebellum: 10.0"	"Cell type enriched"	"Detected in many"	4	"NK-cell: 7.6"	"Lineage enriched"	"Detected in many"	4	"NK-cells: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA005755, HPA006155, CAB008971"	Enhanced		Approved	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"CAB008971: , HPA005755: AB_1855164, HPA006155: AB_1855163"	"unprognostic (4.56e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.79e-2)"	"unprognostic (4.41e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.34e-2)"	"unprognostic (9.87e-3)"	"prognostic favourable (2.54e-7)"	"unprognostic (9.90e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.87e-2)"	0.1	0.6	0.2	0.2	0.3	0.0	5.8	10.0	0.2	0.3	16.5	0.2	0.8	13.2	0.3	6.7	0.1	0.1	10.6	0.1	0.2	0.2	124.3	25.7	0.4	0.1	0.3	0.2	0.2	4.2	0.0	0.1	0.9	0.5	0.1	1.3	1.2	0.1	0.1	0.1	0.7	49.2	0.1	0.4	0.2	0.4	0.3	0.1	0.2	0.1	0.1	0.1	0.1	0.1	1.0	1.1	0.5	0.2	7.6	1.8	0.5	1.2	0.2	0.1	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.1	18.5	0.1	0.1	0.2	1.1	0.5	0.0	0.0	0.1	1.7	0.3	0.1	0.4	7.6	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.1	0.2	0.2	0.5	0.0	1.2	0.2	42.1	0.0	0.1	1.2	0.2	0.3	0.0	109.4	0.1	0.1	0.2	0.2	0.1	0.1	1.5	0.1	0.1	0.1	0.1	0.0	0.5	0.2	0.1	1.5	0.2	0.6	1.0	0.4	1.8	0.2	1.0	0.4	0.7	0.4	7.6	0.1	1.1	0.1	0.5	0.2	0.3	10.0	0.2	0.2	0.2	0.3	0.2	0.5	0.1
PEPD		ENSG00000124299	"Peptidase D"	P12955	19	33386950-33521794	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 92.9;kidney: 106.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015599, HPA072045"	Enhanced		Approved	Nucleoplasm		1000000000	1000000000	Nucleoplasm	Nucleoplasm	"HPA015599: AB_1855192, HPA072045: AB_2732194"	"unprognostic (1.39e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.96e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.99e-1)"	"prognostic favourable (6.50e-9)"	"unprognostic (4.38e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	23.5	17.2	9.8	8.9	10.4	4.1	21.8	7.6	14.9	9.8	60.1	18.7	6.9	58.1	14.3	11.5	14.9	9.6	13.6	8.0	10.8	9.1	106.0	48.6	11.1	10.6	16.0	7.7	12.6	9.0	9.6	12.5	10.4	13.0	9.2	6.6	13.3	9.6	9.0	9.7	11.4	92.9	10.4	17.4	13.4	9.3	8.4	11.5	8.4	15.0	9.7	10.6	11.9	11.9	17.1	32.3	27.5	39.1	16.8	25.8	32.6	13.2	35.9	10.6	17.0	45.2	17.4	24.5	11.7	24.1	15.0	17.1	31.2	11.6	5.4	17.6	29.5	3.4	15.2	9.6	12.4	15.2	15.0	34.3	7.3	31.7	30.9	9.9	41.6	21.4	9.1	13.7	8.5	20.0	6.5	15.6	16.3	16.1	7.6	3.3	14.6	14.6	15.0	14.4	14.9	13.0	34.9	13.0	33.4	21.9	10.8	17.7	7.5	10.8	16.7	14.5	15.7	18.8	13.6	14.3	21.2	4.7	15.5	14.4	20.6	27.5	36.1	2.5	25.8	39.1	22.6	17.1	25.7	23.8	32.3	16.3	16.9	19.6	1.9	16.8	27.2	9.9	23.6	32.6	9.8	10.4	7.6	14.9	10.8	9.1	16.0	7.7	13.0	11.5
PHLPP2	"KIAA0931, PHLPPL, PPM3B"	ENSG00000040199	"PH domain and leucine rich repeat protein phosphatase 2"	Q6ZVD8	16	71637835-71724701	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 29.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048598	Approved		Approved	Vesicles				Vesicles	Vesicles	"HPA048598: AB_2680459"	"unprognostic (5.67e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.29e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.97e-4)"	"unprognostic (3.08e-2)"	"unprognostic (8.85e-3)"	"unprognostic (6.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (8.46e-3)"	"unprognostic (8.27e-2)"	6.4	4.7	12.5	7.0	10.9	8.1	8.4	17.4	14.9	4.4	16.6	4.6	4.3	15.8	5.8	4.9	2.7	4.7	4.1	4.6	11.7	9.0	5.4	4.9	4.8	5.0	6.2	14.9	7.2	4.9	10.2	7.3	4.3	12.6	4.7	17.8	13.2	2.9	5.7	5.3	3.0	29.9	7.0	7.6	3.9	4.2	10.8	4.7	1.0	9.9	1.1	4.9	4.7	9.8	2.4	2.2	1.2	0.7	3.5	1.5	0.4	4.8	6.4	7.0	7.8	5.6	6.8	4.0	7.3	6.6	10.6	8.6	5.9	1.6	9.6	2.9	12.0	10.3	10.1	3.7	13.7	3.4	5.5	2.7	5.5	3.8	4.4	2.3	4.2	5.0	2.2	15.0	4.9	3.9	2.4	2.6	7.3	10.2	3.1	1.8	5.5	1.7	5.1	6.2	3.1	5.0	3.7	6.1	3.2	15.7	4.3	2.5	5.3	1.3	5.4	10.7	7.7	4.5	6.0	6.1	4.2	10.0	6.6	1.9	2.3	0.8	0.5	0.2	1.0	0.7	0.9	2.4	0.8	1.5	0.6	1.6	1.1	0.9	1.2	3.5	0.7	2.2	1.3	0.4	12.5	10.9	17.4	14.9	11.7	9.0	6.2	14.9	12.6	4.7
PI4K2B	"FLJ11105, PI4KIIB, PIK42B"	ENSG00000038210	"Phosphatidylinositol 4-kinase type 2 beta"	Q8TCG2	4	25233975-25279092	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 49.3"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA004099	Approved		Supported	Cytosol				Cytosol	Cytosol	"HPA004099: AB_1855353"	"unprognostic (1.02e-1)"	"unprognostic (6.34e-3)"	"prognostic favourable (9.64e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.68e-2)"	"unprognostic (7.54e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.06e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.32e-1)"	"unprognostic (9.07e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.39e-2)"	"unprognostic (2.02e-2)"	"unprognostic (4.47e-2)"	9.2	7.1	3.4	13.6	2.9	3.9	8.0	3.2	2.3	8.7	48.4	4.1	11.3	19.4	7.4	8.0	13.5	4.9	9.5	4.2	3.1	2.7	12.9	38.6	14.3	9.4	3.5	2.3	6.9	10.5	4.2	5.7	7.7	2.9	6.4	9.8	3.3	22.6	12.0	4.4	8.6	49.3	6.9	4.5	13.8	11.3	8.0	2.7	18.6	16.2	12.9	14.1	7.8	10.3	1.4	1.8	1.5	1.0	0.4	4.1	0.4	11.3	2.0	4.8	5.1	6.5	12.1	11.8	17.1	16.1	15.0	19.2	3.6	12.2	29.4	3.9	12.9	4.7	10.9	8.6	14.9	8.9	3.8	9.4	5.1	9.1	6.2	18.9	7.3	8.1	7.8	5.6	5.9	10.1	6.2	24.7	14.5	4.4	18.2	16.9	8.4	4.6	11.0	18.9	17.1	13.2	8.1	10.1	2.2	8.7	6.9	3.5	9.8	11.0	10.4	10.7	2.7	6.5	11.0	28.4	13.5	22.4	12.5	16.1	10.8	1.5	0.4	0.0	1.3	1.0	0.9	1.4	1.5	1.2	0.3	1.0	1.4	1.3	0.2	0.4	0.9	1.8	4.1	0.4	3.4	2.9	3.2	2.3	3.1	2.7	3.5	2.3	2.9	2.7
PIGR		ENSG00000162896	"Polymeric immunoglobulin receptor"	P01833	1	206928518-206946466	"Cancer-related genes, Plasma proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 139.0;intestine: 320.1;salivary gland: 398.1"	"Cell line enriched"	"Detected in some"	5	"EFO-21: 28.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 731.7"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA006154, CAB009454, HPA012012"	Enhanced				"Intracellular and membrane"	1900000000	1900000000			"CAB009454: AB_2164819, HPA006154: AB_1855370, HPA012012: AB_1855371"	"prognostic favourable (1.22e-5)"	"unprognostic (7.42e-2)"	"unprognostic (4.78e-3)"	"prognostic favourable (2.57e-4)"	"unprognostic (2.31e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.07e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.13e-1)"	"prognostic favourable (5.08e-5)"	"unprognostic (1.83e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.92e-3)"	"unprognostic (3.39e-2)"	0.3	0.3	0.3	74.2	0.3	0.0	6.9	0.3	0.3	35.1	232.8	0.6	0.4	158.9	2.6	0.5	2.6	0.7	139.0	0.3	0.3	0.3	52.5	5.0	25.1	0.3	0.3	0.3	0.6	4.2	0.0	0.9	0.4	0.3	3.0	75.6	0.4	398.1	0.6	0.4	0.4	320.1	2.0	0.3	0.4	25.3	0.6	0.3	0.4	0.4	23.9	22.5	4.9	0.6	3.4	1.1	1.4	0.5	0.5	0.5	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	28.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	1.4	0.2	0.0	0.2	0.0	4.9	0.1	1.3	0.6	2.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.0	0.2	0.4	0.2	0.3	1.0	0.0	0.1	0.0	1.4	0.5	0.3	0.4	0.2	0.5	3.4	0.3	0.3	1.1	3.4	0.5	0.5	1.4	0.5	0.3	0.9	0.2	0.2	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3
PIGZ	"FLJ12768, MGC52163, SMP3"	ENSG00000119227	"Phosphatidylinositol glycan anchor biosynthesis class Z"	Q86VD9	3	196946343-196969060	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.3"	"Group enriched"	"Detected in many"	8	"dendritic cells: 1.6;granulocytes: 1.4;monocytes: 3.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA058599, HPA059920"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA058599: AB_2683771, HPA059920: AB_2684162"	"unprognostic (1.46e-1)"	"unprognostic (3.18e-3)"	"unprognostic (1.06e-2)"	"unprognostic (3.31e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.25e-3)"	"unprognostic (4.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavourable (5.60e-5)"	"unprognostic (1.02e-1)"	"unprognostic (3.93e-2)"	"unprognostic (8.38e-5)"	"unprognostic (5.02e-3)"	6.6	3.1	5.7	5.3	8.6	1.9	3.4	18.5	16.3	3.3	26.5	3.2	2.0	2.9	2.3	1.7	3.2	2.8	4.5	6.4	5.3	7.5	1.6	1.6	3.1	2.0	4.4	6.4	0.8	5.9	2.7	2.9	2.1	10.8	4.6	24.5	4.3	4.7	4.6	10.0	4.5	7.4	5.3	2.8	1.8	3.1	1.4	3.0	3.2	1.7	2.8	2.1	9.9	2.9	0.1	1.6	1.4	3.3	0.0	0.2	0.3	2.0	1.4	0.8	3.3	9.1	4.4	0.8	3.0	8.5	2.3	1.9	1.9	1.7	0.3	6.0	6.7	3.4	0.2	0.4	0.6	0.6	0.4	0.9	0.7	7.3	4.3	0.0	3.4	4.4	6.5	0.3	1.1	2.8	0.2	2.6	2.2	3.6	0.3	1.7	0.1	1.1	0.5	0.1	0.6	3.5	3.8	1.3	1.5	4.2	0.3	1.6	8.4	2.9	6.9	1.9	0.5	5.5	1.0	1.2	0.2	0.1	0.4	1.2	0.7	0.0	1.1	0.8	0.2	3.3	0.0	0.0	0.0	0.0	1.6	0.1	0.0	0.1	1.4	0.0	1.4	0.3	0.0	0.3	5.7	8.6	18.5	16.3	5.3	7.5	4.4	6.4	10.8	3.0
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822475-10838445	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.3;brain: 24.8;intestine: 7.5"	"Cell line enhanced"	"Detected in single"		"HMC-1: 1.4"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042337	Uncertain		Uncertain	"Plasma membrane,Cytosol"				Cytosol	Cytosol	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.4	7.3	9.9	3.2	14.0	0.3	0.3	5.6	5.2	0.4	6.3	10.8	0.0	2.9	0.4	0.4	0.8	0.9	0.7	0.3	13.1	11.6	0.3	0.3	0.4	0.3	12.5	2.3	0.4	0.3	0.3	0.1	0.3	24.8	0.4	7.5	0.0	0.4	0.4	0.4	0.4	5.2	2.5	19.9	0.3	4.9	0.5	12.8	0.0	0.3	0.0	0.3	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	14.0	5.6	5.2	13.1	11.6	12.5	2.3	24.8	12.8
PKLR		ENSG00000143627	"Pyruvate kinase L/R"	P30613	1	155289293-155301434	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 17.2;kidney: 12.4;liver: 47.8"	"Cell line enriched"	"Detected in some"	9	"K-562: 47.4"	"Cancer enriched"	"Detected in some"	9	"liver cancer: 56.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.7"	"Low region specificity"	"Detected in some"			"HPA006653, CAB034376, CAB034378"	Enhanced		Approved	"Golgi apparatus,Cytosol"		2900000	2900000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"CAB034376: AB_2163671, CAB034378: AB_2252321, HPA006653: AB_2667632"	"unprognostic (9.16e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.86e-4)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.07e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.21e-3)"	0.1	0.0	0.1	0.3	0.1	7.2	0.1	0.9	0.2	0.1	4.9	0.1	0.1	5.8	0.1	1.3	0.1	0.0	0.7	0.1	0.1	0.4	12.4	47.8	0.5	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.6	17.2	0.1	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.2	0.1	0.4	0.1	0.1	0.1	0.1
PLA2G10	GXPLA2	ENSG00000069764	"Phospholipase A2 group X"	O15496	16	14672545-14694669	"Enzymes, Predicted secreted proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;stomach 1: 13.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;CAPAN-2: 4.5;SK-BR-3: 2.8;U-266/84: 2.3"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA041893	Uncertain				"Secreted in other tissues"					"HPA041893: AB_10794495"	"unprognostic (8.44e-3)"	"unprognostic (2.37e-1)"	"unprognostic (6.72e-2)"	"prognostic favourable (5.74e-5)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.81e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.30e-2)"	"unprognostic (9.97e-3)"	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.3	9.4			2.4	0.0	0.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0		0.0	4.2	0.0	0.0	0.0		0.2	7.2		0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	13.0	2.1			0.0		0.0	2.8	0.0	0.9	0.5	2.0	0.5	0.1	0.4	0.1	0.1	1.0	0.1	0.2	0.0	0.1	2.7	0.2	0.0	0.0	0.0	0.7	4.5	0.4	0.5	0.0	2.2	0.0	0.0	0.0	0.2	0.1	0.4	0.4	0.0	0.1	0.8	0.9	0.0	0.1	0.0	0.1	0.0	0.2	0.7	0.0	2.1	0.4	0.3	0.4	0.1	0.8	0.3	0.2	0.0	0.3	0.6	0.5	1.1	2.8	0.4	0.5	0.4	0.9	0.0	0.3	0.1	0.0	0.8	2.3	0.7	0.7	0.1	0.1	0.1	0.5	0.5	0.3	0.4	0.3	0.1	0.2	0.4	0.5	0.9	0.3	0.3	2.0	0.1	0.3	0.3	0.1	0.1										
PLA2G2C		ENSG00000187980	"Phospholipase A2 group IIC"	Q5R387	1	20161253-20177424	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;intestine: 4.7"	"Group enriched"	"Detected in some"	5	"HL-60: 4.4;NB-4: 1.4;SK-BR-3: 1.2;U-698: 4.9;U-937: 4.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Secreted - unknown location"						"unprognostic (3.02e-3)"	"unprognostic (2.75e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.00e-4)"	"unprognostic (9.44e-3)"	"unprognostic (6.55e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (8.16e-2)"	0.1	0.1	0.3	0.0	0.3	1.0	0.1	0.2	0.2	0.1	4.7			0.4	0.9	0.3	4.2	0.2	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.3	0.4		0.3	0.0	0.4	0.1	0.0		1.0	0.7		0.2	0.7	0.5	1.2	0.8	0.0	0.2	0.1	1.1	0.9			0.1		0.0	0.9	0.1	0.7	2.4	2.3	1.4	1.3	1.4	0.5	0.2	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.1	0.3	0.3	0.0	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.1	0.7	1.4	0.4	0.1	0.2	0.2	0.4	0.1	0.3	0.2	0.1	0.4	1.2	0.1	0.3	0.1	0.2	0.6	0.2	0.2	0.2	0.2	0.1	4.9	0.4	4.7	0.1	2.3	1.4	0.5	0.7	0.5	1.4	0.6	0.7	0.9	2.4	0.7	0.6	0.5	2.3	1.3	0.4	0.8	0.3	0.5										
PLAC8	"C15, onzin"	ENSG00000145287	"Placenta specific 8"	Q9NZF1	4	83090048-83137075	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 181.6;intestine: 66.5;lymphoid tissue: 74.8"	"Cell line enhanced"	"Detected in many"		"A-431: 31.5;CAPAN-2: 91.0;HL-60: 56.4;NB-4: 27.7;RPMI-8226: 40.7;THP-1: 32.8;U-937: 26.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 181.6"	"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA040465, HPA077912"	Enhanced		Approved	Cytosol				Cytosol	Cytosol	"HPA040465: AB_10794875, HPA077912: AB_2686870"	"unprognostic (6.82e-5)"	"prognostic favourable (3.03e-4)"	"unprognostic (3.29e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (7.44e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-7)"	"unprognostic (3.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.12e-1)"	2.3	1.3	1.7	47.9	5.9	62.0	1.6	0.7	4.1	6.1	44.1	0.6	0.2	14.6	1.0	0.9	34.5	3.1	7.5	2.4	1.4	1.9	1.6	12.4	23.4	51.6	2.5	0.2	1.9	1.2	0.0	1.3	32.3	3.0	2.0	31.4	1.3	9.7	1.0	0.8	0.7	66.5	3.1	5.2	74.8	21.8	0.7	2.7	18.2	1.5	1.4	53.1	3.4	2.5	41.5	181.6	7.0	47.8	77.6	32.9	36.0	31.5	0.2	0.1	0.2	0.0	0.0	5.2	0.8	0.2	2.0	2.4	0.6	91.0	5.3	0.2	9.2	3.3	0.5	0.2	7.5	0.0	0.1	0.1	6.3	2.6	0.3	56.4	0.3	0.1	0.6	0.3	0.4	0.1	0.0	0.4	5.2	0.1	10.7	27.7	0.1	0.1	1.4	1.9	40.7	0.1	0.9	4.6	0.0	0.2	5.2	0.1	0.3	32.8	0.2	0.2	5.9	0.1	0.1	0.3	0.0	14.1	0.4	26.0	0.0	2.7	11.0	7.0	32.9	47.8	24.9	41.5	15.7	18.7	10.0	38.4	19.4	22.0	2.4	77.6	25.8	181.6	1.0	36.0	1.7	5.9	0.7	4.1	1.4	1.9	2.5	0.2	3.0	2.7
PLEKHG6	"FLJ10665, MYOGEF"	ENSG00000008323	"Pleckstrin homology and RhoGEF domain containing G6"	Q3KR16	12	6310436-6328506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 43.4;placenta: 39.6"	"Cell line enhanced"	"Detected in some"		"BEWO: 55.6;CACO-2: 17.6;CAPAN-2: 9.7;RT4: 18.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"neutrophil: 2.5;plasmacytoid DC: 3.9"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.9;granulocytes: 2.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA041459, HPA058230"	Uncertain		Supported	"Cell Junctions,Centrosome"				"Cell Junctions"	"Cell Junctions"	"HPA041459: AB_10794518, HPA058230: AB_2683645"	"unprognostic (1.67e-1)"	"unprognostic (9.93e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.03e-3)"	"unprognostic (5.84e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.18e-2)"	"unprognostic (5.73e-2)"	7.5	0.2	0.3	8.9	0.7	1.0	15.8	0.3	0.4	4.4	30.3	0.4	1.1	19.4	0.6	1.6	19.9	0.5	6.7	1.2	0.3	0.0	1.1	2.5	1.8	0.3	0.3	0.3	0.6	4.5	1.9	3.3	39.6	0.5	2.6	9.6	0.7	8.8	2.3	0.3	6.7	43.4	0.5	0.3	0.4	5.7	0.5	0.3	0.5	3.4	11.3	8.6	6.8	8.6	0.3	3.9	2.5	0.2	0.1	0.4	0.1	0.2	2.1	0.2	0.0	1.1	0.1	55.6	0.1	0.0	0.1	0.1	17.6	9.7	0.1	0.1	0.0	4.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	3.5	0.2	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	2.7	0.0	0.2	4.6	0.3	0.0	0.0	0.1	0.0	18.7	0.1	0.0	0.4	8.3	0.1	2.7	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.6	0.2	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.1	0.4	2.5	0.1	0.1	3.9	0.1	0.1	0.3	0.7	0.3	0.4	0.3	0.0	0.3	0.3	0.5	0.3
PLEKHS1	"bA211N11.2, C10orf81, FLJ23537"	ENSG00000148735	"Pleckstrin homology domain containing S1"	Q5SXH7	10	113751454-113783429	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix, uterine: 26.8;intestine: 38.8;pancreas: 26.6;salivary gland: 53.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.1;RH-30: 4.3;RT4: 16.9;T-47d: 5.8;U-266/70: 3.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA037583			Approved	Vesicles,Centrosome				Centrosome	Centrosome	"HPA037583: "	"unprognostic (2.64e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.74e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.36e-2)"	"unprognostic (8.43e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.21e-2)"	"unprognostic (0.00e+0)"	"unprognostic (4.00e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.27e-1)"	"prognostic favourable (1.03e-4)"	0.2	0.1	0.2	1.6	0.2	0.0	11.7	0.2	0.2	26.8	18.5	0.2	10.2	17.0	1.0	2.2	0.8	3.4	6.4	0.2	0.2	0.1	0.6	0.2	4.8	0.2	0.2	0.2	1.3	26.6	0.0	1.9	0.3	0.3	3.5	1.8	0.4	53.1	4.9	0.2	0.7	38.8	0.2	0.2	0.2	2.9	1.1	0.2	0.2	0.2	1.3	2.0	0.8	0.2	0.8	0.5	1.3	0.3	0.7	0.3	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.2	0.1	0.3	0.1	0.3	0.2	9.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.0	0.1	4.3	0.1	1.4	16.9	0.1	0.2	0.1	1.4	0.1	5.8	0.0	0.0	0.3	0.1	0.0	0.3	3.4	0.1	0.0	0.0	0.0	2.0	0.8	0.1	0.2	0.3	0.1	0.1	0.8	0.2	0.2	0.0	0.5	0.2	0.3	1.3	0.7	0.3	0.5	0.1	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.3	0.2
PLSCR5		ENSG00000231213	"Phospholipid scramblase family member 5"	A0PG75	3	146576555-146606216	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 1.8;intestine: 1.8;parathyroid gland: 5.6"	"Cell line enhanced"	"Detected in single"		"HSkMC: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA047249	Uncertain									"HPA047249: AB_2679997"																		0.1	0.0	0.5	0.1	1.8	0.0	0.1	0.1	0.3	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.4	0.1	0.1	0.1	5.6	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	1.8	0.1	0.1	0.1	0.0	0.6	0.1	0.1	1.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.1	0.3	0.1	0.5	0.4	0.1	0.1	0.1
POF1B	"FLJ22792, POF"	ENSG00000124429	"POF1B, actin binding protein"	Q8WVV4	X	85277396-85379743	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 55.8;skin 1: 55.6"	"Cell line enhanced"	"Detected in some"		"A549: 11.0;CAPAN-2: 11.3;HaCaT: 11.5;RT4: 38.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 44.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.0;naive B-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"B-cells: 6.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA002033, HPA050027"	Approved		Supported	"Nucleoplasm,Golgi apparatus"		430000	430000	"Golgi apparatus"	"Golgi apparatus"	"HPA002033: AB_1079650, HPA050027: "	"unprognostic (2.23e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.54e-3)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.97e-1)"	"unprognostic (3.39e-2)"	"prognostic unfavourable (2.03e-4)"	"unprognostic (1.86e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.57e-4)"	"unprognostic (1.01e-2)"	0.5	0.4	0.3	9.9	0.3	0.0	3.7	0.4	0.4	7.0	41.8	0.0	0.5	10.9	0.8	1.6	21.4	1.6	10.0	6.3	0.3	0.3	2.5	0.5	1.4	0.4	0.3	0.2	1.0	2.9	0.0	2.5	3.4	0.1	3.9	16.9	0.1	5.6	0.9	0.4	55.6	55.8	0.7	0.4	5.5	7.6	0.4	0.0	0.3	0.7	20.3	9.2	4.9	6.9	6.0	0.0	0.0	0.0	0.0	0.8	0.1	1.7	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	11.3	5.8	1.6	0.0	11.5	2.5	0.1	0.0	1.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	1.9	0.0	4.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	38.6	0.0	0.0	0.0	2.9	0.0	1.2	0.5	0.1	0.0	0.0	0.1	0.1	0.9	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	3.2	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.3	0.4	0.4	0.3	0.3	0.3	0.2	0.1	0.0
POU2AF1	"BOB1, OBF1"	ENSG00000110777	"POU class 2 associating factor 1"	Q16633	11	111352252-111455630	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 21.2;lymphoid tissue: 84.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 45.4;Karpas-707: 52.0;U-266/70: 50.7;U-266/84: 22.8;U-698: 93.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	11	"memory B-cell: 19.9;naive B-cell: 14.2"	"Lineage enriched"	"Detected in many"	13	"B-cells: 19.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB011193	Enhanced									"CAB011193: AB_532299"	"prognostic favourable (1.68e-4)"	"prognostic favourable (1.63e-4)"	"unprognostic (1.04e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.88e-1)"	"prognostic favourable (3.59e-4)"	"unprognostic (2.09e-1)"	"unprognostic (3.63e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.81e-2)"	"unprognostic (8.51e-8)"	"unprognostic (2.35e-1)"	"unprognostic (3.90e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.23e-1)"	0.9	0.5	0.6	62.7	0.7	2.0	1.4	0.4	0.6	1.9	7.8	1.8	0.0	6.7	0.7	0.3	8.7	1.1	1.4	0.5	0.8	0.7	2.1	1.0	2.6	42.6	1.0	0.5	1.2	0.5	0.0	0.4	0.5	1.2	1.3	4.1	1.2	8.4	0.9	0.4	0.4	21.2	0.0	1.4	74.2	12.2	1.0	0.9	5.0	1.7	1.4	84.0	5.0	1.4	19.9	0.1	1.5	0.2	0.3	0.7	0.6	0.1	0.1	0.0	0.0	0.8	0.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	45.4	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.7	52.0	0.0	0.1	0.2	0.2	0.0	0.0	9.7	0.1	12.2	0.0	0.1	0.0	0.9	0.1	0.0	0.0	0.2	0.1	0.4	0.0	0.4	0.0	0.0	50.7	22.8	93.3	0.0	0.1	0.0	1.5	0.1	0.3	0.1	0.1	0.1	19.9	0.2	0.1	0.0	14.2	0.2	0.1	0.9	0.3	0.2	0.1	0.7	0.6	0.6	0.7	0.4	0.6	0.8	0.7	1.0	0.5	1.2	0.9
PPIAL4A	"COAS2, PPIAL4, PPIAL4B"	ENSG00000263353	"Peptidylprolyl isomerase A like 4A"	Q9Y536	1	120889746-120890405	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 1.6"	"Cell line enhanced"	"Detected in many"		"NB-4: 4.5;SK-BR-3: 4.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"											HPA058345	Uncertain									"HPA058345: AB_2683685"	"unprognostic (3.49e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.42e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-2)"	"unprognostic (1.91e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-1)"	0.3	0.8		1.0		1.4	0.2		1.2	0.0	0.0			1.6	0.0	0.0	0.0	0.0	0.0	0.1			0.2	1.2	0.0	0.5			0.1	0.0	0.0		0.4		0.0	0.0		0.0	0.0	0.0	0.2	1.0	0.0		0.4	0.4	0.0			0.0		0.0	0.0		3.0	3.2	0.6	1.6	2.2	2.4	3.5	0.9	0.0	0.1	1.4	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	1.0	0.7	0.2	0.0	1.7	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.8	1.0	0.0	0.8	0.0	0.0	0.3	0.2	3.7	0.3	0.6	1.7	4.5	2.4	0.0	0.8	1.5	1.9	0.0	0.0	1.0	0.3	0.3	4.6	0.4	3.0	2.5	0.7	3.0	1.2	2.9	1.6	1.3	0.9	2.4	2.6	1.5	3.1	0.2	1.6	0.6	1.4	1.2	1.4	3.0	2.3	2.4	3.1	2.2	1.5	2.4	0.0	2.2	1.2	3.2	2.4	3.5										
PPIAL4C		ENSG00000263464	"Peptidylprolyl isomerase A like 4C"	A0A0B4J2A2	1	149583865-149584464	"Enzymes, Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.9;intestine: 5.5"	"Cell line enhanced"	"Detected in many"		"NB-4: 14.2;THP-1: 16.6"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"											HPA058345	Uncertain									"HPA058345: AB_2683685"	"unprognostic (3.16e-1)"	"unprognostic (2.83e-2)"			"unprognostic (1.50e-2)"	"unprognostic (7.93e-2)"		"unprognostic (5.98e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.79e-1)"				"unprognostic (6.61e-2)"			"unprognostic (2.25e-1)"	0.0	3.3		2.7		0.1	0.0		1.5	0.0	0.8			5.5	0.8	0.0	0.0	0.0	0.0	0.0			1.0	0.0	1.0	2.9			0.2	0.0	0.9		0.7		0.3	0.0		0.0	0.0	0.2	0.5	2.9	0.0		1.4	0.9	0.0			0.0		0.3	0.0		9.1	9.7	1.9	6.0	4.6	7.8	10.9	3.5	0.3	0.4	3.1	0.1	0.3	2.0	0.5	0.4	1.0	0.7	0.0	4.8	1.2	2.1	0.0	3.9	0.0	0.2	0.6	3.5	0.0	0.5	0.0	0.0	0.1	2.0	1.9	0.1	0.5	0.6	0.3	0.0	0.9	5.3	0.7	0.4	5.2	14.2	6.1	0.1	5.2	0.0	8.9	0.2	0.0	3.9	5.4	1.1	11.1	6.0	5.2	16.6	1.2	3.5	5.5	3.3	8.0	4.2	5.5	9.0	3.8	4.6	7.7	0.9	4.3	1.9	5.4	6.0	6.0	9.1	6.1	5.7	9.4	7.2	5.0	5.9	0.0	4.6	5.3	9.7	7.8	10.9										
PPP1R16A	"MGC14333, MYPT3"	ENSG00000160972	"Protein phosphatase 1 regulatory subunit 16A"	Q96I34	8	144477969-144502121	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 23.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA023755	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA023755: AB_1854268"	"unprognostic (9.63e-2)"	"unprognostic (4.51e-2)"	"unprognostic (5.45e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.79e-2)"	3.0	3.8	6.5	3.1	6.8	2.2	3.0	3.3	4.8	3.0	11.1	3.0	3.0	20.5	3.0	3.0	3.0	6.7	3.0	3.0	6.5	4.6	6.5	5.3	3.0	3.0	3.1	3.0	3.0	5.7	4.0	10.2	3.0	3.0	3.4	1.6	3.0	5.4	4.5	3.4	3.7	23.3	3.0	3.0	3.0	7.8	7.4	3.0	3.0	6.8	3.0	3.0	3.0	3.0	2.5	3.2	0.7	4.1	0.7	3.2	2.1	15.6	12.7	2.1	8.1	0.8	1.5	10.4	4.3	2.7	3.4	2.7	3.3	11.2	2.6	11.4	1.6	10.4	1.1	3.5	0.5	5.3	6.3	3.1	12.3	3.5	2.6	2.2	4.3	1.5	4.8	3.9	1.1	2.4	12.2	3.3	1.2	25.7	7.7	10.2	3.9	16.1	8.2	1.0	5.2	3.0	5.2	6.7	12.9	7.9	7.3	6.5	17.3	4.7	4.0	3.9	18.2	10.6	8.1	2.1	2.1	0.9	12.4	4.3	3.4	0.0	2.3	0.0	3.2	3.4	2.8	2.5	2.3	2.9	3.2	0.5	1.7	3.1	0.7	0.7	4.1	1.8	1.7	2.1	6.5	6.8	3.3	4.8	6.5	4.6	3.1	3.0	3.0	3.0
PRELID2	"FLJ38376, MGC21644"	ENSG00000186314	"PRELI domain containing 2"	Q8N945	5	145471799-145835369	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 31.2"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 15.8;myeloid DC: 5.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 5.2;granulocytes: 15.8"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA042486	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA042486: AB_10797498"	"unprognostic (9.45e-3)"	"unprognostic (1.95e-1)"	"unprognostic (7.58e-3)"	"unprognostic (2.71e-5)"	"unprognostic (1.96e-3)"	"unprognostic (6.53e-4)"	"unprognostic (6.62e-5)"	"unprognostic (2.27e-1)"	"unprognostic (4.21e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavourable (3.78e-4)"	"unprognostic (3.83e-1)"	"prognostic unfavourable (9.65e-6)"	"unprognostic (2.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.83e-4)"	"unprognostic (6.42e-3)"	6.6	2.4	1.6	5.3	2.0	3.9	4.4	0.7	2.9	4.9	16.4	2.3	2.8	10.6	5.2	2.9	2.4	3.0	14.5	6.4	1.4	1.4	2.6	2.7	2.4	2.7	2.3	1.1	5.2	15.9	1.3	2.8	0.9	2.0	4.2	16.2	9.2	4.3	2.7	1.3	3.0	31.2	6.2	2.5	2.1	7.8	2.5	1.5	0.8	4.1	2.4	1.9	4.3	11.6	1.8	5.2	15.8	1.9	1.8	2.0	0.9	11.2	3.7	3.5	5.6	0.8	2.0	0.0	3.7	6.5	7.0	9.9	12.0	18.5	0.0	6.4	4.4	3.4	2.7	8.4	10.4	3.2	4.4	12.9	4.1	6.2	2.1	1.7	13.8	1.1	3.6	8.0	7.1	7.9	7.0	5.2	3.4	1.9	0.0	1.9	1.8	2.5	0.1	0.0	1.8	3.3	1.7	1.5	3.1	4.7	0.6	7.4	5.6	2.5	7.2	6.1	3.3	10.7	8.4	0.2	0.0	0.0	11.0	0.0	2.4	15.8	1.3	0.4	0.8	1.9	0.4	1.7	1.6	1.2	5.2	1.8	0.2	1.2	0.5	1.8	1.3	0.6	2.0	0.9	1.6	2.0	0.7	2.9	1.4	1.4	2.3	1.1	2.0	1.5
PRELID3B	"C20orf45, dJ543J19.5, SLMO2"	ENSG00000101166	"PRELI domain containing 3B"	Q9Y3B1	20	59033145-59042909	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 91.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047721	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047721: AB_2680131"	"unprognostic (1.62e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavourable (5.04e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.54e-3)"	"prognostic unfavourable (6.96e-5)"	"unprognostic (5.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.20e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.96e-2)"	18.6	17.0	14.1	17.0	13.9	13.7	20.4	10.3	14.1	10.0	45.2	8.7	11.2	41.3	9.6	9.6	26.7	8.8	10.3	13.3	12.9	13.4	20.5	30.1	13.5	19.1	15.4	10.0	11.1	24.2	12.7	34.3	28.8	12.3	10.5	30.0	6.1	15.3	12.6	17.2	14.0	91.2	11.6	16.7	19.9	19.3	11.5	12.1	21.4	18.9	25.5	21.2	13.9	14.4	25.8	17.5	26.6	21.0	27.1	27.6	20.2	25.9	12.9	12.6	16.4	9.3	13.3	17.7	19.3	17.2	36.3	19.4	35.8	22.0	41.4	34.1	14.8	28.5	25.4	30.6	38.1	24.5	15.9	28.7	21.8	7.6	19.8	37.4	26.7	11.7	40.6	20.8	48.4	11.7	11.2	18.2	15.4	33.4	42.2	16.7	6.2	35.7	22.0	28.5	23.4	18.0	22.3	22.7	21.7	30.9	52.6	44.4	26.5	29.2	13.8	13.1	12.7	24.0	10.1	12.3	17.5	33.5	14.3	18.4	14.7	26.6	13.6	13.5	21.4	17.9	25.9	25.8	26.1	24.0	17.5	18.6	23.6	24.8	11.7	27.1	21.0	14.7	27.6	20.2	14.1	13.9	10.3	14.1	12.9	13.4	15.4	10.0	12.3	12.1
PRIMA1	PRIMA	ENSG00000175785	"Proline rich membrane anchor 1"	Q86XR5	14	93718298-93788481	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 26.2"	"Cell line enhanced"	"Detected in some"		"HAP1: 7.3;Hep G2: 4.7;NTERA-2: 3.0;SCLC-21H: 12.9;SH-SY5Y: 7.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 16.2"	"Low region specificity"	"Detected in all"			"HPA046671, HPA060047"	Approved		Approved	"Nucleoli,Plasma membrane,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA046671: AB_2679744, HPA060047: AB_2684194"	"unprognostic (3.60e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.54e-2)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (1.03e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.94e-2)"	"unprognostic (6.61e-3)"	"prognostic unfavourable (2.62e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.67e-1)"	"unprognostic (7.94e-4)"	"unprognostic (4.57e-3)"	4.6	6.0	4.2	5.9	16.7	0.4	2.4	4.5	8.2	7.7	26.2	21.7	4.2	4.6	7.9	7.9	13.7	10.7	3.3	4.8	5.8	3.3	1.2	0.7	1.0	0.7	20.2	4.0	6.9	1.2	0.6	0.3	2.2	15.5	8.6	7.6	9.9	4.6	10.2	0.7	2.1	11.6	14.9	24.3	0.7	12.1	1.8	14.7	0.0	1.3	0.9	4.4	4.7	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	7.3	0.0	0.0	0.2	0.4	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.0	0.0	0.0	0.0	0.3	0.0	0.0	12.9	7.3	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	16.7	4.5	8.2	5.8	3.3	20.2	4.0	15.5	14.7
PRKG2	"cGKII, PRKGR2"	ENSG00000138669	"Protein kinase, cGMP-dependent, type II"	Q13237	4	81087370-81215117	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.3"	"Cell line enhanced"	"Detected in some"		"ASC diff: 5.1;ASC TERT1: 3.9;HEL: 20.3;hTCEpi: 4.0;SCLC-21H: 6.3"	"Cancer enhanced"	"Detected in some"		"melanoma: 4.1"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"basophil: 2.0;MAIT T-cell: 2.2"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.0;T-cells: 2.2"	"Low region specificity"	"Detected in many"							"HPA007386, CAB018739"	Approved									"CAB018739: AB_2284387, HPA007386: AB_1079678"	"unprognostic (6.14e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.01e-4)"	"unprognostic (4.33e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.00e-3)"	"unprognostic (1.06e-1)"	4.7	0.4	5.2	0.4	2.9	0.6	2.2	0.8	5.3	1.4	7.7	1.2	0.7	12.2	0.6	0.6	3.8	0.6	0.4	6.3	2.9	3.3	0.7	0.3	4.3	0.3	2.5	1.9	0.3	1.8	0.0	12.1	0.2	9.3	12.7	3.8	1.4	0.8	4.6	0.3	2.1	34.3	0.7	1.3	0.3	1.3	1.7	2.4	0.0	1.3	0.0	0.6	1.2	1.3	0.4	0.0	2.0	0.0	0.4	2.2	0.4	0.1	0.3	0.1	0.0	5.1	3.9	0.0	0.2	0.0	0.0	0.0	0.4	2.3	0.0	0.2	0.9	0.1	0.3	1.5	0.0	0.4	0.0	20.3	0.6	0.0	0.0	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	0.1	0.0	0.8	6.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	2.0	0.0	0.0	0.2	0.0	2.2	0.2	0.5	0.3	0.0	0.4	0.8	0.9	0.0	0.4	0.0	0.0	0.0	0.4	5.2	2.9	0.8	5.3	2.9	3.3	2.5	1.9	9.3	2.4
PRODH	"HSPOX2, PIG6, PRODH1, PRODH2, TP53I6"	ENSG00000100033	"Proline dehydrogenase 1"	O43272	22	18912777-18936553	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 48.9"	"Cell line enriched"	"Detected in some"	8	"RPTEC TERT1: 28.8"	"Cancer enhanced"	"Detected in many"		"testis cancer: 11.0"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"											HPA020361	Approved									"HPA020361: AB_10963116"	"unprognostic (2.46e-2)"	"prognostic favourable (1.54e-4)"	"unprognostic (1.40e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.61e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.94e-2)"	3.8	2.3	20.8	2.8	19.3	2.0	3.3	9.8	21.3	2.0	3.5	16.2	0.1	13.8	2.3	2.2	8.8	2.4	2.2	4.6	22.2	10.8	9.9	6.6	8.6	2.3	14.9	21.8	2.4	2.2	1.9	1.5	2.4	13.5	2.6	2.6	7.4	2.1	2.4	15.5	13.0	48.9	1.9	12.6	2.2	2.1	3.5	9.8	0.1	4.3	4.1	3.7	2.1	2.3	0.4	0.4	0.0	0.0	1.0	0.3	0.0	0.0	0.6	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.3	0.0	2.1	2.9	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	3.4	0.0	0.0	0.0	0.3	28.8	0.6	0.1	0.2	0.6	0.9	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	20.8	19.3	9.8	21.3	22.2	10.8	14.9	21.8	13.5	9.8
PRR15		ENSG00000176532	"Proline rich 15"	Q8IV56	7	29563811-29567295	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 66.1"	"Cell line enhanced"	"Detected in many"		"BEWO: 13.2;CAPAN-2: 17.2;HaCaT: 19.9;RT4: 15.2;SK-BR-3: 33.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Lineage enhanced"	"Detected in single"		"B-cells: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040996, HPA048121"	Enhanced		Uncertain	"Vesicles,Cell Junctions"				Vesicles	Vesicles	"HPA040996: AB_2677241, HPA048121: AB_2680271"	"unprognostic (5.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.97e-2)"	"prognostic favourable (6.37e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.00e-1)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.45e-2)"	"unprognostic (3.69e-3)"	"unprognostic (1.25e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (1.30e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.58e-2)"	3.8	0.5	0.7	14.4	0.4	0.0	3.1	0.4	0.8	22.8	58.9	0.8	2.6	24.8	6.8	13.3	0.7	2.9	12.1	1.0	0.6	0.5	12.7	0.5	3.7	0.6	0.4	0.4	4.0	2.0	0.0	2.7	19.0	0.5	2.7	18.5	0.3	4.6	0.9	0.5	0.3	66.1	1.1	1.1	0.4	16.6	1.4	0.4	0.3	1.0	1.0	1.9	7.0	1.9	1.6	0.0	0.0	0.5	0.0	0.0	0.6	7.2	10.3	0.0	0.0	4.0	5.0	13.2	0.3	0.5	0.2	0.1	9.0	17.2	0.0	1.9	2.4	19.9	2.2	0.0	0.0	0.0	1.4	0.5	1.9	9.8	1.3	0.0	0.0	0.0	3.3	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.2	1.4	1.6	8.2	0.0	0.0	9.1	11.9	15.2	0.2	0.1	1.0	33.5	0.0	2.4	0.0	8.8	0.2	0.0	0.0	0.4	0.8	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.4	0.4	0.8	0.6	0.5	0.4	0.4	0.5	0.4
PRR15L	"ATAD4, MGC11242"	ENSG00000167183	"Proline rich 15 like"	Q9BU68	17	47951967-47957878	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 113.1;pancreas: 75.4;thyroid gland: 61.0"	"Cell line enhanced"	"Detected in some"		"HaCaT: 13.4;MCF7: 12.4;SCLC-21H: 7.8;SK-BR-3: 23.5;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	5	"pons and medulla: 2.2"	"Cell type enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 19.0"	HPA022918	Approved		Approved	Cytosol				Cytosol	Cytosol	"HPA022918: AB_2060743"	"unprognostic (9.91e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.48e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (6.29e-13)"	"prognostic favourable (1.69e-5)"	"unprognostic (1.36e-1)"	"unprognostic (8.26e-2)"	"unprognostic (3.34e-2)"	0.9	0.2	0.2	13.5	0.2	0.0	10.0	0.2	0.3	3.2	88.7	0.6	22.9	44.9	0.6	8.3	4.9	6.6	21.2	0.3	0.4	0.2	37.3	1.6	20.3	0.2	0.2	0.2	1.9	75.4	0.0	8.5	0.2	2.2	8.1	32.0	0.4	38.7	26.7	0.2	3.7	113.1	0.5	0.2	0.2	27.2	1.3	0.2	0.3	61.0	2.5	5.8	2.1	2.4	1.3	0.5	0.0	0.2	1.2	2.2	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	5.5	3.8	0.1	0.2	0.0	13.4	0.0	0.0	0.0	0.2	0.4	0.1	0.0	1.6	0.0	0.2	0.2	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.2	0.2	0.0	0.5	0.2	0.0	0.9	0.7	1.6	7.8	0.3	0.0	23.5	0.0	15.8	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.2	0.3	0.1	0.0	0.0	0.2	0.0	0.4	0.2	2.2	0.1	0.0	0.5	0.5	1.3	0.8	0.6	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.2	0.2	0.3	0.4	0.2	0.2	0.2	2.2	0.2
PRR5L	"FLJ14213, PROTOR-2"	ENSG00000135362	"Proline rich 5 like"	Q6MZQ0	11	36296288-36465204	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.1;intestine: 25.7;lymphoid tissue: 26.1"	"Cell line enhanced"	"Detected in many"		"HeLa: 16.3;HMC-1: 27.1;hTERT-HME1: 28.2;SiHa: 18.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070174			Approved	"Cytokinetic bridge,Cytosol"				"Cytokinetic bridge, Cytosol"	"Cytokinetic bridge, Cytosol"	"HPA070174: AB_2686231"	"unprognostic (6.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.48e-2)"	"prognostic favourable (7.30e-5)"	"unprognostic (2.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.45e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.46e-2)"	"unprognostic (3.03e-3)"	"unprognostic (2.12e-1)"	"prognostic unfavourable (7.71e-8)"	"prognostic unfavourable (4.86e-4)"	"unprognostic (1.66e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.98e-2)"	2.9	1.5	4.2	8.1	15.5	3.1	2.4	1.7	9.5	9.5	25.7	34.1	1.1	2.5	2.6	1.6	1.4	4.9	5.3	1.6	7.2	5.1	3.8	2.3	10.4	6.2	24.9	3.8	11.4	2.0	1.0	2.7	2.8	16.6	2.3	21.4	3.3	6.3	1.6	0.7	1.6	9.3	4.8	22.8	26.1	2.6	1.2	19.7	1.1	3.0	0.2	2.6	3.6	3.6	1.1	4.2	16.9	12.3	4.6	20.1	7.2	0.0	2.8	4.9	0.1	0.7	0.0	0.0	5.9	4.6	12.6	13.0	0.0	0.0	0.0	1.9	7.3	0.2	0.9	3.0	6.1	2.3	1.7	0.6	16.3	0.0	1.6	0.0	27.1	2.0	4.3	1.2	28.2	5.2	0.0	0.0	6.4	1.5	0.3	0.0	0.3	1.1	1.7	0.5	0.5	12.8	3.0	0.0	0.2	18.6	0.0	1.1	0.0	0.2	3.6	10.7	3.3	0.0	7.4	0.1	0.0	0.0	4.6	0.6	3.2	16.9	1.1	13.3	20.1	11.8	4.6	0.0	7.2	16.8	1.3	1.1	1.6	10.8	6.5	4.6	12.3	4.2	0.0	7.2	4.2	15.5	1.7	9.5	7.2	5.1	24.9	3.8	16.6	19.7
PRSS8		ENSG00000052344	"Serine protease 8"	Q16651	16	31131433-31135762	"Enzymes, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 123.2;salivary gland: 143.7"	"Cell line enhanced"	"Detected in some"		"BEWO: 57.3;CACO-2: 37.6;CAPAN-2: 25.8;hTCEpi: 37.0;SK-BR-3: 43.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"pons and medulla: 3.4"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA030436	Uncertain				"Secreted - unknown location"	3500000	3500000			"HPA030436: AB_10602291"	"unprognostic (1.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (9.34e-2)"	"unprognostic (4.08e-1)"	"unprognostic (6.83e-2)"	"unprognostic (5.07e-3)"	"unprognostic (5.78e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.51e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.58e-1)"	"prognostic favourable (2.05e-10)"	"unprognostic (1.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.63e-3)"	0.3	0.2	0.3	11.5	0.3	0.0	7.6	0.7	0.4	8.0	72.6	0.6	12.8	31.6	3.4	46.7	37.2	2.8	45.3	0.3	0.4	0.3	48.0	20.3	30.0	0.3	0.3	0.3	1.3	46.3	2.7	2.6	93.1	3.4	11.4	14.7	1.1	143.7	7.4	0.3	29.7	123.2	0.5	0.3	0.3	37.0	1.8	0.3	11.3	33.4	18.4	26.7	2.6	13.4	0.2	0.0	1.0	0.3	0.0	0.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	57.3	0.0	0.0	0.0	0.0	37.6	25.8	0.0	0.3	0.0	17.0	0.0	16.0	0.0	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	37.0	0.0	0.5	0.0	0.4	0.0	0.0	15.3	0.1	0.3	4.7	0.0	0.1	0.0	0.2	1.7	3.0	0.2	0.1	0.0	43.5	0.0	9.9	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.4	0.4	0.3	0.3	0.3	3.4	0.3
PTGR1	"LTB4DH, ZADH3"	ENSG00000106853	"Prostaglandin reductase 1"	Q14914	9	111549722-111599855	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 117.6;liver: 113.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	9	"dendritic cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA036724	Enhanced					940000	940000			"HPA036724: AB_10670239"	"unprognostic (1.54e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.10e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.46e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.91e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.48e-1)"	"prognostic favourable (5.53e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.22e-2)"	9.9	23.7	6.7	3.4	8.1	0.4	8.0	9.7	10.0	8.0	116.3	2.2	3.0	45.2	8.0	7.8	27.4	14.3	15.2	7.7	7.0	4.2	47.3	113.8	5.2	2.6	3.3	6.6	5.9	4.3	6.2	9.0	3.2	6.4	12.3	6.7	6.8	11.4	6.4	3.3	6.7	117.6	8.7	2.5	2.2	21.2	3.3	3.4	1.1	9.0	36.4	12.5	21.9	23.6	0.3	8.9	0.2	0.9	0.0	0.2	0.5	10.1	43.1	12.6	0.1	46.2	46.7	9.8	16.5	25.1	15.8	16.5	11.7	13.8	0.0	4.7	15.7	12.5	10.2	17.4	19.6	0.0	3.0	2.5	26.8	56.7	10.6	1.4	5.3	33.2	26.3	21.6	11.1	39.8	1.7	0.0	30.5	3.1	0.0	0.3	5.2	10.6	0.0	3.6	0.2	18.4	33.2	14.2	0.6	20.3	6.1	6.0	19.0	6.9	32.1	3.1	6.5	35.2	2.9	0.0	0.0	0.0	15.0	0.0	3.9	0.0	0.9	0.0	0.0	0.1	0.2	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.2	0.0	0.0	8.9	0.0	0.5	6.7	8.1	9.7	10.0	7.0	4.2	3.3	6.6	6.4	3.4
PTK6	BRK	ENSG00000101213	"Protein tyrosine kinase 6"	Q13882	20	63528001-63537370	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.0;intestine: 24.2;skin 1: 24.2"	"Cell line enhanced"	"Detected in some"		"A-431: 11.3;CAPAN-2: 21.8;HaCaT: 17.7;hTCEpi: 24.0;RT4: 13.8;T-47d: 13.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB032952, HPA036070, HPA036071"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"				"Nucleoplasm, Plasma membrane, Cytosol"	"Nucleoplasm, Plasma membrane, Cytosol"	"CAB032952: AB_634461, HPA036070: AB_10602292, HPA036071: AB_10669982"	"unprognostic (2.32e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.72e-2)"	"prognostic unfavourable (1.96e-4)"	"unprognostic (1.28e-1)"	"prognostic unfavourable (1.26e-9)"	"unprognostic (4.19e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.24e-2)"	0.7	0.0	0.4	5.3	0.4	0.0	1.7	0.4	0.4	7.6	18.1	0.5	0.8	13.6	0.6	0.5	44.0	0.0	11.7	0.4	0.4	0.0	0.8	1.7	1.1	0.4	0.4	0.4	0.4	1.4	0.0	0.4	0.6	0.4	2.2	7.4	0.4	7.6	0.4	0.4	24.2	24.2	0.9	0.4	0.4	12.5	0.4	0.4	0.4	0.4	18.9	17.2	6.5	15.0	1.3	4.5	1.2	2.4	0.3	1.9	0.9	11.3	1.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	21.8	0.0	3.9	0.0	17.7	0.0	0.0	0.0	2.8	0.2	0.0	4.5	0.0	0.0	0.0	3.6	0.0	24.0	0.0	0.1	0.0	0.1	1.3	0.1	6.3	0.0	0.1	0.1	8.2	0.0	0.6	0.2	0.0	13.8	0.2	1.2	1.3	4.3	0.0	13.3	0.8	0.1	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.2	0.2	0.6	1.2	2.4	0.4	0.5	1.7	1.9	1.2	0.4	0.1	4.5	1.3	0.4	0.6	1.2	0.3	1.3	0.3	0.5	0.9	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
PTPRO	"GLEPP1, NPHS6, PTP-oc, PTP-U2, PTPU2"	ENSG00000151490	"Protein tyrosine phosphatase, receptor type O"	Q16827	12	15322397-15597399	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1;intestine: 28.5;kidney: 21.6"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 9.3;SCLC-21H: 5.7;SH-SY5Y: 11.2;THP-1: 4.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 8.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 5.2;intermediate monocyte: 10.5;memory B-cell: 8.3;myeloid DC: 7.4;naive B-cell: 7.0;naive CD4 T-cell: 2.9;non-classical monocyte: 10.5;plasmacytoid DC: 9.5"	"Low lineage specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"olfactory region: 215.3"	"Low region specificity"	"Detected in many"			HPA034525	Enhanced				"Intracellular and membrane"					"HPA034525: AB_10669785"	"unprognostic (3.68e-2)"	"unprognostic (3.49e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.87e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.93e-3)"	"unprognostic (5.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (5.43e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.44e-1)"	3.3	1.2	16.2	3.1	26.1	0.6	1.1	1.0	15.3	1.7	10.4	1.5	0.0	2.0	4.5	2.1	0.8	1.2	1.6	0.7	11.3	10.6	21.6	1.6	6.7	3.2	4.8	8.8	0.7	0.6	0.6	3.8	4.4	4.0	0.7	28.5	1.1	0.8	1.1	0.5	0.7	1.9	7.1	2.6	3.6	1.0	0.9	3.5	0.0	0.5	0.0	3.5	1.7	0.5	8.3	9.5	0.0	10.5	0.1	2.9	2.7	0.0	0.1	0.5	0.4	0.6	0.1	0.2	0.0	0.0	0.9	2.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.3	0.1	0.2	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.7	9.3	0.1	0.0	0.0	0.1	0.2	0.3	5.7	11.2	1.3	0.0	0.1	0.1	4.6	0.0	0.1	0.4	0.0	0.4	1.4	0.1	0.4	0.1	0.3	1.7	0.0	5.2	0.0	0.0	10.5	0.0	8.3	1.7	0.4	7.4	7.0	2.9	1.3	0.0	0.1	10.5	9.5	1.3	2.7	16.2	26.1	1.0	15.3	11.3	10.6	4.8	8.8	4.0	3.5
R3HDML	dJ881L22.3	ENSG00000101074	"R3H domain containing like"	Q9H3Y0	20	44336986-44351235	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"brain: 2.4;intestine: 5.9"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;CACO-2: 3.9;U-2 OS: 2.9"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 1.5"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA070264	Enhanced				"Secreted - unknown location"					"HPA070264: AB_2686244"	"unprognostic (1.89e-1)"		"unprognostic (2.23e-1)"				"unprognostic (9.86e-2)"	"unprognostic (9.12e-2)"	"unprognostic (6.06e-3)"		"unprognostic (2.64e-1)"			"unprognostic (6.32e-2)"	"unprognostic (4.95e-3)"			0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.0	1.5			5.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.4	0.5	0.2	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.8	1.4			0.1		0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.2	0.0	0.0	0.3	1.9	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	3.9	0.9	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.5	0.2	1.3	0.9	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.4	0.2	0.0	0.4	0.2	0.0	0.0	0.4	2.9	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.5	0.0	0.0										
RAB11FIP1	"FLJ22524, FLJ22622, Rab11-FIP1, RCP"	ENSG00000156675	"RAB11 family interacting protein 1"	Q6WKZ4	8	37858618-37899467	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.6"	"Cell line enhanced"	"Detected in many"		"K-562: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 39.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 39.0"	"Low region specificity"	"Detected in single"							"CAB017037, HPA023904, HPA024010, HPA025960"	Enhanced		Enhanced	Vesicles				Vesicles	Vesicles	"CAB017037: , HPA023904: AB_1855990, HPA024010: AB_1855991, HPA025960: AB_1855992"	"unprognostic (1.62e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-1)"	"prognostic favourable (6.61e-4)"	"unprognostic (4.32e-1)"	"unprognostic (4.50e-3)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-2)"	"unprognostic (2.82e-3)"	"unprognostic (2.73e-2)"	"prognostic favourable (1.14e-6)"	"unprognostic (4.94e-2)"	"unprognostic (8.41e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.50e-1)"	6.9	3.2	1.3	16.8	1.0	17.8	7.4	1.8	1.3	8.9	37.1	1.9	17.8	13.8	2.9	8.8	30.9	5.6	31.5	5.9	1.1	1.3	8.4	4.1	64.5	8.4	1.1	0.6	4.7	31.5	3.9	12.9	26.0	6.9	7.0	16.4	9.9	20.9	21.3	3.4	13.8	90.6	5.3	1.3	10.9	15.2	5.4	0.9	16.4	8.5	14.9	34.1	9.6	9.6	2.3	6.9	39.0	7.7	4.1	4.0	3.3	17.2	7.6	0.8	3.4	0.2	0.0	23.5	1.8	2.8	3.3	4.2	17.0	9.9	7.0	5.5	2.1	13.4	6.2	3.9	4.9	18.2	5.8	1.3	4.0	4.9	9.3	3.0	15.7	2.2	5.3	1.2	3.4	0.0	29.7	3.5	1.7	4.1	5.0	4.4	5.1	2.3	1.6	4.2	5.4	17.0	17.7	3.2	3.7	4.5	22.5	5.5	15.2	5.8	0.2	0.1	10.2	0.2	0.3	7.1	8.3	1.9	0.1	4.1	2.4	6.9	7.7	13.7	1.8	3.7	4.0	2.3	1.3	1.2	6.9	1.7	0.8	0.9	39.0	4.1	6.9	4.2	2.9	3.3	1.3	1.0	1.8	1.3	1.1	1.3	1.1	0.6	6.9	0.9
RAB17		ENSG00000124839	"RAB17, member RAS oncogene family"	Q9H0T7	2	237574322-237601614	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.8;liver: 37.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 16.2;MCF7: 17.7;SK-BR-3: 19.2;SK-MEL-30: 46.1;T-47d: 12.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	4	"pons and medulla: 5.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035176	Approved									"HPA035176: AB_10696368"	"unprognostic (8.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.44e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.26e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.36e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.68e-2)"	"prognostic favourable (4.14e-4)"	"unprognostic (5.87e-2)"	"prognostic favourable (3.33e-13)"	"unprognostic (1.17e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.44e-1)"	"prognostic favourable (2.51e-4)"	0.8	1.0	0.5	1.4	0.5	0.0	4.7	0.4	0.8	1.2	21.4	1.2	10.3	19.2	0.8	9.5	1.8	2.9	5.2	1.0	1.1	0.5	20.6	37.0	7.9	0.4	0.5	0.4	0.8	25.4	9.8	6.1	6.5	5.3	2.9	4.2	1.9	13.5	15.2	0.7	0.9	57.8	0.6	0.4	0.5	10.0	0.9	0.4	0.6	22.9	0.9	1.2	1.8	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.3	4.0	0.1	0.0	7.9	0.0	0.1	16.2	0.0	0.0	0.0	0.0	10.7	9.8	0.0	2.7	0.0	0.2	0.0	4.8	0.1	0.0	0.0	0.0	0.0	10.4	0.0	0.0	0.0	0.0	3.3	0.0	0.2	0.0	0.0	0.0	0.3	17.7	0.0	0.2	0.2	0.0	0.4	0.0	1.0	4.4	8.8	4.2	0.0	0.0	19.2	46.1	12.0	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.1	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.5	0.4	0.8	1.1	0.5	0.5	0.4	5.3	0.4
REEP6	"C19orf32, DP1L1, FLJ25383, Yip2f"	ENSG00000115255	"Receptor accessory protein 6"	Q96HR9	19	1490747-1497927	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 90.8;liver: 119.0;testis: 71.2"	"Cell line enhanced"	"Detected in many"		"CACO-2: 15.8;Hep G2: 15.0;K-562: 41.8;T-47d: 34.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 114.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA003895, HPA048015"	Enhanced		Supported	"Endoplasmic reticulum"		26000	26000	"Endoplasmic reticulum"	"Endoplasmic reticulum"	"HPA003895: AB_1845723, HPA048015: AB_2680233"	"unprognostic (1.21e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.24e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (6.85e-2)"	"unprognostic (7.38e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.17e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.38e-2)"	2.4	20.1	4.1	0.7	5.9	0.6	3.9	3.1	6.0	1.4	41.7	2.8	4.4	60.2	1.0	5.7	2.7	1.4	7.6	0.9	4.5	1.9	6.1	119.0	0.6	0.7	2.6	2.1	1.7	10.1	0.5	2.2	0.7	2.1	4.9	0.7	27.4	5.6	11.8	0.7	1.7	90.8	1.1	1.6	0.6	1.3	71.2	1.1	0.3	1.6	1.1	2.1	3.2	1.2	1.0	4.2	0.1	4.8	5.8	7.1	2.3	2.0	2.5	0.8	10.3	1.6	0.5	11.5	0.5	0.1	0.5	0.5	15.8	6.4	1.1	3.6	0.3	2.1	2.7	0.1	0.2	0.5	1.1	6.0	0.3	15.0	1.2	0.4	2.0	1.3	1.1	0.0	0.3	0.3	41.8	1.5	0.1	7.9	0.5	1.3	3.8	5.6	1.5	0.3	2.6	3.0	0.9	0.2	5.6	2.8	4.0	1.7	34.9	1.6	0.9	0.8	1.6	2.4	0.4	5.0	1.4	0.1	3.5	2.6	2.3	0.0	1.5	0.0	7.1	1.7	3.8	0.1	2.1	1.5	2.5	1.0	2.8	3.2	0.1	5.8	4.8	4.2	2.0	2.3	4.1	5.9	3.1	6.0	4.5	1.9	2.6	2.1	2.1	1.1
REG4	"GISP, REG-IV, RELP"	ENSG00000134193	"Regenerating family member 4"	Q9BYZ8	1	119794018-119811660	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 55.1;intestine: 121.9"	"Group enriched"	"Detected in some"	22	"PC-3: 44.2;RT4: 12.2"	"Group enriched"	"Detected in many"	21	"colorectal cancer: 180.6;pancreatic cancer: 215.1;stomach cancer: 162.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"naive CD8 T-cell: 18.1"	"Lineage enriched"	"Detected in single"	115	"T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB025867, HPA046555"	Enhanced				"Secreted to digestive system"	400000	400000			"CAB025867: , HPA046555: AB_2679696"	"unprognostic (3.22e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.57e-1)"	"unprognostic (6.52e-2)"	"unprognostic (6.20e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.64e-2)"		"unprognostic (7.10e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (5.12e-3)"	"unprognostic (8.49e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.32e-3)"	0.2	0.1	0.2	4.2	0.2	0.0	0.2	0.2	0.2	0.2	55.5	0.3	0.2	36.3	0.2	0.2	1.2	0.1	55.1	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.2	23.8	0.0	0.2	0.2	0.2	0.6	43.1	0.2	0.6	0.2	0.2	0.1	121.9	0.8	0.2	0.2	2.2	0.7	0.2	0.2	0.2	0.2	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	18.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	44.2	0.0	0.0	0.3	0.0	12.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.8	18.1	0.1	0.0	0.0	0.0	0.0	2.2	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
RETSAT	FLJ20296	ENSG00000042445	"Retinol saturase"	Q6NUM9	2	85342088-85354620	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 86.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 64.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007961, HPA046513"	Uncertain		Uncertain	Nucleoli				Nucleoli	Nucleoli	"HPA007961: AB_1079802, HPA046513: AB_2679680"	"unprognostic (6.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.31e-1)"	"prognostic favourable (4.23e-4)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.59e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.59e-1)"	"prognostic favourable (1.95e-10)"	"unprognostic (2.73e-2)"	"unprognostic (5.34e-1)"	"unprognostic (8.24e-3)"	"unprognostic (9.90e-2)"	65.7	24.8	7.7	9.8	9.1	0.9	35.6	5.6	9.3	7.4	46.5	12.4	12.7	49.0	6.8	12.3	16.7	5.0	17.7	7.3	7.4	5.7	20.6	51.9	7.2	5.1	10.2	7.7	5.5	11.5	13.1	3.5	5.7	8.9	10.1	22.6	10.0	12.5	7.6	24.3	14.3	86.1	7.0	12.7	4.0	18.2	9.2	10.1	3.5	27.2	13.9	9.3	9.9	9.0	3.8	5.6	5.3	10.0	6.5	9.2	4.1	15.9	9.3	5.4	12.5	64.5	12.1	7.0	11.7	14.5	7.1	10.0	6.4	11.2	5.6	9.7	9.3	13.4	7.2	20.4	7.0	6.9	5.0	2.7	7.6	15.7	15.5	5.3	6.2	15.8	28.0	9.1	12.2	11.8	2.9	13.5	13.2	3.4	3.8	2.8	1.7	11.4	2.5	10.7	7.3	12.6	9.4	2.6	4.4	9.8	18.8	31.8	8.8	0.9	9.2	8.0	4.4	7.5	6.1	7.3	6.8	2.2	9.9	6.4	5.5	0.0	5.1	2.4	7.0	5.5	9.2	3.8	5.6	8.8	5.6	2.5	3.8	4.0	5.3	6.5	10.0	4.0	5.8	4.1	7.7	9.1	5.6	9.3	7.4	5.7	10.2	7.7	8.9	10.1
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932163	"Disease related genes, Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 7.4;intestine: 9.2;pancreas: 8.3;stomach 1: 11.8"	"Group enriched"	"Detected in some"	7	"HEK 293: 5.2;U-266/70: 2.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved									"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favourable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.1	7.4	0.1	0.8	0.1	0.0	4.5	0.1	0.4	0.2	6.9	0.2	0.0	3.4	0.1	0.0	0.3	0.1	1.3	0.1	0.1	0.1	0.1	0.1	1.0	0.0	0.1	0.0	0.1	8.3	0.0	2.1	1.5	0.0	0.5	2.0	0.0	1.2	4.0	0.1	0.1	9.2	0.0	0.1	0.1	11.8	0.9	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.0
RIPK3	RIP3	ENSG00000129465	"Receptor interacting serine/threonine kinase 3"	Q9Y572	14	24336021-24340045	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.2;CAPAN-2: 8.1;HDLM-2: 4.6;SK-BR-3: 13.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"														"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.16e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (5.58e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.93e-2)"	7.6	1.3	1.8	9.7	2.4	4.3	6.0	0.9	1.6	4.5	13.6	1.8	1.4	10.6	3.7	3.8	9.2	3.2	12.7	2.6	2.7	0.6	3.8	1.3	6.4	7.2	3.9	0.8	1.7	8.4	0.5	0.9	3.7	2.3	3.7	11.8	3.6	7.5	1.7	2.1	5.9	25.8	2.1	3.8	15.1	9.2	1.6	3.6	7.2	8.7	6.1	13.3	4.6	5.6	3.5	5.2	6.3	8.8	3.9	9.1	4.3	0.0	0.0	0.0	0.0	3.1	3.4	0.0	0.7	4.2	0.0	0.0	0.1	8.1	0.1	2.1	0.3	2.0	0.0	0.1	0.0	4.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	1.5	0.0	0.0	0.0	0.1	13.3	0.0	2.3	3.5	1.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	2.6	5.1	6.3	6.3	7.7	6.4	3.5	5.4	6.2	5.2	3.5	2.9	4.0	2.6	3.9	8.8	2.6	9.1	4.3	1.8	2.4	0.9	1.6	2.7	0.6	3.9	0.8	2.3	3.6
RNF128	"FLJ23516, GRAIL"	ENSG00000133135	"Ring finger protein 128, E3 ubiquitin protein ligase"	Q8TEB7	X	106693794-106796993	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.6;liver: 48.4;thyroid gland: 38.4"	"Cell line enhanced"	"Detected in some"		"BEWO: 17.9;CAPAN-2: 14.8;Hep G2: 12.6;RPTEC TERT1: 13.0;RT4: 37.2;WM-115: 22.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019675	Uncertain									"HPA019675: AB_2670225"	"unprognostic (1.78e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-3)"	"unprognostic (1.92e-4)"	"unprognostic (2.14e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.75e-2)"	"prognostic unfavourable (1.07e-7)"	"unprognostic (1.11e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.30e-2)"	"unprognostic (5.30e-3)"	1.4	20.6	2.4	2.2	7.2	0.0	3.0	0.7	4.2	0.5	24.4	0.9	0.4	24.2	0.2	2.2	4.0	0.3	27.2	0.6	2.8	5.1	24.4	48.4	6.7	0.0	2.4	2.1	0.7	14.5	0.0	11.0	10.5	4.0	3.4	7.8	0.0	25.4	0.8	3.0	3.6	54.6	0.9	1.1	0.2	17.9	0.3	1.0	1.1	38.4	2.3	2.7	10.2	3.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	4.5	0.0	0.0	0.0	1.5	0.8	17.9	0.0	0.1	0.0	0.0	7.8	14.8	0.0	0.0	0.2	5.6	0.0	0.0	0.0	0.0	8.7	0.0	0.1	12.6	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	13.0	37.2	0.0	0.0	0.0	0.9	0.9	0.9	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	6.5	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	7.2	0.7	4.2	2.8	5.1	2.4	2.1	4.0	1.0
RPS6KA1	"HU-1, p90Rsk, RSK, RSK1"	ENSG00000117676	"Ribosomal protein S6 kinase A1"	Q15418	1	26529761-26575030	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 29.6;U-937: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 60.4"	"Low region specificity"	"Detected in all"			"CAB003852, HPA007981"	Enhanced		Supported	Nucleoplasm,Cytosol				Cytosol	Cytosol	"CAB003852: AB_289590, HPA007981: AB_1079850"	"unprognostic (1.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.61e-3)"	"prognostic favourable (7.20e-7)"	"unprognostic (7.35e-2)"	"unprognostic (3.69e-1)"	"unprognostic (6.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.51e-3)"	"unprognostic (2.37e-2)"	"unprognostic (9.64e-2)"	"prognostic favourable (1.84e-4)"	"prognostic favourable (4.58e-4)"	"unprognostic (4.77e-2)"	"unprognostic (7.61e-2)"	"prognostic favourable (8.33e-4)"	11.0	8.2	6.3	24.2	9.7	15.8	5.0	14.4	6.3	4.9	23.2	11.1	4.4	24.5	2.1	3.6	8.9	6.0	8.0	3.4	5.3	5.1	13.6	5.4	26.1	32.7	10.3	3.5	2.1	10.1	10.0	7.4	3.3	8.6	8.6	15.8	3.6	19.0	5.5	1.1	9.0	45.2	2.8	7.9	27.0	9.7	2.7	9.0	15.9	13.9	4.9	17.3	6.2	4.5	5.0	22.0	40.1	18.0	7.9	8.3	17.1	9.7	3.4	2.8	3.7	0.1	0.0	3.7	0.8	1.5	4.2	4.0	4.0	8.1	18.3	4.5	0.5	11.5	6.3	22.7	3.0	15.1	4.1	20.1	8.5	7.0	1.3	23.7	29.6	0.7	8.3	3.8	6.9	1.8	3.4	6.7	0.2	5.4	0.8	23.3	7.2	11.0	12.6	3.6	8.0	12.0	2.7	4.1	1.6	6.9	6.6	3.2	4.2	20.3	1.2	0.2	5.3	0.7	3.3	4.1	4.9	10.0	2.5	31.8	4.0	9.6	18.0	40.1	8.3	16.4	6.9	4.9	6.1	7.3	22.0	5.0	3.9	5.5	34.5	7.9	17.3	8.6	6.0	17.1	6.3	9.7	14.4	6.3	5.3	5.1	10.3	3.5	8.6	9.0
RTL3	"FLJ38865, Mar3, Mart3, SIRH9, ZCCHC5, ZHC5"	ENSG00000179300	"Retrotransposon Gag like 3"	Q8N8U3	X	78656069-78659328	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 2.5;intestine: 2.6;smooth muscle: 2.7;stomach 1: 3.2"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.4;BJ hTERT+ SV40 Large T+ RasG12V: 2.6;fHDF/TERT166: 4.0;HBF TERT88: 5.4;hTEC/SVTERT24-B: 3.9;RH-30: 4.7;U-251 MG: 3.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA051991, HPA053174, HPA075136"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"				Nucleoplasm	Nucleoplasm	"HPA051991: AB_2681683, HPA053174: AB_2682069, HPA075136: AB_2686737"	"unprognostic (3.43e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.29e-1)"			"unprognostic (6.74e-2)"		"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.85e-1)"	"unprognostic (4.00e-6)"	"unprognostic (1.53e-2)"	"unprognostic (3.64e-1)"		"unprognostic (2.49e-1)"	0.6	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	2.6			0.2	2.5	0.2	0.5	0.4	0.5	2.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.2	0.2	0.0	0.0	0.0		0.2	0.5		0.7	0.0	0.1	0.3	1.1	2.7	0.0	0.0	3.2	0.0			0.1		0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.9	2.4	2.6	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	1.4	0.2	3.4	0.2	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SAMD13		ENSG00000203943	"Sterile alpha motif domain containing 13"	Q5VXD3	1	84298366-84389957	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"basophil: 11.2"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 11.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058929	Enhanced		Approved	Mitochondria				Mitochondria	Mitochondria	"HPA058929: AB_2683855"	"unprognostic (3.78e-2)"	"unprognostic (4.93e-2)"	"unprognostic (8.51e-3)"	"unprognostic (7.55e-2)"	"prognostic favourable (1.14e-8)"	"unprognostic (1.78e-1)"	"unprognostic (1.65e-6)"	"unprognostic (2.05e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.80e-3)"	"unprognostic (9.42e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.98e-7)"	"unprognostic (3.99e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.56e-3)"	1.2	5.2	4.9	1.0	12.9	2.1	2.0	9.1	5.8	1.5	16.6	7.4	0.6	2.6	1.8	4.5	1.1	3.7	1.4	1.7	4.8	2.3	1.7	0.4	0.7	0.8	7.9	6.5	0.5	2.3	1.0	2.3	0.5	4.5	3.4	19.4	0.4	13.6	1.9	7.6	1.2	3.0	2.1	5.1	1.5	5.6	12.4	8.5	3.5	8.6	2.0	0.4	2.7	0.7	0.6	1.4	11.2	0.8	0.7	0.5	0.3	0.7	2.6	1.2	4.1	4.3	4.3	2.7	0.3	0.3	0.3	0.3	0.2	4.1	4.3	7.6	0.2	0.8	0.4	1.4	0.6	2.3	2.1	1.5	1.8	0.4	1.1	4.9	0.1	1.5	2.0	0.1	1.2	10.2	0.6	1.2	1.2	1.2	6.3	0.6	4.1	2.6	0.7	3.1	1.6	8.0	2.7	1.7	6.3	0.1	0.2	9.3	1.2	4.6	1.6	1.4	0.4	0.4	1.1	3.3	0.6	7.3	0.5	4.4	1.3	11.2	0.4	0.0	0.1	0.8	0.3	0.2	0.1	0.1	0.9	0.6	0.5	0.5	0.2	0.7	0.3	1.4	0.0	0.3	4.9	12.9	9.1	5.8	4.8	2.3	7.9	6.5	4.5	8.5
SCIN	KIAA1905	ENSG00000006747	Scinderin	Q9Y6U3	7	12570577-12660179	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0"	"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 37.7;SK-BR-3: 40.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA020518, HPA024264"	Enhanced		Enhanced	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA020518: AB_1856619, HPA024264: AB_1856621"	"unprognostic (3.68e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.50e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.64e-5)"	"unprognostic (1.31e-2)"	"unprognostic (3.09e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.24e-1)"	"prognostic favourable (4.26e-8)"	"unprognostic (3.87e-1)"	"unprognostic (4.99e-2)"	"unprognostic (3.13e-2)"	"unprognostic (3.18e-1)"	4.1	1.0	14.5	2.3	30.3	1.0	0.9	1.5	13.3	1.2	11.2	7.5	1.0	16.2	1.2	0.7	14.5	3.6	2.0	0.5	11.1	4.2	30.3	0.6	3.4	0.6	22.8	2.3	0.8	0.9	1.1	3.1	46.0	20.0	2.3	10.2	0.6	9.0	1.0	0.6	2.5	31.7	1.0	27.9	0.6	12.2	4.3	23.4	0.0	1.0	2.7	8.2	5.5	1.1	4.5	1.5	3.5	1.5	2.1	1.9	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.5	0.1	0.0	0.0	0.1	8.3	0.2	0.2	0.1	0.6	0.1	1.3	0.1	0.2	0.0	37.7	1.4	1.7	0.0	0.4	40.9	0.0	4.3	0.3	0.0	0.1	0.3	0.8	0.0	1.4	0.1	0.1	0.0	0.1	0.1	3.5	1.5	1.0	1.7	1.3	1.5	4.5	1.5	1.4	1.0	2.5	1.6	1.9	2.5	2.1	1.4	1.5	1.0	0.8	14.5	30.3	1.5	13.3	11.1	4.2	22.8	2.3	20.0	23.4
SDCBP2	"SITAC18, ST-2"	ENSG00000125775	"Syndecan binding protein 2"	Q9H190	20	1309909-1329239	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 104.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 15.4;HBEC3-KT: 12.8;RT4: 11.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA054554, HPA064490"	Enhanced		Approved	Vesicles,Cytosol				Vesicles	Vesicles	"HPA054554: , HPA064490: AB_2732713"	"unprognostic (1.96e-2)"	"unprognostic (5.44e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.27e-2)"	"unprognostic (2.57e-2)"	"prognostic unfavourable (2.42e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.78e-3)"	"prognostic unfavourable (3.07e-4)"	"unprognostic (3.17e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"prognostic favourable (3.37e-4)"	1.7	0.4	5.2	10.6	6.7	0.2	1.5	1.5	4.9	6.6	59.4	1.2	0.9	46.1	1.5	9.1	32.4	0.9	35.1	1.3	3.5	3.6	2.5	3.8	3.7	0.9	2.8	1.0	1.2	4.4	0.2	1.4	1.9	1.4	3.7	19.0	1.0	6.4	1.9	1.1	13.4	104.7	2.5	1.1	1.1	34.0	1.5	1.6	1.0	4.0	12.5	24.3	17.0	9.8	1.2	2.6	4.4	2.0	2.1	5.3	1.8	8.7	0.4	1.2	0.4	5.1	4.5	0.8	2.7	5.3	2.5	2.4	1.9	15.4	0.9	1.8	1.0	6.8	0.4	12.8	1.2	0.3	0.9	0.7	0.6	1.2	5.2	0.9	1.0	1.6	9.1	1.9	1.9	8.4	1.2	0.7	0.9	2.1	1.4	2.5	1.2	0.6	1.3	0.6	1.7	1.0	11.9	2.1	1.6	1.3	7.8	3.0	0.4	0.7	5.6	1.3	0.5	2.4	1.0	2.4	2.2	0.9	0.6	3.4	0.8	0.4	2.0	4.4	2.4	0.7	1.8	0.6	3.2	2.5	2.6	1.2	2.7	4.7	2.2	2.1	1.3	1.7	5.3	1.8	5.2	6.7	1.5	4.9	3.5	3.6	2.8	1.0	1.4	1.6
SECTM1	K12	ENSG00000141574	"Secreted and transmembrane 1"	Q8WVN6	17	82321024-82334074	"Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 45.9;intestine: 103.1"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 26.8;BJ hTERT+: 27.0;BJ hTERT+ SV40 Large T+: 20.8;PC-3: 21.4;SiHa: 36.8;U-2197: 28.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"neutrophil: 45.9"	"Group enriched"	"Detected in many"	13	"granulocytes: 45.9;monocytes: 16.2"									HPA051214	Approved				"Secreted - unknown location"	26000000	26000000			"HPA051214: AB_2732565"	"unprognostic (2.42e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.69e-2)"	"unprognostic (4.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.55e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.17e-3)"	"unprognostic (7.75e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.31e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.01e-1)"	13.5	1.8	1.1	15.7	2.1	3.7	10.6	0.7	2.1	6.4	33.2	1.0	1.3	26.2	6.1	4.9	6.1	6.5	4.7	6.1	2.3	0.8	16.8	3.9	11.2	21.7	1.5	0.6	7.8	2.5	0.0	1.3	6.1	3.5	8.6	9.4	2.1	20.2	2.2	4.9	6.6	103.1	5.5	4.2	24.0	9.4	2.1	1.4	2.3	5.1	7.0	7.7	7.8	16.2	0.0	2.3	45.9	16.2	0.0	0.1	1.1	5.9	1.3	0.0	0.4	10.5	26.8	0.5	2.9	27.0	20.8	20.5	0.6	12.2	0.0	0.1	8.7	18.1	0.0	1.2	0.8	1.9	0.0	2.5	9.3	1.6	8.1	0.0	0.0	11.4	2.7	1.1	0.4	0.6	0.0	0.0	13.2	0.2	0.0	0.0	0.0	21.4	0.0	0.1	0.3	6.0	0.0	1.3	0.1	36.8	20.0	0.4	1.6	0.5	0.1	2.2	0.2	28.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	9.6	0.0	0.1	16.2	0.1	0.0	0.1	0.0	2.3	0.0	0.0	0.0	45.9	0.0	14.8	1.0	0.0	1.1	1.1	2.1	0.7	2.1	2.3	0.8	1.5	0.6	3.5	1.4
SELENBP1	"hSBP, hSP56, LPSB"	ENSG00000143416	"Selenium binding protein 1"	Q13228	1	151364302-151372733	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 112.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 38.1;HEL: 28.3;HSkMC: 19.6;SK-BR-3: 68.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	4	"myeloid DC: 4.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 4.8"					"Low region specificity"	"Detected in all"			"HPA005741, CAB008366, HPA011731"	Enhanced		Supported	Nucleoli		57000000	57000000	Nucleoli	Nucleoli	"CAB008366: AB_592677, HPA005741: AB_1856662, HPA011731: AB_1856663"	"unprognostic (1.51e-1)"	"unprognostic (7.01e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.25e-3)"	"unprognostic (6.28e-2)"	"prognostic favourable (6.63e-4)"	"unprognostic (1.08e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.78e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.98e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.86e-3)"	27.9	5.1	17.2	28.9	16.4	17.6	18.4	6.5	11.9	15.1	105.1	10.4	15.8	17.2	13.5	23.1	11.0	32.4	28.8	11.7	18.5	5.1	20.8	56.3	64.9	5.6	10.9	14.9	13.2	7.2	1.4	4.1	5.6	11.3	19.1	112.3	27.9	14.5	15.4	15.9	6.4	29.1	22.9	6.5	13.0	29.1	4.1	13.0	0.0	52.9	18.3	6.0	15.8	8.1	0.0	4.8	0.0	1.1	0.0	0.0	5.5	0.0	4.2	7.9	0.4	38.1	15.2	2.0	1.5	0.7	0.8	1.6	4.3	1.3	0.0	7.3	2.6	0.0	0.0	0.1	0.6	0.0	3.6	28.3	14.2	6.8	8.0	0.0	0.0	19.6	0.2	1.3	0.0	4.8	2.8	0.0	2.0	3.1	0.0	0.0	6.3	8.0	0.0	0.4	0.1	1.7	0.0	0.1	0.1	0.0	68.0	0.0	11.7	0.4	0.4	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.5	17.2	16.4	6.5	11.9	18.5	5.1	10.9	14.9	11.3	13.0
SELENOP	"SELP, SeP, SEPP, SEPP1"	ENSG00000250722	"Selenoprotein P"	P49908	5	42799880-42887392	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 248.3;liver: 403.8"	"Group enriched"	"Detected in many"	4	"Hep G2: 90.8;HSkMC: 79.4"	"Cancer enhanced"	"Detected in all"		"liver cancer: 116.7"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036287	Approved		Approved	"Nucleoplasm,Golgi apparatus"	"Secreted to blood"	2300000000	2300000000	"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA036287: AB_10794618"	"unprognostic (7.96e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.05e-1)"	"prognostic favourable (6.97e-6)"	"unprognostic (1.35e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.42e-1)"	53.8	31.4	17.5	13.5	54.6	2.2	41.1	11.9	24.0	34.9	56.8	52.8	24.2	40.9	22.3	39.0	20.5	26.2	44.4	26.6	27.6	17.5	57.5	403.8	55.0	30.4	106.2	16.1	49.1	15.3	18.2	21.4	62.7	63.6	30.5	48.5	27.1	19.5	41.2	16.4	18.1	248.3	16.1	137.1	87.1	21.6	19.6	70.3	6.3	24.5	14.7	11.3	30.0	33.0	2.2	3.6	2.2	0.7	2.7	2.4	1.4	0.1	0.3	1.3	0.1	7.5	2.1	1.3	0.6	1.9	0.0	0.0	2.0	10.7	0.3	6.7	0.2	0.3	0.0	0.0	0.0	0.4	8.7	0.5	0.0	90.8	4.6	0.5	0.0	79.4	0.1	0.0	0.0	0.0	1.0	2.2	3.9	0.2	0.1	1.1	5.2	0.1	0.2	0.3	15.6	2.1	1.2	0.3	0.5	0.4	2.7	0.2	21.2	0.1	0.1	0.5	0.3	0.9	0.1	1.4	0.2	0.3	0.3	1.0	0.2	0.3	0.6	1.8	2.2	0.6	2.4	1.6	1.6	1.7	1.2	2.2	2.4	2.0	2.2	2.7	0.7	3.6	1.5	1.4	17.5	54.6	11.9	24.0	27.6	17.5	106.2	16.1	63.6	70.3
SEMA4G	"FLJ20590, KIAA1619"	ENSG00000095539	"Semaphorin 4G"	Q9NTN9	10	100969518-100985871	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 44.0;liver: 33.9"	"Group enriched"	"Detected in many"	4	"A549: 13.7;CACO-2: 13.1;Hep G2: 47.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"memory B-cell: 2.4"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038362, HPA077752"	Uncertain		Uncertain	"Vesicles,Lipid droplets"	"Intracellular and membrane"	840000	840000	"Vesicles, Lipid droplets"	"Vesicles, Lipid droplets"	"HPA038362: AB_10669524, HPA077752: "	"unprognostic (3.90e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.55e-2)"	"unprognostic (8.11e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.14e-1)"	"unprognostic (3.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.05e-2)"	1.2	5.0	8.2	9.2	5.6	0.2	1.9	17.8	9.0	2.5	34.3	4.9	3.2	25.9	2.1	16.6	1.8	3.1	25.9	1.6	4.9	5.0	9.5	33.9	2.9	1.2	4.2	4.6	9.2	21.3	3.7	4.4	2.2	7.8	8.6	42.3	4.8	4.3	6.1	1.2	7.1	44.0	2.5	2.5	1.8	10.4	2.5	3.7	0.1	9.8	0.5	0.5	2.3	2.4	2.4	1.0	0.4	0.4	0.0	1.3	0.0	0.0	13.7	3.5	1.5	2.2	0.7	3.0	0.5	1.5	0.7	0.7	13.1	2.2	0.2	1.8	0.6	0.9	3.4	0.6	0.6	0.3	2.1	0.7	1.1	47.9	5.7	0.5	0.4	3.7	0.8	0.7	0.4	1.9	1.3	0.1	1.1	0.8	0.2	0.5	0.5	0.8	1.3	0.3	0.6	3.2	0.4	1.1	5.5	0.5	0.9	1.4	3.8	0.6	1.3	0.4	1.6	0.4	0.1	0.4	0.2	0.2	0.4	0.4	0.4	0.0	0.4	0.4	0.3	0.0	0.2	2.4	0.4	1.3	1.0	0.6	0.4	0.2	0.0	0.0	0.2	0.3	0.1	0.0	8.2	5.6	17.8	9.0	4.9	5.0	4.2	4.6	7.8	3.7
SEMA6D	"FLJ11598, KIAA1479"	ENSG00000137872	"Semaphorin 6D"	Q8NFY4	15	47184101-47774223	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.8;placenta: 36.7"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 13.9;SCLC-21H: 12.3;SH-SY5Y: 11.4;U-266/70: 9.1"	"Cancer enhanced"	"Detected in many"		"glioma: 8.9"	"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043109			Approved	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	480000	480000	"Plasma membrane"	"Plasma membrane"	"HPA043109: "	"unprognostic (2.00e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.24e-1)"	"unprognostic (5.36e-2)"	"unprognostic (7.96e-4)"	"unprognostic (1.42e-1)"	"prognostic favourable (5.96e-5)"	"unprognostic (3.74e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.30e-3)"	"unprognostic (2.39e-4)"	5.3	1.9	10.3	3.7	16.7	0.8	5.3	5.4	17.1	5.3	14.7	15.3	4.3	18.9	2.1	2.9	2.0	5.2	4.0	8.3	10.3	11.2	14.2	3.0	8.2	2.2	14.0	13.6	25.0	14.8	16.2	6.1	36.7	15.9	4.8	12.0	10.0	4.4	8.5	15.6	3.1	40.8	3.4	12.7	2.5	3.4	2.6	11.0	0.2	6.3	1.5	1.1	3.1	9.6	0.5	0.0	1.9	0.6	0.0	0.8	0.0	0.0	0.0	2.3	0.0	1.3	1.1	0.2	0.5	13.9	0.3	0.0	0.3	0.1	1.9	0.0	3.5	7.2	2.9	0.9	0.1	0.9	1.7	0.0	4.2	0.0	3.7	0.0	0.1	1.0	7.6	0.0	0.5	0.9	0.1	3.0	0.4	0.7	2.3	0.6	4.4	0.0	1.4	0.1	2.1	1.0	0.9	12.3	11.4	0.1	0.9	3.8	0.4	0.0	0.0	6.4	0.3	0.2	0.0	9.1	0.0	2.1	1.7	0.2	1.6	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.0	0.0	0.0	10.3	16.7	5.4	17.1	10.3	11.2	14.0	13.6	15.9	11.0
SEPHS2	"SPS2, SPS2b"	ENSG00000179918	"Selenophosphate synthetase 2"	Q99611	16	30443631-30446181	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 52.8;liver: 111.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 94.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA047931	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047931: AB_2680216"	"unprognostic (5.33e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.92e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.69e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.86e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.49e-1)"	"prognostic favourable (4.35e-8)"	"unprognostic (2.24e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.62e-2)"	9.0	9.0	4.9	6.9	6.4	4.0	6.7	6.3	8.4	5.3	25.6	5.2	5.5	26.6	7.6	6.1	6.0	6.1	12.6	5.3	5.2	5.1	32.8	111.2	5.8	7.6	5.5	3.8	5.2	10.0	7.3	6.4	7.5	7.7	6.6	13.1	6.2	10.6	4.7	11.1	5.5	52.8	4.9	4.4	10.5	12.1	3.0	4.6	14.1	11.9	6.4	9.5	8.1	4.4	14.6	15.3	20.5	13.7	23.2	18.9	8.9	14.5	13.2	4.7	16.2	14.4	9.2	12.3	10.1	12.5	9.9	12.3	8.1	11.1	20.9	15.6	10.6	8.1	8.6	9.2	10.1	13.3	26.6	20.9	7.1	38.2	18.2	11.6	94.5	11.7	19.7	9.3	17.4	9.1	16.8	13.6	8.8	21.5	17.4	23.9	11.6	9.9	17.0	8.2	16.0	12.2	13.1	9.9	8.5	8.6	25.3	32.7	22.2	38.7	7.6	10.4	7.4	10.0	6.0	11.8	18.8	10.9	9.0	21.6	11.5	6.1	12.9	20.5	11.2	11.2	17.1	12.4	15.9	16.1	15.3	14.6	18.9	12.9	12.9	23.2	13.7	10.9	15.1	8.9	4.9	6.4	6.3	8.4	5.2	5.1	5.5	3.8	7.7	4.6
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 25.4;intestine: 10.8"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 38.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	4	"midbrain: 2.0"	"Group enriched"	"Detected in some"	12	"intermediate monocyte: 2.3;non-classical monocyte: 6.0"	"Lineage enriched"	"Detected in single"	18	"monocytes: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced									"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.0	25.4	0.2	0.8	0.1	0.0	0.0	0.0	0.2	0.2	8.8	1.3	1.3	1.4	0.4	0.0	0.0	0.0	0.7	0.1	0.1	0.4	0.0	0.0	0.0	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	1.0	2.7	0.0	0.0	2.8	0.0	0.0	10.8	0.0	0.1	0.3	1.1	0.2	0.0	0.2	0.2	0.0	0.1	1.3	0.4	0.0	0.3	0.2	6.0	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.0	2.2	38.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.3	0.2	0.1	0.0	0.2	0.1	0.4	2.0	0.0	0.4	0.0
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490444-4587469	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.4;kidney: 31.2"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 13.6;HDLM-2: 30.9;HUVEC TERT2: 14.6;RPTEC TERT1: 30.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	30	"T-cells: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015466, HPA020086"	Approved									"CAB015466: AB_1278942, HPA020086: AB_1849766"	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favourable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	3.3	1.4	8.6	3.4	10.2	0.3	2.9	4.7	12.4	4.0	17.9	2.7	0.5	21.0	4.0	28.8	1.7	1.9	16.3	2.0	10.0	10.2	31.2	29.1	12.8	1.8	8.6	5.8	0.7	1.8	0.4	5.2	5.1	6.7	4.3	6.6	1.9	3.1	2.4	2.2	1.2	40.4	5.6	5.3	0.5	3.4	0.8	4.4	0.0	25.0	1.8	5.0	3.5	1.3	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.9	0.7	4.3	11.3	13.6	3.8	4.6	9.6	1.4	1.4	7.6	0.2	6.0	0.3	2.4	0.0	1.6	2.5	1.3	30.9	2.0	0.0	6.4	0.0	0.3	0.4	0.0	0.9	0.1	5.5	0.0	14.6	0.0	0.0	1.0	0.1	0.0	0.1	1.9	0.8	0.0	0.0	0.0	30.4	2.7	1.0	0.9	0.3	1.7	0.0	0.6	0.2	7.8	2.2	0.1	4.3	1.3	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	8.6	10.2	4.7	11.7	10.0	10.2	8.6	5.8	6.7	4.4
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 71.4;liver: 44.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 21.3;Karpas-707: 19.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced									"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	3.5	1.6	0.5	11.4	1.2	1.4	3.2	0.1	2.0	2.6	36.6	0.8	2.9	36.7	3.1	15.2	6.1	4.7	21.9	8.5	0.9	1.1	18.2	44.3	8.7	8.3	1.0	1.7	2.9	3.0	4.1	1.5	4.9	1.3	4.0	3.7	4.2	8.6	4.3	1.0	6.5	71.4	3.7	1.2	4.7	8.1	2.8	0.8	3.1	8.1	7.6	5.4	4.5	4.4	2.1	8.9	21.7	15.0	2.7	4.6	6.0	1.4	8.5	0.0	4.8	0.9	1.4	3.5	2.9	5.1	1.7	2.9	5.1	21.3	0.6	9.0	3.8	4.6	0.2	0.4	0.4	4.2	0.7	0.1	2.1	4.6	9.4	0.0	4.0	3.9	0.9	1.4	0.3	0.0	0.1	19.7	0.9	4.3	0.1	0.6	0.5	1.9	1.5	0.0	2.6	0.8	2.9	0.1	1.6	1.1	12.4	10.3	2.4	2.5	0.2	1.3	2.7	3.9	0.1	3.5	0.8	0.2	5.2	2.7	4.9	15.3	15.0	12.6	3.5	14.3	2.0	2.1	2.8	2.5	8.9	1.3	1.5	2.2	21.7	2.7	10.8	6.4	4.6	6.0	0.5	1.2	0.1	2.0	0.9	1.1	1.0	1.7	1.3	0.8
SLC22A18AS	"BWR1B, BWSCR1B, ORCTL2S, p27-BWR1B, SLC22A1LS"	ENSG00000254827	"Solute carrier family 22 member 18 antisense"	Q8N1D0	11	2887780-2903740	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 20.1;kidney: 13.4;liver: 13.6"	"Cell line enhanced"	"Detected in some"		"A549: 7.0;CAPAN-2: 6.9;MCF7: 13.0;SK-MEL-30: 24.1;WM-115: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"classical monocyte: 9.1"	"Group enriched"	"Detected in many"	10	"dendritic cells: 4.9;granulocytes: 5.2;monocytes: 9.1"									HPA068288	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA068288: AB_2685969"	"unprognostic (1.43e-1)"	"unprognostic (9.21e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.33e-3)"	"unprognostic (3.16e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.52e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	1.4	0.3	0.2	6.0	0.7	0.0	0.6	0.2	2.2	0.5	13.7	0.6	0.2	12.8	0.8	1.2	1.1	0.4	4.9	0.3	0.2	0.3	13.4	13.6	0.6	0.2	1.3	1.5	0.4	0.2	0.0	0.3	2.0	1.6	0.7	9.8	0.2	4.2	0.2	0.4	1.0	20.1	0.6	1.6	0.8	1.4	0.6	0.4	0.2	0.3	1.6	0.3	0.5	0.9	0.0	4.9	5.2	9.1	0.5	0.6	2.7	0.8	7.0	0.1	0.3	0.0	0.0	0.6	0.4	0.3	0.0	0.2	1.6	6.9	0.0	0.6	0.0	0.4	0.0	0.2	0.0	0.3	0.1	0.0	0.6	4.0	0.5	0.0	0.1	0.1	0.2	0.0	0.4	0.2	0.0	0.6	0.0	13.0	0.0	0.3	0.1	0.3	0.2	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.3	24.1	0.0	0.6	1.4	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.2	1.9	10.8	5.2	9.1	1.6	0.3	5.1	0.1	0.0	0.1	0.3	4.9	0.0	0.0	0.1	2.2	0.5	3.5	0.0	0.6	2.7	0.2	0.7	0.2	2.2	0.2	0.3	1.3	1.5	1.6	0.4
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 24.8;intestine: 94.3;liver: 25.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.0;HDLM-2: 6.9;Hep G2: 11.4;Karpas-707: 9.5;RPMI-8226: 9.2;U-266/70: 14.6"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"plasmacytoid DC: 4.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA047612	Enhanced									"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.3	0.0	0.3	0.5	0.5	0.8	0.3	0.3	0.3	2.3	22.1	0.3	0.8	11.6	0.3	1.6	0.3	24.8	1.8	0.3	0.3	0.3	18.0	25.4	0.6	0.4	0.3	0.3	0.4	0.9	0.0	0.3	0.3	0.4	2.7	0.3	0.3	1.0	0.6	0.3	1.0	94.3	0.3	0.3	0.8	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	0.3	1.2	4.4	0.7	0.1	0.0	0.3	0.0	0.3	1.8	0.3	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	8.0	1.1	4.9	2.6	0.0	0.2	0.0	0.0	0.1	6.9	0.1	0.1	0.6	11.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	9.5	0.0	0.2	4.7	0.9	0.1	0.1	5.7	0.2	9.2	0.4	0.3	0.2	0.3	0.2	1.7	0.0	4.4	0.1	0.3	0.3	0.2	0.1	0.0	14.6	1.7	6.4	0.1	0.4	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.0	0.7	0.0	0.1	4.4	0.3	0.0	0.3	0.5	0.3	0.3	0.3	0.3	0.3	0.3	0.4	0.3
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736405-15741396	"Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 38.8;skeletal muscle: 22.2"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 7.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"cerebellum: 10.4"	"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria				Mitochondria	Mitochondria	"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.5	2.4	1.2	0.9	1.9	2.8	0.7	10.4	1.8	1.1	25.9	0.8	0.5	13.5	1.7	1.4	1.6	1.3	3.6	13.3	1.5	1.2	7.3	3.9	1.1	1.1	0.7	1.8	2.4	18.6	0.6	2.1	1.2	1.5	1.1	1.9	3.7	11.1	0.8	22.2	0.8	38.8	1.0	1.1	1.9	1.4	2.3	1.2	0.5	1.9	11.0	1.9	0.7	1.1	0.7	0.5	2.0	0.5	2.2	4.1	1.1	0.7	0.5	3.5	1.6	1.7	0.7	1.5	0.5	0.3	0.9	0.7	1.5	1.9	0.9	0.8	0.7	0.7	0.6	0.6	0.8	1.2	0.7	1.5	1.2	0.5	0.6	0.4	2.2	0.8	2.7	1.1	0.5	0.4	0.6	3.3	0.6	1.8	3.7	2.0	2.9	1.0	2.0	3.1	1.0	0.3	0.1	0.7	2.8	0.8	1.0	7.5	1.9	2.5	1.8	1.7	2.2	2.3	0.6	3.9	3.6	0.7	0.6	2.2	1.4	1.2	0.5	0.4	1.4	0.2	3.1	0.5	3.0	2.0	0.2	0.7	4.1	2.3	2.0	2.2	0.2	0.5	1.3	1.1	1.2	1.9	10.4	1.8	1.5	1.2	0.7	1.8	1.5	1.2
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960737-149993455	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 81.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 23.6;RPTEC TERT1: 54.3;TIME: 27.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles				Vesicles	Vesicles	"HPA041957: , HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favourable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavourable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	8.5	15.6	2.6	23.2	3.7	1.3	4.7	6.3	2.3	3.8	81.9	3.0	29.4	5.4	4.8	14.2	8.3	3.1	2.6	3.1	2.5	2.6	3.8	1.6	6.8	5.3	3.7	2.3	5.1	2.9	21.4	11.1	16.9	7.6	6.1	75.0	4.9	27.9	36.7	11.2	6.0	13.4	4.3	5.5	3.0	2.4	2.8	3.0	5.2	2.7	4.4	13.0	4.1	2.8	1.6	1.7	7.0	3.3	2.5	3.0	1.1	3.2	3.0	3.7	6.1	4.5	3.2	0.8	3.1	2.8	2.5	3.0	15.3	1.8	2.5	23.6	3.2	2.3	3.5	7.1	4.5	2.0	2.2	3.2	2.4	1.7	3.4	5.8	5.4	3.5	4.2	4.1	5.4	5.9	0.8	2.5	10.4	1.0	2.2	3.0	1.1	4.7	3.2	5.8	1.3	54.3	14.4	1.1	2.9	5.4	1.3	9.2	2.5	3.4	27.9	5.7	4.3	5.0	3.6	1.8	2.4	1.5	5.2	7.1	8.2	7.0	1.1	0.8	2.5	0.8	3.0	1.3	1.5	2.1	1.7	1.6	2.1	2.2	1.0	2.5	3.3	1.7	2.6	1.1	2.6	3.7	6.3	2.3	2.5	2.6	3.7	2.3	7.6	3.0
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340646-128361470	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 56.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Supported	Vesicles				Vesicles	Vesicles	"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favourable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	7.7	7.1	9.9	7.0	13.6	2.5	4.9	9.4	26.5	6.5	25.7	15.8	5.2	54.0	6.6	5.6	26.1	4.4	9.8	7.7	11.6	15.9	17.7	20.8	5.8	5.0	14.8	9.6	5.6	11.3	9.8	5.4	5.8	21.9	5.7	8.3	6.7	7.5	7.3	6.7	24.3	56.1	8.1	11.6	5.1	8.6	13.2	7.9	6.8	12.7	15.2	14.9	8.5	9.5	3.7	7.2	2.6	6.2	1.9	8.1	3.3	10.2	20.1	10.3	13.2	15.7	4.8	11.8	8.7	5.5	10.0	7.3	14.4	10.0	9.6	7.0	9.3	35.2	12.4	10.0	3.1	9.6	19.0	5.7	17.7	12.4	8.4	10.5	9.2	6.3	13.7	10.4	8.3	11.4	13.5	6.7	9.2	25.2	12.4	10.0	4.6	32.0	15.2	10.1	17.8	17.2	15.4	17.9	9.8	14.5	26.7	9.5	13.3	4.0	16.7	12.1	11.8	13.1	10.7	6.0	8.5	3.1	12.3	6.3	13.6	0.0	4.1	2.6	8.1	5.6	6.1	3.7	5.2	6.4	7.2	1.7	4.1	4.3	1.6	1.9	6.2	6.4	3.6	3.3	9.9	13.6	9.4	26.5	11.6	15.9	14.8	9.6	21.9	7.9
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035107-9088478	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.7;intestine: 84.1"	"Group enriched"	"Detected in some"	5	"Daudi: 50.1;THP-1: 12.8;U-266/70: 40.4;U-698: 47.1;U-937: 18.1"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	6	"naive B-cell: 19.7"	"Lineage enriched"	"Detected in many"	7	"B-cells: 19.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA005449	Enhanced									"HPA005449: AB_1078985"	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	5.2	2.2	10.3	4.1	15.0	36.7	3.7	1.1	9.9	2.4	50.4	9.2	0.7	44.8	0.8	4.9	2.5	1.5	0.6	1.4	8.6	6.0	16.2	0.6	0.9	8.1	14.1	2.4	1.6	0.6	0.5	1.9	2.1	10.4	6.7	1.6	0.8	1.8	2.4	25.1	3.1	84.1	1.9	17.8	3.1	0.7	30.2	15.4	0.0	0.8	3.7	7.3	1.8	2.5	19.7	0.7	3.0	2.1	0.6	0.3	0.8	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.2	0.0	0.1	0.3	0.0	50.1	0.0	0.1	0.1	0.4	0.0	0.1	6.5	0.0	0.0	0.9	0.0	0.1	0.8	0.5	0.7	0.7	0.1	0.0	0.0	0.1	0.7	0.0	0.0	0.3	2.8	0.0	0.0	1.3	0.0	1.5	0.0	0.5	0.1	0.1	0.1	0.1	0.2	0.0	12.8	0.0	0.8	0.2	0.1	0.0	40.4	0.0	47.1	0.0	18.1	0.1	3.0	2.1	0.2	0.2	0.5	0.1	3.4	0.2	0.2	0.7	19.7	0.3	0.2	2.2	0.6	0.1	0.4	0.1	0.8	10.3	15.0	1.1	9.9	8.6	6.0	14.1	2.4	10.4	15.4
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236554	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 10.4;kidney: 14.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 5.9;HDLM-2: 3.6;HeLa: 3.9;MCF7: 9.5"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced									"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.2	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.5	0.2	0.2	3.6	0.5	0.2	0.2	0.2	0.0	14.8	0.2	0.2	0.2	0.2	0.2	0.2	0.6	0.0	1.6	0.2	0.2	0.2	0.0	0.2	1.2	0.2	0.2	0.3	10.4	0.2	0.2	0.2	0.4	0.3	0.2	0.2	0.3	0.2	0.2	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	1.7	0.7	2.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.5	5.9	0.4	0.2	0.0	2.9	0.0	0.0	0.0	3.6	0.2	0.0	3.9	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	9.5	0.1	0.1	0.6	1.1	1.3	0.5	0.0	0.0	0.5	0.0	1.4	0.6	1.4	0.3	3.3	0.1	0.3	0.5	0.4	1.9	0.1	1.1	0.4	0.4	0.8	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.0	0.2	0.2	0.2	0.2
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.9"	"Cell line enhanced"	"Detected in many"		"HEL: 48.6;MCF7: 19.3;SK-BR-3: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved									"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favourable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favourable (3.43e-5)"	"unprognostic (1.61e-2)"	4.7	6.6	7.2	15.8	5.3	7.5	7.3	8.0	6.1	6.3	28.6	2.7	5.1	31.0	2.4	10.6	9.8	6.9	18.4	2.3	3.4	4.9	4.7	4.0	8.0	6.1	3.5	4.6	3.9	4.8	2.2	14.0	9.7	3.9	10.8	13.7	5.5	14.5	9.0	6.4	4.6	45.9	3.0	7.1	7.0	16.7	16.8	3.3	9.3	9.3	4.4	16.2	7.1	5.9	7.8	13.1	23.0	10.5	4.1	6.7	4.0	5.2	2.1	0.5	1.0	0.0	0.1	4.6	0.2	0.0	0.2	0.1	1.2	10.7	3.7	5.5	0.0	2.1	1.0	2.7	0.0	1.7	2.6	48.6	1.8	0.1	1.3	1.0	4.8	0.3	1.6	0.0	0.1	1.6	0.9	5.2	0.0	19.3	3.6	2.7	3.7	1.2	3.8	0.0	0.1	4.5	10.0	5.7	0.7	3.1	16.9	1.2	6.3	5.4	2.8	0.0	1.0	0.0	0.0	10.0	6.2	3.6	0.0	8.0	0.5	2.1	3.2	23.0	5.2	8.6	6.7	7.8	3.6	4.6	4.6	5.4	3.1	4.3	3.8	4.1	10.5	13.1	1.8	4.0	7.2	5.3	8.0	6.1	3.4	4.9	3.5	4.6	3.9	3.3
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 77.8;liver: 38.2;pancreas: 101.1"	"Group enriched"	"Detected in some"	60	"CACO-2: 22.2;Hep G2: 32.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 0.9"	"Low region specificity"	"Detected in many"			HPA018423			Approved	Nucleoplasm,Vesicles				Vesicles	Vesicles	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favourable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.2	0.1	0.2	4.1	0.2	0.0	0.2	0.2	0.2	0.2	40.5	0.2	0.2	48.6	0.2	2.3	0.2	0.1	5.9	0.2	0.2	0.1	22.5	38.2	0.2	0.2	0.2	0.2	0.2	101.1	0.0	0.2	0.2	0.2	0.2	9.1	0.2	0.2	0.2	0.2	0.1	77.8	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	22.2	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	32.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 66.0;kidney: 191.5;pancreas: 36.8"	"Cell line enriched"	"Detected in some"	17	"RPTEC TERT1: 48.7"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"				Mitochondria	Mitochondria	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favourable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.2	0.1	0.2	0.7	0.2	0.0	0.2	0.7	0.2	0.3	28.4	0.1	0.1	18.8	1.3	4.6	0.2	0.2	17.9	0.1	0.2	0.2	191.5	5.3	0.2	0.1	0.2	0.1	0.2	36.8	0.0	0.2	0.5	0.1	0.3	3.7	0.2	0.1	0.1	0.2	0.2	66.0	0.1	0.2	0.2	0.3	0.5	0.1	0.1	0.2	0.1	0.1	0.2	0.2	4.0	1.3	2.0	1.3	1.6	2.7	0.3	0.0	0.9	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	2.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.1	0.2	48.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.1	1.3	1.3	1.0	2.6	1.3	1.9	1.9	2.5	1.4	0.4	4.0	2.5	2.7	2.0	1.6	0.6	1.3	0.9	0.3	0.2	0.2	0.7	0.2	0.2	0.2	0.2	0.1	0.1	0.1
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.1;liver: 54.1"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 29.3;SK-BR-3: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"myeloid DC: 4.4;plasmacytoid DC: 13.0"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved									"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favourable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavourable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	6.1	7.0	3.8	5.2	3.9	0.5	7.1	9.2	5.4	4.9	19.9	2.3	15.9	14.5	3.0	7.9	1.6	2.1	6.8	3.0	2.9	5.5	4.6	54.1	4.5	2.0	2.8	4.0	4.2	12.0	5.7	21.5	16.1	3.4	2.2	7.2	2.0	5.9	14.9	0.9	1.6	37.1	4.0	2.4	1.9	16.8	4.3	2.1	1.0	5.8	0.3	2.7	2.2	2.7	0.6	13.0	0.3	0.2	0.3	0.9	0.3	5.9	13.6	0.5	2.9	11.7	8.5	5.4	4.2	6.9	2.9	5.0	8.5	5.8	2.4	4.6	8.3	0.6	3.1	1.4	5.6	29.3	7.7	0.2	5.5	3.8	2.6	0.9	3.4	2.9	1.2	3.1	0.9	3.7	0.2	6.4	0.5	2.7	1.2	0.0	1.3	4.4	0.5	6.0	5.8	11.8	0.1	5.5	1.4	7.2	24.1	1.1	9.4	0.0	1.1	4.5	3.2	4.7	4.7	7.7	9.5	3.2	7.1	0.5	3.1	0.2	0.2	0.0	0.2	0.1	0.9	0.6	0.2	0.1	4.4	0.3	0.4	0.2	0.3	0.3	0.1	13.0	0.1	0.3	3.8	3.9	9.2	5.4	2.9	5.5	2.8	4.0	3.4	2.1
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 34.6;intestine: 65.7"	"Group enriched"	"Detected in some"	4	"CAPAN-2: 4.5;Hep G2: 4.2;RT4: 3.4;SK-BR-3: 1.9;TIME: 3.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"plasmacytoid DC: 2.0"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA046977, HPA054176"	Enhanced									"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favourable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favourable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favourable (6.06e-4)"	0.3	2.4	0.2	11.2	0.3	0.2	2.1	0.2	0.3	5.9	43.6	0.3	7.6	23.7	2.9	3.0	0.6	10.9	34.6	0.2	0.2	0.0	20.4	0.3	9.1	0.6	0.2	0.2	4.9	7.3	0.0	5.0	5.1	0.5	25.7	8.6	0.3	12.0	4.4	0.2	0.1	65.7	1.2	0.2	0.6	23.7	0.8	0.2	0.4	0.5	0.7	4.2	6.3	1.9	0.0	2.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.8	0.0	3.4	0.0	0.3	0.0	1.9	0.0	0.7	0.5	3.4	0.0	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.0	0.0	0.0	0.2	0.3	0.2	0.3	0.2	0.0	0.2	0.2	0.5	0.2
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394756-28407197	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 52.7"	"Cell line enriched"	"Detected in many"	5	"CACO-2: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavourable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	3.1	17.8	4.6	2.5	7.0	1.3	5.1	13.2	5.2	2.9	43.8	5.2	9.4	45.4	2.2	4.5	1.8	6.7	3.0	2.2	4.4	6.0	3.8	17.9	3.2	4.9	4.0	4.0	4.4	5.0	8.1	7.8	5.0	5.0	3.7	2.7	6.1	5.7	5.8	2.0	2.0	52.7	2.6	4.6	4.9	2.3	2.2	4.2	2.2	4.0	0.4	1.2	2.4	2.4	2.7	2.6	7.1	5.9	2.9	1.7	0.8	1.7	7.3	2.4	4.0	2.0	0.4	7.6	2.0	1.5	1.7	1.9	66.1	2.1	0.2	1.2	1.1	5.6	2.7	4.6	1.4	4.2	6.4	0.0	4.5	5.6	0.7	0.0	3.3	0.9	8.5	1.8	5.3	0.1	2.8	0.4	0.3	2.3	0.0	0.2	1.4	0.9	0.1	2.0	0.8	1.3	3.8	6.5	3.4	14.2	6.6	0.9	5.1	1.1	0.2	0.2	2.9	0.4	2.1	3.0	3.4	0.1	0.4	0.4	1.5	7.1	1.6	1.1	0.8	5.9	1.4	2.7	0.9	0.7	2.6	1.7	1.0	1.7	2.3	2.9	4.3	1.1	1.6	0.8	4.6	7.0	13.2	5.2	4.4	6.0	4.0	4.0	5.0	4.2
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 62.9;liver: 50.0"	"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 20.4;T-47d: 15.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"				"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favourable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	6.9	14.2	3.8	5.9	5.7	1.4	6.4	7.6	6.5	8.3	19.6	6.9	2.8	24.0	5.2	7.4	3.1	4.1	12.7	8.1	4.2	4.2	10.4	50.0	6.0	11.4	4.7	3.9	5.0	5.5	4.2	18.2	5.0	6.6	5.3	10.1	17.4	10.3	5.6	8.2	4.0	62.9	4.5	5.1	11.6	4.8	9.3	3.7	11.8	6.8	3.0	6.9	6.1	4.7	9.1	10.4	22.6	15.9	5.6	11.2	7.4	0.0	2.0	0.0	5.5	4.5	1.8	0.1	2.0	11.1	2.2	3.2	0.1	4.7	3.8	3.7	2.8	0.4	2.5	1.0	3.3	2.8	4.9	2.5	0.0	0.0	8.4	0.0	3.3	7.2	2.1	3.3	5.4	4.0	2.7	0.0	10.5	2.0	6.2	0.4	0.2	1.7	2.6	9.9	0.1	20.4	0.6	0.9	0.3	0.0	10.1	4.0	15.0	3.3	1.5	1.1	2.1	0.3	11.7	3.1	1.5	0.5	0.6	0.0	2.0	22.6	8.0	3.0	9.8	11.5	8.4	6.6	7.9	9.6	10.4	9.1	11.2	10.6	8.2	5.6	15.9	9.7	9.2	7.4	3.8	5.7	7.6	6.5	4.2	4.2	4.7	3.9	6.6	3.7
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 48.5"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"				"Plasma membrane"	"Plasma membrane"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavourable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	14.5	5.0	3.2	10.5	4.6	3.3	17.0	4.0	4.8	10.8	38.2	5.0	8.8	48.5	8.1	12.6	8.4	6.5	12.5	9.3	5.0	3.8	15.3	3.7	9.3	10.3	4.8	1.9	9.0	3.3	2.4	4.4	5.6	4.5	10.3	6.9	20.0	8.3	8.4	5.6	5.6	43.4	18.2	5.8	9.7	7.8	6.1	5.5	6.8	6.3	14.7	15.5	15.0	14.9	1.8	2.0	0.1	0.9	2.4	3.9	0.7	5.8	10.9	9.9	4.6	4.6	8.3	7.1	20.0	9.3	7.7	6.0	3.0	3.0	13.4	1.7	7.7	2.5	9.4	9.7	12.3	11.3	3.1	6.1	7.5	3.2	8.0	13.8	5.4	6.6	4.2	11.7	37.8	12.6	4.0	4.7	15.8	2.1	13.8	3.2	6.5	10.9	9.4	7.9	2.6	18.1	4.2	2.5	6.2	9.1	6.8	3.1	15.4	5.4	8.8	18.2	5.1	12.5	15.4	1.8	1.9	7.7	15.9	9.8	8.3	0.0	0.5	0.0	3.0	0.6	2.0	1.2	3.8	3.9	1.4	1.8	1.5	2.7	0.1	2.4	0.9	2.0	3.2	0.7	3.2	4.6	4.0	4.8	5.0	3.8	4.8	1.9	4.5	5.5
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 48.0;intestine: 21.8"	"Group enriched"	"Detected in some"	6	"Hep G2: 18.4;Karpas-707: 5.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.6	0.6	4.3	0.6	21.8	0.5	2.8	1.9	11.2	0.6	1.7	29.7	0.0	10.9	0.6	0.5	0.5	0.6	1.4	0.7	12.1	7.4	9.9	1.0	0.6	0.7	48.0	2.4	0.6	0.5	0.5	0.2	0.5	18.3	0.6	0.8	0.0	0.6	0.8	0.7	0.5	21.8	0.5	34.7	0.6	0.6	0.8	22.9	0.0	0.6	0.0	0.7	0.6	0.1	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	18.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	5.2	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.3	21.8	1.9	8.0	12.1	7.4	48.0	2.4	18.3	22.9
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 25.0;lung: 50.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CACO-2: 5.4;Hep G2: 14.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Region enriched"	"Detected in single"	36	"pons and medulla: 11.2"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Region enriched"	"Detected in some"	5	"midbrain: 69.9"	"Low region specificity"	"Detected in all"			"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"				"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.2	0.3	0.2	0.2	0.1	0.1	6.3	0.1	0.3	1.6	0.9	0.1	0.7	0.1	0.1	0.3	0.1	50.5	0.1	0.1	0.1	0.1	0.6	0.0	0.1	11.3	11.2	0.1	0.0	0.2	0.7	0.1	0.1	0.4	25.0	0.4	0.1	0.1	0.5	0.3	0.1	0.1	0.2	0.1	0.3	0.1	0.3	0.0	0.1	1.0	0.2	0.4	0.3	2.3	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	14.4	1.4	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.1	0.0	1.0	0.0	0.8	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.0	0.4	0.2	0.1	0.0	2.3	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.1	11.2	0.1
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 63.8;intestine: 93.5;kidney: 67.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 48.1;CACO-2: 78.0;EFO-21: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"intermediate monocyte: 59.5;non-classical monocyte: 63.8"	"Lineage enriched"	"Detected in many"	4	"monocytes: 63.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced									"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavourable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	10.4	2.8	1.9	8.3	3.1	3.6	3.2	0.7	2.7	2.6	48.0	4.1	0.2	24.1	2.7	2.3	2.1	4.6	7.6	3.0	2.2	1.6	67.3	6.5	15.3	20.5	3.7	1.0	2.6	2.7	26.3	1.0	6.5	3.2	2.7	3.4	2.1	3.3	0.9	1.6	1.8	93.5	3.5	4.5	32.4	3.0	13.4	2.7	2.1	2.8	0.8	5.7	4.1	3.6	3.0	14.6	5.4	63.8	0.0	0.1	17.8	0.0	2.6	0.2	0.1	0.4	0.9	48.1	0.5	3.9	0.1	0.3	78.0	7.9	3.8	16.9	0.3	2.9	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.8	2.3	0.4	0.4	1.7	0.2	0.2	0.1	6.0	0.0	3.0	0.6	0.1	0.0	0.3	0.8	0.0	0.6	8.4	2.2	0.2	0.2	0.0	0.2	0.1	0.1	0.5	0.1	1.8	0.3	0.2	0.4	0.1	0.1	0.6	0.2	2.0	0.2	0.2	0.0	0.0	41.2	0.1	0.0	59.5	0.0	3.0	0.0	0.0	14.6	2.3	0.1	0.0	5.4	0.0	63.8	0.5	0.1	17.8	1.9	3.1	0.7	2.7	2.2	1.6	3.7	1.0	3.2	2.7
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619707-102711318	"Plasma proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 16.8;intestine: 16.1;stomach 1: 19.8"	"Cell line enhanced"	"Detected in some"		"A-431: 8.1;CACO-2: 5.6;MCF7: 6.3;RT4: 14.2;SK-BR-3: 12.6;T-47d: 15.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"				"Cell Junctions"	"Cell Junctions"	"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.2	0.4	0.9	10.8	1.4	0.0	1.0	0.5	1.9	1.0	15.0	0.6	8.4	4.6	0.2	5.8	0.5	0.2	16.8	0.2	1.5	1.0	4.6	0.2	0.2	0.0	0.9	0.7	0.2	0.2	0.1	1.7	0.0	1.8	4.5	16.1	0.9	3.7	11.7	4.4	1.3	9.5	0.4	1.3	0.2	19.8	5.3	0.6	1.0	0.6	1.8	3.1	2.8	0.2	0.0	0.0	0.3	0.0	0.3	0.1	0.0	8.1	5.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.2	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.0	0.2	2.8	2.5	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	6.3	0.0	0.1	0.2	4.3	0.0	0.0	0.0	1.0	14.2	0.0	0.0	0.0	12.6	0.0	15.8	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.9	1.4	0.5	1.9	1.5	1.0	0.9	0.7	1.8	0.6
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470458-524332	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.8;intestine: 85.1;kidney: 43.6"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 27.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Region enriched"	"Detected in single"	14	"cerebellum: 4.6"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavourable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	0.6	0.6	0.5	16.2	1.0	0.0	0.6	4.2	0.9	0.9	27.5	0.7	1.1	12.7	0.9	3.4	2.4	0.8	65.8	0.6	0.6	0.6	43.6	0.5	0.5	0.9	0.9	0.7	0.8	1.1	0.6	0.9	0.5	1.2	1.4	2.3	1.2	2.1	0.8	0.7	4.2	85.1	1.1	0.6	0.5	22.7	1.1	0.5	0.6	0.7	2.4	2.7	0.8	2.0	1.9	2.0	0.2	1.2	3.5	6.8	2.9	4.2	3.8	6.9	7.3	1.6	1.9	5.5	4.2	2.4	5.1	3.2	9.2	4.8	10.1	5.5	1.8	6.9	3.8	2.5	2.5	27.9	7.2	4.6	16.3	3.3	2.6	3.4	5.9	2.7	5.2	2.2	3.5	1.5	6.0	5.3	1.8	6.5	3.7	16.5	2.6	6.2	5.5	6.5	5.3	1.7	3.6	7.8	3.3	12.5	3.5	2.6	7.9	2.6	1.9	5.9	5.3	4.0	2.6	8.9	3.6	5.7	3.7	15.1	3.7	0.0	1.2	0.1	4.3	0.5	3.8	1.6	5.6	4.1	1.4	1.9	6.8	5.2	0.2	3.5	0.4	2.0	4.2	2.9	0.5	1.0	4.2	0.9	0.6	0.6	0.9	0.7	1.2	0.5
SLX1A	GIYD1	ENSG00000132207	"SLX1 homolog A, structure-specific endonuclease subunit"	Q9BQ83	16	30193887-30197561	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.2;intestine: 26.0"	"Cell line enhanced"	"Detected in many"		"U-266/70: 43.7"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"											HPA047038	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA047038: AB_2679913"	"unprognostic (3.46e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.60e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.67e-1)"		"unprognostic (1.26e-6)"	"unprognostic (2.52e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.86e-1)"	3.4	5.2	2.9	7.7	1.7	7.7	3.7	0.7	1.9	2.0	8.2			26.0	1.6	0.0	5.4	1.0	2.7	4.2	2.7	2.5	7.1	13.1	3.5	5.4	3.0		0.5	6.7	0.9	2.3	2.9		1.8	2.6		2.9	1.5	4.9	3.1	19.6	1.5	2.8	9.5	12.6	0.3			2.1		3.7	3.7	1.9	19.4	35.8	41.6	44.2	17.7	30.6	26.4	15.3	9.6	3.5	3.9	1.0	0.8	21.7	3.4	3.2	1.4	1.3	2.0	11.0	6.3	14.0	2.1	12.2	1.0	1.8	1.6	11.3	11.1	6.5	3.2	19.0	2.2	7.7	17.8	0.9	3.0	1.2	1.7	1.3	5.7	12.2	1.3	15.5	10.0	26.8	11.1	6.4	29.6	0.6	33.7	3.4	4.9	7.0	18.8	0.0	30.0	7.1	5.3	6.7	0.0	9.2	10.6	9.2	5.1	43.7	16.8	5.8	10.2	8.0	6.3	5.8	44.2	41.6	23.5	40.9	16.7	19.4	17.6	19.1	35.8	18.1	8.8	14.9	16.1	17.7	32.5	18.3	30.6	26.4										
SMIM22		ENSG00000267795	"Small integral membrane protein 22"	K7EJ46	16	4788397-4796491	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.3"	"Group enriched"	"Detected in some"	7	"CAPAN-2: 72.8;RT4: 26.8;SCLC-21H: 19.0;SK-BR-3: 54.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA077331			Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA077331: AB_2686834"	"unprognostic (6.55e-2)"	"unprognostic (4.12e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.69e-3)"	"unprognostic (7.82e-2)"	"unprognostic (3.84e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.67e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.27e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.73e-3)"	0.8	0.0	0.8	14.4	0.8	0.2	10.9	0.8	0.8	10.8	47.0	0.9	37.8	27.5	2.5	12.1	2.6	18.0	28.1	0.8	0.8	0.0	6.2	0.9	6.8	0.8	0.8	0.8	2.8	36.2	0.0	12.1	4.1	0.8	10.2	28.1	0.8	42.2	35.3	0.8	2.2	54.3	1.7	0.8	0.8	41.7	27.2	0.8	1.0	0.9	2.8	4.5	18.5	3.6	1.9	1.5	3.9	1.3	0.9	1.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	72.8	0.0	2.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.2	0.0	0.2	0.1	6.2	0.3	26.8	19.0	0.3	0.1	54.7	0.0	4.3	0.0	0.0	0.2	0.2	0.3	0.0	0.1	0.1	0.1	0.0	0.2	0.1	3.9	1.3	1.6	1.3	0.5	0.6	0.7	1.3	0.6	0.3	1.9	1.6	0.7	3.3	0.9	0.6	1.5	0.9	0.3	0.8	0.8	0.8	0.8	0.8	0.0	0.8	0.8	0.8	0.8
SMIM24	"C19orf77, HSPC323"	ENSG00000095932	"Small integral membrane protein 24"	O75264	19	3473986-3480542	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 160.8;intestine: 204.2;kidney: 76.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 45.8;HEL: 21.6;Hep G2: 34.2;MOLT-4: 32.6;REH: 17.9;U-937: 25.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 78.4"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in many"		"NK-cell: 8.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"							"HPA045046, HPA056027"	Enhanced		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Nucleoplasm	"HPA045046: AB_10964444, HPA056027: AB_2683012"	"unprognostic (2.18e-4)"	"unprognostic (4.63e-1)"	"unprognostic (5.68e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.07e-1)"	"prognostic favourable (4.13e-10)"	"unprognostic (1.68e-2)"	"unprognostic (2.14e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.11e-2)"	0.2	0.1	0.7	0.6	0.9	7.0	0.3	0.2	2.2	0.2	137.0	0.4	2.4	71.4	0.2	160.8	0.3	0.3	46.7	0.3	0.4	0.5	76.9	7.2	0.3	0.3	0.4	0.6	0.3	1.6	0.0	0.9	0.2	0.3	0.3	2.0	0.2	0.3	0.4	0.2	0.3	204.2	0.2	0.6	0.4	24.8	1.2	0.3	8.8	0.2	0.2	0.2	0.2	0.2	3.2	2.4	3.0	0.0	8.6	2.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	45.8	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.2	34.2	0.0	1.8	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	32.6	4.6	0.0	0.0	17.9	0.0	1.2	0.4	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	1.8	0.0	25.7	0.0	3.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.7	1.7	0.0	8.6	0.0	2.4	2.1	1.1	0.7	0.9	0.2	2.2	0.4	0.5	0.4	0.6	0.3	0.3
SMIM33		ENSG00000283288	"Small integral membrane protein 33"		5	139470778-139474772	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"			"Tissue enhanced"	"Detected in some"		"blood: 3.5;intestine: 5.8"	"Cell line enhanced"	"Detected in some"		"U-937: 2.8"									"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 2.2;T-cells: 3.5"	"Not detected"	"Not detected"																																			0.0	0.0		0.4		0.4	0.0		0.0	1.2	3.9			1.1	0.0	0.0	0.0	0.0	0.1	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	5.8		0.0	0.0	0.0	0.0	1.3	0.0		0.0	1.0	0.0			0.0		0.0	0.0		0.3	2.2	0.3	0.1	0.6	3.5	0.5	0.6	0.5	0.4	0.4	0.0	0.0	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.5	0.4	0.3	0.4	0.2	0.1	0.0	0.6	0.3	0.3	0.2	0.3	0.1	0.0	0.3	0.4	0.1	0.0	0.1	0.0	0.1	0.3	0.1	0.4	1.3	0.9	0.1	0.1	0.6	0.0	0.2	0.2	0.2	0.7	0.4	0.1	0.9	0.0	0.6	0.7	1.2	0.0	0.3	0.4	0.3	0.3	0.1	0.2	0.1	2.8	0.5	0.1	0.1	0.0	2.3	0.0	3.5	0.3	3.1	2.2	0.0	0.1	0.8	0.4	0.3	0.6	0.0	2.2	1.6	0.5										
SMPD3	NSMASE2	ENSG00000103056	"Sphingomyelin phosphodiesterase 3"	Q9NY59	16	68358325-68448688	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 44.5;intestine: 46.4;lymphoid tissue: 73.0"	"Cell line enhanced"	"Detected in some"		"HMC-1: 9.4;MOLT-4: 13.4;RPMI-8226: 11.1;SCLC-21H: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"plasmacytoid DC: 44.5"	"Lineage enriched"	"Detected in many"	7	"dendritic cells: 44.5"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.1"	"Low region specificity"	"Detected in all"			"CAB033885, HPA065535, HPA069383"	Approved		Supported	"Endoplasmic reticulum"				"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB033885: AB_1126788, HPA065535: , HPA069383: "	"unprognostic (1.21e-1)"	"prognostic favourable (7.72e-4)"	"unprognostic (5.61e-3)"	"prognostic favourable (3.86e-4)"	"unprognostic (2.46e-1)"	"unprognostic (5.85e-4)"	"unprognostic (7.87e-2)"	"unprognostic (8.12e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.04e-3)"	"unprognostic (5.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-3)"	3.5	2.3	6.0	3.1	18.3	1.8	1.6	9.4	15.4	1.0	9.6	2.5	0.0	46.4	1.7	0.7	1.8	2.7	17.2	1.2	8.7	3.6	0.9	3.8	2.1	3.5	2.5	5.0	2.7	1.9	0.7	10.7	0.8	3.9	2.2	5.8	4.3	2.2	0.9	1.8	8.1	42.7	1.2	1.4	3.0	18.6	4.2	4.4	73.0	1.3	1.3	4.3	1.6	1.2	0.6	44.5	6.1	0.0	0.0	0.7	0.3	0.3	0.7	0.3	0.1	0.0	0.0	5.2	0.4	0.0	0.4	0.1	2.9	0.9	0.4	0.5	0.2	1.1	0.0	0.0	0.1	0.3	0.7	0.1	2.1	0.3	0.0	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.8	0.3	0.3	0.2	13.4	2.5	0.6	0.1	0.6	0.2	11.1	0.0	0.1	12.9	2.5	0.4	1.5	0.6	1.0	0.8	0.0	0.4	0.8	1.4	0.1	2.1	1.1	0.2	0.2	0.8	0.2	1.0	0.0	6.1	0.7	0.0	0.1	0.6	0.0	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.0	44.5	0.5	0.3	6.0	18.3	9.4	15.4	8.7	3.6	2.5	5.0	3.9	4.4
SMPDL3B	ASML3B	ENSG00000130768	"Sphingomyelin phosphodiesterase acid like 3B"	Q92485	1	27934993-27959157	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.0;pancreas: 48.0;salivary gland: 25.5;thyroid gland: 24.4"	"Cell line enhanced"	"Detected in many"		"BEWO: 22.6;CAPAN-2: 17.4;NTERA-2: 13.5;RPMI-8226: 14.0;SK-BR-3: 22.6;T-47d: 16.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.6"	"Group enriched"	"Detected in some"	7	"eosinophil: 6.3;myeloid DC: 2.7;neutrophil: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.7;granulocytes: 6.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA030561			Approved	"Golgi apparatus,Cytosol"	"Secreted to blood"	330000	330000	"Golgi apparatus, Cytosol"	"Golgi apparatus, Cytosol"	"HPA030561: "	"unprognostic (1.22e-2)"	"unprognostic (4.45e-1)"	"unprognostic (4.58e-3)"	"unprognostic (3.83e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.95e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.09e-3)"	1.3	0.2	1.1	2.7	1.4	0.6	2.7	5.6	1.2	1.3	14.0	0.5	0.5	12.5	1.1	8.6	1.1	3.5	3.6	0.5	0.8	0.5	5.8	0.8	7.3	2.0	0.3	0.9	1.3	48.0	5.0	1.5	1.0	1.0	2.3	12.6	1.3	25.5	0.5	0.3	0.9	25.0	0.8	0.8	1.6	9.1	1.0	0.3	0.7	24.4	1.4	3.5	1.4	0.5	0.5	2.7	6.3	0.3	0.5	0.2	0.2	2.5	1.2	0.0	0.1	0.0	0.0	22.6	0.0	0.5	0.3	1.7	5.7	17.4	0.8	4.1	0.0	2.8	1.8	1.5	0.2	0.0	11.6	3.7	0.2	1.4	0.0	1.2	0.0	0.1	1.4	3.4	0.2	0.4	0.5	0.2	0.0	9.2	0.0	0.3	13.5	2.1	0.2	0.1	14.0	12.2	4.5	11.7	0.2	0.0	22.6	0.6	16.3	0.7	0.0	0.0	3.9	0.0	0.0	0.1	5.9	0.3	0.3	0.0	0.0	0.4	0.3	6.3	0.0	0.3	0.0	0.5	0.1	0.0	2.7	0.5	0.2	0.0	3.8	0.5	0.0	0.1	0.0	0.2	1.1	1.4	5.6	1.2	0.8	0.5	0.3	0.9	1.0	0.3
SMTN		ENSG00000183963	Smoothelin	P53814	22	31064105-31104757	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 99.3"	"Cell line enhanced"	"Detected in all"		"WM-115: 55.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001721, HPA051778, HPA058590"	Enhanced		Supported	"Nucleoplasm,Actin filaments"		11000	11000	Nucleoplasm	Nucleoplasm	"CAB001721: , HPA051778: AB_2681607, HPA058590: "	"unprognostic (1.36e-2)"	"unprognostic (4.84e-3)"	"unprognostic (5.59e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.38e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.05e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.22e-2)"	"prognostic unfavourable (2.73e-5)"	"unprognostic (2.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (8.41e-3)"	"unprognostic (6.34e-2)"	17.4	3.3	5.0	8.3	3.8	1.5	13.2	12.7	4.7	34.3	99.3	2.0	7.5	10.3	72.4	12.5	26.4	23.5	32.5	27.6	4.3	1.3	7.0	4.7	9.1	1.7	3.6	2.2	18.2	6.8	1.3	2.0	6.0	5.3	34.5	10.6	14.9	4.6	66.7	28.8	6.4	20.3	91.7	1.7	16.9	36.7	6.2	4.0	1.8	5.1	16.8	2.2	61.3	21.4	4.1	1.3	0.3	2.8	0.3	3.1	1.9	19.6	5.9	2.0	7.5	3.1	5.0	16.4	29.5	13.8	24.3	16.7	8.2	6.3	8.8	2.6	16.2	2.9	2.0	17.4	11.5	2.9	16.2	9.3	4.7	9.7	2.8	13.8	16.3	4.1	1.6	32.1	5.3	20.9	9.9	7.3	16.6	17.6	1.5	3.0	2.2	25.1	5.5	5.8	9.3	9.7	6.4	3.2	3.5	9.2	4.4	4.3	5.2	2.2	32.9	17.9	16.9	16.7	21.8	7.0	8.4	5.2	25.9	5.4	55.8	0.0	2.8	0.0	0.5	0.7	0.2	4.1	0.5	1.2	1.3	0.2	3.1	1.7	0.3	0.3	0.7	0.7	0.1	1.9	5.0	3.8	12.7	4.7	4.3	1.3	3.6	2.2	5.3	4.0
SOX6		ENSG00000110693	"SRY-box 6"	P35712	11	15966449-16739591	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.1;kidney: 28.4"	"Cell line enhanced"	"Detected in some"		"CACO-2: 5.8;HAP1: 4.8;hTCEpi: 5.5;SK-MEL-30: 4.9;WM-115: 19.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	30	"neutrophil: 5.4"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 5.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001923, HPA003908"	Enhanced		Supported	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA001923: AB_1080065, HPA003908: AB_1080063"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (6.47e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.89e-4)"	"unprognostic (9.08e-2)"	"unprognostic (7.37e-3)"	"prognostic favourable (6.47e-12)"	"unprognostic (9.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.04e-2)"	1.4	0.9	3.9	0.8	3.5	17.7	0.8	0.8	5.7	1.4	30.5	0.8	2.3	5.0	0.8	4.9	1.6	3.3	6.3	2.5	2.6	2.5	28.4	3.8	2.0	0.8	3.0	0.8	1.7	14.5	0.0	2.9	1.9	0.9	0.8	0.8	1.1	0.8	0.8	8.1	4.5	70.1	0.8	1.4	1.1	0.6	10.3	1.0	0.8	2.8	1.4	0.8	0.8	0.8	0.0	0.0	5.4	0.0	0.0	0.1	0.0	0.0	0.6	4.3	4.1	0.0	0.0	0.0	0.3	1.3	0.1	0.1	5.8	0.0	0.0	3.7	0.0	0.1	4.8	1.3	0.0	0.0	0.5	0.0	0.0	0.2	0.7	0.0	0.0	0.0	5.5	0.0	0.1	0.0	2.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.8	0.0	2.1	0.0	0.0	0.0	0.4	0.0	4.9	0.0	0.0	0.0	2.8	2.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	19.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.0	0.0	0.0	0.0	3.9	3.5	0.8	2.5	2.6	2.5	3.0	0.8	0.9	1.0
SPINK14	SPINK5L2	ENSG00000196800	"Serine peptidase inhibitor, Kazal type 14 (putative)"	Q6IE38	5	148169733-148175398	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"breast: 2.7;intestine: 3.6;liver: 3.5"	"Cell line enriched"	"Detected in single"	6	"SK-BR-3: 2.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted - unknown location"						"unprognostic (4.98e-2)"		"unprognostic (3.44e-1)"				"unprognostic (1.94e-2)"	"unprognostic (2.96e-2)"				"unprognostic (5.69e-1)"		"unprognostic (1.48e-3)"				0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.5	1.4			0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	3.5	0.5	0.0	0.0		0.0	0.1	0.0	0.0	0.5		0.3	3.6		1.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	1.6	0.1			0.2		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SPINK4	"MGC133107, PEC-60"	ENSG00000122711	"Serine peptidase inhibitor, Kazal type 4"	O60575	9	33218365-33248567	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 35.8;intestine: 120.9;lymphoid tissue: 24.3"	"Cell line enriched"	"Detected in some"	6	"HMC-1: 61.9"	"Group enriched"	"Detected in many"	20	"colorectal cancer: 237.5;pancreatic cancer: 269.7;stomach cancer: 111.0"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 5.1"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in many"			HPA007286	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"	"Secreted to digestive system"			"Golgi apparatus, Vesicles"	"Golgi apparatus, Vesicles"	"HPA007286: AB_1080083"	"unprognostic (3.49e-2)"	"unprognostic (2.32e-1)"	"prognostic favourable (8.85e-5)"	"unprognostic (3.09e-4)"		"unprognostic (1.49e-1)"		"unprognostic (1.00e-1)"		"unprognostic (9.66e-2)"	"unprognostic (2.43e-1)"			"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"		"unprognostic (2.42e-3)"	0.2	0.4	0.2	24.3	0.3	0.0	0.2	0.2	0.2	0.2	69.3	0.2	0.2	28.8	0.2	0.2	0.3	0.2	35.8	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.4	0.0	0.4	0.2	0.2	0.3	110.5	2.5	0.2	0.2	0.3	0.2	120.9	4.6	0.2	0.3	0.5	0.3	0.2	0.2	0.2	0.2	0.2	3.4	0.2	0.0	0.0	5.1	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	10.0	0.4	0.0	0.0	61.9	0.0	0.0	0.0	0.1	0.0	1.3	0.1	0.0	1.3	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	5.2	1.0	0.0	5.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.1	0.0	5.1	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.2	0.2	0.2	0.2	0.2	0.2	0.2
SPINT1	"HAI, MANSC2"	ENSG00000166145	"Serine peptidase inhibitor, Kunitz type 1"	O43278	15	40844018-40858207	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 121.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 51.3;HaCaT: 58.6;hTCEpi: 41.7;RT4: 47.5;SK-BR-3: 88.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA006903, HPA031178"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	3400000	3400000	"Plasma membrane, Cytosol"	"Plasma membrane, Cytosol"	"HPA006903: AB_1079038, HPA031178: AB_2732463"	"prognostic unfavourable (6.97e-4)"	"unprognostic (1.00e-3)"	"unprognostic (3.00e-3)"	"unprognostic (5.03e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.19e-1)"	"unprognostic (5.94e-2)"	"unprognostic (6.04e-2)"	"unprognostic (8.24e-3)"	"unprognostic (1.46e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.01e-1)"	"prognostic favourable (1.37e-7)"	"unprognostic (5.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.17e-2)"	2.2	0.5	0.9	11.6	1.2	0.0	12.6	2.9	0.8	12.9	64.4	1.2	38.6	31.9	3.6	25.5	71.1	6.4	30.7	0.8	0.8	0.7	27.9	1.5	18.5	3.7	0.9	0.6	3.4	25.0	28.8	9.7	85.5	1.3	17.5	17.9	3.2	50.8	24.0	0.6	39.1	121.0	2.3	1.0	3.1	17.6	1.9	0.7	4.8	15.4	26.9	44.3	12.8	21.5	5.1	19.0	15.3	10.9	3.6	1.8	3.8	18.8	0.1	0.0	0.1	0.0	0.0	51.3	0.3	0.4	0.6	0.3	30.0	31.5	0.0	22.5	0.0	58.6	4.8	28.2	0.4	0.1	1.6	0.8	0.5	1.6	0.3	3.3	14.9	0.0	41.7	0.6	2.6	2.3	0.4	0.1	0.0	14.6	0.1	2.5	5.8	2.7	1.9	0.0	3.7	28.4	47.5	12.6	0.6	1.4	88.0	2.3	42.0	2.4	0.0	0.0	0.3	0.1	0.0	0.1	3.5	0.1	0.1	2.4	0.1	0.0	10.9	7.9	0.3	9.3	0.5	5.1	1.8	0.8	19.0	3.9	0.7	0.2	15.3	3.6	9.6	2.3	0.2	3.8	0.9	1.2	2.9	0.8	0.8	0.7	0.9	0.6	1.3	0.7
SRI		ENSG00000075142	Sorcin	P30626	7	88205118-88226993	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 140.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019004, HPA073666"	Enhanced		Supported	Nucleoplasm,Cytosol		1400000	1400000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA019004: AB_2670006, HPA073666: AB_2686623"	"unprognostic (1.86e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.24e-3)"	"prognostic favourable (3.08e-4)"	"unprognostic (9.87e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (9.03e-4)"	"unprognostic (1.36e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.14e-3)"	20.6	22.0	47.7	24.6	53.5	18.7	22.4	18.9	43.6	24.1	140.7	32.5	7.0	45.3	18.1	33.1	15.6	39.4	14.2	19.4	35.9	40.2	21.7	14.6	21.9	16.6	45.0	44.8	23.3	18.4	12.1	18.3	21.2	36.9	19.5	115.0	11.1	17.7	18.4	8.7	11.1	62.8	25.2	41.9	14.6	16.2	10.0	28.0	9.2	19.7	9.4	19.4	27.0	18.7	29.7	34.5	95.4	42.1	36.3	36.4	32.7	34.1	13.1	35.5	36.5	57.6	48.6	17.8	20.5	33.3	23.2	27.6	12.2	77.6	38.0	21.7	31.1	34.6	44.6	46.5	30.4	30.6	20.0	19.7	36.2	0.0	34.9	26.2	21.1	49.7	42.6	24.5	35.7	69.5	17.4	33.0	31.8	21.6	38.2	18.0	31.2	26.5	15.9	50.3	21.0	43.2	34.2	25.7	30.5	62.6	36.0	28.6	17.0	11.7	43.4	43.5	36.5	39.9	36.5	30.9	14.3	40.7	42.7	25.1	73.7	86.5	26.1	95.4	31.0	36.5	36.4	29.7	34.5	35.2	34.5	24.9	25.8	29.8	16.3	36.3	42.1	27.5	34.7	32.7	47.7	53.5	18.9	43.6	35.9	40.2	45.0	44.8	36.9	28.0
SSTR1		ENSG00000139874	"Somatostatin receptor 1"	P30872	14	38207999-38213067	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"brain: 15.0;intestine: 14.3;stomach 1: 22.8"	"Cell line enhanced"	"Detected in some"		"BJ: 46.8;BJ hTERT+: 13.0;BJ hTERT+ SV40 Large T+: 8.6;fHDF/TERT166: 27.6;HeLa: 10.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003207, HPA031506"	Approved		Supported	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA003207: , HPA031506: AB_2673913"	"unprognostic (1.40e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.34e-2)"	"unprognostic (9.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.16e-3)"	"unprognostic (3.20e-2)"	"unprognostic (1.72e-2)"	"unprognostic (9.19e-2)"	"prognostic favourable (4.28e-4)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.28e-2)"	0.7	0.4	6.8	0.6	6.9	0.0	0.6	0.5	15.0	0.9	3.7	0.6	0.1	14.3	1.0	0.6	0.4	0.7	0.5	0.8	4.3	10.4	2.2	6.7	5.5	0.1	6.8	4.0	0.6	3.8	0.1	1.4	2.8	2.8	1.2	2.5	0.2	0.2	0.5	0.7	0.4	8.2	0.6	1.3	0.7	22.8	0.1	0.7	0.1	0.3	0.1	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	46.8	13.0	8.6	0.7	0.4	0.0	0.0	0.0	27.6	0.1	0.0	0.0	6.3	0.0	0.0	0.0	10.6	0.0	2.6	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	1.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.9	0.5	15.0	4.3	10.4	6.8	4.0	2.8	0.7
SSU72P3		ENSG00000284546	"SSU72 pseudogene 3"		11	4329865-4330449	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"intestine: 1.1"	"Cell line enhanced"	"Detected in single"		"HEK 293: 2.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.3	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.4		0.0	1.1		0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
SSU72P5		ENSG00000284018	"SSU72 pseudogene 5"		11	4233288-4233872	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in single"		"intestine: 1.3"	"Cell line enriched"	"Detected in single"	5	"HEK 293: 4.2"									"Not detected"	"Not detected"			"Not detected"	"Not detected"																																							0.0	0.0		0.0		0.0	0.0		0.2	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.2	0.0			0.0	0.0	0.0	0.3			0.0	0.0	0.0		0.0		0.0	1.3		0.0	0.0	0.0	0.0	0.0	0.9		0.1	0.0	0.2			0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"Suppression of tumorigenicity 14"	Q9Y5Y6	11	130159562-130210376	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 94.1"	"Cell line enhanced"	"Detected in some"		"CACO-2: 35.7;CAPAN-2: 72.1;HaCaT: 50.5;RPMI-8226: 47.3;SK-BR-3: 33.4;T-47d: 50.5;U-698: 34.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"plasmacytoid DC: 18.2"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 18.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047014			Approved	Nucleoplasm,Vesicles		220000	220000	"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA047014: AB_2679902"	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favourable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	10.1	1.8	0.7	21.9	1.8	0.5	5.5	0.8	1.4	8.9	48.6	0.5	23.8	33.8	2.8	16.9	38.9	9.7	32.4	1.1	0.5	0.5	30.5	3.2	9.5	7.5	1.8	0.6	3.6	34.3	8.4	9.5	12.7	1.5	12.1	15.4	0.7	25.1	15.8	0.7	17.8	94.1	1.2	1.8	4.0	16.7	2.1	1.5	5.2	24.0	20.1	28.4	8.3	14.9	3.8	18.2	2.3	2.7	0.0	0.1	0.8	26.2	0.0	0.0	0.1	0.0	0.0	14.3	0.0	0.0	0.0	0.0	35.7	72.1	26.0	2.7	0.0	50.5	0.0	16.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.4	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.1	0.2	0.1	0.0	0.0	47.3	4.7	21.5	2.9	0.0	0.2	33.4	0.0	50.5	5.1	0.0	0.0	0.4	0.1	0.1	0.0	0.0	34.4	0.0	8.0	0.0	0.0	2.7	2.3	0.0	1.5	0.1	3.8	0.0	0.0	4.5	2.3	0.0	0.0	0.3	0.0	0.2	18.2	0.0	0.8	0.7	1.8	0.8	1.4	0.5	0.5	1.8	0.6	1.5	1.5
ST6GALNAC1	"SIAT7A, ST6GalNAcI"	ENSG00000070526	"ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 1"	Q9NSC7	17	76624761-76643838	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 69.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 6.1;HaCaT: 6.8;HEL: 10.9;K-562: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory CD4 T-cell: 11.2;naive CD4 T-cell: 4.2"	"Lineage enriched"	"Detected in single"	25	"T-cells: 11.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA014767, HPA014975"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus"		1200000	1200000	"Golgi apparatus"	"Golgi apparatus"	"HPA014767: , HPA014975: AB_1857529"	"unprognostic (4.59e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.32e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.31e-3)"	"prognostic favourable (2.54e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.58e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.87e-3)"	"unprognostic (5.58e-2)"	1.4	0.3	1.2	13.9	2.6	0.7	1.3	0.8	3.2	20.4	50.9	3.1	0.3	19.8	6.3	1.8	19.6	1.5	26.6	4.1	1.6	1.3	0.4	1.1	5.7	1.1	1.8	1.2	2.0	1.1	0.1	0.4	1.7	3.7	2.6	69.4	0.1	20.8	1.4	0.9	0.6	49.0	1.9	1.5	6.0	23.9	4.0	0.6	0.0	0.5	4.5	21.6	1.9	2.6	0.0	0.0	0.4	0.0	0.0	11.2	1.1	0.1	1.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	6.1	0.0	6.8	0.0	1.8	0.0	0.0	0.0	10.9	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.6	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	11.2	0.2	0.0	0.0	4.2	0.0	0.4	0.0	0.0	0.0	1.4	1.1	1.2	2.6	0.8	3.2	1.6	1.3	1.8	1.2	3.7	0.6
STAP2	"BKS, STAP-2"	ENSG00000178078	"Signal transducing adaptor family member 2"	Q9UGK3	19	4324043-4342786	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.9"	"Cell line enhanced"	"Detected in many"		"A-431: 27.0;HaCaT: 22.4;MCF7: 32.1;RT4: 43.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"NK-cell: 10.8"	"Group enriched"	"Detected in many"	6	"dendritic cells: 2.9;NK-cells: 10.8;T-cells: 3.4"	"Region enriched"	"Detected in single"	13	"cerebellum: 32.8"	"Low region specificity"	"Detected in single"			"HPA002375, HPA027761"	Approved									"HPA002375: AB_1078285, HPA027761: AB_1845364"	"unprognostic (1.42e-1)"	"prognostic favourable (2.76e-4)"	"unprognostic (3.52e-1)"	"prognostic favourable (3.03e-5)"	"unprognostic (4.35e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.52e-1)"	"unprognostic (7.81e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.43e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.00e-2)"	"prognostic favourable (4.13e-4)"	2.5	6.6	0.7	12.6	1.1	0.0	5.8	0.9	1.0	8.8	26.0	0.7	23.3	28.4	4.9	12.0	31.6	5.4	10.9	1.7	0.7	0.4	12.9	24.7	6.8	4.0	0.7	0.6	7.0	12.5	6.4	2.5	7.6	1.5	12.8	21.7	3.3	23.9	19.4	1.6	24.0	54.9	2.5	0.7	1.2	8.3	1.7	0.8	5.1	13.3	28.1	21.9	7.6	12.8	0.9	2.9	0.3	0.2	10.8	3.4	1.2	27.0	0.1	2.1	2.0	0.1	1.5	11.7	0.5	2.9	0.9	0.8	16.2	11.3	0.0	4.5	0.8	22.4	0.3	16.0	0.5	4.8	0.2	0.0	0.1	11.3	3.8	0.0	0.2	1.2	13.8	1.6	4.1	2.9	1.0	6.2	0.5	32.1	0.4	0.2	1.5	6.7	1.1	0.2	0.7	9.5	43.2	0.7	1.1	0.0	8.7	4.7	19.6	0.1	4.3	0.0	0.4	0.2	0.6	0.0	0.4	0.3	0.1	0.1	1.9	0.3	0.2	0.0	0.8	0.0	3.4	0.9	1.1	0.1	0.9	0.2	3.4	1.9	0.2	10.8	0.0	2.9	3.3	1.2	0.7	1.1	0.9	1.0	0.7	0.4	0.7	0.6	1.5	0.8
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014369-94028610	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 10.4;HaCaT: 2.2;hTCEpi: 7.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"				"Intermediate filaments"	"Intermediate filaments"	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.4	0.2	0.3	7.0	0.4	0.0	4.0	1.8	3.5	3.9	11.7	0.1	1.5	5.7	0.5	13.6	12.8	0.8	2.3	0.3	0.5	0.3	1.0	0.4	7.1	0.1	0.3	0.7	0.5	7.7	7.1	0.5	0.7	0.1	4.3	10.6	0.1	9.8	3.2	0.2	6.9	20.9	0.1	0.4	1.0	6.0	0.4	0.1	0.4	0.4	5.0	1.5	0.7	4.1	1.2	0.0	0.0	0.3	0.0	0.7	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	10.4	0.1	0.1	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.3	0.0	0.1	7.1	0.0	0.7	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.4	1.2	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.3	0.5	1.2	0.7	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.4	1.8	3.5	0.5	0.3	0.3	0.7	0.1	0.1
STYK1	"DKFZp761P1010, NOK, SuRTK106"	ENSG00000060140	"Serine/threonine/tyrosine kinase 1"	Q6J9G0	12	10618939-10674318	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.8;stomach 1: 16.0"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 18.2;HDLM-2: 10.8;HMC-1: 11.9;HUVEC TERT2: 16.4;TIME: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"NK-cell: 12.5"	"Lineage enriched"	"Detected in many"	7	"NK-cells: 12.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 2.3"	"Not detected"	"Not detected"			"HPA040468, HPA048569"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA040468: AB_2676998, HPA048569: AB_2680446"	"unprognostic (2.30e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.11e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.85e-2)"	"unprognostic (5.08e-3)"	"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.21e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.70e-14)"	"unprognostic (5.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.45e-2)"	0.6	0.3	2.6	2.3	10.6	1.0	3.8	0.1	13.4	2.2	14.4	0.7	0.5	2.1	0.5	1.1	8.9	1.9	6.2	0.1	1.8	1.6	0.5	0.3	1.2	2.4	1.8	4.2	0.4	0.3	0.0	8.4	3.4	2.1	10.6	15.8	0.0	7.8	2.6	0.2	2.6	10.3	0.6	0.6	1.0	16.0	0.3	0.7	0.0	0.4	0.6	2.8	4.3	3.6	0.0	0.0	0.4	0.0	12.5	1.9	0.2	2.9	0.1	0.0	0.4	0.0	0.0	0.9	4.8	0.5	2.2	2.1	1.6	18.2	0.2	3.1	1.2	0.8	0.9	5.0	4.8	10.8	0.3	0.7	1.3	0.1	0.0	1.4	11.9	0.2	0.2	3.4	0.2	16.4	0.2	0.2	5.2	1.7	0.1	0.8	2.7	1.3	0.0	1.4	0.2	1.6	9.4	0.6	0.0	2.7	2.9	0.0	2.3	0.3	15.2	0.6	2.5	0.3	0.6	0.0	0.6	0.1	2.1	0.1	3.5	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.3	0.4	12.5	0.0	0.0	0.0	0.2	2.6	10.6	0.1	13.4	1.8	1.6	1.8	4.2	2.1	0.7
SULT1A2	"HAST4, STP2"	ENSG00000197165	"Sulfotransferase family 1A member 2"	P50226	16	28591943-28597109	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.5;liver: 26.2;seminal vesicle: 24.2"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.7;EFO-21: 8.6;Hep G2: 31.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.8"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	7	"classical monocyte: 10.2;intermediate monocyte: 7.0;myeloid DC: 3.5;neutrophil: 12.6;non-classical monocyte: 3.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 3.5;granulocytes: 12.6;monocytes: 10.2"									"HPA049500, HPA051051"	Supported									"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (4.15e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.53e-1)"	"unprognostic (6.13e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.49e-4)"	"unprognostic (5.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.52e-3)"	1.0	1.9	0.6	2.5	1.0	0.5	1.2	1.6	0.7	0.3	9.8	0.6	5.9	25.7	0.5	1.1	0.9	0.6	1.6	2.1	0.8	0.5	2.3	26.2	11.9	0.3	0.6	0.6	0.9	1.4	1.0	1.2	2.7	0.7	0.3	6.8	4.6	0.9	24.2	0.2	0.2	37.5	0.2	0.6	2.7	0.7	0.3	0.2	0.5	4.5	0.5	0.2	1.9	1.1	0.2	3.5	12.6	10.2	0.4	0.5	3.9	1.3	0.6	0.6	0.5	0.1	0.3	6.7	0.7	0.0	0.1	0.0	1.3	2.9	0.2	8.6	0.2	1.1	0.3	0.4	0.2	0.4	0.3	1.2	1.6	31.9	0.5	1.0	1.3	0.2	0.5	0.5	0.1	0.2	0.7	1.4	0.1	1.5	0.2	2.0	1.0	0.3	1.2	0.2	0.6	0.1	1.3	0.4	0.9	0.2	4.5	0.0	3.1	0.6	0.4	1.6	1.0	1.3	0.5	2.4	1.3	0.3	0.4	0.5	0.5	1.1	10.2	0.1	0.3	7.0	0.5	0.1	0.2	0.2	3.5	0.2	0.3	0.3	12.6	0.4	3.6	0.8	0.4	3.9	0.6	1.0	1.6	0.7	0.8	0.5	0.6	0.6	0.7	0.2
SULT1A3	"STM, TL-PST"	ENSG00000261052	"Sulfotransferase family 1A member 3"	P0DMM9	16	30199228-30204310	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 27.8;intestine: 31.0"	"Cell line enhanced"	"Detected in all"		"CAPAN-2: 39.2;Hep G2: 53.7"	"Not detected"	"Not detected"							"Group enriched"	"Detected in many"	10	"classical monocyte: 27.8;intermediate monocyte: 24.0;myeloid DC: 16.2;non-classical monocyte: 11.1"	"Group enriched"	"Detected in many"	11	"dendritic cells: 16.2;monocytes: 27.8"									"HPA049500, HPA051051"	Supported					3200000	3200000			"HPA049500: AB_2680796, HPA051051: AB_2681327"	"unprognostic (2.61e-1)"	"unprognostic (1.72e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.18e-8)"	"unprognostic (2.34e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.48e-5)"	1.4	3.8	5.6	4.3	4.9	7.5	2.5	14.0	6.3	2.1	6.7			31.0	2.5	4.5	4.0	3.7	2.0	1.7	5.6	5.2	6.6	10.1	3.8	3.2	4.3		2.9	4.3	8.1	8.0	3.0		5.8	6.1		5.3	5.2	1.5	5.6	17.9	4.0	3.4	5.7	2.7	2.1			6.4		5.8	3.6	2.4	1.5	16.2	1.4	27.8	0.4	2.0	11.2	4.8	10.1	10.0	7.0	9.2	5.3	13.5	5.4	4.5	5.4	6.1	4.3	39.2	4.9	28.4	5.1	12.7	10.4	4.2	5.3	4.5	7.5	3.9	13.8	53.7	3.8	3.3	9.2	7.4	6.8	5.9	2.1	6.2	1.2	31.0	3.7	14.9	2.6	20.5	5.9	5.9	10.9	4.0	9.0	7.0	4.4	4.0	5.2	1.4	15.9	2.3	6.0	7.3	2.3	10.6	5.2	7.8	3.1	9.2	8.6	3.0	3.8	5.7	6.3	1.4	27.8	0.1	2.0	24.0	0.3	1.5	0.3	0.6	16.2	0.3	0.3	0.3	0.4	0.4	11.1	0.2	0.3	11.2										
SULT1E1	"EST, STE"	ENSG00000109193	"Sulfotransferase family 1E member 1"	P49888	4	69841212-69860152	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.8;liver: 26.2;vagina: 15.8"	"Group enriched"	"Detected in some"	19	"HHSteC: 37.1;HSkMC: 16.8;hTCEpi: 14.0;HUVEC TERT2: 10.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	8	"pons and medulla: 3.3"	"Cell type enhanced"	"Detected in single"		"neutrophil: 1.7"	"Low lineage specificity"	"Detected in single"											"HPA028213, HPA028728, CAB047344"	Enhanced		Uncertain	"Nuclear membrane,Cytosol"				"Nuclear membrane, Cytosol"	"Nuclear membrane, Cytosol"	"CAB047344: , HPA028213: AB_10599848, HPA028728: AB_10601894"	"unprognostic (5.60e-2)"	"prognostic favourable (4.06e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.22e-3)"	"unprognostic (8.62e-2)"	"unprognostic (6.48e-5)"	"unprognostic (2.48e-1)"	"unprognostic (4.11e-2)"		"unprognostic (5.55e-2)"	0.1	9.8	0.1	0.1	0.3	0.1	1.1	0.1	0.4	13.1	8.9	0.5	0.1	19.8	0.4	3.7	0.4	0.1	1.2	0.1	0.1	0.0	1.5	26.2	2.0	0.1	0.3	0.3	0.2	0.1	0.0	0.4	0.1	3.3	1.0	0.1	0.3	4.7	0.3	0.1	10.9	37.8	0.5	0.3	0.1	1.3	0.4	0.1	0.6	0.2	0.1	1.0	0.4	15.8	0.6	0.2	1.7	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	37.1	0.0	0.0	16.8	14.0	0.0	0.4	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.6	0.2	0.1	1.7	0.3	0.3	0.2	0.0	0.0	0.1	0.3	0.1	0.4	0.1	0.0	0.3	0.3	3.3	0.1
TACR2	"NK2R, NKNAR, SKR, TAC2R"	ENSG00000075073	"Tachykinin receptor 2"	P21452	10	69403903-69416867	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"intestine: 56.3;smooth muscle: 35.5"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 8.5;U-87 MG: 4.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 6.7"	"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 4.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA076573			Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA076573: AB_2732313"	"unprognostic (2.83e-1)"	"unprognostic (1.58e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.22e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.96e-2)"	"unprognostic (3.72e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.88e-4)"	"unprognostic (5.59e-3)"	"unprognostic (4.31e-3)"	"unprognostic (1.25e-3)"	"unprognostic (1.32e-1)"	1.6	0.1	0.5	3.1	0.5	0.1	1.2	0.5	1.1	11.1	56.3	0.2	0.4	4.1	12.3	0.9	19.6	7.2	1.2	1.9	0.5	0.3	0.2	0.5	0.8	0.5	0.2	0.4	2.0	0.8	0.0	0.1	0.1	0.4	14.9	8.2	0.2	0.4	0.9	1.1	0.4	14.2	35.5	0.8	0.5	16.5	0.9	0.5	0.1	0.4	0.8	0.4	19.4	3.1	1.2	2.0	0.5	4.2	0.1	0.8	0.3	1.9	1.2	0.4	0.6	3.0	0.2	0.2	0.5	0.3	0.5	0.7	0.7	0.3	0.2	0.5	0.5	0.7	0.1	0.1	0.0	0.4	0.5	1.6	0.6	1.9	0.3	0.0	3.0	0.5	0.7	0.0	0.0	0.2	0.4	2.5	0.0	0.8	0.1	0.5	0.4	1.9	0.1	0.0	0.0	0.0	1.0	0.8	0.6	1.3	2.6	8.5	1.1	0.2	0.8	3.0	0.4	1.2	1.0	1.2	1.3	0.2	4.9	0.3	1.7	0.5	1.5	0.1	0.3	4.2	0.4	1.2	0.8	0.3	2.0	0.6	0.4	0.2	0.2	0.1	1.7	0.3	0.1	0.3	0.5	0.5	0.5	1.1	0.5	0.3	0.2	0.4	0.4	0.5
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.2"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.3;NB-4: 1.1;SK-BR-3: 1.1;U-266/70: 2.8"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043862, HPA054366"	Uncertain									"HPA043862: AB_2678703, HPA054366: AB_2682464"			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5			1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.5		0.1	1.9		0.1	0.0	0.0	0.0	2.2	0.2	0.0	0.2	0.2	0.4			0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.5	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TBC1D3	"DKFZp434P2235, PRC17, TBC1D3A"	ENSG00000274611	"TBC1 domain family member 3"	Q8IZP1	17	38181659-38192541	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"endometrium 1: 3.4;intestine: 5.5;lymphoid tissue: 3.5;testis: 5.5"	"Cell line enhanced"	"Detected in some"		"AF22: 9.0;REH: 5.6;U-138 MG: 7.8;U-266/70: 12.1;U-266/84: 4.7;U-698: 6.1"	"Not detected"	"Not detected"							"Cell type enhanced"	"Detected in single"		"neutrophil: 2.2"	"Lineage enhanced"	"Detected in single"		"granulocytes: 2.2"									"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.0	0.0		0.0	1.5	0.5			0.0	3.4	0.0	0.0	0.0	1.5	0.0			0.1	0.0	0.0	1.7			0.0	0.0	0.0		0.0		2.9	1.9		0.0	0.0	0.0	0.2	5.5	0.0		0.0	0.0	5.5			0.0		3.5	0.0		0.0	0.0	2.2	0.0	0.0	0.9	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.6	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	12.1	4.7	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0										
TBC1D3D		ENSG00000274419	"TBC1 domain family member 3D"	A0A087WVF3	17	38003976-38014902	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"intestine: 7.9;skin 1: 4.2"	"Cell line enhanced"	"Detected in some"		"AF22: 3.8;CAPAN-2: 11.3;HaCaT: 8.2;HeLa: 9.2;RPMI-8226: 4.9;RT4: 5.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046969, HPA047745, HPA052553"	Approved		Uncertain	Vesicles				Vesicles	Vesicles	"HPA046969: , HPA047745: AB_2680144, HPA052553: "																		0.0	0.0		0.0		0.0	0.2		0.0	0.0	0.0			2.0	1.1	0.0	0.0	0.0	0.0	0.9			0.0	0.0	0.4	0.2			0.0	0.0	0.0		0.8		1.5	0.8		0.0	0.0	0.8	4.2	7.9	0.0		0.0	0.0	2.6			0.0		0.5	0.0		0.0	0.0	0.7	0.2	0.0	0.3	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	2.1	9.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	4.9	0.0	5.5	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	2.9	1.0	0.0	3.4	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0										
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649977-24667033	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 57.3;intestine: 55.7"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 15.6;neutrophil: 57.3"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 57.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"			"Nucleoplasm, Nuclear bodies"	"Nucleoplasm, Nuclear bodies"	"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favourable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavourable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favourable (1.47e-5)"	6.8	4.8	8.2	15.4	9.2	3.7	5.6	10.8	7.5	6.1	36.0	3.7	4.9	25.8	4.9	5.2	4.9	4.5	6.2	8.1	6.8	6.9	16.4	10.4	6.5	7.1	7.7	6.3	5.7	5.9	4.4	9.4	5.7	6.5	12.3	27.9	3.6	4.9	4.8	5.0	4.8	55.7	6.1	5.8	6.3	5.1	21.1	5.7	8.2	5.3	4.1	7.3	9.6	7.0	5.3	3.3	57.3	3.9	6.9	8.3	5.7	17.7	14.1	16.1	18.6	25.0	25.6	12.6	15.8	20.3	15.1	20.4	19.3	10.1	21.4	27.8	16.5	13.1	19.6	18.0	20.7	27.3	20.5	20.0	15.0	31.5	15.9	30.6	19.3	17.1	17.0	15.8	14.3	24.4	17.8	9.2	22.7	12.6	23.8	19.6	14.4	12.2	20.7	17.0	22.9	26.0	25.2	20.4	11.7	12.9	32.7	25.8	15.0	17.8	18.2	14.8	12.3	11.0	23.0	13.3	39.1	29.2	10.2	40.4	23.6	15.6	3.5	7.1	6.9	3.7	8.3	5.3	8.0	7.5	3.3	3.5	6.6	7.2	57.3	6.9	3.9	3.1	7.9	5.7	8.2	9.2	10.8	7.5	6.8	6.9	7.7	6.3	6.5	5.7
TJP3	ZO-3	ENSG00000105289	"Tight junction protein 3"	O95049	19	3708109-3750813	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 47.0"	"Cell line enhanced"	"Detected in some"		"BEWO: 22.3;CAPAN-2: 22.4;MCF7: 9.9;SK-BR-3: 13.0;T-47d: 27.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	4	"gdTCR: 2.0;MAIT T-cell: 6.2;memory CD4 T-cell: 4.8;memory CD8 T-cell: 3.8;naive CD4 T-cell: 5.3;naive CD8 T-cell: 1.9;T-reg: 5.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 6.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"CAB013244, HPA046863, HPA053337"	Enhanced		Enhanced	"Nucleoplasm,Cell Junctions"				"Nucleoplasm, Cell Junctions"	"Nucleoplasm, Cell Junctions"	"CAB013244: AB_2533257, HPA046863: AB_2679845, HPA053337: "	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.80e-1)"	"prognostic favourable (1.83e-6)"	"unprognostic (2.78e-1)"	"prognostic favourable (9.52e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.78e-1)"	"prognostic favourable (9.36e-8)"	"unprognostic (8.58e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.62e-3)"	0.2	0.0	0.3	8.4	0.4	0.0	3.6	0.2	0.3	3.3	34.9	0.7	15.0	23.0	0.7	5.0	16.0	7.9	22.8	0.6	0.5	0.1	4.4	8.0	10.1	0.6	0.2	0.2	2.2	5.9	2.0	1.6	2.7	1.1	2.6	7.7	1.6	26.1	20.5	0.4	4.3	47.0	0.6	0.2	0.4	15.2	1.4	0.2	0.6	5.5	2.6	8.3	4.5	3.4	1.0	0.0	0.0	0.0	0.0	6.2	1.7	0.1	3.3	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	6.6	22.4	4.0	0.6	0.0	5.2	0.3	0.0	0.0	0.2	0.1	0.0	0.5	1.6	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.9	0.0	0.1	0.4	0.1	0.0	0.0	2.9	0.7	3.5	0.1	0.1	0.8	13.0	0.0	27.5	0.1	0.0	0.0	0.5	0.0	0.0	0.8	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	6.2	0.7	4.8	3.8	0.0	1.0	5.3	1.9	0.0	0.0	0.0	0.0	5.5	1.7	0.3	0.4	0.2	0.3	0.5	0.1	0.2	0.2	1.1	0.2
TKFC	"DAK, DKFZP586B1621, NET45"	ENSG00000149476	"Triokinase and FMN cyclase"	Q3LXA3	11	61333210-61353295	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 90.2;liver: 42.8"	"Cell line enhanced"	"Detected in all"		"Hep G2: 39.8;RPMI-8226: 42.0;T-47d: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039486, HPA048186"	Enhanced		Approved	Nucleoplasm,Cytosol		4800000	4800000	"Nucleoplasm, Cytosol"	"Nucleoplasm, Cytosol"	"HPA039486: AB_10795402, HPA048186: AB_2680305"	"unprognostic (4.00e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.42e-2)"	"prognostic favourable (1.32e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.15e-1)"	"prognostic favourable (8.38e-5)"	"unprognostic (2.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.30e-1)"	"unprognostic (4.02e-1)"	3.1	34.7	3.6	6.1	5.3	5.3	4.6	3.7	7.3	3.4	43.4	7.6	8.0	69.5	4.6	7.8	6.2	5.9	8.8	2.8	3.1	2.6	17.4	42.8	3.5	5.2	3.3	5.3	4.5	9.8	3.0	5.5	3.9	4.4	5.0	2.3	7.3	7.2	7.1	4.6	6.1	90.2	2.6	3.1	5.4	5.7	17.1	3.4	5.5	6.4	6.3	6.7	5.4	3.9	9.7	18.4	5.4	11.4	5.3	10.9	7.8	6.0	15.3	2.7	9.3	3.4	3.7	7.6	3.5	3.8	3.3	2.1	6.9	14.6	7.5	12.4	2.5	8.5	5.0	6.6	1.1	12.9	6.7	4.6	8.1	39.8	5.8	3.9	7.8	5.8	4.5	3.1	11.0	3.3	8.1	14.5	2.4	27.4	3.4	3.6	7.4	10.5	6.1	4.2	42.0	5.3	10.7	10.4	9.3	6.5	11.4	5.9	42.0	2.8	3.9	6.6	6.9	5.2	2.1	26.9	22.2	6.7	6.8	3.6	6.0	2.3	11.4	5.4	6.7	6.8	8.6	9.7	7.8	6.5	18.4	9.7	5.6	5.9	0.9	5.3	5.3	9.0	10.9	7.8	3.6	5.3	3.7	7.3	3.1	2.6	3.3	5.3	4.4	3.4
TLDC2	"C20orf118, dJ132F21.2"	ENSG00000101342	"TBC/LysM-associated domain containing 2"	A0PJX2	20	36876121-36894235	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 54.9"	"Cell line enriched"	"Detected in some"	10	"HMC-1: 27.5"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 9.4"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	5	"basophil: 7.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 7.1"	"Region enriched"	"Detected in many"	4	"cerebellum: 6.3"	"Region enriched"	"Detected in single"	12	"cerebellum: 15.5"	HPA047468	Enhanced									"HPA047468: AB_2680059"	"unprognostic (9.06e-3)"	"unprognostic (3.35e-4)"	"unprognostic (4.60e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.40e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavourable (9.97e-5)"	"unprognostic (7.25e-2)"	"unprognostic (6.20e-2)"	"unprognostic (5.59e-2)"	"unprognostic (4.87e-2)"	5.5	1.2	0.9	11.3	0.9	1.4	3.4	0.9	0.9	2.1	21.1	0.9	1.6	18.4	2.5	1.8	1.8	2.7	16.0	3.5	0.9	0.2	3.2	0.9	6.0	2.5	0.9	0.9	2.8	2.1	0.0	1.1	0.9	0.9	2.8	12.8	1.6	2.1	0.9	0.9	2.3	54.9	1.8	0.9	4.5	1.5	1.9	0.9	1.1	2.0	1.7	1.3	2.3	2.6	0.8	1.4	7.1	1.0	1.4	1.2	0.7	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.4	0.2	0.1	0.5	0.3	0.0	0.0	0.0	0.1	0.2	1.0	0.1	2.8	0.0	0.3	27.5	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.5	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.1	7.1	1.0	0.1	0.3	0.9	0.6	0.3	0.5	0.2	1.4	0.8	1.2	0.3	0.0	1.4	0.9	0.4	0.7	0.7	0.9	0.9	0.9	0.9	0.9	0.2	0.9	0.9	0.9	0.9
TMC4		ENSG00000167608	"Transmembrane channel like 4"		19	54160108-54173250	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"intestine: 45.8;seminal vesicle: 49.1"	"Cell line enriched"	"Detected in some"	6	"T-47d: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.4;neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048635	Approved									"HPA048635: AB_2680470"	"unprognostic (7.55e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.68e-3)"	"unprognostic (7.59e-2)"	"unprognostic (3.09e-1)"	"prognostic favourable (1.54e-8)"	"unprognostic (6.70e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.79e-2)"	1.2	0.4	0.8	4.7	1.2	0.0	6.5	0.5	0.7	3.7	31.0	0.0	32.0	19.7	2.0	16.2	2.9	8.7	21.8	1.7	0.9	0.8	11.8	0.8	9.6	0.0	0.8	0.0	3.8	25.0	0.3	11.1	6.9	0.0	8.6	7.5	0.0	34.5	49.1	0.8	1.3	45.8	0.8	0.6	0.3	8.2	0.6	0.0	1.0	17.1	2.8	5.6	6.7	2.7	0.0	0.0	1.5	1.4	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	1.1	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	1.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.5	0.7	0.9	0.8	0.8	0.0	0.0	0.0
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 33.6;intestine: 23.2;lymphoid tissue: 52.9"	"Cell line enhanced"	"Detected in some"		"Daudi: 15.4;HL-60: 20.4;HMC-1: 41.5;Karpas-707: 35.2;RPMI-8226: 21.8;U-266/70: 17.1;U-937: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"				"Golgi apparatus"	"Golgi apparatus"	"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favourable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favourable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavourable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	3.6	1.6	2.3	30.1	4.6	33.6	1.9	0.7	2.3	1.7	4.4	3.5	0.1	4.2	2.5	2.1	2.5	2.1	6.2	1.5	2.3	1.7	3.4	3.1	10.7	38.7	4.0	0.8	0.9	1.2	0.1	1.3	1.5	2.8	2.4	1.9	2.6	10.2	1.0	0.6	1.7	23.2	1.0	5.1	52.9	4.1	0.7	3.7	49.7	3.1	1.8	36.6	3.9	2.5	5.0	2.1	5.5	6.6	6.7	13.1	4.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	15.4	0.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	20.4	41.5	0.0	0.0	0.0	0.0	0.0	1.3	35.2	0.0	0.4	7.0	0.9	0.0	0.1	0.4	0.1	21.8	0.0	0.0	0.0	0.0	0.0	0.7	0.2	2.3	4.2	0.0	0.0	0.0	0.0	0.0	17.1	0.7	1.5	0.0	17.3	0.0	2.3	1.8	5.5	13.1	3.1	9.4	5.0	10.5	12.9	2.1	5.0	9.4	8.4	3.0	6.7	6.6	1.9	5.7	4.2	2.3	4.6	0.7	2.3	2.3	1.7	4.0	0.8	2.8	3.7
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 25.1;kidney: 22.6;placenta: 28.0"	"Cell line enhanced"	"Detected in some"		"A-431: 9.5;CAPAN-2: 17.9;EFO-21: 12.6;RPTEC TERT1: 31.5;SK-BR-3: 11.1;T-47d: 30.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 3.2"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"				"Plasma membrane"	"Plasma membrane"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavourable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favourable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.5	2.2	0.9	2.8	1.9	0.0	2.1	0.6	1.6	6.3	14.7	6.0	1.5	22.7	1.6	3.5	0.4	4.6	4.8	2.3	1.6	1.1	22.6	7.8	5.5	0.1	4.2	0.7	0.9	9.6	6.4	2.0	28.0	4.8	1.6	2.9	1.4	6.1	2.2	0.1	1.1	25.1	0.4	13.4	0.8	2.0	3.0	2.1	0.1	8.8	0.4	0.7	2.1	2.4	0.5	0.3	0.9	3.2	0.0	2.0	0.4	9.5	0.7	0.1	0.0	0.0	0.0	6.4	0.1	0.0	0.0	0.0	2.2	17.9	0.1	12.6	0.0	8.1	0.0	4.1	0.0	0.1	0.0	0.0	1.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.6	0.4	0.0	0.7	0.1	0.1	0.0	31.5	2.4	0.1	0.0	0.4	11.1	0.0	30.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	0.0	3.2	0.0	0.5	1.3	0.8	0.0	0.0	1.1	0.6	0.0	0.0	2.4	0.3	2.0	0.4	0.9	1.9	0.6	1.6	1.6	1.1	4.2	0.7	4.8	2.1
TMEM150B	"TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 37.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.8;HMC-1: 4.6;U-937: 20.0"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"classical monocyte: 9.3"	"Group enriched"	"Detected in many"	8	"granulocytes: 3.7;monocytes: 9.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavourable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	10.5	2.2	0.5	3.1	1.5	0.3	8.3	0.4	1.1	0.8	6.1	0.4	1.2	37.0	0.7	3.0	1.0	1.4	1.7	3.5	1.8	0.6	2.4	5.4	12.7	7.3	0.6	0.3	2.3	0.8	0.0	0.8	5.4	2.1	2.7	4.2	1.2	1.1	0.2	1.5	0.6	31.5	2.3	1.2	14.1	1.2	1.7	0.4	0.3	1.2	0.2	2.0	1.8	3.0	0.0	0.8	3.7	9.3	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	1.2	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	20.0	0.1	3.7	9.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.0	1.2	0.5	1.5	0.4	1.1	1.8	0.6	0.6	0.3	2.1	0.4
TMEM171	PRP2	ENSG00000157111	"Transmembrane protein 171"	Q8WVE6	5	73120292-73131817	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 18.2;intestine: 20.1;kidney: 25.4;stomach 1: 16.7;thyroid gland: 25.9"	"Cell line enhanced"	"Detected in many"		"LHCN-M2: 20.5;RPTEC TERT1: 15.6;WM-115: 57.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 18.2;memory CD8 T-cell: 6.3"	"Lineage enriched"	"Detected in single"	86	"T-cells: 18.2"	"Region enriched"	"Detected in single"	5	"hippocampal formation: 0.9"	"Region enhanced"	"Detected in single"		"pons and medulla: 3.6"	HPA042308	Approved									"HPA042308: AB_10796901"	"unprognostic (7.34e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.74e-3)"	"unprognostic (2.81e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.22e-1)"	"prognostic favourable (3.93e-10)"	"unprognostic (6.13e-3)"	"unprognostic (2.43e-1)"	"unprognostic (9.10e-3)"	"unprognostic (1.57e-1)"	0.2	0.2	0.8	5.6	2.1	0.0	0.7	0.7	3.3	0.4	20.1	3.2	2.2	16.2	0.2	1.4	3.9	0.2	1.5	0.2	1.2	0.7	25.4	3.9	0.4	0.1	0.9	1.6	0.2	0.6	0.0	0.3	0.1	1.1	0.5	18.9	0.6	1.4	2.8	0.6	0.7	18.8	0.6	1.4	14.6	16.7	0.6	0.6	0.0	25.9	3.2	6.3	0.4	0.3	0.0	0.0	0.2	0.0	0.0	18.2	0.5	7.3	0.3	0.0	0.0	2.4	3.2	0.0	2.3	10.9	4.4	7.5	0.2	3.5	0.0	5.0	2.9	5.5	0.1	0.3	3.5	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.3	0.7	0.2	6.0	0.5	2.7	0.0	0.1	20.5	0.7	0.0	0.0	0.6	0.4	0.0	0.0	3.7	15.6	0.1	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.3	6.5	0.1	0.0	0.0	0.0	6.0	0.0	57.2	0.0	0.0	0.0	1.3	0.0	18.2	0.0	0.7	6.3	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.5	0.8	2.1	0.7	3.3	1.2	0.7	0.9	1.6	1.1	0.6
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 40.2;intestine: 39.3"	"Cell line enhanced"	"Detected in many"		"MCF7: 14.9;RT4: 16.9;SCLC-21H: 17.4;SK-BR-3: 27.0;T-47d: 23.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"neutrophil: 2.0"	"Low lineage specificity"	"Detected in single"							"Low region specificity"	"Detected in all"			"HPA053790, HPA071312"	Uncertain		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavourable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.1	0.2	3.5	0.2	0.1	1.6	0.2	0.3	8.6	15.6	0.2	8.0	15.1	1.7	2.9	40.2	4.4	9.6	0.2	0.2	0.1	5.3	18.0	1.5	0.2	0.2	0.3	0.9	24.7	3.1	5.4	14.3	0.4	5.1	4.0	0.3	10.3	12.0	2.3	17.9	39.3	1.2	0.2	0.2	7.5	3.8	0.2	0.5	0.3	22.9	31.9	10.0	15.8	0.8	0.8	2.0	0.5	0.4	0.5	0.0	9.5	6.4	0.0	0.0	0.0	0.0	2.1	0.3	0.1	0.4	0.0	8.7	11.4	0.2	3.4	0.1	7.4	0.0	4.3	0.1	0.1	0.2	0.0	5.9	4.0	0.1	0.0	0.0	0.0	4.2	0.1	3.8	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.3	8.4	0.2	0.0	4.6	3.3	16.9	17.4	0.0	2.8	27.0	0.0	23.9	0.0	0.0	0.0	3.6	4.5	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.5	0.2	0.5	0.1	0.3	0.2	0.3	0.2	0.1	0.8	0.4	0.3	2.0	0.4	0.2	0.8	0.3	0.0	0.2	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.4	0.2
TMEM229A		ENSG00000234224	"Transmembrane protein 229A"	B2RXF0	7	124030916-124033023	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;intestine: 16.4;testis: 10.6"	"Cell line enriched"	"Detected in some"	44	"SH-SY5Y: 54.6"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA056391	Uncertain		Approved	"Plasma membrane"				"Plasma membrane"	"Plasma membrane"	"HPA056391: AB_2683114"					"unprognostic (2.52e-2)"			"unprognostic (3.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.21e-2)"		"unprognostic (4.74e-2)"	"unprognostic (2.31e-1)"		"unprognostic (4.31e-3)"	0.4	1.5	6.9	0.5	7.6	0.4	0.4	1.3	9.0	0.8	0.5	7.6	0.0	16.4	0.7	1.2	0.4	1.7	0.6	0.9	8.0	4.6	0.5	0.4	0.5	0.4	10.6	4.9	1.0	0.4	2.5	1.0	0.6	5.6	0.8	0.6	0.6	0.7	0.5	0.4	0.4	7.7	0.7	7.3	0.6	3.7	10.6	8.7	0.0	0.5	0.0	0.4	1.1	0.1	0.0	0.0	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.1	0.0	6.9	7.6	1.3	6.1	8.0	4.6	10.6	4.9	5.6	8.7
TMEM238L	LINC00675	ENSG00000263429	"Transmembrane protein 238 like"		17	10794913-10804099	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"ductus deferens: 19.9;intestine: 19.0;seminal vesicle: 14.6;stomach 1: 23.0"	"Cell line enriched"	"Detected in some"	8	"RT4: 9.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 13.0"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																		"unprognostic (7.23e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.59e-2)"	"unprognostic (2.99e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.30e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.19e-2)"	0.0	0.0	0.2	7.5	0.6	0.0	0.6	0.0	1.0	0.0	18.3	0.0	19.9	8.8	0.0	1.1	3.2	0.0	9.5	0.0	0.4		0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.5	19.0	0.0	0.0	14.6	0.0	0.2	14.0	1.2	0.0	0.0	23.0	0.0	0.0	0.0	0.0	2.8	3.1	6.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	9.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TMEM37	"PR, PR1"	ENSG00000171227	"Transmembrane protein 37"	Q8WXS4	2	119429901-119438520	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 110.5;kidney: 82.5"	"Group enriched"	"Detected in some"	5	"EFO-21: 13.1;Hep G2: 34.4;RPTEC TERT1: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"intermediate monocyte: 2.8;naive CD4 T-cell: 3.3"	"Group enriched"	"Detected in many"	31	"monocytes: 2.8;T-cells: 3.3"	"Low region specificity"	"Detected in many"							HPA053794	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"				"Nucleoli fibrillar center"	"Nucleoli fibrillar center"	"HPA053794: AB_2682265"	"unprognostic (2.54e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.59e-3)"	"unprognostic (2.56e-1)"	"unprognostic (9.60e-2)"	"unprognostic (5.20e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.83e-2)"	"unprognostic (7.30e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.61e-2)"	18.5	5.2	0.6	5.9	1.0	0.0	10.0	0.5	1.2	6.7	60.3	1.8	3.8	16.2	3.1	3.8	2.8	1.4	18.5	5.7	1.0	0.4	82.5	40.8	9.5	8.7	0.9	0.7	5.9	5.8	20.1	0.7	13.4	1.3	4.5	5.6	6.3	2.8	6.5	1.6	4.4	110.5	1.9	1.4	11.5	6.6	6.4	0.7	1.2	21.0	1.6	2.2	3.4	2.4	0.0	0.0	0.0	2.8	0.0	3.3	0.6	0.0	3.4	0.3	0.1	2.1	0.2	0.5	0.1	0.0	0.0	0.0	5.3	3.0	0.0	13.1	1.6	0.8	1.4	0.0	0.0	0.0	1.3	0.4	2.0	34.4	2.9	0.0	0.0	4.8	0.0	0.0	0.0	2.8	0.1	5.2	0.0	0.3	0.0	0.3	2.5	0.1	0.0	0.0	4.5	28.8	2.3	0.4	0.2	0.1	1.4	0.0	0.6	0.8	1.8	0.0	5.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.6	1.0	0.5	1.2	1.0	0.4	0.9	0.7	1.3	0.7
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.4"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"				Nucleoplasm	Nucleoplasm	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavourable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavourable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavourable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	8.1	23.9	7.8	4.8	10.2	9.3	10.1	4.9	11.5	10.6	26.8	11.7	6.3	24.5	9.1	11.1	20.6	9.0	8.6	8.3	7.5	8.4	15.8	26.1	11.3	9.0	8.1	5.4	14.2	10.7	6.7	5.7	9.0	8.6	10.1	8.6	11.9	11.2	9.4	8.3	16.6	54.4	8.0	8.7	12.4	8.7	11.2	7.4	11.3	9.0	18.1	16.7	8.8	12.5	12.8	16.4	7.8	8.4	8.5	16.7	6.5	20.6	7.5	5.0	6.2	8.0	8.6	14.8	8.0	7.0	10.1	7.4	19.5	8.2	6.4	15.3	7.4	14.4	13.8	8.5	10.2	10.7	12.7	11.1	4.5	19.6	8.9	12.0	6.3	8.0	12.8	9.1	10.5	7.7	19.7	16.0	6.4	8.0	7.3	6.9	8.3	11.9	7.4	7.7	11.7	8.7	15.2	5.1	6.5	6.9	17.7	12.1	21.1	9.4	5.6	6.0	7.5	12.5	16.6	23.7	36.0	12.9	9.1	7.2	7.2	7.8	6.3	5.1	13.2	6.6	16.7	12.8	13.6	14.3	7.0	12.4	15.0	16.1	2.4	8.5	8.4	16.4	11.1	6.5	7.8	10.2	4.9	11.5	7.5	8.4	8.1	5.4	8.6	7.4
TMEM45B	"BC016153, FLJ40787"	ENSG00000151715	"Transmembrane protein 45B"	Q96B21	11	129815819-129860003	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 106.6"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.5;Hep G2: 14.8;PC-3: 18.7;RT4: 49.6;T-47d: 14.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"memory CD4 T-cell: 3.6;naive CD4 T-cell: 4.3;neutrophil: 13.1"	"Group enriched"	"Detected in many"	12	"granulocytes: 13.1;T-cells: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA015474, HPA015878"	Approved		Approved	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA015474: , HPA015878: AB_2205046"	"unprognostic (4.92e-3)"	"unprognostic (7.94e-2)"	"unprognostic (5.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.44e-3)"	"unprognostic (7.11e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.33e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.52e-1)"	0.2	0.2	0.6	9.0	0.9	0.0	4.0	0.3	0.7	6.6	50.3	0.5	1.7	40.4	1.2	4.1	29.5	6.5	9.3	0.4	1.2	0.6	9.6	13.2	4.5	1.9	0.4	0.7	1.4	3.1	0.0	2.9	1.2	2.3	4.0	29.0	0.3	7.3	2.4	0.2	10.9	106.6	1.5	0.5	0.6	7.4	0.7	0.2	0.5	9.1	21.9	19.9	9.4	10.9	0.6	0.4	13.1	0.6	0.7	4.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	14.5	6.3	0.1	2.7	0.0	8.4	0.0	0.0	0.0	0.0	0.2	0.1	0.8	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.5	0.0	18.7	0.1	0.0	0.9	8.0	49.6	1.5	0.2	0.0	4.1	0.0	14.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.6	0.1	0.3	0.2	0.3	0.2	3.6	0.9	0.0	0.6	4.3	0.7	13.1	0.7	0.2	0.4	0.6	1.3	0.6	0.9	0.3	0.7	1.2	0.6	0.4	0.7	2.3	0.2
TMEM54	CAC-1	ENSG00000121900	"Transmembrane protein 54"	Q969K7	1	32894594-32901438	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 50.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061992			Approved	Vesicles				Vesicles	Vesicles	"HPA061992: AB_2684652"	"unprognostic (2.67e-1)"	"unprognostic (2.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.98e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavourable (3.08e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.42e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.43e-2)"	"unprognostic (6.82e-3)"	"unprognostic (2.13e-2)"	"unprognostic (9.06e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.40e-2)"	3.2	3.3	16.1	21.5	10.7	0.0	8.5	2.7	10.6	10.0	70.0	8.2	7.0	37.9	8.5	9.4	28.8	5.0	24.2	4.5	9.7	9.4	11.4	4.4	7.2	2.4	10.9	5.7	6.2	12.4	9.0	4.7	47.3	6.8	14.7	37.4	7.4	11.8	8.4	1.9	26.9	76.7	7.3	7.3	3.1	35.0	3.7	6.0	1.1	23.6	16.9	14.2	12.5	15.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	31.3	8.5	0.0	8.1	15.6	9.4	30.6	4.6	7.5	11.1	14.4	21.2	50.5	0.0	13.7	6.2	19.3	7.3	27.1	3.4	36.4	1.5	0.0	3.0	1.1	11.3	0.1	0.4	8.0	24.8	17.1	4.7	4.9	4.2	0.0	5.8	33.6	0.0	0.6	2.6	14.8	4.2	12.8	0.1	4.1	40.2	0.4	4.2	3.2	21.0	10.5	22.8	6.1	9.3	11.0	11.7	24.6	9.8	1.1	2.6	3.6	7.8	0.8	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.1	10.7	2.7	10.6	9.7	9.4	10.9	5.7	6.8	6.0
TMEM74B	"C20orf46, FLJ11190"	ENSG00000125895	"Transmembrane protein 74B"	Q9NUR3	20	1180561-1185415	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.9;intestine: 16.0"	"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;Hep G2: 9.7;K-562: 16.4;Karpas-707: 7.4"	"Low cancer specificity"	"Detected in many"							"Cell type enhanced"	"Detected in single"		"memory B-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045213	Approved		Approved	"Nucleoplasm,Golgi apparatus"				"Nucleoplasm, Golgi apparatus"	"Nucleoplasm, Golgi apparatus"	"HPA045213: AB_10961999"	"unprognostic (1.51e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.05e-3)"	"unprognostic (5.73e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.91e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.77e-4)"	"unprognostic (9.58e-2)"	"prognostic favourable (3.07e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (2.55e-7)"	"unprognostic (1.20e-1)"	"unprognostic (9.77e-2)"	"unprognostic (8.37e-2)"	"unprognostic (5.07e-3)"	2.3	0.3	4.3	0.3	13.9	0.0	1.1	2.3	7.3	0.1	0.7			12.5	0.6	0.3	0.7	3.9	2.5	3.9	2.3	6.9	0.6	1.0	9.4	0.9	2.3		0.0	0.6	0.2	3.5	12.2		0.5	0.9		3.3	11.3	2.9	4.6	16.0	1.1	1.1	0.6	2.7	0.9			1.6		0.4	0.7	0.0	1.6	0.1	0.0	0.1	0.0	0.5	0.3	0.0	4.8	2.7	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.7	0.7	0.1	0.9	0.0	0.3	3.6	0.5	0.1	0.0	4.6	1.1	0.0	9.7	0.0	0.0	1.3	0.0	1.0	0.0	0.2	0.1	16.4	7.4	0.0	0.1	0.1	0.1	3.3	0.4	0.0	0.2	0.0	0.8	0.7	0.7	2.1	0.1	0.0	0.1	0.0	0.1	2.0	0.0	3.2	0.1	0.1	3.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.3	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.3										
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464551-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 75.6;pancreas: 64.5;prostate: 68.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 14.6;MCF7: 6.3;RT4: 35.2;SK-BR-3: 7.2;T-47d: 5.4"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA034493, HPA035787"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"			"Cell Junctions"	"Cell Junctions"	"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favourable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favourable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.2	0.1	0.2	15.5	0.4	0.0	6.1	0.2	0.5	1.3	38.7	0.4	24.4	17.5	0.5	0.9	10.7	2.2	17.3	0.2	0.3	0.1	19.4	18.4	20.7	0.2	0.2	0.2	0.7	64.5	0.0	1.3	1.0	0.4	68.2	18.5	0.3	52.3	35.7	0.2	2.1	75.6	0.9	0.2	0.3	36.7	0.8	0.3	0.5	19.9	3.9	10.2	5.9	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	14.6	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.1	0.5	1.3	0.0	0.0	0.0	1.4	0.6	35.2	0.0	0.4	0.0	7.2	0.1	5.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.4	0.2	0.5	0.3	0.1	0.2	0.2	0.4	0.3
TNFRSF11A	"CD265, FEO, LOH18CR1, PDB2, RANK"	ENSG00000141655	"TNF receptor superfamily member 11a"	Q9Y6Q6	18	62325287-62391292	"CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 28.7;intestine: 23.9;salivary gland: 34.3"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"NK-cell: 8.9"	"Lineage enriched"	"Detected in many"	8	"NK-cells: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB010391, HPA047976"	Approved		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"			"Plasma membrane"	"Plasma membrane"	"CAB010391: AB_2205352, HPA047976: AB_2680227"	"unprognostic (4.08e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.73e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.96e-4)"	"unprognostic (4.24e-3)"	"unprognostic (7.79e-4)"	"unprognostic (1.52e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.69e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.02e-2)"	"unprognostic (7.07e-2)"	6.5	1.7	1.7	4.8	1.2	0.2	4.3	0.4	2.3	1.5	18.4	0.8	7.6	23.1	0.9	1.9	3.8	1.3	28.7	1.1	1.3	0.7	0.9	0.8	2.3	7.4	1.0	1.0	0.7	2.9	0.1	10.1	2.8	0.7	2.1	13.9	1.3	34.3	12.9	0.6	3.3	23.9	1.3	2.9	1.2	4.3	1.2	0.8	0.7	2.0	1.8	2.3	2.3	2.3	0.0	0.6	0.2	0.0	8.9	1.0	0.0	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.2	0.0	1.5	0.1	0.9	3.5	0.3	0.1	51.3	2.3	0.0	0.5	0.7	0.0	0.2	0.5	0.1	0.1	0.3	1.3	1.3	0.0	0.0	0.0	0.4	0.0	0.0	2.5	8.1	0.1	0.0	0.2	0.6	0.6	8.7	0.3	0.2	1.3	0.0	0.5	0.1	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	8.9	0.0	0.6	1.0	0.0	1.7	1.2	0.4	2.3	1.3	0.7	1.0	1.0	0.7	0.8
TNFRSF13C	"BAFFR, CD268"	ENSG00000159958	"TNF receptor superfamily member 13C"	Q96RJ3	22	41922023-41926818	"CD markers, Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 20.3;intestine: 18.9;lymphoid tissue: 69.1"	"Group enriched"	"Detected in some"	6	"REH: 19.9;U-698: 10.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	51	"memory B-cell: 14.5;naive B-cell: 20.3"	"Lineage enriched"	"Detected in single"	59	"B-cells: 20.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA003246, CAB008380"	Enhanced									"CAB008380: AB_590602, HPA003246: AB_1078264"	"unprognostic (3.43e-4)"	"prognostic favourable (4.44e-7)"	"unprognostic (6.52e-2)"	"unprognostic (9.10e-2)"	"unprognostic (7.64e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.89e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.79e-8)"	"unprognostic (2.21e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.77e-1)"	"unprognostic (9.44e-2)"	0.9	0.8	0.8	41.0	1.0	3.3	0.6	1.0	2.0	0.5	1.2	4.4	0.0	0.7	0.4	0.2	5.0	0.5	0.6	0.6	0.8	0.9	0.9	0.5	1.8	48.4	1.0	0.6	0.4	0.4	0.0	0.4	0.1	1.8	0.6	0.7	0.5	5.8	0.0	1.2	2.0	18.9	0.1	1.1	69.1	1.4	0.7	0.6	2.0	0.8	0.3	51.4	9.5	0.7	20.3	0.2	0.3	0.2	0.2	0.2	0.5	0.3	0.2	1.1	2.3	0.0	0.0	0.5	0.1	0.1	0.2	0.8	0.9	0.5	1.8	0.4	0.2	0.3	0.6	0.0	0.3	0.4	2.2	0.2	0.3	0.2	0.1	1.6	0.4	0.1	0.0	0.4	0.1	0.0	0.4	1.8	0.2	0.7	1.5	1.7	0.7	0.1	19.9	2.4	1.5	0.0	0.2	1.2	0.3	0.1	0.4	0.3	0.4	2.2	0.2	0.5	2.6	0.9	0.3	2.1	1.0	10.8	0.1	1.7	0.5	0.3	0.1	0.1	0.1	0.1	0.2	14.5	0.2	0.1	0.0	20.3	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.5	0.8	1.0	1.0	2.0	0.8	0.9	1.0	0.6	1.8	0.6
TNFRSF17	"BCM, BCMA, CD269, TNFRSF13A"	ENSG00000048462	"TNF receptor superfamily member 17"	Q02223	16	11965107-11968068	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 34.1;intestine: 17.8;lymphoid tissue: 28.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;RPMI-8226: 39.9;U-266/70: 118.6;U-266/84: 58.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	59	"memory B-cell: 34.1;naive B-cell: 26.9;plasmacytoid DC: 27.9"	"Group enriched"	"Detected in many"	62	"B-cells: 34.1;dendritic cells: 27.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									2200000	2200000				"prognostic favourable (1.35e-5)"	"unprognostic (3.41e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.41e-2)"	"unprognostic (6.47e-2)"	"prognostic favourable (1.58e-6)"	"unprognostic (9.75e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.85e-6)"	"unprognostic (2.06e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.54e-2)"	"unprognostic (1.10e-1)"	0.6	0.4	0.4	24.0	0.9	0.3	5.4	0.5	0.4	1.5	17.8	0.2	0.2	12.3	0.5	0.2	3.7	1.1	4.9	0.7	0.4	0.4	1.3	0.8	3.0	22.4	0.4	0.2	0.9	3.1	0.0	0.5	0.3	0.2	1.0	9.4	0.6	14.2	0.2	0.4	0.4	11.7	0.2	0.4	22.2	9.4	2.2	0.3	3.1	1.1	1.4	28.8	7.6	0.7	34.1	27.9	0.5	0.1	0.2	0.1	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	118.6	58.9	9.2	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	34.1	0.0	0.0	0.0	26.9	0.0	0.0	0.5	0.2	0.0	27.9	0.0	3.7	0.4	0.9	0.5	0.4	0.4	0.4	0.4	0.2	0.2	0.3
TNFSF15	"MGC129934, MGC129935, TL1, TL1A, VEGI, VEGI192A"	ENSG00000181634	"TNF superfamily member 15"	O95150	9	114784635-114806126	"Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.0;kidney: 16.2;salivary gland: 28.7"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.5;hTEC/SVTERT24-B: 7.6;HUVEC TERT2: 14.5;RT4: 14.2;TIME: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 2.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.8;granulocytes: 1.2;monocytes: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012948, HPA046522"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"	"Secreted to blood"			"Nuclear membrane"	"Nuclear membrane"	"HPA012948: AB_1858024, HPA046522: AB_2679683"	"unprognostic (3.41e-1)"	"unprognostic (2.06e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.78e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.64e-5)"	"unprognostic (1.97e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.68e-3)"	"unprognostic (4.46e-3)"	1.2	1.3	0.3	3.1	0.5	0.0	0.7	0.2	0.9	1.9	7.3	0.1	1.3	10.8	0.9	1.3	2.8	0.8	2.0	0.3	1.7	0.3	16.2	0.5	5.2	0.5	0.4	0.1	0.7	1.4	0.2	0.5	6.0	0.7	9.8	2.2	0.6	28.7	4.4	0.3	0.6	15.0	2.0	0.4	1.5	3.0	0.6	0.1	0.9	1.3	1.8	2.4	6.4	1.6	0.3	2.8	1.2	1.8	0.3	0.1	0.4	0.4	3.8	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.0	0.1	0.2	2.7	1.4	0.0	0.0	11.5	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	7.6	0.0	14.5	0.0	0.8	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	14.2	0.1	0.0	0.0	0.7	0.0	1.1	0.0	6.6	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.8	0.1	0.1	1.8	0.0	0.3	0.1	0.0	2.8	0.3	0.1	0.1	1.2	0.3	0.2	1.5	0.0	0.4	0.3	0.5	0.2	0.9	1.7	0.3	0.4	0.1	0.7	0.1
TP53I3	PIG3	ENSG00000115129	"Tumor protein p53 inducible protein 3"	Q53FA7	2	24077433-24085861	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 55.0"	"Cell line enriched"	"Detected in many"	6	"T-47d: 113.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB017479, HPA022012, HPA028742"	Enhanced		Supported	Vesicles		200000	200000	Vesicles	Vesicles	"CAB017479: AB_2303667, HPA022012: AB_1858202, HPA028742: AB_10603456"	"unprognostic (3.66e-2)"	"unprognostic (1.41e-3)"	"unprognostic (5.55e-2)"	"unprognostic (8.04e-2)"	"unprognostic (7.10e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.83e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.86e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.57e-3)"	10.3	9.5	2.7	11.7	2.7	6.3	6.3	2.5	3.6	12.0	42.1	3.6	10.5	18.4	8.5	7.0	43.2	6.1	17.8	5.0	1.6	3.2	28.2	11.5	15.7	5.3	2.1	2.0	4.7	20.3	4.0	4.6	13.0	3.3	6.6	15.5	6.7	11.3	6.9	4.9	2.8	55.0	6.1	2.3	5.6	9.0	41.3	1.9	8.6	9.0	10.6	9.0	8.2	21.8	3.6	11.1	11.4	13.4	0.2	0.4	4.0	4.9	16.2	9.5	3.9	7.5	16.8	6.9	4.9	6.1	4.3	6.0	4.1	8.9	0.6	2.8	8.1	1.5	2.4	8.7	2.6	3.7	0.3	1.4	5.7	10.6	4.9	0.6	2.9	18.1	13.9	11.5	2.8	19.3	1.2	4.2	18.1	3.3	0.8	0.1	7.2	6.6	1.7	8.4	0.1	7.2	7.7	1.3	6.1	6.5	1.4	1.0	113.2	1.0	14.2	4.9	12.0	3.3	2.4	1.9	1.2	0.5	1.7	0.0	1.2	7.3	13.4	11.4	0.2	8.5	0.1	3.6	0.2	0.4	11.1	2.6	0.0	0.3	2.8	0.2	3.8	4.8	0.3	4.0	2.7	2.7	2.5	3.6	1.6	3.2	2.1	2.0	3.3	1.9
TPSG1	"PRSS31, TMT"	ENSG00000116176	"Tryptase gamma 1"	Q9NRR2	16	1221651-1225257	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 16.0"	"Group enriched"	"Detected in some"	9	"HMC-1: 22.3;MCF7: 7.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA060458	Enhanced									"HPA060458: AB_2684283"	"unprognostic (1.86e-1)"	"unprognostic (3.46e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.58e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.92e-2)"	"unprognostic (6.39e-2)"	"prognostic unfavourable (1.76e-8)"	"unprognostic (2.19e-1)"	"unprognostic (1.70e-1)"	"unprognostic (8.65e-4)"	"unprognostic (5.70e-2)"	1.3	0.6	0.4	4.5	0.4	0.0	3.1	0.4	0.4	0.6	14.4	0.4	0.4	14.0	1.2	0.4	0.7	0.5	1.0	0.4	0.4	0.0	0.4	0.4	0.6	0.4	0.4	0.4	2.0	0.4	0.0	3.2	0.4	0.4	1.1	8.8	0.4	0.4	0.4	0.4	1.1	16.0	1.2	0.4	0.4	1.0	1.3	0.4	0.4	0.4	1.1	0.4	1.4	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151945-30160934	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.0;kidney: 3.1;liver: 5.9;placenta: 5.8"	"Cell line enriched"	"Detected in single"	11	"EFO-21: 1.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	18	"hippocampal formation: 4.0"	HPA043325	Uncertain									"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.6	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	5.9	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	0.0	0.9	1.0	3.0	0.0	0.0	1.4	0.1	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113106	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;lymphoid tissue: 7.4;urinary bladder: 12.2"	"Cell line enriched"	"Detected in single"	490	"RT4: 79.5"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA046400	Uncertain									"HPA046400: AB_2679652"	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.1	0.0	0.1	7.4	0.1	0.0	0.1	0.1	0.1	0.2	16.3	0.1	0.1	1.2	0.1	0.1	0.1	0.1	3.3	0.1	0.1	0.0	0.1	1.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	2.1	0.4	0.1	0.1	0.1	0.1	0.1	13.7	0.7	0.1	0.1	4.8	2.0	0.1	0.1	0.1	0.1	0.1	12.2	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075617	"Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 20.8;urinary bladder: 20.1;vagina: 12.1"	"Cell line enriched"	"Detected in some"	6	"HHSteC: 24.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"memory CD8 T-cell: 2.6"	"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favourable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.2	0.2	9.1	0.2	0.0	0.2	0.2	0.4	0.4	16.8	0.3	0.0	4.8	0.2	0.3	2.2	0.2	5.7	0.3	0.2	0.2	0.2	0.2	0.3	0.8	0.3	0.0	0.4	0.2	0.0	0.2	0.3	0.1	4.7	7.5	0.0	0.2	0.0	0.2	0.2	20.8	3.8	0.2	0.4	7.9	0.4	0.0	0.6	0.2	0.3	1.4	20.1	12.1	0.5	0.6	0.1	1.1	0.3	2.6	0.2	0.0	2.4	0.7	0.0	0.0	0.1	0.0	0.3	2.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.4	1.3	0.1	0.0	0.5	0.0	24.1	0.0	0.2	1.6	0.0	1.1	0.2	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.5	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	2.3	0.0	0.3	0.0	0.1	3.8	1.1	0.0	0.3	0.2	0.0	1.8	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.5	2.6	0.0	0.5	0.0	0.4	0.1	0.3	1.1	0.6	1.0	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.3	0.0	0.1	0.0
TRPC7		ENSG00000069018	"Transient receptor potential cation channel subfamily C member 7"	Q9HCX4	5	136213320-136365545	"Predicted membrane proteins, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"adrenal gland: 2.2;brain: 1.6;intestine: 1.3;kidney: 1.5;pituitary gland: 2.2;testis: 2.4"	"Cell line enhanced"	"Detected in some"		"EFO-21: 1.7;SCLC-21H: 1.0"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB022592, HPA031126"	Uncertain		Uncertain	"Actin filaments,Focal adhesion sites"				"Focal adhesion sites"	"Focal adhesion sites"	"CAB022592: , HPA031126: AB_10603221"			"unprognostic (1.49e-1)"		"unprognostic (2.08e-1)"					"unprognostic (3.03e-2)"	"unprognostic (2.89e-5)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-1)"	"unprognostic (9.99e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.78e-2)"		0.0	2.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0			1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	1.5	0.0	0.0	0.0	0.0		0.0	0.0	0.0	2.2	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.4			0.1		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"epididymis: 4.1;intestine: 6.3;pancreas: 4.5;seminal vesicle: 4.0"	"Cell line enhanced"	"Detected in some"		"MCF7: 3.2;RPMI-8226: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"					"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA043315	Uncertain									"HPA043315: AB_2678422"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7			6.1	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0		0.0	4.5	0.0	0.5	0.0		0.2	0.5		0.0	4.0	0.0	0.0	6.3	0.0	0.0	0.0	0.5	0.9			3.1		0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.6	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0										
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 16.1;intestine: 19.5"	"Cell line enhanced"	"Detected in some"		"BEWO: 7.5;HeLa: 4.4;Karpas-707: 2.5;RT4: 7.2;U-266/70: 2.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	6	"basophil: 16.1;neutrophil: 6.6"	"Lineage enriched"	"Detected in single"	30	"granulocytes: 16.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"														"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	2.9	0.0	1.3	0.5	1.2	2.5	1.1	1.3	1.2	0.8	13.3	0.2	1.0	7.2	0.4	0.2	0.6	0.4	1.0	0.5	1.9	1.2	3.1	0.2	1.5	0.2	2.6	0.0	0.4	0.2	3.8	4.9	0.2	1.6	1.7	17.5	0.4	1.1	0.0	1.6	0.8	19.5	0.7	5.0	3.9	0.2	1.7	0.5	1.6	0.3	1.1	2.1	0.5	0.6	0.3	0.3	16.1	0.1	0.5	0.1	0.0	0.0	1.6	0.2	0.2	0.0	0.0	7.5	0.1	0.0	0.0	0.1	2.1	0.2	0.6	0.0	0.1	0.3	0.5	0.5	0.0	0.1	0.2	0.2	4.4	0.3	0.1	0.1	0.2	0.3	0.2	0.0	0.0	0.2	0.0	2.5	0.1	0.9	0.0	0.1	0.6	0.2	0.0	0.0	0.3	0.0	7.2	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.2	1.1	0.2	0.0	2.7	0.0	0.2	0.1	0.1	0.3	16.1	0.1	1.9	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	6.6	0.5	0.1	0.3	0.0	0.0	1.3	1.2	1.3	1.2	1.9	1.2	2.6	0.0	1.6	0.5
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557995	"Disease related genes, FDA approved drug targets, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"intestine: 15.4;skeletal muscle: 29.1"	"Cell line enhanced"	"Detected in some"		"A-431: 3.5;BEWO: 5.3;CACO-2: 4.2;RH-30: 13.0;T-47d: 5.5;U-266/70: 3.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.4"	"Cell type enhanced"	"Detected in some"		"basophil: 2.9"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in many"	6	"cerebellum: 14.0"	HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"				"Plasma membrane"	"Plasma membrane"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.4	0.2	0.4	3.2	2.4	0.9	4.1	0.3	1.2	0.6	10.6	0.1	0.3	3.2	0.2	0.2	2.3	0.3	0.8	0.3	0.4	0.3	0.2	1.1	0.3	0.5	0.4	0.2	0.3	0.9	0.0	0.7	0.4	0.0	0.2	2.9	0.3	0.5	0.4	29.1	8.4	15.4	0.5	0.5	0.4	1.6	0.8	0.0	0.0	0.2	9.7	3.0	0.7	2.1	0.7	0.6	2.9	0.6	0.6	0.7	0.1	3.5	0.0	0.5	0.1	0.2	0.6	5.3	0.2	0.0	0.0	0.0	4.2	0.9	0.2	1.0	0.1	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.6	0.1	0.2	0.8	0.3	0.0	0.7	1.8	0.0	0.1	0.1	0.0	0.7	0.1	0.2	0.1	0.5	0.1	13.0	0.2	0.0	0.2	0.1	0.0	0.2	0.6	0.0	5.5	0.2	0.1	0.1	0.2	0.1	0.1	3.5	2.7	0.0	0.1	0.1	0.0	2.9	0.4	0.4	0.7	0.2	0.5	0.7	0.4	0.7	0.1	0.5	0.4	0.6	1.0	0.6	0.6	0.6	0.2	0.1	0.4	2.4	0.3	1.2	0.4	0.3	0.4	0.2	0.0	0.0
TSPAN1	"NET-1, TSPAN-1"	ENSG00000117472	"Tetraspanin 1"	O60635	1	46175073-46185958	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.0;testis: 119.0"	"Cell line enhanced"	"Detected in some"		"A-431: 21.2;CAPAN-2: 36.7;HaCaT: 25.6;hTCEpi: 29.8;RPTEC TERT1: 107.6;RT4: 51.6"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 455.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	90	"plasmacytoid DC: 8.9"	"Lineage enriched"	"Detected in single"	90	"dendritic cells: 8.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011909	Approved		Approved	Nucleoplasm,Vesicles				"Nucleoplasm, Vesicles"	"Nucleoplasm, Vesicles"	"HPA011909: AB_2668565"	"unprognostic (1.21e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.12e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.88e-3)"	"unprognostic (8.73e-2)"	"prognostic favourable (9.28e-6)"	"unprognostic (5.90e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.90e-2)"	"unprognostic (4.30e-2)"	1.7	0.6	1.7	4.8	2.4	0.0	1.5	11.4	3.5	9.0	59.9	1.8	1.5	2.2	1.8	4.6	1.9	13.9	2.6	2.6	2.2	0.0	46.0	1.9	5.7	2.1	2.4	1.7	1.5	1.5	15.4	3.3	1.5	2.1	22.7	70.0	3.3	16.1	7.8	1.5	0.1	18.3	1.9	1.8	1.6	24.6	119.0	1.9	1.6	13.9	1.8	1.9	21.0	1.5	0.0	8.9	0.0	0.0	0.0	0.0	0.0	21.2	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	36.7	0.0	6.9	0.0	25.6	0.0	18.8	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	29.8	0.1	10.6	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	1.3	0.0	0.0	0.2	107.6	51.6	0.3	0.0	0.0	2.2	0.1	1.5	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	1.7	2.4	11.4	3.5	2.2	0.0	2.4	1.7	2.1	1.9
TSPAN11		ENSG00000110900	"Tetraspanin 11"	A1L157	12	30926428-30996599	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"intestine: 25.6"	"Group enriched"	"Detected in some"	6	"AF22: 18.5;HSkMC: 18.3;NTERA-2: 14.7;SCLC-21H: 7.1;SH-SY5Y: 14.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							HPA066789			Approved	Vesicles				Vesicles	Vesicles	"HPA066789: AB_2685723"	"unprognostic (4.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.18e-2)"	"unprognostic (4.51e-1)"	"prognostic favourable (5.28e-4)"	"unprognostic (4.28e-2)"	"prognostic favourable (3.43e-4)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.03e-2)"	"unprognostic (5.77e-3)"	"unprognostic (2.04e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.79e-1)"	3.1	2.5	6.4	16.0	3.8	0.0	2.5	15.2	12.7	9.0	25.6	9.0	3.0	4.4	6.4	7.8	8.8	2.4	12.2	8.8	5.0	4.7	1.6	1.0	8.5	2.6	4.1	3.8	1.9	1.4	0.3	1.5	0.8	3.8	5.4	11.0	12.2	3.8	6.8	0.8	6.5	10.9	8.3	2.6	2.6	4.5	1.6	3.7	0.0	4.0	12.3	8.9	6.6	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	18.5	0.0	0.0	0.2	0.1	0.2	0.5	0.0	0.0	0.0	0.5	0.0	1.1	1.6	0.4	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	18.3	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	14.7	0.1	0.0	0.0	0.3	0.0	0.0	7.1	14.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	3.8	15.2	4.3	5.0	4.7	4.1	3.8	3.8	3.7
TTC38	FLJ20699	ENSG00000075234	"Tetratricopeptide repeat domain 38"	Q5R3I4	22	46267961-46294008	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 59.8;liver: 92.8"	"Cell line enhanced"	"Detected in many"		"Hep G2: 34.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"gdTCR: 36.0"	"Group enriched"	"Detected in many"	5	"granulocytes: 10.1;NK-cells: 13.5;T-cells: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029302	Approved		Approved	Cytosol		19000	19000	Cytosol	Cytosol	"HPA029302: AB_10601704"	"unprognostic (7.78e-2)"	"unprognostic (5.85e-2)"	"unprognostic (4.92e-3)"	"prognostic favourable (3.21e-6)"	"unprognostic (8.34e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.72e-2)"	"unprognostic (3.62e-2)"	"unprognostic (9.45e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.66e-2)"	"unprognostic (7.34e-3)"	"unprognostic (9.02e-2)"	"unprognostic (4.12e-1)"	"unprognostic (4.97e-1)"	"unprognostic (8.33e-2)"	10.5	8.1	3.8	8.8	5.0	16.1	14.0	3.9	4.4	5.5	31.6	5.5	6.2	31.2	6.6	5.0	6.7	5.9	15.0	10.9	3.8	3.3	47.2	92.8	5.3	5.0	6.0	2.2	10.0	19.8	3.0	5.9	3.1	5.3	8.7	12.9	7.5	10.4	6.9	8.6	3.9	59.8	5.2	3.9	8.4	9.1	2.5	5.5	1.0	8.2	4.7	4.2	5.3	5.8	0.9	4.0	10.1	4.3	13.5	36.0	13.4	5.6	6.2	7.9	16.5	7.5	6.5	8.0	8.3	5.4	9.0	7.1	10.1	4.1	0.0	5.3	8.4	5.1	7.9	6.6	3.3	12.6	17.8	7.4	14.0	34.9	10.4	4.1	29.1	11.1	3.5	4.1	4.7	7.5	5.4	9.3	5.7	5.5	0.1	12.9	6.0	6.2	0.0	3.8	3.7	6.1	6.5	1.4	11.2	11.4	7.8	6.1	12.5	8.3	8.8	6.5	7.1	4.9	5.2	7.3	4.3	0.8	4.3	6.4	6.6	10.1	4.3	8.0	36.0	4.1	3.9	0.9	3.5	16.0	4.0	0.7	1.5	15.4	2.9	13.5	3.0	1.6	1.6	13.4	3.8	5.0	3.9	4.4	3.8	3.3	6.0	2.2	5.3	5.5
TTLL6	FLJ35808	ENSG00000170703	"Tubulin tyrosine ligase like 6"	Q8N841	17	48762235-48817214	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"fallopian tube: 4.8;intestine: 5.0;testis: 17.6"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 9.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA052397	Enhanced		Approved	Vesicles,Microtubules				Microtubules	Microtubules	"HPA052397: AB_2681812"	"unprognostic (5.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.04e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.21e-5)"	"unprognostic (1.10e-2)"	"unprognostic (6.01e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.28e-1)"	"unprognostic (6.68e-2)"	"unprognostic (2.09e-3)"	0.1	0.0	0.5	3.3	0.5	0.0	0.1	0.1	1.1	0.2	3.6	0.1	1.3	1.6	0.8	0.1	0.1	4.8	1.4	0.1	0.8	0.4	1.8	0.1	1.1	0.1	0.2	1.1	0.8	0.6	0.0	0.3	0.1	0.9	0.1	5.0	0.3	0.1	0.1	0.1	0.0	2.0	0.1	0.1	0.1	0.1	17.6	0.1	0.1	0.1	0.8	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.3	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.1	1.1	0.8	0.4	0.2	1.1	0.9	0.1
UGT1A5	UGT1E	ENSG00000240224	"UDP glucuronosyltransferase family 1 member A5"	P35504	2	233712992-233773299	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"gallbladder: 3.7;intestine: 13.9"	"Cell line enhanced"	"Detected in some"		"RPMI-8226: 1.7;RT4: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																												"unprognostic (2.18e-3)"							"unprognostic (1.36e-1)"				0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	11.2	0.0	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	9.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UGT1A8	UGT1H	ENSG00000242366	"UDP glucuronosyltransferase family 1 member A8"	Q9HAW9	2	233617645-233773310	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 13.0;urinary bladder: 15.7"	"Cell line enriched"	"Detected in single"	58	"RT4: 51.2"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.4"					"Not detected"	"Not detected"			"Not detected"	"Not detected"																								"unprognostic (1.27e-2)"			"unprognostic (1.35e-1)"	"unprognostic (1.42e-3)"				"unprognostic (1.23e-1)"	"unprognostic (4.78e-1)"	"unprognostic (9.71e-12)"	"unprognostic (9.26e-2)"			"unprognostic (1.96e-1)"	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	13.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0		4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	7.3	0.0	0.0	0.0	0.0	0.0	3.3	5.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0										
UGT2B17		ENSG00000197888	"UDP glucuronosyltransferase family 2 member B17"	O75795	4	68537184-68568527	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 68.1;liver: 21.6"	"Group enriched"	"Detected in some"	7	"BEWO: 3.1;NB-4: 3.5;RPMI-8226: 5.1;SH-SY5Y: 2.3;U-2197: 2.1"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 16.3;liver cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	38	"memory B-cell: 3.3;naive B-cell: 11.9"	"Lineage enriched"	"Detected in single"	59	"B-cells: 11.9"									HPA045108	Supported									"HPA045108: AB_2679218"	"unprognostic (1.66e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (8.44e-3)"		"unprognostic (9.67e-2)"	"unprognostic (4.80e-3)"	"unprognostic (8.52e-2)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.75e-1)"		"unprognostic (1.76e-1)"	0.4	0.1	0.4	4.7	0.4	0.0	0.4	0.4	0.4	0.4	55.6	0.4	0.4	54.1	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.1	0.4	21.6	0.4	0.4	0.4	0.4	0.4	0.4	0.0	0.4	0.4	0.4	0.4	20.7	0.4	0.4	0.4	0.4	0.1	68.1	1.1	0.4	0.4	0.1	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.4	11.9	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	5.1	0.2	0.0	0.3	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.3	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026911-41039217	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 52.2;kidney: 60.9;liver: 29.9"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.2;Hep G2: 4.4;RPTEC TERT1: 15.8;U-266/70: 5.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"T-reg: 2.4"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015725	Enhanced		Approved	Centrosome				Centrosome	Centrosome	"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	0.4	0.2	0.4	0.6	0.4	0.3	0.5	0.4	0.4	0.4	9.9	0.5	0.4	23.7	0.8	0.8	0.5	0.7	10.2	0.4	0.4	0.1	60.9	29.9	0.9	0.4	0.4	0.4	0.5	17.7	0.1	0.6	0.8	0.4	0.5	0.7	0.4	0.5	0.4	0.4	0.6	52.2	0.4	0.4	1.2	15.9	0.6	0.4	0.4	0.7	0.4	0.4	0.4	0.4	0.3	1.0	0.7	0.3	0.0	2.4	0.2	0.6	0.3	0.8	1.1	0.2	0.1	0.7	0.0	0.1	0.0	0.0	8.2	0.1	0.1	3.1	0.0	0.2	0.2	0.3	0.1	1.2	1.6	0.8	0.0	4.4	0.1	0.4	0.3	0.2	0.7	0.0	0.5	0.0	0.6	0.5	0.0	0.2	1.0	2.6	0.3	0.2	1.0	0.1	0.6	15.8	0.0	0.7	0.7	0.0	0.1	1.5	0.2	0.2	0.2	0.0	0.5	0.4	0.1	5.2	2.6	0.7	0.0	1.8	0.0	0.0	0.0	0.7	1.3	0.0	0.1	0.2	0.7	0.2	0.1	0.3	0.4	0.0	0.0	0.0	0.3	1.0	2.4	0.2	0.4	0.4	0.4	0.4	0.4	0.1	0.4	0.4	0.4	0.4
UNC5D	"KIAA1777, Unc5h4"	ENSG00000156687	"Unc-5 netrin receptor D"	Q6UXZ4	8	35235457-35796550	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.4;intestine: 11.7;pituitary gland: 14.2;prostate: 10.6"	"Group enriched"	"Detected in some"	4	"HEK 293: 4.1;HeLa: 3.9;NTERA-2: 13.5;SH-SY5Y: 4.8;U-251 MG: 4.1"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA042940	Uncertain									"HPA042940: AB_10959525"	"unprognostic (7.88e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.87e-1)"		"unprognostic (8.47e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.48e-8)"	"unprognostic (1.34e-1)"	"unprognostic (9.15e-2)"	"unprognostic (4.28e-1)"		0.3	3.9	8.4	0.4	13.5	0.3	0.4	2.8	15.4	5.0	0.9	0.5	0.1	11.7	3.8	0.5	0.4	0.6	0.3	0.3	3.6	9.4	5.0	0.3	0.5	0.3	1.3	8.1	0.3	0.6	0.4	14.2	0.3	4.7	10.6	1.5	3.3	0.4	0.8	0.3	0.4	3.9	2.4	0.8	0.4	0.6	1.6	0.8	0.0	2.1	0.0	0.3	0.3	0.4	0.0	0.0	0.8	0.2	0.3	0.1	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	13.5	1.4	0.1	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.3	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	8.4	13.5	2.8	15.4	3.6	9.4	1.3	8.1	4.7	0.8
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316019	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.8;liver: 17.4;skin 1: 18.8"	"Group enriched"	"Detected in some"	9	"CACO-2: 11.7;Hep G2: 4.8;SCLC-21H: 5.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in some"			HPA035729	Uncertain									"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.1	0.0	0.1	0.1	0.1	0.0	0.6	0.1	0.1	0.5	1.4	0.1	0.1	9.2	0.1	0.5	5.9	1.0	1.6	0.1	0.1	0.0	2.5	17.4	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.5	0.1	0.1	18.8	9.8	0.1	0.1	0.1	0.1	0.1	0.1	1.6	0.1	3.9	2.1	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1
USH1C	"AIE-75, DFNB18, harmonin, NY-CO-37, NY-CO-38, PDZ-73, PDZ73, PDZD7C"	ENSG00000006611	"USH1 protein network component harmonin"	Q9Y6N9	11	17493895-17544416	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"gallbladder: 26.0;intestine: 57.0;kidney: 22.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 35.2;HeLa: 12.5"	"Group enriched"	"Detected in many"	7	"colorectal cancer: 34.5;pancreatic cancer: 18.8;renal cancer: 29.4;stomach cancer: 15.3"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"olfactory region: 2.2"	"CAB013690, HPA027398, HPA027492, HPA028033"	Enhanced		Enhanced	Cytosol				Cytosol	Cytosol	"CAB013690: , HPA027398: AB_10601775, HPA027492: AB_10601898, HPA028033: AB_10601782"	"unprognostic (3.60e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.10e-1)"	"prognostic unfavourable (2.20e-4)"	"unprognostic (2.22e-1)"		"unprognostic (2.78e-1)"	"unprognostic (1.51e-2)"	"unprognostic (9.65e-2)"	"prognostic favourable (9.41e-4)"	"unprognostic (1.29e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.61e-1)"	0.1	0.1	1.6	4.3	7.1	0.0	0.0	0.8	3.3	0.1	23.8	6.2	0.0	40.5	0.0	6.3	0.0	1.3	26.0	0.3	5.0	2.3	22.1	0.4	0.0	0.0	4.8	1.9	0.3	2.1	0.0	5.2	0.0	3.5	0.1	20.7	1.8	0.0	0.1	0.0	0.0	57.0	0.9	10.2	0.0	11.5	0.2	3.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	35.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.6	7.1	0.8	2.3	5.0	2.3	4.8	1.9	3.5	3.6
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 57.1;parathyroid gland: 45.8"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 22.7;HDLM-2: 32.0;U-937: 31.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"classical monocyte: 3.7;eosinophil: 2.1;intermediate monocyte: 7.0;myeloid DC: 5.7;neutrophil: 7.5;non-classical monocyte: 6.9"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.7;granulocytes: 7.5;monocytes: 7.0"	"Region enhanced"	"Detected in single"		"olfactory region: 2.5"	"Low region specificity"	"Detected in some"			"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"				Nucleoplasm	Nucleoplasm	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favourable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.0	9.2	0.2	10.0	0.3	2.5	7.8	0.3	0.6	3.5	40.9	0.4	4.1	21.2	1.2	7.7	10.2	1.1	10.7	1.5	0.5	0.3	13.0	0.6	8.3	3.8	0.5	0.1	1.3	6.5	45.8	11.7	4.4	0.6	2.1	12.6	0.4	4.9	2.8	5.3	15.2	57.1	1.2	1.5	3.1	2.6	1.5	0.2	2.0	1.9	9.4	8.2	4.0	5.2	0.7	5.7	7.5	7.0	0.2	0.8	1.2	5.4	0.9	0.0	0.0	4.7	6.9	0.1	6.7	3.4	5.7	5.0	4.0	4.6	1.4	7.3	4.6	10.2	0.2	22.7	2.7	32.0	1.6	2.4	1.3	0.3	3.5	4.8	7.7	9.3	10.6	6.3	10.4	0.4	0.7	1.5	2.6	3.7	0.1	2.3	0.0	7.4	0.1	0.0	3.5	5.2	5.5	2.6	0.1	5.7	16.5	2.0	18.6	2.7	0.4	11.0	2.9	3.2	3.8	0.9	0.0	1.2	3.4	31.4	2.7	0.2	3.7	2.1	0.0	7.0	0.1	0.7	0.3	0.0	5.7	0.1	0.1	0.0	7.5	0.2	6.9	0.6	0.8	1.2	0.2	0.3	0.3	0.6	0.5	0.3	0.5	0.1	0.6	0.2
VILL		ENSG00000136059	"Villin like"	O15195	3	37988059-38007188	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 46.3;stomach 1: 52.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 20.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 22.4"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA035675	Enhanced									"HPA035675: AB_10671223"	"unprognostic (7.86e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavourable (1.35e-4)"	"prognostic favourable (1.75e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.66e-3)"	"unprognostic (5.55e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (7.43e-3)"	2.7	2.1	7.1	12.3	7.2	6.3	3.4	4.7	5.3	5.3	28.0	1.7	3.9	33.2	6.2	3.2	3.8	4.1	21.8	3.3	5.3	4.1	2.8	0.6	7.0	7.3	2.9	4.6	3.9	2.2	0.6	3.4	3.6	2.9	8.5	14.8	4.5	3.8	4.8	1.0	5.1	46.3	3.8	3.4	6.3	52.5	3.5	3.5	12.1	4.5	3.1	9.6	15.0	3.8	5.4	4.6	0.1	3.9	4.0	9.2	4.8	6.4	0.0	0.2	0.3	2.3	1.9	0.7	1.8	1.5	1.9	1.8	4.8	20.1	3.1	2.9	1.2	1.5	1.4	0.2	0.4	0.6	0.0	5.7	0.0	0.4	2.9	5.9	7.8	2.8	1.9	1.8	0.0	3.7	5.6	1.8	2.1	0.0	9.5	6.8	0.1	0.0	3.7	0.0	1.5	0.6	7.8	0.1	0.2	0.0	0.4	1.3	0.5	9.8	2.2	0.8	0.3	2.5	0.0	1.2	2.3	0.9	0.5	8.6	4.0	0.0	3.9	0.0	8.7	2.4	9.2	4.4	5.8	4.9	2.6	5.4	7.4	5.4	0.1	4.0	1.6	4.6	6.8	4.8	7.1	7.2	4.7	5.3	5.3	4.1	2.9	4.6	2.9	3.5
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750798-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.5;lymphoid tissue: 64.7"	"Group enriched"	"Detected in some"	4	"HeLa: 2.1;SH-SY5Y: 6.8;TIME: 4.8;U-2 OS: 2.0"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"			"Endoplasmic reticulum"	"Endoplasmic reticulum"	"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	1.2	5.7	9.7	64.7	8.3	0.3	0.9	1.5	20.1	0.6	31.5	0.5	0.3	7.5	0.7	0.4	13.1	0.5	4.2	1.1	12.4	7.7	0.9	0.6	1.7	0.4	2.7	8.3	0.4	3.8	0.5	0.4	0.5	1.6	6.3	28.3	3.2	0.4	6.9	0.8	0.4	32.5	18.0	0.4	5.2	13.2	0.5	0.1	0.0	1.3	0.5	0.4	9.1	4.3	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.4	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.1	6.8	0.0	0.0	0.0	0.0	0.0	4.8	0.0	2.0	0.2	0.1	0.5	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	9.7	8.3	1.5	20.1	12.4	7.7	2.7	8.3	1.6	0.1
VSIG10		ENSG00000176834	"V-set and immunoglobulin domain containing 10"	Q8N0Z9	12	118063593-118136026	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 60.9"	"Cell line enhanced"	"Detected in many"		"HAP1: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA062022	Enhanced		Approved	"Centriolar satellite,Cytosol"				Cytosol	Cytosol	"HPA062022: AB_2732675"	"unprognostic (1.32e-1)"	"unprognostic (7.76e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.42e-2)"	"prognostic unfavourable (1.76e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavourable (7.53e-4)"	"unprognostic (2.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.48e-2)"	8.1	10.2	2.6	9.8	3.1	0.4	18.0	2.9	2.6	8.2	31.6	2.7	5.2	11.7	4.5	4.5	8.9	4.0	7.6	3.6	2.4	2.2	6.2	11.9	11.6	3.8	3.2	1.4	5.9	10.9	8.9	4.0	12.2	3.4	8.4	13.9	4.0	6.3	6.4	12.9	4.6	60.9	3.8	2.5	3.3	5.5	3.9	2.5	1.7	26.3	6.1	4.9	6.1	8.6	0.7	2.4	3.5	2.0	0.4	0.6	0.4	4.9	7.3	3.2	10.6	13.2	6.0	8.0	8.6	5.6	4.3	3.5	2.1	11.9	0.7	3.4	6.3	12.2	22.1	2.2	5.1	2.4	3.3	1.1	6.9	3.2	2.6	0.7	1.8	2.7	6.5	3.3	2.1	9.3	1.4	0.1	4.0	5.3	0.0	0.7	9.8	4.7	1.8	8.7	0.0	6.2	16.2	2.7	3.4	8.4	3.5	2.2	7.8	3.4	10.8	4.9	3.1	6.1	4.3	0.1	0.1	0.0	7.1	3.5	9.8	0.6	2.0	2.3	0.4	0.6	0.6	0.0	0.4	0.2	2.4	0.7	0.4	0.6	3.5	0.4	0.2	0.7	0.6	0.4	2.6	3.1	2.9	2.2	2.4	2.2	3.2	1.4	3.4	2.5
XDH	"XO, XOR"	ENSG00000158125	"Xanthine dehydrogenase"	P47989	2	31334321-31414715	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.6;liver: 32.5"	"Cell line enhanced"	"Detected in some"		"BJ: 6.1;HBEC3-KT: 15.0;hTERT-HME1: 23.9;U-251 MG: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low cell type specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062641, HPA069323"	Supported		Uncertain	Nucleoplasm,Nucleoli	"Intracellular and membrane"			Nucleoplasm	Nucleoplasm	"HPA062641: AB_2684816, HPA069323: AB_2686121"	"unprognostic (8.58e-2)"	"unprognostic (4.07e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.06e-2)"	"unprognostic (4.38e-3)"	"unprognostic (7.48e-3)"	"unprognostic (3.55e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.51e-2)"	"unprognostic (1.24e-6)"	"unprognostic (2.25e-1)"	"unprognostic (5.25e-2)"	"unprognostic (2.54e-1)"	"prognostic favourable (8.73e-6)"	0.2	0.2	0.2	2.4	0.2	0.0	17.8	0.2	0.2	2.6	17.9	0.1	0.0	20.1	0.3	6.3	9.3	0.2	1.8	0.2	0.1	0.2	0.4	32.5	0.2	0.0	0.2	0.0	0.2	0.4	0.0	1.5	3.7	0.1	1.2	4.2	0.1	20.9	0.0	0.7	1.0	78.6	0.1	0.2	0.2	1.3	0.2	0.0	0.2	0.3	2.4	6.1	1.8	1.1	0.7	0.3	1.0	0.6	0.7	0.5	0.0	1.5	0.3	0.0	0.0	0.0	0.1	0.1	6.1	3.5	0.7	1.1	0.2	1.7	0.0	1.2	0.2	3.2	0.0	15.0	0.8	0.7	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.3	0.9	23.9	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.3	0.1	0.0	1.1	3.3	4.4	3.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	1.9	0.1	6.5	1.9	0.1	0.0	0.2	0.0	0.0	0.5	0.6	0.2	0.2	0.2	0.4	0.1	0.3	0.3	0.0	0.7	0.2	0.5	1.0	0.7	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.1	0.0
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685756-37732130	"Blood group antigen proteins, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.6"	"Cell line enhanced"	"Detected in many"		"HEL: 24.7;HL-60: 12.7;K-562: 15.9;NB-4: 11.7;RPMI-8226: 11.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"basophil: 9.4;eosinophil: 6.8"	"Lineage enriched"	"Detected in single"	94	"granulocytes: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria				Mitochondria	Mitochondria	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.6	2.9	4.9	3.0	5.1	14.0	1.1	10.2	8.3	1.8	16.5	1.2	0.0	12.9	1.2	0.8	2.7	4.8	2.0	8.1	4.7	6.6	1.4	2.1	1.5	0.7	3.0	5.9	1.2	7.9	2.2	3.8	1.4	4.4	2.1	13.8	1.0	8.6	1.5	5.9	1.2	23.6	3.2	1.6	1.2	13.3	3.5	0.2	0.1	1.4	5.9	0.8	2.9	2.5	0.0	0.0	9.4	0.0	0.0	0.0	0.7	9.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	8.2	0.1	0.0	1.5	8.8	0.0	0.0	0.0	2.4	24.7	1.4	0.0	0.0	12.7	2.0	0.0	0.4	0.0	0.0	0.0	15.9	6.3	0.0	0.9	0.1	11.7	3.1	3.2	0.0	0.0	11.2	0.0	0.6	2.3	0.0	0.4	0.8	0.0	1.2	3.1	0.0	0.0	0.4	0.0	1.3	5.4	8.9	0.0	0.1	6.8	0.0	9.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.7	4.9	5.1	10.2	8.3	4.7	6.6	3.0	5.9	4.4	0.2
ZACN	"L2, LGICZ, LGICZ1, ZAC, ZAC1"	ENSG00000186919	"Zinc activated ion channel"	Q401N2	17	76071961-76083666	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in single"		"intestine: 2.1"	"Cell line enhanced"	"Detected in single"		"SiHa: 2.1"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"														"unprognostic (8.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.10e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.16e-5)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-7)"	"unprognostic (6.27e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.4	0.1	2.1			1.2	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0		0.0	0.1	0.0	0.1	0.1		0.4	0.0		0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.3	0.3	0.1			0.1		0.0	0.0	0.0	0.2	0.4	0.1	0.7	0.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.4	0.6	0.3	0.2	0.2	0.0	0.4	0.2	0.3	0.5	0.1	0.2	0.3	0.1	0.4	0.1										
ZBTB7B	"c-Krox, hcKrox, ZBTB15, ZFP67, ZNF857B"	ENSG00000160685	"Zinc finger and BTB domain containing 7B"	O15156	1	155002630-155018522	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 54.0"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006811, HPA025820"	Enhanced		Enhanced	Nucleoplasm				Nucleoplasm	Nucleoplasm	"HPA006811: AB_1859046, HPA025820: AB_1859045"	"unprognostic (5.13e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.36e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.53e-2)"	9.4	11.1	3.0	8.8	4.7	11.6	11.1	4.0	4.9	9.5	33.7	11.3	22.3	27.3	5.4	4.5	29.1	5.9	13.2	6.4	4.3	2.1	9.3	19.1	10.5	6.3	8.0	4.3	6.2	18.2	5.1	6.4	11.3	5.9	9.9	8.1	9.6	19.1	18.6	11.8	33.3	54.0	5.4	5.6	10.3	11.2	3.8	7.3	1.8	14.3	11.2	16.0	8.6	12.4	2.0	2.3	5.7	3.4	1.5	2.5	4.3	7.4	13.3	1.2	4.1	6.1	3.5	16.4	5.1	6.1	5.4	6.3	8.9	10.8	3.2	9.2	5.8	11.4	3.7	7.2	1.1	17.7	4.2	5.4	22.3	5.9	9.0	4.1	15.0	4.5	25.9	7.4	9.2	4.2	7.7	15.1	3.1	14.1	0.1	9.3	4.0	11.1	3.0	0.9	20.4	8.1	7.8	7.6	7.8	9.8	26.5	4.1	16.4	14.0	3.5	3.5	6.2	6.9	4.3	18.0	11.0	3.4	8.2	13.8	4.0	0.9	3.2	2.9	1.5	3.4	0.5	1.6	2.0	0.9	2.3	2.0	1.7	0.5	5.7	1.5	2.9	0.2	2.5	4.3	3.0	4.7	4.0	4.9	4.3	2.1	8.0	4.3	5.9	7.3
ZNF511-PRAP1		ENSG00000283496	"ZNF511-PRAP1 readthrough"		10	133309410-133352529	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"				"Tissue enhanced"	"Detected in many"		"intestine: 31.6;liver: 23.8"	"Cell line enhanced"	"Detected in many"		"BEWO: 6.9;CACO-2: 7.0;Hep G2: 16.6"									"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA035360, HPA038713, HPA052451"	Supported									"HPA035360: AB_10601931, HPA038713: AB_10673117, HPA052451: AB_2681839"																		2.1	1.6	1.1	5.0	1.7	1.2	6.2	3.0	2.7	3.1	11.9	1.9	4.9	31.6	3.9	3.5	3.5	1.3	3.0	4.8	1.8		13.7	23.8	2.1	4.7	2.2	1.9	4.9	9.7	0.9	2.1	1.5	1.7	5.1	7.6	2.9	5.0	3.0	5.8	1.3	28.1	4.4	0.8	3.0	3.4	6.5	2.7	3.2	4.6	7.1	3.0	2.0	4.8	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	3.3	5.2	0.0	0.0	6.9	0.0	1.4	0.0	0.0	7.0	2.2	0.0	3.3	1.7	0.1	0.8	0.0	2.1	0.3	0.0	0.9	0.0	16.6	0.0	1.3	1.8	0.0	0.0	1.5	5.0	0.0	0.3	6.3	0.0	0.0	3.4	5.3	0.3	0.0	0.9	1.2	3.0	0.2	0.3	0.5	5.6	0.3	2.8	2.4	0.0	0.5	0.0	0.0	3.1	2.6	0.1	1.5	0.0	0.8	0.4	1.1	0.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0										
